Text

Submittal of Annual Radioactive Effluent Release Report for 2016
	ML17146B131
Person / Time
Site:	Susquehanna
Issue date:	05/24/2017
From:	Berryman B; Susquehanna, Talen Energy
To:	; Document Control Desk, Office of Nuclear Reactor Regulation
References
	PLA-7607
	Download: ML17146B131 (562)
	v • d • e

TALEN~

Brad Berryman Susquehanna Nuclear, LLC Site Vice President 769 Salem Boulevard Berwick, PA 18603 Tel. 570.542.2904 Fax 570.542.1504 ENERGY Brad.Berryman@talenenergy.com MAYL2 4 2017 U. S. Nuclear Regulatory Commission 10 CFR 50.36a Attn: Document Control Desk Washington, DC 20555-0001 SUSQUEHANNA STEAM ELECTRIC STATION RADIOACTIVE EFFLUENT RELEASE REPORT AND OFFSITE DOSE CALCULATION MANUAL -

RESUBMITTAL Docket No. 50-387 PLA-7607 and 50-388 Reference 1: Susquehanna Steam Electric Station, "Radioactive Effluent Release Report and Offsite Dose Calculation Manual," dated April 25, 2017.

The purpose of this letter is to resubmit the annual Radioactive Effluent Release Report for SSES Units 1 and 2 for the period covering January 1 through December 31, 2016 and the SSES Offsite Dose Calculation Manual as revised through December 31, 2016.

This report supersedes the report previously submitted on April 25, 2017 (Reference 1).

This submittal is in accordance with 10 CFR 50.36a, the Susquehanna Steam Electric Station (SSES) Units 1 and 2 Technical Specification (TS) 5.6.3, and Units 1 and 2 TS 5.5.1.C.3.

Should you have any questions regarding this submittal, please contact Mr. Jason Jennings, Manager- Nuclear Regulatory Affairs at (570) 542-3155.

This letter contains no new regulatory commitments.

B. Berryman : Radioactive Effluent Release Report for SSES Units 1 and 2 : SSES Offsite Dose Calculation Manual Copy: Mr. D. J. Allard, PA DEP/BRP

- 2 _. Document Control Desk PLA-7607 Regional Administrator, NRC Region 1 Mr. J. Furia, NRC Region I, Health Physicist Ms. T. E. Hood, NRC Project Manager Ms. T. Lewis, PA DEP/BRP Mr. R. Maiers, PA DEP/ BRP Ms. L. Micewski, NRC Sr. Resident Inspector Mr. W. Nestel, INPO Mr. D. Russo, ANI Mr. M. Shields, PA DEP/BRP

Attachment 1 to PLA-7607 Radioactive Effluent Release Report for SSES Units 1and2

RADIOACTIVE EFFLUENT RELEASE REPORT REPORT PERIOD: 01/01/16 -12/31/16 Prepared by:

~Hickey ~

~ti Health Physicist Reviewed by:

Approved by:

Jee. &Jsewood

Manager - Plant Chemistry I Environmental Susquehanna Nuclear, LLC 769 Salem Blvd.

Berwick, Pennsylvania 18603

TABLE OF CONTENTS SECTION PAGE

1. Introduction, Summary and Supplemental Information 1-1 '

2. Effluent and Waste Disposal Data 2-1

3. Meteorological Data and Dispersion Estimates 3-1

4. Dose Measurements and Assessments 4-1

5. Changes to the Offsite Dose Calculation Manual (ODCM), 5-1 Technical Requirements Manual (TRM) and the Solid Radioactive Waste Process Control Program

6. Miscellaneous Technical Requirements Manual (TRM), FSAR, 6-1 40CFR190 and NEI Groundwater Protection Initiative Reporting

7. Corrections to Previous Radioactive Effluent Release Reports 7-1

8. Effluent from Systems Classified as Insignificant Effluent Pathways . 8-1 Appendix A ODCM/TRM

i l

i

~

~~

LIST OF TABLES ~

if*

PAGE i*

r!

Table 1-1 ~

Technical Requirement Limits 1-10 I

~

Table 2-1 Airborne Effluent - Summation of All Releases 2-4 l

Table 2-2 Airborne Effluent - Radionuclides Released 2-5 Table 2-3 Waterborne Effluent- Summation ofAll Releases 2-8 Table 2-4 Waterborne Effluent - Radionuclides Released 2-9 Table 2-5 Estimated Total Errors Associated with 2-12 Table 2-6 Table 2-7 Effluents Measurements Waste Disposition Asbestos - Class A HIC (Non-Processed) 2-15 2-16 I~

~

I Table 2-8 Non-Processed DAW (FWH) - Burial 2-17 i I

[

Table 2-9 Condensate Demineralizer/Radwaste Demineralizer 2-18 Class A HIC (Pyrolysis) r*

Table 2-10 Processed DAW - Class A Strong Tight Container (Compacted) 2-19 I ~

g

~

Table 2-11 Liquid Radwaste Filter Media- Class A HIC (Pyrolysis) 2-20 i

Ia

!r~

Table 2-12 CFS Filters - Class A HIC (Compacted) 2-21 H Table 2-13 RWCU Filter Media- Class A HIC (Pyrolysis) 2-22 ~

LIST OF TABLES (cont.) PAGE Table 3-1 Meteorological Data Recovery for 2016 3-3 Table 3-2 Joint Frequency Distribution of Wind Speed and Wind 3-4 Direction 1Om versus Delta Temperature 60-1 Om for the Period of January 1, 2016 through December 31, 2016 Table 3-3 Joint Frequency Distribution of Wind Speed and Wind 3-12 Direction 60m versus Delta Temperature 60-1 Om for the Period of January 1, 2016 through December 31, 2016 Table 3-4 2016 SSES Annual Relative Concentrations No Decay, 3-20 Undepleted X/Q (sec/m 3)

Table 3-5 2016 SSES Annual Relative Concentrations 2.26-Day 3-21 Decay, Undepleted X/Q {sec/m 3 )

Table 3-6 2016 SSES Annual Relative Concentrations 8-Day 3-22 3

Decay, Depleted X/Q (sec/m )

Table 3-7 2016 SSES Annual Relative Deposition (D/Q meters"2) 3-23 Table 3-8 2016 Atmospheric Dispersion Estimates for RETDAS 3-24 Input at Selected Locations Table 3-9 2016 Atmospheric Dispersion Estimates at the Nearest 3-25 Residence within a 5-Mile Radius by Sector Table 3-10 2016 Atmospheric Dispersion Estimates at the Nearest 3-26 Garden within a 5-mile Radius by Sector.

Table 3-11 2016 Atmospheric Dispersion Estimates at the Nearest 3-27 Animal raised for Meat Consumption within a 5-Mile Radius By Sector Table 3-12 2016 Atmospheric Dispersion Estimates at All Dairy 3-27 Locations Table 4-1 Site-Specific Parameters Used for RETDAS Calculations 4-2 (Danville Receiver) for 2016 Table 4-2 Summary of Maximum Individual Doses to Members 4-5 of the Public Data Period: 1/1/16 to 12/31/16

LIST OF TABLES (cont.) PAGE Table 4-3 Calculated Collective Doses to Members of the 4-6 Public Within the Riverlands/Energy Information Center Complex Data Period: 1/1/16 to 12/31/16 Table 4-4 Summary of Maximum Individual Doses from Airborne Effluent 4-6 Table 6-1 NEI Ground Water Protection Initiative Reporting 6-4 Table 8-1 Annual Release from Systems Classified as 8-3 Insignificant Effluent Pathways

LIST OF FIGURES

~*

l' PAGE j Figure 1-1 Airborne Effluent Release Points 1-6 ~

!~

Figure 1-2 Waterborne Effluent Pathway 1-7 I~

~

[

Figure 2-1 Susquehanna River Monthly Average Flow Rates 2-10 Data Period: 2016 '

Figure 2-2 Monthly Liquid Radwaste Discharge Totals 2-11 Figure 3-1 2016 Annual Wind Rose 1OM Level - 3-26 Primary Tower It

~

r'll Figure 3-2 2016 Annual Wind Rose 60M Level - 3-27 Primary Tower !

I!

Figure 3-3 Pasquil Stability Class Prevalences 3-28 i

u

~

Data Period: 2016 ~

Figure 4-1 Figure 6-1 Airborne-Dose Calculation Locations SSES Tritium Effluent Releases 4-7 6-5 I i II

~

f.

I n

~

I I

SECT/ON1 INTRODUCTION,

SUMMARY

AND SUPPLEMENTAL INFORMATION I II i

I; I Ir. I I!

I i

~

I' I

I I

I f

~

f I

INTRODUCTION The submittal of the 2016 Radioactive Effluent Release Report is in accordance with Susquehanna Nuclear, LLC Tech Spec. 5.6.3. The enclosed information is consistent with the objectives outlined in the Offsite Dose Calculation Manual (ODCM) and Process Control Program (PCP). The 2016 Radioactive Effluent Release Report is in conformance with 10CFR50.36a and 10CFR50, Appendix I, Section IV.B.1.

Susquehanna Nuclear, LLC is located in Salem Township, Luzerne County; Pennsylvania. It is on the west bank of the Susquehanna River, 8 km northeast of Berwick. The station consists of two boiling water reactor generating units. Each unit has completed an Extended Power Uprate process which has increased licensed thermal power from 3293 MWt (megawatt thermal) to 3952 MWt. Unit-1 completed the power uprate in 2010 and Unit 2 completed the power uprate in 2011. The reactor and generating units were supplied by General Electric, while the Bechtel Corporation served as architect-engineer and constructor.

Construction of the Station began in the early 1970s. Fuel load began in Unit 1 in July of 1982. Initial criticality was achieved in the Unit 1 reactor on September 10, 1982.

The reactor reached 100% power for the first time on February 4, 1983. Commercial

operation of Unit 1 was declared on June 8, 1983. Initial criticality of Unit 2 occurred on May 8, 1984. Unit 2 was declared commercial on February 12, 1985.

Airborne effluents are released from the Station via five rooftop vents on the reactor building (see Figure 1~1 ). Continuous sampling for particulates and iodines is performed at each vent as well as continuous monitoring for noble gases. A program of periodic sampling and analysis for tritium and noble gases along with periodic analysis of particulate and iodine samples is conducted as specified in the plant Technical Requirements. All waterborne effluents are released in batch mode and are sampled and analyzed prior fo release. Waterborne effluents from the site are released into the cooling tower blowd.own line for dilution prior to release to the Susquehanna River (see Figure 1-2). Slowdown line flow rates are at least 5,000 gpm during periods of liquid radwaste release. The diluted effluent is introduced to the river by way of a perforated diffuser pipe placed on the river bed. The diffuser serves to mix the station discharge with the main flow of the river.

This report presents *a summary of the quantities of radioactive materials which were released from the Station during the period from January 1 to December*31, 2016. In addition, this report serves as a medium for notifying the US Nuclear Regulatory Commission staff of changes to the ODCM, PCP and documentation of any exceptions to the effluent monitoring program which must be reported per Technical Requirements.

Airborne and waterborne radioactive effluent releases to the environment during the report period were sampled and analyzed in accordance with the Technical Requirements. All radioactive effluent releases were within the concentration and 1-2

release limits specified in the Technical Requirements. Calculations and terms utilized in this report are those outlined in the ODCM.

Section 1 contains supplemental information pertaining to effluents from the Susquehanna plant. Included are regulatory limits (Table 1-1 ), sampling and analysis methods, characterization of the number and duration of batch and abnormal releases and a brief summary of the applicable year's effluents.

Section 2 contains effluent and waste disposal data for the report period. Table 2-1 contains a summation of all airborne releases, grouped into the radionuclide categories of gases, particulates, iodines, and tritium. Average release rates are presented arid compared to the applicable limits. Table 2-2 presents the activity totals of specific radionuclides in airborne effluents.

Waterborne effluents are summarized in Table 2-3. Average diluted concentrations are presented' and compared to the applicable limits. Table 2-4 presents the release quantities of specific radionuclides in waterborne effluents over the report period.

Figures 2-1 and 2-2 present the Susquehanna River Monthly Average Flow Rates for 2016 and the Monthly Liquid Radwaste Discharge Totals for 2016, respectively.

Table 2-5 contains estimates of the errors associated with the measurements involved in quantifying effluents. Sampling errors, counting errors, and errors associated with

. determining effluent flow rates and volumes all contribute to the total error of effluent measurements.

Error estimates are presented for each category of radionuclide detected in airborne and waterborne effluents and solid wastes during the report period (Error Ana,lysis of the Radioactive Effluent Sampling and Analysis Program at the SSES, Hydro Nuclear Serviees; 1985).

Tables 2-7 through 2~14 present a characterization of the solid radioactive waste shipped offsite during the report period. An estimate of major nuclide composition is presented for each waste type. Also included are the volumes and curie contents associated with each type of solid waste. The number of waste shipments from the site transported directly fbr burial or disposal are listed in Table 2-6.

Section 3 presents meteorological data for 2016, including data recovery, joint frequency distribution of wind*speed and direction, stability class distribution, and atmospheric dispersion estimates for selected locations.

Section 4 of this report contains an assessment of the calculated doses attributed to the reported radiological effluents for the calendar year. The Radioactive Effluent Tracking and Dose Assessment Software (RETDAS) computer code was used for calculation of doses from waterborne effluents. Site-specific parameters used in the calculations for the Danville receiver are shown in Table 4-1. The RETDAS code was also used for calculation of doses from airborne effluents. The calculated doses and direct radiation estimates can be used to estimate the doses to maximally exposed members of the public. Table 4-2 summarizes maximum calculated doses to members of the public 1-3

from airborne and waterborne effluents. Table 4-3 presents calculated collective doses to members of the public within the Riverlands/Energy Information Center Complex.

Table 4-4 summarizes the calculated doses for residences and other occupied areas within the site boundary and the nearest dairy. Additionally, Section 4 includes a description of the methodology used in the calculation and resultant dose impact of Carbon-14 releasedfrom the station.

Section 5 of this report documents changes to the Offsite Dose Calculation Manual, Technical Requirements Manual and the Solid Radioactive Waste Process Control Program.

Section 6 presents a listing of cases (if any) in which airborne or waterborne effluent monitoring instrumentation was declared inoperable and was not restored to operability within the time period specified in Technical Requirements 3.11.1.4, 3.11.1.5 and 3.11.2.6 Action Statements. In addition, this .section presents issues (if any) with the collection of milk or fresh leafy vegetables per Technical Requirement 3.11.4.1 and changes due to the land use census per Technical Requirement 3.11.4.2. Section 6 also includes reporting associated with the Nuclear Energy Institute (NEI) Groundwater Protection Initiative.

Section 7 contains corrections (if any) to previous Radioactive Effluent Release Reports.

Section 8 contains information on effluent and offsite dose from the systems classified as insignificant effluent pathways.

1-4

SUMMARY

During 2016 there were one hundred twenty three (123) liquid batch releases resulting in a total release volume of approximately one million two hundred seventy two thousand (1,272,000) gallons. The total number of liquid batch releases and total volume released in 2016 was lower than the corresponding values for 2015 (161 releases resulting in 1,705,000 gallons released in 2015). The predominant radionuclide released in liquid effluents during 2016 was tritium. Approximately thirty eight (38) curies of tritium were released in liquid effluents in 2016, compared to forty nine (49) cu.ries released in 2015. When compared with all radionuclides released in liquid effluents in 2016, Co-60 was the main contributor to the resultant offsite dose.

Consi~tent with previous years, the offsite dose from liquid releases in 2016 was less than one percent (1 %) of the annual limits for both organ and whole body dose.

In 2010, an industry initiative (supported by EPRI and NEI) was established to evaluate and report gaseous effluent Carbon-14 (C-14) in the Annual Radioactive Effluent Release Report. The initiative is rooted in Regulatory Guide 1.21, Revision 2, "Measuring, Evaluating, and Reporting Radioactive Material in Liquid and Gaseous Effluents and Solid Waste", in that the NRC has reco~mended that U.S. nuclear power plants evaluate Whether c.:.14 is a "principal radionuclide", and if so, report the amount of C-14 released. The C-14 reported as released from the Susquehanna station in 2016 is calculatE?d based on samples taken from each. unit's Offgas system in October 2012, specifically.the Offgas post.::treatment sample stream. Approximately 43 Curies of C-14 were released in gaseous effluents in 2016. See section 4 for additional details on C-14 released:in airborne effluents.

Historically, tritium has been the* predominant radionuclide (both in curies and resultant offsite dose) released in gaseous effluents from the Susquehanna station.

Approximately twenty nine (29) curies of tritium were released in* gaseous effluents in 2016 compared to twelve (12) curies in 2015. The resultant maximum offsite organ dose due to gas.eous effluents from Unit-1 for 2016 was 1.43E-1 mrem, which is 0.95%

of the per unit annual limit of fifteen (15) mrem. The resultant maximum offsite organ dose due to gase.ous effluents from Llnit-2 for 2016 was 1.55E-1 mrem, which is 1.03%

of the per unit annual limit of fifteen (15) mrem. The maximum offsite dose from gaseous effluents in 2016 is greater than the maximum offsite dose from gaseous effluents in 2015.primarily due to the increase in airborne effluent tritium.

FIGURE 1-1 AIRBORNE EFFLUENT RELEASE POINTS l

UNIT '1 sens UNIT 2 IU!lBlNE TURBINE BUILDING BUILDING EXHAUST EXHAUST VENT VENT

..:l b

7'",,-611 5'-6" 1-6

FIGURE 1-2 WATERBORNE EFFLUENT PATHWAY FROM EVAPORATOR HEATING REACTOR WELL SEAL LEAK DRAIN STEAM CONDENSATE RETURN TANK REACTOR BUILDING DRAINS FROM PHASE SEPARATORS (DECANT)

DRYWEU DRAINS LIQUID EFFLUENT RELEASE FLOWPATH FROM RHR SYSTEM (SUPPRESSION POOL TRANSFERS) TURBINE BUILDING DRAINS (M-161, M-162, M-163 AND M-164)

RADWASTE BUILDING DRAINS RADWASTE BUILDING DRAINS

_.-...._,..,..,..,..,..,..,..,..,..,..--l~t41"'".....,..,..,..,..,..,..,..,..,.....LIQUIDRADWASTERECYCLEm..,,..,..,..,..,..,..,..,..,..,..,.......

UQUID RADWASTE*

COLLECTION AND SURGE TANKS OT-302A TH RU F OT-304A THRU D LIQUID UQUID RAD WASTE RADWASTE FILTERS DEMINERALIZER OF-302A & B 0-301 UQUID RADWASTE COLLECTION TANK PUMPS CONDENSATE OP-301A, B & C STORAGE TO 0 TANKS WASTE MIXING TANKS SPENT RESIN TANKS OT-522A & B SWMS SWMS LIQUID RADWASTE SAMPLE TANK PUMPS OP-522A, B & C i

RADWASTE BUILDING SAMPLE STATION FUEL POOL CLEANUP SYSTEM CHEMICAL DECON !I I

!---------------------=

i !I CHEMICAL WASTE t TANK DT-314 D AST D STI A EVAPO RATO RS SAMPLE TANK OE-302A B 1 OT-321 1'4 ** **** ---** -----=

(2) CONDENSATE DEMIN*

RESIN REGEN. TANKS, EVAPORATOR i.

CONCENTRATE '

STORAGE TANK II, OT-322 CHEMICAL WASTE CONDENSATE STORAGE TANK NEUTRAUZING TANK PUMPS DISCHARGE PUMP OP-328 1P-130A, BAND 2P-130A, B PERSONNEL DECONTAMINATION (DETERGENTS)

FLOOR DECON (SOLUTIONS} CASK CLEANING DRAINS REGULATED SHOP DRAINS LAUNDRY DRAINS (3)

LAUNDRY DRAIN FILTERS OF-313A1-A3 OF313B1-B3 (1} RADWASTE EVAPORATORS (2) COND DEM!N RESINS CURRENTLY (3} CONTAMINATED CLOTHING CURRENTLY ARE NOT USED NOT REGENERATED NOT LAUNDERED ONSITE SUSQUEHANNA RIVER 1-7

SUPPLEMENTAL INFORMATION

1. Regulatory Limits Technical Requirements 3.11.1 and 3.11.2 outline requirements for release of radioactive liquid and gaseous effluents, respectively. Concentration of radioactive materials released in liquid effluents and resulting dose are limited in unrestricted areas. Dose and dose rate due to radioactive materials released in gaseous effluents are limited in areas at or beyond the site boundary. Technical Requirement limits are listed in Table 1~1.

2. Maximum Permissible Concentrations in Waterborne Effluents The concentration of radioactive material released in liquid effluents to unrestricted areas is*limited to 10 times the concentrations specified in 1Q CFR Part 20 Appendix B Table 2, Column 2, for radionuclides other than dissolved or entrained noble gases.

For dissolved or entrained noble gases, the concentration is limited to 2.0E-04 JiCi/ml total activity (TRO 3.11.1.1 ).

3. Average Energy of Fission and Activation Gas The Calculation of Noble Gas Effluent Average Energies E-Bar Beta and Gamma for 2016 resulted in an Annual E-Bar Beta value of 4.38E-1 MeV and E-Bar Gamma value of 1.20E+O MeV.

4. Measurements and Approximations of Total Radioactivity Analyses of specific radionuclides in effluent samples are used to evaluate the radioactive composition and concentration of effluents.

5. Methods of Quantifying Effluents

a. Fission and Activation Gases: Gas samples are routinely collected monthly and analyzed with ahigh resolution (HPGE) detector system which incorporates a data reduction program to determine radionuclide composition in terms of specific activity. Data from the continuous vent monitors are used to determine the average concentration of noble gases. The high resolution *

(HPGE) isotopic scan is used to convert the continuous vent monitor activity to actual activity based on the determined nuclide mixture. The vent and sample flow rates are continuously monitored and the average flow rates for each vent are used to calculate the total activity released in a given time period. When the continuous monitors are out of service, manual grab samples are taken from each vent once every eight hours (once every four 1-8

hours for the standby gas treatment vent when standby gas treatment system is in service). *

b. Iodines: Iodine is continuously collected on charcoal or silver zeolite cartridges via an representative sampling assembly in each vent. Filters are normally exchanged once per week and analyzed on a high resolution (HPGE) system. The daily average flow rates for the vents and sample pumps are averaged for the duration of the sampling period and a ratio of vent flow rate to sample flow rate is determined. The ratio is used to determine the total activity of each isotope released during the time period in question. When the continuous samplers are out of service, iodine is continuously collected from alternate sampling ports available on the sample lines or directly from the affected rooftop vent(s).

c. Particulates: Particulates are continuously collected via an isokinetic sampling assembly in each vent. Filters are normally exchanged once per week and analyzed _on a high resolution (HPGE) system. Flow rate corrections are performed .the same as for iodines. When the continuous samplers are out of service, particulates are continuously collected from alternate sampling ports available on the sample lines or directly from the affected rooftop vent(s).

d. Tritium: Airborne tritium is collected monthly via bubbler sampler. The sample is collected for one hour at a flow rate of approximately 1000 cc/min.

Tritium activity in the bubbler sample is determined by liquid scintillation counting.[ The liquid sample tritium concentration is then convertec;J to* air concentration by volume proportion.

e. Waterborne Effluents: Each tank of liquid radwaste is sampled and analyzed for principal gamma emitters prior to release. Each sample tank is recirculated for a sufficient amount of time prior to sampling to ensure that a representative sample is.obtained. Samples are analyzed cm a high resolution (HPGE) system and release permits are generated based on the values obtained from the* isotopic analysis and the most recent values for tritium, gross alpha, iron-55, and strontium-89 and -90. An aliquot based on release volume is saved and added to monthly and quarterly composite containers. The monthly tritium analysis is done in-house. A monthly composite is sent to a vendor laboratory for gross alpha analysis. A quarterly composite is sent to a vendor laboratory for iron-55, strontium-89 and-90 analyses.

The concentration of each radionuclide in each batch is multiplied by the volume of the batch to determine the total quantity of each nuclide released in each batch. The isotopic totals for each batch are summed to determine the total source term for the report period.

1-9

TABLE 1*1 TECHNICAL REQUIREMENT LIMITS A. NOBLE GASES:

1. s500 mrem/year- TOTAL BODY s3000 mrem/year - SKIN instantaneous dose rate limit at and beyond the site boundary (TRO 3.11.2.1.1)

2. s5 mrad - AIR GAMMA s;10 mrad - AIR BETA quarterly air dose limits per reactor unit at and beyond the site boundary (TRO 3.11.2.2a)

3. s10 mrad-AIRGAMMA s20 mrad-AIR BETA annual air dose limits per reactor unit at and beyond the site boundary (TRO 3.11.2.2.b)

B. AIRBORNE 1..131, 1-133, TRITIUM, PARTICULATES WITH HALF-LIVES > 8 DAYS:

1. s1500 mrem/year - ORGAN (inhalation pathways only)

instantaneous dose rate limit at and beyond the site boundary (TRO 3.11.2.1.11.A)

2. s7.5 mrem - ORGAN quarterly dose limit per reactor unit at and beyond the site boundary {TRO 3.11.2.3.a)

3. s15 mrem - ORGAN annual dose limit per reactor unit at and beyond the site boundary (TRO 3.11.2.3.b) 1-10

C. LIQUID EFFLUENTS:

1. s;1.5 mrem - TOTAL BODY s;s.o mrem - ORGAN

- quarterly dose limits per unit (TRO 3.11.1.2.a)

2. s;3.0 mrem -TOTAL BODY S:10.0 mrem - ORGAN

- annual dose limits per unit (TRO 3.11.1.2.b)

D. AIRBORNE EFFLUENT: BASES FOR PERCENT OF APPLICABLE LIMIT VALUES IN TABLE 2-1 Fission and Activation Gases Derived release rate limits based on the Technical Requirement (TRO 3.11.2.1.1.A and B) limits of 500 mrem/yr to the total body and *3000 mrem/yr to the skin were calculated (PPL calculation EC-ENVR-1041 Rev. 7) from the expected mix of noble gas radionuclides presented in Attachment A of ODCM-QA-003, Effluent Monitor Setpoints. The lower limit of 2.00E+06

µCi/min (3.33E+04 µCi/sec) based on total body dose rate is used.

lodine-131 A derived release rate limit for 1-131 based on the Technical Requirement (TRO 3.11 .. 2.1.11.A) limit of 1500 mrem/yrfrom 1-131, 1-133, tritium and particulates with half-lives greater than 8 days was calculated {PPL calculation EC-ENVR-1041 Rev. 7) based on the ratio of the expected annual release quantities of 1-131and1-133 provided in Attachment E of ODCM-QA-004, Airborne Effluent Dose Calculations. The limit is 1.36E+02 µCi/min 1-131 (2.27E+OO µCi/sec).

Particulates A derived release rate limit for particulate activity other than iodines based on the Technical Requirement (TRO 3.11.2.1.11.A) limit of 1500 mrem/yr from 1-131, 1-133, tritium and particulates with half-lives greater than 8 days was calculated (PPL calculation EC-ENVR-1041 Rev. 7) based on the expected annual release quanities of particulate radionuclides provided in Attachment E of ODCM-QA~004, Airborne Effluent Dose Calculations. The limit is 3.83E+03 µCi/min (6.38E+01 µCi/sec).

1-1'1

Tritium A derived release rate was calculated based on the 10 CFR 20, Appendix B, Table 2, Column 1, Effluent Concentration Limit for tritium (1.0E-07 µCi/cc) to 3

unrestricted areas. An atmospheric dispersion factor of 4.1 E-05 sec/m was assumed (PPL calculation EC-ENVR-1040). The limit is 1.46E+05 µCi/min (2.44E+03 µCi/sec):

Radionuclide Fractional Summation The sum of the percentages of applicable limits for particulates, iodine and tritium must be less than 100%.

E. WATERBORNE EFFLUENT: BASES FOR PERCENT OF APPLICABLE LIMIT VALUES IN TABLE 2-3 Fission and Activation Products Concentrations of fission and activation products in liquid effluent from radwaste effluent are determined for each batch prior to release.. Each isotope concentration is compared to ten times the 10CFR20 Appendix B, Table 2, Column 2 Effluent Concentration Values (TRO 3.11.1.1 ).

Tritium Liquid effluentquarterly tritium concentrations are compared to ten times the 1D* CFR 20 Appendix B, Table 2, Column 2, Effluent Concentration value of 1.0E-03 µCi/ml to unrestricted areas.

Dissolved and Entrained Gases Liquid effluent concentrations for dissolved and entrained gases are comparecl to the limiting value for total noble gas activity of 2.0E-04 µCi/ml (TRO 3'.11.1.1).

Radionuclide Fractional Summation The sum of the percentages of applicable limits for fission and activation products, tritium and dissolved and entrained gases must be less than 100%.

1-12

. 0 i

Il '

SECTION 2 EFFLUENT AND WASTE DISPOSAL DATA 2-1

Airborne Effluents Summaries of the radionuclide total curie activities and average release rates are included in Tables 2-1 and 2-2. Total for Period values in Table 2-2 may not equal the sum of the Curies listed for each radionuclide due to unit rounding of the individual isotopes. Carbon-14 (C-14) activity released is not included in Tables 2-1 or 2-2. See Section 4 for additional details on the calculation of C-14 released in 2016 from the Susquehanna station. If a radionuclide was not detected, zero activity was used for that isotope in dose calculations and the activity is listed as "<MDC" (less than the minimum detectable concentration) in Tables 2-1 and 2-2. <MDC indicates that no activity was positively detected in any sample when samples were analyzed with techniques which achieved the required Lower Limits of Detection (LLD) as specified in the Technical Requirement (TRO) Table 3.11.2.1-1, Radioactive Gaseous Effluent Sampling and Analysis Program. In all cases, the measurement laboratory MDCs were at or below the LLD levels required by Technical Requirements. The following are typical measurement laboratory MDCs.

Typical MDCs Radionuclide MDC CuCi/ccl Kr-87 4.3 E-08 Kr-88 4.6 E-08 Xe-133 3.0 E-08 Xe-133m 1.1 E-07 Xe-135 1.5 E-08 Xe-135m 8.0 E-08 Xe-138 1.5 E-07 Mn-54 2.9 E-13 Fe-59 2.8 E-13 Co-58 1.8 E-13 Co-60 3.8 E-13 Zn-65 1.0,E-13 Mo-99 1.0 E-12 Cs-134 2.4 E-13 cs.;137 1.1 E-13 Ce-141 1.0 E-13 Ce-144 5.0 E-13 1-131 4.4 E-14 Sr-89 1.1 E-13 Sr-90 1.3 E-14 H-3 1.5 E-08 Gross Alpha 2.3 E-14 2-2

Batch Releases

1. Number of Batch Releases: o:

2. Total Time Period for Batch Release: NA

3. Maximum Time Period for a Batch Release: NA

4. Average Time Period for a Batch Release: NA

5. Minimum Time Period for a Batch Release: NA Abnormal Releases

1. Number of Releases 2*

2. Total Activity Released 5.55E-7 Ci

The Unit-1 Turbine Building west exterior wall was open to the outside environment at various times in March and April 2016 to support the Feedwater Heater replacement project. Air samples were taken at the exterior wall opening throughout the project duration. Gamma

isotopic analysis results for air samples taken at the wall opening indicated Co-60 on the following dates and at the corresponding concentrations:

March 29th 22:25 through March 30th 05:10 Co-60 Concentration: 2.97E-12 uCi/Cc*

April 181 07:30 throug-h April 2nd 07:15 Co-60 Concentration: 6.82E-13 uCi/cc Based on the identified Co-60 conc~ntration values, the maximum site boundary x/q and a calculated exhaust flow rate (per AR/EWR 2016-09983) out the Unit-1 Turbine Building west exterior wall opening during the time periods in question, the resultant total offsite dose to a member of the public was 3.56E-5 mRem.

2-3

TABLE 2-1 AIRBORNE EFFLUENT* SUMMATION OF ALL RELEASES First Second Third Fourth A Fission and Activation Gas Unit Quarter Quarter Quarter* Quarter Total Release Ci <MDC <MDC 3.86E+01 1.14E+02 AveraQe Release Rate for Period µCi/sec 0 0 4.86E+OO 1.43E+01 Percent of Applicable Limit (3.33E+04 % 0 0 1.46E-02 4.30E-02 uCi/sec)

B. Iodines Total 1-131 Ci <MDC <MDC <MDC <MDC Averaoe Release Rate for Period uCi/sec 0 a 0 0 Percent of Applicable Limit (2.27E+OO % 0 0 0 0

µCi/sec)

C. Particulate Particulate with Half-Life >8 Days Ci 3.31E-05 6.89E-05* <MDC 1.01E-04 Avera!'.le Release Rate for Period uCi/sec 4.21E-06 8.76E-06 a '1.27E-05 Percent of Applicable Limit (6.38E+01 % 6.60E-06 1.37E-05 0 2.00E-05

µCi/sec)

Gross Alpha Radioactivity Ci <MDC <MDC <MDC '<MDC D. Tritium Total Release Ci <MDC <MDC 1.01 E+01 1.84E+01 Averaae Release Rate for Period uCi/sec. 0 0 1.28E+OO 2.31E+OO Percent of Applicable Limit (2.44E+03 % 0 0 5.23E-02 9.47E-02

µCi/sec)

E. Radionuclide Fractional Summation Sum of Percent of Applicable Limit % <0.01 <0.01 0.07 0.14 During Period for B, C and D (Limit=

100%)

2-4

TABLE 2-2 AIRBORNE. EFFLUENT*- RADIONUCLIDES RELEASED Releases in Continuous Mode First Second Third .Fourth Nuclides Released Unit Quarter Quarter Quarter Quarter A. Fission and Activation Gases N-13 Ci <MDC <MDC <MDC <MDC Ar-41 Ci <MDC <MDC 3.49E+D1 9.85E+D1 Kr-85 Ci <MDC <MDC <MDC <MDC Kr-85m Ci <MDC <MDC 1.18E+OO 3.44E+OO Kr-87 Ci <MDC <MDC 8.58E-02 2.26E-01 Kr-88 Ci <MDC <MDC 1.97E+OO 4.12E+OO Kr-89 Ci <MDC <MDC <MDC *<MDC Xe-133 Ci <MDC <MDC 5.43E-01 7.12E+OO Xe-135 Ci <MDC <MDC <MDC 4.88E-01 Xe-135m Ci <MDC <MDC <MDC 2.91E-02 Xe-137 Ci <MDC <MDC <MDC <MDC Xe-138 Cl <MDC <MDC <MDC <MDC Total for Period Ci 0 0 3.86E+01 1.14E+02 B. Iodines 1-131 Ci <MDC <MDC <MDC <MDC 1-133 Ci <MDC <MDC <MDC <MDC 1-135 Ci <MDC <MDC <MDC <MDC Total for Period Ci 0 0 0 0 C. Particulate Cr-51 Cl <MDC 3.96E-05 <MDC <MDC Mn-54 Ci <MDC <MDC <MDC <MDC Fe-59 Ci <MDC <MDC . <MDC <MDC Co-57 Ci <MDC <MDC <MDC <MDC Co-58 Ci <MDC <MDC <MDC <MDC Co-60 Ci 3.31E-05 2.93E-05 <MDC <MDC Zn-65 Ci <MDC <MDC <MDC <MDC Sr-89 Ci <MDC <MDC <MDC <MDC Sr-90 Ci <MDC <MDC <MDC <MDC Cs-134 Ci <MDC <MDC <MDC <MDC Cs-137 Cl <MDC <MDC <MDC <MDC Ce-141 Ci <MDC <MDC <MDC <MDC Ce-144 Ci <MDC <MDC <MDC <MDC Ba-133 Ci <MDC <MDC <MDC 1.01 E-04 Ba-La-140 Ci <MDC <MDC <MDC <MDC Total for Period Cl 3.31E-05 6.89E-05 0 1.01E-04 2-5

Waterborne Effluents Summaries of the radionuclide total curie activities, average diluted concentrations, and percent of applicable Technical Requirement limits are included in Tables 2-3 and 2-4.

Total for Period values in Table 2-4 may not equal the sum of the Curies listed for each r?-dionuclide due to unit rounding of the individual isotopes.

Batch Releases* Qtr.1 Qtr. 2 gtr. 3 Qtr.4 Annual

1. Number of Batch Releases 30 41 26 26 123

2. Total Time Period for Batch Releases 3.44E+03 7.12E+03 4.00E+03 2.92E+03

1.75E+04

3. Maximum Time Period for a Batch 2.92E+02 2.96E+02 3.03E+02 2.93E+02 3.03E+02 Release

4. Average Time Period for a Batch 1.15E+02 1.74E+02 1.54E+02 1.12E+02 1.42E+02 Release

5. Minimum Time Period for a Batch 3.60E+01 4.20E+01 4.30E+01 5.50E+01 3.60E+01 Release*

6. Average Cooling Tower Slowdown 8.64E+03 1.17E+04 1.32E+04 1.21E+04 1.15E+04 Flow Rate During Periods of Release

7. Susquehanna River Flow Rate 8.76E+06 4.71E+06 1.18E+06 3.99E+06 4.65E+06

Units of time and flow are expressed in minutes and gallons per minute (gpm),

respectively.

If a radionuclide was not detected, zero activity was used for that isotope in dose calculations and the activity is listed as ~<MDC" (less than the miniumum detectable concentration) in Tables 2-3 and 2-4. <MDC indicates that no activity was positively detected in any sample when samples were analyzed with techniques which achieved the required Lower Limits of Detection (LLD} as specified in the Technical Requirement 3.11.1.1-1, Radioactive Liquid Waste Sampling and Analysis Program. In all cases, the measurement laboratory MDCs were at or below the LLD levels required by Technical Requirements. The followirig are typical measurement laboratory MDCs.

Radionuclide MDC {µCi/mil Mn-54 4.5 E-08 Fe-59 5.0 E-08 Co-58 4.0 E-08 Co-60 5.4 E-08 Zn-65 4.9 E-08 Mo-99 1.7 E-07 1-131 2.0 E-08 Cs-134 2.2 E-08 Cs-137 2.6 E-08 Ce-141 3.2 E-08 Ce-144 1.3 E-07 Sr-89 4.4 E-08 Sr-90 1.6 E-08 Fe-55 8.2 E-07 H-3 3.6 E-06 Gross Alpha 3.7 E-09 2-6

Abnormal Releases

1. Number of releases 0 0 0 0

2. Volume Released {Gallons) N/A N/A NIA N/A

3. Total Activity Released (Ci) N/A N/A N/A N/A 2-7

TABLE 2-3 WATERBORNE EFFLUENT *SUMMATION OF ALL RELEASES First Second Third Fourth A

Fission and Activation Products Unit Quarter Quarter Quarter Quarter

1. Total Release (excluding: Tritium, Ent.

Gases, Aloha) Ci 2.44E-03 4.79E-03 6.78E-04 1.93E-03

2. Average Diluted.Concentration DurinQ Period µCi/ml 2.17E-08 1.52E-08 3.38E-09 1.44E-08

3. Sum of Average Diluted Cr/Ln Ratio Durin!=I Period Unitless 2.49E-04 3.82E-04 1.03E-04 2.98E-04

4. Percent of Aoolicable Limit (Ratio < 1.0) % 0.02 0.04 0.01 0.03 B. Tritium

1. Total Release Ci 7.59E+OO 1.58E+01 8.61E+OO 6.28E+OO

2. Average Diluted Concentration DurinQ Period µCi/ml 6.76E-05 4.99E-05 4.30E-05 4.67E-05

3. Percent of Aoolicable Limit (1.0E-2 µCi/ml) % 0.68 0.50 0.43 0.47 C. Dissolved and Entrained Gases

1. Total Release Ci <MDC <MDC <MDC 3.22E-05

2. Average Diluted Concentration µCi/ml 0 0 0 2.40E-10 Durirn:i Period

3. Percent of Aoolicable Limit (2.0E-4 µCl/ml) % 0 0 0 <0.01 D. Radionuclide Fractional Summation

1. Sum of Percent of Applicable Limit During Period for A, B and C Limit = 100% % 0.70 0.54 0.44 0.50 E. Gross Al ha Radioactivit

1. Total Release Ci <MDC <MDC <MDC <MDC F. Volume of Water Released Gallons 2.36E+05 5.44E+05 2.94E+05 1.98E+05 (Prior to Dilution) Liters 8.91E+05 2.06E+06 1.11E+06 7.50E+05 G. Volume of Dilution Water Gallons 2.94E+07 8.30E+07 5.26E+07 3.53E+07 Used During Period of Release Liters 1.11E+08 3.14E+D8 1.99E+08 1.34E+08 H. Volume of Dilution Water Gallons 1.37E+09 1.57E+09 1.63E+09 1.75E+09 Used Over Entire Period Liters. 5.20E+09 5.96E+09 6.15E+09 6.63E+09

TABLE 2-4 WATERBORNE EFFLUENT - RADIONUCLIDES RELEASED Releases in Batch Mode Nu elides Unit First Second Third Fourth Released Quarter Quarter Quarter Quarter A. Fission and Activation Products Fe-59 Ci 1.50E-05 <MDC <MDC <MDC Cr-51 Ci 1.28E-03 3.66E-04 <MDC 3.85E-04 Mn-54. Ci 6.69E-05 2.59E-04 2.12E-06 1.31E-05 Fe-55 Ci <MDC <MDC <MDC <MDC Co-58 Ci 2.18E-04 5.90E-04 4.25E-05 2.94E-04

Zn-69m Ci 9.13E-06 <MDC <MDC <MDC Co-60 Ci . 7.43E-04 3.40E-03 5.74E-04 1.0?E-03 Zn-65 Ci . 5.23E-05 1.66E-04 5.91E-05. 1.23E-04 Sr-89 Ci <MDC <MDC. <MDC <MDC Sr-90 Ci .<MDC <MDC <MDC <MDC Nb-95

Ci 1.02E-05 <MDC <MDC <MDC Mo-99 Cl. <MDC <MDC <MDC 3.57E-05 Tc-99m Ci 7.61E-06 <MDC <MDC 1.99E-06 Te-131m Ci <MDC 8.58E-06 <MDC <MDC Sb-124 Cl <MDC <MDC <MDC 3.05E-06 Ta-182 Ci 3.56E-05 <MDC <MDC <MDC Ta-183 Ci <MDC <MDC <MDC 3.37E-06 Total for Period Ci 2.44E-03 4.79E-03 6.78E~04 1.93E-03 B. Tritium Total for Period Ci 7.59E+OO .1.58E+01 8.61E+OO 6.28E+OO

c. Dissolved and Entrained .Gases Ar-41 Ci <MDC <MDC <MDC <MDC Kr-85 Ci <MDC <MDC <MDC <MDC Kr-85m Ci <MDC <MDC <MDC <MDC Kr-87 Ci <MDC <MDC <MDC <MDC Kr-88 Ci <MDC <MDC <MDC <MDC Xe-131 ni Ci <MDC <MDC <MDC <MDC Xe-133m Ci <MDC <MOC <MDC <MDC Xe-133 Ci <MDC <MDC <MDC 3.22E-05 Xe-135m Ci <MDC <MDC <MDC <MDC Xe-135 Ci <MDC <MDC <MDC <MDC Total for Period Ci 0 0 0 3.22E-05

Zn-69m identified in a liquid radwaste batch release. Resultant offsite dose impact due to the release of Zn-69m not calculated due to: 1) no dose conversion factor for Zn-69m in the ODCM (ODCM revision to add dose conversion factors for Zn-69m is pending issuance); 2) minimal concentration released (9.13 uCi); and 3) due to the short half-life of Zn-69m (13.7 hours8.101852e-5 days 0.00194 hours 1.157407e-5 weeks 2.6635e-6 months ) it Is an unlikely offsite dose contributor.

2-9

~---------------- -------

Figure 2-1 Susquehanna River Monthly Average Flow Rates Data Period: 2016 12.0

-E a..

Cl 10.0 c

0

- ~

E cu 8.0 Ek'!

~ 6.0 LL.

0 4'

en

...4' td 4.0 2.0 I --.-2016 I 2-10

Figure 2-2 Monthly Liquid Radwaste Discharge Totals "O

(I) e>-

.... en (l;S c:

.c: 0 o=

~ ~ 150

(!) 0 e8

~

s T""

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec I -+-201e I 2-11

TABLE 2-5 ESTIMATED TOTAL ERRORS ASSOCIATED WITH EFFLUENTS MEASUREMENTS ESTIMATED MEASUREMENT TOTAL ERROR

1. Airborne Effluents

a. Fission and Activation Gases 15.9%

b. 1-131 13.3%

c. Particulates (incl. Gross Alpha) 15.8%

d. Tritium 13.6%

2. Waterborne Effluents

a. Fission and Activation Products 5.0%

b. Tritium 3.3%

c. Dissolved and Entrained Gases 8.4%

d. Gross Alpha Activity 6.0%

e. Volume of Waste Released 5.0%

(Prior to Dilution)

f. Volume of Dilution Water Used During Period 15.0%

ESTIMATED MAXIMUM MEASUREMENT ERROR

3. Solid Wastes

a. Asbestos - Class A HIC (Non-Processed) +/-25%

b. Non-Processed DAW (FWH)-Burial +/-25%

c. Condensate Demineralizer I Radwaste Demineralizer +/-25%

Class A HIC (Pyrolysis)

d. Processed DAW - Class A Strong Tight Container +/-25%

(Compacted)

e. Liquid Radwaste Filter Media- Class A HIC (Pyrolysis) +/-25%

f. CFS Filters - Class A HIC (Compacted) +/-25%

g. RWCU Filter Media Class A HIC (Pyrolysis) +/-25%

2-12

SUSQUEHANNA STEAM ELECTRIC STATION RADIOACTIVE WASTE REPORT RADIOACTIVE EFFLUENT RELEASE REPORT SOLID RADIOACTIVE WASTE 2-13

REPORT NOTES

1. All activities reported in Milli-Curies (mCi) unless otherwise noted.

2. Reported activities, as indicated with the(<) sign, are comprised in whole or part of MDL values.

3. Estimated maximum measurement error is +/-25%.

TABLE 2-6 WASTE DISPOSITION Data Period: January 1, 2016 - December 31, 2016 A. SOLID WASTE SHIPPED OFF-SITE FOR BURIAL OR DISPOSAL Number of Shipments Mode of Transportation Destination 3 (FWH) Highway WCS, Texas B. IRRADIATED FUEL SHIPMENTS Number of Shipments Mode of Transportation . Destination NONE 2-15

Table 2-7 Annual Waste Release Summary Report Year: 2016 \

Class: A Volume Reduction Vendor: No Source: Asbestos Container: HIC {High Integrity Container)

Process: Non-Processed Nuclides Activity (mCi) JI.

0 of Total C-14 < O.OOOE+OO 0.00 JI.

0 C0-58 3.039E-Ol 23.55 %

C0-60 3.354E-01 25.99 %

CR-51 l.984E-01 15.37 %

CS-137 8.546E-04 0.07 %

FE-55 2.996E-01 23.21 %

FE-59 9.926E-03 0.77 %

H-3 6.826E-02 5.29 %

I-129 < O.OOOE+OO 0.00 %

MN-54 3.597E-02 2.79 JI.

NB-95 8.595E-03 0.67' %

NI-63 l.358E-02 1. 05 %

TC-99 ZN-65 ZR-95

< O.OOOE+OO 9.889E-03 6.268E-03 0.00 0.77 0.49 JI.

0 JI.

Total Activity (Ci) . 0. 001 100.00 %

Container Volume 34.820 ft3 0.986 m3

Table 2-8 Annual Waste Release Summary Report Year: 2016 Class: A Volume Reduction Vendor: No Source: Non-Processed DAW {FWH)

Container: None Process: BURIAL Nuclides Activity (mCi) % of Total C-14 5.910E-03 0.01 %

C0-58 7.0lOE-01 1.60 %

C0-60 2.069E+Ol 47.28 %

CR-51 8.930E-01 2.04 %

CS-137 5.460E-02 0.12 %

FE-55 1.787E+Ol 40.83 %

FE-59 1.225El-Ol 0.28 %

H-3 2.757E-02 0.06

$?,-

0 I-129 2.433E-03 0.01 $?,-

MN-54 1.827E+OO 4.17 %

NB-95 6.780E-02 0.15 $?,-

0 NI-63 8.730E-01 1. 99 %

TC-99 3.240E-02 0.07 JI,.

0 ZN-65 ZR-95 4.700E-01

1. 277E-Ol

1. 07 0.29 J!.

Total Activity . (Ci) D.044 100.00 %

Container Volume 6900.000 ft3 195.390 m3

Table2-9 Annual waste Release Sununary Report Year: 2016 Class: A Volume Reduction Vendor: Yes Source: Condensate Demineralizer / Radwaste Demineralizer Container: HIC (High Integrity Container)

Process: Pyrolysis Nuclides Activity (mCi) % of Total*

C-14 6.917E+02 3.90 %

C0-58 4.128E+02 2.32 !!-

0 C0-60 1.086E+04 61.16 ll-0 CR-51 3.710E+Ol 0.21 %

CS-137 4.435E+Ol 0.25 %

FE-55 2.838E+03 15.98 %

FE-59 1.018E+Ol 0.06 %

H-3 5.008E+02 2.82 %

HF-181 2.241E-01 0.00 %

I-129 1.161E+OO 0.01 %

I-131 1. 286E-06 0.00 %

LA-140. < O.OOOE+OO 0.00 !I-0 MN-54 i.169E+03 6.58 %

NB-95 5 ,.f56E+Ol 0.31 !I-0 NI-63 4.062E+02 2.29 ll-0 SB-124 2.325E+OO 0.01 %

SB-125 6.385E+Ol 0 .3.6 %

SN-,113 7.826E+OO 0.04 !!-

0 SR-89 2.094E-Ol 0,00 ll-0 SR-90 4.042E-01 0.00 %

TA-:\.82 4.366E+Ol 0.25 %*

TC-99 7.928E+OO 0.04 ll-0 ZN-65 5.192E+02 2.92 !I-0 ZR-'-95 8.503E+Ol 0.48 % .... __

Total Activity (Ci) 17.757 100.00 %

Container Volume 4360.000 ft3 123.464 m3 2-18

Table 2..10 Annual Waste Release Summary Report Year: 2016 Class: A Volume Reduction Vendor; Yes Source: Processed DAW Container: Strong Tight Container Process; Compacted Nuclides Activity (mCi} % of Total C-14 3.39BE+OO 0.02 %

C0-58 9.367E+Ol 0.46 %

C0-60 5. 727E+03 28.23 %

CR-51 1.423E+02 0.70 %

CS-137 2.027E+Ol 0.10 %

FE-55 l.333E+04 65.70 %

.FE-59 7.245E+OO 0.04 %

H-3 1.011E+02 0.50 %

I-129 < O.OOOE+OO o.oo %

MN-54 4.482E+02 2.21 ~

0 NB-95 3.003E+01 0.15 %

NI-63 1.843E+02 0.91 %

SB-125 l.225E+Ol 0.06 %

SR-90 4.070E-02 0.00 %

TA-182 5.590E+OO 0.03 %

TC-99 < O.OOOE+OO 0.00 %

ZN-65 l.802E+02 0.89 %

ZR-95 4.729E+OO 0.02 ~

0 Total Activity (Ci} 20.290 100.00 %

Container Volume 8321.000 ft3 235.629 m3 2-19

Table 2-11 Annual Waste*Release Summary Report Year: 2016 Class: A Volume Reduction Vendor: Yes Source: Liquid Radwaste Filter Media Container: HIC (High Integrity Container)

Process: Pyrolysis Nuclides ACtivity (mCi) % of Total C-14 l.BBOE+oo 0.01 %

C0-58 6.482E+02 2.42 %

C0-60 l.430E+04 53.50 %

CR-51 7.871E+Ol 0.29 %

CS-137 1. 355E+Ol 0 .. 05 %

FE-55 8.865E+03 33.16 %

FE-59 1.000E-02 0.00 %

H-3 4.160E+Ol 0.16 %

I-129 1. lOOE-01 0.00 %

MN-54 l.099E+03 4.11 %

NB-95 8. 710E+OO 0.03 %

NI-63 8.155E+02 3.05 %

SR-90 2.200E-Ol o.oo %

TA-182 5.573E:+Ol 0.21 %

TC-99 2.790E+OO 0.01 %

ZN-65 7.674E+02 2.87 %

ZR-95 3.158E+01 0.12 %

Total Activity (Ci) 26.730 100.00 %

Container Volume 138,300 ft3 3.916 m3 2-20

Table 2-12 Annual Waste Release Summary Report Year: 2016 Class: A Volume Reduction Vendor: Yes Source: CFS Filters Container: HIC (High Integrity Container)

Process: Compacted Nuclides Activity (mCi) %. of Total C-14 C0-57 C0-58 8.00SE-01 l.OlOE-01 7.925E+OO 0.01 0.00 0.09

.!l-C0-60 2.626E+03 30.78 %

CS-137 2.270E+OO 0.03 %

FE-55 5.559E+03 65.16 %-

H-3 3.976E+Ol 0.47 .!l-I-129 < O.OOOE+OO 0.00 J1..

MN-54 1.520E+02 1. 78 %

NB-95 NI-63 2.530E-06 8.356E+Ol 0.00 0.98 J1,.

SB-125 8R-89 SR-90 6.666E+OO l.270E-05 2.SSOE-03 0.08 0.00 0.00 J1..

Q

!\-

TC-99 < O.OOOE+OO 0.00 %

ZN-65 5.284E+Ol 0.62 %

~-~---------------- ------------ .... -- ------------

Total Activity {Ci) 8.531 100.00 %

Container Volume 560.100 ft3 15.861 m3 2-21

Table 2-13 Annual Waste Release Summary Report Year: 2016 Class: A Volume Reduction Vendor: Yes Source: RWCU Filter Media Container: HIC (High Integrity Container)

Process: Pyrolysis Nuclides Activity (mCi) % of Total C-14 7.lOOE-01 0.00 %

C0-57 1. 800E+OO 0.01 %

C0-58 6.000E-02 0.00 %

C0-60 2.036E+04 63.24 %

CS-137 2.170E+Ol 0.07 %

FE-55 1.059E+04 32.89 %

H-3 1.730E+OO 0.01 %

I-129 2.000E-02 o.oo %"

MN-54 4.162E+02 1.29 %

NI-63 6.748E+02 2.10 %

SR-90 1.000E-01 0.00 %

TC-99 5.900E-Ol 0.00 %

ZN-65 1.262E+02 0 . 39 %

Total Activity (Ci) 32.194 100.00 %

Container Volume 28.940 ft3 0.820 m3

METEOROLOGY AND DISPERSION DATA Meteorological data have been collected at the Susquehanna Nuclear, LLC site since the early 1970s. At the present time, the meteorological system is based on a 300-foot high tower located approximately 1,000 feet to the southeast of the plant. Wind sensors are mounted at the 1Om and 60m elevations on this tower. Vertical temperature differential is measured with redundant sensor pairs between the 1Om and 60m levels.

Sigma theta (the standard deviation of horizontal wind direction) is calculated from wind direction at both levels. Dew point and ambient temperature sensors are present at the 10m level. Precipitation is measured at ground level.

A back-up meteorological tower was erected in 1982. It is a 1Om tower providing alternate measurements of wind speed, wind direction, and sigma th.eta. A 1Om downriver meteorological tower is also available. This tower measures wind speed, wind direction, sigma theta, temperature and dew point.

Meteorological data are transmitted to the plant Control Room, Technical Support Center, Emergency Operations Facility for emergency response availability, and ABSG Consulting, Inc. ABSG Consulting, Inc., located in Rockville, Maryland, provides meteorological consulting services to Susquehanna Nuclear, LLC.

Regulatory Guide 1.23 (Safety Guide 23) requires at least 90% data recovery for meteorological instrumentation. During 2016, all meteorological instrumentation met the 90% data recovery requirement. Table 3-1 lists the percent valid data recovery values for the parameters monitored as part of the Susquehanna Nuclear, LLC Meteorological Monitoring Program.

Dispersion modeling for effluents from normal operation is done using the MIDA$

system XDCALC program, a straight-line Gaussian plume model designed to estimate average relative concentration. The model was developed in accordance with Regulatory Guide 1.111. For periods when the wind speed is calm, the actual wind direction that last occurred is used.

XDCALC and the XQINTR program that interpolates X/Q values to exact locations both use terrain correction factors to account for the temporal and spatial*variations in the airflow in the region. A straight-line trajectory model assumes that a constant mean wind transports and diffuses effluents in the direction of airflow from the release point within the entire region of interest. The terrain correction factors were taken from FSAR Table 2.3-128.

Tables 3-2 and 3-3 provide the joint frequency distribution of wind speed and direction (as a function of delta temperature) at the 10 and 60 meter elevations of the primary meteorological tower. Table 3-4 lists no decay, undepleted X/Q values at various distances from the site. Table 3-5 lists 2.26 day decay, undepleted X/Q values at various distances from the site. Table 3-6 lists 8-day decay, depleted X/Q values at various distances from the site and Table 3-7 is a listing of D/Q (relative deposition) values at various distances from the site.

3-2

METEOROLOGICAL DATA RECOVERY FOR 2016 Parameter Percent Valid Data Recovery Wind Speed 10m- Primary (1) 99.9 Wind Speed 60m - Primary 99.9 Wind Speed 1Om - Backup <2J 74.4 Wind Speed 1Om - Downriver (3> 100.0 Wind Direction 1Om - Primary 100.0 Wind Direction 60m - Primary 100.0 Wind Direction tom - Backup 74.4 Wind Direction 1Om - Downriver 100.0 Temperature 10m - Primary 99.7 Dew Point 1Om - Primary 100.0 Delta Temperature 60m - Primary 99.8 Sigma Theta 1Om - Primary 99.9 Sigma Theta 60m - Primary 99.9 Sigma Theta 1Om - Backup 74.4 Sigma Theta 1Om - Downriver 100.0 Precipitation - Primary 100.0 COMPOSITE PARAMETERS Wind Speed and Direction 10m, Delta 99.8 Temperature 60-10m Wind Speed and Direction 60m, Delta 99.8 Temperature 60-10m (1) SSES "Primary" meteorological tower (2) SSES "Backup" meteorological tower (3) SSES "Downriver" meteoroloQical tower 3-3

TABLE3-2 SSES Joint Frequency Distribution Of Wind Speed And Wind Direction lOm Versus Delta Temperature 60-lOm For The Period Of January 1, 2016 Through December 31, 2016 Joint Frequency Distribution Hours at Each Wind Speed and Direction Total Period Period of Record "" 1/1/2016 00:00 - 12/31/2016 23:00 Elevation: Speed: lO_SPD Direction: 10 WD Lapse: DT60-lOA Stability Class A Delta Temperature Extremely Unstable Wind Speed (mph)

Wind Direction 0.6-3.5 3.6-7.5 7.6-12.5 12.6-18.5 18.6-24.5 >24.6 Total N 0 1 1 0 0 0 2 NNE 3 1 1 0 0 0 5 NE 0 2 0 0 0 0 2 ENE 1 3 0 0 0 0 4 E 1 1 0 0 0 0 2 ESE 2 0 0 0 0 0 2 SE 1 3 2 0 0 0 6 SSE 2 1 1 0 0 0 4 s 2 1 8 .1 0 0 12 SSW 1 1 8 0 0 0 10

.SW 0 3 13 0 0 0 16 WSW 0 0 0 2 0 0 2 w 0 0 0 0 0 0 .0 WNW 0 0 0 0 0 0 0 NW 0 0 0 0 0 0 0 NNW 0 0 0 0 0 0 0 Total 13 17 34 3 0 0 67 Calm Hours not Included above for : Total Period *4 Variable Direction Hours for: Total Period 0 Invalid Hours for: Total Period . 19 Valid Hours for this Stability Class for: Total Period 67 Total Hours for Period 8784

TABLE3-2' (Continued)

SSES Joint Frequency Distribution Of Wind Speed And Wind Direction 10m Versus Delta Temperature 60-lOm For The Period Of Januaryl, 2016 Through December 31, 2016 (Continued)

Joint Frequency Distribution Hours at Each Wind Speed and Direction Total Period Period of Record= 1/1/2016 00:00 - 12/31/2016 23:00 Elevation: Speed: !O_SPD Direction: 10 WD Lapse: DT60-10A Stability Class B Delta Temperature Moderately Unstable Wind Speed (mph)

Wind Direction 0.6-3.5 3.6-7.5 7.6-12.5 12.6-18.5 18.6-24.5 >24.6 Total N 0 0 6 1 0 0 7 NNE 0 6 6 0 0 0 12 NE 0 14 1 0 0 0 15 ENE 1 8 1 0 0 0 10 E 4 2 0 0 0 0 6 ESE 1 1 0 0 0 0 2 SE 1 3 0 0 0 0 4 SSE 0 1 7 0 0 0 8 s 0 3 2 0 0 0 5 SSW 0 12 6 0 0 0 18 SW 0 11 2.3 5 0 0 39 WSW 0 0 6 6 0 0 12 w 0 0 0 0 0 0 0 WNW 0 0 0 0 0 0 0 NW 0 1 0 0 0 0 1 NNW 0 0 1 0 0 0 1 Total 7 62 59 12 0 0 140 Calm Hours not Included above for : Total Period 4 Variable Direction Hours for: Total Period

0 Invalid Hours for: Total Period 19 Valid Hours for this Stability Class for: Total Period 140 Total Hours for Period 8784 3-5

TABLE3-2 (Continued)

SSES Joint Frequency Distribution Of Wind Speed And Wind Direction lOm Versus Delta Temperature 60-10m For The Period Of January 1, 2016 Through December 31, 2016 (Continued)

Joint Frequency Distribution Hours at Each Wind Speed and Direction Total Period Period of Record = 1/1/2016 00:00 - 12/3.1/2016 23:00 Elevation: Speed: lO_SPD Direction: lO_WD Lapse: DT60-10A Stability Class C Delta Temperature Slightly Unstable Wind Speed (mph)

Wind Direction 0.6-3.5 3.6-7.5 7.6-12.5 12.6w18.5 18,6w24,5 >24.6 Total N 0 13 13 0 0 0 26 NNE 0 33 11 0 0 0 44 NE 1 25 0 0 0 0 26 ENE 1 .18 0 0 0 0 19 E 2 14 2 0 0 0 18 ESE 0 1 0 0 0 0 1 SE 0 9 1 0 0 0 10 SSE 2 7 5 0 0 0 14 s 2 16 10 2 0 0 30 SSW 0 13 5 0 0 0 18 SW 0 43 62 4 0 0 109 WSW 0 1 19 4 0 0 24 w 0 2 2 0 0 0 4 WNW 0 1 0 0 0 ff 1 NW 0 1 3 0 0 0 4 NNW 0 2 11 4 0 0 17 Total 8 . 199 144 14 0 0 365 Calm Hours not Included above for : Total Period 4 Variable Direction Hours for: Total Period 0 Invalid Hours for: Total Period 19 Valid Hours for this Stability Class for: Total Period 365 Total Hours for Period 8784 3-6

TABLE3-2 (Continued)

SSES Joint Frequency Distribution* Of Wind Speed And Wind Direction iOm Versus Delta Temperature 60-lOm For The Period Of January 1, 2016 Through December 31, 2016 (Continued)

Joint Frequency Distribution Hours at Each Wind Speed and Direction Total Period Period of Record "' 1/1/2016 00:00 - 12/31/2016 23:00 Elevation: Speed: lO_SPD Direction: lO_WD Lapse: DT60-10A Stability Class D Delta Temperature Neutral Wind Speed (mph)

Wind Direction 0.6-3.5 3.6-7.5 7.6-12.5 12.6-18.5 18.6-24.5 >24.6 Total N 29 146 107 2 0 0 284 NNE 54 151 49 0 0 0 254 NE 85 168 22 0 0 0 275 ENE 100 78 8 0 0 0 186 E 108 55 7 0 0 0 170 ESE 86 40 7 0 0 0 133 SE 92 70 4 0 0 0 166 SSE 95 143 24 0 0 0 262 s 74 180 34 0 0 0 288 SSW 68 192 33 2 0 0 295 SW 36 287 250 28 0 0 601 WSW 17 95 170 78 6 0 366 w 19 62 88 34 0 0 203 WNW 6 56 73 53 1 0 189 NW 10 78 157 40 0 0 285 NNW 11 105 155 17 0 0 288 Total 890 1906 1188 254 7 0 4245 Calm Hours not Included above for : Total Period 4 Variable Direction Hours for: Total Period 0 Invalid Hours for: Total Period 19 Valid Hours for this Stability Class for: Total Period 4245 Total Hours for Period 8784 3-7

TABLE3-2 (Continued)

SSES Joint Frequency Distribution Of Wind Speed And Wind Direction 10m Versus Delta Temperature 60-lOm For The Period Of January 1, 2016 Through December 31, 2016 (Continued)

Joint Frequency Distribution Hours at Each Wind Speed and Direction Total Period Period of Record= 1/1/2016 00:00 - 12/31/2016 23:00 Elevation: Speed: lO_SPD Direction: 10_WD Lapse: DT60-IOA Stability Class E Delta Temperature Slightly Stable Wmd Speed (mph)

Wmd Direction 0.6-3.5 3.6-7.5 7.6-12.5 12.6-18.5 18.6-24.5 >24.6 Total N 42 45 3 0 0 0 90 NNE 82 84 4 0 0 0 170 NE 159 58 0 0 0 0 217 ENE 292 30 0 0 0 0 322 E 192 8 3 0 0 0 203 ESE 131 8 0 0 0 0 139 SE 112 18 2 0 0 0 132 SSE 114 33 3 6 0 0 156 s 135 110 10 2 0 0 257 SSW 78 148 13 0 0 0 239 SW . 29 85 20 *O 0 0 134 WSW 13 30 3 0 0 0 46 w 4 8 0 0 0 0 12 WNW 7 10 2 0 0 0 19 NW 4 20 2 0 0 0 26 NNW 9 35 1 0 0 0 45 Total 1403 730 66 8 0 0 2207 Calm Hours not Included above for : Total Period

4 Variable Direction Hours for: Total Period 0 Invalid Hours for: Total Period 19 Valid Hours for this Stability Class for: Total Period 2207 Total Hours for Period 8784

TABLE3-2 (Continued)

SSES Joint Frequency Distribution Of Wind Speed And Wind Direction lOm Versus Delta Temperature 60-lOm For The Period Of January 1, 2016 Through December 31, 2016 (Continued)

Joint Frequency Distribution Hours at Each Wind Speed and Direction Total Period Period of Record = 1/1/2016 00:00 - 12/31/2016 23 :00 Elevation: Speed: lO_SPD Direction: lO_WD Lapse: DT60-10A Stability Class F Delta Temperature Moderately Stable Wmd Speed (mph)

Wind Direction 0.6-3.5 3.6-7.5 7.6-12.5 12.6-18.5 18.6-24.5 >24.6 Total N 7 8 0 0 0 0 15 NNE 30 11 0 0 0 0 41 NE 110 9 0 0 0 0 119 ENE 388 42 0 0 0 0 430 E 191 0 0 0 0 0 191 ESE 63 0 0 0 0 0 63 SE 44 0 0 0 0 0 44 SSE 35 1 0 0 0 0 36 s 35 6 0 0 0 0 41 SSW 9 7 1 0 0 0 17 SW 8 13 0 0 0 0 21 WSW 3 0 1 0 0 0 4 w 1 1 0 0 0 0 2 WNW 0 0 0 0 0 0 0 NW 3 0 0 0 0 0 3 NNW 1 1 0 0 0 0 2 Total 928 99 2 0 0 0 1029 Calm Hours not Included above for : Total Period 4 Variable Direction Hours for: Total Period 0 Invalid Hours for: Total Period 19 Valid Hours for this Stability Class for: Total Period 1029 Total Hours for Period 8784 3-9

TABLE3-2 (Continued)

SSES Joint Frequency Distribution Of Wind Speed And Wind Direction 10m Versus Delta Temperature 60-lOm For The Period Of January 1, 2016 Through December 31,

2016 (Continued)

Joint Frequency Distribution Hours at Each Wind Speed and Direction Total Period Period of Record= 111/2016 00:00 - 12/31/2016 23:00 Elevation: Speed: IO_SPD Direction: lO_WD Lapse: DT60-10A Stability Class G Delta Temperature Extremely Stable Wind Speed (mph)

Wmd Direction 0.6-3.5 3.6-7.5 7.6-12.5 12.6-18.5 18.6-24.5 >24.6 Total N 4 1 0 0 0 0 5 NNE 7 1 0 0 0 0 8 NE 93 3 0 0 0 0 96 ENE 422 16 0 0 0 0 438 E 97 0 0 0 0 0 97 ESE 29 0 0 0 0 0 29 SE 8 0 0 *O 0 0 8 SSE 10 0 0 0 0 0 IO s 7 2 0 0 0 0 9 SSW 4 3 0 0 0 0 7 SW 1 0 0 0 0 0 1 WSW 0 0 0 0 0 0 0 w 0 0 0 0 0 0 0 WNW 0 0 0 0 0 0 0 NW 0 0 0 0 0 0 0 NNW 0 0 0 0 0 0 0 Total 682 26 0 0 0 0 708 Calm Hours not Included above for : Total Period 4 Variable Direction Hours for: Total Period 0 Invalid Hours for: Total Period 19 Valid Hours for this Stability Class for: Total Period 708 Total Hours for Period 8784

TABLE3-2 (Continued)

SSES Joint Frequency Distribution Of Wind Speed And Wind Direction 10m.Versus Delta Temperature 60-lOm For The Period Of January 1, 2016 Through December 31, 2016 (Continued)

Joint Frequency Distribution Hours at Each Wind Speed and Direction Summary of All Stability Classes Total Period Period of Record= 1/112016 00:00 - 12/31/2016 23:00 Elevation: Speed: lO_SPD Direction: IO_WD Lapse: DT60-10A Delta Temperature Wind Speed (mph)

Wind Direction 0.6-3.5 3.6-7.5 7.6-12.5 12.6-18.5 18.6-24.5 >24.6 Total N 82 214 130 3 0 0 429 NNE 176 287 71 0 0 0 534 NE 448 279 23 0 0 0 750 ENE 1205 195. 9 0 0 0 1409 E 595 80 12 0 0 0 687 ESE 312 50 7 0 0 0 369 SE 258 103 9 0 0 0 370 SSE 258 186 40 6 o: 0 490 s 255 318 64 5 0 0 642 SSW 160 376 66 2 0 0 604 SW 74 442 368 37 0 0 921 WSW 33 126 199 90 6 0 454 w 24 73 90 34 0 0 221 WNW 13 67. 75 53 1 0 209 NW 17 100 162 40 0 0 319 NNW 21 143 168 21 0 0 353 Total 3931 3039 1493 291 7 0 8761 Calm Hours not Included above for : Total Period 4 Variable Direction Hours for: Total Period 0 Invalid Hours for: Total Period 19 Valid Hours for this Stability Class for: Total Period 8761 Total Hours for Period 8784

TABLE3-3 SSES Joint.Frequency Distribution Of Wind Speed And Wind Direction 60m Versus Delta Temperature 60-lOm For The Period Of January 1, 2016 Through December 31, 2016 Joint Frequency Distribution Hours at Each Wind Speed and Direction Total Period Period of Record = 1/1/2016 00:00 - 12/31/2016 23:00 Elevation: Speed: 60_SPD Direction: 60_WD Lapse: DT60-10A Stability Class A Delta Temperature Extremely Unstable Wind Speed (mph)

Wind Direction 0.6-3.5 3.6-7.5 7.6-12.5 12.6-18.5 18.6-24.5 >24.6 Total N 4 1 0 1 0 0 6 NNE 1 1 0 1 0 0 3 NE 3 4 2 0 0 0 9 ENE 2 0 0 0 0 0 2 E 1 1 0 0 0 0 2 ESE 0 0 0 0 0 0 0 SE 0 0 4 1 0 0 5 SSE 3 0 1 1 0 0 5 s 0 1 2 4 3 0 10 SSW 1 3 4 0 2 0 10 SW 0 1 10 7 0 0 18 WSW 0 0 0 0 2 0 2 w 0 0 0 0 0 0 0 WNW 0 0 0 0 0 0 0 NW 0 0 0 0 0 0 0 NNW 0 0 0 0 0 0 0 Total 15 12 23 15 7 0 72 Calm Hours not Included above for : Total Period 2 Variable Direction Hours for: Total Period 0 Invalid Hours for: Total Period 15 Valid Hours for this Stability Class for: Total Period 72 Total Hours for Period 8784 3-12

TABLE3-3 (Continued)

SSES Joint Frequency Distribution Of Wind Speed And Wind Direction 60m Versus Delta Temperature 60-lOm For The Period Of January 1, 2016 Through December 31, 2016 (Continued)

Joint Frequency Distribution Hours at Each Wind Speed and Direction Total Period Period of Record == 1/1/2016 00:00 - 12/31/2016 23:00 Elevation: Speed: 60_SPD Direction: 60_WD Lapse: DT60-10A Stability Class B Delta Temperature Moderately Unstable Wind Speed (mph)

Wind Direction 0.6-3.5 3.6-7.5 7.6-12.5 12.6-18.5 18.6-24.5 >24.6 Total N 0 0 .0 8 0 0 8 NNE 0 I 15 4 0 0 20 NE 2 7. 4 1 0 0 14 ENE 3 3 3 0 0 0 9 E 1 1 0 0 0 0 2 ESE 0 1 0 0 0 0 1 SE 0 0 0 1 0 0 1 SSE 0 2 3 1 0 0 6 s 0 0 2 3 1 0 6 SSW 0 1 7 3 0 0 11 SW 0 3 ' 27 9 1 0 40 WSW 0 0 1 12 7 0 20 w 0 0 0 0 0 0 0 WNW 0 0 0 0 0 0 0 NW 0 0 0 0 0 0 0 NNW 0 0 2 0 0 0 2 Total 6 19 64 42 9 0 140 Calm Hours not Included above for : Total Period 2 Variable Direction Hours for: Total Period 0 Invalid Hours for: Total Period 15 Valid Hours for this Stability Class for: Total Period 140 Total Hours for Period 8784

TABLE3-3 (Continued)

SSES Joint Frequency Distribution Of Wind Speed And Wind Direction 60m Versus Delta Temperature 60-lOm For The Period Of January 1, 2016 Through December 31, 2016 (Continued)

Joint Frequency Distribution Hours at Each Wind Speed and Direction Total Period Period of Record "' 1/1/2016 00:00 - 12/31/2016 23:00 Elevation: Speed: 60_SPD Direction: 60_WD Lapse: DT60-10A

Stability Class C Delta Temperature Slightly Unstable Wmd Speed (mph)

Wind Direction 0.6-3.5 3.6-7.5 7.6-12.5 12.6-18.5 18.6-24.5 >24.6 Total N 0 12 12 8 0 0 32 NNE 0 17 24 4 0 0 45 NE 1 21 9 0 0 0 31 ENE 1 11 2 0 0 0 14 E 1 9 0 2 0 0 12 ESE 0 2 0 0 0 0 2 SE 1 5 5 1 0 0 12 SSE 0 2 5 2 0 0 9 s 1 2 9 7 3 0 22 SSW 0 8 12 2 1 0 23 SW 0 6 69 18 0 0 93 WSW 0 1 12 27 4 0 44 w 0 2 1 1 1 0 5 WNW 0 0 0 0 0 0 0 NW 0 0 6 4 0 0 10 NNW 0 1 6 4 0 0 n Total 5 99 172 80 9 0 365 Calm Hours not Included above for : Total Period 2 Variable Direction Hours for: Total Period 0 Invalid Hours for: Total Period 15 Valid Hours for this Stability Class for: Total Period 365 Total Hours for Period 8784

TABLE3-3 (Continued)

SSES Joint Frequency Distribution Of Wind Speed And Wind Direction 60m Versus Delta Temperature 60-lOm For The Period Of January 1, 2016 Through December 31, 2016 (Continued)

Joint Frequency Distribution Hours at Each Wind Speed and Direction Total Period Period of Record = 1/1/2016 00:00 - 12/31/2016 23:00 Elevation: Speed: 60_SPD Direction: 60_WD Lapse: DT60-10A Stability Class D Delta Temperature Neutral Wind Speed (mph)

Wind Direction 0.6-3.5 3.6-7.5 7.6-12.5 12.6-18.5 18.6-24.5 >24.6 Total N 15 64 150 47 0 0 276 NNE 39 119 130 52 1 0 341 NE 71 112 58 13 1 0 255 ENE 58 59 20 1 .o 0 138 E 38 33 32 5 0 0 108 ESE 31 27 19 3 0 0 80 SE 39 69 40 3 1 0 152 SSE 36 73 69 8 2 0 188 s 40 71 91 35 4 0 241 SSW 38 124 78 44 7 0 291 SW 21 203 197 81 1 0 503 WSW 12 76 190 287 78 11 654 w 7 42 99 105 26 0 279 WNW 2 26 95 97 22 0 242 NW 2 35 120 95 4 0 256 NNW 5 30 149 57 0 0 241 Total 454 1163 1537 933 147 11 4245 Calm Hours not Included above for : Total Period 2 Variable Direction Hours for: Total Period 0 Invalid Hours for: Total Period 15 Valid Hours for this Stability Class for: Total Pe1iod 4245 Total Hours for Period 8784 3-15

TABLE3-3 (Continued)

SSES Joint Frequency Distribution Of Wind Speed And Wind Direction 60m Versus Delta Temperature 60-lOm For The Period Of January 1, 2016 Through December 31, 2016 (Continued)

Joint Frequency Distribution Hours at Each Wind Speed and Direction Total Period Period of Record = 1/1/2016 00:00 - 12/31/2016 23:00 Elevation: Speed: 60_SPD Direction: 60_WD Lapse: DT60-10A Stability Class E Delta Temperature Slightly Stable Wind Speed (mph)

Wind Dfrection 0.6-3,5 3.6-7.5 7.6-12.5 12.6-18.5 18.6-24.5 >24.6 Total N 31 105 26 2 0 0 164 NNE 78 197 55 5 0 0 335 NE 89 90 42 3 0 0 224 ENE 63 30 7 0 0 0 100 E 47 28 6 3 0 0 84 ESE 39 19 9 0 0 0 67

. SE 62 24 12 2 0 0 100 SSE 30 44 20 3 4 3 104 s 53 56 53 14 1 1 178 SSW 48 67 99 28 2 0 244 SW 35 116 118 27 0 0 296 WSW 12 43 80 32 2 0 169 w 9 15 11 0 0 0 35 WNW 3 10 12 1 0 0 26 NW 8 8 20 1 0 0 37 NNW 10 16 18 1 0 0 45 Total 617 868 588 122 9 4 2208 Calm Hours not Included above for : Total Period 2 Variable Direction Hours for: Total Period 0 Invalid Hours for: Total Period 15 Valid Hours for this Stability Class for: Total Period 2208 Total Hours for Period 8784 3-16

TABLE3-3 (Continued)

SSES Joint Frequency Distribution Of Wind Speed And Wind Direction 60m Versus Delta Temperature 60-lOm For The Period 0£ January 1, 2016 Through December31, 2016 (Continued)

Joint Frequency Distribution Hours at Each Wind Speed and Direction Total Period Period of Record = 1/1/2016 00:00 - '* 12/31/2016 23:00 Elevation: Speed: 60_SPD Direction: 60_WD Lapse: DT60-10A Stability Class F Delta Temperature Moderately Stable Wind Speed (mph)

Wind Direction 0.6-3.5 3.6-7.5 7.6-12.5 12.6-18.5 18.6-24.5 >24.6 Total N 31 134 9 0 0 0 174 NNE 54 229 8 0 0 0 291 NE 73 35 3 0 0 0 111 ENE 55 5 0 0 0 0 60 E 40 3 0 0 0 0 43 ESE 30 3 0 0 0 *o 33 SE 30 5 1 0 0 0 36 SSE . 19 8 0 0 0 0 27 s 27 19 4 0 0 0 50 SSW 9 36 6 2 0 0 53 SW 13 31 30 0 0 0 74 WSW 2 IO 20 6 0 0 38 w 5 2 1 1 0 0 9 WNW 2 4 .o 0 0 0 6 NW 3 5 2 0 0 0 10 NNW 3 11 0 0 0 0 14 Total 396 540 84 9 0 0 1029 Calm Hours not Included above for : Total Period 2 Variable Direction Hours for: Total Period 0 Invalid Hours for: Total Period 15 Valid Hours for this Stability Class for: Total Period 1029 Total Hours for Period 8784 3-17

TABLE3-3 (Continued)

SSES Joint Frequency Distribution Of Wind Speed And Wind Direction 60m Versus Delta Temperature 60-10m For The Period Of January 1~ 2016 Through December 31, 2016 (Continued)

Joint Frequency Distribution Hours at Each Wind Speed and Direction Total Period Period of Record = 1/1/2016 00:00 - 12/31/2016 23:00 Elevation:. Speed: 60"-SPD Direction: 60_WD Lapse: DT60-10A Stability Class G Delta Temperature . Extremely Stable Wind Speed (mph)

Wind Direction 0.6-3.5 3.6-7.5 7.6-12.5 12.6-18.5 18.6-24,5 >24,6 Total N 11 84 6 0 0 0 101 NNE 51 183 8 0 0 0 242 NE 54 51 0 0 0 0 105 ENE 28 5 0 0 0 0 33 E 36 8 0 0 0 0 44 ESE 26 5 0 0 0 0 31 SE 31 5 0 0 . 0. 0 36 SSE 13 6 0 0 0 0 19 s 7 14 2 0 0 0 23 SSW 4 15 5 0 0 0 24 SW 4 19 6 1 0 0 30 WSW 1 3 2 1 0 0 7 w 0 1 0 0 0 0 1 WNW 0 4 0 0 0 0 4 NW 1 0 1 O' 0. 0 2 NNW 2 3 1 0 0 0 6 Total 269 406 31 2 0 0 708 Calm Hours not Included above for : Total Period

2 Variable Direction Honrs for: Total Period 0 Invalid Hours for: Total Period 15 Valid Hours for this Stability Class for: Total Period 708 Total Hours for Period 8784

TABLE3-3 (Continued)

SSES Joint Frequency Distribution Of Wind Speed And Wilid Direction 60m Versus Delta Temperature 60-lOm For The Period Of January 1, 2016 Through December 31, 2016 (Continued)

Joint Frequency Distribution Hours at Each Wind Speed and Direction Summary of All Stability Classes.

Total Period Period of Record= 11112016 00:00 - 12/31/2016 23:00 Elevation: Speed: 60 SPD Direction: 60_WD Lapse: DT60-10A Delta Temperature Wind Speed (mph)

Wind Directioµ. 0.6-3.5 3.6-7.5 1.6-12.5 12.6-18.5 18.6-24.5 >24.6 Total N 92 400 203 66 0 0 761 NNE 223 747 240 66 1 0 1277 NE 293 320 118 17 I 0 749 ENE 210 113 32 1 0 0 356 E 164 . 83 38 10 0 0 295 ESE 126 57 28 3 0 0 214 SE 163 108 62 8 l 0 342 SSE 101 135 98 15 6 3 358 s 128 163 163 63 12 1 530 SSW 100 254 211 79 12 0 656 SW 73 379 457 143 2 0 1054 WSW 27 133 305 365 93 11 934 w 21 62 112 107 27 0 329 WNW 7 44 107 98 .22 0 278 NW 14 48 149 100 4 0 315 NNW 20 61 176 62 0 0 319 Total 1762 3107 2499 1203 181 15 8767 Calm Hours not Included above for : Total Period 2 Variable Direction Hours for: Total Period 0 Invalid Hours for: Total Period 15 Valid Hours for this Stability Class for: Total Period 8767 Total Hours for Period 8784 3-19

TABLE3-4 3

2016 SSES Annual Relative Concentrations.- No Decay1 Undepleted X/Q (sec/m )

Miles Direction 0-1 1-2 2-3 3-4 4-5 5-10 10-20 20-30 30-40 40-50 From N 4.32E-06 8.14E-07 3.40E-07 l.80E-07 l.16E-07 4.32E-08 1.20E-08 5.82E-09 3.67E-09 2.61E-09 NNE 6.70E-06 l.35E-06 6.04E-07 3.25E-07 2.lOE-07 7.80E-08 2.ISE-08 1.06E-08 6.75E-09 4.83E-09 NE l.53E-05 2.84E-06 l.29E-06 7.38E-07 4.89E-07 1.94E-07 5.89E-08 2.97E-08 l.91E-08 l.39E-08 ENE 4.70E-05 8.62E-06 4.20E-06 2.49E-06 l.67E-06 6.61E-07 l.93E-07 9.36E-08 6.06E-08 4.46E-08 E 2.08E-05 3.78E-06 l.67E-06 9.45E-07 6.32E-07 2.57E-07 8.l3E-08 4.llE-08 2.66E-08 1.94E-08 ESE l.13E-05 2.19E-06 9.92E-07 5.56E-07 3.70E-07 1.49E-07 4.16E-08 1.83E-08 l.17E-08 8.49E-09 SE 9.94E-06 l.98E-06 9.04E-07 5,08E-07 3.36E-07 l.36E-07 3.37E-08 l.24E-08 7.92E-09 5.68E-09 SSE 9.92E-06

l.92E-06 8.46:£.:07 4.73E-07 3.17E-07 l.35E-07 3.50E-08 I.24E-08 7.90E-09 5.65E-09 s 7.94E-06 1.68E-06 8.14E-07 4.71E-07 3.23E-07 I.49E-07 4.12E-08 1.41E-08 8.97E-09 6.42E-09 SSW 7.19E-06 l.44E-06 6.58E-07 3.70E-07 2.44E-07 1.0tE-07 2.59E-08 9.75E-09 6.14E-09 4.36E-09 SW 6.27E-06 1.25E-06 5.90E-07 3.37E-07 2.24E-07 9.68E-08 2.45E-08 8.12E-09 5.0BE-09 3.56E-09 WSW 2.99E-06 5.84E-07 2.72E-07 l.60E-07 1.09E-07 5.13E-08 I.59E-08 5.92E-09 3.0lE-09 l.63E-09 w l.39E-06 2.63E-07 l.13E-07 6.14E~os 3.99E-08 1.60E-08 4.21E-09 l.67E-09 l.02E-09 7.00E-10 WNW l.26E-06 2.33E-07 9.28E-08 4.83E-08 3.07E-08 l.12E-08 3.0lE-09 1.41E-09 B.64E-10 5.94E-10 NW 2.lOE-06 3.90E-07 l.56E-07 7.96E-08 5.0SE-08 1.BlE-08 4.76E-09 2.24E-09 1.38E-09 9.54E-10 NNW 2.SOE-06 4.74E-07 l.99E-07 l.OSB-07 6.62E-08 2.29E-08 5.66B-09 2.67E-09 1.65E-09 1.14E-09

TABLE3-5 2016 SSES Annual Relative Concentrations - 2.26-Day Decay, Undepleted X/Q (sec/ms)

Miles Direction 0-1 1-2 2-3 3-4 4-5 5-10 10-20 20-30 30-40 40-50 From N 4.31E-06 8.09E-07 3.37E-07 l.78E-07 l.14E-07 4.20E-08

1.13E-08 5.27E-09 3.19E-09 2.17E-09 NNE 6.69E-06 1.34E-06 5.98E-07 3.20E-07 2.06E-07 7.54E-08 2.0lE-08 9.45E-09 5.75E-09 3.93E-09 NE l.53E-05 2.81E-06 l.28E-06 7.24E-07 4.78E-07 1.86E-07 5.42E-08 2.58E-08 1.57E-08 1.0SE-08 ENE 4.68E-05 8.55E-06 4.14E-06 2.44E-06 I.62E-06. 6.34E-07 1.77E-07 8.llE-08 4.96E-08 3.45E-08 E 2.07E-05 3.74E-06 l.64E-06 9.23E-07 6.13E-07

2.44E-07 7.35E-08 3.48E-08 2.lOE-08 1.43E-08 ESE l.13E-05 2.17E-06 9.76E-07 5.43E-07 3.58E-07

1.42E-07 3.75E-08 1.54E-08 9.21E-09 6.22E-09 SE 9.91E-06 1.96E-06 8.90E-07 4.97E-07 3.27E-07 1.30E-07 3.07E-08 1.06E-08 6.37E-09 4.30E-09 SSE 9.89E-06 1.90E-06 8.35E-07 4.64E-07 3.09E-07 1.30E-07 3.22E-08 l.08E-08 6 ..49E-09 4.39E-09 s 7.92E-06 l.67E-06 8.04E-07 4.63E-07 3.16E-07 1.44E-07 3.82E-08 L25E-08 7.56E-09 5.15E-09 SSW 7.18E-06 l.44E-06 6.52E-07 3.65E-07 2.40E-07 9.80E-08 2.45E~os 8.88E-09 5.39£-09 3.69E-09 SW 6.26E-06 1.24E-06 5.85E-07 3.33E-07 2.21E-07 9.46E-08 2.34E-08 7.50E-09 4.54E-09 3.09E-09 WSW 2.99E-06 5.81E-07 2.70E-07 1.59E-07 1.08E-07 5.02E-08 1.52E-08 5.47E-09 2.69E-09 1.41E-09 w I.39E-06 2.61E-07 1.12E-07 6.07E-08 3.94£-08 1.57E-08 4.02E-09 l.55E-09 9.17£-10 6.09E-10 WNW 1.26E-06 2.32E-07 9.22E-08 4.79E-08 3.04E-08 l.lOE-08 2.90E-09 1.32£-09 7.86E-10 5.26E-10 NW 2.lOE-06 3.89,E-07 1.55E-07 7.89E-08 4.99E-08. 1.78E-08 4.56E-09 2.0BE-09 1.24E-09 8.33E-10 NNW 2.SOE-06 4.72E-07 l.98E-07 l.04E-07 6.54E-08 2.25E-08 5.43E-09 2.49E-09 1.49E-09 l.OlE-09 3-21

TABLE3-6 2016 SSES Annual Relative Concentrations Day Decay, Depleted XJQ (sec/m3)

Miles Direction 0-1 1-2 2-3 3-4 4-5 5-10 10-20 20-30 30-40 40-50 From N 3.95E-06 6.89E-07 2.75E-07 l.40E-07 8.70E-08 3.0lE-08 7.36E-09 3.13E-09 l.77E-09 l.14E-09 NNE 6.12E-06 1.14E-06 4.89E-07 2.52E-07 l.57E-07 5.42E-08 1.32E-08 5.67E-09 3.23E-09 2.09E-09 NE l.40B-05 2.40E-06 l.OSE-06 5.70E-07 3.66E-07 l.34E-07 3.61B-08 1.58~-08 9.04E-09 5.94E-09 ENE 4.29E-05 7.30E-06 3.39E-06 l.92E-06 l.24E-06 4.58E-07 l.18E-07 4.97E-08 2.87E-08 l.90E-08 E 1.90E-05 3.20E-06 l.35E-06 7.30E-07 4.72E-07 l.78E-07 4.95E-08 2.17E-08 l.25E-08 8.18E-09 ESE l.03E-05 l.85E-06 8.0lE-07 4.30E-07. 2.76E-07 l.03E-07 2.53E-08 9.61E-09 5.48E-09 3.57E-09 SE 9,08E-06 l.67E-06 7.30E-07 3.93E-07 2.51E-07 9.41E-08 2.06E-08 6.57E-09 3.73E-09 2.41E-09 SSE 9.06E-06 1.62E-06 6.84E-07 3.66E-07 2.37E-07 9.36E-08 2.14E-08 6.61B-09 3.74E-09 2.41E-09 s 7.26E-06 1.42E-06 6.58E-07 3.65E-07 2.41B-07 1.04E-07 2.52E-08 7.53E-09 4.28E-09 2.77E-09 SSW 6.57E-06 1.22E-06 S.32B-07 2.87E-07 . l.83E-07 7.0lB-08 l.60E-08 5.25E-09 2.96E-09 l.91E-09 SW 5,73E-06 1.06E-06 4.77E-07 2.61E-07 l.68E-07 6.75E-08 1.SIE-08 4.39E-09 2.46E-09 1.57E-09 WSW 2.73E-06 4.95E-07 2.20E-07 l.24E-07 8.20E-08 3.58E-08 9.84E-09 3.20E-09 l.46E-09 7.19E-10 w 1.27E-06 2.22E-07 9.1 lE-08 4.76E-08 2.99E-08 1.12B-08 2.60E-09 9.03E-10 4.96E-10 3.09E-10 WNW l.lSE-06 l.97B-07 7.51E-O~ 3.75E-08 2.3IE-08 7.84E-09 l.87E-09 7.64E-10 4.21B-10 2.64E-10 NW I.92E-06 3.31B-07 1.26E-07 6.18E-08 3.79E-08 l.26E-08 2.95E-09 l.21E-09 6.71E-10 4.2m~10 NNW 2.29B-06 4.02E-07 l.61E-07 8.17E-08 4.97E-08 l.60E-08 3.50E-09 1.45E-09 8.02E-10 5.0SE-10 3-22

TABLE3-7 2016 SSES Annual Relative Concentrations - DIQ (m"2)

Miles Direction 0-1 1-2 2-3 3-4 4-5 5-10 10-20 20-30 30-40 40-50 From N 2.49E-08 3.67E-09 l.51E-09 7.14E-10 4.22E-10 l.34E-10 3.20E-ll 1.18E-11 6.29E-12 3.95E-12 NNE 2.86E-08 4.43E-09 l.92E-09 9.14E-10 5.38E-10 l.68E-10 3.91E-11 1.44E-ll 7.68E-12 4.83E-12 NE 3.76E~08 5.66E-09 2.42E-09 1.17E-09 6.95E7l0 2.24E-10 5.49E-11 2.02E-ll 1.08E-11 6.78E-12 ENE 7.51E-08 1.17E-08 5.20E-09 2.54E-09 l.SOE-09 4.75B-10 1.0SE-10 3.80E-11 2.03E-ll l.27E-ll E 3.56E-08 5.20E-09 2.12E-09 l.OlE-09 6.03E-10 1.99E-IO 5.04E-11 l.85E-11 9.90E-12 6.22E-12 ESE 2.20E-08 3.32E-09 l.42E-09 6.84E-10 4.09E-10 1.36E-10 3.08E-11 9.94E-12 5.31E-l2 3.33E-12 SE 2.63E-08 4.00E-09 1.75E-09 8.63E-10 5.18E-10 l.75B-10 3.64E-11 9.97E-12 5.32E-12 3.34E-12 SSE 3.31E-08 4.93E-09 2.lOE-09 1.04E*09 6.33E-IO 2.26E-IO 4.97E-11 l.32E-ll 7.05E-12 4.43E-12 s 3. IOE-08 4.96E-09 2.33E-09 1.20E-09 7.47E-10 2.89E-10 6.74E-11 1.73E-ll 9.23E-12 5.80E-12 SSW 3.SOE-08 5.35E-09 2.40E-09 l.22B-09 7.36E-10 2.57E-10 5.70E-11 l.63E-ll 8.69E-12 5.46E-12 SW 4.80E-08 7.63E-09 3.59E-09 l.86E-09 l.15E-09 4.3lE-10 9.74E-11 2.48E-11 l.32E-ll 8.32E-12 WSW 2.7DE-08 4.17E-09 1.95E-09 1.04E-09 6.63E-10 2.73E-10 7.69E-1 I 2.22E-11 9.73E-12 4.77E-12 w 1.lOE-08 l.65E-09 7.15E-10 3.57E-10 2.18E-10 7.79E-ll 1.90B-11 5.96E-12 3.18E-12 2.00E-12 WNW l.16E-08 l.67E-09 6.73E-10 3.22E-10 l.91E-10 6.19E-11 l.53E-11 5.63E-l2 3.0IB-12 1.89E-12 NW l.90E-08 2.78E-09 1.llE-09 5.19E-10 3.07E-10 9.73E-ll 2.33E-ll 8.60B-12 4.59E-12 2.88E-12 NNW 2.12E-08 3.15E-09 1.33E-09 6.43E-10 3.77E-10 l.15E-10 2.58E-l 1 9.SlE-12 5.08E-12 3.191H2 3-23

- l TABLE3-8 2016 ATMOSPHERIC DISPERSION ESTIMATES FOR RETDAS INPUT AT SELECTED LOCATIONS X/QDEC+

AFFECTED SECTOR LOCATION MILES X/Q(l) X/QDEd2) DEP(3) DEPOSITION(4)

Maximum (XJQ) 12/WSW 1.22 1.19E-05 l.18E-05 l.02E-05 1.66E-08 Site Boundary Closest (X/Q) Site 9/S 0.38 6.56E-06 6.55E-06 6.lOE-06 4.02E-08 Boundary Maximum (XJQ) 12/WSW 1.3 1.08E-05 l.07E-05 9.20E-06 l.49E-08.

Residence Maximum (D/Q) 16/NNW 0.6 7.54E-06 7.52E-06 6.80E-06 2.41E-08 Residence Maximum (D/Q) 12/WSW 1.3 l.08E-05 1.07E-05 9.20E-06 l.49E-08 Garden Maximum (D/Q) 12/WSW 1.7 7.24E-06 7.17E-06

6.06E-06 9.58E-09 Dairy Maximum (D/Q) 12/WSW 1.7 7.24E-06 7.l 7E-06 6.06E-06 958E-09 Meat Producer 3/NE Riverlands I EIC 0.7 3,83E-06 3.82E-06 3.42E-06 2.73E-08 12/WSW Tower's Club 0.5 4.69E-05 4.68E-05 4.28E-05 7,SOE-08 1 XIQ RELATIVE CONCENTRATION (SEC/M")

2 X/QDEC DECAYED AND UNDEPLETED, HALF*LIFE 2.26 DAYS (SEC/M")

3 X/QDEC+DEP DECAYED AND DEPLETED, HALF*LIFE 8 DAYS (SEC/M")

4 DEPOSITION RELATIVE DEPOSITION RATE (1/M")

3-24

I l

I TABLE3-9 I

~

2016 ATMOSPHERIC DISPERSION ESTIMATES f.

AT THE NEAREST RESIDENCE WITHIN A 5-MILE RADIDS BY SECTOR SECTOR NUMBER 1

AFFECTED SECTOR N

NAME M. Burd-Wida MILES 1.3 X/Q(l) 2.06E-06 X/QDEc(2) 2.04E-06 X/QDEC+

DEP(3) l.76E-06 DEPOSITION(4) 6.30E-09 II 2 NNE E. Ashbridge III 1 2.61E-06 2.60E-06 2.28E-06 1.07E-08 I

3 4

NE ENE W. Tuggle B. Ditkosky/ T.Davis 0.9 2.1 2.64E-06 3.53E-07 2.64E-06 3.SlE-07 2.32E-06 2.90E-07 l.79E-08 2.52E-09 Ii 5 E L. Kozlowski 1.4 2.92E-07 2.91E-07 2.48E-07 l.86E-09 ;

6 ESE R. Panetta 0.5 l.26E-06 1.26E-06

1.lSE-06 l.16E-08 I~

7 SE J. Futoma 0.5 2.lOE-06 2.lOE-06 l.92E-06 1.90E-08 Ili ff 8 SSE M.Naunczek 0.6 1.90E-06 l.89E-06 . l.71E-06 l.54E-08 9 s S. Slusser I l.51E-06 l.50E-06 l.31E-06 7.44E-09 10 SSW S. Molnar 0.9 2.84E-06 2.83E-06 2.49E-06 l.05E-08 11 SW F. Michael 1.5 2.84E-06 2.82E-06 2.40E-06 5.67E-09 12 WSW F. Michael 1.3 1.08E-05 1.07E-05 9.20E-06 l.49E-08 13 w F.Hummel 1.2 5.35E-06 5.30E-06 4.59E-06 7.68E-09 14 WNW J. Confer 1.1 3.49E-06 3.46E-06 3.0lE-06 5.67E-09 15 NW C. McGraw, Jr. 0.8 4.98E-06 4.95E-06 4.40E-06 1.18E-08 16 NNW G. John 0.6 7.54E-06 7.52E-06 6.80E-06 2.41E-08 1 X/Q RELATIVE CONCENTRATION (SEC/M~)

0 2 X/QDEC DECAYED AND UNDEPLETED, HALF-LIFE 2.26 DAYS (SEC/M )

0 3 X/Q DEC+DEP DECAYED AND DEPLETED, HALF-LIFE 8 DAYS (SEC/M )

4 DEPOSITION RELATIVE DEPOSITION RATE (1/M"')

3-25

TABLE3-10 2016 ATMOSPHERIC DISPERSION ESTIMATES AT THE NEAREST GARDEN WITHIN A 5-MILE RADIUS BY SECTOR SECTOR AFFECTED X/QDEC+

NAME MILES NUMBER SECTOR X/Q(l) X/QDEC(2) DEP(3) DEPOSITION(4) 1 N B. J. Wojcik 3.2 5.45E-07 5.36E-07 4.26E-07 1.43E-09 2 NNE R Chapin 2.3 7.47E-07 7.41E-07 6.09E-07 2.74E-09 3 NE M. Welch 2.7 5.l9E-07 5.15E-07 4.16E-07 3.09E-09 4 ENE G.Dennis 2.4 2.90E-07 2.88E-07 2.35E-07 2.07E-09 5 E. I.Brown 4.3 4.31E-08 4.26E-08 3.25E-08 2.38E-10 6 ESE B. Hoffman 3.1 6.llE-08 6.06E-08 4.81E-08 4.20E-10 7 SE R. Shibilski. 0.6 l.59E-06 l.58E-06 l.43E-06 l.38E-08 8 SSE H.Roinick 2.9 l.SOE-07 1.49E-07 l.20E-07 9.65E-10 9 s B. J. Caluch 3.5 l.8QE-07 l.78E-07 l.40E-07 7.14ff*l0 10 SSW M. Fink 1.3 1.66E-06 l.65E-06 1.42E-06 5.66E-09 11 SW R. Broody 1.9 1.97E-06 l.95E-06 1.64E-06 3.82E-09 12 WSW F. Michael 1.3 l.08E-05 1.07E-05 9.20E-06 1.49E-08 13 w R White 2.0 2.39E-06 2.35E-06 l.97E-06 3.13E~09 14 WNW P.Moskaluk 1.3 2.72E-06 2.69E-06 2.32E-06 4.25E-09 15 NW T. Dawson 0.9 4.19E-06 4.16E-06 3.67E-06 9.61E-09 16 NNW P. Culver 4 3.82E-07 3.74E-07 2.90E-07 7.97E-10 1 X/Q RELATIVE CONCENTRATION (SEC/M")

2 X/Q DEC DECAYED AND UNDEPLETED, HALF-LIFE 2.26 DAYS (SEC/MW}

3 X/QDEC+DEP DECAYED AND DEPLETED, HALF-LIFE 8 DAYS (SEC/M°)

4 DEPOSITION RELATIVE DEPOSITION RATE (1/M~)

3-26

TABLE3-11 2016 ATMOSPHERIC DISPERSION ESTIMATES AT THE NEAREST ANIMAL RAISED FOR MEAT CONSUMPTION WITHIN A 5-MILE RADIUS BY SECTOR SECTOR AFFECTED XJQDEC+

NUMBER SECTOR NAME MILES X/Q(l) X/QDEd2) DEP(3) DEPOSITION(4) 2 NNE R. Chapin 2.3 7.47E707 7.41E-07 6.09E-07 2.74E-09 4 ENE G.Dennis 2.4 2.90E-07 2.88E-07 2.35E-07 2.07E-09 5 E J. Bloss 4.5 3.99B~08 3.93E-08 2.99E-08 2.17E-10 10 SSW K.. Davis 14 2.44E-08 2.29E-08 l.52E-08 4.51E-11 12 WSW T. & M. Berger 1.7 7.24E-06 7.17E-06 6.06E-06 9.58E-09 13 w J. &N. Dent 5.0 5.24E-07 5.07E-07 3.85E-07 4.79E-10 15 NW T.Dawson 0.9 4.19E-06 4.16E-06 3.67E-06 9.61E-09 TABLE3-12 2016 ATMOSPHERIC DISPERSION ESTIMATES AT ALL DAIRY LOCATIONS SECTOR AFFECTED XJQDEC+

NUMBER SECTOR NAME MILES X/QDEC(2)

X/Q(l) DEP(3) DEPOSITION(4) 5 E J. Bloss 4.5 3.99E-08 3.93E-08 2.99E-08 2.17E-10 10 SSW K.. Davis 14 2.44E-08 2.29E-08 l.52E-08 4.SIE-11 12 WSW T. & M. Berger 1.7 7.24E-06 7.17E-06 6.06E-06 9.58E-09 13 w J. &.N.Dent 5 5.24E-07 5.07E-07 3.85E-07 4.79E-10 1 XJQ RELATIVE CONCENTRATION (SEC/M~)

2 X/QDEC DECAYED AND UN DEPLETED, HALF-LIFE 2.26 DAYS {SEC/M~)

3 XJQ DEC+DEP DECAYED AND DEPLETED, HALF-LIFE B DAYS (SEC/M~)

4 DEPOSITION RELATIVE DEPOSITION RATE {1/M")

3-27

FIGURE3-1 2016 ANNUAL WIND ROSE lOM LEVEL - PRIMARY TOWER Ai.JriP~te: 11512017 9:23:2? AM WIND ROSE (WINDS

. NFROM)

'.f o: tm~ PERCENT to.LMS (NOT 1NµL.JbEo 1N rl'.on S~art OQ,te: 1/1/2016 OD: ~~

E;nd bate: 12/31}2016 2.3:00 S~h$or$

. 10.:.SPDSE!leiciec! . -* ~~-=1

tocWO . .

LE!gi;in\J *. . ** . *...

/:;. \!/IND SPEED LE~STHAN J.5 MPH ~

ic wiNO spE:£o't:E:ss THAN r5 MPH

~*. WJNOSPEED LESS THAN 1i5 MPH

. ~

wiNo SPEED (iREATERTHAN~:zpMPH

'--~~~~~~~~~~~~~~~~~~~-----'

This wind rose displays the frequency of hourly average wind direction from a given sector. In 2016, the predominant wind direction occurred 16.l % of the time from the ENE sector. The average wind speed was 5.0 mph and the average wind speed for the predominant sector (ENE) was 2. 7 mph. The sectors with the highest average wind speeds were WSW and WNW (9 .3 mph).

3-28

FIGURE 3-2 2016 ANNUAL WIND ROSE 60M LEVEL - PRIMARY TOWER Run Date: 115/ 2017 9:24:48 AM WIND ROSE (WINDS FROM)

N 0.08% PERCENT CALM S (NOT INCLUDED IN PLOT) 16 %

Start Date: 1/1 /2016 00:00 E End Date: 12/31/2016 23:00 Sensors Selected 60 SPD 60=WD ESE

[

Legend - - - - - - - - - - ,

t. WIND SPEED LE SS THAN 3.5 MPH n WIND SPEED LE SS THAN 75 MPH a WIND SPEED LE SS THAN 12.5 MPH SSW s ~ WIND SPEED GREATER THAN 12.5 MPH

\

This wind rose displays the frequency of hourly average wind direction from a given sector. In 2016, the predominant wind direction occurred 14.6 % of the time from the NNE sector. The average wind speed was 7. 7 mph and the average wind speed for the predominant sector (NNE) was 6.1 mph. The sector with the highest average wind speed was WSW (12.5 mph.).

3-29

FIGURE 3-3 PASQUIL STABILITY CLASS PREVALENCES DATA Period: 2016 Joint Frequency Distributions at 10 Meters Wind Speed and Direction 1OM vs. Delta Temperature 60-1 OM (Based on 8,761 Valid Hours)

C 3-30

SECT/ON4 DOSE MEASUREMENTS AND ASSESSMENTS

. 4-1

Radiological Impact on Man

.Sampling and analysis of airborne and waterborne effluents were performed in accordance with the frequencies, types of analysis, and Lower Limit of Detection (LLD) outlined in the Susquehanna Nuclear, LLC Technical Requirements Manual.

Radioactive material was detected in some of the airborne and wate.rborne effluent samples analyzed. Dose calculations using measured and calculated effluent activity levels, meteorological data from the current reporting period and average river flow dilution factors resulted in estimated doses to individuals at levels below 10 CFR 20 and 10 CFR 50, Appendix I limits. Direct radiation resulting from plant operation (reported in the 2016 Annual Radiological Environmental Operating Report) contributed a maximum of 8.92E-1 mrem (measured at location 9S2 and based on an occupancy time by a member of the public of 20 hours2.314815e-4 days 0.00556 hours 3.306878e-5 weeks 7.61e-6 months per quarter) at the Protected Area Boundary south of the plant. Based on airborne effluent sample data, the maximum organ (including thyroid)/total body dose is 2.98E-1 mrem (CHILD, LUNG Table 4-4). The maximum organ/total body dose from all liquid effluent is 2.73E-3 mrem (ADULT, GI-LU Table 4-2). Conservatively adding the maximum organ/total body dose from liquid and gaseous effluent and the maximum total body dose determined from* direct radiation results in a dose of 1.19 mrem, which is 4.8% .of the 40CFR 190 limit of 25 mrem to total body/organ (except thyroid) and 1.6% of the 40CFR190 limit of 75 mrem to the thyroid.

Doses to a maximally exposed member of the public from waterborne effluents are calculated for fish ingestion and shoreline exposure at the plant outfall, and drinking water ingestion at Danville, PA. Site specific parameters used in the calculations for the Danville receiver, specific for actual average blowdown and river level for the entire year are shown in Table 4-1.

TABLE 4-~

SITE-SPECIFIC PARAMETERS USED FOR RETDAS CALCULATIONS (DANVILLE RECEIVER)

FOR2016 PARAMETER ENTIRE YEAR Cooling Tower Slowdown (CFS) 26.8 Average Net River Level (ft.) 5.8 Dilution Factor at DanvilleC1l 312.5 Transit time to Danville (hr.)(1} 30.2 1

< lFrom ODCM-QA-005, Att. E 4-2

Summaries of maximum individual doses resulting from airborne and waterborne radioactive effluent releases from each unit are given in Table 4-2. Meteorological data from Section 3 were used to calculate the dose from airborne effluents.

The Radioactive Effluent Release Report includes an assessment of the radiation dose from radioactive effluents to members of the public within the site boundary.

Within the Site Boundary there are several areas frequented by members of the public. There are no significant exposure pathways from waterborne effluents in these areas. Doses from airborne effluent are calculated for members of the public for the following locations: Riverlands Energy Information Center, the Towers Club, and residence with the maximum' X/Q value; the garden, dairy and meat producing farm with the maximum D/Q value; and the site boundary with the maximum X/Q value. Summaries of the calculated maximum doses within the site boundary and selected locations beyond the site boundary resulting from airborne effluents are presented in Table 4-4. The above referenced locations are shown on Figure 4-1.

In the area comprising the Riverlands recreation area, which surrounds the Energy Information Center, three pathways of radiation exposure can be identified: plume, ground, and inhalation. There are no significant exposure pathways from waterborne effluents in this area. There are approximately 40,000 visitors to the Riverlands/Energy Information Center complex each year. For dose calculations, it is assumed the visitor stays in the area for one hour. The calculated dose rate and

collective dose for visitors to the Riverlands/Energy lnformatiqn Center during 2016 are shown on Table 4-3.

Use of the RETDAS code yields calculated doses' for the Riverlands area for the

- report period. These doses assume an occupancy factor of 100% for a member of the public during 2016. These calculated dose values are shown on Table 4-4.

In Regulatory Guide 1.21, Revision 2, "Measuring, Evaluating, and Reporting Radioactive Material in Liquid and Gaseous Effluents and Solid Waste", the NRG has recommended that U.S. nuclear power plants evaluate whether Carbon-14 (C-

14) is a "principal radionuclide", and if so, report the amount of C-14 released.

Radioactive effluent releases of C-14 have not increased but the decline in releases of other radionuclides has resulted in C-14 possibly becoming more prominent, specifically in airborne effluents. This regulatory guidance has led to an industry initiative to evaluate and report C-14 in the Annual Radioactive Effluent Release Report.

Information for C-14 dose impact is included as supplemental information in this report. Reportable values for dose impact do not include C-14 contribution. C-14, with a half-life of 5730 years, is a naturally occurring isotope of carbon produced by cosmic ray interactions in the atmosphere. Nuclear weapons testing in the 1950s and 1960s significantly increased the amount of C-14 in the atmosphere. C-14 is also produced in commercial nuclear reactors, but the amounts produced are much less than those produced naturally or. from weapons testing.

4-3

_J

In December 2010 the Electric Power Research Institute (EPRI) published Report 1021106, "Estimation of Carbon-14 in Nuclear Power Plant Gaseous Effluents",

which provides conservative technical guidance to support the calculation of C-14 released in radioactive effluents*. In a BWR the majority of C-14 is generated in the reactor core by neutron activation of reactor coolant, specifically 17O(n,a) 14C. Thus C-14 generation is directly proportional to reactor power. As documented in the EPRI report (for a BWR), approximately 99% of the C-14 produced in the reactor core is discharged as gaseous effluent (primarily as C02) through the offgas system. The remaining 1% is released in the form of solid radwaste. There is minimal (<1 %) C-14 released in the liquid effluent pathway.

In October of 2012 Susquehanna, in conjunction with an offsite lab, performed sampling and analysis for airborne effluent C-14 released from the station via each units offgas system.

Since both Susquehanna units are essentially identical in reactor design, a single '

value for the C-14 release rate (in the C02 form from the offgas system sample results) is used in the calculation of C-14 released from each unit. The release rate value. is corrected to 100% power then scaled to the fraction of full power year for each unit. The fraction of a full power year is calculated as-the Effective Full Power Days for the year in question divided by 365 to get the fraction of effective vs full year operation.

Based on the above outlined methodology, approximately 43 Curies of C-14 were released in gaseous effluents in 2016.

The airborne effluent pathway with the highest offsite dose potential (for C-14 releases) is the vegetation ingestion pathway. The maximum expected annual dose from C-14 released from Susquehanna Unit-1 (3.26E-1 mrem) and Unit-2 (4.01 E-1 mrem) has been calculated based on methodology in Regulatory Guide 1.109 and includes site specific parameters {e.g., nearest garden with highest X/Q value, producing both broad leaf and non-broad leaf vegetation). The maximum organ dose from airborne effluent C-14 released from the Susquehanna station in 2016 is well below the 10CFR50, Appendix I, ALARA design objective (i.e., 15 mrem/yr per unit). The annual dose to the maximally exposed individual from all gaseous releases of C-14 (calculated by the above referenced methodology) is 7.27E-1 mrem to the critical organ (bone) and 1.45E-1 mrem to the total.body.

Conservatively adding the maximum dose (calculated based on liquid and gaseous effluent sample results combined with direct radiation results) referenced on page 4-2 to the_ maximum dose due to the calculated release of C-14 (7.27E-1 mrem, CHILD, BONE) bounds the dose *that any member of the public receives from station operations to 1.92 mrem, which is 7.7% of the 40CFR190 limit of 25 mrem to total body/organ (except thyroid) and 2.6% of the 40CFR190 limit of 75 mrem to the thyroid.

4-4

TABLE 4-2

SUMMARY

OF MAXIMUM INDIVIDUAL DOSES 4

TO MEMBERS OF THE PUBLIC < >

DATA PERIOD: 1/1/16 TO 12/31/16

- - ~:!:::~. ~

~*ii~~~~:

..:*.::**~i~~

DIST AFFECTED ES SECTOR Li 'd(I) Teen Total Bod 7.75E-04 0.03 3 Li 'd(l) Adult GI-LLI 1.37E-03 O.Dl 10 1 Noble Gas NIA Air Dose 1.95E+OO 0.5 WSW 20.0 10 Gamma-mRad) 1 Noble Gas NIA Air Dose 6.84E-01 0.5 WSW 3.42 20 Beta-mRad) 1 Airborne Child Liver 1.43E-01 0.5 WSW 0.95 15 Iodine, Tritium and Particulates 2 Li 'd(I) Teen Total Bod 7.75E-04 0.03 3

'd(I) 2 Li Adult GI-LLI 1.37E-03 0.01 10 2 Noble Gas NIA' Air Dose 4.93E-02 0.5 WSW 0.49 10 Gamma-mRad) 2 Noble Gas NIA Air Dose 2.53E-02 0.5 WSW 0.13 20.

eta-mRad 2 Airborne Child Liver 1.55E-01 0.5 WSW 1.03 15 Iodine, Tritium and Particulates 1

< )Estimated dose is based on a site total activity release equally divided between Unit 1 and Unit 2.

2

< >1 O CFR 50, Appendix I limi_ts are in terms of mrad or mrem/reactor-year for airborne and waterborne effluent from each unit.

3

( >ooses from liquid effluent are estimated from fish ingestion and shoreline exposure at the site outfall and from the drinking water pathway at Danville, PA.

4

( >oose due to calculated release of C-14 not included.

4-5

TABLE 4-3 CALCULATED COLLECTIVE DOSES TO MEMBERS OF THE PUBLIC WITHIN THE RIVERLANDS/ENERGY INFORMATION CENTER COMPLEX DATA PERIOD: 1/1/16 TO 12/31/16

-~~TffR'~?~~:? ::(*:::'.=::.:"?.:*:*;?;.*~:: . .:*... *.': * .:\ .. * .. ***=: .* ..:~t:*:*

. .-'i*:..::*:*'. * .**:.. APPLICABLE *.DO

-,:GR.o:U-P,/ .-::**:'."ORGAN*.:*.* . **-:.:.=:* *M'R Noble Gas N/A Total Body 1.86E-05 7.42E-04 Noble Gas N/A Skin 6.59E-06 2.64E-04 Iodine, Tritium and Child GI-LL! 2.88E-06 1.15E-04 Particulates<3>

1

< )Estimated dose and dose rate is based on annual site total activity release.

<2 lc~llective dose is based on 40,000 person-hours.

3

<l Dose due to calculated release of C~14 not included.

SUMMARY

OF MAXIMUM INDIVIDUAL DOSES FROM AIRBORNE EFFLUENT MAXIMUM MAXIMUM MAXIMUM TOTAL BODY ORGAN THYROID DOSE AGE DOSE AGE GROUP, DOSE AGE LOCATION PATHWAY {MREM} GROUP (MREM) ORGAN CMREMl GROUP

1. Maximum Site Boundary XJQ Total (All) 7.54E-02 (CHILD) 7.55E-02 (CHILD, LUNG) 7.53E*02 (CHILD)

2. Maximum D/Q Garden Maximum X/Q Residence Total (All} 6.84E-02 (CHILD) 6.85E*02 (CHILD, LUNG) 6.83E-02 {CHILD}

3. Maximum D/Q Dairy Maximum DIQ Meat Total (All) 4.5BE-02 (CHILD) 4.59E-02 (CHILD, LUNG). 4.58E-02 (CHILD)

4. Tower's Club Total (All) 2.97E*01 (CHILD) 2.98E*01 CCHILD, LUNG) 2.97E*01 (CHILD)

5. Riverland/EIC Total CAlll 2.53E-02 (CHILD) 2.53E*02 {CHILD Gl-LLll 2.52E-02 (CHILD)

Note: The doses shown above are based on 100% occupancy at the indicated locations. They are based on a composite of all pathways resulting in a total dose to the maximally exposed individual due to airborne effluents from both Unit-1 and Unit-2 operations. Dose due to calculated release of C-14 not included.

4-6

FIGURE 4-1 AIRBORNE-DOSE CALCULATION LOCATIONS 16-NNW 14-13- -E 11-SW

. . _.-----~-----------*--"

Indicates airborne-dose calculation location per Table 4-4 4-7

SECTIONS CHANGES TO THE OFFS/TE DOSE CALCULATION MANUAL (ODCM),

TECHNICAL REQUIREMENTS MANUAL (TRM)

AND THE SOLID RADIOACTIVE WASTE PROCESS CONTROL PROGRAM 5-1

SECTJON4 DOSE MEASUREMENTS AND ASSESSMENTS 4-1

I I~

Radiological Impact on Man I~

I Sampling and analysis of airborne and waterborne effluents were performed in accordance with the frequencies, types of analysis, and Lower Limit of Detection (LLD) outlined in the Susquehanna Nuclear, LLC Technical Requirements Manual.

Radioactive material was detected in some of the airborne and waterborne effluent samples analyzed. Dose calculations using measured and calculated effluent activity levels, meteorological data from the current reporting period and average river flow dilution factors resulted in estimated doses to individuals at levels below 10 CFR 20 and 10 CFR 50, Appendix I limits. Direct radiation resulting from plant II operation (reported in the 2016 Annual Radiological .Environmental Operating ~

Report) contributed a maximum of 8.92E-1 mrem (measured at location 9S2 and based on an occupancy time by a member of the public of 20 hours2.314815e-4 days 0.00556 hours 3.306878e-5 weeks 7.61e-6 months per quarter) at I !

the Protected Area Boundary south of the plant. Based on airborne effluent sample data, the maximum organ (including thyroid)/total body dose is 2.98E-1 mrem l (CHILD, LUNG Table 4-4). The maximum organ/total body dose from all liquid !

effluent is 2.73E-3 mrem (ADULT, GI-LU Table 4-2). Conservatively adding the maximum orgari/total body dose from liquid and gaseous effluent and the maximum total body dose determined from direct radiation results in a dose of 1.19 mrem, which is 4.8% of the 40CFR 190 limit of 25 mrem to total body/organ (except thyroid) and 1.6% of the 40CFR190 limit of 75 mrem to the thyroid.

Doses to a maximally exposed member of the public from waterborne effluents are calculated for fish ingestion and shoreline exposure at the plant outfall, and drinking Ir water ingestion c,:tt Danville, PA. Site specific parameters used in the calculations i for the Danville receiver, specific for actual average blowdown and river level for the !

entire year are shown in Table 4-1.

TABLE 4-~

I f; SITE-SPECIFIC PARAMETERS USED FOR RETDAS CALCULATIONS. I (DANVILLE RECEIVER)

FOR2016 i ~*

PARAMETER ENTIRE YEAR Cooling Tower Slowdown (CFS) 26.8 Average Net River Level (ft.) 5.8 1

Dilution Factor at Danville( > 312.5 Transit time to Danville (hr.)( 1} 30.2 1

< lFrom ODCM-QA-005, Att. E 4-2

Summaries of maximum individual doses resulting from airborne and waterborne radioactive effluent releases from each unit are given in Table 4-2. Meteorological data from Section 3 were used to calculate the dose from airborne effluents.

The Radioactive Effluent Release Report includes an assessment of the radiation

- dose from radioactive effluents to members of the public within the site boundary.

Within the Site Boundary there are several areas frequented by members of the public. There are no significant exposure pathways from waterborne effluents in these areas. Doses from airborne effluent are calculated for members of the public for the following locations: Riverlands Energy Information Center, the Towers Club, and residence with the maximum X/Q value; the garden, dairy and meat producing farm with the maximum D/Q value; and the site boundary with the maximum X/Q value. Summaries of the calculated maximum doses within the site boundary and selected locations beyond the site boundary resulting from airborne effluents are presented in Table 4-4. The above referenced locations are shown on Figure 4-1.

In the area comprising the Riverlands recreation area, which surrounds the Energy Information Center, three pathways of radiation exposure can be identified: plume, ground, and inhalation. There are no significant exposure pathways from waterborne effluents in this area. There are approximately 40,000 visitors to the Riverlands/Energy Information Center complex each year. For dose calculations, it is assumed the visitor stays in the area for one hour. The calculated dose rate and

*collective dose for visitors to the Riverlands/Energy Information Center during 2016 are shown on Table 4-3.

Use of the RETDAS code yields calculated doses for the Riverlands area for the

- report period. These doses assume an occupancy factor of 100% for a member of the public during 2016. These calculated dose values are shown on Table 4-4.

In Regulatory Guide 1.21, Revision 2, "Measuring, Evaluating, and Reporting Radioactive Material in Liquid and Gaseous Effluents and Solid Waste", the NRC has recommended that U.S. nuclear power plants evaluate whether Carbon-14 (C-

14) is a "principal radionuclide", and if so, report the <:lmount of C-14 released.

Radioactive effluent releases of C-14 have not increased but the decline in releases of other radionuclides has resulted in C-14 possibly becomir:ig more prominent, specifically in airborne effluents. This regulatory guidance has led to an industry initiative to evaluate and report C-14 in the Annual Radioactive Effluent Release Report.

Information for C-14 dose impact is included as supplemental information in this report. Reportable values for dose impact do not include C-14 contribution. C-14, with a half-life of 5730 years, is a naturally occurring isotope of carbon produced by cosmic ray interactions in the atmosphere. Nuclear weapons testing in the 1950s

and 1960s significantly increased the amount of C-14 in the atmosphere. C-14 is also produced in commercial nuclear reactors, but the amounts produced are much less than those produced naturally or. from weapons testing.

4-3

i

~

I In December 2010 the Electric Power Research Institute (EPRI) published Report 1021106, "Estimation of Carbon-14 in. Nuclear Power Plant Gaseous Effluents",

which provides conservative technical guidance to support the calculation of C-14 released in radioactive effluents. In a BWR the majority of C-14 is generated in the

. reactor core by neutron activation of reactor coolant, specifically 17O(n,a) 14C. Thus C-14 generation is directly proportional to reactor power. As documented in the EPRI report (for a BWR), approximately 99% of the C-14 produced in the reactor I

core is discharged as gaseous effluent (primarily as C02 ) through the offgas system. The remaining 1% is released in the form of solid radwaste. There is minimal (<1 %) C-14 released in the liquid effluent pathway.

In October of 2012 Susquehanna, in conjunction with an offsite lab, performed sampling and analysis for airborne effluent C-14 released from the station via each units offgas system.

Since both Susquehanna units are essentially identical in reactor design, a single value for the C-14 release rate (in the C02 form from the offgas system sample results) is used in the calculation of C-14 released from each unit. The release rate value is corrected to 100% power then scaled to the fraction of full power year for each unit. The fraction of a full power year is calculated as the Effective Full Power Days for the year in question divided by 365 to get the fraction of effective vs full year operation.

Based on the above outlined methodology, approximately 43 Curies of C-14 were released in gaseous effluents in 2016.

The airborne effluent pathway with the highest offsite dose potential (for C-14 releases) is the vegetation ingestion pathway. The maximum expected annual dose from C-14 released from Susquehanna Unit-1 (3.26E-1 mrem) and Unit.;2 (4.01 E-1 mrem) has been calculated based on methodology in Regu,latory Guide 1.109 and includes site specific parameters (e.g., nearest garden with highest X/Q value, producing both broad leaf and non-broad leaf vegetation). The maximum organ dose from airborne effluent C-14 released from the Susquehanna station in 2016 is well below the 10CFR50, Appendix I, ALARA design objective (i.e., 15 mrem/yr per unit). The annual dose to the maximally exposed individual from all .

gaseous releases of C-14 (calculated by the above referenced methodology) is 7.27E-1 rrirem to the critical organ (bone) and 1.45E-1 mrem to the total body.

Conservatively adding the maximum dose (calculated based on liquid and gaseous effluent sample results combined with direct radiation results) referenced on page 4-2 to the.maximum dose due to the*calculated release of C-14 (T.27E-1 mrem, CHILD, BONE) bounds the dose that any member of the public receives from station operations to 1.92 mrem, which is 7. 7% of the 40CFR190 limit of 25 mrem to total body/organ (except thyroid) and 2.6% of the 40CFR190 limit of 75 mrem to the thyroid.

4-4

TABLE 4-2

SUMMARY

OF MAXIMUM INDIVIDUAL DOSES TO MEMBERS OF THE PUBLIC <4l DATA PERIOD: 1/1/16 TO 12/31/16 J~11£

... . . ~:~: .

. :""i&!

DIST AFFECTED ES SECTOR Li 'd(l) Teen Total Bod 7.75E-04 0.03 3 1 Li 'd(J) Adult Gl-LLI 1.37E-03 O.ol 10 1 Noble Gas NIA Air Dose l.95E+OO 0.5 WSW 20.0 10 Gamma-mRad) 1 Noble Gas NIA Air Dose 6.84E-01 0.5 WSW 3.42 20 Beta-mRad) 1 Airborne Child Liver l.43E-Ol 0.5 WSW 0.95 15 Iodine, Tritium and Particulates 2 Li 'd(I) Teen Total Bod 7.75E-04 (3 0.03 3 2 Li 'd(l) Adult 1.37E-03 (3 0.01 10 Gl-LLI 2 Noble Gas NIA Air Dose 4.93E-02 0.5 WSW 0.49 10 Gamma-mR.ad) 2 Noble Gas NIA Air Dose 2.53E-02 0.5 WSW 0.13 20.

eta-mRad 2 Airborne Child Liver l.55E-01 0.5 WSW 1.03 15 Iodine, Tritium and Particulates 1

< lEstimated dose is based on a site total activity release equally divided between Unit 1 and Unit 2 ..

2

< l10 CFR 50, Appendix I limits are in terms of mrad or mrem/reactor-year for airborne and waterborne effluent from each u*nit.

3

( >ooses from liquid effluent are estimated from fish ingestion and shoreline exposure at the site outfall and from the drinking water pathway at Danville, PA.

4

< loose due to calculated release of C-14 not included.

4-5

TABLE 4-3 CALCULATED COLLECTIVE DOSES TO MEMBERS OF THE PUBLIC WITHIN THE RIVERLANDS/ENERGY INFORMATION CENTER COMPLEX DATA PERIOD: 1/1/16 TO 12/31/16 Noble Gas. NIA Total Body 1.86E-05 7.42E-04 Noble Gas NIA Skin 6.59E-06 2.64E-04 Iodine, Tritium and Child Gl-LLI 2.88E-06 1.15E-04 Particulates<3>

1

< )Estimated dose and dose rate is based on annual site total activity release.

2

< )Collective dose is based on 40,000 person-hours.

3

< ) Dose due to calculated release of C-14 not included.

TABLE 4-4

SUMMARY

OF MAXIMUM INDIVIDUAL DOSES FROM AIRBORNE EFFLUENT MAXIMUM MAXIMUM MAXIMUM TOTAL BODY ORGAN THYROID DOSE AGE DOSE AGE GROUP, DOSE AGE LOCATION PATHWAY {MREM) GROUP (MREM) ORGAN CM REM} GROUP

1. Maximum Site Boundary X/Q Total {All) 7.54E-02 (CHILD) 7.55E-02 . (CHILD, LUNG) 7.53E-02 (CHILD)

2. Maximum D/Q Garden Maximum X/Q Residence Total (All} 6.84E-02 CCHILD} 6.85E-02 {CHILD, LUNG) 6.83E-02 {CHILD)

3. Maximum D/Q Dairy Maximum DIQ Meat Total (AU} 4.5BE-02 (CHILD) 4.59E*02 {CHILD, LUNG) 4.58E-02 {CHILD)

4. Tower's Club Total (All) 2.97E-01 (CHILD) 2.9BE-01 (CHILD, LUNG) 2.97E*01 (CHILD}

5. Riverland!EIC Total (AID 2.53E-02 (CHILD) 2.53E-02 CCHILD.Gl-LLll 2.52E-02 (CHILD\

Note: The doses shown above are based on 100% occupancy at the indicated locations. They are based on a composite of all pathways resulting in a total dose to the maximally exposed individual due to airborne effluents from both Unit-1 and Unit-2 operations. Dose due to calculated release of C-14 not included.

4-6

FIGURE 4-1 AIRBORNE~DOSE CALCULATION LOCATIONS

,,~-... -"

14- 4-ENE

(_

13- -E 11-SW

~--*---------*---'

Indicates airborne-do~e c~lculation lo-~tion per Table 4-4 l __ 4-7

SECTIONS CHANGES TO THE OFFS/TE DOSE CALCULATION MANUAL (ODCM)T

.TECHNICAL REQUIREMENTS MANUAL (TRM)

AND THE SOLID RADIOACTIVE. WASTE. PROCESS CONTROL PROGRAM 5-1 .

CHANGES TO THE OFFSITE DOSE CALCULATION MANUAL The Susquehanna Nuclear LLC ODCM consists of nine (9) individual procedures.

0 DCM-QA-004, Airborne Effluent Dose Calculations, was revised in 2016. Revision 6 was issued February 19, 2016.

ODCM-QA-004 Revision 6 included references and a listing of line loss correction factors for the Vent Effluent Radiation Monitoring System (VERMS) and to delete the Post Accident Vent Stack Sampling System (PAVSSS) from the procedure.

Additionally, position titles were updated. The VERMS modification replaces existing Eberline SPING and PAVSSS monitoring/sampling equipment.

The above referenced changes to the ODCM have been evaluated as to not decrease the level of effluent control or the accuracy and/or reliability of dose calculations or set-point controls in a non-conservative direction.

I; 5-2 f II I

i*

J

CHANGES TO THE TECHNICAL REQUIREMENTS MANUAL Section 3.11 and 3.6.1 of the Unit-1 and Unit-2 Technical Requirements Manual (TRM) by reference are part of the ODCM. The following limits and requirements are contained in Section 3.11: liquid and gaseous effluent dose limits, liquid and gaseous effluent treatment system operability criteria (based on effluent dose), liquid and gaseous effluent treatment system operability criteria and the conduct of the Radiological Environmental Monitoring Program. Section 3.6.1 contains requirements for venting or purging of primary containment.

Section 3.11.2.6 (Radioactive Gaseous Effluent Monitoring Instrumentation) and Section 83.11.2.6 (Radioactive Gaseous Effluent Monitoring Instrumentation-Bases) of the Unit 1 and Unit 2 TRM were revised on August 11, 2016 and October 6, 2016.

The changes made on August 11th included an update to TRO 3.11.2.6 Condition G and Table 3.11.2.6-1 to include equipment installed as part of the Turbine Vent Effluent Radiation Monitoring System (VERMS) modification. Section 83.11.2.6 was updated to replace the summary/description of the Eberline SPING system operation with a summary/description of the VERMS operation. *The Turbine VERMS modification replaced the existing Turbine vent Eberline SPING and PAVSSS monitoring/sampling equipment.

The changes made on October 61h included an update to T*Ro 3.11.2.6 Condition J and Table 3.11.2.6-1 to include equipment installed as part of the Standby Gas Treatment System (SGTS) Vent Effluent Radiation Monitoring System (VERMS) modification. The SGTS VERMS modification replaced the existing SGTS vent Eberline SPING and PAVSSS monitoring/sampling equipment The above referenced changes to the TRM have been evaluated as to not decrease the level of effluent control or the accuracy and/or reliability of dose calculations or set-point controls in a non-conservative direction.

5-3

PROCESS CONTROL PROGRAM CHANGES There were no changes made to the Process Control Program and its implementing procedures in 2016.

NDAP-QA-0646, Solid Radioactive Waste Process Control Program, continues to fully implement the requirements and intent of the following:

1. Section 11.4 and 13.5 of the FSAR

2. Section 3.7.4 of the Technical Requirements Manual

3. 10 CFR 20, 10 CFR 61, 10 CFR 71, 49 CFR 100-177, and 40 CFR 261 5-4

_J

. SECTION6 MISCELLANEOUS Tf;CHNICAL REQUIREMENTS MANUAL (TRM),

FSAR, 40CFR190 AND NE/ GROUNDWATER PROTECTION INITIATIVE REPORTING

.1. TRM Action 3.11.1.4.F.2 required the reporting of Liquid Radwaste Effluent Monitoring Instrumentation inoperability not corrected in a timely manner.

None to report for 2016.

2. TRM Action 3.11.1.5.C.1 requires the reporting of Radioactive Liquid Process Effluent Monitoring Instrumentation inoperability not corrected in a timely manner, or if required sampling/analysis was not performed during the inoperable period.

None to report for 2016.

3. TRM Action 3.11.2.6.K requires an explanation for Radioactive Gaseous Effluent Monitoring Instrumentation required actions and completion times not met.

None to report for 2016.

4. TRM Action 3.11.4.1.F.2 requires reporting the cause of the unavailability of milk or fresh leafy vegetable samples and identify the new locations for oQtaining replacements.

None to report for 2016.

5. TRM Action 3.11.4.2.A requires reporting when land use census identifies a new location which yields a calculated dose or dose commitment greater than the values currently being calculated in Requirement 3.11.2.3 (Gaseous Effluent Dose *due to Iodine, Tritium, and Radionuclides in Particulate Form).

None to report for 2016.

6. TRM Action 3.11.4.2.B requires reporting when land use census identifies a

locations that yield calculated dose or dose commitment (via the same exposure pathway) 20 percent greater than at a location from which samples are currently being obtained in accordance with Requirement 3.11.4.1 (Radiological Environmental Monitoring Program).

None to report for 2016.

7. The limits outlined in 40CFR190.10 (Environmental Standards for the Uranium Fuel Cycle-Standards for Normal Operations) were not exceeded by station operations during 2016. Refer to Section 2 and Section 4 for specific values.

6-2

__ _ _ _ _ J

8. FSAR Section 11.6.11 requires the reporting of airborne radioactivity detected in the Low Level Radwaste Holding Facility.

Only naturally occurring airborne radioactivity was detected above analysis MDC's in air samples from the Low Level Radwaste Holding Facility during 2016.

9. The Susquehanna Nuclear station has implemented an Action Plan in response to the NEI Initiative on Groundwater Protection. Part of the Action Plan includes the assessment of the current groundwater monitoring

program. Groundwater is sampled and analyzed quarterly as part of the Radiological Environmental Monitoring Program (REMP). REMP groundwater sampling locations are defined in ODCM-QA-008 Attachment G.

In August 2006, additional groundwater sampling was initiated at locations which are not listed in the ODCM. The additional locations are three manholes which collect water from a perimeter drain system. The perimeter drain system consists of perforated piping installed just above the footing along the exterior base of the vertical walls of the reactor, turbine and radwaste buildings. Outlined in Table 6-1 are the tritium analysis results from sampling of the perimeter drain system. No nuclear by-;product gamma emitting radionuclides were identified above analysis l\/IDC's for the perimeter drain samples in 2016. The tritium results reported in Table 6-1 did not exceed any Reporting Level thresholds in the Susquehanna Nuclear Technical Requirements Manual or any reporting criteric:i. established in response to the NEI Groundwater Protection Initiative. Figure 6-1 is a trend graph of airborne and waterborne effluent tritium releases from the Susquehanna Nuclear Station startir1g in 1982.

10. O.n 8/17/16 at 01 :30 while performing alternate sampling in support of installing new ventilation effluent radiation monitors on the Unit-1 Turbine Bldg. vent, the alternate sample pump was found without power. Sampling was re-established at 02:05.

The sample pump was last observed in service on 8/16/2016 at 21:30.

Continuous sampling could have been lost tor up to4 hours 35 minutes.

Per Technical Requirements Manual (TRM) Table 3.1.1.2.1 "1, continuous iodine and particulate samples are obtained at a minimum frequency of once per 7 days. The TRM Bases allows for a 1 hour1.157407e-5 days 2.777778e-4 hours 1.653439e-6 weeks 3.805e-7 months interruption of continuous sampling for routine maintenance or filter/cartridge change"out.

The interruption to continuous sampling was at most 4.5 hours5.787037e-5 days 0.00139 hours 8.267196e-6 weeks 1.9025e-6 months out of a nominal 168 hour0.00194 days 0.0467 hours 2.777778e-4 weeks 6.3924e-5 months sampling period (7 days), or 2.3% of time. During the sampling period there were no indications of any plant chang*es which would have impacted Unit-1 Turbine vent airborne effluent releases. Therefore the particulate and iodine sample obtained, including the period when the sample pump was out of service, is representative of Unit-1 Turbine vent airborne effluents for the sampling period.

6-3

TABLE 6-1 NEI Ground Water Protection Initiative Reporting Perimeter Drain Sampling Results: 2016.

Manhole FD-1 Manhole FD-2 Manhole FD-3 (1653- NW corner (953 - l/S RCA @ U2 (759 - E of U2 CST) of RW Bldg.) HP Cont. Pt. Closet)

Date Tritium (pCi/liter) Tritium (pCi/liter) Tritium (pCi/liter) 02/16/2016 298 179. 151 05/16/2016 216 <MDC <MDC 08/15/2016 170 <MDC. <MDC 11/14/2016 322 <MDC <MDC

<MDC = Less than Minimum Detectable Concentration 6-4

___J

. Figure 6-1 SSES Tritium Effluent Releases (Airborne; Waterborne &Total Curies Released)

,, 250 (I) tn 200

-"' 150 (I)

Q) a:

0 100

-:1 (I)

~ 50 u .0 N oq- CD 00 0 C\I ~ CD co 0 C\I v CD co 0 C\I ~ CD co co co co O'> O'> (j) O'> (j) 0 0 0 0 0 ~ ~ ~ ~

O') 0) 0) 0) 0) 0) 0) 0) 0) 0 0 0 0 0 0 0 0 0 T"" T"" T"" T"" T"" T"" T"" T"" T"" C\I C\J. N N N N N N N Year -+-Airborne H-3

-waterborne H-3

--Total Curies 6-5

SECTION 7 CORRECTIONS TO PREVIOUS RADIOACTIVE EFFLUENT RELEASE REPORTS 7-1

CORRECTIONS TO PREVIOUS RADIOACTIVE EFFLUENT RELEASE REPORTS ODCM-QA-008, Radiological Environmental Monitoring Program, was revised in 2015.

Revision 17 was issued effective 1/27/2015.

A summary of the changes made to ODCM-QA-008 in revision 17 was not included in Section 5 (Changes to the Offsite Dose Calculation Manual (ODCM), Technical Requirements Manual (TRM) and the Solid Radioactive Waste Process Control Program) of the 2015 Radioactive Effluent Release Report. The entire ODCM was submitted as Appendix A to the 2015 Radioactive Effluent Release Report, which included the changes made to ODCM-QA-008 Revision 17.

ODCM-QA-008 Revision 17 changes included:

)

1. Update Attachment G to add airborne radioiodine and particulate sampling locations 981 (Transmission Line East of Route 11) and 10S3 (East of Confers Lane, South of Towers Club).

2. Update Attachments D and E and add Reference 3.22 to correspond with the changes made to Attachment G.

The Unit-2 TRM Section 3.11.2.6, Table 3.11.2.6-1 was incorrectly identified as being revised on April 23, 2015 in the 2015 Radioactive Effluent Reiease Report. The actual date of the revision to the Unit-2 TRM Table 3.11.2.6-1 was February 19, 2015.

7-2

SECTIONB EFFLUENT FROM SYSTEMS CLASSIFIED AS INSIGNIFICANT EFFLUENT PATHWAYS 8-1

EFFLUENT FROM SYSTEMS CLASSIFIED AS INSIGNIFICANT EFFLUENT PATHWAYS Insignificant Effluent Pathways are: 1) evaporation from the Unit 1 and Unit 2 Condensate Storage Tanks {CST's); 2) evaporation from the common Refueling Water Storage Tank (RWST); 3) gaseou~ effluent from the Hydrogen Seal Oil, Main Turbine and RFPT lubrication oil mist eliminators which vent to the turbine building roofs.

These pathways are not continuously monitored. The CSTs and RWST are sampled monthly to determine the concentration of radionuclides present in these tanks. Tritium analysis on these samples is performed quarterly. Airborne release to the environment from the tanks is estimated based on conservative estimates of the evaporation; rates from each of the tanks using a modified method established within Chapter 7 of EPAAP-42. A conservative carry-over fraction of radionuclides from the water to the evaporated liquid is then assumed. Airborne release to the environment from the demisters assumes the average moisture (condensate) concentration of the lubrication oil as measured via sampling during 2016. The calculation also assumes immediate removal of 100% of the water by the oil mist eliminators as it passes through the

turbines.

The annual release of tritium, iodines and particulates with half-lives greater than 8 days was calculated based on the conservative assumptions outlined above. The calculated releases are shown in Table 8-1. All nuclides, except for tritium, released from insignificant effluent pathways are negligible compared to the airborne release data shown in Tables 2-1 and 2-2. The maximum dose to the public from a release of

0. 68 Ci of tritium is calculated to be 1:90E-3 mrem (child). This is a fraction of the maximum dose from airborne effluent reported in Section 4.

TABLE 8-1 ANNUAL RELEASE FROM SYSTEMS CLASSIFIED AS INSIGNIFICANT EFFLUENT PATHWAYS Ul-CSTand U2-CST and Main Turbine/RFPT Main Turbine/RFPT Nuclide RWST Lube Oil Sistems Lube Oil Sistems Total (Ci) (Ci) (Ci) (Ci)

H-3 3.48E-02 3.20E-Ol 3.25E-Ol 6.80E-01 Mn-54 4.75E-10 6.27E-08 3.04E-08 9.35B-08 Co-60 5.68£-07 3.86£-07 l.51E-07 1.1 lE-06 Co-58 1.94E-09 2.20B-07 9.35E-08 3.15E-07 Zn-65 2.32E-10 8.41E-08 8.25E-09 9.26E-08 Xe-135 O.OOE+OO 2.70E-07 O.OOE+OO 2.70E-07 Cs-137 3.03E-10 O.OOB+OO O.OOE+OO 3.03E-10 Sn-125 6.76E-09 0.00E+OO O.OOE+OO 6.76£-.09 8-3

- - - "' (* .

Attachment 2 to PLA-7607 SSES Offsite Dose Calculation Manual

For Information Only

PROCEDURE COVER SHEET PPLSUSQUEHANN~LLCPROCEDURE ODCM INTRODUCTION ODCM-QA-001 Revision 3 Page 1of17

--- /

ADHERENCE LEVEL: INFORMATION USE QUALITY CLASSIFICATION: APPROVAL CLASSIFICATION:

( X ) QA Program ( ) Non-QA Program ( x) Plant ( ) Non-Plant

( ) Instruction EFFECTIVE DATE: /(I!.~ /~!fJ1 PERIODIC REVIEW FREQUENCY: NIA PERIODIC REVIEW DUE DATE: N/A RECOMMENDED REVIEWS:

Nuclear Emergency Planning Procedure Owner: F.J. Hickey Responsible Supervisor: Chemistry.Support Supervisor Responsible FUM: Manager-Plant Chemist~

\

Responsible Approver: Vice President-Nuclear Operations F"ORM NDAP-QA-0002-1, Rev. 4, Page f of .1 (Electronic Form)

For Information Only ODCM-QA-001 Revision 3 Page 2of17 PROCEDURE REVISION

SUMMARY

TITLE: ODCM INTRODUCTION The revisions described below are clarification adding detail and editorial in

nature and do not change any limits or analyses. Thus, Revision 3 of ODCM-QA-001 maintains the level of radioactive effluent control required pursuant to 10CFR20.1302, 40CFR190, 10CFR50.36a and Appendix I to 10CFRSO and does not impact the accuracy or reliability of effluent, dose, or setpoint calculations.

In addition, these changes (1) do not alter the conduct of the radiological environmental monitoring program, (2) do not change the radioactive effluent controls and radiological environmental monitoring activities, and (3) do not change the information to be included in the Annual Radiological Environmental Operating and Radioactive Effluent Release Reports.

1) Update title of Chemistry Support Supervisor-SSE$ to Chemistry Support Supervisor.

2) Update Reference 3.12, and step 4.2.1 to replace NDAP-00-1203 with NDAP-QA-0524.

3) Update position titles in the Table of Contents and Section 4.

4) Revised Definition 5.2 to clarify the referenced drawing title.

5) Update Attachments A and B to clarify the required information to be included in the Radioactive Effluent Release Report and the Annual Radiological Environmental Operating Report. Update to include reporting guidance in support of the NEI Groundwater Protection Initiative.

6) Update title of Chemistry Department-SSES to Plant Chemistry in step 6.1.

7) Update Step 2.4 to clarify the procedure for generating the Annual Radiological Environmental Operating Report.

8) Added/revised Reference 3.8 to support item 7 above.

9) Revised Reference 3.9 to update the procedure title.

_ For Information Only ODCM-QA-001 Revision 3 Page 3 of 17 TABLE OF CONTENTS SECTION PAGE

1. PURPOSE 5

2. POLICY/DISCUSSION 5 2.1 Derived Release Concentrations and Dose Rates 5 2.2 Radioactive Effluent Control Program (RECP) 5 2.3 Radioactive Effluent Release Report 5 2.4 Annual Radiological Environmental Operating Report 6 2.5 Special Reports 6

3. REFERENCES . 6

4. RESPONSIBILITIES 7 4.1 Vice President-Nuclear Operations 7 4.2 General Manager-Nuclear Engineering 7 4.3 Manager-Quality Assurance 7 4.4 Manager-Plant Chemistry 7 4.5 Manager-Regulatory Affairs 7 4.6 Chemistry Support Personnel 8 4.7 Chemistry Support Supervisor 8

5. DEFINITIONS 8

6. PROCEDURE 8 6.1 Organization 8

7. RECORDS 10

For Information Only-**

ODCM-QA-001 Revision 3 Page 4of17 ATTACHMENTS ATTACHMENT PAGE A Contents of Radioactive Effluent Release Report 11 8 Contents of Annual Radiological Environmental Operating Report 17 J

For Information Only ODCM-QA-001 Revision 3 Page 5 of 17

1. PURPOSE The purpose of this procedure is to describe the overall purpose and organization of the SSES Offsite Dose Calculation Manual (ODCM).

2. POLICY/DISCUSSION The purpose of the ODCM is to provide the parameters and methodology to be used in calculating offsite doses and effluent monitoring setpoints for the Susquehanna Steam Electric Station, Units 1 and 2. The ODCM contains the requirements of the Radiological Effluent Control Program (RECP) as described in Section 2.2 and the Radiological Environmental Monitoring Program (REMP} as defined in TR 3.11.4.

Remedial actions to be taken when program limits (TROs} are exceeded are specified in the Technical Requirements Manual (TRM). The ODCM includes methods for determining maximum individual, whole body, and organ doses due to waterborne and airborne effluents to ensure compliance with the dose limitations in the Technical Requirem~nts (TR). Methods are also included for performing dose calculations to ensure compliance with the waterborne and airborne treatment system operability sections of the Technical Requirements. This manual includes the required inputs for inclusion in the Radioactive Effluent Release Report and the Annual Radiological Environmental Operating Report.

2.1 Derived Release Concentrations and Dose Rates The ODCM uses 10 times the concentrations of Appendix B, Table 2, Column 2 of 10CFR20.1001-20.2402 as concentration limits for liquid releases and the instantaneous release rates which are no longer referenced in 10CFR20 but come directly from TR 3.11.2 for gaseous releases as confirmed in the 6/93 NRC response to NUMARC.

2.2 Radioactive Effluent Control Program (RECP)

The Radioactive Effluent Control Program (RECP) is a comprehensive program as detailed in TS 5.5.4 which provides control of radioactive effluent for maintaining the dose to members of the public from radioactive effluent as low as reasonably achievable. The RECP is defined in TR's 3.6.1, 3.11.1, 3.11.2, and 3.11.3.

2.3 Radioactive Effluent Release Report The Radioactive Effluent Release Report covers the operation of the station during the previous year and must be submitted prior to May 1 of each year in accordance with TS 5.6.3. The report is prepared in accordance with Procedure SC-099-002 and the required topics for the report are provided in Attachment A.

For Information Only ODCM-QA-001 Revision 3 Page 6 of 17 2.4 Annual Radiological Environmental Operating Report This report, submitted prior to May 15 of each year, contains the summaries, interpretations and analyses of the results of the Radiological Environmental Monitoring Program for the previous year as spelled out in ODCM-QA-008. The report is prepared in accordance with Procedure SC-099-004 and the required topics for the report are provided in Attachment B.

2.5 Special Reports These reports are required to be submitted to the NRC when the limits of TR's 3.11.1.2, 3.11.1.3, 3.11.2.2, 3.11.2.3, 3.11.2.4, 3.11.2.5, 3.11 .3, and 3.11 .4.1 (Condition B, C, or D) are exceeded. Special reports shall be submitted within 30 days and shall address the actions required in the TRM.

3. REFERENCES 3.1 TS 5.5.1, Offsite Dose Calculation Manual (ODCM) 3.2 TS 5.5.4, Radioactive Effluent Control Program "

3.3 TR 2.1.1, ODCM 3.4 TR 2.1 .4, Radioactive Effluent Controls 3.5 TR 3.6.1, Containment Venting or Purging 3.6 TR 3.11, Radioactive Effluents 3.7 SC-099-002, Preparation of Radioactive Effluent Release Report 3.8 SC-099-004, Performance of REMP Annual TS!TRM Surveillances 3.9 10CFR20 Appendix B, Annual Limits on Intake and Derived Air Concentrations of Radionuclides for Occupational Exposure; Effluent Concentrations; Concentrations for Release to Sewerage 3.10 NDAP-QA-0646, Solid Radioactive Waste Process Control Program 3.11 Letter from T. Murley, Director, Office of Nuclear Reactor Regulations, to T. Tipton, Vice President and Director of Operations, NUMARC, 6/93 3.12 NDAP-QA-1180, Radiological Effluent Monitoring and Control 3.13 NDAP-QA-0524, Equipment Reliability and Station Health Process

For Information Only ODCM-QA-001 Revision 3 Page 7 of 17

4. RESPONSIBILITIES 4.1 Vice President-Nuclear Operations 4.1.1 Ensures that the ODCM is used in performance of the surveillance requirements and for compliance with the TROs stated in the TRM relative to radioactive effluent.

4.1.2 Approves revisions to the ODCM.

4.2 General Manager-Nuclear Engineering 4.2.1 Provides modification engineering and support in accordance with NDAP-QA-0524 for equipment and systems involved with the conduct of the effluent and environmental monitoring programs at SSES.

4.3 Manager-Quality Assurance 4.3.1 Periodically assesses the SSES effluent, environmental and meteorological programs for compliance with the requirements of the TRM and the ODCM.

4.4

Manager-Plant Chemistry 4.4.1 Ensures the adequacy and correctness of methodologies described in the ODCM.

4.4.2 Is responsible for reviewing revisions to the ODCM.

4.4.3 . Approves both the Radioactive Effluent Release and the Annual Radiological Environmental Operating Reports submitted to the NRG.

4.4.4 Manages the programs for the assessment of the radiological environmental impact of SSES.

4.5 Manager-Regulatory Affairs 4.5.1 Submits the required radiological effluent and environmental reports to the NRC.

4.5.2 Notifies the appropriate groups of NRC licensing requirements.

For _Info_rr:n~!<?.r1. Only --*--***- *- ***---*.

ODCM-QA-001 Revision 3 Page 8 of 17 4_6 Chemistry Support Personnel 4.6.1 Develops methodologies used in performance of effluent dose calculations and establishment of setpoints.

4.6.2 Performs dose calculations necessary for fulfillment of SSES Technical Requirements Surveillance.

4.6.3 Prepares and submits the Radioactive Effluent Release Report to Regulatory Affairs for submittal to the NRC.

4.6.4 Prepares and submits the Annual Radiological Environmental Operating Report to Regulatory Affairs for submittal to the NRC.

4.7 Chemistry Support Supervisor

4. 7 .1 Reviews Radioactive Effluent Release Report and Annual Radiological Environmental Operating Report to assure adequacy of content in accordance with Attachments A and B, respectively.

" 4.7.2 Ensures development of appropriate revisions to the ODCM.

5. DEFINITIONS 5.1 ECL - Effluent Concentration Limit as defined by TAO 3.11.1.1.

5.2 Site Boundary - Is that line beyond which the land is not owned, leased or otherwise controlled by the licensee. (PPL Drawing C243786, SH1, "Susquehanna S.E.S. Unit - 1&2 Site Facilities and Boundary Map.")

5.3 Unrestricted Area - The area at or beyond the site boundary access to which is neither limited nor controlled by the licensee for purposes of protection of individuals from exposure to radiation and radioactive materials, or any area within the site boundary used for residential quarters or for industrial, commercial, institutional and/or recreational purposes.

6. PROCEDURE 6.1 Organization Plant Chemistry shall develop and maintain a set of procedures as described in the following subsections.

6.1_1 ODCM-QA-001 - ODCM Introduction This procedure describes the overall purpose and organization of theODCM.

_J

For Information Only ODCM-QA-001 Revision 3 Page 9of17 6.1.2 ODCM-QA-002 - ODCM Review and Revision Control This procedure describes the initiation, review and processing of revisions to the ODCM and establishes responsibility for the ODCM.

6.1.3 ODCM-QA-003 - Effluent Monitor Setpoints This procedure describes the policies pertaining to and the methodology used in establishing effluent monitor setpoints.

6.1.4 ODCM-QA-004 - Airborne Effluent Dose Calculations This procedure provides the methodology and parameters used in calculating air dose resulting from noble gas effluent and maximum individual, whole body, and organ doses due to airborne effluents to ensure compliance with the dose limitations in the Technical Requirements Manual.

6.1.5 ODCM-QA-005 - Waterborne Effluent Dose Calculations This procedure provides the methodology and parameters to be used in calculating maximum individual, whole body, and organ doses due to waterborne effluents to ensure compliance with the dose limitations in the Technical Requirements Manual.

6.1.6 ODCM-QA-006 - Total Dose Calculations This procedure provides the methodology and parameters to determine the total dose to a member of the public from the fuel cycle in the vicinity of the SSES site.

6.1.7 ODCM-QA-007 -Radioactive Waste Treatment Systems This procedure defines the operabiiity requirements of the radioactive waste treatment systems and monitoring instruments.

It also includes reporting requirements where changes are made to systems or when operability is not maintained in accordance with the TAM.

For Information Only ODCM-QA-001 Revision 3 Page 10 of 17 6.1 .8 ODCM-QA-008 - Radiological Environmental Monitoring Program This procedure provides the methodology and parameters used to determine doses to the public resulting from inhalation, ingestion, and direct shine from radiologically contaminated environmental sampling media based on measured activity concentrations in those media. This procedure also describes the Radiological Environmental Monitoring Program (REMP), which includes the annual land use census survey and interlaboratory comparison program.

6.1.9 ODCM-QA-009 - Dose Assessment Policy Statements The p!:Jrpose of this procedure is to state dose and effluent policy statements that are not directly associated with any other section of the ODCM.

7. RECORDS Except for ODCM-QA-002, no records are specified by the ODCM. Records are generated in performance of other procedures that use the information contained in the ODCM. Control of these records is specified in the controlling procedures.-

For Information Only Attachment A ODCM-QA-001 Revision 3 Page 11of17 CONTENTS OF RADIOACTIVE EFFLUENT RELEASE REPORT (NOTE: All data and information is referenced to RG 1.21 unless otherwise noted.)

General

Provide an estimate of total error associated with the measurement of radioactivity combining errors with sampling and measuring.

Values stated using three significant figures.

Values stated using external floating point form using "E" to denote exponent to the base 10.

The term "not detected" should not be used.

Annual report for previous year to be submitted prior to May 1 of each year (TS 5.6.3).

A single submittal may be made tor both S~ES units (TS 5.6.3).

ODCM shall be submitted to the NRG in the format of a complete legible copy of the entire ODCM for the period of the report in which any change in the ODCM was made. Each change shall be identified by markings in the margin of the affected pages clearly indicating the area of the page that was changed, and shall indicate the date (i.e., month and year) the change was implemented (TS 5.5.1.C.3).

Liquid Radwaste Effluent Monitoring Instrumentation inoperability not corrected in a timely manner (TAM Action 3.11.1.4.F.2).

Radioactive Liquid Process Monitoring Instrumentation (Table 3.11.1.5-1) inoperability not corrected* in a timely manner (TRM Action 3.11.1.5.C.1 ).

Explanation for Radioactive Gaseous Effluent Monitoring Instrumentation required actions and completion times not met (TRM Action 3.11.2.6.K).

Land use census identifies a new location which yields a calculated dose or dose commitment greater than the values currently being calculated (TRM Action 3.11.4.2.A).

Land use census identifies a location(s) that yields a calculated dose or dose commitment (via the same exposure pathway) 20 percent greater than at a location from which samples are currently being obtained (TRM Action 3.11.4.2.B).

Identify the cause of the unavailability of milk or fresh leafy vegetable samples and identify the new location(s) fo~ obtaining replacements (TRM Action 3.11.4.1.F.2).

Page 1of6

For Information Only Attachment A ODCM-QA-001 Revision 3 Page 12 of 17

Detectable airborne radioactivity in the Low Level Radwaste Holding Facility (FSAR 11.6.11).

Additional miscellaneous reporting requirements (e.g., Summary of applicable sampling performed in support of the NEI Groundwater Protection Initiative which is not included in the Annual Radiological Environmental Operating Report).

Liquid Effluent

1. Mixed Fission and Activation Products Quarterly sums of total curies of radioactive material determined to be released in liquid effluents (not including tritium, dissolved and entrained gases, and alpha-emitting material).

Average concentrations (µCi/ml) of mixed fission and activation products released to unrestricted areas, averaged over the quarterly periods covered by the report.

Percent of applicable limit of average concentrations released to unrestricted areas.

Include the limit used and the bases in the supplemental report information.

Quarterly sums of total curies for each of the radionuclides determined to be released in liquid effluents based on analyses performed. Data should be separated by type of release mode, i.e., continuous or batch.

2. Tritium

Quarterly sums of total curies of tritium determined to be released in liquid effluents.

Average concentrations (µCi/ml) of tritium released in liquid effluents to unrestricted areas, averaged over the quarterly periods covered by the report.

Percent of applicable limit of average concentrations released to unrestricted areas, i.e., percent of 3 x 10*3 µCi/ml. Include the timit and the bases in the supplemental report information.

3. Dissolved and Entrained Gases

Quarterly sums of total curies of gaseous radioactive material determined to be released in liquid effluents.

Average concentrations (µCi/ml) of dissolved and entrained gaseous radioactive material released to unrestricted areas averaged over the quarterly periods covered by the report.

Page 2 of 6

For Information Only Attachment A ODCM-QA-001 Revision 3 Page 13 of 17

Percent of limit of average concentrations released to unrestricted areas. Include the limit used and the bases in the supplemental report information.

Quarterly sums of total curies for each of the radionuclides determined to be released as dissolved and entrained gases in liquid effluents.

4. Alpha Radioactivity

Quarterly sums of total curies of gross alpha-emitting material determined to be released in liquid effluents.

5. Volumes

Quarterly sums, in liters, of total measured volume, prior to dilution, of liquid effluent released.

Quarterly sums of total determined volume, in liters, of dilution water used during the period of the report.

6. Stream Flow *.

Data on the average flow of the stream during periods of effluent release should be collected and reported in the Supplemental Information section of the report.

7. Abnormal Releases

Include the number of releases, the volume released, the total activity released and any applicable discussion of onsite or offsite impacts due to the abnormal release(s).

If any REMP monitored pathways were impacted due to an abnormal release, then applicable discussion of the impact(s) to be included in the Annual Radiological Environmental Operating Report.

Gaseous Effluent

1. Gases

Quarterly sums of total curies of fission and activation gases released.

Average release rates (µCi/sec) of fission and activation gases for the quarterly periods covered by the report.

Percent of limit for releases of fission and activation gases.

Page 3 of 6

For Information 0-nly Attachment A ODCM-QA-001 Revision 3 Page 14 of 17

Quarterly sums of total curies for each of the radionuclides determined to be released based on analyses of fission and activation gases. The data should be categorized by: (1) elevated releases, batch and continuous modes, and (2) ground-level releases, batch and continuous modes.

2. Iodines

Quarterly sum of total curies of iodine-131 released.

Quarterly average release rate (µCi/sec} of iodine-131.

Percent of limit for iodine-131 for each quarter.

Quarterly sums of total curies of each of the isotopes, iodine-131, iodine-133, and iodine-135 determined to be released.

3, Particulates

Quarterly sums of total curies of radioactive material in particulate form with half-lives greater than eight days determined to be released.

Average release rate (µCi/sec) of radioactive material in particulate form with half-lives greater than eight days.

Percent of limit for radioactive material in particulate form with half-lives greater than eight days.

Quarterly sums of total curies for each of the radionuclides in particulate form determined to be released based on analyses performed.

Quarterly sums of total curies of gross alpha radioactivity determined to be released.

4. Tritium

Quarterly sums of total curies of tritium determined to be released in gaseous effluents.

Average release rate (µCi/sec) of tritium.

Percent of appropriate limits for tritium

5. Table 2-2 should list nuclides even if the total is reported as zero (AR 281707).

Page 4 of 6

For* Information Only

Attachment A ODCM-QA-001 Revision 3 Page 15 of 17

6. Abnormal Releases

Include the number of releases, the total activity released and any applicable discussion of onsite or offsite impacts due to the abnormal release(s). If any REMP monitored pathways were impacted due to an abnormal release, then applicable discussion of the impact(s) to be included in the Annual Radiological Environmental Operating Report.

Solid Radwaste (SRWl

Total curie quantity and radionuclide composition for solid waste shipped for burial or disposal.

Total SRW volume in cubic meters.

Total SAW radioactivity in curies for the categories of waste specified (a) spent resins, filter sludges, evaporator bottoms, etc., (b) dry compressible waste, contaminated equipment,

etc., (c) irradiated components, control rods, etc., (d) other (describe) as applicable. [Note:

Our reporting typically breaks these categories into more detail.]

Estimate of the major nuclide composition in each category of SRW

The disposition of SRW shipments (number of shipments, mode of transport and destination). [Note: This involves shipments that lead to burial or disposal during the year. It does not include shipments for processing.]

The disposition of irradiated fuel shipments (number of shipments, mode of transport and destination).

Licensee initiated changes to the Process Control Program to include detailed information to support rationale for changes, change did not reduce the overall conformance of the solidification waste product to existing criterion for solid radwaste, changes reviewed and recommended for approval by PORC. (FSAR 13.4.4.1)

Meteorological Data

Cumulative joint frequency distribution of wind speed, wind direction and atmospheric stability.

Radioloaical Impact on Man

Total body and significant organ doses to individuals in unrestricted areas from receiving water-related exposure pathways.

Page 5 of 6

For Information Only Attachment A ODCM-QA-001 Revision 3 Page 16 of 17

Total body and skin doses to individuals exposed at the point of maximum offsite ground-level concentrations of radioactive materials in gaseous effluents.

Organ doses to individuals in unrestricted areas from radioactive iodines and radioactive material in particulate form from all pathways of exposure.

Total body doses to individuals in unrestricted areas from direct radiation from the facility.

Calculated doses to members of the public within the Riverlands/lnformation Center Complex.

Supplemental Information

(Per RG 1.21, Page 1.21-13)

Standards for Normal Operation

(Per 40 CFR 190.10)

Page 6 of 6

For Information Only -----**----

Attachment B ODCM-QA-001 Revision 3 Page 17 of 17 CONTENTS OF ANNUAL RADIOLOGICAL ENVIRONMENTAL OPERATING REPORT

REMP Summary Description (TS 5.6.2)

Sampling Location Maps and Tables with Distances and Directions from SSES (TRS 3.11.4.1.1)

Tables of all Detectable Primary Analysis Results and Radiation Measurements (TRS 3.11.4.1.2 and TS 5.6.2}

Tables with a Statistical Summary of Analysis Results (TS 5.6.2)

Data Interpretation (TS 5.6.2)

Comparison of Indicator Location Data with Other Periods and Controls (TS 5.6.2)

Trend Analyses for Detectable Results (TS 5.6.2)

Dose Evaluation with Environmental Impact Assessment (TRS 3.11-4.1.3)

lnterfaboratory Comparison Results (TRS 3.11.4.3.1)

Deviations from Sampling/Analysis Requirements (TRM 3.11.4.1.A)

Non-SSES Radionuclide Activiti~etected (TRM 3.11.4.1.E)

Explanation of Unavailable Monitoring Results (TS 5.6.2}

ff an abnormal release of radioactive material occurred which impacted a REMP monitored pathway, then the REMP sample results, associated discussions and any applicable offsite dose calculations shall be included in the report.

Page 1 of 1

For Information Only PROCEDURE COVER SHEET SUSQUEHANNA NUCLEAR, LLC PROCEDURE ODCM REVIEW AND REVISION CONTROL ODCM-QA-002 Revision 6 Page 1of8 ADHERENCE LEVEL: INFORMATION USE QUALITY CLASSIFICATION: APPROVAL CLASSIFICATION:

( X ) QA Program ( ) Non-QA Program ( x) Plant ( ) Non-Plant

( ) Instruction I I -

EFFECTIVE DATE: oZ I I& I ~tJ/7 PERIODIC REVIEW FREQUENCY: ,</A PERIODIC REVIEW DUE DATE: µA RECOMMENDED REVIEWS:

Procedure Owner: Chemistry Responsible Supervisor: Chemistry Support Supervisor Responsible FU~: Manager-Plant Chemistry/Environmental Responsible Approver: Plant General Manager-Nuclear

For Information Only ODCM-QA-002 Revision 6 Page 2 of 8 PROCEDURE REVISION

SUMMARY

TITLE: ODCM REVIEW AND REVISION CONTROL

1) Update procedure references and position titles throughout the procedure.

2) Miscellaneous typographical corrections.

The above changes to ODCM-QA-002 have been evaluated as to not decrease the level of effluent control or the accuracy and/or reliability of dose calculations or setpoint determinations as required by 10CFR20.1302, 40CFR190, 10CFR50.36a and 10CFR50, App. I.

In addition, these changes do not alter the conduct of the radiological environmental monitoring program, do not change the radioactive effluent controls and radiological environmental monitoring activities, and do not change the information to be included in the Annual Radiological Environmental Operating and Radioactive Effluent Release Reports.

For Information Only ODCM-QA-002 Revision 6 Page 3 of 8 TABLE OF CONTENTS SECTION PAGE

1. PURPOSE 4

2. POLICY/DISCUSSION 4

3. REFERENCES 4

4. RESPONSIBILITIES 5 4.1 Plant General Manager-Nuclear 5 4.2 Manager-Plant Chemistry/Environmental 5 4.3 Chemistry Support Supervisor 5 4.4 Chemistry Support Personnel 5 4.5 All Personnel 5

5. DEFINITIONS 6

6. PROCEDURE 6

7. RECORDS 7 ATTACHMENTS ATTACHMENT PAGE A SSES ODCM CHANGE REQUEST (FORM ODCM-QA-002-1) 8

For Information Only ODCM-QA-002 Revision 6 Page 4 of 8

1. PURPOSE The purpose of this procedure is to describe the initiation, review, and processing of revisions to the ODCM and to establish responsibility for the ODCM.

This procedure constitutes part of the SSES Offsite Dose Calculation Manual (ODCM},

which is a licensing basis document.

2. POLICY/DISCUSSION 2.1 The ODCM is part of the Licensing Basis of SSES and is required by TS 5.5.1.

2.2 The ODCM procedures are controlled as Plant Functional Unit Procedures in accordance with the requirements of NDAP-QA-0004, with the following additional guidance and controls:

2.2.1 ODCM procedures shall be numbered as follows:

ODCM-QA-nnn, where nnn is a sequential number starting with 001.

2.2.2 ODCM procedures shall be reviewed and accepted by the Manager-Plant Chemistry/Environmental prior to PORC review.

2.2.3 Changes to the procedures comprising the ODCM require PORC review prior to approval. Changes, which are solely administrative corrections or an expedited review revision, are exempt from PORC review.

2.2.4 ODCM procedures shall be issued and controlled by Nuclear Records Document Control Services (NR-DCS) in accordance with NR procedures. The distribution list shall be maintained by DCS.

2.3 Changes to the Radioactive Effluent Control Program (RECP) are controlled in accordance with NDAP-QA-0730, but are reported as changes to the ODCM in the Radioactive Effluent Release Report.

3. REFERENCES 3.1 TS 5.5.1, Offsite Dose Calculation Manual (ODCM) 3.2 NDAP-QA-0004, Procedure Change Process 3.3 NDAP-QA-0101, Document Review

For Information Only ODCM-QA-002 Revision 6 Page 5 of 8 3.4 OPS-1-M, Quality Assurance for Radiological Environmental Monitoring, Radioactive Effluents, Meteorology, The Environmental Protection Plan, and The Offsite Dose Calculation Manual 3.5 NDAP-QA-0730, Licensing Document Changes 3.6 10CFR20.1302, Compliance with Dose Limits for Individual Members of the Public 3.7 40CFR190, Environmental Radiation Protection Standards for Nuclear Power Operation 3.8 10CFR50.36a, Technical Specifications on Effluents from Power Reactors 3.9 10CFR50, Appendix I, Numerical Guides for Design Objectives and Limiting Conditions for Operation to Meet "As Low As Is Reasonably Achievable" for Radioactive Material in Light-Water Cooled Nuclear Power Reactors *

4. RESPONSIBILITIES 4.1 Plant General Manager-Nuclear 4.1.1 Approves revisions to the ODCM.

4.2 Manager-Plant Chemistry/Environmental 4.2.1 Is the Responsible Functional Unit Manager (FUM).

4.3 Chemistry Support Supervisor 4.3.1 Ensures the adequacy and correctness of methodologies described in the ODCM.

4.3.2 Responsible for reviewing revisions to the ODCM.

4.4 Chemistry Support Personnel 4.4.1 Maintain the ODCM.

4.4.2 Process revisions to the ODCM.

4.5 All Personnel 4.5.1 Submit comments on ODCM contents and proposed revisions to the Chemistry Support Group.

For Information Only ODCM-QA-002 Revision 6 Page 6 of 8

5. DEFINITIONS None

6. PROCEDURE 6.1 Personnel shall submit proposed ODCM revisions on the SSES Offsite Dose Calculation Manual Change Request Form ODCM-QA-002-1. The submitter shall complete Sections 1 through 5 according to the directions on the form, including sufficient detail of the revision and technical basis of the change to support the rationale for the change and to enable the Chemistry Support Group to proceed. The submitter should provide at least one-month lead time between the submittal date and the requested implementation date to permit preparation, review by interested parties, and approval of the ODCM revision. Changes tracked by other mechanisms (e.g., Condition Reports and Modifications) do not require use of Form ODCM-QA-002-1.

6.2 Chemistry Support Personnel shall sign and date Form(s) ODCM-QA-002-1 on receipt, and retain the form(s) in a work file created for this ODCM revision.

Chemistry Support Personnel may contact the form submitter to discuss the details of the revision.

6.3 Chemistry Support Personnel shall prepare a draft of the ODCM revision based on information in Form(s) ODCM-QA-002-1.

6.3.1 The preparer shall ensure that the change does not reduce the level of effluent control or the accuracy and/or reliability of dose calculations or setpoint determinations as required by 10CFR20.1302, 40CFR190, 10CFR50.36a and 10CFR50, Appendix I.

6.3.2 The preparer shall include a statement to this effect in the Procedure Revision Summary.

6.3.3 If compliance to the criterion in Step 6.3.1 cannot be demonstrated, the preparer shall make appropriate changes to ensure compliance, else the proposed revision shall be dismissed.

6.3.4 Each change shall be identified by markings in the margin of the affected pages, clearly indicating the area of the page that was changed. The date the change is implemented is indicated on the Procedure Cover sheet.

For Information Only ODCM-QA-002 Revision 6 Page 7 of 8 6.4 Chemistry Support Personnel shall follow the process described in NDAP-QA-0004 for plant procedures.

6.4.1 All review comments and resolutions shall be documented according to NDAP-QA-0101.

6.4.2 The review shall sustain that the change does not reduce the accuracy or reliability of dose calculations and/or setpoint determinations.

6.5 Chemistry Support Personnel shall schedule the proposed ODCM revision for PORC review in accordance with PORC procedures.

6.6 Chemistry Support Personnel shall present the ODCM revision to PORC, along with originating information (Form(s) ODCM-QA-002-1), review documentation (Form NDAP-QA-0101-1), any technical material (calculations, studies, etc.)

necessary to support the ODCM revision, the evaluation required in Step 6.3.1 and appropriate signature approvals.

6.7 Chemistry Support Personnel shall submit to the NRC a complete, legible copy of the revised ODCM in the Radioactive Effluent Release Report for the period of the report in which any change to the ODCM was made.

7. RECORDS The following shall be submitted to Nuclear Records in accordance with NR procedures:

7.1 Form(s) ODCM-QA-002-1, with attachments, if any.

\

7 .2 Review package, assembled in accordance with the requirements of NDAP-QA-0004 and NDAP-QA-0101. .

For Information Only Attachment A ODCM-QA-002 Revision 6 Page 8 of 8 SSES OFFSITE DOSE CALCULATION MANUAL CHANGE REQUEST

1. ODCM~QA-_ Submit a separate form for each ODCM procedure to be revised.

2. Describe proposed revisions to the SSES ODCM below. Include references to sections, figures, tables, parameters, and equations with sufficient detail to convey complete and correct information. If necessary, use additional pages. If proposed revision can be more clearly indicated on marked up copy(s) of the current ODCM, then attach these marked up pages to this form.

3. Reason for revision: include references to Condition Reports, Audit Services observations or findings, Licensing Issues, DCPs, etc., as applicable. If necessary, use additional pages.

4. Additional pages attached? NoD YesD Number of additional pages

5. Requested date for implementation of revision:

Requested by: ~~~~~~~~~~~~

Cost Area: -~~~

Date:

To be completed by Chemistry Support - SSES FORM ODCM-QA-002-1, Rev. 2, Page 1 of 1

I For Information Only I

PROCEDURE COVER SHEET PPL SUSQUEHANNA, LLC PROCEDURE EFFLUENT MONITOR SETPOINTS ODCM-QA-003 Revision 7 Page 1 of 16 ADHERENCE LEVEL: INFORMATION USE QUALITY CLASSIFICATION: APPROVAL CLASSIFICATION:

( X ) QA Program ( ) Non-QA Program ( x) Plant ( } Non-Plant

( ) Instruction I I EFFECTIVE DATE: 01~4/Jotl PERIODIC REVIEW FREQUENCY: NIA PERIODIC REVIEW DUE DATE: JJA RECOMMENDED REVIEWS:

Nuclear Emergency Pl~nning I

Procedure Owner: Francis Hickey Responsible Supervisor: Manager-Plant Chemistry/Environmental Responsible FUM: Manager-Plant Chemistry/Environmental Responsible Approver: Plant Manager FORM NDAP-QA-0002~1, Rev. 4, Page 1 of 1 (Electronic Form)

For Information Only ODCM-QA-003 Revision 7 Page 2of16 PROCEDURE REVISION

SUMMARY

TITLE: EFFLUENT MONITOR SETPOINTS The changes made do not reduce or compromise the level of effluent control or the accuracy and/or reliability of dose calculations or setpoint determinations as required by 10CFR20.1302, 40CFR190, 10CR50.36a and 10CFR50, Appendix I.

Additionally, the changes outlined below (1) do not alter the conduct of the radiological environmental monitoring program, (2) do not change the radioactive effluent controls and raqiological environmental monitoring activities, and (3) do not change the information to be included in the Annual Radiological Environmental Operating and Radioactive Effluent Release Reports.

1) Procedure revised to incorporate setpoint guidance to support the current airborne effluent SPING units as well as the VERMS units. Added guidance includes the determination of a Limiting Release Rate for each vent release point.

For Information Only ODCM-QA-003 Revision 7 Page 3of16 TABLE OF CONTENTS SECTION PAGE

1. PURPOSE 4

2. POLICY/DISCUSSION 4 2.1 ODCM Setpoints are Upper Limit Values 4 2.2 Waterborne Effluent Monitors 4 2.3 Airborne Effluent Monitors 5 2.4 Selection of Data for Determination of Dose Rate Compliance 6

3. REFERENCES 6

4. RESPONSIBILITIES 7 4.1 Manager - Plant Chemistry/Environmental 7

5. DEFINITIONS 7

6. PROCEDURE 8 6.1 Liquid Effluent Monitoring 8 6.2 Airborne Effluent Monitoring ~ Noble Gas 13

7. RECORDS 15 ATTACHMENTS ATTACHMENT PAGE A Parameters Used to Determine Airborne Effluent Monitor Setpoints 16

For frifo"rmatfori- Only ODCM-QA-003 Revision 7 Page 4of16

1. PURPOSE This procedure discusses the methodology to be used in determining effluent monitor alarm/trip setpoints to be used to ensure compliance with the concentration and instantaneous release rate limits ih the Technical Requirements Manual (Sections 3.11.1.1 and 3.11.2.1) and provides operational flexibility while giving reasonable assurance of meeting the design objectives of 10CFR50, Appendix I.

This procedure constitutes part of the SSES Offsite Dose Calculation Manual which is a licensing basis document.

2. POLICY/DISCUSSION 2.1 ODCM Setpoints are Upper Limit Values 2.1.1 Effluent monitor alarm/trip setpoints calculated in accordance with the ODCM shall be considered upper limit values. Higher (less conservative) setpoints shall not be used, however, lower (more conservative) setpoints may be used as required to maximize the utility of the monitor.

2.2 Waterborne Effluent Monitors 2.2.1 A gross radioactivity monitor providing automatic termination of liquid effluent releases is present on the liquid radwaste effluent line. Flow rate measurement devices are also present on the liquid radwaste effluent line and the discharge line (cooling tower blowdown).

2.2.2 Precautions, limitations, and setpoints applicable to the operation of the SSES liquid effluent monitors are provided in the applicable plant procedures.

2.2.3 The liquid effluent monitor setpoints are determined in accordance with the methodology and parameters described in Section 6.1 and controlled as "field set" in accordance with applicable plant procedures.

2.2.4 Setpoint values are to be calculated to ensure that alarm and trip actions occur upon approaching 1o times the EC limits of 10CFR20, Appendix B, Table 2, Column 2 and 2E-4 µCi/ml for total dissolved gases at the release point to the Unrestricted Area.

"i=or Information Only ODCM-QA-003 Revision 7 Page 5of16 2.2.5 Setpoint values for monitors used for leak detection (if set more conservatively than the EC limits) should be based on X times background values provided such values do not result in concentrations greater than the EC limits at the Unrestricted Area.

The setpoint is established based on operating experience.

2.3 Airborne Effluent Monitors 2.3.1 Noble gas activity monitors, iodine, and particulate samplers are present on the reactor building ventilation system (Units 1 and 2),

the turbine building ventilation system (Units 1 and 2), and the standby gas treatment system exhaust vents. Effluent system flow rate and sampler flow rate are measured on all of the systems allowing the vent monitor microprocessor to calculate release rates based on measured flow rates.

2.3.2 Precautions, limitations, and setpoints applicable to the operation of the SSES airborne effluent monitors are provided in the applicable plant procedures.

2.3.3 Setpoints are conservatively established for each effluent monitor so that the instantaneous dose rates of TRO 3.11.2.1. I will not be exceeded.

2.3.4 The general methodology for establishing plant ventilation airborne effluent monitor setpoints is based upon a site limiting release rate derived from site-specific meteorological dispersion conditions, vent flow rates, and measured or expected radionuclide mixtures in the gaseous effluents. The site limiting r release rate can then be converted to vent limiting concentrations or vent limiting release rates for input as setpoints for the applicable detectors.

2.3.5 The main condenser offgas pre~treatment mo,nitor provides

, indication of offgas activity prior to input to the holdup system.

A_larm setpoints are based on the Technical Specification 3.7.5 noble gas release rate limit of 330 millicuries/second or less at the motive steam jet condenser discharge.

2.3.6 Noble gas activity monitor setpoints are established at release rates which permit some margin for corrective action to be taken before exceeding the offsite instantaneous dose rates of TRO 3.11.2.1.I.

For Ii'lforma*tron-cnry-- ~--- --- -----------------------------

ODCM-QA-003 Revision 7 Page 6of16 2.4 Selection of Data for Determination of Dose Rate Compliance 2.4.1 Airborne effluent monitor setpoints are maintained in accordance with Section 2.3, to alarm before the dose rate limits of the Technical Requirements Manual TRO 3.11.2.1. I are exceeded.

Station alarm response procedures contain instructions for investigation and verification of monitor alarms. Because setpoint calculations must include assumptions about the composition of the monitored effluent, a monitor high alarm does not necessarily indicate that a dose rate limit has been exceeded.

2.4.2 Valid 10-minute or valid 15-minute averaged data should be the primary information used to determine the compliance status of an incident. One-minute averaged data should also be reviewed if available, but they may or may not provide additional information depending on the magnitude of the release due to the manner in which the monitors update values to be stored and associated statistical considerations. Averages over a longer period should be used only when data with higher resolution is not available.

Grab sample analyses should be performed whenever possible to confirm or disprove monitor data, and to provide indication of the nuclide specific composition of the effluent. When grab sample data are available which, based on vent monitor data, are indicative of the period of elevated release, dose rate calculations should be performed using the actual effluent mix. The determination of compliance status should not be based on monitor data alone when it is possible to collect and analyze a vent sample which will be representative of the period of elevated release.

3. REFERENCES 3.1 TS 3.7.5, [Radioactive Effluents] Main Condenser 3.2 TR 3.11.1.1, [Radioactive Effluents] [Liquid Effluents] Concentration 3.3 TR 3.11.1.4, Liquid Radwaste Effluent Monitoring Instrumentation 3.4 TR 3.11.1.5, Radioactive Liquid Effluent Monitoring Instrumentation 3.5 TR 3: 11.2.1, [Radioactive Effluents] [Gaseous Effluents] Dose Rate 3.6 TR 3.11.2.6, Radioactive Gaseous Effluent Monitoring Instrumentation

3. 7 10CFR20.1301, Dose limits for individual members of the public

For tnformation Only ODCM-QA-003 Revision 7 Page 7of16 3.8 10CFR20 Appendix 8, Annual Limits on Intake (ALis) and Derived Air Concentrations (DACs) of Radionuclides for Occupational Exposure: Effluent Concentrations; Concentrations for Release to Sewerage 3.9 40CFR190, Environmenta.1 radiation protection standards for nuclear power operations*

3.1 o 10CFRSO Appendix I, Numerical Guides for Design Objectives and Limiting Conditions for Operation to Meet the Criterion "As Low as is Reasonably Achievable" for Radioactive Material in Light-Water Cooled Nuclear Power I Reactor Effluents

' 3.11 EC-RADN-1041, Rev. 6, SSES "Expected" Liquid and Gaseous Effluent Releases and Aquatic and Atmospheric Doses 3.12 The importance of P-32 in Nuclear Reactor Liquid Effluents, USNRC Edward F.

Branagan Jr., Charles R. Nichols, and Charles A Willis; 1982 3.13 PPL AR# 401298, "Deletion of LRW Composite Sample P-32 Analysis 5/2002" 3.14 EC-ENVR-1042, Airborne Effluent Dose Conversion Factors Used in Chemistry Procedures.

4. RESPONSIBILITIES 4.1 Manager - Plant Chemistry/Environmental 4.1.1 Is responsible for calibrating, functionally testing, and providing alarm responses for radiological effluent monitoring equipment.

4.1.2 Ensures adequacy and correctness of methodology used to establis~ setpoints.

4.1.3 Is responsible for development of methodology and calculations used to establish setpoints

5. DEFINITIONS 5.1 Actual Tank Activity - The sum of the products of tank concentrations and volume for each isotope.

5.2 Cs-137 Equivalent- Concentration equivalent of 1.00E-06 µCi/ml ECL for Cs-137.

5.3 ECL - Effluent Concentration Limits as defined in 10CFR20, Appendix B.

For Information Only ODCM-QA-003 Revision 7 Page 8of16

6. PROCEDURE 6.1 Liquid Effluent Monitoring Chemistry shall develop procedures implementing the following requirements for Liquid Effluent Monitoring.

6.1.1 Discharge Termination Chemistry shall determine the setpoint concentration for the discharge termination, which limits the maximum concentration being released, as follows:

Cr =X"'LC,., (Eq. 6.1-1) n Where:

Cr = The setpoint concentration at which the discharge would be terminated (µCi/ml).

X = A unitless number greater than one that is chosen to prevent spurious alarms that might result from non-uniformity in the activity concentrations of the liquid discharges.

C,n = The concentration of isotope n in the contents of the tank to be discharged as determined by pre-release sampling and analyses. The summation shall include gamma-emitting isotopes only (including noble gases). The minimum L C ,n used in the setpoint determination is 9.0E-6 uCi/ml. 9.0E-6 uCi/ml is the TRM concentration limit for Cs-134 which is the most restrictive of the principal gamma emitting isotopes required to be analyzed i.n liquid effluents (per TRM Bases 3.11.1.1 ).

The setpoint concentration is based on the activity of the isotopes to which the monitor responds, i.e., gamma-emitting isotopes only. It is used to establish the radiation monitor setpoint (count rate) in units of cpm or cps.

For Information Only ODCM-QA-003 Revision 7 Page 9of16 6.1.2 Radiation Monitor Setpoint The radiation monitor setpoint is the sum of the background count rate and the count rate equivalent of the setpoint concentration.

The count rate equivalent of the setpoint concentration in units of

µCi/ml is determined by dividing the setpoint concentration by the calibration factor (also referred to as conversion constant or calibration constant in units of µCi/ml/cpm).

Chemistry shall determine the radiation monitor setpoint as follows: -

c s~..L+B (Eq. 6.1-2)

K Where:

S = the radiation monitor setpoint (cpm) i C1 = the setpoint concentration at which the discharge would be terminated from Eq. 6.1-1 (µCi/ml)

K = the radiation monitor calibration factor (µCi/ml/cpm)

B = the background radiation level for the radiation monitor (cpm)

The alarm setpoint may be established ~t a suitable fraction of the setpoint for discharge termination.

I I

- Far Information Only ODCM-QA-003 Revision 7 Page 10of16 6.1.3 Discharge Flow Rate Limit Determination The flow rate below which tank discharges must be maintained depends on the magnitude of the dilution required to ensure compliance with the limits of TR 3.11.1.1:

Chemistry shall establish the maximum Discharge Flow Rate using the following equation:

f = F (Eq. 6.1-3)

Y*(I:cntL,, + I;cN0il2E-4)-1

" NGi Where:

f = The maximum discharge rate from the tank (gpm).

F = The minimum dilution flow rate of 5000 gpm provided by the blowdown flow from the Cooling Towers and any

,_ overflow from the spray pond (gpm).

Y = A unitless number that* is chosen to ensure that the dilution flow is conservatively determined.

Cn * = The concentration of isotope n in the contents of the tank to be discharged as determined by pre-release sampling and analyses. The summation shall include previous composite sample results for non-gamma emitting radionuclides such as H-3, Fe-55, Sr-89, and Sr-90 {µCi/ml).

Ln = Ten (10) times the effluent concentration (EC) for isotope n per 10CFR20, Appendix B, Table 2, Column 2 for radionuclides other than noble gases. To maintain compatibility with other federal regulations, the maximum permissible concentration (MPC) value from 10CFR20, Appendix B, Table II, Column 2 (pre-199410CFR20) may be used for those isotopes for which the MPC is more restrictive than (10 x EC).

CNGi = The concentration of noble gas isotope i in the contents of the tank to be discharged. The summation shall include all dissolved and entrained noble gases.

Selecting values of X (Section 6.1.1) and Y (Section 6.1.3) is a matter of experience and the expected margin needed between the activity concentration and the maximum concentration limit (1 Ox ECL).

Y must be greater than X in order to ensure release concentrations are within allowable limits.

For Information* O'nly ODCM-QA-003 Revision 7

Page 11 of 16 6.1.4 Post-Release Evaluation Chemistry shall perform post-release evaluations.using actual composite sample results to recalculate the highest diluted

LCr/Ln. . .

6.1.5 Service W~ter, SOHR Service Water, and RHR Service Water The Service Water System provides screened water from the cooling tower basin for cooling plant systems and equipment. The supplemental Decay Heat Removal Service Water System (SOHR) provides decay heat removal during refueling outages when the Service Water System is shut down. The Residual Heat Removal (RHR) Service Water System provides water from the Engineered Safeguard Service Water (ESSW) spray pond to the RHR heat exchangers. In post-accident conditions, RHR Service Water can supply water for vessel and containment flooding. The Service Water, SDHR Service Water, and RHR Service Water Systems are not normal pathways for liquid effluents. Radiation monitors are in place on these systems to provide indication of leaks across heat exchangers into the service water.

The high radiation setpoints for these monitors are set at 1E-5/cal.

factor (IE-5 = 10 times the Cs-137 equivalent). Considering the radionuclides predominant in SSES liquid effluents e.g., Co-58, Co-60, Fe-59, Mn-54 and Cr-51, use of a setpoint based on the Cs-137 ECL is reasonable based on the following parameters:

1) photon abundance (85%), photon energy (0.662 MeV)

2) magnitude of applicable ECL (1 E-6 µCi/ml)

Because Service Water, SOHR Service Water, and RHR Service Water systems are not normal release pathways for liquid effluents, no credit should be taken for possible dilution scenarios.

All service water should be maintained below 1E-5 µCi/ml {10 times the Cs-137 equivalent ECL) or as established by Chemistry based on operating experience (Section 2.2.5).

For Information Only ODCM-QA-003 Revision 7 Page 12of16 If some background contribution is to be added to the calculated High and Alert setpoints, a Downscale or Low Rad Setpoint is also required in order to minimize the chance of a change in the background of a monitor masking a significant trend in monitored activity. The alarm setpoints for Service Water, SDHR Service Water and RHR Service Water monitors are then determined as follows:

a. When monitor background s(1 E-5)/Cal. Factor:

HI RAD Setpoint =0.5 Background + (1 E-5)/Cal. Factor DOWNSCALE or LOW RAD Setpoint =0.5 Background

b. When monitor background >(1 E-5)/Cal. Factor:

HI RAD Setpoint =Background + 0.5 (1 E-5)/Cal. Factor DOWNSCALE or LOW RAD Setpoint = Background - 0.5 (1 E-5)/Cal. Factor Where:

Setpoint = alarm threshold value to be entered into monitor (cps for Service Water and SOHR Service Water, cpm for RHR Service Water)

Background = monitor background at most recent background determination (cps for Service Water, and SOHR Service Water, cpm for RHR Service Water)

(1E-5) = 10 times the Cs-137 ECL (µCi/ml)

Cal. Factor = monitor response factor per unit Cs-137 concentration determined during most recent calibration (µCi/ml per cps for Service Water and SOHR Service Water,

µCi/ml per cpm for RHR Service Water)

The ALERT RAD setpoints for the RHR Service Water monitors are maintained at 80% of the applicable HI RAD setpoint (cpm).

For Information Only ODCM-QA-003 Revision 7 Page 13of16 6.2 Airborne Effluent Monitoring - Noble Gas The methodology outlined in Section 6.2 shall be utilized in implementing the requirements for Airborne Effluent Monitoring of Noble Gas. The site limiting release rate is based on not exceeding the instantaneous dose rates of TRO 3.11.2.1.1 . Using the site limiting release rate, methodology is provided to determine the plant vent monitor limiting activity concentration and individual plant vent monitor limiting activity release rates. Depending on the design of the effluent radiation monitoring system, either the monitor limiting concentration or the monitor limiting release rate can be used to establish plant vent radiation monitor setpoints.

6.2.1 Site Limiting Release Rate - Noble Gas

a. The limiting total body and skin release rates are calculated as follows:

LTB = QNG

DRTB

k (Eq. 6.2-1 a)

DTB (Eq. 6.2-1b)

Where:

Lrs = limiting release rate- noble gas total body (µCi/min)

Ls = limiting release rate- noble gas skin (µCi/min)

QNG = total noble gas source term (Ci)

DRrs = total body dose rate limit for the noble gas effluent (500 mrem/year) (ref. TRO 3.11.2.1, I.A)

DRs = total skin dose rate limit for the noble gas effluent (3000 mrem/year) (ref. TRO 3.11.2.1, 1.8)

Dm = limiting total body offsite dose resulting from the noble gas source term ONG (mrem)

Ds = limiting skin offsite dose resulting from the noble gas source term QNG (mrem)

For Information Only ODCM-QA-003

- - Revision 7 Page 14of16

.k = units conversion factor (1 E6 µCi/Ci) * (1 yr/365 days) * (1 day/ 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months )

(1 hour/60 minutes)

Dra and Ds are determined in accordance with ODCM-QA-004 using the noble gas source term and dispersion parameters provided in Attachment A.

Note, QNa is the sum of the noble gas activities provided in Attachment A.. The ratio of the annual source term to the corresponding total body and skin dose is used in the above equations. Thus, either the total annual release per unit or the total annual release for the site may be used.

b. The site limiting release rate for noble gas, LNG* shall be set as the lesser of Lra and Ls and the site limiting release rate for noble gas implemented in the Emergency Plan.

The Emergency Plan may be revised to implement the lesser of Lrs and Ls to provide additional flexibility in plant operations.

6.2.2 Monitor Limiting Concentration ~ Noble Gas The limiting noble gas concentration applicable to all plant vents shall be determined as follows:

(Eq. 6.2-2)

Where:

CNG monitor limiting noble gas conc~ntration (µCi/cc)

LNG = site limiting release rate - noble gas from Section 6.2.1

(µCi/min)

Fv = vent flow high limit for vent V (cc/min)

For Information Only ODCM-QA-003 Revision 7 Page 15of16 6.2.3 Monitor Limiting Release Rate - Noble Gas The limiting plant vent noble gas release rate shall be determined for each plant as follows:

(Eq. 6.2-3)

Where:

R~a monitor limiting noble gas release rate (µCi/min) for plant ventV LNG = site limiting release rate - noble gas from Section 6.2.1

(µCi/min)

Fv = vent flow high limit for vent V (cc/min)

7. RECORDS None

For Inf~rmatlorf Only -

Attachment A ODCM-QA-003 Revision 7 Page 16of16 PARAMETERS USED TO DETERMINE AIRBORNE EFFLUENTS MONITOR SETPOINTS

..i NUCLID~ '. TOTAi!. *RELEAS~ (1) *

(Ci/year per re.actor)*

Ar-41 1.02E+02 Kr-83m O.OOE+OO Kr-85m 3.09E+02 Kr-85 2.60E+02 Kr-87 1.42E+01 Kr-88 6.32E+01 Kr-89 1.47E+02 Xe-131m 5.90E+01 Xe-133m 6.00E+OO Xe-133 8.36E+03 Xe-135m 6.70E+02 Xe-135 9.73E+02 Xe-137 4.68E+02 Xe-138 2.10E+02 Annual Average Dispersion Parameters - Limiting Site Boundary (2)

Relative Concentration 1.25E-5 sec/m 3 Decayed Relative Concentration 1.24E-5 sec/m3 Decayed, Depleted Relative Concentration

1.07E-5 sec/m3 Notes:

1. Design basis "expected" gaseous effluent releases per EC-RADN-1041

2. 1999-2003 Meteorological Data per EC-ENVR-1057, Rev. 0 Page 1of1

For Information Only PROCEDURE COVER SHEET PPL SUSQUEHANNA, LLC PROCEDURE AIRBORNE EFFLUENT DOSE CALCULATIONS ODCM-QA-004 Revision 6 Page 1 of65 ADHERENCE LEVEL: INFORMATION USE QUALITY CLASSIFICATION: APPROVAL CLASSIFICATION:

( X ) QA Program ( ) Non-QA Program ( x) Plant ( ) Non-Plant

( ) Instruction J I EFFECTIVE DATE: c;{ /;q /c2.0/t, PERIODIC REVIEW FREQUENCY: NIA PERIODIC REVIEW DUE DATE: N/A RECOMMENDED REVIEWS:

Nuclear Emergency Planning Procedure Owner: Chemistry Responsible Supervisor: Manager-Plant Chemistry/Environmental Responsible FUM: Manager-Plant Chemistry/Environmental Responsible Approver: Plant General Manager-Nuclear

.4 **

For Information Only ODCM-QA-004 Revision 6 Page 2 of 65 PROCEDURE REVISION

SUMMARY

TITLE: AIRBORNE EFFLUENT DOSE CALCULATIONS The changes made do not reduce or compromise the level of effluent control or the accuracy and/or reliability of dose calculations or setpoint determinations as required by 10CFR20.1302, 40CFR 190, 10CFR50.36a and 10CFRSO, Appendix I. Additionally, the changes outlined below (1) do not alter the conduct of the radiological environmental monitoring program, (2) do not change the radioactive effluent controls and radiological environmental monitoring activities, and (3) do not change the information to be included in the Annual Radiological Environmental Operating and Radioactive Effluent Release Reports.

1) Update Steps 6.4.1 and 6.4.2 to include reference to and a listing of line loss correction factors for the Vent Effluent Radiation Monitoring System (VERMS) and to delete PAVSS from the list of Effluent Monitors.

~) Add Reference 3.18 and 3.19 to support item 1 above.

3) Update Responsible Approver title.

For Information Only ODCM-QA-004 Revision 6 Page 3 of 65 TABLE OF CONTENTS SECTION

1. PURPOSE

2. POLICY/DISCUSSION 4

3. REFERENCES 7

4. RESPONSIBILITIES 8

5. DEFINITIONS 8

6. PROCEDURE 9 6.1 Noble Gases 9 6.2 Radionuclides Other Than Noble Gases 11 6.3 Airborne Effluent Monitoring - Iodine and Particulate 12 6.4 Airborne Monitor Line Loss Corrections 15 6.5 Airborne Effluent Dose Calculations Exceeding Twice the Quarterly or Annual TRM Values 17 6.6 Projected Dose from Gaseous Effluent 17

7. RECORDS 17 ATTACHMENTS ATTACHMENT PAGE A Dose Factors for Noble Gases 18 B Annual Average Dispersion Factors Used for Monthly Surveillances 19 c ODCM Maximum Pathway Dose Factors: Radionuclides*other than 20 Noble Gases D Evaluation of Insignificant Effluent Pathway Gaseous Releases 64 E Parameters Used To Determine Particulate/Iodine Limiting Release 65 Rates

For Information Only ODCM-QA-004 Revision 6 Page 4 of 65

1. PURPOSE The purpose of this procedure is to provide the methodology and parameters used in calculating air dose resulting from noble gas effluent and maximum individual, total body, and organ doses due to airborne effluents to ensure compliance with the dose limitations in the Technical Requirements Manual (Sections 3.11.2.2, 3.11.2.3, 3.11.2.5 and 3.11.3) and 10CFR20.1302.

This procedure constitutes part of the SSES Offsite Dose Calculation Manual (ODCM) which is a licensing basis document.

2. POLICY/DISCUSSION 2.1 Meteorological Parameters 2.1.1 The meteorological parameters are provided by the SSES meteorology program. Instrumentation and controls necessary to ensure that sufficient meteorological data are available to determine radiation doses to the public as a result of radioactive releases are specified in TR 3.3.3.

2.1.2 Annual dose calculations for the Radioactive Effluent Release Report are based on the actual meteorological conditions concurrent with the reporting year.

2.1.3 Monthly dose calculations are based on the limiting sector average annual dispersion factors based on a selected period of time. The dispersion factors currently used are provided in Attachment B.

2.1.4 Use of the no-decay-undepleted X/Q is recommended for dose computations, because it is conservative for all isotopes.

Consideration for depletion of radioiodines and particulates and radioactive dercay of the plume is acceptable, but not required.

2.1.5 The methodology described herein incorporates parameters outlined in Regulatory Guide 1.109, Rev. 1, October, 1977, Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purposes of Evaluating Compliance with 10CFR50, Appendix I, and NUREG-0133, Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants.

2.2 Noble Gases 2.2.1 The methods for sampling and analysis of continuous ventilation releases are given in the applicable plant procedures.

For Information Only ODCM-QA-004 Revision 6 Page 5 of 65 2.3 Radionuclides Other Than Noble Gases 2.3.1 The methods for sampling and analysis of continuous ventilation releases for radioiodines and.radioactive particulates are given in the applicable plant procedures and shall be performed in accordance with TR Table 3.11.2.1-1.

2.4 Effluent Data 2.4.1 The total number of Curies released for each radionuclide during the time period being evaluated is supplied by the SSES effluent monitoring program.

2.4.2 For determination of compliance with the Technical Requirements Manual dose limits, effluent totals shall be based only on activity positively detected at the 95% confidence level.

2.4.3 Applicable airborne pathways at SSES include immersion, inhalation, ground exposure, vegetable ingestion, and cow-milk ingestion. The grass-to-meat-to-man airborne pathway is applicable depending on its identification in the annual Land Use Census Report. If a specific airborne exposure pathway does not exist {based on the most recent Land Use Census results) then offsite dose calculations for the applicable exposure pathway do not need to be performed.

2.4.4 Quarterly doses are the summation of the applicable monthly values.

2.4.5 Effluent data from the following Insignificant Effluent Pathways shall be included in the Radioactive Effluent Release Report:

Units 1 and 2 CSTs, Units 1 and 2 Main Turbine and RFPT Lube Oil Systems, Units 1 and 2 Hydrogen Seal Oil Systems, the RWST, Batch Lube Oil Tank and Noble Gases Entrained in Liquid Effluents.

The contribution from Insignificant Effluent Pathways to the total dose from all SSES effluents should be small enough that the dose from these pathways combined with the dose from Significant Effluent Pathways would not be expected to challenge the radiological effluent dose limits for the SSES. Insignificant Pathway Effluents will be tracked and evaluated quarterly.

For Information Only ODCM-QA-004 Revision 6 Page 6of65 2.4.6 When a gaseous effluent noble gas monitor indicates a release has occurred, a noble gas isotopic mix shall be selected and assigned to that release period. If a representative sample cannot or was not obtained during the release, then the isotopic mix should be based on the applicable unit current conditions as appropriate.

2.5 Assignment of Releases to the Reactor Units 2.5.1 For determination of compliance with SSES radioactive effluent dose limits which are on a "perreactor unit" basis:

a. Effluents from the Unit 1 Reactor Building vent and the Unit 1 Turbine Building vent shall be included as Unit 1 releases. Effluentfrom the following Insignificant Effluent Pathways associated with Unit 1 shall also be included in the Unit 1 releases: the Unit 1 Condensate Storage Tank Vent, the Unit 1 Main Turbine and RFPT Lube Oil System vents, and the Unit 1 Hydrogen Seal Oil system vent. The Radwaste Building vent shall also be included in Unit 1 releases.

b. Effluents from the Unit 2 Reactor Building vent and the Unit 2 Turbine Building vent shall be included as Unit 2 releases. Effluents from the following Insignificant Effluent Pathways associated with Unit 2 shall also be included in the Unit 2 releases: the Unit 2 Condensate Storage Tank vent, the Unit 2 Main Turbine and RFPT Lube Oil System vents, and the Unit 2 Hydrogen Seal Oil System vent.

c. Effluents from the Standby Gas Treatment System vent and the following Insignificant Effluent Pathways common to both Units 1 and 2 shall be divided equally between Units 1 and 2 releases, or apportioned appropriately between the units if sufficient information is available:

Refueling Water Storage Tank, Noble Gases Entrained in Liquid Effluents and Batch Lube Oil Tank.

I

For Information Only ODCM-QA-004 Revision 6 Page 7of65

3. REFERENCES 3.1 TR Table 3.11.2.1-1, Radioactive Gaseous Waste Sampling and Analysis Program 3.2 TR 3.11.2.2, [Radioactive Effluents] [Gaseous Effluents] Dose-Noble Gases 3.3 TR 3.11.2.3, [Radioactive Effluents] [Gaseous Effluents] Dose-Iodine, Tritium, and Radionuclides in Particulate Form 3.4 TR 3.11.2.5, [Radioactive Effluents] [Gaseous Effluents] Ventilation Exhaust Treatment System 3.5 TR 3.11.3, Total Dose 3.6 TR 3.3.3, Meteorological Instrumentation 3.7 10CFR20 Appendix B, Annual Limits on Intake (ALis) and Derived Air Concentrations (DACs) of Radionuclides for Occupational Exposure; Effluent Concentrations; Concentrations for Release to Sewage 3.8 Regulatory Guide 1.109, Rev. 1, October, 1977, Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purposes of Evaluating Compliance with 10 CFR 50, Appendix I 3.9 NUREG-0133, Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants, October 1978 3.10 CH-RM-005, SSES Meteorological Monitoring Program 3.11 ODCM-QA-006, Total Dose Calculations 3.12 PPL Calculation EC-ENVR-1055, Rev. 0, "Evaluation of Dose Factors for Liquids and Gaseous Effluent Releases" 3.13 SSES Annual Land Use Census Report 3.14 PPL Calculation EC-ENVR-1008, Rev. 4, "Unmonitored Release Analysis:

Systems Identified in PLl-77223" 3.15 Analysis of the Effluent Sampling Line Particulate and Iodine Losses for the Susquehanna Steam Electric Station by Watts-Bar Jones, February 1988 (PLl-55451 and PLl-54729) 3.16 PPL Calculation EC-RADN-1041, Rev. 6, SSES Expected Liquid and Gaseous Effluent Releases and Aquatic and Atmospheric Doses 3.17 PPL Calculation EC-ENVR-1057, Rev. 0, Offsite X/Q Values for the SSES Based on 1999-2003 Meteorological Data 3.18 PPL Calculation EC-079-1034, Rev. 0, VERMS Particulate and Iodine Line Losses Analysis.

3.19 LDCN Nos. 4552, 4553

For Information Only ODCM-QA-004 Revision 6 Page 8 of 65

4. RESPONSIBILITIES 4.1 Manager - Plant Chemistry/Environmental 4.1.1 Ensures adequacy and correctness of methodology to be used in calculating doses resulting from airborne effluents as necessary for fulfillment of Technical Requirement Surveillances (3.11.2.2.1, 3.11.2.3.1, 3.11.3).

4.1.2 Ensures the cumulative dose contributions for the current calendar quarter and current calendar year are determined every 31 days in fulfillment of TRSs 3.11.2.2.1, 3.11.2.3.1, 3.11.3.

4.1.3 Ensures methodology and parameters to be used in calculating doses resulting from airborne effluents are developed to ensure compliance with the dose limitations in the Technical Requirements Manual.

5. DEFINITIONS 5.1 FID - Fraction of airborne radioiodine effluent that is estimated to be elemental iodine. The fraction of iodine deposited (FID) is assumed to be 0.5 (Regulatory Guide 1.109 (page 1.109-26)).

5.2 MEMBER(S) OF THE PUBLIC - Shall include all persons who are not occupationally associated with the plant. This category does not include employees of the utility, its contractors, or vendors. Also excluded from this category are persons who enter the site to service equipment or to make deliveries. This category does include persons who use portions of the site for recreational, occupational, or other purposes not associated with the plant.

5.3 UNRESTRICTED AREA - Shall be any area at or beyond the site boundary, access to which is not controlled by the licensee for purposes of protection of individuals from exposure to radiation and radioactive materials, or any area within the site boundary used for residential quarters or for industrial, commercial, institutional, and/or recreational purposes.

For Information Only ODCM-QA-004 Revision 6 Page 9 of 65

6. PROCEDURE 6.1 Noble Gases 6.1.1 The dose rate at a specified location due to noble gases released in airborne effluents shall be determined by the following equation for total body dose:

(Eq. 1) (Ref. 3.9) and by the following equation for skin dose:

v where:

Dre ::: the annual total body dose (mrem/yr)

K, ::: the total body dose factor due to gamma emissions for each identified noble gas radionuclide (i) from 3

Attachment A (mrem/yr per µCi/m )

(X/O)v = the relative concentration factor for the specified location from\lent release point (v) such as from Attachment B (sec/m 3) the release rate of radionuclide (i) from vent (v)

(µCi/sec)

Ds ::: the annual skin dose (mrem/yr) the skin dose factor due to the beta emissions for each identified noble gas radionuclide (i) from Attachment A (mrem/yr per µCi/m 3 )

M; ::: the air dose factor due to gamma emissions for each identified noble gas radionuclide (I) from Attachment A (mrad/yr per µCi/m3) 1.1 = unit conversion constant of 1.1 mrem/mrad converts air dose to skin dose J

For Information Only ODCM-QA-004 Revision 6 Page 10 of 65 6.1.2 The air dose at a specified location due to noble gases released in airborne effluents during any specified time period shall be determined by the following equation for gamma radiation:

(Eq. 3) (Ref. 3.9) and by the following equation for beta radiation:

(Eq. 4) (Ref. 3.9) where:

Dg = the total gamma air dose from airborne effluents for the specified time period (mrad)

Db = the total beta air dose from airborne effluents for the specified time period (mrad) 3.17E-8 = the inverse of seconds in a year (yr/sec)

M; = the air dose factor due to gamma emissions for each identified noble gas radionuclide (i) from Attachment A (mrad/yr per µCi/m3)

N; = the air dose factor due to beta emissions for each identified noble gas radionuclide ~i) from Attachment A (mrad/yr per µCi/m )

(X/O)v = the relative concentration factor for the specified location such as from Attachment B (sec/m3)

Oiv = the integrated release of radionuclide (i) from all

. vents (v) for a specified time period. (µCi)

For Information Only ODCM-QA-004 Revision 6 Page 11 of 65 6.2 Radionuclides Other Than Noble Gases 6.2.1 The dose rate at a specified location due to inhalation of radioactive materials released in airborne effluent (including 1-131 and 1-133) shall be determined by the following equation-for any organ:

where:

= the annual organ dose (mrem/yr)

= the dose factor based on inhalation pathway for each radionuclide other than noble gases (i) for the inhalation pathway from Attachment C.

(mrem/yr per µCi/m 3)

= the relative concentration. factor for the specified location from Attachment B. (sec/m 3)

= the release rate of radionuclide (i) from vent (v)

(µCi/sec) 6.2.2 The critical organ dose to an individual from radionuclides other than noble gases released in airborne effluent (including 1-131 and 1-133) during any specified time period at a specified location shall be determined by the following equation:

(Eq. 6) where:

= the total dose to a critical organ from radionuclides other than noble gases for a specified time period (mrem)

= the dose factor based on inhalation pathway for each radionuclide other than noble gases (i) for the inhalation pathway (mrem/yr per µCi/m 3 ) and for ingestion and ground plane pathways (mrem-m 2/yr per µCi/sec) from Attachment C

For Information Only ODCM-QA-004 Revision 6 Page 12 of 65

= Relative concentration (X/Q) (sec/m 3) for the inhalation pathway and relative deposition (D/Q:

m-2) for the ingestion and ground pathways such as from Attachment B

= the integrated release of radionuclide (i) from all vents (v) for a specified time period (µCi) 3.17E-8 = the inverse of seconds in a year (yr/sec)

For radioiodines, the deposition model considers only the element.al fraction of the effluent. Thus, d~position is computed only for that fraction of the effluent that is estimated to be elemental iodine. The fraction iodine deposited (FID) is assumed to be 0.5 (Regulatory Guide 1.109 (page 1.109-26)). The deposition pathway dose factors for radioiodines presented in Attachment C have been adjusted by a factor of 0.5.

6.3 Airborne Effluent Monitoring - Iodine and Particulate The methodology outlined in Equations 7, 8, 9, and 10 shall be utilized in implementing the following requirements for Airborne Effluent Monitoring of iodine and particulates. Note, the methodology for determining the limiting release rate and concentration for airborne iodine and particulates is evaluated in EC-ENVR-1040.

6.3.1 Site Limiting Release Rate - Iodine

a. The limiting 1-131 release rate shall be determined as follows:

(Eq. 7)

Where:

= limiting release rate- 1-131 (µCi/min)

= total 1-131 source term (Ci)

= dose rate limit for 1-131, 1-133, tritium, and particulate effluent (1500 mrem/year maximum organ, inhalation) (ref. TRO 3.11.2.1, II.A)

For Information Only ODCM-QA-004 Revision 6 Page 13 of 65

= limiting (maximum) organ dose for all age groups resulting from the total 1-131 and 1-133 source term (mrem) k = units conversion factor (1 E6 µCi/Ci) * (1 yr/365 days) * (1 day/24 hours)

(1 hour/ 60 minutes) 0 1p shall be determined per equation 6 using the iodine source term and dispersion parameters provided in Attachment E.

Note, Q1 is the 1-131 activity provided in Attachment E. The ratio of the annual source term to the corresponding organ dose is used in the above equations. Thus, either the total annual release per unit or the total annual release for the site may be used.

6.3.2 Limiting Concentration Iodine The limiting 1-131 concentration shall be determined as follows:

(Eq. 8)

Where:

Ci = limiting 1-131 concentration (µCi/cc)

L, = limiting 1-131 release rate from step 6.3.1 (µCi/min)

Fv = vent flow high limit for vent V (cc/min)

For Information Only ODCM-QA-004 Revision 6 Page 14 of 65 6,3.3- Site Limiting* Release Rate - Particulates

-* a. The limiting release rate for particulates shall be determined as follows:

-- Qp *DRIP

k (Eq.9)

LP Dp Where:

Lp = limiting release rate- particulates (µCi/min)

Qp = total particulate source term (Ci) dose rate limit for 1-131, 1-133, tritium, and particulate effluent (1500 mrem/year maximum organ, inhalation) (ref. TRO

3. 11.2.1, II.A)

.limiting (maximum) organ dose for all age groups resulting from the source term Qp (mrem) k = units conversion factor (1 E6 µCi/Ci)* (1 yr/365 days)* (1 day/ 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months ) * (1 hour/ 60 minutes)

Op shall be determined per equation 6 using the particulate source term and dispersion parameters provided in Attachment E.

Note, Qp is the sum of the particulate activities provided in Attachment E. The ratio of the annual source term to the corresponding organ dose is used in the above equations.

Thus, either the total annual release per unit or the total annual release for the site may be used.

For Information Only ODCM-QA-004 Revision 6 Page 15 of 65 6.3.4 Limiting Concentration - Particulates The limiting particulate concentration shall be determined as follows:

(Eq. 10)

Where:

limiting particulate concentration (µCi/cc)

limiting particulate release rate from step 6.3.3

(µCi/min)

Fv = vent flow high limit for vent v (cc/min) 6.4 Airborne Monitor Line Loss Corrections 6.4.1 Line Loss Correction Factors are included for both the SPING monitors and the Vent Effluent Radiation Monitoring System (VERMS) monitors. Chemistry shall apply the following correction factors as applicable to sample analysis results in order to correct for airborne effluent monitor sample line loss in accordance with station procedures:

CORRECTION FACTORS (Ref. 3.15) 6.4.2 Effluent Monitors Particulates (SPINGS)

Reactor Building Unit 1: Refuel Floor 1.5 3.2 Reactor Building Unit 1: Roof 1.0 1.0 Reactor Building Unit 2: Refuel Floor 1.5 3.2 Reactor Building Unit 2: Roof 1.0 1.0 Turbine Building Unit 1: Refuel Floor 1.6 3.6 Turbine Building Unit 1: Roof 1.0 1.0 Turbine Building Unit 2: Refuel Floor 1.6 3.6 Turbine Building Unit 2: Roof 1.0 1.0 Standby Gas Treatment; Refuel Floor 1.5 3.9 Standby Gas Treatment; Roof 1.0 1.0

For Information Only ODCM-QA-004 Revision 6 Page 16 of 65 (Ref. 3.18)

Effluent Monitors (VERMS)

VERMS Monitor/Sample Location Iodine Particulates Reactor Building Unit 1: Normal Sample Cond. Skid - Refuel Floor 1.72 3.94 Reactor Building Unit 2: Normal Sample Cond. Skid - Refuel Floor 1.72 3.61 Turbine Building Unit 1: Normal Sample Cond. Skid - Refuel Floor 1.72 4.00 Turbine Building Unit 2: Normal Sample Cond. Skid - Refuel Floor 1.72 3.90 SGTS Normal Sample Cond. Skid - Refuel Floor 1.72 3.50 Turbine Building Unit 1: Sample Cond. Skid Grab Sample - Tb-2 729' 1.73 5.90 Turbine Building Unit 2: Sample Cond. Skid Grab Sample - Tb-2 729' 1.73 5.90 SGTS Sample Cond. Skid Grab Sample - Tb-2 729' 1.73 6.00 Turbine Building Unit 1: Sample Cond. Skid Grab Sample (Shielded) - Tb-2 729' 1.73 14.00 Turbine Building Unit 2: Sample Cond. Skid Grab Sample (Shielded) - Tb-2 729' 1.73 13.90 SGTS Sample Cond. Skid Grab Sample (Shielded) - Tb-2 729' 1.73 13.20

For Information Only ODCM-QA-004 Revision 6 Page 17 of 65 6.5 Airborne Effluent Dose Calculations Exceeding Twice the Quarterly or Annual TRMValues 6.5.1 When the results of airborne dose calculations exceed twice the value of TR's 3.11.2.2.a, 3.11.2.2.b, 3.11.2.3.a, or 3.11.2.3.b, calculations shall be made which include the direct radiation contribution in accordance with ODCM-QA-006 to determine if the limits of TR 3.11.3 have been exceeded. If the limits of TR 3.11.3 have been exceeded, a special report shall be prepared and submitted to the NRC within 30 days which addresses the actions specified in TR 3.11.3.

6.6 Projected Dose from Gaseous Effluent 6.6.1 Doses from gaseous effluents released to unrestricted areas are projected at least every 31 days as required by TRM 3.11.2.5.

These projections are made by averaging the doses from previous operating history as appropriate, for what would be indicative of expected future operations.

7. RECORDS None

For Information Only Attachment A ODCM-QA-004 Revision 6 Page 18 of 65 DOSE FACTORS FOR NOBLE GASES (1)

Total Body Gamma Air Beta Air Dose Factor Skin Dose Factor Dose Factor Dose Factor K; L1 M; N; 3

Radionuclide (mrem/yr per µCi/m~) (mrem/yr per µCi /m") (mrad/yr per µCi/m ) (mrad/yr per µCi/m")

Kr-83m 7.56E-02 --- 1.93E+01 2.88E+02 Kr-85m 1.17E+03 1.46E+03 1.23E+03 1.97E+03 Kr-85 1.61E+01 1.34E+03 1.72E+01 1.95E+03 Kr-87 5.92E+03 9.73E+03 6.. 17E+03 1.03E+04 Kr-88 1.47E+04 2.37E+03 1.52E+04 2.93E+03 Kr-89 1.66E+04 1.01E+04 1.73E+04 1.06E+04 Kr-90 1.56E+04 7.29E+03 1.63E+04 7.83E+03 Xe-131m 9.15E+01 4.76E+02 1.56E+02 1.11E+03 Xe-133m 2.51 E+02 9.94E+02 3.27E+02 1.48E+03 Xe-133 2.94E+02 3.06E+02 3.53E+02 1.05E+03 Xe-135m 3.12E+03 7.11E+02 3.36E+03 7.39E+02 Xe-135 1.81 E+03 1.86E+03 1.92E+03 2.46E+03 Xe-137 1.42E+03 1.22E+04 1.51 E+03 1.27E+04 Xe-138 8.83E+03 4.13E+03 9.21E+03 4.75E+03 Ar-41 8.84E+03 2.69E+03 9.30E+03 3.28E+03

1. The listed dose factors are for radionuclides that may be detected in airborne effluents and derived from Table B-1 in Reg. Guide 1.109.

Page 1 of 1

For Information Only Attachment B ODCM-QA-004 Revision 6 Page 19 of 65 ANNUAL AVERAGE DISPERSION FACTORS USED FOR MONTHLY SURVEILLANCES <1>

Type of Location Direction Distance XIQ XIQ XIQ D/Q (per m 2 )

3 (miles) (sec/m ) (sec/m3 ) 3 (sec/m )

no decay 2.260 day 8.000 day decav decav undeoleted undeoleted deoleted Maximum Site Boundarv WSW 1.22 l.25E-05 l.24E-05 1. O?E-05 1.60E-08 Closest Site Boundarv s 0.38 5.88E-06 5.87E-06 5.47E-06 3.88E-08 Maximum X/Q Residence WSW 1.3 l.14E-05 l.13E-05 9.?0E-06 1.43E-08 Maximum D/Q Residence NE 0.9 2.86E-06 2. 85E-.06 2.51E-06 l.81E-08 Maximum D/Q Dairv Animal WSW 1. 7 7.75E-06 7.66E-06 6.48E-06 9.36E-09 Maximum D/Q Garden WSW 1. 3 l.14E-05 1.13E-05 9.70E-06 l.43E-08 Notes:

1. January, 1999, through December, 2003, meteorological data.

Page 1 of 1

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 20 of65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways &Tritium Ingestion: (mrem/yr)/(µCi/m"3))

Deposition Pathways: (m"2 * (mrem/yr)/(µCi/sec)

Age Group: ADULT Pathway: Grs/Goat/Milk (GMILK)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 O.OOe+OO 1.56e+03 1.56e+03 1.56e+03 1. 56e+03 l.56e+03 O.OOe+OO l.56e+03 C-14 2.63e+08 5.27e+07 5.27e+07 5.27e+07 5.27e+07 5.27e+07 O.OOe+OO 5.27e+07 NA-24 2.94e+05 2.94e+05 2.94e+05 2.94e+05 2.94e+05 2.94e+05 O.OOe+OO 2.94e+05 P-32 3.19e+09 l.28e+09 O.OOe+OO O.OOe+OO O.OOe+OO 2.3le+09 O.OOe+OO 7.93e+08 CR-51 O.OOe+OO O.OOe+OO 2.05e+03 7.56e+02 4.55e+03 8.63e+05 O.OOe+OO 3.43e+03 MN-54 O.OOe+OO 1. Ole+06 O.OOe+OO 3.0le+05 O.OOe+OO 3.09e+06 O.OOe+OO l.93e+05 MN-56 0.00e+OO 5.07e-04 0.00e+OO 6.44e-04 O.OOe+OO 1.62e-02 O.OOe+OO 9.00e-05 FE-55 3.27e+05 2.26e+05 O.OOe+OO O.OOe+OO 1.26e+05 l.29e+05 O.OOe+OO 5.26e+04 FE-59 3.86e+05 9.08e+05 0.00e+OO O.OOe+OO 2.54e+05 3.03e+06 O.OOe+OO 3.48e+05 C0-58 O.OOe+OO 5.66e+05 O.OOe+OO O.OOe+OO O.OOe+OO 1.15e+07 O.OOe+OO 1.27e+06 C0-60 O.OOe+OO 1.97e+06 O.OOe+OO O.OOe+OO O.OOe+OO 3.70e+07 O.OOe+OO 4.34e+06 NI-63 8.08e+08 5.60e+07 *o. OOe+OO O.OOe+OO O.OOe+OO l.17e+07 O.OOe+OO 2. 71e+07 NI-65 4.52e-02 5.87e-03 O.OOe+OO O.OOe+OO O.OOe+OO l.49e-01 O.OOe+OO 2.68e-03 CU-64 O.OOe+OO 2.67e+03 O.OOe+OO 6. 72e+03 O.OOe+OO 2.27e+05 O.OOe+OO 1.25e+03 ZN-65 1. 65e+08 5.24e+08 O.OOe+OO 3.50e+08 O.OOe+OO 3.30e+08 O.OOe+OO 2.37e+08 ZN-69 2.64e-13 5. 04e-13 O.OOe+OO 3.28e-13 O.OOe+OO 7.58e-14 O.OOe+OO 3.51e-14 BR-83 O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO 1. 71e-02 O.OOe+OO l.19e-02 BR-84 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.65e-29 O.OOe+OO 2.lOe-24 RB-86 O.OOe+OO 3.1le+08 O.OOe+OO O.OOe+OO .O.OOe+OO 6.14e+07 O.OOe+OO l.45e+08 RB-88 O.OOe+OO 2.99e-46 O.OOe+OO O.OOe+OO O.OOe+OO 4.14e-57 O.OOe+OO 1.59e-46 RB-89 O.OOe+OO 7.93e-55 O.OOe+OO O.OOe+OO O.OOe+OO 4.6le-68 O.OOe+OO 5.58e-55 SR-89 3.05e+09 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 4.89e+08 O.OOe+OO 8.75e+07 SR-90 9.83e+l0 0.00e+OO O.OOe+OO 0.00e+OO O.OOe+OO 2.84e+09 O.OOe+OO 2.4le+l0 SR-91 6 .11e+04 O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO 2. 91e+05 O.OOe+OO 2.47e+03 SR-92 1.04e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.07e+Ol O.OOe+OO 4.51e-02 Y-90 8.51e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 9.02e+04 O.OOe+OO 2.28e..:01 Y-91 1. 03e+03 O.OOe+OO O.OOe+OO O.OOe+OO o. ooe+_oo 5.67e+05 O.OOe+OO 2.76e+Ol Y-91M 7.59e-21 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.23e-20 O.OOe+OO 2.94e-22 Y-92 6.78e-06 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.19e-Ol O.OOe+OO 1. 98e-07 Y-93 2.69e-02 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 8.54e+02 O.OOe+OO 7.44e-04 ZR-95 l.13e+02 3.63e+01 0.00e+OO 5.70e+Ol O.OOe+OO l.15e+05 O.OOe+OO 2.46e+Ol ZR-97 5.21e-02 1. 05e-02 O.OOe+OO 1.59e-02 O.OOe+OO 3.26e+03 O.OOe+OO 4.81e-03 NB-95 9.91e+03 5.5le+03 O.OOe+OO 5.45e+03 O.OOe+OO 3.35e+07 O.OOe+OO 2.96e+03 M0-99 O.OOe+OO 2.98e+06 O.OOe+OO 6.74e+06 O.OOe+OO 6.90e+06 O.OOe+OO 5.66e+05 TC-99M 4.02e-01 1.14e+OO O.OOe+OO 1. 72e+Ol 5.56e-01 6. 72e+02 O.OOe+OO 1.44e+Ol TC-101 3.77e-61 5.44e-61 O.OOe+OO 9.79e-60 2.78e-61 1. 63e-72 O.OOe+OO 5.33e-60 RU-103 l.22e+02 O.OOe+OO O.OOe+OO 4.66e+02 O.OOe+OO 1.43e+04 O.OOe+OO 5.26e+Ol RU-105 1.04e-04 O.OOe+OO O.OOe+OO 1. 34e-03 O.OOe+OO 6.35e-02 O.OOe+OO 4.lOe-05 Page 1of44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 21 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/mA3))

Deposition Pathways: (mA2 * (mrem/yr)/(µCi/sec)

AgeGroup: ADULT Pathway: Grs/Goat/Milk (GMILK)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-106 2.45e+03 O.OOe+OO O.OOe+OO 4.73e+03 O.OOe+OO 1.58e+05 O.OOe+OO 3.10e+02 AG-110M 6.99e+06 6.46e+06 O.OOe+OO 1. 27e+07 O.OOe+OO 2.64e+09 O.OOe+OO 3.84e+06 TE-125M 1.96e+06 7.08e+05 5.88e+05 7.95e+06 O.OOe+OO 7.8le+06 O.OOe+OO 2.62e+05 TE-127 7.88e+Ol 2.83e+Ol 5.83e+Ol 3.21e+02 O.OOe+OO 6.2le+03 O.OOe+OO 1. 70e+Ol TE-127M 5.49e+06 1.96e+06 1.40e+06 2.23e+07 O.OOe+OO 1.84e+07 O.OOe+OO 6.70e+05 TE-129 3 .53e-11 1. 32e-11 2.71e-11 1.48e-10 O.OOe+OO 2.66e-11 O.OOe+OO 8.59e-12 TE-129M 7.23e+06 2.70e+06 2.48e+06 3.02e+07 O.OOe+OO 3.64e+07 O.OOe+OO 1.14e+06 TE-131 4.82e-34 2.02e-34 3.97e-34 2 .1le-33 O.OOe+OO 6.83e-35 O.OOe+OO 1. 52e-34 TE-131M 4.34e+04 2.12e+04 3.36e+04 2.15e+05 O.OOe+OO 2.11e+06 O.OOe+OO 1. 77e+04 TE-132 2.88e+05 1.87e+05 2.06e+05 1. 80e+06 O.OOe+OO 8.82e+06 O.OOe+OO 1. 75e+05 I-130 2.53e+05 7.46e+05 6 .33e+07 1.17e+06 O.OOe+OO 6.43e+05 O.OOe+OO 2.95e+05 I-131 1.78e+08 2.54e+08 8.33e+l0 4.36e+OB O.OOe+OO 6.7le+07 O.OOe+OO 1.46e+OB I-132 1. Ole-01 2.69e-01 9.4le+OO 4.28e-01 O.OOe+OO 5.05e-02 O.OOe+OO 9.41e-02 I-133 2.33e+06 4.05e+06 5.95e+08 7.06e+06 O.OOe+OO 3.64e+06 O.OOe+OO l.23e+06 I-134 1.27e-12 3.46e-12 6.00e-11 5.51e-12 O.OOe+OO 3.02e-15 O.OOe+OO 1.24e-12 I-135 7.76e+03 2.03e+04 1.34e+06 3.26e+04 O.OOe+OO 2.29e+04 O.OOe+OO 7.50e+03 CS-134 1. 70e+l0 4.04e+10 O.OOe+OO 1.3le+l0 4.34e+09 7.06e+08 O.OOe+OO 3.30e+l0 CS-136 7.90e+08 3.12e+09 O.OOe+OO l.74e+09 2-. 38e+OB 3.54e+08 O.OOe+OO 2.25e+09 CS-137 2.2le+l0 3.03e+l0 O.OOe+OO l.03e+10 3.42e+09 5.86e+08 O.OOe+OO l.98e+10 CS-138 2.95e-23 5.83e-23 O.OOe+OO 4.29e-23 4.23e-24 2.49e-28 O.OOe+OO 2.89e-23 BA-139 5.48e-09 3.9le-12 O.OOe+OO 3.65e-12 2.22e-12 9.72e-09 O.OOe+OO l.60e-10 BA-140 3.23e+06 4.05e+03 O.OOe+OO l.38e+03 2.32e+03 6.64e+06 O.OOe+OO 2 .1le+05 BA-141 5. 71e-47 4.31e-50 O.OOe+OO 4.0le-50 2.45e-50 2.69e-56 O.OOe+OO 1.93e-48 BA-142 4.12e-81 4. 24e-84 O.OOe+OO 3.58e-84 2.40e-84 O.OOe+OO O.OOe+OO 2.59e-82 LA-140 5.42e-01 2.73e-01 O.OOe+OO O.OOe+OO O.OOe+OO 2.0le+04 O.OOe+OO 7.22e-02 LA-142 2.29e-12 l.04e-12 O.OOe+OO O.OOe+OO O.OOe+OO 7. 62e-09 O.OOe+OO 2.60e-13 CE-141 5.8le+02 3.93e+02 O.OOe+OO l.83e+02 O.OOe+OO 1.50e+06 0.00e+OO 4.46e+Ol CE-143 5.00e+OO 3.69e+03 O.OOe+OO 1.63e+OO O.OOe+OO l.38e+05 O.OOe+OO 4.09e-Ol CE-144 4.29e+04 1.79e+04 O.OOe+OO 1.06e+04 O.OOe+OO l.45e+07 0.00e+OO 2.3le+03 PR-143 1.89e+Ol 7.60e+OO O.OOe+OO 4.39e+OO O.OOe+OO 8.30e+04 O.OOe+OO 9.39e-01 PR-144 8.25e-55 3.43e-55 O.OOe+OO 1.93e-55 O.OOe+OO 1.19e-61 O.OOe+OO 4.19e-56 ND-147 1.13e+Ol 1. 31e+Ol O.OOe+OO 7.64e+OO O.OOe+OO 6.27e+04 O.OOe+OO 7.82e-01 W-187 7.83e+02 6. 55e+02 O.OOe+OO O.OOe+OO O.OOe+OO 2.15e+05 O.OOe+OO 2.29e+02 NP-239 4.41e-01 4.34e-02 O.OOe+OO 1. 35e-01 O.OOe+OO B.90e+03 O.OOe+OO 2. 39e-02 PU-239 3.36e+06 4.04e+05 O.OOe+OO 3.76e+05 O.OOe+OO 3.09e+05 O.OOe+OO 8.86e+04 U-235 3. 71e+08 O.OOe+OO O.OOe+OO 8.67e+07 O.OOe+OO 3.62e+07 O.OOe+OO 2.25e+07 Page 2 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 22 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/mA3))

Deposition Pathways: (ml\2 * (mrem/yr)/(µCi/sec)

AgeGroup: ADULT Pathway: Ground Plane Deposition (GPO)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB NA-24 l.20e+07 1. 2 Oe+07 l.20e+07 1.20e+07 l.20e+07 l.20e+07 1.39e+07 l.20e+07 CR-51 4.66e+06 4.66e+06 4.66e+06 4.66e+06 4.66e+06 4.66e+06 5.5le+06 4.66e+06 MN-54 l.39e+09 l.39e+09 l.39e+09 l.39e+09 1. 39e+09 l.39e+09 1.63e+09 l.39e+09 MN-56 9.04e+05 9.04e+05 9.04e+05 9.04e+05 9.04e+05 9.04e+05 1.07e+06 9.04e+05 FE-59 2.73e+08 2.73e+08 2.73e+08 2.73e+08 2.73e+08 2.73e+08 3.2le+08 2.73e+08 C0-58 3.79e+08 3.79e+08 3.79e+08 3.79e+08 3.79e+08 3.79e+08 4.44e+08 3.79e+08 C0-60 2.:).5e+10 2.15e+l0 2.15e+10 2.15e+10 2.15e+l0 2.15e+l0 2.53e+l0 2.15e+l0 NI-65 2.97e+05 2.97e+05 2.97e+05 2.97e+05 2.97e+05 2.97e+05 3.45e+05 2.97e+05 CU-64 6.07e+05 6.07e+05 6.07e+D5 6.07e+05 6.07e+D5 6.07e+05 6.88e+05 6.D7e+05 ZN-65 7.47e+08 7.47e+08 7.47e+D8 7.47e+08 7.47e+08 7.47e+D8 8.60e+08 7.47e+08 BR-83 4.87e+03 4.87e+D3 4.87e+03 4.87e+03 4. 87e+D3 4.87e+03 7.08e+03 4.87e+03 BR-84 2.03e+05 2.03e+05 2.03e+D5 2.D3e+05 2.03e+05 2.03e+D5 2.36e+05 2.03e+05 RB-86 8.99e+06 8.99e+06 8.99e+06 8.99e+06 8.99e+D6 8.99e+06 1.03e+07 8.99e+06 RB-88 3.3le+04 3.31e+D4 3.3le+04 3.3le+D4 3.3le+04 3.3le+04.3.78e+04 3.3le+D4 RB-89 1.21e+D5 l.21e+05 l.2le+05 1.2le+05 l.2le+05 l.2le+05 1.45e+05 1.2le+05 SR-89 2.16e+04 2.16e+04 2.16e+D4 2.16e+04 2.16e+04 2.16e+04 2.51e+04 2.16e+04 SR-91 2.15e+06 2.15e+D6 2.15e+D6 2.15e+06 2.15e+06 2.15e+06 2.5le+06 2.15e+06 SR-92 7.77e+05 7.77e+D5 7.77e+05 7. 77e+05 7.77e+05 7.77e+D5 8.63e+05 7.77e+05 Y-90 4.49e+03 4.49e+D3 4.49e+03 4.49e+D3 4.49e+D3 4.49e+D3 5.31e+03 4.49e+03 Y-91 1.07e+06 1.07e+06 1. 07e+D6 1. 07e+06 1.07e+06 1. 07e+D6 1.21e+D6 1.06e+06 Y-91M l.00e+05 l.00e+05 l.0De+D5 l.00e+D5 l.00e+D5 1. 0De+05 1.16e+D5 l.00e+05 Y-92 1.8De+05 l.80e+05 l.80e+D5 1.80e+D5 1.80e+05 l.8De+05 2.14e+05 1.80e+05 Y-93 1.83e+05 l.83e+05 1.83e+05 1.83e+05 1.83e+05 1.83e+05 2.Sle+OS 1.83e+05 ZR-95 2.45e+08 2.45e+08 2.45e+D8 2.45e+D8 2.45e+D8 2.45e+08 2.84e+08 2.45e+08 ZR-97 2.96e+06 2.96e+06 2.96e+06 2.96e+06 2.96e+D6 2.96e+D6 3.45e+06 2.96e+06 NB-95 l.37e+08 l.37e+08 1. 37e+08 l.37e+08 1.37e+08 1.37e+08 1.61e+08 1. 37e+08 M0-99 4.DOe+06 4.00e+D6 4.00e+06 4.00e+06 4.00e+06 4.00e+D6 4.63e+06 4.00e+06 TC-99M l.84e+05 l.84e+D5 l.84e+05 l.84e+05 l.84e+D5 1.84e+D5 2.lle+05 1.84e+05 TC-101 2.04e+04 2.04e+04 2.04e+04 2.04e+04 2.04e+D4 2.04e+D4 2.26e+04 2.04e+04 RU-103 1.08e+08 1.08e+08 1.08e+08 1.08e+08 1. 08e+08 1.08e+08 l.26e+08 1.08e+08 RU-105 6.37e+05 6.37e+05 6.37e+05 6.37e+D5 6.37e+05 6.37e+D5 7.21e+05 6.37e+05 RU-106 4.22e+08 4.22e+08 4.22e+08 4. 22e+08 4.22e+08 4.22e+D8 5.D7e+08 4.22e+08 AG-llOM 3.44e+09 3.44e+09 3.44e+09 3.44e+09 3.44e+09 3.44e+09 4.0le+D9 3.44e+09 TE-125M l.55e+06 l.55e+06 1. 55e+06 1.55e+06 1.55e+06 1.55e+D6 2.13e+06 1.55e+06 TE-127 2.98e+D3 2.98e+03 2.98e+03 2.98e+03 2.98e+03 2.98e+D3 3.28e+D3 2.98e+03 TE-127M 9.17e+04 9.17e+04 9.17e+D4 9*.11e+04 9.17e+D4 9.17e+D4 1.08e+05 9.17e+04 TE-129 2.62e+04 2.62e+D4 2.62e+04 2.62e+D4 2.62e+D4 2.62e+D4 3.10e+04 2.62e+04 TE-129M l.98e+07 1.98e+07 1.98e+07 1.98e+07 l.98e+07 1.98e+07 2.3le+07 1.98e+07 Page 3 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 23 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/mA3))

Deposition Pathways: (mA2 * (mrem/yr)/(µCi/sec)

AgeGroup: ADULT Pathway: Ground Plane Deposition (GPD)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB TE-131 2.92e+04 2.92e+04 2.92e+04 2.92e+04 2. 92e+04 2.92e+04 3.45e+07 2.92e+04 TE-131M 8.03e+06 8.03e+06 8.03e+06 8.03e+06 8.03e+06 8.03e+06 9.46e+06 8.03e+06 TE-132 4.24e+06 4.24e+06 4.24e+06 4.24e+06 4.24e+06 4.24e+06 4.98e+06 4.24e+06 I-130 5.5le+06 5.51e+06 5.5le+06 5.5le+06 5.51e+06 5.51e+06 6.69e+06 5.51e+06 I-131 1. 72e+07 1. 72e+07 1. 72e+07 1.72e+O~ 1.72e+07 1. 72e+07 2.09e+07 1.72e+07 I-132 1.25e+06 1.25e+06 1. 25e+06 1.25e+06 l.25e+06 1.25e+06 l.47e+06 1. 25e+06 I-133 2.45e+06 2.45e+06 2.45e+06 2.45e+06 2.45e+06 2.45e+06 2.98e+06 2.45e+06 I-134 4.47e+05 4.47e+05 4.47e+05 4.47e+05 4.47e+05 4.47e+05 5.31e+05 4.47e+05 I-135 2.53e+06 2.53e+06 2.53e+06 2.53e+06 2.53e+06 2.53e+06 2.95e+06 2.53e+06 CS-134 6.86e+09 6.86e+09 6.86e+09 6.86e+09 6.86e+09 6.86e+09 8.00e+09 6.86e+09 CS-136 1.5le+08 1.5le+08 1.51e+OB 1.5le+OB 1.5le+08 l.5le+OB l.71e+08 1.51e+OB CS-137 l.03e+10 l.03e+10 1.03e+10 1.03e+l0 1. 03e+l0 1.03e+l0 l.20e+10 1.03e+10 CS-138 3.59e+05 3.59e+05 3.59e+05 3.59e+05 3.59e+05 3.59e+05 4.10e+05 3.59e+05 BA-139 1.06e+05 l.06e+05 1.06e+05 1. 06e+05 1.06e+05 l.06e+05 l.19e+05 l.06e+05 BA-140 2.05e+07 2.05e+07 2.05e+07 2.05e+07 2.05e+07 2.05e+07 2.35e+07 2.05e+07 BA-141 4.17e+04 4.17e+04 4.17e+04 4.17e+04 4.17e+04 4.17e+04 4.75e+04 4.17e+04 BA-142 4.49e+04 4.49e+04 4.49e+04 4.49e+04 4.49e+04 4.49e+04 5. lle+04 4.49e+04 LA-140 1. 92e+07 1.92e+07 1.92e+07 1. 92e+07 1.92e+07 1.92e+07 2.18e+07 1.92e+07 LA-142 7.60e+05 7.60e+05 7.60e+05 7.60e+05 7.60e+05 7.60e+05 9.12e+05 7.60e+05 CE-141 l.37e+07 1. 37e+07 1. 37e+07 1.37e+07 1.37e+07 1. 3 7e+07 1.54e+07 1.37e+07 CE-143 2.31e+06 2.31e+06 2.31e+06 2.3le+06 2.3le+06 2.3le+06 2.63e+06 2.31e+06 CE-144 6.95e+07 6.95e+07 6.95e+07 6.95e+07 6.95e+07 6.95e+07 8.04e+07 6.95e+07 PR-144 1.84e+03 l.84e+03 1.84e+03 1.84e+03 1.84e+03 l.84e+03 2.lle+03 l.84e+03 ND-147 8.39e+06 8.39e+06 8.39e+06 8.39e+06 8.39e+06 8.39e+06 1.0le+07 8.39e+06 W-187 2.35e+06 2.35e+06 2.35e+06 2.35e+06 2.35e+06 2.35e+06 2.73e+06 2.35e+06 NP-239 1. 71e+06 1. 71e+06 1. 71e+06 1. 71e+06 1.7le+06 1. 71e+06 l.98e+06 1.71e+06 PU-239 2.29e+06 2.29e+06 2.29e+06 2.29e+06 2.29e+06 2.29e+06 2.23e+07 2.29e+07 U-235 9.28e+09 9.28e+09 9.28e+09 9.28e+09 9.28e+09 9.28e+09 l.16e+10 9.28e+09 Page 4 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 24 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/m/\3))

Deposition Pathways: (m/\2 * (mrem/yr)/(µCi/sec)

AgeGroup: ADULT Pathway: Inhalation (INHL)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 O.OOe+OO 1.26e+03 1.26e+03 1. 26e+03 1.26e+03 1.26e+03 O.OOe+OO 1.26e+03 C-14 1.82e+04 3.41e+03 3.41e+03 3.41e+03 3.41e+03 3.41e+03 O.OOe+OO 3.41e+03 NA-24 1.02e+04 1.02e+04 1.02e+04 1.02e+04 1.02e+04 1.02e+04 O.OOe+OO 1.02e+04 P-32 1. 32e+06 7.7le+04 O.OOe+OO O.OOe+OO O.OOe+OO 8.64e+04 O.OOe+OO 5.01e+04 CR-51 O.OOe+OO O.OOe+OO 5.95e+01 2.28e+01 1.44e+04 3.32e+03 O.OOe+OO 1.00e+02 MN-54 O.OOe+OO 3.96e+04 O.OOe+OO 9.84e+03 1.40e+06 7.74e+04 O.OOe+OO 6.30e+03 MN-56 O.OOe+OO 1. 24e+OO O.OOe+OO 1. 30e+OO 9.44e+03 2.02e+04 O.OOe+OO 1. 83e-01 FE-55 2.46e+04 1.70e+04 O.OOe+OO O.OOe+OO 7.2le+04 6.03e+03 O.OOe+OO 3.94e+03 FE-59 1.18e+04 2.78e+04 O.OOe+OO O.OOe+OO 1. 02e+06 1.88e+05 O.OOe+OO 1.06e+04 C0-58 O.OOe+OO 1.58e+03 O.OOe+OO O.OOe+OO 9.28e+05 1.06e+05 O.OOe+OO 2.07e+03 C0-60 O.OOe+OO 1.15e+04 O.OOe+OO O.OOe+OO 5.97e+06 2.85e+05 O.OOe+OO 1.48e+04 NI-63 4. 32e+05 3.14e+04 o.-ooe+oo O.OOe+OO 1. 78e+05 1.34e+04 O.OOe+OO 1.45e+04 NI-65 1.54e+OO 2.lOe-01 O.OOe+OO O.OOe+OO 5.60e+03 1. 23e+04 O.OOe+OO 9.12e-02 CU-64 O.OOe+OO 1.46e+OO O.OOe+OO 4.62e+OO 6.78e+03 4.90e+04 O.OOe+OO 6.15e-01 ZN-65 3.24e+04 1. 03e+05 O.OOe+OO 6.90e+04 8.64e+05 5.34e+04 O.OOe+OO 4.66e+04 ZN-69 3.38e-02 6.51e-02 O.OOe+OO 4.22e-02 9.20e+02 1.63e+Ol O.OOe+OO 4.52e-03 BR-83 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.32e+02 O.OOe+OO 2.41e+02 BR-84 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1. 64e-03 O.OOe+OO 3.13e+02 BR-85 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.28e+Ol RB-86 O.OOe+OO 1.35e+05 O.OOe+OO O.OOe+OO O.OOe+OO 1.66e+04 O.OOe+OO 5.90e+04 RB-88 0.00e+OO 3.87e+02 O.OOe+OO O.OOe+OO O.OOe+OO 3.34e-09 O.OOe+OO 1.93e+02 RB-89 O.OOe+OO 2.56e+02 O.OOe+OO O.OOe+OO O.OOe+OO 9.28e-12 O.OOe+OO 1.70e+02 SR-89 3.04e+05 O.OOe+OO O.OOe+OO O.OOe+OO 1. 40e+06 3.50e+05 O.OOe+OO 8.72e+03 SR-90 9.92e+07 O.OOe+OO O.OOe+OO 0 ._OOe+OO 9.60e+06 7.22e+05 O.OOe+OO 6.10e+06 SR-91 6.19e+01 O.OOe+OO O.OOe+OO O.OOe+OO 3.65e+04 1.91e+05 O.OOe+OO 2.50e+OO SR-92 6.74e+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.65e+04 4.30e+04 O.OOe+OO 2.91e-01 Y-90 2.09e+03 O.OOe+OO O.OOe+OO O.OOe+OO 1. 70e+05 5.06e+05 O.OOe+OO 5.61e+Ol Y-91 4.62e+05 O.OOe+OO O.OOe+OO O.OOe+OO 1. 70e+06 3.85e+05 O.OOe+OO 1.24e+04 Y-91M 2.61e-01 O.OOe+OO O.OOe+OO O.OOe+OO 1.92e+03 1.33e+OO O.OOe+OO 1.02e-02 Y-92 1.03e+01 O.OOetOO O.OOe+OO O.OOe+OO 1.57e+04 7.35e+04 O.OOe+OO 3.02e-01 Y-93 9.44e+01 O.OOe+OO O.OOe+OO O.OOe+OO 4.85e+04 4.22e+05 O.OOe+OO 2.6le+OO ZR-95 1.07e+05 3.44e+04 O.OOe+OO 5.42e+04 1. 77e+06 1. 50e+05 O.OOe+OO 2.33e+04 ZR-97 9.68e+01 1. 96e+Ol O.OOe+OO 2.97e+01 7.87e+04 5.23e+05 0.00e+OO 9.04e+OO NB-95 1.41e+04 7.82e+03 O.OOe+OO 7.74e+03 5.05e+05 1.04e+05 O.OOe+OO 4.21e+03 M0-99 O.OOe+OO l.21e+02 O.OOe+OO 2.91e+02 9.12e+04 2.48e+05 O.OOe+OO 2.30e+01 TC-99M 1.03e-03 2.91e-03 O.OOe+OO 4.42e-02 7.64e+02 4.16e+03 O.OOe+OO 3.70e-02 TC-101 4.18e-05 6.02e-05 O.OOe+OO 1.08e-03 3.99e+02 1.09e-11 O.OOe+OO 5.90e-04 RU-103 1.53e+03 O.OOe+OO O.OOe+OO 5.83e+03 5.05e+05 1.10e+05 O.OOe+OO 6.58e+02 Page 5 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 25 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/m"3))

Deposition Pathways: (m"2 * (mrem/yr)/(µCi/sec)

AgeGroup: ADULT Pathway: Inhalation (INHL)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin. TB RU-105 7.90e-01 O.OOe+OO O.OOe+OO 1.02e+OO 1.10e+04 4.82e+04 O.OOe+OO 3. lle-01 RU-106 6.91e+04 O.OOe+OO O.OOe+OO 1.34e+05 9.36e+06 9.12e+05 O.OOe+OO 8.72e+03 AG-llOM 1.08e+04 1. 00e+04 O.OOe+OO l.97e+04 4.63e+06 3.02e+05 O.OOe+OO 5.94e+03 TE-125M 3.42e+03 1.58e+03 1.05e+03 1.24e+04 3.14e+05 7.06e+04 O.OOe+OO 4.67e+02 TE-127 1. 40e+OO 6.42e-01 1. 06e+OO 5.lOe+OO 6.51e+03 5.74e+04 O.OOe+OO 3.lOe-01 TE-127M 1.26e+04 5.77e+03 3.29e+03 4.58e+04 9.60e+05 1.50e+05 O.OOe+OO 1.57e+03 TE-129 4.98e-02 2.39e-02 3.90e-02 1.87e-Ol 1. 94e+03 1.57e+02 O.OOe+OO l.24e-02 TE-129M 9.76e+03 4.67e+03 3.44e+03 3.66e+04 1.16e+06 3.83e+05 O.OOe+OO l.58e+03 TE-131 l. lle-02 5.95e-03 9.36e-03 4.37e-02 l.39e+03 l.84e+Ol O.OOe+OO 3.59e-03 TE-131M 6.99e+Ol 4.36e+Ol 5.50e+Ol 3.09e+02 1.46e+05 5.56e+05 O.OOe+OO 2.90e+Ol TE-132 2.60e+02 2.15e+02 1. 90e+02 1. 46e+03 2.88e+05 5.10e+05 O.OOe+OO 1.62e+02 I-130 4.58e+03 l.34e+04 1.14e+06 2.09e+04 O.OOe+OO 7.69e+03 O.OOe+OO 5.28e+03 I-131 2.52e+04 3.58e+04 1.19e+07 6.13e+04 O.OOe+OO 6.28e+03 O.OOe+OO 2.05e+04 I-132 1.16e+03 3.26e+03 1.14e+05 5.18e+03 O.OOe+OO 4.06e+02 O.OOe+OO l.16e+03 I-133 8.64e+03 1.48e+04 2.15e+06 2.58e+04 O.OOe+OO 8.88e+03 O.OOe+OO 4.52e+03 I-134 6.44e+02 l.73e+03 2.98e+04 2.75e+03 O.OOe+OO 1. Ole+OO O.OOe+OO 6.15e+02 I-135 2.68e+03 6.98e+03 4.48e+05 l. lle+04 O.OOe+OO 5.25e+03 O.OOe+OO 2.57e+03 CS-134 3.73e+05 8.48e+05 O.OOe+OO 2.87e+05 9.76e+04 1.04e+04 O.OOe+OO 7.28e+05 CS-136 3.90e+04 1.46e-to5 O.OOe+OO 8.56e+04 1.20e+04 l.17e+04 O.OOe+OO l.10e+05 CS-137 4.78e+05 6.2le+05 O.OOe+OO 2.22e+05 7.52e+04 8.40e+03 O.OOe+OO 4.28e+05 CS-138 3.3le+02 6.2le+02 O.OOe+OO 4.80e+02 4.86e+Ol 1.86e-03 O.OOe+OO 3.24e+02 BA-139 9.36e-01 6.66e-04 O.OOe+OO 6.22e-04 3.76e+03 8.96e+02 O.OOe+OO 2.74e-02 BA-140 3.90e+04 4.90e+Ol O.OOe+OO 1. 67e+Ol l.27e+06 2.18e+05 O.OOe+OO 2.57e+03 BA-141 l.OOe-01 7.53e-05 O.OOe+OO 7.00e-05 1.94e+03 1.16e-07 O.OOe+OO 3.36e-03 BA-142 2.63e-02 2. 70e-05 O.OOe+OO 2.29e-05 l.19e+03 1. 57e-16 O.OOe+OO 1.66e-03 LA-140 3.44e+02 1. 74e+02 O.OOe+OO O.OOe+OO 1.36e+05 4.58e+05 0.00e+OO 4.58e+Ol LA-142 6. 83e-01 3.lOe-01 O.OOe+OO O.OOe+OO 6.33e+03 2.lle+03 O.OOe+OO 7.72e-02 CE-141 1.99e+04 1. 35e+04 O.OOe+OO 6.26e+03 3.62e+05 l.20e+05 O.OOe+OO 1. 53e+03 CE-143 1.86e+02 1.38e+02 O.OOe+OO 6.08e+Ol 7.98e+04 2.26e+05 O.OOe+OO 1. 53e+Ol CE-144 3.43e+06 1.43e+06 O.OOe+OO 8.48e+05 7.78e+06 8.16e+05 O.OOe+OO 1. 84e+05 PR-143 9.36e+03 3.75e+03 O.OOe+OO 2.16e+03 2.Ble+05 2.00e+05 O.OOe+OO 4.64e+02 PR-144 3.0le-02 1. 25e-02 O.OOe+OO 7.05e-03 1.02e+03 2.15e-08 O.OOe+OO 1. 53e-03 ND-147 5.27e+03 6.10e+03 O.OOe+OO 3.56e+03 2.2le+05 1.73e+05 O.OOe+OO 3.65e+02 W-187 8.48e+OO 7.08e+OO O.OOe+OO O.OOe+OO 2.90e+04 l.55e+05 O.OOe+OO 2.48e+OO NP-239 2.30e+02 2.03e+02 O.OOe+OO 7.00e+Ol 3.76e+04 1.19e+05 O.OOe+OO 1.24e+Ol PU-239 1.33e+l0 8.56e+09 O.OOe+OO 2.64e+09 1. 38e+09 3.30e+05 O.OOe+OO 6.20e+08 U-235 8.00e+07 O.OOe+OO O.OOe+OO 1.87e+07 3.92e+08 3.87e+06 O.OOe+OO 4.86e+06 Page 6 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 26 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/m"3))

Deposition Pathways: (m"2 * (mrem/yr)/(µCi/sec)

AgeGroup: ADULT Pathway: Grs/Cow/Meat (CMEAT)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 O.OOe+OO 3.25e+02 3.25e+02 3.25e+02 3.25e+02 3.25e+02 O.OOe+OO 3.25e+02 C-14 2.41e+08 4.83e+07 4.83e+07 4.83e+07 4.83e+07 4.83e+07 O.OOe+OO 4.83e+07 NA-24 l.40e-03 1.40e-03 1. 40e-03 l.40e-03 1. 40e-03 1. 40e-03 O.OOe+OO 1. 40e-03 P-32 7.25e+08 2.90e+08 O.OOe+OO O.OOe+OO O.OOe+OO 5.24e+08 O.OOe+OO 1. 80e+08 CR-51 O.OOe+OO O.OOe+OO 4.22e+03 1. 55e+03 9.36e+03 1.77e+06 O.OOe+OO 7.05e+03 MN-54 O.OOe+OO 9.18e+06 O.OOe+OO 2.73e+06 O.OOe+OO 2.81e+07 O.OOe+OO 1.75e+06 MN-56 O.OOe+OO 1.Ble-53 O.OOe+OO 2.30e-53 O.OOe+OO 5.77e-52 O.OOe+OO 3.2le-54 FE-55 2.93e+08 2.03e+08 O.OOe+OO O.OOe+OO 1 ;13e+08 1.16e+08 O.OOe+OO 4.73e+07 FE-59 2.66e+08 6.24e+08 O.OOe+OO O.OOe+OO 1.75e+08 2.08e+09 O.OOe+OO 2.39e+08 C0-58 O.OOe+OO l.82e+07 O.OOe-i-00 O.OOe+OO O.OOe+OO 3.70e+08 O.OOe+OO 4.09e+07 C0-60 O.OOe+OO 7.52e+07 O.OOe+OO O.OOe+OO O.OOe+OO l.4le+09 O.OOe+OO 1. 66e+08 NI-63 1.89e+10 l.31e+09 O.OOe+OO O.OOe+OO O.OOe+OO 2.73e+08 O.OOe+OO 6.34e+08 NI-65 2.69e-52 3.50e-53 O.OOe+OO O.OOe+OO O.OOe+OO 8.87e-52 O.OOe+OO 1. 60e-53 CU-64 O.OOe+OO 2.~le-07 O.OOe+OO 7.09e-07 O.OOe+OO 2.40e-05 O.OOe+OO l.32e-07 ZN-65 3.56e+08 l.13e+09 O.OOe+OO 7.57e+08 0.00e-i-00 7 .13e+08 O.OOe+OO 5.12e+08 RB-86 O.OOe+OO 4.88e+08 0.00e+OO O.OOe+OO O.OOe+OO 9.62e+07 O.OOe+OO 2.27e+08 SR-89 3.02e+08 O.OOe+OO O.Obe+OO O.OOe+OO O.OOe+OO 4.84e+07 O.OOe+OO 8.66e+06 SR-90 1.24e+l0 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 3.59e+08 O.OOe+OO 3.05e+09 SR-91 l.59e-10 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 7.59e-10 O.OOe+OO 6.44e-12 SR-92 l.39e-49 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.76e-48 O.OOe+OO 6.03e-51 Y-90 1. 08e+02 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.15e+06 O.OOe+OO 2.9le+OO Y-91 l.13e+06 O.OOe+OO O.OOe+OO b.OOe+OO O.OOe+OO 6.23e+08 O.OOe+OO 3.03e+04 Y-92 1. 73e-39 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 3. 02e-35 O.OOe+OO 5.04e-41 Y-93 4.91e-12 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.56e-07 O.OOe+OO 1.36e-13 ZR-95 1.87e+06 6.0le+05 O.OOe+OO 9.43e+05 O.OOe+OO 1.90e+09 O.OOe+OO 4.07e+05 ZR-97 2.12e-05 4.28e-06 O.OOe+OO 6.47e-06 0.00e+OO l.33e+OO O.OOe+OO 1.96e-06 NB-95 2.30e+06 1.28e+06 O.OOe+OO l.26e+06 O.OOe+OO 7.76e+09 O.OOe+OO 6.87e+05 M0-99 O.OOe+OO 1.0le+05 O.OOe+OO 2.28e+05 O.OOe+OO 2.33e+05 O.OOe+OO 1.92e+04 TC-99M 4.80e-21 l.36e-20 O.OOe+OO 2.06e-19 6.65e-21 8.03e-18 O.OOe+OO 1.73e-19 RU-103 1.05e+08 O.OOe+OO O.OOe+OO 4.02e+08 O.OOe+OO 1.23e+l0 O.OOe+OO 4.53e+07 RU-105 6.40e-28 O.OOe+OO O.OOe+OO 8.27e-27 O.OOe+OO 3.91e-25 O.OOe+OO 2.53e-28 RU-106 2.80e+09 O.OOe+OO O.OOe+OO 5.40e+09 O.OOe+OO l.8le+ll O.OOe+OO 3.54e+08 AG-llOM 6.68e+06 6.18e+06 O.OOe+OO 1. 22e+07 O.OOe+OO 2.52e+09 O.OOe+OO 3.67e+06 TE-125M 3.59e+08 1. 30e+08 1. 08e+08 1.46e+09 O.OOe+OO l.43e+09 O.OOe+OO 4.8le+07 TE-127 2.23e-10 8.00e-11 l.65e-10 9.08e-10 O.OOe+OO 1.76e-08 O.OOe+OO 4.82e-11 TE-127M 1.12e+ci9 3.99e+08 2.85e+08 4.53e+09 0.00e+OO 3.74e+09 O.OOe+OO l.36e+08 TE-129M l.14e+09 4.23e+08 3.90e+08 4.74e+09 O.OOe+OO 5.71e+09 O.OOe+OO 1.80e+08 TE-131M 4.58e+02 2.24e+02 3.55e+02 2.27e+03 O.OOe+OO 2.22e+04 O.OOe+OO 1.87e+02 Page 7 of 44

For Information Only Attachment C

ODCM-QA-004 Revision 6 Page 27 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/m11.3))

Deposition Pathways: (m11.2 * (mrem/yr)/(µCi/sec)

AgeGroup: ADULT Pathway: Grs/Cow/Meat (CMEAT)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB

~----------------------------------------------------------------

TE-132 1.43e+06 9.24e+05 1. 02e+06 8.90e+06 O.OOe+OO 4.37e+07 O.OOe+OO 8.67e+05 I-130 1.09e-06 3.23e-06 2.73e-04 5.04e-06 O.OOe+OO 2.78e-06 O.OOe+OO l.27e-06 I-131 5.38e+06 7.70e+06 2.52e+09 1. 32e+07 O.OOe+OO 2.03e+06 O.OOe+OO 4.41e+06 I-132 4.25e-59 1.14e-58 3.98e-57 1.Ble-58 O.OOe+OO 2 .13e-59 O.OOe+OO 3.98e-59 I-133 l.87e-Ol 3.25e-01 4.77e+Ol 5.67e-01 O.OOe+OO 2.92e-01 O.OOe+OO 9.90e-02 I-135 2.37e-17 6.2le-17 4.09e-15 9.96e-17 O.OOe+OO 7.0le-17 O.OOe+OO 2.29e-17 CS-134 6.58e+08 1.57e+09 O.OOe+OO 5.06e+08 1.68e+08 2.74e+07 O.OOe+OO 1.28e+09 CS-136 1.2le+07 4.77e+07 O.OOe+OO 2.65e+07 3.63e+06 5.4le+06 O.OOe+OO 3.43e+07 CS-137 8. 72e+OB 1.19e+09 O.OOe+OO 4.05e+08 l.35e+08 2.31e+07 O.OOe+OO 7.81e+08

BA-140 2.88e+07 3.62e+04 O.OOe+OO 1.23e+04 2.07e+04 5.93e+07 O.OOe+OO l.89e+06 LA-140 3.75e-02 1.89e-02 O.OOe+OO O.OOe+OO O.OOe+OO 1.39e+03 O.OOe+OO 5.00e-03 LA-142 4.59e-92 2.09e-92 O.OOe+OO O.OOe+OO O.OOe+OO l.52e-88 O.OOe+OO 5.20e-93 CE-141 1.4le+04 9.5le+03 O.OOe+OO 4.42e+03 O.OOe+OO 3.63e+07 O.OOe+OO l.08e+03 CE-143 2.04e-02 l.5le+Ol O.OOe+OO 6.62e-03 O.OOe+OO 5.63e+02 O.OOe+OO 1. 67e-03 CE-144 1.46e+06 6.09e+05 O.OOe+OO 3.62e+05 O.OOe+OO 4.93e+08 O.OOe+OO 7.83e+04 PR-143 2.10e+04 8.42e+03 O.OOe+OO 4.86e+03 O.OOe+OO 9.20e+07 O.OOe+OO 1.04e+03 ND-147 7.08e+03 8.19e+03 O.OOe+OO 4.79e+03 O.OOe+OO 3.93e+07 O.OOe+OO 4.90e+02 W-187 2. lle-02 1. 76e-02 O.OOe+OO O.OOe+OO O.OOe+OO 5.77e+OO O.OOe+OO 6.16e-03 NP-239 2.61e-01 2.57e-02 O.OOe+OO 8.0le-02 O.OOe+OO 5.27e+03 O.OOe+OO l.42e-02 PU-239 2.78e+07 3.34e+06 O.OOe+OO 3. lle+06 O.OOe+OO 2:56e+06 O.OOe+OO 7.33e+05 U-235 7.47e+08 0.00e+OO O.OOe+OO 1.74e+08 O.OOe+OO 7.28e+07 O.OOe+OO 4.53e+07 Page 8 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 28 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/m 11 3))

Deposition Pathways: (m 112 * (mrem/yr)/(µCi/sec)

AgeGroup: ADULT Pathway: Grs/Cow/Mil_k (CMILK)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 O.OOe+OO 7.63e+02 7.63e+02 7.63e+02 7.63e+02 7.63e+02 O.OOe+OO 7.63e+02 C-14 2.63e+08 5.27e+07 5.27e+07 5.27e+07 5.27e+07 5.27e+07 O.OOe+OO 5.27e+07 NA-24 2.45e+06 2.45e+06 2.45e+06 2.45e+06 2.45e+06 2.45e+06 O.OOe+OO 2.45e+06 P-32 2.66e+09 1.06e+09 O.OOe+OO O.OOe+OO O.OOe+OO 1. 92e+09 O.OOe+OO 6.61e+08 CR-51 O.OOe+OO O.OOe+OO 1.71e+04 6.30e+03 3.79e+04 7.19e+06 O.OOe+OO 2.86e+04 MN-54 O.OOe+OO 8.41e+06 O.OOe+OO 2.50e+06 O.OOe+OO 2.58e+07 O.OOe+OO 1.61e+06 MN-56 O.OOe+OO 4.23e-03 O.OOe+OO 5.37e-03 O.OOe+OO 1.35e-01 O.OOe+OO 7.50e-04 FE-55 2.5le+07 l.74e+07 O.OOe+OO O.OOe+OO 9.68e+06 9.95e+06 O.OOe+OO 4.05e+06 FE-*59 2.97e+07 6.98e+07 O.OOe+OO O.OOe+OO 1.95e+07 2.33e+08 O.OOe+OO 2.68e+07 C0-58 O.OOe+OO 4.71e+06 O.OOe+OO O.OOe+OO O.OOe+OO 9.56e+07 O.OOe+OO 1.06e+07 C0-60 O.OOe+OO 1.64e+07 O.OOe+OO O.OOe+OO O.OOe+OO 3.08e+08 O.OOe+OO 3.62e+07 NI-63 6.73e+09 4.67e+08 O.OOe+OO O.OOe+OO o:ooe+oo 9.74e+07 O.OOe+OO 2.26e+08 NI-65 3.77e-01 4.89e-02 O.OOe+OO O.OOe+OO O.OOe+OO 1. 24e+OO O.OOe+OO 2.23e-02 CU-64 O.OOe+OO 2.39e+04 O.OOe+OO 6.03e+04 O.OOe+OO 2.04e+06 O.OOe+OO 1.12e+04 ZN-65 1.37e+09 4.37e+09 O.OOe+OO 2. 92e+09 O.OOe+OO 2.75e+09 O.OOe+OO 1.97e+09 ZN-69 2.20e-12 4.20e-12 O.OOe+OO 2.73e-12 O.OOe+OO 6.31e-13 O.OOe+OO 2. 92e-13 BR-83 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.43e-01 O.OOe+OO 9.90e-02 BR-84 O.OOe+OO O. 00,e+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.38e-28 O.OOe+OO l.75e-23 RB-86 O.OOe+OO 2.60e+09 O.OOe+OO 0.00e+OO O.OOe+OO 5.12e+08 O.OOe+OO 1.21e+09 RB-88 O.OOe+OO 2.49e-45 O.OOe+OCi O.OOe+OO O.OOe+OO 3.45e-56 O.OOe+OO 1.32e-45 RB-89 O.OOe+OO 6.61e-54 O.OOe+OO O.OOe+OO O.OOe+OO 3.84e-67 O.OOe+OO 4.65e-54 SR-89 l.45e+09 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.33e+08 O.OOe+OO 4.17e+07 SR-90 4.68e+l0 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO l.35e+09 O.OOe+OO l.15e+10 SR-91 2. 91e+04 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1. 38e+05 O.OOe+OO 1.17e+03 SR-92 4.97e-01 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 9.84e+OO O.OOe+OO 2.15e-02 Y-90 7.09e+Ol O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 7.52e+05 O.OOe+OO l.90e+OO Y-91 8.59e+03 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 4.73e+06 O.OOe+OO 2.30e+02 Y-91M

6.32e-20 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.86e-19 O.OOe+OO 2.45e-21 Y-92 5.65e-05 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 9.90e-01 O.OOe+OO 1. 65e-06 Y-93 2.24e-01 O.OOe+OO 0.00e+OO 0.00e+Oci O.OOe+OO 7.12e+03 O.OOe+OO 6.20e-03 ZR-95 9.43e+02 3.03e+02 O.OOe+OO 4.75e+02 O.OOe+OO 9.59e+05 O.OOe+OO 2.05e+02 ZR-97 4.34e-01 8.77e-02 O.OOe+OO l.32e-Ol O.OOe+OO 2. 72e+04 O.OOe+OO 4.0le-02 NB-95 8.26e+04 4.59e+04 O.OOe+OO 4.54e+04 0 .. OOe+OO 2.79e+08 O.OOe+OO 2.47e+04 M0-99 O.OOe+OO 2.48e+07 O.OOe+OO 5.6le+07 O.OOe+OO 5.75e+07 O.OOe+OO 4.72e+06 TC-99M 3.35e+bo 9.46e+OO O.OOe+OO l.44e+02 4.63e+OO 5 .*6oe+03 O.OOe+OO l.21e+02 TC-101 3.14e-60 4.53e-60 O.OOe+OO 8.16e-59 2.31e-60 1.36e-71 O.OOe+OO 4.44e-59 RU-103 1. 02e+03 O.OOe+OO O.OOe+OO 3.89e+03 O.OOe+OO 1.19e+05 O.OOe+OO 4.39e+02 RU-105 8.66e-04 O.OOe+OO O.OOe+OO l.12e-02 O.OOe+OO 5.29e-01 O.OOe+OO 3.42e-04 Page 9 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 29of65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/mA3))

Deposition Pathways: (m"2 * (mrem/yr)/(µCi/sec)

AgeGroup: ADULT Pathway: Grs/Cow/Milk (CMILK)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-106 2.04e+04 O.OOe+OO O.OOe+OO 3.94e+04 O.OOe+OO 1.32e+06 0.00e+OO 2.58e+03 AG-110M 5.82e+07 5.39e+07 O.OOe+OO 1. 06e+08 O.OOe+OO 2.20e+10 o.ooe+oo 3.20e+07 TE-125M 1.63e+07 5.90e+06 4.90e+06 6.63e+07 O.OOe+OO 6.5le+07 0.00e+OO 2.18e+06 TE-127 6.56e+02 2.36e+02 4.86e+02 2.67e+03 O.OOe+OO 5.18e+04 0.00e+OO l.42e+02 TE-127M 4.58e+07 1. 64e+07 1.17e+07 1. 86e+08 O.OOe+OO 1.54e+08 O.OOe+OO 5.58e+06 TE-129 2.94e-10 l.lOe-10 2.25e-10 l.24e-09 O.OOe+OO 2.22e-10 0.00e+OO 7.16e-11 TE-129M 6.02e+07 2.25e+07 2.07e+07 2.5le+08 O.OOe+OO 3.03e+08 0. 00,e+OO 9.53e+06 TE-131 4.02e-33 1. 68e-33 3.3le-33 1. 76e-32 O.OOe+OO 5.69e-34 0.00e+OO 1.27e-33 TE-131M 3.62e+05 1.77e+05 2.80e+05 1. 79e+06 O.OOe+OO 1.76e+07 O.OOe+OO 1.47e+05 TE-132

2. 40e+06 l.56e+06 1. 72e+06 1. 50e+07 O.OOe+OO 7.35e+07 O.OOe+OO 1.46e+06 I-130 2 .1le+05 6.22e+05 5.27e+07 9. 71e+05 O.OOe+OO 5.36e+05 0.00e+OO 2.45e+05 I-131 1.48e+08 2.12e+08 6.94e+10 3.63e+08 O.OOe+OO 5.59e+07 O.OOe+OO l.21e+08 I-132 8.38e-02 2.24e-01 7.84e+OO 3.57e-01 O.OOe+OO 4.21e-02 O.OOe+OO 7.84e-02 I-133 1. 94e+06 3.37e+06 4.96e+08 5.89e+06 ~.OOe+OO 3.03e+06 0.00e+OO 1. 03e+06 I-134 1. 06e-12 2.89e-12 5. OOe-11 4.59e-12 O.OOe+OO 2.52e-15 0.00e+OO 1.03e-12 I-135 6.46e+03 1.69e+04 1.12e+06 2. 71e+04 O.OOe+OO 1.9le+04 0.00e+OO 6.25e+03 CS-134 5.65e+09 1. 35e+10 O.OOe+OO 4.35e+09 1.45e+09 2.35e+08 0.00e+OO l.lOe+lO CS-136 2.63e+08 1. 04e+09 O.OOe+OO 5.78e+08 7.93e+07 l.18e+08 O.OOe+OO 7.48e+08 CS-137 7.38e+09 1. Ole+lO O.OOe+OO 3.43e+09 l.14e+09 1.95e+08 O.OOe+OO 6.6le+09 CS-138 9.85e-24 1. 94e-23 O.OOe+OO 1.43e-23 1. 41e-24 8.29e-29 0.00e+OO 9.63e-24 BA-139 4.57e-08 3.25e-11 O.OOe+OO 3.04e-11 1.85e-11 8.1oe-08 O.OOe+OO 1. 34e-09 BA-140 2.69e+07 3 .38e+04 O.OOe+OO 1.15e+04 1.93e+04 5.54e+07 0.00e+OO l.76e+06 BA-141 4.76e-46 3.59e-49 O.OOe+OO 3.34e-49 2.04e-49 2.24e-55 0.00e+OO 1. 60e-4 7 BA-142 3.43e-80 3.53e-83 O.OOe+OO 2.98e-83 2.00e-83 4.83e-98 O.OOe+OO 2.16e-81 LA-140 4.52e+OO 2.28e+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.67e+05 O.OOe+OO 6.02e-01 LA-142 1.9le-11 8.70e-12 O.OOe+OO O.OOe+OO 0. O.Oe+OO 6.35e-08 O.OOe+OO 2.17e-12 CE-141 4.85e+03 3.28e+03 O.OOe+OO l.52e+03 O.OOe+OO 1.25e+07 0.00e+OO 3.72e+02 CE-143 4.16e+Ol 3.08e+04 O.OOe+OO l.36e+Ol O.OOe+OO 1.15e+0.6 0.00e+OO 3.41e+OO CE-144 3.58e+05 1. 50e+05 O.OOe+OO 8.87e+04 O.OOe+OO 1.2le+08 O.OOe+OO 1. 92e+04 PR-143 1.58e+02 6.34e+01 O.OOe+OO 3.66e+Ol .0. OOe+OO 6.92e+05 O.OOe+OO 7. 83e+OO PR-144 6.88e-54 2.86e-54 O.OOe+OO 1.61e-54 O.OOe+OO 9.89e-61 0.00e+OO 3.49e-55 ND-147 9.42e+Ol l.09e+02 O.OOe+OO 6.36e+Ol. O.OOe+OO 5.23e+05 O.OOe+OO 6.5le+OO W-187 6.53e+03 5.46e+03 O.OOe+OO O.OOe+OO O.OOe+OO 1.79e+06 O.OOe+OO l.91e+03 NP-239 3.68e+OO 3.61e-Ol O.OOe+OO l.13e+OO O.OOe+OO 7.42e+04 O.OOe+OO 1.99e-01 PU-239 2.80e+07 3.37e+06 0.00e+OO 3.13e+06 O.OOe+OO 2.57e+06 O.OOe+OO 7.38e+05 U-235 3.10e+09 O.OOe+OO O.OOe+OO 7.23e+08 O.OOe+OO 3.02e+08 O.OOe+OO l.88e+08 Page 10 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 30 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/ml\3))

Deposition Pathways: (ml\2 * (mrem/yr)/(µCi/sec)

AgeGroup: ADULT Pathway: Vegetation (VEG)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 O.OOe+OO 2. 26e+03 2.26e+03 2.26e+03 2.26e+03 2.26e+03 O.OOe+OO 2.26e+03 C-14 2.28e+08 4.55e+07 4.55e+07 4.55e+07 4.55e+07 4.55e+07 O.OOe+OO 4.55e+07 NA-24 2.68e+05 2.68e+05 2.68e+05 2.6Be+05 2.68e+05 2.68e+05 O.OOe+OO 2.68e+05 P-32 2.18e+08 8.73e+07 O.OOe+OO O.OOe+OO O.OOe+OO l.58e+08 O.OOe+OO 5.43e+07 CR-51 O.OOe+OO O.OOe+OO 2.78e+04 1. 02e+04 6.16e+04 l.17e+07 O.OOe+OO 4.64e+04 MN-54 O.OOe+OO 3.13e+08 O.OOe+OO 9.3le+07 O.OOe+OO 9.59e+08 O.OOe+OO *5.97e+07 MN-56 O.OOe+OO 1. 55e+Ol O.OOe+OO l.96e+Ol O.OOe+OO 4.93e+02 O.OOe+OO 2.74e+OO FE-55 2.10e+08 1. 45e+08 O.OOe+OO O.OOe+OO 8.08e+07 8.3le+07 O.OOe+OO 3.38e+07 FE-59 1.26e+08 2.96e+08 O.OOe+OO O.OOe+OO 8.28e+07 9.88e+08 O.OOe+OO 1.14e+08 C0-58 O.OOe+OO 3.07e+07 O.OOe+OO O.OOe+OO O.OOe+OO 6.23e+08 O.OOe+OO 6.89e+07 C0-60 O.OOe+OO 1. 67e+08 O.OOe+OO O.OOe+OO O.OOe+OO 3.14e+09 O.OOe+OO 3.69e+08 NI-63 l.04e+10 7.22e+08 O.OOe+OO O.OOe+OO O.OOe+OO 1. 5le+08 O.OOe+OO 3.49e+08 NI-65 5.97e+Ol 7.76e+OO O.OOe+OO O.OOe+OO O.OOe+OO l.97e+02 O.OOe+OO 3.54e+OO CU-64 O.OOe+OO 9.15e+03 O.OOe+OO 2.3le+04 O.OOe+OO 7.80e+05 O.OOe+OO 4.30e+03 ZN-65 3.17e+08 l.Ole+09 O.OOe+OO 6.75e+08 O.OOe+OO 6.36e+08 O.OOe+OO 4.56e+08 ZN-69 5.08e-06 9. 71e-06 O.OOe+OO 6.31e-06 O.OOe+OO 1.46e-06 O.OOe+OO 6.75e-07 BR-83 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 4.34e+OO O.OOe+OO 3.0le+OO BR-84 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1. 69e-16 O.OOe+OO 2.15e-11 RB-86 O.OOe+OO 2.19e+08 O.OOe+OO O.OOe+OO O.OOe+OO 4.32e+07 O.OOe+OO 1. 02e+08 RB-88 O.OOe+OO 2.68e-22 O.OOe+OO O.OOe+OO O.OOe+OO 3.70e-33 O.OOe+OO l.42e-22 RB-89. O.OOe+OO 1.04e-26 O.OOe+OO O.OOe+OO O.OOe+OO 6.02e-40 0.00e+OO 7.29e-27 SR-89 9.97e+09 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1. 60e+09 O.OOe+OO 2.86e+08 SR-90 6.05e+ll O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.75e+10 O.OOe+OO 1.48e+ll SR-91 3.02e+05 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO l.44e+06 O.OOe+OO l.22e+04 SR-92 4.15e+02 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 8.23e+03 O.OOe+OO l.80e+Ol Y-90 l.33e+04 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.4le+08 O.OOe+OO 3.56e+02 Y-91 5.lle+06 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.8le+09 O.OOe+OO 1.37e+05 Y-91M 4.78e-09 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.40e-08 0.00e+OO 1. 85e-10 Y-92 8.97e-Ol O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.57e+04 O.OOe+OO 2.62e-02 Y-93 1.68e+02 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 5.34e+06 O.OOe+OO 4.65e+OO ZR-95 1.17e+06 3.77e+05 O.OOe+OO 5.9le+05 O.OOe+OO l.19e+09 O.OOe+OO 2.55e+05 ZR-97 3.36e+02 6.78e+Ol O.OOe+OO l.02e+02 O.OOe+OO 2.10e+07 O.OOe+OO 3.lOe+Ol NB-95 l.42e+05 7.92e+04 O.OOe+OO 7.83e+04 O.OOe+OO 4.8le+08 O.OOe+OO 4.26e+04 M0-99 O.OOe+OO 6.15e+06 O.OOe+OO l.39e+07 O.OOe+OO 1. 43e+07 O.OOe+OO 1.17e+06 TC-99M 3.06e+OO 8.66e+OO O.OOe+OO 1. 32e+02 4.24e+OO 5 .13e+03 O.OOe+OO 1.10e+02 TC-101 6.02e-31 8.68e-31 O.OOe+OO l.56e-29 4.44e-31 2.61e-42 O.OOe+OO 8.51e-30 RU-103 4.77e+06 O.OOe+OO O.OOe+OO 1.82e+07 O.OOe+OO 5.57e+08 O.OOe+OO 2.06e+06 RU-105 5.30e+Ol O.OOe+OO O.OOe+OO 6.85e+02 O.OOe+OO 3.24e+04 O.OOe+OO 2.09e+Ol Page 11 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 31of65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/mA3))

Deposition Pathways: (m"2 * (mrem/yr)/(µCi/sec)

AgeGroup: ADULT Pathway: Vegetation (VEG)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-106 1.93e+08 O.OOe+OO O.OOe+OO 3. 72e+08 O.OOe+OO 1. 25e+10 O.OOe+OO 2.44e+07 AG-110M l.05e+07 9.75e+06 O.OOe+OO l.92e+07 O.OOe+OO 3.98e+09 O.OOe+OO 5.79e+06 TE-125M 9.65e+07 3.50e+07 2.90e+07 3.93e+08 O.OOe+OO 3.85e+08 O.OOe+OO 1.29e+07 TE-127 5.62e+03 2.02e+03 4.16e+03 2.29e+04 O.OOe+OO 4.43e+05 O.OOe+OO l.22e+03 TE-127M 3.49e+08 1.25e+08 8.92e+07 1.42e+09 O.OOe+OO L17e+09 O.OOe+OO 4.26e+07 TE-129 7.16e-04 2.69e-04 5.49e-04 3.0le-03 O.OOe+OO 5.40e-04 O.OOe+OO 1. 74e-04 TE-129M 2 .*5le+08 9.37e+07 8.63e+07 l.05e+09 O.OOe+OO l.27e+09 O.OOe+OO 3.98e+07 TE-131 l.26e-15 5.26e-16 1.04e-15 5.51e-15 O.OOe+OO 1. 78e-i6 O.OOe+OO 3.97e-16 TE-131M 9.10e+05 4.45e+05 7.05e+05 4.51e+06 O.OOe+OO 4.42e+07 O.OOe+OO 3. 71e+05 TE-132 4.30e+06 2.78e+06 3.07e+06 2.68e+07 O.OOe+OO 1.32e+08 O.OOe+OO 2.6le+06 I-130 1. 95e+OS 5.75e+05 4.88e+07 8.98e+05 O.OOe+OO 4.95e+05 O.OOe+OO 2.27e+05 I-131 4.04e+07 5.77e+07 1.89e+10 9.90e+07 O.OOe+OO 1.52e+07 O.OOe+OO 3.31e+07 I-132 2.79e+Ol 7.46e+Ol 2.61e+03 l.19e+02 O.OOe+OO 1. 40e+01 O.OOe+OO 2.61e+01 I-133 l.04e+06 1. 81e+06 2.66e+08 3.15e+06 O.OOe+OO 1. 63e+06 O.OOe+OO 5.5le+05 I-134 4.44e-05 1. 21e-04 2.09e-03 l.92e-04 O.OOe+OO 1.05e-07 O.OOe+OO 4.3le-05 I-135 1.93e+04 5.05e+04 3.33e+06 8.09e+04 O.OOe+OO 5.70e+04* O.OOe+OO 1.86e+04 CS-134 4.67e+09 l .1le+10 O.OOe+OO 3.59e+09 l.19e+09 1.94e+08 O.OOe+OO 9.08e+09 CS-136 4.27e+07 1. 68e+08 O.OOe+OO 9.37e+07 1.28e+07 1.9le+07 O.OOe+OO 1.21e+08 CS-137 6.36e+09 8.70e+09 O.OOe+OO 2.95e+09 9.8le+08 1. 68e+08 O.OOe+OO 5.70e+09 CS-138 3.42e-ll 6.74e-11 O.OOe+OO 4.95e-11 4.89e-12 2.88e-16 O.OOe+OO 3.34e-11 BA-139 2. 71e-02 1. 93e-05 O.OOe+OO 1.BOe-05 1.lOe-05 4.80e-02 O.OOe+OO 7.93e-04 BA-140 1.28e+08 1. 61e+05 O.OOe+OO 5.49e+04 9.24e+04 2.64e+08 O.OOe+OO 8.41e+06 BA-141 9.05e-22 6.84e-25 O.OOe+OO 6.36e-25 3.88e-25 4.26e-31 O.OOe+OO 3.05e-23 BA-142 3.96e-39 4.07e-42 O.OOe+OO 3.44e-42 2.30e-42 5.57e-57 O.OOe+OO 2.49e-40 LA-140 1. 97e+03 9.95e+02 O.OOe+OO O.OOe+OO O.OOe+OO 7.3le+07 O.OOe+OO 2.63e+02 LA-142 1.93e-04 8.77e-05 O.OOe+OO O.OOe+OO O.OOe+OO 6.41e-01 O.OOe+OO 2.19e-05 CE-141 1. 97e+05 1.33e+05 O.OOe+OO 6.19e+04 O.OOe+OO 5.10e+08 O.OOe+OO 1.51e+04 CE-143 9.96e+02 7.36e+05 O.OOe+OO 3.24e+02 O.OOe+OO 2.75e+07 O.OOe+OO 8.15e+Ol CE-144 3.29e+07 l.38e+07 O.OOe+OO 8.16e+06 O.OOe+OO 1.11e+10 O.OOe+OO 1. 77e+06 PR-143 6.26e+04 2.5le+04 O.OOe+OO 1.45e+04 O.OOe+OO 2.74e+08 O.OOe+OO 3.10e+03 PR-144 2.39e-26 9.93e-27 O.OOe+OO 5.60e-27 O.OOe+OO 3.44e-33 O.OOe+OO l.22e-27 ND-147 3.33e+04 3.85e+04 O.OOe+OO 2.25e+04 O.OOe+OO 1.85e+08 O.OOe+OO 2.30e+03 W-187 3.79e+04 3.17e+04 O.OOe+OO O.OOe+OO O.OOe+OO 1.04e+07 O.OOe+OO 1.1le+04 NP-239 1.43e+03 1.40e+02 O.OOe+OO 4.37e+02 O.OOe+OO 2.88e+07 O.OOe+OO 7.73e+Ol PU-239 5.81e+l0 6.98e+09 O.OOe+OO 6.50e+09 O.OOe+OO 5.34e+09 O.OOe+OO 1.53e+09 U-235 6.42e+l0 O.OOe+OO O.OOe+OO 1.50e+l0 O.OOe+OO 6.26e+09 O.OOe+OO 3.90e+09 Page 12 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 32 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/m"3))

Deposition Pathways: (m"2 * (rnrem/yr)/(µCi/sec)

AgeGroup: TEEN Pathway: Grs/Goat/Milk (GMILK)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 O.OOe+OO 2.03e+03 2.03e+03 2.03e+03 2.03e+03 2.03e+03 O.OOe+OO 2.03e+03 C-14 4.86e+08 9.72e+07 9.72e+07 9.72e+07 9.72e+07 9.72e+07 O.OOe+OO 9.72e+07 NA-24 5.12e+05 5.12e+05 5.12e+05 5.12e+05 5.12e+05 5.12e+05 O.OOe+OO 5.12e+05 P-32 5.88e+09 2.35e+09 O.OOe+OO O.OOe+OO O.OOe+OO 3.18e+09 O.OOe+OO 1.47e+09 CR-51 O.OOe+OO O.OOe+OO 3.33e+03 1.31e+03 8.55e+03 1.0le+06 O.OOe+OO 5.99e+03 MN-54 O.OOe+OO 1.68e+06 O.OOe+OO 5.02e+05 O.OOe+OO 3.45e+06 O.OOe+OO 3.34e+05 MN-56 O.OOe+OO 8.99e-04 O.OOe+OO 1.14e-03 O.OOe+OO 5.92e-02 O.OOe+OO 1.60e-04 FE-55 5.79e+05 4.11e+05 O.OOe+OO O.OOe+OO 2.60e+05 1.78e+05 O.OOe+OO 9.57e+04 FE-59 6.74e+05 1.57e+06 O.OOe+OO O.OOe+OO 4.96e+05 3.72e+06 O.OOe+OO 6.07e+05 C0-58 O.OOe+OO 9.52e+05 O.OOe+OO O.OOe+OO O.OOe+OO 1.31e+07 O.OOe+OO 2.20e+06 C0-60 O.OOe+OO 3.34e+06 O.OOe+OO 0.00e+OO O.OOe+OO 4.35e+07 O.OOe+OO 7.52e+06 NI-63 1.42e+09 1.00e+08 O.OOe+OO O.OOe+OO O.OOe+OO 1.60e+07 O.OOe+OO 4.81e+07 NI-65 8.27e-02 1.06e-02 O.OOe+OO O.OOe+OO O.OOe+OO 5.73e-01 O.OOe+OO 4.82e-03 CU-64 O.OOe+OO 4.75e+03 O.OOe+OO 1.20e+04 O.OOe+OO 3.68e+05 O.OOe+OO 2.23e+03 ZN-65 2.53e+08 8.78e+08 O.OOe+OO 5.62e+08 O.OOe+OO 3.72e+08 O.OOe+OO 4.10e+08 ZN-69 4.86e-13 9.25e-13 O.OOe+OO 6.04e-13 O.OOe+OO 1.70e-12 O.OOe+OO 6.47e-14 BR-83 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.19e-02 BR-84 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO 3.76e-24 RB-86 O.OOe+OO 5.68e+08 O.OOe+OO O.OOe+OO O.OOe+OO 8.40e+07 O.OOe+OO 2.67e+08 RB-88 O.OOe+OO 5.44e-46 O.OOe+OO O.OOe+OO O.OOe+OO 4.66e-53 O.OOe+OO 2.90e-46 RB-89 O.OOe+OO 1.40e-54 O.OOe+OO O.OOe+OO O.OOe+OO 2.15e-63 O.OOe+OO 9.93e-55 SR-89 5.62e+09 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 6.69e+08 O.OOe+OO 1.61e+08 SR-90 1.39e+11 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 3.90e+09 O.OOe+OO 3.43e+l0 SR-91 1.12e+05 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 5.09e+05 O.OOe+OO 4.46e+03 SR-92 1.91e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 4.86e+01 O.OOe+OO 8.14e-02 Y-90 1.56e+Ol O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.29e+05 O.OOe+OO 4.21e-01 Y-91 l.90e+03 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 7.77e+05 O.OOe+OO 5.08e+Ol Y-91M 1.39e-20 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 6.56e-19 O.OOe+OO 5.31e-22 Y-92 1.25e-05 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 3.44e-01 O.OOe+OO 3.63e-07 Y-93 4.97e-02 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.52e+03 O.OOe+OO 1.36e-03 ZR-95 1.98e+02 6.25e+01 O.OOe+OO 9.18e+Ol O.OOe+OO l.44e+05 O.OOe+OO 4.30e+Ol ZR-97 9.49e-02 1.88e-02 O.OOe+OO 2.85e-02 O.OOe+OO 5.08e+03 O.OOe+OO 8.65e-03 NB-95 l.69e+04 9.37e+03 O.OOe+OO 9.08e+03 O.OOe+OO 4.0le+07 O.OOe+OO 5.16e+03 M0-99 O.OOe+OO 5.37e+06 0.00e+OO l.23e+07 O.OOe+OO 9.62e+06 O.OOe+OO l.02e+06 TC-99M 6.97e-01 1.94e+OO O.OOe+OO 2.89e+Ol 1.0Be+OO 1.28e+03 O.OOe+OO 2.52e+Ol TC-101 6.90e-61 9.81e-61 O.OOe+OO 1.77e-59 5.98e-61 1.68e-67 O.OOe+OO 9.64e-60 RU-103 2.17e+02 O.OOe+OO O.OOe+OO 7.66e+02 O.OOe+OO 1.82e+04 O.OOe+OO 9.29e+Ol RU-105 1.90e-04 O.OOe+OO O.OOe+OO 2.39e-03 O.OOe+OO 1.53e-01 O.OOe+OO 7.36e-05 Page 13 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 33 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/m"3))

Deposition Pathways: (m"2 * (mrem/yr)/(µCi/sec)

AgeGroup: TEEN Pathway: Grs/Goat/Milk (GMILK)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-106 4.50e+03 O.OOe+OO O.OOe+OO 8.68e+03 O.OOe+OO 2.16e+05 0.00e+OO 5.67e+02 AG-llOM 1.16e+07 1.09e-t07 O.OOe+OO 2. 09e+07 O.OOe+OO 3.07e+09 0.00e+OO 6.65e+06 TE-125M 3.6le+06 l.30e+06 l.Ole+06 O.OOe+OO O.OOe+OO 1.06e+07 0.00e+OO 4.82e+05 TE-127 1.46e+02 5.17e+Ol 1.0le+02 5.9le+02 O.OOe+OO 1.13e+04 O.OOe+OO 3.148+01 TE-127M 1.0le+07 3.59e+06 2.41e+06 4.lle+07 O.OOe+OO 2.52e+07 O.OOe+OO 1.20e+06 TE-129 6.49e-11 2.42e-ll 4.64e-11 2. 72e-10 O.OOe+OO 3.SSe-10 O.OOe+OO 1. 58e-11 TE-129M 1.32e+07 4.90e+06 4.26e+06 5.53e+07 O.OOe+OO 4.96e+07 0.00e+OO 2.09e+06 TE-131 8.82e-34 3.63e-34 6.79e-34 3.86e-33 O.OOe+OO 7.24e-35 0.00e+OO 2.76e-34 TE-131M 7.90e+04 3.79e+04 5.70e+04 3.95e+05 O.OOe+OO 3.04e+06 O.OOe+OO 3.16e+04 TE-132 5.15e+05 3.26e+05 3.44e+OS 3.13e+06 O.OOe+OO 1.03e+07 O.OOe+OO 3.07e+05 I-130 4.45e+05 l.29e+06 l.05e+08 1.98e+06 O.OOe+OO 9.89e+05 0.00e+OO 5.14e+05 I-131 3.22e+08 4.Sle+OB 1.32e+ll 7.77e+08 O.OOe+OO 8.93e+07 O.OOe+OO 2.43e+08 I-132 1. 78e-Ol 4.67e-01 1. 57e+Ol 7.35e-Ol O.OOe+OO 2.03e-01 0.00e+OO 1.67e-01 I-133 4.25e+06 7.2le+06 1.0le+09 1.27e+07 O.OOe+OO 5.46e+06 0.00e+OO 2.20e+06 I-134 2.27e-12 6.00e-12 1. OOe-10 9.46e-12 O.OOe+OO 7.9le-14 0.00e+OO 2.16e-12 I-135 1. 38e+04 3.55e+04 2.28e+06 5.60e+04 O.OOe+OO 3.93e+04 0.00e+OO l.32e+04 CS-134 2.95e+l0 6.93e+10 O.OOe+OO 2.20e+l0 8.4le+09 8.62e+08 O.OOe+OO 3.22e+10 CS-136 l.35e+09 5.29e+09 O.OOe+OO 2.88e+09 4.54e+OB 4.26e+08 O.OOe+OO 3.55e+09 CS-137 4.02e+l0 5.34e+l0 O.OOe+OO 1.82e+10 7.06e+09 7.60e+OB o.ooe+oo 1.86e+l0 CS-138 5.36e-23 l.03e-22 O.OOe+OO 7.59e-23 8.84e-24 4.67e-26 O.OOe+OO 5.14e-23 BA-139 1. Ole-08 7 .13e-12 O.OOe+OO 6. 72e-12 4.92e-12 9.04e-08 0.00e+OO 2.95e-10 BA-140 5.82e+06 7.14e+03 O.OOe+OO 2.42e+03 4.80e+03 8.98e+06 0.00e+OO 3.75e+05 BA-141 1.05e-46 7.83e-50 O.OOe+OO 7.27e-50 5.36e-50 2.24e-52 0.00e+OO 3.SOe-48 BA-142 7.46e-81 7.46e-84 O.OOe+OO 6.31e-84 4.96e-84 2.29e-92 O.OOe+OO 4.59e-82 LA-140 9.74e-01 4.78e-01 O.OOe+OO O.OOe+OO O.OOe+OO 2.75e+04 0.00e+OO 1.27e-01 LA-142 4.14e-12 1. 84e-12 O.OOe+OO O.OOe+OO O.OOe+OO 5.60e-08 O.OOe+OO 4.58e-13 CE-141 1.07e+03 7.12e+02 O.OOe+OO 3.35e+02 O.OOe+OO 2.04e+06 O.OOe+OO 8.18e+Ol CE-143 9.18e+OO 6.68e+03 O.OOe+OO 3.00e+OO O.OOe+OO 2.0le+OS 0.00e+OO 7.46e-01 CE-144 7.90e+04 3.27e+04 O.OOe+OO 1.95e+04 O.OOe+OO l.99e+07 0.00e+OO 4.25e+O~

PR-143 3.48e+Ol l.39e+Ol O.OOe+OO 8.08e+OO O.OOe+OO 1.15e+05 O.OOe+OO l.73e+OO PR-144 l.52e-54 6.23e-55 O.OOe+OO 3.57e-55 O.Ooe+OO 1. 68e-57 0.00e+OO 7.7le-56 ND-147 2.18e+Ol 2.36e+Ol O.OOe+OO l.39e+Ol O.OOe+OO 8.53e+04 0.00e+OO 1.42e+OO W-187 1. 43e+03 l.17e+03 O.OOe+OO O.OOe+OO O.OOe+OO 3.16e+05 0.00e+OO 4.09e+02 NP-239 8.42e-Ol 7.94e-02 0.00e+OO 2.49e-01 O.OOe+OO l.28e+04 0.00e+OO 4.4le-02 PU-239 4.58e+06 5.56e+05 O.OOe+OO 5.13e+05 O.OOe+OO 4.22e+05 0.00e+OO l.20e+05 U-235 6.82e+08 O.OOe+OO O.OOe+OO 1. 60e+08 O.OOe+OO 4.95e+07 0.00e+OO 4.15e+07 Page 14 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 34 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(uCi/m"3))

Deposition Pathways: (m"2 * (mrem/yr)/(µCi/sec)

AgeGroup: TEEN Pathway: Ground Plane Deposition (GPD)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB NA-24 1.20e+07 l.20e+07 1. 20e+07 l.20e+07 1.20e+07 1.20e+07 l.39e+07 1.20e+07 CR-51 4.66e+06 4.66e+06 4.66e+06 4.66e+06 4.66e+06 4.66e+06 5.51e+06 4.66e+06 MN-54 1. 39e+09 1.39e+09 1.39e+09 l.39e+09 1.39e+09 1.39e+09 1. 63e+09 1.39e+09 MN-56 9.04e+05 9.04e+05 9.04e+05 9.04e+05 9.04e+05 9.04e+05 l.07e+06 9.04e+05 FE-59 2.72e+08 2. 72e+08 2. 72e+08 2.72e+OB 2. 72e+08 2. 72e+08 3.20e+08 2. 72e+08 C0-58 3.79e+08 3.79e+08 3.79e+OB 3.79e+08 3.79e+08 3.79e+08 4.44e+08 3.79e+OB C0-60 2.15e+10 2.15e+10 2.lSe+lO 2.15e+l0 2.15e+10 2.lSe+lO 2.53e+l0 2.15e+l0 NI-65 2.97e+05 2.97e+05 2.97e+05 2.97e+05 2.97e+05 2.97e+05 3.45e+05 2.97e+05 CU-64 6.07e+05 6.07e+05 6.07e+OS 6.07e+05 6.07e+05 6.07e+OS 6.88e+05 6.07e+05 ZN-65 7.47e+OB 7.47e+08 7.47e+08 7.47e+08 7.47e+08 7.47e+08 8.60e+08 7.47e+08 BR-83 4.87e+03 4.87e+03 4.87e+03 4.87e+03 4.87e+03 4.87e+03 7.08e+03 4.87e+03 BR-84 2. 03e+05 2.03e+05 2.03e+05 2.03e+OS 2.03e+05 2.03e+05 2.36e+05 2.03e+OS RB-86 8.99e+06 8.99e+06 8.99e+06 8.99e+06 8.99e+06 8.99e+06 1.03e+07 8.99e+06 RB-88 3.3le+04 3.3le+04 3.31e+04 3.3le+04 3.31e+04 3.3le+04 3.78e+04 3. 3le+04 RB-89 1.2le+05 1.2le+05 1.2le+05 l.2le+OS 1.21e+OS l.21e+05 1.45e+05 1.21e+05 SR-89 2.16e+04 2.16e+04 2.16e+04 2.16e+04 2.16e+04 2.16e+04 2.51e+04 2.16e+04 SR-91 2.15e+06 2.15e+06 2.15e+06 2.15e+06 2.15e+06 2.15e+06 2.5le+06 2.15e+06 SR-92 7.77e+05 7.77e+OS 7. 77e+05 7.77e+05 7. 77e+OS 7. 77e+05 8.63e+05 7.77e+OS Y-90 4.49e+03 4.49e+03 4.49e+03 4.49e+03 4.49e+03 4.49e+03 5.31e+03 4.49e+03 Y-91 l.07e+06 1. 07e+06 1. 07e+06 1. 07e+06 l.07e+06 1. 07e+06 1.21e+06 1.07e+06 Y-91M 1.00e+05 l.00e+05 1.00e+05 l.OOe+OS 1.00e+05 1. OOe+OS l.16e+05 1.00e+05 Y-92 l.80e+05 l.80e+OS l.80e+05 l.80e+05 l.80e+05 l.80e+05 2.14e+05 1.80e+05 Y-93 1.83e+OS 1.83e+OS 1.83e+05 1. 83e+05 l.83e+OS 1.83e+OS 2.5le+05 1.83e+05 ZR-95 2.45e+08 2.45e+08 2.45e+08 2.45e+08 2.45e+08 2.45e+08 2.84e+08 2.45e+08 ZR-97 2.96e+06 2.96e+06 2.96e+06 2.96e+06 2.96e+06 2.96e+06 3.45e+06 2.96e+06 NB-95 l.37e+08 1.37e+08 1. 37e+08 l.37e+08 1. 37e+08 l.37e+08 l.61e+08 l.37e+08 M0-99 4.00e+06 4.00e+06 4.00e+06 4.00e+06 4.00e+06 4.00e+06 4.63e+06 4.ooero6 TC-99M 1.84e+05 1.84e+OS 1.84e+05 l.84e+05 1. 84e+05 1.84e+05 2.lle+05 1. 84e,'+05 TC-101 2.04e+04 2.04e+04 2.04e+04 2.04e+04 2.04e+04 2.04e+04 2.26e+04 2.04e+04 RU-103 l.OBe+OB l.08e+08 l.08e+08 1. 08e+08 1. 08e+08 1. 08e+08 l.26e+08 1. 08e+08 RU-105 6.37e+05 6.37e+05 6.37e+05 6.37e+05 6.37e+05 6.37e+05 7.2le+05 6.37e+05 RU-106 4.22e+08 4.22e+08 4.22e+08 4.22e+08 4.22e+08 4.22e+08 5.07e+08 4.22e+08 AG-llOM 3.44e+09 3.44e+09 3.44e+09 3.44e+09 3.44e+09 3.44e+09 4.0le+09 3.44e+09 TE-125M l.55e+06 1.55e+06 1.55e+06 l.55e+06 1.55e+06 1.55e+06 2.13e+06 1.55e+06 TE-127 2.98e+03 2.98e+03 2.98e+03 2.98e+03 2.98e+03 2.98e+03 3.28e+03 2.98e+03 TE-127M 9.16e+04 9.16e+04 9.16e+04 9.16e+04 9.16e+04 9.16e+04 1. 08e+05 9.16e+04 TE-129 2.62e+04 2.62e+04 2.62e+04 2.62e+04 2. 62e+04 2.62e+04 3.10e+04 2.62e+04 TE-129M 1. 98e+07 1.98e+07 l.98e+07 l.98e+07 1.98e+07 1.98e+07 2.3le+07 l.98e+07 Page 15 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 35 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(uCi/m"3))

Deposition Pathways: (m"2 * (mrem/yr)/(uCi/sec)

AgeGroup: TEEN Pathway: Ground Plane Deposition (GPD)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB TE-131 2.92e+04 2.92e+04 2.92e+04 2.92e+04 2. 92e+04 2.92e+04 3.45e+07 2.92e+04 TE-131M 8.03e+06 8.03e+06 8.03e+06 8.03e+06 8.03e+06 8.03e+06 9.46e+06 8.03e+06 TE-132 4.24e+06 4.24e+06 4.24e+06 4.24e+06 4.24e+06 4.24e+06 4.98e+06 4.24e+06 I-130 5.51e+06 5.51e+06 5.51e+06 5.5le+06 5.5le+06 5.51e+06 6.69e+06 5.5le+06 I-131 1. 72e+07 :). . 72e+07 1. 72e+07 1.72e+07 1. 72e+07 1. 72e+07 2.09e+07 1. 72e+07 I-132 1. 25e+06 1.25e+06 1.25e+06 1.25e+06 1.25e+06 1.25e+06 1.47e+06 1.25e+06 I-133 2.45e+06 2.45e+06 2.45e+06 2.45e+06 2.45e+06 2.45e+06 2.98e+06 2.45e+06 I-134 4.47e+05 4.47e+05 4.47e+05 4.47e+05 4.47e+05 4.47e+05 5.3le+05 4.47e+05 I-135 2.53e+06 2.53e+06 2.53e+06 2.53e+06 2.53e+06 2.53e+06 2.95e+06 2.53e+06 CS-134 6.86e+09 6.86e+09 6.86e+09 6.86e+09 6.86e+09 6.86e+09 8.00e+09 6.86e+09 CS-136 1.5le+08 l.51e+08 1.51e+08 1.51e+08 1.5le+08 l.51e+08 1. 7le+08 1.5le+08 CS-137 l.03e+10 l.03e+10 1.03e+10 1.03e+l0 l.03e+l0 1. 03e+l0 1. 20e+l0 1. 03e+10 CS-138 3.59e+05 3.59e+05 3.59e+05 3.59e+05 3.59e+05 3.59e+05 4.10e+05 3.59e+05 BA-139 1.06e+05 l.06e+05 1.06e+05 1.06e+05 l.06e+05 l.06e+05 l.19e+05 l.06e+05 BA-140 2.05e+07 2.05e+07 2.05e+07 2.05e+07 2.05e+07 2.05e+07 2.35e+07 2.05e+07 BA-141 4.17e+04 4.17e+04 4.17e+04 4.17e+04 4.17e+04 4.17e+04 4.75e+04 4.17e+04 BA-142 4.49e+04 4.49e+04 4.49e+04 4.49e+04 4.49e+04 4.49e+04 5.lle+04 4.49e+04 LA-140 1.92e+07 1. 92e+07 l.92e+07 1.92e+07 1.92e+07 1.92e+07 2.18e+07 l.92e+07 LA-142 7.60e+05 7.60e+05 7.60e+05 7.60e+05 7.60e+05 7.60e+05 9.12e+05 7.60e+05 CE-141 1.37e+07 l.37e+07 1.37e+07 1.37e+07 1.37e+07 l.37e+07 1. 54e+07 l.37e+07 CE-143 2.31e+06 2.3le+06 2.31e+06 2.3le+06 2.31e+06 2.3le+06 2.63e+06 2.3le+06 CE-144 6.95e+07 6.95e+07 6.95e+07 6.95e+07 6.95e+07 6.95e+07 8.04e+07 6.95e+07 PR-144 l.84e+03 l.84e+03 1.84e+03 1.84e+03 l.84e+03 l.84e+03 2. lle+03 1.84e+03 ND-147 8.39e+06 8.39e+06 8.39e+06 8.39e+06 8.39e+06 8.39e+06 l.Ole+07 8.39e+06 W-187 2.35e+06 2.35e+06 2.35e+06 2.35e+06 2.35e+06 2.35e+06 2.73e+06 2.35e+06 NP-239 1.7le+06 l.71e+06 1. 71e+06 1.71e+06 1. 71e+06 1. 71e+06 1. 98e+06 1.7le+06 PU-239 2.29e+06 2.29e+06 2.29e+06 2.29e+06 2.29e+06 2.29e+06 2.23e+07 2.29e+06 U-235 9.28e+09 9.28e+09 9.28e+09 9.28e+09 9.28e+09 9.28e+09 l.16e+l0 9.28e+09 Page 16 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 36 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/m"3))

Deposition Pathways: (m"2 * (mrem/yr)/(µCi/sec)

AgeGroup: TEEN Pathway: Inhalation (INHL)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 O.OOe+OO 1. 27e+03 l.27e+03 l.27e+03 l.27e+03 l.27e+03 O.OOe+OO l.27e+03 C-14 2.60e+04 4.87e+03 4.87e+03 4.87e+03 4.87e+03 4.87e+03 O.OOe+OO 4.87e+03 NA-24 1. 38e+04 l.38e+04 l.38e+04 l.38e+04 l.38e+04 1.38e+04 O.OOe+OO l.38e+04 P-32 l.89e+06 l.10e+05 O.OOe+OO O.OOe+OO O.OOe+OO 9.28e+04 O.OOe+OO 7.16e+04 CR-51 0.00e+OO O.OOe+OO 7.50e+Ol 3.07e+Ol 2.10e+04 3.00e+03 O.OOe+OO 1.35e+02 MN-54 O.OOe+OO 5.lle+04 o .'ooe+oo l.27e+04 l.98e+06 6.68e+04 O.OOe+OO 8.40e+03 MN-56 O.OOe+OO 1. 70e+OO O.OOe+OO 1.79e+OO l.52e+04 5.74e+04 O.OOe+OO 2.52e-01 FE-55 3.34e+04 2.38e+04 O.OOe+OO O.OOe+OO l.24e+05 6.39e+03 O.OOe+OO 5.54e+03 FE-59 l.59e+04 3.70e+04 O.OOe+OO O.OOe+OO l.53e+06 1.78e+05 O.OOe+OO 1.43e+04 C0-58 O.OOe+OO 2.07e+03 O.OOe+OO O.OOe+OO l.34e+06 9.52e+04 O.OOe+OO 2.78e+03 C0-60 O.OOe+OO l.51e+04 O.OOe+OO O.OOe+OO 8.72e+06 2.59e+05 O.OOe+OO l.98e+04 NI-63 5.80e+05 4.34e+04 O.OOe+OO O.OOe+OO 3.07e+05 1.42e+04 O.OOe+OO 1.98e+04 NI-65 2.18e+OO 2.93e-01* O.OOe+OO O.OOe+OO 9.36e+03 3.67e+04 O.OOe+OO l.27e-01 CU-64 O.OOe+OO 2.03e+OO O.OOe+OO 6.4le+OO 1.lle+04 6.14e+04 O.OOe+OO 8.48e-01 ZN-65 3.86e+04 l.34e+05 O.OOe+OO 8.64e+04 1.24e+06 4.66e+04 O.OOe+OO 6.24e+04 ZN-69 4. 83e-02 9.20e-02 O.OOe+OO 6.02e-02 l.58e+03 2.85e+02 O.OOe+OO 6.46e-03 BR-83 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO 3.44e+02 BR-84 0. OOe+OO. O.OOe+OO 0. OOe+O,O 0. OOe+OO. O.OOe+OO O.OOe+OO O.OOe+OO 4.33e+02 BR-85 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO l.83e+Ol RB-86 O.OOe+OO l.90e+05 O.OOe+OO O_. OOe+OO O.OOe+OO 1. 77e+04 O.OOe+OO 8.40e+04 RB-88 O.OOe+OO 5.46e+02 O.OOe+OO O.OOe+OO O.OOe+OO 2.92e-05 O.OOe+OO 2.72e+02 RB-89 O.OOe+OO 3.52e+02 O.OOe+OO 0.00e+OO O.OOe+OO 3.38e-07 O.OOe+OO 2.33e+02 SR-89 4.34e+05 O.OOe+OO O.OOe+OO O.OOe+OO 2.42e+06 3.71e+OS O.OOe+OO 1. 2Se+04 SR-90 l.08e+08 O.OOe+OO O.OOe+OO O.OOe+OO 1. 65e+07 7.65e+05 O.OOe+OO 6.68e+06 SR-91 8.80e+01 O.OOe+OO O.OOe+OO O.OOe+OO 6.07e+04 2.59e+OS O.OOe+OO 3.51e+OO SR-92 *9. 52e+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.74e+04 l.19e+05 O.OOe+OO 4.06e-01 Y-90 2.98e+03 O.OOe+OO O.OOe+OO O.OOe+OO 2.93e+05 5.59e+05 O.OOe+OO 8.00e+Ol Y-91 6.6le+05 O.OOe+OO O.OOe+OO O.OOe+OO 2.94e+06 4.09e+05 O.OOe+OO 1.77e+04 Y-91M 3.70e-01 O.OOe+OO O.OOe+OO O.OOe+OO 3.20e+03 3.02e+Ol O.OOe+OO 1. 42e-02 Y-92 l.47e+Ol O.OOe+OO O.OOe+OO O.OOe+OO 2.68e+04 1.65e+05 O.OOe+OO 4.29e-01 Y-93 l.35e+02 O.OOe+OO O.OOe+OO O.OOe+OO 8.32e+04 5.79e+05 O.OOe+OO 3. 72e+OO ZR-95 l.46e+05 4.58e+04 O.OOe+OO 6.74e+04 2.69e+06 1.49e+OS O.OOe+OO 3.15e+04 ZR-97 l.38e+02 2.72e+Ol O.OOe+OO 4.12e+Ol l.30e+05 6.30e+05 O.OOe+OO l.26e+Ol NB-95 l.86e+04 1. 03e+04' O.OOe+OO l.00e+04 7.5le+05 9.68e+04 O.OOe+OO 5.66e+03 M0-99 O.OOe+OO 1.69e+02 O.OOe+OO 4. lle+02 l.54e+05 2.69e+05 O.OOe+OO 3.22e+Ol TC-99M 1. 38e-03 3.86e-03 O.OOe+OO 5.76e-02 1.15e+03 6 .13e+03 O.OOe+OO 4.99e-02 TC-101 5. 92e-05 8.40e-05 O.OOe+OO 1. 52e-03 6.67e+02 8.72e-07 O.OOe+OO 8.24e-04 RU-103 2.10e+03 O.OOe+OO O.OOe+OO 7.43e+03 7.83e+OS 1. 09e+OS O.OOe+OO 8.96e+02 Page 17 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 37 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/mll.3))

Deposition Pathways: (m11.2 * (mrem/yr)/(µCi/sec)

AgeGroup: TEEN Pathway: Inhalation (INHL)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-105 1.12e+OO O.OOe+OO O.OOe+OO 1.41e+OO 1. 82e+04 9.04e+04 O.OOe+OO 4.34e-01 RU-106 9.84e+04 O.OOe+OO O.OOe+OO 1.90e+05 1.61e+07 9.60e+05 O.OOe+OO 1.24e+04 AG-110M 1.38e+04 1.3le+04 O.OOe+OO 2.50e+04 6.75e+06 2.73e+05 O.OOe+OO 7.99e+03 TE-125M 4.88e+03 2.24e+03 1.40e+03 O.OOe+OO 5.36e+05 7.50e+04 O.OOe+OO 6.67e+02 TE-127 2.0le+OO 9 .12e-01 1.42e+OO 7.28e+OO 1.12e+04 8.08e+04 O.OOe+OO 4.42e-01 TE-127M 1.80e+04 8.16e+03 4.38e+03 6.54e+04 1. 66e+06 1.59e+05 O.OOe+OO 2.18e+03 TE-129 7.lOe-02 3.38e-02 5.18e-02 2.66e-01 3.30e+03 1.62e+03 O.OOe+OO 1. 76e-02 TE-129M 1.39e+04 6.58e+03 4.58e+03 5.19e+04 1.98e+06 4.05e+05 O.OOe+OO 2.25e+03 TE-131 1.58e-02 8.32e-03 1.24e-02 6.18e-02 2.34e+03 1.51e+Ol O.OOe+OO 5.04e-03 TE-131M 9.84e+01 6.0le+Ol 7.25e+01 4.39e+02 2.38e+05 6.21e+05 O.OOe+OO 4.02e+Ol TE-132 3.60e+02 2.90e+02 2.46e+02 1.95e+03 4.49e+05 4.63e+05 O.OOe+OO 2.19e+02 I-130 6.24e+03 1. 79e+04 1.49e+06 2.75e+04 O.OOe+OO 9.12e+03 O.OOe+OO 7.17e+03 I-131 3.54e+04 4.91e+04 1.46e+07 8.40e+04 O.OOe+OO 6.49e+03 O.OOe+OO 2.64e+04 I-132 1.59e+03 4.38e+03 1.Sle+05 6. 92e+03 O.OOe+OO 1. 27e+03 O.OOe+OO 1.58e+03 I-133 l.22e+04 2.05e+04 2.92e+06 3.59e+04 O.OOe+OO 1.03e+04 O.OOe+OO 6.22e+03 I-134 8.88e+02 2. 32e+03 3.95e+04 3.66e+03 O.OOe+OO 2.04e+Ol O.OOe+OO 8.40e+02 I-135 3.70e+03 9.44e+03 6.2le+05 1. 49e+04 O.OOe+OO 6.95e+03 O.OOe+OO 3.49e+03 CS-134 5.02e+OS 1.13e+06 O.OOe+OO 3.75e+05 1.46e+05 9.76e+03 O.OOe+OO 5.49e+05 CS-136 5.15e+04 1. 94e+05 O.OOe+OO 1.10e+05 1.78e+04 1.09e+04 O.OOe+OO 1.37e+05 CS-137 6.70e+OS 8.48e+05 O.OOe+OO 3.04e+05 1. 21e+05 8.48e+03 O.OOe+OO 3 .11e+05 CS-138 4.66e+02 8.56e+02 O.OOe+OO 6.62e+02 7.87e+Ol 2.70e-01 O.OOe+OO 4.46e+02 BA-139 l.34e+OO 9.44e-04 O.OOe+OO 8.88e-04 6.46e+03 6.45e+03 O.OOe+OO 3.90e-02 BA-140 5.47e+04 6.70e+Ol O.OOe+OO 2.28e+Ol 2.03e+06 2.29e+05 O.OOe+OO 3.52e+03 BA-141 l.42e-01 1. 06e-04 O.OOe+OO 9.84e-05 3.29e+03 7.46e-04 O.OOe+OO 4.74e-03 BA-142 3.70e-02 3.70e-05 O.OOe+OO 3.14e-05 l.9le+03 4.79e-10 O.OOe+OO 2.27e-03 LA-140 4.79e+02 2.36e+02 O.OOe+OO O.OOe+OO 2.14e+05 4.87e+05 O.OOe+OO 6.26e+Ol LA-142 9.60e-01 4.25e-01 O.OOe+OO O.OOe+OO 1.02e+04 1.20e+04 O.OOe+OO 1.06e-01 CE-141 2.84e+04 1. 90e+04 O.OOe+OO a.a8e+03 6.14e+05 1.26e+05 O.OOe+OO 2.17e+03 CE-143 2.66e+02 1. 94e+02 O.OOe+OO 8.64e+01 1.30e+05 2.55e+05 O.OOe+OO 2.16e+Ol CE-144 4.89e+06 2.02e+06 O.OOe+OO 1.2le+06 1.34e+07 8.64e+05 O.OOe+OO 2.62e+05 PR-143 1.34e+04 5.31e+03 O.OOe+OO 3.09e+03 4.83e+05 2.14e+05 O.OOe+OO 6.62e+02 PR-144 4.30e-02 1. 76e-02 O.OOe+OO l.Ole-02 1.75e+03 2.35e-04 O.OOe+OO 2.18e-03 ND-147 7.86e+03 8.56e+03 O.OOe+OO 5.02e+03 3. 72e+05 1. 82e+05 O.OOe+OO 5.13e+02 W-187 1.20e+Ol 9.76e+OO O.OOe+OO O.OOe+OO 4.74e+04 1. 77e+05 O.OOe+OO 3.43e+OO NP-239 3.38e+02 2.88e+02 O.OOe+OO 1.00e+02 6.49e+04 l.32e+05 O.OOe+OO 1.77e+Ol PU-239 1.38e+l0 8.96e+09 O.OOe+OO 2.75e+09 2.34e+09 3.50e+05 O.OOe+OO 6.44e+08 U-235 1.14e+08 O.OOe+OO O.OOe+OO 2.67e+07 6.75e+08 4.10e+05 O.OOe+OO 6.94e+06 Page 18 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 38 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/mA3))

Deposition Pathways: (mA2 * (mrem/yr)/(µCi/sec)

AgeGroup: TEEN Pathway: Grs/Cow/Meat (CMEAT)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 0.00e+OO 1.94e+02 l.94e+02 1.94e+02 l.94e+02 l.94e+02 O.OOe+OO 1.94e+02 C-14 2.04e+08 4.08e+07 4.08e+07 4.08e+07 4.08e+07 4.08e+07 O.OOe+OO 4.08e+07 NA-24 l.12e-03 l.12e-03 1.12e-03 l.12e-03 l.12e-03 1.12e-03 O.OOe+OO 1.12e-03 P-32 6.13e+08 2.44e+08 O.OOe+OO O.OOe+OO O.OOe+OO 3.3le+08 O.OOe+OO l.53e+08 CR-51 O.OOe+OO O.OOe+OO 3.13e+03 l.24e+03 8.05e+03 9.48e+05 O.OOe+OO 5.64e+03 MN-54 O.OOe+OO 7.00e+06 O.OOe+OO 2.09e+06 O.OOe+OO 1.44e+07 O.OOe+OO l.39e+06 MN-56 O.OOe+OO l.47e-53 O.OOe+OO l.86e-53 O.OOe+OO 9.67e-52 O.OOe+OO 2.61e-54 FE-55 2.38e+08 l.69e+08 O.OOe+OO O.OOe+OO 1.07e+08 7.31e+07 O.OOe+OO 3.94e+07 FE-59 2.12e+08 4.96e+08 O.OOe+OO O.OOe+OO l.56e+08 l.17e+09 0.00e+OO 1. 9le+08 C0-58 O.OOe+OO 1.41e+07 O.OOe+OO O.OOe+OO O.OOe+OO 1.94e+08 O.OOe+OO 3.24e+07 C0-60 O.OOe+OO 5.84e+07 O.OOe+OO O.OOe+OO O.OOe+OO 7.60e+08 O.OOe+OO l.31e+08 NI-63 1.52e+l0 l.07e+09 O.OOe+OO O.OOe+OO O.OOe+OO l.71e+08 O.OOe+OO 5.15e+08 NI-65 2.26e-52 2.88e-53 O.OOe+OO O.OOe+OO O.OOe+OO 1.56e-51 O.OOe+OO 1.31e-53 CU-64 O.OOe+OO 2.30e-07 O.OOe+OO 5.81e-07 O.OOe+OO l.78e-05 O.OOe+OO l.08e-07 ZN-65 2.50e+08 8.69e+08 O.OOe+OO 5.56e+08 O.OOe+OO 3.68e+08 O.OOe+OO 4.05e+08 RB-86 O.OOe+OO 4.07e+08 O.OOe+OO O.OOe+OO O.OOe+OO 6.02e+07 O.OOe+OO l.9le+08 SR-89 2.55e+08 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 3. 03e+07 O.OOe+OO 7.29e+06 SR-90 8.05e+09 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.26e+08 O.OOe+OO l.99e+09 SR-91 1.34e-10 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 6.08e-10 O.OOe+OO 5.33e-12 SR-92 l.17e-49 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.98e-48 O.OOe+OO 4.98e-51 Y-90 9.12e+Ol O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 7.53e+05 O.OOe+OO 2.46e+OO Y-91 9.54e+05 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 3.9le+08 O.OOe+OO 2.56e+04 Y-92 l.46e-39 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 4.0le-35 O.OOe+OO 4 .22e-41 Y-93 4.14e-12 O.OOe+OO o;ooe+oo O.OOe+OO O.OOe+OO 1.27e-07 O.OOe+OO 1.14e-13 ZR-95 1.50e+06 4.73e+05 O.OOe+OO 6.96e+05 0.00e+OO l.09e+09 O.OOe+OO 3.26e+05 ZR-97 1.77e-05 3.SOe-06 O.OOe+OO 5.31e-06 O.OOe+OO 9.49e-01 O.OOe+OO 1. 61e-06 NB-95 l.80e+06 9.96e+05 O.OOe+OO 9.65e+05 O.OOe+OO 4.26e+09 O.OOe+OO 5.48e+05 M0-99 O.OOe+OO 8.33e+04 O.OOe+OO l.9le+05 O.OOe+OO 1.49e+05 O.OOe+OO 1.59e+04 TC-99M 3.81e-21 1.06e-20 O.OOe+OO 1. 58e-19 5.90e-21 6.98e-18 O.OOe+OO l.38e-19 RU-103 8.57e+07 O.OOe+OO O.OOe+OO 3.02e+08 O.OOe+OO 7.16e+09 O.OOe+OO 3.66e+07 RU-105 5.35e-28 O.OOe+OO O.OOe+OO 6.75e-27 O.OOe+OO 4.32e-25 O.OOe+OO 2.08e-28 RU-106 2.36e+09 O.OOe+OO O.OOe+OO 4.55e+09 O.OOe+OO 1.13e+ll O.OOe+OO 2.97e+08 AG-110M 5.06e+06 4.79e+06 O.OOe+OO 9.13e+06 O.OOe+OO 1. 35e+09 O.OOe+OO 2.9le+06 TE-125M 3.03e+08 1.09e+08 8.47e+07 O.OOe+OO O.OOe+OO 8.95e+08 0.00e+OO 4.05e+07 TE-127 l.89e-10 6.70e-11 l.30e-10 7.66e-10 O.OOe+OO 1. 46e-08 O.OOe+OO 4. 07e-11 TE-127M 9.42e+08 3.348+08 2;24e+08 3.82e+09 O.OOe+OO 2.35e+09 O.OOe+OO l.12e+08 TE-129M 9.51e+08 3.53e+08 3.07e+08 3.98e+09 O.OOe+OO 3.57e+09 O.OOe+OO 1. 50e+08 TE-131M 3.82e+02 1.83e+02 2.75e+02 1.91e+03 O.OOe+OO 1. 47e+04 O.OOe+OO l.53e+02 Page 19 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 39 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/m"3))

Deposition Pathways: (m"2 * (mrem/yr)/(µCi/sec)

AgeGroup: TEEN Pathway: Grs/Cow/Meat (CMEAT)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB TE-132 l.17e+06 7.40e+05 7.80e+05 7.10e+06 O.OOe+OO 2.34e+07 O.OOe+OO 6.97e+05 I-130 8.Ble-07 2.SSe-06 2.08e-04 3. 92e-06 O.OOe+OO l.96e-06 O.OOe+OO 1.02e-06 I-131 4.47e+06 6.26e+06 1. 83e+09 1.08e+07 O.OOe+OO 1.24e+06 O.OOe+OO 3.36e+06 I-132 3.45e-59 9.03e-59 3.04e-57 1.42e-58 O.OOe+OO 3.93e-59 O.OOe+OO 3.24e-59 I-133 1.56e-01 2.65e-01 3.70e+Ol 4.65e-01 O.OOe+OO 2.00e-01 O.OOe+OO 8.08e-02 I-135 1.93e-17 4.97e-17 3.20e-15 7.84e-17 O.OOe+OO 5.50e-17 O.OOe+OO 1.84e-17 CS-134 5.23e+OB 1. 23e+09 O.OOe+OO 3.9le+08 1.49e+08 l.53e+07 O.OOe+OO 5.7le+OB CS-136 9.41e+06 3.70e+07 O.OOe+OO 2.02e+07 3.18e+06 2.98e+06 O.OOe+OO 2.49e+07 CS-137 7.24e+08 9.63e+08 0.00e+OO 3.28e+08 1.27e+08 1.37e+07 O.OOe+OO 3.36e+08 BA-140 2.38e+07 2.92e+04 O.OOe+OO 9.88e+03 1.96e+04 3.67e+07 O.OOe+OO l.53e+06 LA-140 3.09e-02 1.52e-02 O.OOe+OO O.OOe+OO O.OOe+OO 8.71e+02 O.OOe+OO 4.04e-03 LA-142 3.79e-92 1. 68e-92 O.OOe+OO O.OOe+OO O.OOe+OO 5.13e-88 O.OOe+OO 4.19e-93 CE-141 1.18e+04 7.88e+03 O.OOe+OO 3.7le+03 O.OOe+OO 2.25e+07 O.OOe+OO 9.05e+02 CE-143 1. 71e-02 1.25e+Ol O.OOe+OO 5.59e-03 O.OOe+OO 3.75e+02 O.OOe+OO l.39e-03 CE-144 l.23e+06 5.08e+05 O.OOe+OO 3.04e+05 O.OOe+OO 3.09e+08 O.OOe+OO 6.60e+04 PR-143 1.77e+04 7.05e+03 O.OOe+OO 4.10e+03 O.OOe+OO 5.8le+07 O.OOe+OO 8.79e+02 ND-147 6.24e+03 6.79e+03 O.OOe+OO 3.99e+03 O.OOe+OO 2.45e+07 O.OOe+OO 4.07e+02 W-187 1. 76e-02 l.44e-02 O.OOe+OO O.OOe+OO O.OOe+OO 3.89e+OO O.OOe+OO 5.04e-03 NP-239 2.28e-01 2.15e-02 O.OOe+OO 6.76e-02 O.OOe+OO 3.46e+03 O.OOe+OO l.20e-02 PU-239 l.74e+07 2. lle+06 O.OOe+OO l.94e+06 O.OOe+OO 1.60e+06 O.OOe+OO 4.56e+05 U-235 6.28e+08 O.OOe+OO O.OOe+OO 1.47e+08 O.OOe+OO 4.56e+07 O.OOe+OO 3.82e+07 Page 20 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 40 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/m"3))

Deposition Pathways: (m"2 * (mrem/yr)/(µCi/sec)

AgeGroup: TEEN Pathway: Grs/Cow/Milk (CMILK)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 O.OOe+OO 9.94e+02 9.94e+02 9.94e+02 9.94e+02 9.94e+02 O.OOe+OO 9.94e+02 C-14 4.*B6e+OB 9. 72e+07 9. 72e+07 9.72e+07 9.72e+07 9. 72e+07 O.OOe+OO 9. 72e+07 NA-24 4.27e+06 4.27e+06 4.27e+06 4.27e+06 4.27e+06 4.27e+06 O.OOe+OO 4.27e+06 P-32 4.90e+09 1. 96e+09 O.OOe+OO O.OOe+OO O.OOe+OO 2.65e+09 O.OOe+OO l.22e+09 CR-51 O.OOe+OO O.OOe+OO 2.77e+04 1.09e+04 7.13e+04 B.39e+06 O.OOe+OO 4.99e+04 MN-54 O.OOe+OO 1.40e+07 O.OOe+OO 4.18e+06 O.OOe+OO 2.88e+07 O.OOe+OO 2.78e+06 MN-56 O.OOe+OO 7.49e-03 O.OOe+OO 9.48e-03 O.OOe+OO 4.93e-01 O.OOe+OO 1.33e-03 FE-55 4 -.45e+07 3.16e+07 O.OOe+OO O.OOe+OO 2.00e+07 l.37e+07 O.OOe+OO 7.36e+06 FE-59 5.18e+07 l.2le+08 O.OOe+OO O.OOe+OO 3.82e+07 2.86e+08 O.OOe+OO 4.67e+07 C0-58 O.OOe+OO 7.94e+06 O.OOe+OO O.OOe+OO O.OOe+OO 1. 09e+08 O.OOe+OO l.83e+07 C0-60 O.OOe+OO 2.78e+07 O.OOe+OO O.OOe+OO O.OOe-i-00 3.62e+08 O.OOe+OO 6.26e+07 NI-63 l.18e+10 8.35e+08 O.OOe+OO O.OOe+OO O.OOe+OO l.33e+08 O.OOe+OO 4.0le+08 NI-65 6*. 90e-01 8.81e-02 O.OOe+OO O.OOe+OO O.OOe+OO 4.78e+OO O.OOe+OO 4.0le-02 CU-64 O.OOe+OO 4.26e+04 O.OOe+OO l.08e+05 O.OOe+OO 3.31e+06 O.OOe+OO 2.0le+04 ZN-65 2.lle+09 7.32e+09 O.OOe+OO 4.68e+09 O.OOe+OO 3.10e+09 O.OOe+OO 3.41e+09 ZN-69 4.05e-12 7. 71e-12 O.OOe+OO 5.04e-12 O.OOe+OO 1. 42e-11 O.OOe+OO 5.39e-13 BR-83 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1. 83e-01 BR-84 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 3.14e-23 RB-86 O.OOe+OO 4.73e+09 O.OOe+OO O.OOe+OO O.OOe+OO 7.00e+08 O.OOe+OO 2.22e+09 RB-88 O.OOe+OO 4.53e-45 O.OOe+OO O.OOe+OO O.OOe+OO 3.88e-52 O.OOe+OO 2.42e-45 RB-89 O.OOe+OO l.17e-53 O.OOe+OO O.OOe+OO O.OOe+OO 1. 79e-62 O.OOe+OO 8.28e-54 SR-89 2.68e+09 O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO 3.19e+08 O.OOe+OO 7.66e+07 SR-90 6.61e+10 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.86e+09 O.OOe+OO 1. 63e+l0 SR-91 5.34e+04 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.42e+05 O.OOe+OO 2.12e+03 SR-92 9.09e-01 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.32e+Ol O.OOe+OO 3.88e-02 Y-90 1.30e+02 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.08e+06 O.OOe+OO 3.51e+OO Y-91 1.58e+04 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 6.48e+06 O.OOe+OO 4.24e+02 Y-91M l.16e-19 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 5.46e-18 O.OOe+OO 4.42e-21 Y-92 1.04e-04 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.87e+OO O.OOe+OO 3.02e-06 Y-93 4.14e-01 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.26e+04 O.OOe+OO 1.14e-02 ZR-95 l.65e+03 5.2le+02 O.OOe+OO 7.65e+02 O.OOe+OO l.20e+06 O.OOe+OO 3.58e+02 ZR-97 7.9le-01 1.57e-Ol O.OOe+OO 2.37e-01 O.OOe+OO 4.24e+04 O.OOe+OO 7.21e-02 NB-95 1.4le+05 7.81e+04 0.00e+OO 7.57e+04 O.OOe+OO 3.34e+08 O.OOe+OO 4.30e+04 M0-99 O.OOe+OO 4.48e+07 O.OOe+OO l.02e+08 O.OOe+OO 8.02e+07 O.OOe+OO 8.54e+06 TC-99M 5.80e+OO 1.62e+Ol 0.00e+OO 2.4le+02 8.99e+OO l.06e+04 O.OOe+OO 2.10e+02 TC-101 5.75e-60 8.18e-60 O.OOe+OO 1. 48e-58 4.98e-60 1. 40e-66 O.OOe+OO 8.03e-59 RU-103 1.81e+03 O.OOe+OO O.OOe+OO 6.38e+03 O.OOe+OO 1.51e+05 O.OOe+OO 7.74e+02 RU-105 1. 58e-03 O.OOe+OO O.OOe+OO 1. 99e-02 O.OOe+OO 1.28e+OO O.OOe+OO 6.14e-04 Page 21of44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 41of65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/m"3))

Deposition Pathways: (m"2 * (mrem/yr)/(µCi/sec)

AgeGroup: TEEN Pathway: Grs/Cow/Milk (CMILK)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-106 3.75e+04 O.OOe+OO O.OOe+OO 7.24e+04 O.OOe+OO 1.80e+06 O.OOe+OO 4.73e+03 AG-llOM 9.63e+07 9.lle+07 O.OOe+OO 1. 74e+08 O.OOe+OO 2.56e+10 O.OOe+OO 5.54e+07 TE-125M 3.00e+07 1.08e+07 8.39e+06 O.OOe+OO O.OOe+OO 8.86e+07 O.OOe+OO 4.02e+06 TE-127 l.22e+03 4.3le+02 8.39e+02 4.93e+03 O.OOe+OO 9.39e+04 O.OOe+OO 2.62e+02 TE-127M 8.44e+07 2.99e+07 2.0le+07 3.42e+OB O.OOe+OO 2.lOe+OB O.OOe+OO 1.00e+07 TE-129 5.41e-10 2.02e-10 3.86e-10 2.27e-09 O.OOe+OO 2.96e-09 O.OOe+OO 1.32e-10 TE-129M 1.10e+08 4.09e+07 3.55e+07 4.61e+08 O.OOe+OO 4 .13e+08 O.OOe+OO 1. 74e+07 TE-131 7.35e-33 3.03e-33 5.66e-33 3.2le-32 O.OOe+OO 6.03e-34 O.OOe+OO 2.30e-33 TE-131M 6.58e+05 3.16e+05 4.75e+05 3.29e+06 O.OOe+OO 2.53e+07 O.OOe+OO 2. 63e+05 TE-132 4.30e+06 2.72e+06 2.87e+06 2.6le+07 O.OOe+OO 8.61e+07 O.OOe+OO 2.56e+06 I-130 3. 71e+05 1. 07e+06 8.75e+07 l.65e+06 O.OOe+OO 8.24e+05 O.OOe+OO 4.28e+05 I-131 2.69e+08 3.76e+OB 1.lOe+ll 6.48e+OB O.OOe+OO 7.44e+07 O.OOe+OO 2.02e+OB I-132 1. 49e-Ol 3.89e-Ol 1.3le+Ol 6.12e-01 0. OOe+OO. 1. 69e-01 O.OOe+OO l.40e-01 I-133 3.54e+06 6.0le+06 8.39e+OB 1.05e+07 0. 00.e+OO 4.55e+06 O.OOe+OO 1.83e+06 I-134 1. 89e-12 5.00e-12 8. 34e-ll 7.89e-12 O.OOe+OO 6.59e-14 O.OOe+OO l.BOe-12 I-135 l.15e+04 2.96e+04 1.90e+06 4.67e+04 O.OOe+OO 3.28e+04 O.OOe+OO 1.10e+04 CS-134 9.82e+09 2.3le+l0 O.OOe+OO 7.34e+09 i.80e:t-09 2.87e+08 O.OOe+OO 1. 07e+10 CS-136 4.48e+08 l.76e+09 Q-. OOe+OO 9.60e+08 l.Sle+OB 1. 42e+08 O.OOe+OO l.19e+09 CS-137 l.34e+10 1.78e+l0 O.OOe+OO 6.06e+09 2.35e+09 2.53e+08 O.OOe+OO 6.20e+09 CS-138 1.79e-23 3.43e-23 O.OOe+OO 2.53e-23 2.95e-24 l.56e-26 O.OOe+OO 1. 72e-23 BA-139 B.45e-08 5.94e-ll O.OOe+OO 5. 60e-ll 4.lOe-11 7.53e-07 O.OOe+OO 2.46e-09 BA-140 4.85e+07 5.95e+04 O.OOe+OO 2.02e+04 4.00e+04 7.49e+07 O.OOe+OO 3.13e+06 BA-141 8.74e-46 6.53e-49 O.OOe+OO 6.06e-49 4.47e-49 l.86e-51 O.OOe+OO 2.92e-47 BA-142 6.22e-80 6.22e-83 O.OOe+OO 5.26e-83 4.14e-83 1. 91e-91 O.OOe+OO 3.83e-81 LA-140 8. lle+OO 3.99e+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.29e+05 O.OOe+OO l.06e+OO LA-142 3.45e-ll 1. 53e-ll O.OOe+OO O.OOe+OO O.OOe+OO 4.67e-07 O.OOe+OO 3.82e-12 CE-141 8.88e+03 5.93e+03 O.OOe+OO 2.79e+03 O.OOe+OO 1.70e+07 O.OOe+OO 6.8le+02 CE-143 7.65e+Ol 5.57e+04 O.OOe+OO 2.SOe+Ol O.OOe+OO l.67e+06 O.OOe+OO 6.22e+OO CE-144 6.58e+05 2. 72e+05 O.OOe+OO 1.63e+05 O.OOe+OO l.66e+OB O.OOe+OO 3.54e+04 PR-143 2.90e+02 l.16e+02 O.OOe+OO 6.73e+Ol O.OOe+OO 9.55e+05 O.OOe+OO 1.44e+Ol PR-144 1. 27e-53 5.19e-54 O.OOe+OO 2.98e-54 O.OOe+OO 1. 40e-56 O.OOe+OO 6.43e-55 ND-147 -l.81e+02 1.97e+02 O.OOe+OO 1.16e+02 O.OOe+OO 7. lle+OS O.OOe+OO 1.18e+Ol W-187 1.19e+04 9.73e+03 O.OOe+OO O.OOe+OO O.OOe+OO 2.63e+06 O.OOe+OO 3.41e+03 NP-239 7.02e+OO 6.62e-01 O.OOe+OO 2.08e+OO O.OOe+OO 1.06e+OS O.OOe+OO 3.67e-01 PU-239 3.82e+07 4.63e+06 O.OOe+OO 4.27e+06 O.OOe+OO 3.52e+06 O.OOe+OO 1.00e+06 U-235 5.6Be+09 O.OOe+OO O.OOe+OO 1. 33e+09 O.OOe+OO 4.13e+08 O.OOe+OO 3.46e+OB Page 22 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 42 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES

{Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/m"3))

Deposition Pathways: (m"2 * (mrem/yr)/(µCi/sec)

AgeGroup: TEEN Pathway: Vegetation (VEG)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 O.OOe+OO 2.59e+03 2.59e+03 2.59e+03 2.59e+03 2.59e+03 O.OOe+OO 2.59e+03 C-14 3.69e+08 7.38e+07 7.38e+07 7~38e+07 7.38e+07 7.38e+07 O.OOe+OO 7.38e+07 NA-24 2.38e+05 2.38e+05 2.38e+05 2.38e+05 2.38e+05 2.38e+05 O.OOe+OO 2.38e+05 P-32 2.50e+08 9.97e+07 O.OOe+OO O.OOe+OO O.OOe+OO l.35e+08 O.OOe+OO 6.24e+07 CR-51 O.OOe+OO O.OOe+OO 3.43e+04 l.35e+04 8.80e+04 l.04e+07 O.OOe+OO 6.17e+04 MN-54 O.OOe+OO 4.54e+08 0.00e+OO l.36e+08 O.OOe+OO 9.32e+08 O.OOe+OO 9.0le+07 MN-56 O.OOe+OO l.39e+Ol O.OOe+OO l.76e+Ol O.OOe+OO 9.18e+02 O.OOe+OO 2.48e+OO FE-55 3.26e+08 2.31e+08 O.OOe+OO O.OOe+OO l.47e+08 1.00e+08 O.OOe+OO 5.39e+07 FE-59 1.79e+08 4.19e+08 O.OOe+OO O.OOe+OO l.32e+08 9.90e+08 O.OOe+OO 1.62e+08 C0-58 O.OOe+OO 4.36e+07 O.OOe+OO O.OOe+OO O.OOe+OO 6.0le+08 O.OOe+OO 1.00e+08 C0-60 O.OOe+OO 2.49e+08 O.OOe+OO O.OOe+OO O.OOe+OO 3.24e+09 O.OOe+OO 5.60e+08 NI-63 1.61e+l0 l.14e+09 O.OOe+OO O.OOe+OO O.OOe+OO 1.81e+08 O.OOe+OO 5.45e+08 NI-65 5.56e+Ol 7.lle+OO O.OOe+OO O.OOe+OO O.OOe+OO 3.85e+02 O.OOe+OO 3.24e+OO CU-64 O.OOe+OO 8.29e+03 0-. OOe+OO 2.10e+04 O.OOe+OO 6.43e+05 O.OOe+OO 3.90e+03 ZN-65 4.24e+08 l.47e+09 O.OOe+OO 9.42e+08 O.OOe+OO 6.23e+08 O.OOe+OO 6.87e+08 ZN-69 4.75e-06 9.06e-06 O.OOe+OO 5.92e-06 O.OOe+OO 1. 67e-05 O.OOe+OO 6.34e-07 BR-83 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO o.ooe+oo 2.82e+OO BR-84 0.00e+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO 1. 96e-11 RB-86 O.OOe+OO 2.74e+08 O.OOe+OO O.OOe+OO O.OOe+OO 4.05e+07 O.OOe+OO 1. 29e+08 RB-88 O.OOe+OO 2.47e-22 O.OOe+OO O.OOe+OO O.OOe+OO 2.12e-29 O.OOe+OO l.32e-22 RB-89 O.OOe+OO 9.33e-27 O.OOe+OO O.OOe+OO O.OOe+OO l.*43e-35 O.OOe+OO 6.60e-27 SR-89 1.51~+10 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.80e+09 O.OOe+OO 4.34e+08 SR-90 7.51e+11 O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO 2. lle+lO O.OOe+OO 1. 85e+ll

SR-91 2.83e+05 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.28e+06 O.OOe+OO l.12e+04 SR-92 3.87e+Ci2 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 9.85e+03 O.OOe+OO 1.65e+Ol Y-90 1.24e+04 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO l.02e+08 O.OOe+OO 3.34e+02 Y-91 7.83e+06 O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO 3.2le+09 O.OOe+OO 2.10e+05 Y-91M 4.45e-09 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.lOe-07 O.OOe+OO 1. 70e-10 Y-92 B.43e-01 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.3le+04 O.OOe+OO 2.44e-02 Y-93 1.58e+02 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 4.82e+06 O.OOe+OO 4.33e+OO ZR-95 1. 72e+06 5.43e+05 O.OOe+OO 7.98e+05 O.OOe+OO 1.25e+09 O.OOe+OO 3.73e+05 ZR-97 3.lle+02 6.15e+Ol O.OOe+OO 9.33e+Ol O.OOe+OO 1.67e+07 O.OOe+OO 2.83e+Ol NB-95 1. 92e+05 1. 07e+05 0.00e+OO l.03e+05 O.OOe+OO 4.56e+08 o. oo'e+oo 5.87e+04 M0-99 O.OOe+OO 5.64e+06 O.OOe+OO l.29e+07 O.OOe+OO l.Ole+07 O.OOe+OO l.08e+06 TC-99M 2.70e+OO 7.54e+OO o.ooe+oo 1.12e+02 4.19e+OO 4.95e+03 O.OOe+OO 9. 77e+Ol TC-101 5.60e-31 7. 97e-31 0.00e+OO 1. 44e-29 4.86e-31 1. 36e-37 O.OOe+OO 7.83e-30 RU-103 6.82e+06 O.OOe+OO O.OOe+OO 2.40e+07 O.OOe+OO 5.70e+08 O.OOe+OO 2. 9le+06 RU-105 4.92e+Ol O.OOe+OO O.OOe+OO 6.2le+02 O.OOe+OO 3.97e+04 O.OOe+OO l.9le+Ol Page 23 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 43of65 DOSE FACTORS: RADIONUCLIDES OTHE.R THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium lngestiori: (mrem/yr)/(µCi/m"3))

Deposition Pathways: (m"2 * (mrem/yr)/(µCi/sec)

AgeGroup: TEEN Pathway: Vegetation (VEG)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-106 3.10e+08 O.OOe+OO O.OOe+OO 5.97e+08 O.OOe+OO 1.48e+10 O.OOe+OO 3.90e+07 AG-llOM 1. 52e+07 l.43e+07 O.OOe+OO 2.74e+07 O.OOe+OO 4.03e+09 O.OOe+OO 8. 72e+06 TE-125M 1.48e+08 5.34e+07 4.14e+07 O.OOe+OO O.OOe+OO 4.37e+08 O.OOe+OO 1.98e+07 TE-127 5.30e+03 1.88e+03 3.65e+03 2.15e+04 O.OOe+OO 4.09e+05 O.OOe+OO l.14e+03 TE-127M 5.5le+08 1. 96e+08 1.31e+08 2.24e+09 O.OOe+OO 1.37e+09 O.OOe+OO 6.56e+07 TE-129 6.70e-04 2.50e-04 4.79e-04 2.81e-03 O.OOe+OO 3.66e-03 O.OOe+OO 1.63e-04 TE-129M 3.62e+08 1. 34e+08 1.17e+08 l.5le+09 O.OOe+OO 1.36e+09 0.00e+OO 5.72e+07 TE-131 1.17e-15 4.82e-16 9.0le-16 5.lle-15 O.OOe+OO 9.60e-17 O.OOe+OO 3.66e-16 TE-131M 8.42e+05 4.04e+05 6.08e+05 4.21e+06 O.OOe+OO 3.24e+07 O.OOe+OO 3.37e+05 TE-132 3.9le+06 2.47e+06 2.6le+06 2.37e+07 O.OOe+OO 7.83e+07 O.OOe+OO 2.33e+06 I-130 1. 74e+05 5.05e+05 4. llei+07 7.77e+05 o,ooe+oo 3.88e+05 O.OOe+OO 2.02e+05 I-131 3.84e+07 5.38e+07 1.57e+10 9.26e+07 O.OOe+OO l.06e+07 O.OOe+OO 2.89e+07 I-132 2.5le+Ol 6.58e+Ol 2.22e+03 l.04e+02 O.OOe+OO 2.87e+Ol O.OOe+OO 2.36e+Ol I-133 9.65e+05 1. 64e+06 2.29e+08 2.87e+06 O.OOe+OO 1.24e+06 0.00e+OO 5.00e+05 I-134 4.0le-05 1. 06e-04 l.77e-03 1.68e-04 O.OOe+OO 1. 40e-06 O.OOe+OO 3.82e-05 I-135 1.74e+04 4.48e+04 2.88e+06 7.08e+04 O.OOe+OO 4.97e+04 O.OOe+OO l.66e+04 CS-134 7.10e+09 1.67e+l0 O.OOe+OO 5.3le+09 2.03e+09 2.08e+08 O.OOe+OO 7.75e+09 CS-136 4.37e+07 1. 72e+08 O.OOe+OO 9.36e+07 1. 48e+07 1. 38e+07 O.OOe+OO 1.16e+08 CS-137 1.0le+lO l.35e+l0 O.OOe+OO 4.59e+09 1.78e+09 l.92e+08 O.OOe+OO 4.70e+09 CS-138 3.15e-11 6. OSe-11 O.OOe+OO 4.47e-11 5.20e-12 2.74e-14 0.00e+OO 3. 02e-ll BA-139 2.55e-02 1. 79e-05 O.OOe+OO 1.69e-05 1. 24e-05 2.27e-01 O.OOe+OO 7.42e-04 BA-140 1.38e+08 l.69e+05 O.OOe+OO 5.74e+04 l.14e+05 2.13e+08 O.OOe+OO 8.89e+06 BA-141 8.46e-22 6.. 3le-25 O.OOe+OO 5.86e-25 4.32e-25 1.80e-27 O.OOe+OO 2.82e-23 BA-142 3.65e-39 3.65e-42 O.OOe+OO 3.08e-42 2.43e-42 1.12e-50 O.OOe+OO 2.24e-40 LA-140 l.80e+03 8.86e+02 O.OOe+OO O.OOe+OO O.OOe+OO 5.09e+07 O.OOe+OO 2.36e+02 LA-142 1. 77e-04 7.86e-05 O.OOe+OO O.OOe+OO O.OOe+OO 2.39e+OO 0.00e+OO 1. 96e-05 CE-141 2.83e+05 l.89e+05 O.OOe+OO 8.89e+04 O.OOe+OO 5.40e+08 0.00e+OO 2.17e+04 CE-143 9.3le+02 6.77e+05 O.OOe+OO 3.04e+02 O.OOe+OO 2.04e+07 O.OOe+OO 7.57e+Ol CE-144 5.27e+07 2.18e+07 O.OOe+OO 1.30e+07 O.OOe+OO 1.33e+l0 0.00e+OO 2.83e+06 PR-143 7.00e+04 2.79e+04 O.OOe+OO l.62e+04 O.OOe+OO 2.30e+08 0.00e+OO 3.48e+03 PR-144 2.24e-26 9.18e-27 O.OOe+OO 5.27e-27 O.OOe+OO 2.47e-29 O.OOe+OO l.14e-27 ND-147 3.62e+04 3.94e+04 O.OOe+OO 2.3le+04 O.OOe+OO 1. 42e+08 O.OOe+OO 2.36e+03 W-187 3.53e+04 2.88e+04 O.OOe+OO O.OOe+OO O.OOe+OO 7.7Be+06 O.OOe+OO l.Ole+04 NP-239 1.38e+03 1. 3le+02 O.OOe+OO 4.10e+02 O.OOe+OO 2.10e+07 0.00e+OO 7.25e+Ol PU-239 6.95e+l0 8.44e+09 O.OOe+OO 7.79e+09 O.OOe+OO 6.42e+09 0.00e+OO l.83e+09 U-235 l.04e+ll O.OOe+OO O.OOe+OO 2.43e+10 O.OOe+OO 7.53e+09 0.00e+00*6.31e+09 Page 24 of 44

For Information Only Attachment C ODCM-QA-004

...... Revision 6 Page 44 of65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/m113))

Deposition Pathways: (m 112 * (mrem/yr)/(µCi/sec)

AgeGroup: CHILD Pathway: Grs/Goat/Milk (GMILK)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 O.OOe+OO 3.20e+03 3.20e+03 3.20e+03 3.20e+03 3.20e+03 O.OOe+OO 3.20e+03 C-14 1 . .20e+09 2.39e+08 2.39e+08 2.39e+08 2.39e+08 2.39e+08 O.OOe+OO 2.39e+08 NA-24 1. 07e+06 1. 07e+06 l.07e+06 l.07e+06 1.07e+06 1. 07e+06 O.OOe+OO 1.07e+06 P-32 1.45e+l0 4.37e+09 O.OOe+OO O.OOe+OO O.OOe+OO 2.58e+09 O.OOe+OO 3.60e+09 CR-51 O.OOe+OO O.OOe+OO 6.78e+03 l.85e+03 1.24e+04 6.48e+05 O.OOe+OO 1.22e+04 MN-54 O.OOe+OO 2.52e+06 O.OOe+OO 7.06e+05 O.OOe+OO 2.lle+06 O.OOe+OO 6.70e+05 MN-56 O.OOe+cio 1. 57e-03 O.OOe+OO 1.90e-03 O.OOe+OO 2.27e-Ol O.OOe+OO 3.54e-04 FE-55 l.45e+06 7.7le+05 O.OOe+OO O.OOe+OO 4.36e+05 l.43e+05 O.OOe+OO 2.39e+05 FE-59 1.56e+06 2.53e+06 O.OOe+OO O.OOe+OO 7.33e+05 2.63e+06 O.OOe+OO 1. 26e+06 C0-58 O.OOe+OO l.46e+06 O.OOe+OO O.OOe+OO O.OOe+OO 8.49e+06 O.OOe+OO 4.45e+06 C0-60 O.OOe+OO 5.18e+06 O.OOe+OO O.OOe+OO O.OOe+OO 2.87e+07 O.OOe+OO l.53e+07 NI-63 3.56e+09 1.91e+08 O.OOe+OO O.OOe+OO O.OOe+OO l.28e+07 O.OOe+OO l.21e+08 NI-65 2.02e-01 1.91e-02 O.OOe+OO O.OOe+OO O.OOe+OO 2.33e+OO O.OOe+OO l.lle-02 CU-64 O.OOe+OO 8.35e+03 O.OOe+OO 2.02e+04 O.OOe+OO 3.92e+05 O.OOe+OO 5.04e+03 ZN-65 4.96e+08 1.32e+09 O.OOe+OO 8.33e+08 O.OOe+OO 2.32e+08 O.OOe+OO 8.22e+08 ZN-69 l.19e-12 1. 73e-12 O.OOe+OO l.05e-12 O.OOe+OO 1. 09e-10 O.OOe+OO 1. 59e-13 BR-83 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 5.38e-02 BR-84 O.OOe+OO O.OOe+OO O.OOe+OO 0 .. OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 8.51e-24 RB-86 O.OOe+OO 1.05e+09 O.OOe+OO O.OOe+OO O.OOe+OO 6.77e+07 O.OOe+OO 6.47e+08 RB-88 O.OOe+OO 1.00e-45 O.OOe+OO O.OOe+OO O.OOe+OO 4.91e-47 O.OOe+OO 6.95e-46 RB-89 O.OOe+OO 2.46e-54 O.OOe+OO O.OOe+OO O.OOe+OO 2.15e-56 O.OOe+OO 2.19e-54 SR-89 1. 39e+l0 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 5.38e+08 O.OOe+OO 3.97e+08 SR-90 2.35e+ll O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 3.16e+09 0.00e+OO 5.95e+10 SR-91 2.75e+05 O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO 6.08e+05 O.OOe+OO l.04e+04 SR-92 4.66e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 8.83e+Ol O.OOe+OO l.87e-01 Y-90 3.87e+Ol 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.10e+05 O.OOe+OO 1.04e+OO Y-91 4.68e+03 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 6.24e+05 O.OOe+OO 1.25e+02 Y-91M 3.39e-20 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 6.65e-17 O.OOe+OO 1. 23e-21 Y-92 3.08e-05 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 8.89e-01 O.OOe+OO 8.80e-07 Y-93 l.22e-01 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO l.82e+03 O.OOe+OO 3.35e-03 ZR-95 4.60e+02 l.Ole+02 O.OOe+OO l.45e+02 O.OOe+OO l.05e+05 O.OOe+OO 9.00e+Ol ZR-97 2.31e-01 3.34e-02 O.OOe+OO 4.79e-02 O.OOe+OO 5.05e+03 O.OOe+OO l.97e-02 NB-95 3.82e+04 l.49e+04 O.OOe+OO 1.40e+04 O.OOe+OO 2.75e+07 O.OOe+OO l.06e+04 M0-99 O.OOe+OO 9.77e+06 O.OOe+OO 2.09e+07 O.OOe+OO 8.08e+06 O.OOe+OO 2.42e+06 TC-99M l.60e+OO 3.13e+OO O.OOe+OO 4.55e+Ol l.59e+OO l.78e+03 O.OOe+OO 5.19e+Ol TC-101 l.69e-60 1. 77e-60 O.OOe+OO 3.02e-59 9.36e-61 5.63e-60 O.OOe+OO 2.24e-59 RU-103 5.14e+02 O.OOe+OO O.OOe+OO 1.29e+03 O.OOe+OO 1.33e+04 O.OOe+OO 1.98e+02 RU-105 4.63e-04 O.OOe+OO O.OOe+OO 4.07e-03 O.OOe+OO 3.02e-Ol O.OOe+OO 1. 68e-04 Page 25 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 45 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/m11 3))

Deposition Pathways: {m 112 * (mrem/yr)/(µCi/sec)

AgeGroup: CHILD Pathway: Grs/Goat/Milk (GMILK)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-106 1.11e+04 O.OOe+OO O.OOe+OO 1. 50e+04 O.OOe+OO 1. 73e+05 O.OOe+OO 1.38e+03 AG-110M 2.51e+07 1. 69e+07 O.OOe+OO 3.15e+07 O.OOe+OO 2.0le+09 O.OOe+OO l.35e+07 TE-125M 8.85e+06 2.40e+06 2.49e+06 O.OOe+OO O.OOe+OO 8.54e+06 O.OOe+OO l.18e+06 TE-127 3.59e+02 9.68e+Ol 2.48e+02 1.02e+03 O.OOe+OO 1.40e+04 O.OOe+OO 7.70e+Ol TE-127M 2.50e+07 6. 72e+06 5.97e+06 7.12e+07 O.OOe+OO 2. 02e+07 O.OOe+OO 2.96e+06 TE-129 l.60e-10 4.47e-11 1.14e-10 4.68e-10 O.OOe+OO 9.97e-09 O.OOe+OO 3.80e-ll TE-129M 3.26e+07 9.10e+06 l.05e+07 9.56e+07 O.OOe+OO 3.97e+07 O.OOe+OO 5.06e+06 TE-131 2.16e-33 6.60e-34 1.66e-33 6.54e-33 O.OOe+OO i.14e-32 O.OOe+OO 6.44e-34 TE-131M l.92e+05 6.65e+04 1. 37e+05 6.44e+05 0.00e+OO 2.70e+06 O.OOe+OO 7.08e+04 TE-132 l.23e+06 5.45e+05 7.93e+05 5.06e+06 O.OOe+OO 5.48e+06 O.OOe+OO 6.58e+05 I-130 1.04e+06 2.10e+06 2.32e+08 3.14e+06 O.OOe+OO 9.83e+05 O.OOe+OO 1.08e+06 I-131 7.82e+08 7.87e+08 2.60e+ll l.29e+09 O.OOe+OO 7.00e+07 O.OOe+OO 4.47e+08 I-132 4.22e-01 7.75e-Ol 3.60e+Ol l.19e+OO O.OOe+OO 9.12e-01 O.OOe+OO 3.56e-01 I-133 l.03e+07 l.28e+07 2.37e+09 2.13e+07 O.OOe+OO 5.15e+06 O.OOe+OO 4.83e+06 I-134 5.36e-12 9.96e-12 2.29e-10 1. 52e-11 O.OOe+OO 6.61e-12 O.OOe+OO 4.58e-12 I-135 3.26e+04 5.87e+04 5.20e+06 9.00e+04 O.OOe+OO 4.47e+04 O.OOe+OO 2.78e+04 CS-134 6.79e+l0 1.12e+ll O.OOe+OO 3.45e+l0 l.24e+l0 6.0le+08 O.OOe+OO 2.35e+l0 CS-136 3.04e+09 8.35e+09 O.OOe+OO 4.44e+09 6.63e+08 2.93e+08 O.OOe+OO 5.40e+09 CS-137 9.67e+10 9.26e+l0 O.OOe+OO 3.02e+10 1.09e+10 5.80e+08 O.OOe+OO 1. 37e+l0 CS-138 l.30e-22 1.Sle-22 O.OOe+OO l.27e-22 l.37e-23 8.32e-23 O.OOe+OO l.lSe-22 BA-139 2.49e-08 1. 33e-11 O.OOe+OO 1.16e-11 7.82e-12 l.44e-06 O.OOe+OO 7.22e-10 BA-140 1.4le+07 1. 23e+04 O.OOe+OO 4.0le+03 7.34e+03 7.12e+06 O.OOe+OO 8.2le+05 BA-141 2.58e-46 1.44e-49 O.OOe+OO l.25e-49 8.49e-49 l.47e-46 O.OOe+OO 8.40e-48 BA-142 l.80e-80 1.30e-83 O.OOe+OO 1. 05e-83 7.62e-84 2.35e-82 O.OOe+OO l.Ole-81 LA-140 2.33e+OO 8.15e-01 O.OOe+OO O.OOe+OO O.OOe+OO 2.27e+04 O.OOe+OO 2.75e-01 LA-142 1. OOe-11 3.19e-12 O.OOe+OO O.OOe+OO O.OOe+OO 6.32e-07 O.OOe+OO 9.98e-13 CE-141 2.63e+03 l.3le+03 O.OOe+OO 5.74e+02 O.OOe+OO l.63e+06 O.OOe+OO 1.94e+02 CE-143 2.25e+Ol l.22e+04 O.OOe+OO 5.12e+OO O.OOe+OO 1. 79e+05 O.OOe+OO 1.77e+OO CE-144 1.95e+05 6.lle+04 O.OOe+OO 3.38e+04 O.OOe+OO 1.59e+07 O.OOe+OO 1.04e+04 PR-143 8.62e+Ol 2.59e+Ol O.OOe+OO 1.40e+Ol O.OOe+OO 9.30e+04 O.OOe+OO 4.28e+OO PR-144 3.76e-54 l.16e-54 O.OOe+OO 6.16e-55 O.OOe+OO 2.Sle-51 O.OOe+OO 1.89e-55 ND-147 5.34e+Ol 4.32e+Ol O.OOe+OO 2.37e+Ol O.OOe+OO 6.85e+04 O.OOe+OO 3.35e+OO W-187 3.47e+03 2.06e+03 O.OOe+OO O.OOe+OO O.OOe+OO 2.89e+05 O.OOe+OO 9.23e+02 NP-239 2.07e+OO l.49e-01 O.OOe+OO 4.30e-01 O.OOe+OO 1.10e+04 O.OOe+OO 1.05e-01 PU-239 6.37e+06 6.8le+05 O.OOe+OO 6.02e+05 O.OOe+OO 3.38e+05 O.OOe+OO l.63e+05 U-235 1. 69e+09 O.OOe+OO O.OOe+OO 2.77e+08 O.OOe+OO 3.96e+07 O.OOe+OO 1. 02e+08 Page 26 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 46 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/m"3))

Deposition Pathways: (m"2 * (mrem/yr)/(µCi/sec)

AgeGroup: CHILD Pathway: Ground Plane Deposition (GPO)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB NA-24 1.20e+07 l.20e+07 l.20e+07 l.20e+07 l.20e+07 1. 20e+07 l.39e+07 l.20e+07 CR-51 4.66e+06 4.66e+06 4.66e+06 4.66e+06 4.66e+06 4.66e+06 5.5le+06 4.66e+06 MN-54 l.39e+09 1.39e+09 l.39e+09 l.39e+09 1. 39e+09 l.39e+09 l.63e+09 1. 39e+09 MN-56 9.04e+05 9.04e+05 9.04e+05 9.04e+05 9.04e+05 9.04e+05 l.07e+06 9.04e+OS FE-59 2. 72e+08 2. 72e+08 2. 72e+08 2. 72e+08 2. 72e+08 2. 72e+08 3.20e+08 2. 72e+08 C0-58 3.79e+08 3.79e+08 3.79e+08 3.79e+08 3.79e+08 3.79e+08 4.43e+08 3.79e+08 C0-60 2.15e+10 2.15e+l0 2.15e+10 2.*15e+lO 2.15e+10 2.15e+10 2.53e+l0 2.15e+10 NI-65 2.97e+05 2.97e+05 2.97e+05 2.97e+05 2.97e+05 2.97e+05 3.45e+05 2.97e+05 CU-64 6.07e+05 6.07e+05 6.07e+05 6.07e+OS 6.07e+05 6.07e+05 6.88e+OS 6.07e+OS ZN-65 7.47e+08 7.47e+08 7.47e+08 7.47e+08 7:47e+08 7.47e+08 8.60e+08 7.47e+08 BR-83 4.87e+03 4.87e+03 4.87e+03 4.87e+03 4.87e+03 4.87e+03 7.08e+03 4.87e+03 BR-84 2.03e+05 2.03e+05 2.03e+OS 2.03e+05 2.03e+05 2.03e+05 2.36e+05 2.03e+OS RB-86 8.99e+06 8.99e+06 8.99e+06 8.99e+06 8.99e+06 8.99e+06 l.03e+07 8.99e+06 RB-88 3.31e+04 3.31e+04 3.3le+04 3.3le+04 3.31e+04 3.31e+04 3.78e+04 3.3le+04 RB-89 l.21e+05 1. 2le+05 l.2le+05 l.2le+OS l.21e+05 l.21e+OS l.45e+OS l.2le+05 SR-89 2.16e+04 2.16e+04 2.16e+04 2.16e+04 2.16e+04 2.16e+04 2.51e+04 2.16e+04 SR-91 2.15e+06 2.15e+06 2.15e+06 2.15e+06 2.15e+06 2.15e+06 2.5le+06 2.15e+06 SR-92 7.77e+OS* 7.77e+05 7.77e+05 7.77e+05 7.77e+05 7.77e+05 8.63e+05 7. 77e+05 Y-90 4.49e+03 4.49e+03 4.49e+03 4.49e+03 4.49e+03 4.49e+03 5.3le+03 4.49e+03 Y-91 1. 07e+06 l.07e+06 1. 07e+06 1.07e+06 l.07e+06 1. 07e+06 1. 21e+06 1.07e+06 Y-91M 1.00e+05 l.00e+05 l.OOe+OS l.OOe+OS 1. 00e+05 1.00e+05 1.16e+OS 1.00e+OS Y-92 1. 80e+05 l.80e+05 l.80e+05 l.80e+05 1. 80e+05 l.80e+OS 2.14e+05 1.80e+05 Y-93 1.83e+05 l.83e+05 1.83e+05 1. 83e+05 1.83e+05 1.83e+05 2.Sle+OS 1.83e+05 ZR-95 2.45e+08 2.45e+08 2.45e+08 2.45e+08 2.45e+08 2.45e+08 2.84e+08 2.45e+OB ZR-97 2.96e+06 2.96e+06 2.96e+06 2.96e+06 2.96e+06 2.96e+06 3.45e+06 2.96e+06 NB-95 1.37e+08 l.37e+08 l.37e+08 1.37e+08 l.37e+08 1.37e+08 1. 61e+OB l.37e+08 M0-99 4.00e+06 4.00e+06 4.00e+06 4.00e+06 4.00e+06 4.00e+06 4.63e+06 4.00e+06 TC-99M l.84e+05 1.84e+05 1.84e+05 l.84e+05 1.84e+05 1.84e+05 2. lle+OS 1.84e+05 TC-101 2.04e+04 2.04e+04 2.04e+04 2.04e+04 2.04e+04 2.04e+04 2.26e+04 2.04e+04 RU-103 l.08e+08 1. 08e+08 1.08e+08 1.0Be+OB 1. 08e+08 1. 08e+08 1. 26e+08 1.08e+08 RU-105 6.37e+OS 6.37e+05 6.37e+05 6.37e+05 6.37e+05 6.37e+OS 7.2le+OS 6.37e+OS RU-106 4.22e+08 4.22e+08 4.22e+08 4.22e+08 4.22e+08 4.22e+08 5.07e+08 4.22e+08 AG-llOM 3.44e+09 3.44e+09 3.44e+09 3.44e+09 3.44e+09 3.44e+09 4.0le+09 3.44e+09 TE-125M l.55e+06 1.55e+06 l.55e+06 l.55e+06 l.55e+06 1. 55e+06 2.13e+06 1.55e+06 TE-127 2.98e+03 2.98e+03 2.98e+03 2.98e+03 2.98e+03 2.98e+03 3.28e+03 2.98e+03 TE-127M 9.17e+04 9.17e+04 9.17e+04 9.17e+04 9.17e+04 9.17e+04 1.08e+05 9.17e+04 TE-129 2.62e+04 2.62e+04 2.62e+04 2.62e+04 2.62e+04 2.62e+04 3.10e+04 2. 62e+04 TE-129M 1.98e+07 1.98e+07 1.98e+07 l.98e+07 1. 98e+07 1.98e+07 2.3le+07 1.98e+07 Page 27 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 47 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/m11 3))

Deposition Pathways: (m 112 * (mrem/yr)/(µCi/sec)

AgeGroup: CHILD Pathway: Ground Plane Deposition (GPO)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB TE-131 2.92e+04 2.92e+04 2.92e+04 2.92e+04 2.92e+04 2.92e+04 3.45e+07 2. 92e+04 TE-131M 8.03e+06 8.03e+06 8.03e+06 8.03e+06 8.03e+06 8.03e+06 9.46e+06 8.03e+06 TE-132 4.24e+06 4.24e+06 4.24e+06 4.24e+06 4.24e+06 4.24e+06 4.98e+06 4.24e+06 I-130 5.51e+06 5.51e+06 5.51e+06 5.51e+06 5.5'1e+06 5.51e+06 6.69e+06 5.51e+06 I-131 1.72e+07 1.72e+07 1. 72e+07 1. 72e+07 1.72e+07 1. 72e+07 2.09e+07 1.72e+07 I-132 1.25e+06 1.25e+06 1.25e+06 1.25e+06 1.25e+06 1.25e+06 1.47e+o6 1.25e+06 I-133 2.45e+06 2.45e+06 2.45e+06 2.45e+06 2.45e+06 2.45e+06 2.98e+06 2.45e+06 I-134 4.47e+OS 4.47e+05 4.47e+05 4.47e+05 4.47e+05 4.47e+05 5.31e+05 4.47e+05 I-135 2.53e+06 2.53e+06 2.53e+06 2.53e+06 2.53e+06 2.53e+06 2.95e+06 2.53e+06 CS-134 6.86e+09 6.86e+09 6.86e+09 6.86e+09 6.86e+09 6.86e+09 8.00e+09 6.86e+09 CS-136 l.5le+08 1.51e+08 1.51e+08 l.Sle+OB 1.Sle+OB 1.Sle+OB 1. 71e+08 1. 51e+08 CS-137 1.03e+10 1. 03e+l0 1.03e+l0 1. 03e+10 1. 03e+10 1.03e+10 1. 20e+10 1.03e+l0 CS-138 3.59e+OS 3.59e+05 3.59e+05 3.59e+05 3.59e+05 3.59e+05 4.10e+05 3.59e+05 BA-139 1.06e+OS 1.06e+05 1.06e+05 1.06e+05 1.06e+OS 1.06e+05 l.19e+05 1.06e+05 BA-140 2.05e+07 2.05e+07 2.05e+07 2.05e+07 2.0Se+07 2.05e+07 2.35e+07 2.05ei-07 BA-141 4.17e+04 4.17e+04 4.17e+04 4.17e+04 4.17e+04 4.17e+04 4.75e+04 4.17e+04 BA-142 4.49e+04 4.49e+04 4.49e+04 4.49e+04 4.49e+04 4.49e+04 5. lle+04 4.49e+04 LA-140 1.92e+07 l.92e+07 1.92e+07 1.92e+07 l.92e+07 1. 92e+07 2.18e+07 1.92e+07 LA-142 7.60e+OS 7.60e+05 7.60e+05 7.60e+05 7.60e+OS 7.60e+05 9.12e+05 7.60e+05 CE-141 1.37e+07 1. 37e+07 1.37e+07 1.37e+07 1.37e+07 1.37e+07 1.54e+07 1.37e+07 CE-143 2.31e+06 2.3le+06 2.31e+06 2.3le+06 2.31e+06 2.31e+06 2.63e+06 2.3le+06 CE-144 6.95e+07 6.95e+07 6.9Se+07 6.95e+07 6.95e+07 6.95e+07 8.04e+07 6.95e+07 PR-144 1.84e+03 1.84e+03 l.84e+03 l.84e+03 1.84e+03 l.84e+03 2. lle+03 1.84e+03 ND-147 8.39e+06 8.39e+06 8.39e+06 8.39e+06 8.39e+06 8.39e+06 1.0le+07 s.39e+o6 W-187 2.35e+06 2.35e+06 2.35e+06 2.35e+06 2.35!=!+06 2.35e+06 2.73e+06 2.35e+06 NP-239 1.71e+06 1. 71e+06 1. 71e+06 l.7le+06 1. 71e+06 1. 71e+06 1.98e+06 1. 71e+06 PU-239 2.29e+06 2.29e+06 2.29e+06 2.29e+06 2.29e+06 2.29e+06 2.23e+07 2.29e+06 U-235 9.28e+09 9.28e+09 9.28e+09 9.28e+09 9.28e+09 9.28e+09 1.16e+10 9.28e+09 Page 28of44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 48 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES

{Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/m"3))

Deposition Pathways: (m"2 * (mrem/yr)/(µCi/sec)

AgeGroup: CHILD Pathway: Inhalation (INHL)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 O.OOe+OO l.13e+03 l.13e+03 1.13e+03 l.13e+03 l.13e+03 O.OOe+OO l.13e+03 C-14 3.59e+04 6.73e+03 6.73e+03 6.73e+03 6.73e+03 6.73e+03 O.OOe+OO 6.73e+03 NA-24 l.6le+04 l.6le+04 l.6le+04 l.6le+04 l.6le+04 l.6le+04 O.OOe+OO l.6le+04 P-32 2.60e+06 l.14e+05 O.OOe+OO O.OOe+OO O.OOe+OO 4.22e+04 O.OOe+OO 9.88e+04 CR-51 O.OOe+OO O.OOe+OO 8.55e+Ol 2.43e+Ol l.70e+04 l.08e+03 O.OOe+OO l.54e+02 MN-54 O.OOe+OO 4.29e+04 O.OOe+OO l.00e+04 l.58e+06 2.29e+04 O.OOe+OO 9.5le+03 MN-56 O.OOe+OO 1.66e+OO O.OOe+OO l.67e+OO l.3le+04 l.23e+05 O.OOe+OO 3.12e-01 FE-55 4.74e+04 2.52e+04 O.OOe+OO O.OOe+OO l.lle+05 2.87e+03 O.OOe+OO 7.77e+03 FE-59 2.07e+04 3.35e+04 O.OOe+OO O.OOe+OO l.27e+06 7.07e+04 O.OOe+OO l.67e+04 C0-58 O.OOe+OO l.77e+03 O.OOe+OO O.OOe+OO l.lle+06 3.44e+04 O.OOe+OO 3.16e+03 C0-60 O.OOe+OO l.3le+04 O.OOe+OO O.OOe+OO 7.07e+06 9.62e+04 O.OOe+OO 2.26e+04 NI-63 8.2le+05 4.63e+04 O.OOe+OO O.OOe+OO 2.75e+05 6.33e+03 O.OOe+OO 2.80e+04 NI-65 2.99e+OO 2.96e-01 O.OOe+OO O.OOe+OO 8.18e+03 8.40e+04 O.OOe+OO l.64e-01 CU-64 O.OOe+OO l.99e+OO O.OOe+OO 6.03e+OO 9.58e+03 3.67e+04 O.OOe+OO l.07e+OO ZN-65 4.26e+04 1.13e+05 O.OOe+OO 7.14e+04 9.95e+05 l.63e+04 O.OOe+OO 7.03e+04 ZN-69 6.70e-02 9.66e-02 O.OOe+OO 5.85e-02 l.42e+03 l.02e+04 O.OOe+OO 8.92e-03 BR-83 O~OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 4.74e+02 BR-84 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 5.48e+02 BR-85 O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.53e+Ol RB-86 O.OOe+OO l.98e+05 O.OOe+OO 0.00e+OO O.OOe+OO 7.99e+03 O.OOe+OO l.14e+05 RB-88 O.OOe+OO 5.62e+02 O.OOe+OO O.OOe+OO O.OOe+OO l.72e+Ol O.OOe+OO 3.66e+02 RB-89 O.OOe+OO 3.45e+02 O.OOe+OO O.OOe+OO 0.00e+OO l.89e+OO O.OOe+OO 2.90e+02 SR-89 5.99e+05 O.OOe+OO O.OOe+OO O.OOe+OO 2.16e+06 l.67e+05 O.OOe+OO 1.72e+04 SR-90 l.Ole+08 O.OOe+OO O.OOe+OO O.OOe+OO 1.48e+07 3.43e+05 O.OOe+OO 6.44e+06 SR-91 1.2le+02 O.OOe+OO O.OOe+OO O.OOe+OO 5.33e+04 1.74e+05 O.OOe+OO 4.59e+OO SR-92 1.31e+Ol O.OOe+OO O.OOe+OO O.OOe+OO 2.40e+04 2.42e+05 0.00e+OO 5.25e-01 Y-90 4.lle+03 O.OOe+OO O.OOe+OO O.OOe+OO 2.62e+05 2.68e+05 O.OOe+OO l.lle+02 Y-91 9.14e+05 O.OOe+OO O.OOe+OO O.OOe+OO 2.63e+06 l.84e+05 O.OOe+OO 2.44e+04 Y-91M 5.07e-01 O.OOe+OO O.OOe+OO O.OOe+OO 2.8le+03 l.72e+03 O.OOe+OO l.84e-02 Y-92 2.04e+Ol O.OOe+oo O.OOe+OO O.OOe+OO 2.39e+04 2.39e+05 O.OOe+OO 5.8le-01 Y-93 l.87e+02 O.OOe+OO O.OOe+OO O.OOe+OO 7.44e+04 3.89e+05 O.OOe+OO 5.lle+OO ZR-95 1.90e+05 4.18e+04 O.OOe+OO 5.96e+04 2.23e+06 6.lle+04 O.OOe+OO 3.70e+04 ZR-97 l.88e+02 2.72e+Ol O.OOe+OO 3.89e+Ol 1.13e+05 3.51e+05 O.OOe+OO 1.60e+Ol NB-95 2.35e+04 9.18e+03 O.OOe+OO 8.62e+03 6.14e+05 3.70e+04 O.OOe+OO 6.55e+03 M0-99 O.OOe+OO 1.72e+02 O.OOe+OO 3.92e+02 l.35e+05 1.27e+05 O.OOe+OO 4.25e+Ol TC-99M 1.78e-03 3.48e-03 O.OOe+OO 5.07e-02 9.51e+02 4.81e+03 O.OOe+OO 5.77e-02 TC-101 8.lOe-05 8.Sle-05 O.OOe+OO 1.45e-03 5.85e+02 1.63e+Ol O.OOe+OO 1.08e-03 RU-103 2.79e+03 O.OOe+OO O.OOe+OO 7.03e+03 6.62e+05 4.48e+04 O.OOe+OO 1.07e+03 Page 29 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 49 of65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/m"3))

Deposition Pathways: (m"2 * (mrem/yr)/(µCi/sec)

AgeGroup: CHILD Pathway: Inhalation (INHL)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-105 1. 53e+OO O.OOe+OO O.OOe+OO 1.34e+OO 1.59e+04 9.95e+04 O.OOe+OO 5.55e-01 RU-106 l.36e+05 O.OOe+OO O.OOe+OO 1. 84e+05 1.43e+07 4.29e+05 O.OOe+OO 1. 69e+04 AG-llOM 1.69e+04 1.14e+04 O.OOe+OO 2.12e+04 5.48e+06 1.00e+05 O.OOe+OO 9.14e+03 TE-125M 6.73e+03 2.33e+03 1. 92e+03 O.OOe+OO 4.77e+05 3.38e+04 O.OOe+OO 9.14e+02 TE-127 2.77e+OO 9.51e-01 1. 96e+OO 7.07e+OO 1.00e+04 5.62e+04 O.OOe+OO 6.lle-01 TE-127M 2.49e+04 8.55e+03 6.07e+03 6.36e+04 1.48e+06 7.14e+04 O.OOe+OO 3. 02e+03 TE-129 9.77e-02 3.SOe-02 7.14e-02 2.57e-Ol 2.93e+03 2.55e+04 O.OOe+OO 2.38e-02 TE-129M 1.92e+04 6.85e+03 6.33e+03 5.03e+04 1.76e+06 1.82e+05 0.00e+OO 3.04e+03 TE-131 2.17e-02 8.44e-03 1. 70e-02 5. 88e-02 2.05e+03 l.33e+03 O.OOe+OO 6. 59e-03 TE-131M l.34e+02 5. 92e+Ol 9.77e+Ol 4.00e+02 2.06e+05 3.08e+05 O.OOe+OO 5.07e+Ol TE-132 4.8le+02 2. 72e+02 3.18e+02 1. 77e+03 3.77e+05 1.38e+05 O.OOe+OO 2.63e+02 I-130 8.18e+03 l.64e+04 1.85e+06 2.45e+04 O.OOe+OO 5. lle+03 O.OOe+OO 8.44e+03 I-131 4.81e+04 4.8le+04 1. 62e+07 7.88e+04 O.OOe+OO 2.84e+03 O.OOe+OO 2.73e+04 I-132 2.12e+03 4.07e+03 1.94e+05 6.25e+03 O.OOe+OO 3.20e+03 O.OOe+OO 1.88e+03 I-133 l.66e+04 2.03e+04 3.85e+06 3.38e+04 O.OOe+OO 5.48e+03 O.OOe+OO 7.70e+03 I-134 l.17e+03 2.16e+03 5.07e+04 3.30e+03 O.OOe+OO 9.55e+02 O.OOe+OO 9.95e+02 I-135 4.92e+03 8.73e+03 7.92e+05 l.34e+04 O.OOe+OO 4.44e+03 O.OOe+OO 4.14e+03 CS-134 6.5le+05 1.0le+06 O.OOe+OO 3.30e+05 1.21e+05 3.85e+03 O.OOe+OO 2.25e+05 CS-136 6.5le+04 1.71e+05 O.OOe+OO 9.55e+04 l.45e+04 4.18e+03 O.OOe+OO 1.16e+05 CS-137 9.07e+05 8.25e+05 O.OOe+OO 2.82e+05 l.04e+05 3.62e+03 O.OOe+OO l.28e+05 CS-138 6.33e+02 8.40e+02 O.OOe+OO 6 ;22e+02 6.8le+Ol 2.70e+02 O.OOe+OO 5.55e+02 BA-139 l.84e+OO 9.84e-04 O.OOe+OO 8.62e-04 5.77e+03 5. 77e+04 O.OOe+OO 5.37e-02 BA-140 7.40e+04 6.48e+Ol O.OOe+OO 2. lle+Ol l.74e+06 l.02e+05 O.OOe+OO 4.33e+03 BA-141 l.96e-01 1. 09e-0.4 O.OOe+OO 9.47e-05 2. 92e+03 2.75e+02 O.OOe+OO 6.36e-03 BA-142 5.00e-02 3.60e-05 O.OOe+OO 2.91e-05 1.64e+03 2.74e+OO O.OOe+OO 2.79e-03 LA-140 6.44e+02 2.25e+02 O.OOe+OO O.OOe+OO 1.83e+05 2.26e+05 O.OOe+OO 7.55e+Ol LA-142 1.29e+OO 4.lle-01 O.OOe+OO O.OOe+OO 8.70e+03 7.59e+04 O.OOe+OO 1.29e-01 CE-141 3. 92e+04 1.95e+04 O.OOe+OO 8.55e+03 5.44e+05 5.66e+04 O.OOe+OO 2.90e+03 CE-143 3.66e+02 l.99e+02 O.OOe+OO 8.36e+Ol l.15e+05 l.27e+05 O.OOe+OO 2.88e+Ol CE-144 6.77e+06 2.12e+06 O.OOe+OO l.17e+06 1.20e+07 3.89e+05 O.OOe+OO 3.62e+05 PR-143 l.85e+04 5.55e+03 O.OOe+OO 3.00e+03 4.33e+b5 9.73e+04 O.OOe+OO 9.14e+02 PR-144 5.96e-02 l.85e-02 O.OOe+OO 9.77e-03 1.57e+03 l.97e+02 O.OOe+OO 3.00e-03 ND-147 1.08e+04 8.73e+03 O.OOe+OO 4.8le+03 3.28e+05 8.2le+04 O.OOe+OO 6.81e+02 W-187 1.63e+Ol 9.66e+OO O.OOe+OO O.OOe+OO 4.lle+04 9.10e+04 O.OOe+OO 4.33e+OO NP-239 4.66e+02 3.0le+02 O.OOe+OO 9.73e+Ol 5.8le+04 6.40e+04 O.OOe+OO 2.35e+Ol PU-239 1.03e+10 6.22e+09 O.OOe+OO 1.77e+09 2.12e+09 l.57e+OS O.OOe+OO 4.74e+08 U-235 1.58e+OB O.OOe+OO O.OOe+OO 2.59e+07 6.03e+OB 1.84e+05 O.OOe+OO 9.58e+06 Page 30 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 50of65 DOSE FACTORS: RADIONUCLJDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/mA3))

Deposition Pathways: (mA2 * (mrem/yr)/(µCi/sec)

AgeGroup: CHILD Pathway: Grs/Cow/Meat (CMEAT)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB

~-----------------------------------------------

H-3 O.OOe+OO 2.34e+02 2.34e+02 2.34e+02 2.34e+02 2.34e+02 O.OOe+OO 2.34e+02 C-14 3.83e+08 7.67e+07 7.67e+07 7.67e+07 7.67e+07 7.67e+07 O.OOe+OO 7.67e+07 NA-24 1. 78e-03 1.78e-03 1.78e-03 1. 78e-03 l.78e-03 1. 78e-03 O.OOe+OO 1.78e-03 P-32 1.15e+09 3.48e+08 O.OOe+OO O.OOe+OO O.OOe+OO 2.05e+08 O.OOe+OO 2.86e+08 CR-51 O.OOe+OO O.OOe+OO 4.88e+03 1.33e+03 8.9le+03 4.66e+05 O.OOe+OO 8.80e+03 MN-54 O.OOe+OO 8.0le+06 O.OOe+OO 2.25e+06 O.OOe+OO 6. 72e+06 O.OOe+OO 2.13e+06 MN-56 O.OOe+OO 1. 96e-53 O.OOe+OO 2.37e-53 O.OOe+OO 2.84e-51 O.OOe+OO 4.42e-54 FE-55 4.57e+08 2.43e+08 O.OOe+OO O.OOe+OO 1.37e+08 4.49e+07 O.OOe+OO 7.5le+07 FE-59 3.77e+08 6.09e+08 O.OOe+OO O.OOe+OO 1. 77e+08 6.34e+08 O.OOe+OO 3.04e+08 C0-58 O.OOe+OO 1.64e+07 O.OOe+OO O.OOe+OO O.OOe+OO 9.58e+07 O.OOe+OO 5.03e+07 C0-60 O.OOe+OO 6.93e+07 O.OOe+OO O.OOe+OO O.OOe+OO 3.84e+08 O.OOe+OO 2.04e+08 NI-63 2.91e+l0 1. 56e+09 O.OOe+OO O.OOe+OO O.OOe+OO 1.05e+08 O.OOe+OO 9. 9le+08 NI-65 4.22e-52 3.97e-53 O.OOe+OO O.OOe+OO O.OOe+OO 4.86e-51 O.OOe+OO 2.32e-53 CU-64 O.OOe+OO 3.0Be-07 O.OOe+OO 7.45e-07 O.OOe+OO 1.45e-05 0.00e+OO 1.86e-07 ZN-65 3.76e+08 1.00e+09 O.OOe+OO 6.30e+08 O.OOe+OO 1.76e+08 O.OOe+OO 6.22e+08 RB-86 O.OOe+OO 5.77e+OB O.OOe+OO O.OOe+OO O.OOe+OO 3. 71e+07 O.OOe+OO 3.55e+08 SR-89 4. 82e+08 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1. 87e+07 0.00e+OO 1.38e+07 SR-90 l.04e+l0 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.40e+08 O.OOe+OO 2.64e+09 SR-91 2.52e-10 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 5.55e-10 O.OOe+OO 9.49e-12 SR-92 2.18e-49 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 4.13e-48 O.OOe+OO 8.75e-51 Y-90 1.73e+02 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 4.92e+05 O.OOe+OO 4.62e+OO Y-91 1. 80e+06 O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO 2.40e+08 O.OOe+OO 4.82e+04 Y-92 2.74e-39 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 7.92e-35 O.OOe+OO 7.84e-41 Y-93 7.78e-12 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO l.16e-07 O.OOe+OO 2.14e-13 ZR-95 2.66e+06 5.86e+05 O.OOe+OO 8.38e+05 O.OOe+OO 6.lle+08 O.OOe+OO 5.21e+05 ZR-97 3.29e-05 4.76e-06 O.OOe+OO 6.83e-06 O.OOe+OO 7.21e-01 O.OOe+OO 2.Ble-06 NB-95 3.10e+06 1*.21e+06 O.OOe+OO l.13e+06 O.OOe+OO 2.23e+09 O.OOe+OO 8.62e+05 M0-99 O.OOe+OO l.16e+05 O.OOe+OO 2.47e+05 O.OOe+OO 9.58e+04 O.OOe+OO 2.87e+04 TC-99M 6.69e-21 l.3le-20 O.OOe+OO 1.90e-19 6.66e-21 7.46e-18 O.OOe+OO 2.17e-19 RU-103 l.55e+08 O.OOe+OO 0 :OOe+OO 3.90e+08 O.OOe+OO 4.0le+09 O.OOe+OO 5.96e+07 RU-105 9.99e-28 O.OOe+OO O.OOe+OO 8.78e-27 O.OOe+OO 6.52e-25 O.OOe+OO 3.63e-28 RU-106 4.44e+09 O.OOe+OO O.OOe+OO 5.99e+09 O.OOe+OO 6.90e+l0 O.OOe+OO 5.54e+OB AG-110M 8.39e+06 5.67e+06 O.OOe+OO l.06e+07 O.OOe+OO 6.74e+OB O.OOe+OO 4.53e+06 TE-125M 5.69e+08 l.54e+OB l.60e+OB O.OOe+OO O.OOe+OO 5.49e+08 O.OOe+OO 7.59e+07 TE-127 3.56e-10 9. 59e-11 2.46e-10 l.Ole-09 O.OOe+OO 1.39e-08 O.OOe+OO 7.63e-11 TE-127M 1.78e+09 4.78e+08 4.24e+OB 5.06e+09 O.OOe+OO 1.44e+09 O.OOe+OO 2.lle+OB TE-129M 1.79e+09 5.00e+OB 5.78e+OB 5.26e+09 O.OOe+OO 2.19e+09 O.OOe+OO 2.78e+08 TE-131M 7 .1le+02 2.46e+02 5.05e+02 2.38e+03 O.OOe+OO 9.97e+03 O.OOe+OO 2.62e+02 Page 31of44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 51of65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/mA3))

Deposition Pathways: (mA2 * (mrem/yr)/(µCi/sec)

AgeGroup: CHILD Pathway: Grs/Cow/Meat (CMEAT)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli *Skin TB TE-132 2.13e+06 9.44e+05 1.38e+06 8.77e+06 O.OOe+OO 9.50e+06 O.OOe+OO 1.14e+06 I-130 1. 58e-06 3.18e-06 3.5le-04 4.76e-06 O.OOe+OO 1. 49e-06 O.OOe+OO 1.64e-06 I-131 8.30e+06 8.34e+06 2.76e+09 l.37e+07 O.OOe+OO 7.43e+05 O.OOe+OO 4.74e+06 I-132 6.24e-59 1.lSe-58 5.32e-57 1. 75e-58 O.OOe+OO 1.35e-58 O.OOe+OO 5.27e-59 I-133 2.90e-Ol 3.59e-01 6.66e+Ol 5.98e-Ol O.OOe+OO 1.45e-01 O.OOe+OO l.36e-01 I-135 3.49e-17 6.29e-17 5.57e-15 9.64e-17 O.OOe+OO 4.79e-17 O.OOe+OO 2.97e-17 CS-134 9.22e+08 1.5le+09 O.OOe+OO 4.69e+08 l.68e+08 8.16e+06 O.OOe+OO 3.19e+08 CS-136 l.62e+07 4.47e+07 O.OOe+OO 2.38e+07 3.55e+06 l.57e+06 O.OOe+OO 2.89e+07 CS-137 l.33e+09 1.28e+09 O.OOe+OO 4.16e+08 1. 50e+08 7.99e+06 O.OOe+OO l.88e+08 BA-140 4.39e+07 3.85e+04 O.OOe+OO l.25e+04 2.29e+04 2.22e+07 O.OOe+OO 2.56e+06 LA-140 5.65e-02 1.98e-02 O.OOe+OO O.OOe+OO O.OOe+OO 5.5le+02 O.OOe+OO 6.66e-03 LA-142 7.00e-92 2.23e-92 O.OOe+OO O.OOe+OO O.OOe+OO 4.42e-87 O.OOe+OO 6.99e-93 CE-141 2.22e+04 l.lle+04 O.OOe+OO 4.86e+03 O.OOe+OO 1.38e+07 O.OOe+OO l.65e+03 CE-143 3.2le-02 1.74e+Ol O.OOe+OO 7.31e-03 O.OOe+OO 2.55e+02 O.OOe+OO 2.52e-03 CE-144 2.32e+06 7.26e+05 O.OOe+OO 4.02e+05 O.OOe+OO l.89e+08 O.OOe+OO 1.24e+05 PR-143 3.34e+04 l.00e+04 O.OOe+OO 5.44e+03 O.OOe+OO 3.6le+07 O.OOe+OO 1.66e+03 ND-147 l.l 7e+04 9.48e+03 O.OOe+OO 5.20e+03 b.OOe+OO l.50e+07 O.OOe+OO 7.34e+02 W-187 3.27e-02 l.94e-02 O.OOe+OO O.OOe+OO O.OOe+OO 2. 72e+OO O.OOe+OO 8.69e-03 NP-239 4.30e-Ol 3.08e-02 O.OOe+OO 8.92e-02 O.OOe+OO 2.28e+03 O.OOe+OO 2.17e-02 PU-239 1.85e+07 1.98e+06 O.OOe+OO 1. 75e+06 O.OOe+OO 9.80e+05 O.OOe+OO 4.74e+05 U-235 l.19e+09 O.OOe+OO O.OOe+OO 1.95e+08 O.OOe+OO 2.79e+07 O.OOe+OO 7.19e+07 Page 32 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 52of65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/m"3))

Deposition Pathways: (m"2 * (mrem/yr)/(µCi/sec)

AgeGroup: CHILD Pathway: Grs/Cow/Milk (CMILK)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 O.OOe+OO l.57e+03 1.57e+03 l.57e+03 1. 57e+03 l.57e+03 O.OOe+OO 1. 57e+03 C-14 l.20e+09 2.39e+08 2.39e+08 2.39e+08 2.39e+08 2.39e+08 O.OOe+OO 2.39e+08 NA-24 8.88e+06 8.88e+06 8.88e+06 8.88e+06 8.88e+06 8.88e+06 O.OOe+OO 8.88e+06 P-32 1.21e+l0 3.64e+09 O.OOe+OO O.OOe+OO O.OOe+OO 2.15e+09 O.OOe+OO 3.00e+09 CR-51 O.OOe+OO O.OOe+OO 5.65e+04 l.54e+04 l.03e+05 5.40e+06 O.OOe+OO 1. 02e+05 MN-54 O.OOe+OO 2.10e+07 O.OOe+OO 5.88e+06 O.OOe+OO 1.76e+07 O.OOe+OO 5.59e+06 MN-56 O.OOe+OO 1. 31e-02 O.OOe+OO 1.58e-02 O.OOe+OO l.89e+OO O.OOe+OO 2.95e-03 FE-55 l.12e+08 5.93e+07 O.OOe+OO O.OOe+OO 3.35e+07 1.10e+07 O.OOe+OO 1.84e+07 FE-59 1.20e+08 1.95e+08 O.OOe+OO O.OOe+OO 5.64e+07 2.03e+08 O.OOe+OO 9.69e+07 C0-58 O.OOe+OO 1.21e+07 O.OOe+OO O.OOe+OO O.OOe+OO 7.07e+07 O.OOe+OO 3.7le+07 C0-60 O.OOe+OO 4.32e+07 O.OOe+OO O.OOe+OO O.OOe+OO 2.39e+08 O.OOe+OO 1.27e+08 NI-63 2.97e+l0 1. 59e+09 O.OOe+OO O.OOe+OO O.OOe+OO l.07e+08 O.OOe+OO 1.0le+09 NI-65 1. 69e+OO 1. 59e-01 O.OOe+OO O.OOe+OO O.OOe+OO 1.94e+Ol O.OOe+OO 9.27e-02 CU-64 O.OOe+OO 7.49e+04 O.OOe+OO 1.81e+05 O.OOe+OO 3.52e+06 O.OOe+OO 4.53e+04 ZN-65 4 .13e+09 l.lOe+lO O.OOe+OO 6.94e+09 O.OOe+OO 1.93e+09 O.OOe+OO 6.85e+09 ZN-69 9.95e-12 1. 44e-11 O.OOe+OO 8.72e-12 O.OOe+OO 9.06e-10 O.OOe+OO 1. 33e-12 BR-83 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 4.49e-01 BR-84 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 7.09e-23 RB-86 0.00e+OO 8. 77e+09 O.OOe+OO O.OOe+OO O.OOe+OO 5.64e+08 O.OOe+OO 5.39e+09 RB-88 O.OOe+OO 8.34e-45 O.OOe+OO O.OOe+OO O.OOe+OO 4.09e-46 O.OOe+OO 5.79e-45 RB-89. O.OOe+OO 2.05e-53 O.OOe+OO O.OOe+OO O.OOe+OO 1. 79e-55 O.OOe+OO l.83e-53 SR-89 6.62e+09 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.56e+08 O.OOe+OO l.89e+08 SR-90 1.12e+ll O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO 1.5le+09 O.OOe+OO 2.83e+10 SR-91 1.31e+05 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.89e+05 O.OOe+OO 4.95e+03 SR-92 2.22e+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO 4.20e+Ol O.OOe+OO 8.90e-02 Y-90 3.23e+02 O.OOe+OO o. ooe+oo* O.OOe+OO O.OOe+OO 9.18e+05 O.OOe+OO 8.63e+OO Y-91 3.90e+04 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 5.20e+06 O.OOe+OO 1.04e+03 Y-91M 2.83e-19 O.OOe+OO O.OOe+OO 0 ..OOe+OO O.OOe+OO 5.54e-16 O.OOe+OO 1.03e-20 Y-92 2.56e-04 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 7.4le+OO O.OOe+OO 7.34e-06 Y-93 1. 02e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.52e+04 O.OOe+OO 2.79e-02 ZR-95 3.83e+03 8.42e+02 O.OOe+OO 1.2le+03 O.OOe+OO 8.79e+05 O.OOe+OO 7.50e+02 ZR-97 1.92e+OO 2.78e-01 O.OOe+OO 3.99e-01 O.OOe+OO 4.2le+04 O.OOe+OO 1. 64e-01 NB-95 3.18e+05 1.24e+05 O.OOe+OO 1. *16e+05 O.OOe+OO 2.29e+08 O.OOe+OO 8.85e+04 M0-99 O.OOe+OO 8.14e+07 O.OOe+OO 1. 74e+08 O.OOe+OO 6.74e+07 O.OOe+OO 2.02e+07 TC-99M 1.33e+Ol 2.61e+Ol O.OOe+OO 3.79e+02 l.33e+Ol 1.49e+04 O.OOe+OO 4.33e+02 TC-101 1.41e-59 1.48e-59 0.00e+OO 2.52e-58 7.80e-60 4.69e-59 O.OOe+OO 1. 87e-58 RU-103 4.28e+03 O.OOe+OO O.OOe+OO 1. 08e+04 O.OOe+OO l. lle+05 O.OOe+OO l.65e+03 RU-105 3.86e-03 O.OOe+OO O.OOe+OO 3.39e-02 O.OOe+OO 2.52e+OO O.OOe+OO l.40e-03 Page 33 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 53 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/mA3))

Deposition Pathways: (m"2 * (mrem/yr)/(µCi/sec)

AgeGroup: CHILD Pathway: Grs/Cow/Milk (CMILK)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-106 9.24e+04 O.OOe+OO O.OOe+OO l.25e+05 O.OOe+OO l.44e+06 O.OOe+OO 1.15e+04 AG-llOM 2.09e+08 1.4le+08 O.OOe+OO 2.63e+08 O.OOe+OO 1. 68e+l0 O.OOe+OO 1.13e+08 TE-125M 7.38e+07 2.00e+07 2.07e+07 O.OOe+OO O.OOe+OO 7.12e+07 O.OOe+OO 9.84e+06 TE-127 2.99e+03 8.07e+02 2.07e+03 8.5le+03 O.OOe+OO 1.17e+05 O.OOe+OO 6.41e+02 TE-127M 2.08e+08 5.60e+07 4.97e+07 5.93e+08 O.OOe+OO l.69e+OB o.ooe+oo 2.47e+07 TE-129 1. 33e-09 3. 72e-10 9.52e-10 3.90e-09 O.OOe+OO 8.31e-08 O.OOe+OO 3 .17e-10 TE-129M 2.71e+08 7.58e+07 8.75e+07 7.97e+08 O.OOe+OO 3.3le+08 O.OOe+OO 4.21e+07 TE-131 l.BOe-32 5.50e-33 1.38e-32 5.45e-32 O.OOe+OO 9.47e-32 O.OOe+OO 5.37e-33 TE-131M l.60e+06 5.54e+05 l.14e+06 5.36e+06 O.OOe+OO 2.25e+07 O.OOe+OO 5.90e+05 TE-132 l.03e+07 4.54e+06 6.61e+06 4.21e+07 O.OOe+OO 4.57e+07 O.OOe+OO 5.48e+06 I-130 8.67e+05 l.75e+06 1.93e+OB 2.62e+06 O.OOe+OO 8.19e+05 O.OOe+OO 9. 03e+05 I-131 6.52e+OB 6.56e+OB 2.17e+ll 1.08e+09 O.OOe+OO 5.84e+b7 O.OOe+OO 3.73e+OB I-132 3.5le-01 6.46e-01 3.00e+Ol 9.89e-01 O.OOe+OO 7.60e-01 O.OOe+OO 2. 97e-01 I-133 8.6le+06 l.06e+07 l.98e+09 1.77e+07 O.OOe+OO 4.29e+06 O.OOe+OO 4.03e+06 I-134 4.47e-12 8.30e-12 1. 91e-10 1. 27e-ll O.OOe+OO 5.50e-12 O.OOe+OO 3.82e-12 I-135 2. 72e+04 4.89e+04 4.33e+06 7.50e+04 O.OOe+OO 3.73e+04 O.OOe+OO 2.32e+04 CS-134 2.26e+10 3.72e+l0 O.OOe+OO 1.15e+l0 4.13e+09 2.00e+OB O.OOe+OO 7.84e+09 CS-136 1.0le+09 2.78e+09 O.OOe+OO 1.48e+09 2.2le+OB 9.77e+07 O.OOe+OO 1.80e+09 CS-137 3.22e+10 3.09e+10 O.OOe+OO 1.0le+lO 3.62e+09 l.93e+OB O.OOe+OO 4.56e+09 CS-138 4.33e-23 6.02e-23 O.OOe+OO 4.23e-23 4.56e-24 2.77e-23 O.OOe+OO 3.82e-23 BA-139 2.0Be-07 1. lle-10 O.OOe+OO 9.68e-ll 6.52e-ll 1.20e-05 O.OOe+OO 6.02e-09 BA-140 1. l 7e+08 l.03e+05 O.OOe+OO 3.34e+04 6.12e+04 5.94e+07 O.OOe+OO 6.84e+06 BA-141 2.15e-45 l.20e-48 O.OOe+OO 1.04e-48 7.07e-48 1.22e-45 O.OOe+OO 7.00e-47 BA-142 1. 50e-79 l.OBe-82 O.OOe+OO 8.73e-83 6.35e-83 1. 96e-81 O.OOe+OO 8.37e-81 LA-140 1.94e+Ol 6.79e+OO O.OOe+OO O.OOe+OO O.OOe+OO l.89e+05 O.OOe+OO 2.29e+O.O LA-142 8. 33e-ll 2.66e-ll O.OOe+OO O.OOe+OO O.OOe+OO 5.27e-06 O.OOe+OO 8.32e-12 CE-141 2.19e+04 1.09e+04 O.OOe+OO 4.78e+03 O.OOe+OO 1.36e-t07 O.OOe+OO 1. 62e+03 CE-143 1.88e+02 1.02e+05 O.OOe+OO 4.27e+Ol O.OOe+OO l.49e+06 O.OOe+OO 1.47e+Ol CE-144 1.62e+06 5.09e+05 O.OOe+OO 2.82e+05 O.OOe+OO l.33e+08 O.OOe+OO B.66e+04 PR-143 7.18e+02 2.16e+02 O.OOe+OO 1.17e+02 O.OOe+OO 7.75e+05 O.OOe+OO 3.56e+Ol PR-144 3.14e-53 9.70e-54 O.OOe+OO 5.13e-54 O.OOe+OO 2.09e-50 O.OOe+OO l.SBe-54 ND-147 4.45e+02 3.60e+02 O.OOe+OO 1.98e+02 O.OOe+OO 5.71e+05 O.OOe+OO 2.79e+Ol W-187 2.89e+04 1.7le+04 O.OOe+OO O.OOe+OO O.OOe+OO 2.4le+06 O.OOe+OO 7.69e+03 NP-239 1.73e+Ol 1. 24e+OO O.OOe+OO 3.59e+OO O.OOe+OO 9.18e+04 O.OOe+OO 8.72e-01 PU-239 5. 3le+07 5.68e+06 O.OOe+OO 5.02e+06 O.OOe+OO 2.82e+06 O.OOe+OO 1. 36e+06 U-235 1.41e+10 O.OOe+OO O.OOe+OO 2.31e+09 O.OOe+OO 3.30e+08 O.OOe+OO 8.52e+08 Page 34of44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 54 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/m"3))

Deposition Pathways: (m"2 * (mrem/yr)/(µCi/sec)

AgeGroup: CHILD Pathway: Vegetation (VEG)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB

~-------------------------------------------------------

H-3 O.OOe+OO 4.0le+03 4.0le+03 4.01e+03 4.0le+03 4.0le+03 O.OOe+OO 4.0le+03 C-14 8.89e+08 1.78e+08 1.78e+08 1.78e+08 1.78e+08 1.78e+08 O.OOe+OO 1.78e+08 NA-24 3 .'71e+05 3. 71e+05 3. 71e+05 3. 71e+05 3. 71e+05 3.7le+05 O.OOe+OO 3. 71e+05 P-32 5.23e+08 1.58e+08 O.OOe+OO O.OOe+OO O.OOe+OO 9 .3le+07 O.OOe+OO 1.30e+08 CR-51 O.OOe+bo O.OOe+OO 6.5De+04 1.78e+04 1.19e+05 6.21e+06 O.OOe+OO 1.17e+05 MN-54 O.OOe+OO 6.65e+08 O.OOe+OD 1. 86e+08 O.OOe+OO 5.58e+08 0.00e+OO 1. 77e+08 MN-56 O.DOe+OO 1.82e+Ol O.OOe+OO 2.21e+Ol O.OOe+DD 2.64e+03 O.OOe+OO 4.12e+OO FE-55 8.0le+08 4.25e+08 O.OOe+OO O.OOe+OO 2.4De+08 7.87e+07 O.OOe+OO 1.32e+08 FE-59 3.97e+08 6.43e+08 O.OOe+OO O.OOe+OO l.86e+08 6.70e+08 O.OOe+OO 3.20e+08 C0-58 O.OOe+OO 6.44e+07 O.OOe+OO O.OOe+OO O.OOe+OO 3.76e+08 0.. OOe+OO 1.97e+08 C0-60 O.OOe+OO 3.78e+08 O.OOe+OO O.OOe+OO O.OOe+OO 2.10e+09 O.OOe+OO l.12e+09 NI-63 3.95e+l0 2.lle+09 O.OOe+OO O.OOe+OO O.OOe+OO l.42e+08 O.OOe+OO l.34e+09 NI-65 1. 02e+02 9.61e+OO O.OOe+OO O.OOe+OO O.OOe+OO l.18e+03 O.OOe+OO 5.61e+OO CU-64 O.OOe+OO 1.09e+04 O.OOe+OO 2.64e+04 O.OOe+OO 5.13e+05 O.OOe+OO 6.60e+03 ZN-65 8.13e+08 2.17e+09 O.OOe+OO 1.36e+09 O.OOe+OO 3.80e+08 O.OOe+OO l.35e+09 ZN-69 8.77e-06 1.27e-05 O.OOe+OO 7.69e-06 O.OOe+OO 7.99e-04 O.DOe+OO 1.17e-06 BR-83 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 5.2le+OO BR-84 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OD O.OOe+OO O.OOe+OO O.OOe+OO 3. 33e-11 RB-86 O.OOe+OO 4.52e+08 O.OOe+OO O.OOe+OO O.OOe+OO 2.9le+07 O.OOe+OO 2.78e+08 RB-88 O.OOe+OO 3.41e-22 O.OOe+OO O.OOe+OO O.OOe+OO 1.67e-23 O.OOe+OO 2.37e-22 RB-89 O.OOe+OO 1.23e-26 O.OOe+OO O.OOe+OO O.OOe+OO 1. 07e-28 O.OOe+OO 1. 09e-26 SR-89 3.60e+10 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO l.39e+09 O.OOe+OO 1. 03e+09 SR-90 1.24e+l2 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1. 68e+l0 O.OOe+OO 3.15e+ll SR-91 5.20e+05 O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO l.15e+06 O.OOe+OO 1. 96e+04 SR-92 7.09e+02 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO l.34e+04 O.OOe+OO 2.84e+Ol Y-90 2.31e+04 O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO 6.56e+07 O.OOe+OO 6.17e+02 Y-91 l.86e+07 O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO 2.48e+09 O.OOe+OO 4.99e+05 Y-91M 8.15e-09 O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO 1.60e-05 O.OOe+OO 2.97e-10 Y-92 1.55e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 4.48e+04 O.OOe+OO 4.44e-02 Y-93 2.9le+02 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 4.34e+06 O.OOe+OO 7.99e+OO ZR-95 3.86e+06 8.48e+05 O.OOe+OO 1.21e+06 O.OOe+OO 8.84e+08 O.OOe+OO 7.55e+OS ZR-97 5.68e+02 8.20e+Ol O.OOe+OO 1.18e+02 O.OOe+OO 1.24e+07 O.OOe+OO 4.84e+Ol NB-95 4.10e+05 1.60e+05 O.OOe+OO l.50e+05 O.OOe+OO 2.95e+08 O.OOe+OO 1.14e+05 M0-99 O.OOe+OO 7.70e+06 O.OOe+OO 1.65e+07 O.OOe+OO 6.37e+06 O.OOe+OO 1.9le+06 TC-99M 4.65e+OO 9.13e+OO O.OOe+OO 1. 33e+02 4.63e+OO 5.19e+03 O.OOe+OO 1.5le+02 TC-101 1. 03e-30 1.0Be-30 O.OOe+OO 1. 84e-29 5.70e-31 3.43e-30 O.OOe+OO l.37e-29 RU-103 1. 53e+07 O.OOe+OO O.OOe+OO 3.86e+07 O.OOe+OO 3.96e+08 O.OOe+OO 5.89e+06 RU-105 9.0le+Ol O.OOe+OO O.DDe+OO 7.92e+02 O.OOe+OO 5.88e+04 O.OOe+OO 3.27e+Ol Page 35 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 55 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/mA3)).

Deposition Pathways: (mA2 * (mrem/yr)/(µCi/sec)

AgeGroup: CHILD Pathway: Vegetation (VEG)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-106 7.45e+08 O.OOe+OO O.OOe+OO 1.01e+09 O.OOe+OO 1.16e+10 O.OOe+OO 9.30e+07 AG-110M 3.21e+07 2.17e+07 O.OOe+OO 4.04e+07 O.OOe+OO 2.58e+09 O.OOe+OO 1.73e+07 TE-125M 3.50e+08 9.50e+07 9.84e+07 O.OOe+OO O.OOe+OO 3.38e+08 O.OOe+OO 4.67e+07 TE-127 9. 77e+03 2.64e+03 6.76e+03 2.78e+04 O.OOe+OO 3.82e+05 O.OOe+OO 2.10e+03 TE-127M 1.32e+09 3.56e+OB 3.16e+08 3.77e+09 O.OOe+OO 1.07e+09 O.OOe+OO 1.57e+08 TE-129 1.24e-03 3.46e-04 8.85e-04 3.63e-03 O.OOe+OO 7. 72e-02 O.OOe+OO 2.95e-04 TE-129M 8.4le+08 2.35e+08 2.71e+08 2.47e+09 O.OOe+OO 1.03e+09 O.OOe+OO 1.31e+08 TE-131 2.15e-15 6.57e-16 1.65e-15 6.51e-15 O.OOe+OO 1.13e-14 O.OOe+OO 6.41e-16 TE-131M 1.54e+06 5.32e+05 1.09e+06 5.15e+06 O.OOe+OO 2.16e+07 O.OOe+OO 5.66e+05 TE-132 7.00e+06 3.10e+06 4.51e+06 2.88e+07 O.OOe+OO 3.12e+07 O.OOe+OO 3.74e+06 I-130 3.06e+05 6.18e+05 6.81e+07 9.24e+05 O.OOe+OO 2.89e+05 O.OOe+OO 3.19e+05 I-131 7.14e+07 7.19e+07 2.38e+10 1.18e+08 O.OOe+OO 6.40e+06 O.OOe+OO 4.08e+07 I-132 4.46e+01 8.20e+Ol 3.81e+03 1. 26e+02 O.OOe+OO 9.66e+Ol O.OOe+OO 3.77e+01 I-133 1. 76e+06 2.18e+06 4.04e+08 3.63e+06 O.OOe+OO 8.77e+05 O.OOe+OO 8.24e+05 I-134 7.13e-05 1.32e-04 3.05e-03 2.02e-04 O.OOe+OO 8.78e-05 O.OOe+OO 6.09e-05 I-135 3.09e+04 5.57e+04 4.93e+06 8.54e+04 O.OOe+OO 4.24e+04 O.OOe+OO 2.63e+04 CS-134 1.60e+l0 2.63e+l0 O.OOe+OO 8.15e+09 2.93e+09 1.42e+08 O.OOe+OO 5.55e+09 CS-136 8.24e+07 2.26e+08 O.OOe+OO 1. 21e+OB l.80e+07 7.96e+06 O.OOe+OO l.47e+08 CS-137 2.39e+10 2.29e+l0 O.OOe+OO 7.46e+09 2.69e+09 1.43e+08 O.OOe+OO 3.38e+09 CS-138 5.73e-11 7. 97e-11 O.OOe+OO 5.60e-11 6.03e-12 3.67e-11 O.OOe+OO 5.05e-11 BA-139 4.70e-02 2.51e-05 O.OOe+OO 2.19e-05 1.47e-05 2. 71e+OO O.OOe+OO 1. 3 6e-03 BA-140 2. 77e+08 2.42e+05 O.OOe+OO 7.89e+04 1.44e+05 1.40e+08 O.OOe+OO 1. 6le+07 BA-141 1. 56e-21 8.74e-25 O.OOe+OO 7.56e-25 5.14e-24 8.90e-22 O.OOe+OO 5.0Be-23 BA-142 6.60e-39 4.75e-42 O.OOe+OO 3.84e-42 2.79e-42 8.60e-41 O.OOe+OO 3.68e-40 LA-140 3.24e+03 1.13e+03 O.OOe+OO O.OOe+OO O.OOe+OO 3.16e+07 O.OOe+OO 3.82e+02 LA-142 3.2le-04 1. 02e-04 O.OOe+OO O.OOe+OO O.OOe+OO 2.03e+01 O.OOe+OO 3.20e-05 CE-141 6.56e+05 3.27e+05 O.OOe+OO 1. 43e+05 O.OOe+OO 4.08e+08 O.OOe+OO 4.86e+04 CE-143 l. 71e+03 9.29e+05 O.OOe+OO 3.90e+02 O.OOe+OO 1.36e+07 O.OOe+OO 1.35e+02 CE-144 l.27e+08 3.98e+07 O.OOe+OO 2.2le+07 O.OOe+OO l.04e+l0 O.OOe+OO 6.78e+06 PR-143 1.46e+05 4.37e+04 O.OOe+OO 2.37e+04 O.OOe+OO l.57e+08 O.OOe+OO 7.22e+03 PR-144 4.17e-26 1.29e-26 O.OOe+OO 6.8le-27 O.OOe+OO 2.77e-23 0.00e+OO 2.lOe-27 ND-147 7.14e+04 5.79e+04 O.OOe+OO 3.17e+04 O.OOe+OO 9.16e+07 O.OOe+OO 4.48e+03 W-187 6.42e+04 3.80e+04 O.OOe+OO O.OOe+OO O.OOe+OO 5.34e+06 O.OOe+OO 1.71e+04 NP-239 2.56e+03 1.84e+02 O.OOe+OO 5.3le+02 O.OOe+OO 1.36e+07 O.OOe+OO 1.29e+02 PU-239 9.4Be+10 l.Ole+lO O.OOe+OO 8.97e+09 O.OOe+OO 5.04e+09 O.OOe+OO 2.43e+09 U-235 2.5le+ll O.OOe+OO O.OOe+OO 4.12e+10 O.OOe+OO 5.90e+09 O.OOe+OO l.52e+l0 Page 36 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 56of65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(uCi/m"3))

Deposition Pathways: (m"2 * (mrem/yr)/(uCi/sec)

AgeGroup: INFANT Pathway: Grs/GoaUMilk (GMILK)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 O.OOe+OO 4.86e+03 4.86e+03 4.86e+03 4.86e+03 4.86e+03 O.OOe+OO 4.86e+03 C-14 2.34e+09 5.00e+08 5.00e+08 5.00e+08 5.00e+08 5.00e+08 O.OOe+OO 5.00e+08 NA-24 l.86e+06 l.86e+06 1. 86e+06 1. 86e+06 l.86e+06 1. 86e+06 O.OOe+OO 1.86e+06 P-32 2.99e+10 i.13e+l0 O.OOe+OO O.OOe+OO O.OOe+OO 2.60e+09 O.OOe+OO 7.46e+09 CR-51 O.OOe+OO O.OOe+OO l.26e+04 2.76e+03 2.46e+04 5.64e+05 O.OOe+OO 1.94e+04 MN-54 O.OOe+OO 4.68e+06 O.OOe+OO l.04e+06 O.OOe+OO 1. 72e+06 O.OOe+OO 1. 06e+06 MN-56 O.OOe+OO 3.84e-03 O.OOe+OO 3.30e-03 O.OOe+OO 3.49e-01 O.OOe+OO 6.62e-04 FE'-55 1. 76e+06 l.14e+06 O.OOe+OO O.OOe+OO 5.55e+05 1. 44e+05 O.OOe+OO 3.03e+05 FE-59 2.92e+06 5.10e+06 O.OOe+OO O.OOe+OO l.51e+06 2.43e+06 O.OOe+OO 2.0le+06 C0-58 O.OOe+OO 2. 9le+.06 O.OOe+OO O.OOe+OO O.OOe+OO 7.25e+06 O.OOe+OO 7.26e+06 C0-60 O.OOe+OO l.06e+07 O.OOe+OO O.OOe+OO O.OOe+OO 2.52e+07 O.OOe+OO 2.50e+07 NI-63 4.19e+09 2.59e+08 O.OOe+OO O.OOe+OO O.OOe+OO 1.29e+07 O.OOe+OO 1.46e+08 NI-65 4.28e-01 4.85e-02 O.OOe+OO O.OOe+OO O.OOe+OO 3.69e+OO O.OOe+OO 2.21e-02 CU-64 O.OOe+OO 2.08e+04 O.OOe+OO 3.5le+04 O.OOe+OO 4.26e+05 O.OOe+OO 9.61e+03 ZN-65 6.66e+08 2.29e+09 O.OOe+OO 1.11e+09 O.OOe+OO 1.93e+09 O.OOe+OO l.05e+09 ZN-69 2.54e-12 4.58e-12 O.OOe+OO l.90e-12 O.OOe+OO 3.73e-10 O.OOe+OO 3.4le-13 BR-83 O.OOe+OO O.OOe+OO O.OOe+OO O.DOe+OO O.OOe+OO O.OOe+OO O.OOe+OO l.14e-Ol BR-84 O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO 1. 64e-23 RB-86 O.OOe+OO 2.67e+09 O.OOe+OO 0.00e+OO O.OOe+OO 6.84e+07 O.OOe+OO 1.32e+09 RB-88 O.OOe+OO 2.62e-45 O.OOe+OO O.OOe+OO O.OOe+OO 2.55e-45 O.OOe+OO 1.44e-45 RB-89 O.OOe+OO 6.02e-54 O.OOe+OO O.OOe+OO O.OOe+OO 2.05e-54 O.OOe+OO 4.15e-54 SR-89 2.64e+l0 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 5.43e+08 O.OOe+OO 7.58e+08 SR-90 2.55e+ll 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO 3.19e+09 O.OOe+OO 6.50e+10 SR-91 5.73e+05 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 6.79e+05 O.OOe+OO 2.08e+04 SR-92 9.91e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1. 07e+02 O.OOe+OO 3.68e-01 Y-90 8.18e+Ol O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO l.13e+05 O.OOe+OO 2.19e+OO Y-91 8.79e+03 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 6.30e+05 O.OOe+OO 2.34e+02 Y-91M 7.20e-20 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.40e-16 O.OOe+OO 2.45e-21 Y-92 6.54e-05 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO l.25e+OO O.OOe+OO l.84e-06 Y-93 2.60e-01 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.05e+03 O.OOe+OO 7.08e-03 ZR-95 8.17e+02 1. 99e+02 O.OOe+OO 2.15e+02 O.OOe+OO 9.91e+04 O.OOe+OO 1.4le+02 ZR-97 4.89e-01 8.39e-02 0.00e+OO 8.46e-02 O.OOe+OO 5.35e+03 O.OOe+OO 3.83e-02 NB-95 7.12e+04 2.93e+04 0.00e+OO 2.10e+04 O.OOe+OO 2.48e+07 O.OOe+OO 1. 70e+04 M0-99 Q.OOe+OO 2.50e+07 O.OOe+OO 3.73e+07 O.OOe+OO 8.23e+06 O.OOe+OO 4.87e+06 TC-99M 3.32e+OO 6.85e+OO O.OOe+OO 7.37e+Ol 3.58e+OO l.99e+03 O.OOe+OO 8.83e+Ol TC-101 3.59e-60 4.52e-60 O.OOe+OO 5.37e-59 2.47e-60 7.68e-58 O.OOe+OO 4.47e-59 RU-103 l.04e+03 O.OOe+OO O.OOe+OO 2.17e+03 O.OOe+OO 1.27e+04 O.OOe+OO 3.48e+02 RU-105 9.77e-04 O.OOe+OO O.OOe+OO 7.18e-03 O.OOe+OO 3.89e-01 O.OOe+OO 3.29e-04 Page 37 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 57 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(uCi/mA3))

Deposition Pathways: (mA2 * (mrem/yr)/(uCi/sec).

AgeGroup: INFANT Pathway: Grs/Goat/Milk (GMILK)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-106 2.28e+04 O.OOe+OO O.OOe+OO 2.70e+04 O.OOe+OO l.73e+05 0.00e+OO 2.85e+03 AG-llOM 4.63e+07 3.38e+07 O.OOe+OO 4.84e+07 O.OOe+OO l.75e+09 O.OOe+OO 2.24e+07 TE-125M 1..8le+07 6.05e+06 6.09e+06 O.OOe+OO O.OOe+OO 8.62e+06 O.OOe+OO 2.45e+06 TE-127 7.62e+02 2.55e+02 6.20e+02 l.86e+03 O.OOe+OO l.60e+04 O.OOe+OO l.64e+02 TE-127M 5.05e+07 l.68e+07 l.46e+07 l.24e+08 O.OOe+OO 2.04e+07 O.OOe+OO 6.12e+06 TE-129 3.39e-10 1. l 7e-10 2.84e-10 8.45e-10 O.OOe+OO 2. 71e-08 O.OOe+OO 7. 92e-11 TE-129M 6.69e+07 2.29e+07 2.57e+07 l.67e+08 O.OOe+OO 3.99e+07 O.OOe+OO l.03e+07 TE-131 4.59e-33 1. 69e-33 4.09e-33 1. l 7e-32 O.OOe+OO 1. 85e-31 O.OOe+OO l.29e-33 TE-131M 4.06e+05 l.63e+05 3.3le+05 l.12e+06 O.OOe+OO 2.75e+06 O.OOe+OO l.35e+05 TE-132 2.53e+06 l.26e+06 1.85e+06 7.85e+06 O.OOe+OO 4.64e+06 O.OOe+OO 1.17e+06 I-130 2.14e+06 4.70e+06 5.27e+08 5.17e+06 O.OOe+OO 1. Ole+06 O.OOe+OO 1.89e+06 I-131 1.63e+09 l.92e+09 6.32e+ll 2.25e+09 O.OOe+OO 6.87e+07 O.OOe+OO 8.46e+08 I-132 8.75e-01 l.78e+OO 8 .33e+Ol l.98e+OO O.OOe+OO 1. 44e+OO 0.00e+OO 6.33e-01 I-133 2.18e+07 3.18e+07 5.78e+09 3.73e+07 O.OOe+OO 5.37e+06 0.00e+OO 9.30e+06 I-134 1.lle-11 2.28e-11 5.31e-10 2.55e-ll O.OOe+OO 2.35e-11 O.OOe+OO 8.lOe-12 I-135 6.79e+04 l.35e+05 1.2le+07 1. 50e+05 O.OOe+OO 4.88e+04 O.OOe+OO 4.92e+04 CS-134 l.09e+ll 2.04e+ll O.OOe+OO 5.25e+l0 2.15e+10 5.54e+08 O.OOe+OO 2.06e+10 CS-136 5.93e+09 1.74e+10 O.OOe+OO 6.95e+09 l.42e+09 2.65e+08 O.OOe+OO 6.5le+09 CS-137 1.54e+ll l.8le+ll O.OOe+OO 4.85e+10 1. 96e+l0 5.65e+08 O.OOe+OO 1. 28e+l0 CS-138 2.74e-22 4.45e-22 O.OOe+OO 2.22e-22 3.47e-23 7.12e-22 O.OOe+OO 2.16e-22 BA-139 5.30e-08 3.51e-ll O.OOe+OO 2.lle-11 2.13e-11 3.36e-06 O.OOe+OO 1. 53e-09 BA-140 2.89e+07 2.89e+04 O.OOe+OO 6.87e+03 l.78e+04 7,lle+06 O.OOe+OO 1.49e+06 BA-141 5.48e-46 3.75e-49 O.OOe+OO 2.26e-49 2.28e-49 6.69e-45 O.OOe+OO 1. 73e-47.

BA-142 3.79e-80 3.15e-83 O.OOe+OO 1.8le-83 1. 9le-83 l.56e-79 O.OOe+OO l.87e-81 LA-140 4.87e+OO l.92e+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.26e+04 O.OOe+OO 4.94e-01 LA-142 2.lOe-11 7. 71e-12 O.OOe+OO O.OOe+OO O.OOe+OO l.3le-06 O.OOe+OO l.85e-12 CE-141 5.20e+03 3.17e+03 O.OOe+OO 9.79e+02 O.OOe+OO 1.64e+06 O.OOe+OO 3.74e+02 CE-143 4. 77e+Ol 3.17e+04 O.OOe+OO 9.22e+OO O.OOe+OO l.85e+05 O.OOe+OO 3.61e+OO CE-144 2.79e+05 1.14e+05 O.OOe+OO 4.62e+04 O.OOe+OO l.60e+07 O.OOe+OO 1. 56e+04 PR-143 l.78e+02 6.67e+Ol O.OOe+OO 2.48e+Ol O.OOe+OO 9.4le+04 O.OOe+OO 8.84e+OO PR-144 8.00e-54 3.09e-54 O.OOe+OO 1.12e-54 O.OOe+OO l.44e-49 O.OOe+OO 4.03e-55 ND-147 l.06e+02 1.09e+02 O.OOe+OO 4.19e+Ol O.OOe+OO 6.89e+04 O.OOe+OO 6.66e+OO W-187 7.3le+03 5.08e+03 O.OOe+OO O.OOe+OO O.OOe+OO 2.99e+05 O.OOe+OO l.76e+03 NP-239 4.38e+OO 3.92e-01 O.OOe+OO 7.81e-01 O.OOe+OO l.13e+04 O.OOe+OO 2.21e-01 PU-239 6.81e+06 7.65e+05 O.OOe+OO 6.32e+05 O.OOe+OO 3.41e+05 O.OOe+OO 1.75e+05 U-235 2.3le+09 O.OOe+OO O.OOe+OO 4.90e+08 O.OOe+OO 4.00e+07 O.OOe+OO 1.76e+08 Page 38 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 58 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(uCi/m/\3))

Deposition Pathways: (m/\2 * (mrem/yr)/(uCi/sec)

AgeGroup: INFANT Pathway: Ground Plane Deposition (GPD)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB NA-24 l.20e+07 l.20e+07 l.20e+07 l.20e+07 l.20e+07 l.20e+07 l.39e+07 l.20e+07 CR-51 4.66e+06 4.66e+06 4.66e+06 4.66e+06 4.66e+06 4.66e+06 5.5le+06 4.66e+06 MN-54 l.39e+09 l.39e+09 l.39e+09 l.39e+09 l.39e+09 l.39e+09 l.63e+09 l.39e+09 MN-56 9.04e+05 9.04e+05 9.04e+05 9.04e+05 9.04e+05 9.04e+05 l.07e+06 9.04e+05 FE-59 2.72e+08 2.72e+08 2.72e+08 2.72e+08 2.72e+08 2.72e+08 3.20e+08 2.72e+08 C0-58 3.79e+08 3.79e+08 3.79e+08 3.79e+08 3.79e+08 3.79e+08 4.44e+08 3.79e+08 C0-60 2.15e+10 2.15e+10 2.15e+10 2.15e+l0 2.15e+10 2.15e+l0 2.53e+l0 2.15e+l0 NI-65 2.97e+05 2.97e+05 2.97e+05 2.97e+05 2.97e+05 2.97e+05 3.45e+05 2.97e+05 CU-64 6.07e+05 6.07e+05 6.07e+05 6.07e+05 6.07e+05 6.07e+05 6.88e+05 6.07e+05 ZN-65 7.47e+08 7.47e+08 7.47e+08 7.47e+08 7.47e+08 7.47e+08 8.60e+08 7.47e+08' BR-83 4.87e+03 4.87e+03 4.87e+03 4.87e+03 4.87e+03 4.87e+03 7.08e+03 4.87e+03 BR-84 2.03e+05 2.03e+05 2.03e+05 2.03e+05 2.03e+05 2.03e+05 2.36e+05 2.03e+05 RB-86 8.99e+06 8.99e+06 8.99e+06 8.99e+06 8.99e+06 8.99e+06 l.03e+07 8.99e+06 RB-88 3.3le+04 3.3le+04 3.3le+04 3.3le+04 3.3le+04 3.31e+04 3.78e+04 3.3le+04 RB-89 l.21e+05 1.21e+05 l.2le+05 1.2le+05 l.2le+05 l.2le+05 1.45e+05 1.2le+05 SR-89 2.16e+04 2.16e+04 2.16e+04 2.16e+04 2.16e+04 2.16e+04 2.51e+04 2.16e+04 SR-91 2.15e+06 2.15e+06 2.15e+06 2.15e+06 2.15e+06 2.15e+06 2.5le+06 2.15e+06 SR-92 7.77e+05 7.77e+05 7.77e+05 7.77e+05 7.77e+05 7.77e+05 8.63e+05 7.77e+05 Y-90 4.49e+03 4.49e+03 4.49e+03 4.49e+03 4.49e+03 4.49e+03 5.31e+03 4.49e+03 Y-91 l.07e+06 l.07e+06 l,07e+06 1.07e+06 l.07e+06 l.07e+06 1.21e+06 1.07e+06 Y-91M 1.00e+05 l.OOe+OS l.00e+05 l.00e+05 l.00e+05 l.00e+05 l.16e+05 l.00e+05 Y-92 l.80e+05 1.80e+05 l.80e+05 l.80e+05 1.80e+05 l.80e+05 2.14e+05 l.80e+05 Y-93 l.83e+05 l.83e+05 l.83e+05 1.83e+05 1.83e+05 l.83e+05 2.5le+05 l.83e+05 ZR-95 2.45e+08 2.45e+08 2.45e+08 2.45e+08 2.45e+08 2.45e+08 2.84e+08 2.45e+08 ZR-97 2.96e+06 2.96e+06 2.96e+06 2.96e+06 2.96e+06 2.96e+06 3.45e+06 2.96e+06 NB-95 l.37e+08 l.37e+08 l.37e+08 l.37e+08 l.37e+08 l.37e+08 l.6le+08 l.37e+08 M0-99 4.00e+06 4.00e+06 4.00e+06 4.00e+06 4.00e+06 4.00e+06 4.63e+06 4.00e+06 TC-99M l.84e+05 1.84e+05 l.84e+05 l.84e+05 l.84e+05 l.84e+05 2.lle+05 l.84e+05 TC-101 2.04e+04 2.04e+04 2.04e+04 2.04e+04 2.04e+04 2.04e+04 2.26e+04 2.04e+04 RU-103 l.08e+08 l.08e+08 l.08e+08 l.08e+08 l.08e+08 l.08e+08 l.26e+08 l.08e+08 RU-105 6.37e+05 6.37e+05 6.37e+05 6.37e+05 6.37e+05 6.37e+05 7.2le+05 6.37e+05 RU-106 4.22e+08 4.22e+08 4.22e+08 4.22e+08 4.22e+08 4.22e+08 5.07e+08 4.22e+08 AG-llOM 3.44e+09 3.44e+09 3.44e+09 3.44e+09 3.44e+09 3.44e+09 4.0le+09 3.44e+09 TE-125M l.55e+06 l.55e+06 l.55e+06 l.55e+06 l.55e+06 l.55e+06 2.13e+06 l.55e+06 TE-127 2.9Be+03 2.98e+03 2.98e+03 2.98e+03 2.98e+03 2.98e+03 3.28e+03 2.98e+03 TE-127M 9.17e+04 9.17e+04 9.17e+04 9.17e+04 9.17e+04 9.17e+04 l.08e+05 9.17e+04 TE-129 2.62e+04 2.62e+04 2.62e+04 2.62e+04 2.62e+04 2.62e+04 3.10e+04 2.62e+04 TE-129M l.98e+07 l.98e+07 l.98e+07 1.98e+07 l.98e+07 l.98e+07 2.3le+07 1.98e+07 Page 39of44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 59 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/m"3))

Deposition Pathways: (m"2 * (mrem/yr)/(µCi/sec)

AgeGroup: INFANT Pathway: Ground Plane Deposition (GPO)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB TE-131 2 .92e+04 2.92e+04 2.92e+04 2.92e+04 2.92e+04 2.92e+04 3.45e+07 2.92e+04 TE-131M 8.03e+06 8.03e+06 8.03e+06 8.03e+06 8.03e+06 8.03e+06 9.46e+06 8.03e+06 TE-132 4.24e+06 4.24e+06 4.24e+06 4.24e+06 4.24e+06 4.24e+06 4.98e+06 4.24e+06 I-130 5.51e+06 5.Sle+06 5.51e+06 5.5le+06 5.51e+06 5.5le+06 6.69e+06 5.51e+06 I-131 1. 72e+07 1. 72e+07 1.72e+07 1.72e+07 1. 72e+07 1. 72e+07 2.09e+07 1. 72e+07 I-132 l.25e+06 1.25e+06 1.25e+06 1.25e+06 l.25e+06 1.25e+06 l.47e+06 l.25e+06 I-133 2.45e+06 2.45e+06 2.45e+06 2.45e+06 2.45e+06 2.45e+06 2.98e+06 2.45e+06 I-134 4.47e+05 4.47e+05 4.47e+05 4.47e+05 4.47e+05 4.47e+05 5.31e+05 4.47e+05 I-135 2.53e+06 2.53e+06 2.53e+06 2.53e+06 2.53e+06 2.53e+06 2.95e+06 2.53e+06 CS-134 6.86e+09 6.86e+09 6.86e+09 6.86e+09 6.86e+09 6.86e+09 8.00e+09 6.86e+09 CS-136 l.51e+08 1.Sle+08 1. 51e+08 1.51e+08 1. 51e+08 1.51e+08 1.71e+08 1 .. 51e+08 CS-137 1. 03e+l0 1. 03e+10 1.03e+10 1.03e+10 1. 03e+l0 1.03e+10 1. 20e+l0 1. 03e+10 CS-138 3.59e+05 3.59e+05 3.59e+05 3.59e+05 3.59e+05 3.59e+05 4.10e+05 3.59e+05 BA-139 1. 06e+05 1.06e+05 l.06e+05 1.06e+05 1.06e+05 1.06e+05 1.19e+05 1.06e+05 BA-140 2.05e+07 2.05e+07 2.05e+07 2.05e+07 2.05e+07 2.05e+07 2.35e+07 2.05e+07 BA-141 4.17e+04 4.17e+04 4.17e+04 4.17e+04 4.17e+04 4.17e+04 4.75e+04 4.17e+04 BA-142 4.49e+04 4.49e+04 4.49e+04 4.49e+04 4.49e+04 4.49e+04 5.lle+04 4.49e+04 LA-140 1.92e+07 1.92e+07 1.92e+07 l.92e+07 1.92e+07 l.92e+07 2.18e+07 l.92e+07 LA-142 7.60e+05 7.60e+05 7.60e+05 7.60e+05 7.60e+05 7.60e+05 9.12e+05 7.60e+05 CE-141 1.37e+07 1. 37e+07 l.37e+07 l.37e+07 1.37e+07 1.37e+07 1.54e+07 1. 37e+07 CE-143 2.3le+06 2.31e+06 2.31e+06 2.31e+06 2.3le+06 2.3le+06 2.63e+06 2.3le+06 CE-144 6.95e+07 6.95e+07 6.95e+07 6.95e+07 6.95e+07 6.95e+07 8.04e+07 6.95e+07 PR-144 1.84e+03 1.84e+03 l.84e+03 1.84e+03 l.84e+03 1.84e+03 2 .lle+03 1.84e+03 ND-147 8.39e+06 8.39e+06 8.39e+06 8.39e+06 8.39e+06 8.39e+06 l.Ole+07 8.39e+06 W-187 2.35e+06 2.35e+06 2.35e+06 2.35e+06 2.35e+06 2.35e+06 2.73e+06 2.35e+06 NP-239 1. 71e+06 1. 71e+06 1. 71e+06 1. 71e+06 L 71e+06 1. 71e+06 1.98e+06 1. 71e+06 PU-239 2.29e+06 2.29e+06 2.29e+06 2.29e+06 2.29e+06 2.29e+06 2.23e+07 2.29e+06 U-235 9.28e+09 9.28e+09 9.28e+09 9.28e+09 9 .-28e+09 9.28e+09 l.16e+10 9.28e+09 Page 40 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 60 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/m 113))

Deposition Pathways: (m 11 2 * (mrem/yr)/(µCi/sec)

AgeGroup: INFANT Pathway: Inhalation (INHL)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 O.OOe+OO 6.47e+02 6.47e+02 6.47e+02 6.47e+02 6.47e+02 O.OOe+OO 6. 47e+02 C-14 2.65e+04 5.3le+03 5.3le+03 5.3le+03 5.3le+03 5.3le+03 O.OOe+OO 5.3le+03 NA-24 l.06e+04 1. 06e+04 1.06e+04 1. 06e-+04 1.06e+04 1.06e+04 O.OOe+OO l.06e+04 P-32 2.03e+06 l.12e+05 O.OOe+OO O.OOe+OO O.OOe+OO 1.61e+04 O.OOe+OO 7.74e+04 CR-51 O.OOe+OO O.OOe+OO 5.75e+Ol 1. 32e+Ol l.28e+04 3.57e+02 O.OOe+OO 8.95e+Ol MN-54 O.OOe+OO 2.53e+04 O.OOe+OO 4.98e+03 l.00e+06 7.06e+03 O.OOe+OO 4.98e+03 MN-56 O.OOe+OO 1.54e+OO O.OOe+OO 1.lOe+OO l.25e+04 7.17e+04 O.OOe+OO 2.2le-01 FE-55 l.97e+04 l.18e+04 O.OOe+OO O.OOe+OO 8.69e+04 1.10e+03 O.OOe+OO 3.33e+03 FE-59 1.36e+04 2.35e+04 O.OOe+OO O.OOe+OO 1.02e+06 2.48e+04 O.OOe+OO 9.48e+03 C0-58 O.OOe+OO l.22e+03 O.OOe+OO O.OOe+OO 7.77e+05 1. lle+04 O.OOe+OO l.82e+03 C0-60 O.OOe+OO 8.02e+03 0.00e+OO O.OOe+OO 4.51e+06 3.19e+04 O.OOe+OO 1.18e+04 NI-63 3.39e+05 2.04e+04 O.OOe+OO O.OOe+OO 2.09e+05 2.42e+03 O.OOe+OO l.16e+04 NI-65 2.39e+OO 2.84e-01 O.OOe+OO O.OOe+OO 8.12e+03 5.0le+04 O.OOe+OO l.23e-01 CU-64 O.OOe+OO l.88e+OO O.OOe+OO 3.98e+OO 9.30e+03 1. 50e+04 O.OOe+OO 7.74e-01 ZN-65 l.93e+04 6.26e+04 O.OOe+OO 3.25e+04 6.47e+05 5.14e+04 O.OOe+OO 3.lle+04 ZN-69 5.39e-02 9.67e-02 O.OOe+OO 4.02e-02 l.47e+03 l.32e+04 O.OOe+OO 7.18e-03 BR-83 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 3.8le+02 BR-84 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 4.00e+02 BR-85 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO 2.04e+Ol RB-86 O.OOe+OO l.90e+05 0.00e+OO O.OOe+OO O.OOe+OO 3.04e+03 O.OOe+OO 8.82e+04 RB-88 O.OOe+OO 5.57e+02 O.OOe+OO O.OOe+OO O.OOe+OO 3.39e+02 O.OOe+OO 2.87e+02 RB-89 O.OOe+OO 3.2le+02 O.OOe+OO 0.00e+OO O.OOe+OO 6.82e+Ol O.OOe+OO 2.06e+02 SR-89 3.98e+05 O.OOe+OO O.OOe+OO O.OOe+OO 2.03e+06 6.40e+04 0.00e+OO 1.14e+04 SR-90 4.09e+07 O.OOe+OO O.OOe+OO O.OOe+OO l.12e+07 1.31e+05 O.OOe+OO 2.59e+06 SR-91 9.56e+Ol O.OOe+OO O.OOe+OO O.OOe+OO 5.26e+04 7.34e+04 O.OOe+OO 3.46e+OO SR-92 1.05e+Ol O.OOe+OO O.OOe+OO 0.00e+OO 2.38e+04 1.40e+05 O.OOe+OO 3.91e-Ol Y-90 3.29e+03 O.OOe+OO O.OOe+OO 0.00t?+00 2.69e+05 1.04e+05 O.OOe+OO 8.82e+Ol Y-91 5.88e+05 O.OOe+OO O.OOe+OO O.OOe+OO 2.45e+06 7.03e+04 O.OOe+OO l.57e+04 Y-91M 4.07e-01 O.OOe+OO O.OOe+OO O.OOe+OO 2.79e+03 2.35e+03 O.OOe+OO 1.39e-02 Y-92 1.64e+Ol O.OOe+OO 0.00e+OO O.OOe+OO 2.45e+04 l.27e+05 O.OOe+OO 4.61e-01 Y-93 l.50e+02 O.OOe+OO O.OOe+OO O.OOe+OO 7.64e+04 l.67e+05 O.OOe+OO 4.07e+OO ZR-95 l.15e+05 2.79e+04 O.OOe+OO 3.lle+04 l.75e+06 2.17e+04 O.OOe+OO 2.03e+04 ZR-97 1.50e+02 2.56e+Ol O.OOe+OO 2.59e+Ol 1.10e+05 l.40e+05 O.OOe+OO l.17e+Ol NB-95 1. 57e+04 6.43e+03 O.OOe+OO 4.72e+03 4.79e+05 l.27e+04 O.OOe+OO 3.78e+03 M0-99 O.OOe+OO 1.65e+02 O.OOe+OO 2.65e+02 l.35e+05 4.87e+04 O.OOe+OO 3.23e+Ol TC-99M l.40e-03 2.88e-03 O.OOe+OO 3. lle-02 8. lle+02 2.03e+03 O.OOe+OO 3. 72e-02 TC-101 6.51e-05 8.23e-05 O.OOe+OO 9.79e-04 5.84e+02 8.44e+02 O.OOe+OO 8.12e-04 RU-103 2.02e+03 O.OOe+OO O.OOe+OO 4.24e+03 5.52e+05 l.6le+04 O.OOe+OO 6.79e+02 Page 41of44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 61of65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & T~itium Ingestion: (mrem/yr)/(µCi/m"3))

Deposition Pathways: (m"2 * (mrem/yr)/(µCi/sec)

AgeGroup: INFANT Pathway: Inhalation (INHL)

Nuciide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-105 1.22e+OO O.OOe+OO O.OOe+OO 8.99e-01 1.57e+04 4.84e+04 O.OOe+OO 4.lOe-01 RU-106 8.68e+04 O.OOe+OO O.OOe+OO 1.07e+05 1.16e+07 1.64e+05 O.OOe+OO 1.09e+04 AG-110M 9.98e+03 7.22e+03 O.OOe+OO 1.09e+04 3.67e+06 3.30e+04 O.OOe+OO 5.00e+03 TE-125M 4.76e+03 1.99e+03 l.62e+03 O.OOe+OO 4.47e+05 1.29e+04 O.OOe+OO 6.58e+02 TE-127 2.23e+OO 9.53e-01 l.85e+OO 4.86e+OO l.04e+04 2.44e+04 O.OOe+OO 4.89e-Ol TE-127M 1.67e+04 6.90e+03 4.87e+03 3.75e+04 l.3le+06 2.73e+04 O.OOe+OO 2.07e+03 TE-129 7.88e-02 3.47e-02 6.75e-02 1.75e-01 3.00e+03 2.63e+04 O.OOe+OO l.88e-02 TE-129M l.4le+04 6.09e+03 5.47e+03 3.18e+04 1.68e+06 6.90e+04 O.OOe+OO 2.23e+03 TE-131 1. 74e-02 8.22e-03 1. 58e-02 3.99e-02 2.06e+03 8.22e+03 O.OOe+OO 5.00e-03 TE-131M 1.07e+02 5.50e+Ol 8.93e+Ol 2.65e+02 l.99e+05 1.19e+05 O.OOe+OO 3.63e+Ol TE-132 3.72e+02 2.37e+02 2.79e+02 1.04e+03 3.40e+05 4.4le+04 O.OOe+OO 1. 76e+02 I-130 6.36e+03 1. 39e+04 1.60e+06 1.53e+04 O.OOe+OO 1.99e+03 O.OOe+OO 5.57e+03 I-131 3.79e+04 4.44e+04 1.48e+07 5.18e+04 O.OOe+OO 1.06e+03 O.OOe+OO 1. 96e+04 I-132 1.69e+03 3.54e+03 1.69e+05 3.95e+03 O.OOe+OO 1.90e+03 O.OOe+OO 1.26e+03 I-133 1.32e+04 1.92e+04 3.56e+06 2.24e+04 O.OOe+OO 2.16e+03 O.OOe+OO 5.60e+03 I-134 9.2le+02 l.88e+03 4.45e+04 2.09e+03 0.00e+OO l.29e+03 O.OOe+OO 6.65e+02 I-135 3.86e+03 7.60e+03 6.96e+05 8.47e+03 O.OOe+OO 1. 83e+03 O.OOe+OO 2.77e+03 CS-134 3.96e+05 7.03e+05 O.OOe+OO 1. 90e+05 7.97e+04 1.33e+03 O.OOe+OO 7.45e+04 CS-136 4.83e+04 1.35e+05 O.OOe+OO 5.64e+04 1.18e+04 1.43e+03 O.OOe+OO 5.29e+04 CS-137 5.49e+05"6.12e+05 O.OOe+OO 1. 72e+05 7.13e+04 1.33e+03 O.OOe+OO 4.55e+04 CS-138 5.05e+02 7.81e+02 O.OOe+OO 4.10e+02 6.54e+Ol 8.76e+02 O.OOe+OO 3.98e+02 BA-139 1.48e+OO 9.84e-04 O.OOe+OO 5.92e-04 5.95e+03 5.10e+04 0.00e+OO 4. 30e-02 BA-140 5.60e+04 5.60e+Ol O.OOe+OO l.34e+Ol 1. 60e+06 3.84e+04 O.OOe+OO 2.90e+03 BA-141 l.57e-01 1.08e-04 O.OOe+OO 6.50e-05 2.97e+03 4.75e+03 O.OOe+OO 4.97e-03 BA-142 3.98e-02 3.3De-05 O.ODe+OO 1. 90e-05 1.55e+03 6.93e+D2 O.OOe+OO 1. 96e-03 LA-140 5.05e+02 2.00e+02 O.ODe+OO O.OOe+OO 1.68e+05 8.48e+04 O.OOe+OO 5.15e+Ol LA-142 l.03e+OO 3.77e-01 O.DOe+OO O.OOe+DO 8.22e+03 5.95e+04 O.OOe+OO 9.04e-02 CE-141 2.77e+04 l.67e+04 O.OOe+OO 5.25e+03 5.17e+05 2.16e+04 O.OOe+OO 1. 99e+03 CE-143 2.93e+02 l.93e+02 O.OOe+OO 5.64e+Ol l.16e+05 4.97e+04 O.OOe+OO 2.21e+Ol CE-144 3.19e+06 1.2le+06 O.OOe+OO 5.38e+05 9.84e+06 1. 48e+05 O.OOe+OO 1. 76e+05 PR-143 l.4De+04 5.24e+03 O.OOe+OO 1.97e+03 4.33e+05 3. 72e+04 O.OOe+OO 6.99e+02 PR-144 4.79e-02 l.85e-02 O.OOe+OO 6.72e-03 1. 6le+03 4.28e+03 O.OOe+OO 2.4le-03 ND-147 7.94e+03 8.13e+03 O.OOe+OO 3.15e+03 3.22e+05 3.12e+04 O.OOe+OO 5.00e+02 W-187 l.30e+Ol 9.02e+OO O.OOe+OO O.OOe+OO 3.96e+04 3.56e+04 O.OOe+OO 3.12e+OO NP-239 3.7le+02 2.98e+02 O.OOe+OO 6.62e+Ol 5.95e+04 2.49e+04 O.OOe+OO 1. BBe+Ol PU-239 4.10e+09 2.46e+09 O.OOe+OO 6.93e+08 1.19e+09 5.99e+04 O.OOe+OO 1.BBe+OB U-235 7.0le+07 O.OOe+OO O.OOe+OO 1.4le+07 4.59e+08 7.03e+07 O.OOe+OO 4.93e+06 Page 42 of 44

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 62 of65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: .(mrem/yr)/(µCi/m"3))

Deposition Pathways: (m"2 * (mrem/yr)/(µCi/sec)

AgeGroup: INFANT Pathway: Grs/Cow/Milk (CMILK)

Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 O.OOe+OO 2.38e+03 2.38e+03 2.38e+03 2.38e+03 2.38e+03 O.OOe+OO 2.38e+03 C-14 *2.34e+09 5.00e+08 5.00e+08 5.00e+08 5.00e+08 5.00e+08 O.OOe+OO 5.00e+08 NA-24 1.55e+07 l.55e+07 1. 55e+07 l.55e+07 1.55e+07 l.55e+07 O.OOe+OO 1.55e+07 P-32 2.49e+l0 9.43e+09 O.OOe+OO O.OOe+OO O.OOe+OO 2.17e+09 O.OOe+OO 6.2le+09 CR-51 O.OOe+OO O.OOe+OO l.05e+05 2.30e+04 2. 05e+0*5 4.70e+06 O.OOe+OO 1.61e+05 MN-54 O.OOe+OO 3.90e+07 O.OOe+OO 8.64e+06 O.OOe+OO 1.43e+07 O.OOe+OO 8.84e+06 MN-56 O.OOe+OO 3.20e-02 O.OOe+OO 2.75e-02 O.OOe+OO 2.9le+OO O.OOe+OO 5.51e-03 FE-55 1.35e+08 8.73e+07 O.OOe+OO O.OOe+OO 4.27e+07 1. lle+07 O.OOe+OO 2.33e+07 FE-59 2.24e+08 3.92e+08 *O.OOe+OO O.OOe+OO l.16e+08 l.87e+08 O.OOe+OO 1.55e+08 C0-58 O.OOe+OO 2.43e+07 O.OOe+OO O.OOe+OO O.OOe+OO 6.04e+07 O.OOe+OO 6.05e+07 C0-60 O.OOe+OO 8.82e+07 O.OOe+OO O.OOe+OO 0.00e+OO 2.10e+08 O.OOe+OO 2.08e+08 NI-63 3.50e+l0 2.16e+09 O.OOe+OO O.OOe+OO O.OOe+OO 1. 0Be+08 O.OOe+OO 1.2le+09 NI-65 3.57e+OO 4.04e-Ol O.OOe+OO o.ooe+oo O.OOe+OO 3.0Be+Ol O.OOe+OO 1. 84e-01 CU-64 O.OOe+OO 1.86e+05 O.OOe+OO 3.15e+05 O.OOe+OO 3.82e+06 O.OOe+OO 8.62e+04 ZN-65 5.55e+09 1.90e+l0 O.OOe+OO 9.23e+09 0.00e+OO l.6le+l0 O.OOe+OO 8.78e+09 ZN-69 2 .12e-11 3.8le-11 O.OOe+OO 1. 58e-ll O.OOe+OO 3. lle-09 o. ooe+oo. 2.84e-12 BR-.83 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 9.52e-01 BR-84 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1. 37e-22 RB-86 O.OOe+OO 2.23e+10 O.OOe+OO O.OOe+OO 0.00e+OO 5.70e+08 O.OOe+OO l.lOe+lO RB-88 O.OOe+OO 2.19e-44 O.OOe+OO O.OOe+OO O.OOe+OO 2 .13e-44 O.OOe+OO 1.20e-44 RB-89 O.OOe+OO 5.02e-53 O.OOe+OO O.OOe+OO O.OOe+OO 1. 71e-53 O.OOe+OO 3.46e-53 SR-89 1.26e+l0 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.59e+08 O.OOe+OO 3.6le+08 SR-90 1. 22e+ll O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.52e+09 O.OOe+OO 3.lOe+lO SR-91 2.73e+05 O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO 3.23e+05 O.OOe+OO 9.88e+03 SR-92 4. 72e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 5.09e+Ol O.OOe+OO 1. 75e-01 Y-90 6. 82e+02 O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO 9.42e+05 O.OOe+OO l.83e+Ol Y-91 7.33e+04 O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO 5.25e+06 O.OOe+OO 1.95e+03 Y-91M 6.00e-19 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.00e-15 O.OOe+OO 2.04e-20 Y-92 5.45e-04 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.04e+Ol O.OOe+OO l.53e-05 Y-93 2.17e+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO 1.71e+04 O.OOe+OO 5.90e-02 ZR-95 6.8le+03 1. 66e+03 O.OOe+OO l.79e+03 O.OOe+OO 8.26e+05 O.OOe+OO l.18e+03 ZR-97 4.07e+OO 6.99e-01 O.OOe+OO 7.05e-01 O.OOe+OO 4.46e+04 O.OOe+OO 3.19e-01 NB-95 5.94e+05 2.44e+05 O.OOe+OO l.75e+05 O.OOe+OO 2.06e+08 O.OOe+OO 1.4le+05 M0-99 O.OOe+OO 2.08e+OB O.OOe+OO 3.lle+OB O.OOe+OO 6.B6e+07 O.OOe+OO 4.06e+07 TC-99M 2.77e+Ol 5. 71e+Ol O.OOe+OO 6.15e+02 2.99e+Ol 1.66e+04 O.OOe+OO 7.36e+02 TC-101 2.99e-59 3.77e-59 O.OOe+OO 4.48e-58 2.05e-59 6.40e-57 O.OOe+OO 3.73e-58 RU-103 8. 67e+03 0 .. OOe+OO O.OOe+OO l.80e+04 0.00e+OO 1.06e+05 O.OOe+OO 2.90e+03 RU-105 8.14e-03 O.OOe+OO O.OOe+OO 5.98e-02 O.OOe+OO 3.24e+OO O.OOe+OO 2.74e-03 Page 43 of 44 I

For Information Only Attachment C ODCM-QA-004 Revision 6 Page 63 of 65 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)

Units: Airborne Pathways & Tritium Ingestion: (mrem/yr)/(µCi/m11 3 Deposition Pathways: (m 11 2 * (mrem/yr)/(µCi/sec) AgeGroup: INFANT Pathway: Grs/Cow/Milk (CMILK) Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-106 1.90e+05 O.OOe+OO O.OOe+OO 2.25e+05 O.OOe+OO 1. 45e+06 O.OOe+OO 2.38e+04 AG-llOM 3.86e+08 2.82e+08 O.OOe+OO 4.03e+08 O.OOe+OO 1.46e+l0 O.OOe+OO l.86e+08 TE-125M 1. 5le+08 5.04e+07 5.07e+07 O.OOe+OO O.OOe+OO 7.18e+07 O.OOe+OO 2.04e+07 TE-127 6.35e+03 2.13e+03 5.17e+03 1.55e+04 O.OOe+OO 1.33e+05 O.OOe+OO 1. 37e+03 TE-127M 4.2le+08 1. 40e+08 1.22e+08 1.04e+09 O~OOe+OO 1.70e+08 O.OOe+OO 5.10e+07 TE-129 2.83e-09 9.75e-10 2.37e-09 7.04e-09 O.OOe+OO 2.26e-07 O.OOe+OO 6.60e-10 TE-129M 5.57e+08 l.9le+08 2.14e+08 1.39e+09 O.OOe+OO 3.33e+08 O.OOe+OO 8.58e+07 TE-131 3.82e-32 l .41e-32 3.4le-32 9.78e-32 O.OOe+OO 1. SSe-30 O.OOe+OO l.07e-32 TE-131M 3.38e+06 l.36e+06 2.76e+06 .9.37e+06 O.OOe+OO 2.29e+07 O.OOe+OO 1.12e+06 TE-132 2. lle+07 1. 05e+07 1. 54e+07 6.54e+07 O.OOe+OO 3.87e+07 O.OOe+OO 9.76e+06 I-130 l.78e+06 3.92e+06 4.39e+08 4.3le+06 O.OOe+OO 8.40e+05 O.OOe+OO l.57e+06 I-131 1. 36e+09 1. 60e+09 5.27e+ll l.87e+09 O.OOe+OO 5.72e+07 O.OOe+OO 7.05e+08 I-132 7.29e-Ol l.48e+OO 6.94e+Ol 1. 65e+OO O.OOe+OO 1.20e+OO O.OOe+OO 5.27e-01 I-133 1. 82e+07 2.65e+07 4.8le+09 3. lle+07 O.OOe+OO 4.48e+06 O.OOe+OO 7.75e+06 I-134 9.27e-12 1. 90e-ll 4.43e-10 2 .12e-ll O.OOe+OO 1.96e-ll O.OOe+OO 6.75e-12 I-135 5.65e+04 1.13e+05 1.0le+07 l.25e+05 O.OOe+OO 4.07e+04 O.OOe+OO 4.10e+04 CS-134 3.65e+l0 6.BOe+lO O.OOe+OO l.75e+l0 7.18e+09 1. 85e+08 O.OOe+OO 6.87e+09 CS-136 1. 98e+09 5.8le+09 O.OOe+OO 2.32e+09 4.74e+08 8.83e+07 O.OOe+OO 2.17e+09 CS-137 5.15e+10 6.02e+l0 O.OOe+OO l.62e+l0 6.55e+09 1. 88e+08 O.OOe+OO 4.27e+09 CS-138 9.13e-23 1. 48e-22 O.OOe+OO 7.40e-23 1.16e-23 2.37e-22 O.OOe+OO 7.20e-23 BA-139 4.42e-07 2.93e-10 O.OOe+OO l.76e-10 1. 78e-10 2.80e-05 O.OOe+OO 1. 28e-08 BA-140 2.4le+08 2.4le+05 O.OOe+OO 5.72e+04 l.48e+05 5 .92e+07 O.OOe+OO l.24e+07 BA-141 4.57e-45 3.13e-48 O.OOe+OO 1. 88e-48 l.90e-48 5.58e-44 O.OOe+OO l.44e-46 BA-142 3.16e-79 2.62e-82 O.OOe+OO l.5le-82 1. 59e-82 l.30e-78 O.OOe+OO l.55e-80 LA-140 4.06e+Ol l.60e+Ol O.OOe+OO O.OOe+OO O.OOe+OO l.88e+05 O.OOe+OO 4.12e+OO LA-142 l.75e-10 6.43e-ll O.OOe+OO O.OOe+OO O.OOe+OO 1. 09e-05 O.OOe+OO 1.54e-ll CE-141 4.34e+04 2.65e+04 O.OOe+OO 8.16e+03 O.OOe+OO l.37e+07 O.OOe+OO 3.lle+03 CE-143 3.98e+02 2.64e+05 O.OOe+OO 7.68e+Ol O.OOe+OO l.54e+06 O.OOe+OO 3.0le+Ol CE-144 2.33e+06 9.52e+05 O.OOe+OO 3.85e+05 O.OOe+OO l.33e+08 0.00e+OO l.30e+05 PR-143 l.49e+03 5.56e+02 O.OOe+OO 2.07e+02 O.OOe+OO 7.84e+05 O.OOe+OO 7.37e+Ol PR-144 6.66e-53 2.58e-53 O.OOe+OO 9.34e-54 O.OOe+do 1. 20e-48 O.OOe+OO 3.36e-54 ND-147 8.8le+02 9.05e+02 O.OOe+OO 3.49e+02 O.OOe+OO 5.74e+05 0.00e+OO 5.55e+Ol W-187 6.09e+04 4.24e+04 O.OOe+OO O.OOe+OO O.OOe+OO 2.49e+06 O.OOe+OO l.46e+04 NP-239 3.65e+Ol 3.27e+OO O.OOe+OO 6.5le+OO O.OOe+OO 9.44e+04 O.OOe+OO l.85e+OO PU-239 5.68e+07 6.38e+06 O.OOe+OO 5.27e+06 O.OOe+OO 2.84e+06 O.OOe+OO 1. 46e+06 U-235 l.92e+l0 O.OOe+OO O.OOe+OO 4.09e+09 O.OOe+OO 3.33e+08 0.00e+OO l.46e+09 Page 44 of 44

For Information Only Attachment D ODCM-QA-004 Revision 6 Page 64of65 EVALUATION OF INSIGNIFICANT EFFLUENT PATHWAY GASEOUS RELEASES (Ref. 3.14) The following calculation is utilized for evaluation of gaseous effluent releases from insignificant effluent gaseous release pathways as identified in Section 2.4.5. The offsite dose is calculated via the methodology outlined in Sections 6.1 or 6.2 by inputting the Insignificant Effluent Pathway Release Rate (µCi/sec) calculated as follows: ** Release Rate (µCi/sec)= Concentration (µCi/cc) x TC x Evap. Rate (cc/min or cc/sec) Where: Release Rate = Gaseous effluent release rate (µCi/sec) from sources defined in Section 2.4.5. Concentration = Radionuclide concentration (µCi/cc) in Chemistry samples from sources defined in Section 2.4.5. TC = Coolant-Condensate Transfer Coefficient (unitless; see values below) Evap. Rate = Evaporation Rate of Insignificant Effluent Source Volume (see values below) TC Values; Tritium (H-3) ::: 1.0 Noble Gases ::: 1.0 Iodines =0.02 All Others ='0.001 Evap. Rate: RWST == 8.052 cc/min CST (U1 & U2) == 26.22 cc/min Main Turbine/RFPT Lube Oil Release Rate = 12.66 cc/sec Hydrogen Seal Oil Vapor Release Rate == 10.05 cc/sec Total Vapor Release Rate (CST & Oil)== 1388.82 cc/min If a Release Flow-rate (cfm) is desired to evaluate Activity Released, then, if Evaporation Rate= cc/sec, then Evaporation Rate/472 =Flow-rate (cfm) or , if Evaporation Rate == cc/min, then Evaporation Rate x 2.19e-3 = Flow-rate (cfm) Page 1 of 1

For Information Only Attachment E ODCM-QA-004 Revision 6

Page 65 of 65 PARAMETERS USED TO DETERMINE PARTICULATE/IODINE LIMITING RELEASE RATES 1-131 1.34E-01 1-133 1.45E+OO Cr-51 . 2.0SE-05 Mn-54 5.52E-05 Fe-59 7.10E-06 Co-58 7.00E-06 Co-60 1.23E-04 Zn-65 6.53E-05 Sr-89 1.25E-05 Sr-90 1.40E-07 Nb-95 1.00E-04 Zr-95 1.81E-05 Ru-103 4.21E-05 A -110m 2.40E-08 Sb-124 1.40E-06 Cs-134 7.46E-05 Cs-136 7.10E-06 Cs-137 1.11E-04 Ba-140 2.51E-04 Ce-141 2.91E-05 Annual Average Dispersion Parameters - Limiting Site Boundary (2)

Relative Concentration 1.25E-5 sec/m 3 Decayed Relative Concentration 1.24E-5 sec/m 3 Decayed, Depleted Relative 1.07E-5 sec/m 3 Concentration Deposition Rate 1.60E-8 m-2 Notes:

1. Design basis "expected" gaseous effluent releases per EC-RADN-1041, Rev. 6

2. 1999-2003 Meteorological Data per EC-ENVR-1057, Rev. 0 Page 1 of 1

For Information Only PROCEDURE COVER SHEET PPL SUSQUEHANNA, LLC PROCEDURE WATERBORNE EFFLUENT DOSE CALCULATIONS ODCM-QA-005 Revision 4 Page 1of49 ADHERENCE LEVEL: INFORMATION USE QUALITY CLASSIFICATION: APPROVAL CLASSIFICATION: ( X ) QA Program ( ) Non-QA Program (X) Plant ( ) Non-Plant ( ) Instruction EFFECTIVE DATE: *. ~/J> ;(xJ;o PERIODIC REVIEW FREQUENCY: N/A PERIODIC REVIEW DUE DATE: N/A RECOMMENDED REVIEWS: Nuclear Emergency Planning Proc:edure Owner: Francis J. Hickey Responsible Supervisor: Manager-Plant Chemistry/Environmental Responsible FUM: Manager-Plant Chemistry/Environmental Responsible Approver: Vice President-Nuclear O~erations FORM NDAP-QA-0002-1, Rev. 4, Page 1 of 1 (Electronic Form)

ODCM-QA-005 Revision 4 Page 2 of 49 PROCEDURE REVISION

SUMMARY

TITLE: WATERBORNE EFFLUENT DOSE CALCULATIONS Most of the revisions described below are editorial in nature. The changes made do not reduce or compromise the level of effluent control or the accuracy and/or reliability of dose calculations or setpoint determinations as required by 10CFR20.1302, 40CFR190, 10CFR50.36a and 10CFR50, Appendix I. Additionally, the changes outlined below (1) do not alter the.conduct of the radiological environmental*monitoring program, (2} do not change the radioactive effluent controls and radiological environmental monitoring activities, and (3} do not change the information to be included in the Annual Radiological Environmental Operating and Radioactive Effluent Release Reports.

1) Incorporate PCAF No. 2008-1156.

2} Update the title of Manager-Plant Chemistry to Manager-Plant Chemistry/Environmental. .*

3) Updated Section 2.3.1 to clarify the data used to support dose projections.

I

ODCM-QA-005 Revision 4 Page 3 of 49 TABLE OF CONTENTS SECTION PAGE

1. PURPOSE 5

2. POLICY/DISCUSSION 5 2.1 Applicable Pathways 5 2.2 Effluent Data 5 2.3 Projected Dose 6 2.4 Assignment of Releases to the Reactor Units 6

3. REFERENCES 6

4. RESPONSIBILITIES 7 4.1 Manager-Plant Chemistry/Environmental 7

5. DEFINITIONS 8

6. PROCEDURE 8 6.1 Liquid Effll1ent Dose Calculation 8 6.2 Projected Dose from Liquid Effluent 10 6.3 Waterborne Effluent Dose Calculations Exceeding Twice the TAM Values 1O

7. RECORDS 11 ATTACHMENTS ATTACHMENT PAGE A Dose Commitment Factors for Potable Water Pathway 12 B Dose Commitment Factors for Fish Pathway 20 c Dose Commitment Factors for Shoreline Pathway 28 I

For Information Only ODCM-OA-005 Revision 4 Page 4 of 49 ATTACHMENTS ATTACHMENT PAGE D Radioactive Decay Constants 36 E Dilution Factors and Transit Times for SSES Effluents to Danville, PA 37 F Site Specific Information 39 G Consolidated Dose Calculation 40 H Maximum Hypothetical Composite Dose Factors 42 Maximum Hypothetical Water Ingestion Dose Factors - Infant 48

For Information Only ODCM-QA-005 Revision 4 Page 5 of 49

1. PURPOSE The purpose of this procedure is to provide the methodology and parameters to be used in calculating maximum individual, whole-body and organ doses due to waterborne effluents to ensure compliance with the dose limitations in the Technical Requirements Manual (Sections 3.11 .1.2, 3.11.3) and 10CFR20.1302.

This procedure constitutes part of the SSES Offsite Dose Calculation Manual (ODCM) which is a licensing basis document.

2. POLICY/DISCUSSION 2.1 Applicable Pathways 2.1.1 The calculations of dose received by the hypothetical maximally exposed individual are based on ingestion of fish and drinking water and exposure on the .shoreline. Drinking water is taken from the nearest public drinking water intake location (Danville Water Authority). Shoreline and fish ingestion are associated with the SSES river outfall (edge of initial mixing zone).

2.1.2 Methodology for calculating dose to the maximum hypothetical offsite individual has been developed for composite (fish, drinking water and shoreline exposure) liquid effluent pathways. This methodology incorporates shore width, usage, dilution, and transit parameters specific to the SSES site. Any revision to these parameters should be reviewed against FSAR Table 11.2-15. 2.1 .3 Calculated dose contributions from the three waterborne effluent pathways are summed to obtain the total dose to a member of the public from liquid effluent. If a specific waterborne exposure pathway does not exist (based on the most recent Land Use Census results) then offsite dose calculations for the applicable exposure pathway do not need to be performed. 2.1.4 Effluent data from the following Insignificant Pathway shall be evaluated for inclusion in the Radioactive Effluent Release Report: Sewage Treatment Plant. 2.2 Effluent Data 2.2.1 The total number of curies released for each radionuclide during the time period being evaluated is supplied by the SSES radiation monitoring program.

For Information Only ODCM-QA-005 Revision 4 Page 6 of 49 2.2.2 For determination of compliance with SSES Technical Requirements Manual dose limits, effluent totals shall be based only on activity positively detected at the 95% confidence level. 2.3 Projected Dose 2.3.1 The projected quarterly dose contribution from batch releases for which radionuclide concentrations are determined by periodic composite sample analysis, as stated in TR Table 3.11.1.1-1 may be approximated by assuming an average concentration based on the previous monthly or quarterly composite analysis. 2.3.2 The calculated dose contributions from these radionuclides shall be based on the actual composite analysis. The cumulative dose commitment to the total body or any organ for a quarterly or annual analysis shall be based on the summation of isotopic activities and average cooling tower blowdown f ram all releases occurring during that time period. 2.4 Assignment of Releases to the Reactor Units 2.4.1 For determination of compliance with SSES radioactive effluent dose limits which are on a "per reactor unit" basis, waterborne effluents shall be equally divided between Unit 1 and Unit 2 release totals. (Ref. 3.11) *

3. REFERENCES 3.1 TR Table 3.11.1.1-1, Radioactive Liquid Waste Sampling and Analysis Program.

3.2 TR 3.11.1.2 Liquid Effluents Dose 3.3 TR 3.11.3 Total Dose 3.4 10CFR20.1302, Compliance with the Dose Limits for Individual Members of the Public 3.5 10CFR20 Appendix B, Annual Limits on Intake (ALis) and Derived Air Concentrations (DACs) of Radionuclides for Occupational Exposure; Effluent Concentrations; Concentrations for Release to Sewerage. 3.6 10CFR50 Appendix I, Numerical Guides for Design Objectives and Limiting Conditions for Operation to Meet the Criterion "As Low as is Reasonably Achievable" for Radioactive Material in Light-water Cooled Nuclear Power Reactor Effluents.

For Information Only ODCM-QA-005 Revision 4 Page 7 of 49 3.7 40CFR190, Environmental radiation protection standards for nuclear power operations. 3.8 Regulatory Guide 1.109, Rev. 1, October, 1977, Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purposes of Evaluating Compliance with 10CFR50, Appendix I. 3.9 SSES License Action Request 97-002, Clarification of Specifications 3.11.1.2 and 3.11.1.3, 1/20/97. 3.10 FSAR Table 11.2-15, Input Data for Aquatic Dose Calculations. 3.11 NUREG-0133 Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants, October 1978. 3.12 "Study of Travel Time and Mixing Characteristics for the Susquehanna River Below the Susquehanna Steam Electric Station," The Sutron Corporation, Sutron Report No. SCRSS-0007, November, 1985. 3.13 Kocher, D. C., "Radioactive Decay Tables," DOE/TIC Report 11026, Oak Ridge National Laboratory, Oak Ridge, TN, 1981. 3.14 PPL Calculation EC-RADN-1041, Rev. 5, "SSES 'Expected' Liquid and Gaseous Effluent Aquatic Doses and Atmospheric Doses - NWC/CFS/HWC." 3.15 PPL Calculation EC-ENVR-1055, Rev. O, "Evaluation of Dose Factors for Liquid and Gaseous Effluent Releases." 3.16 PPL Calculation EC-ENVR-0501 (OT-93-RKB-019), Liquid Dose Factor Calculations - Liquid Pathway Dose Factors for SSES ODCM. 3.17 "Importance of P-32 in Nuclear Reactor Liquid Effluents," Edward F. Branagan, Jr., Charles R. Nichols and Charles A. Willis, USNRC June 1982. 3.18 PPL AR No. 401298 "Deletion of LRW Composite Sample P-32 Analysis," May 2002.

4. RESPONSIBILITIES 4.1 Manager-Plant Chemistry/Environmental 4.1 .1 Ensures adequacy and correctness of methodology used in calculating doses resulting from waterborne effluents as necessary for fulfillment of Technical Requirement Surveillances (Sections 3.11.1.2.1 and 3.11.3.1 ).

For Information Only ODCM-OA-005 Revision4 Page 8 of 49 4.1.2 Ensures dose calculations necessary for fulfillment of Technical Requirement Surveillances (Sections 3.11.1.2.1 and 3.11.3.1) are performed. 4.1.3 Ensures methodology and parameters to be used in calculating doses resulting from waterborne effluents are developed to ensure compliance with the dose limitations in the Technical Requirements Manual.

5. DEFINITIONS None

6. PROCEDURE 6.1 Liquid Effluent Dose Calculation The dose due to radionuclides released in liquid effluent to unrestricted areas is calculated via equations*1, 2 and 3 as outlined below. The equations incorporate the methodology as described in Regulatory Guide 1.109. A consolidated version of the Regulatory Guide 1.109 dose calculation methodology is outlined in

Attachment G.

Mp Uap ~Q "A*t R~pi= 1119 -F-~ iDaipie P Potable Water (1) l Rapi -1119

                                    -     Mp Uap kJ~Q i B;p Daipi e*A*t' P                  Fish (2)

F i MUW R *pJ. -1119 P F*p ~ Q.l T* D .. [e*A;tp][l- e*J..,th) Shoreline (3)

                                   -                ~       . I DlpJ l

Where: B;p = Equilibrium bioaccumulation factor for nuclide i in pathway p, expressed as the ratio of the concentration in biota (pCi/kg) to the radionuclide concentration in water (pCi/liter), i.e., liter/kg (Ref. 3.8 Table A-1) Daipi = Dose factor specific to a given age group a, radionuclide i, pathway p, and organ j, which can be used to calculate the radiation dose from ingestion of a radionuclide or from standing on contaminated ground (Ref. 3.8 Table E-6, E-11 through E-14) (mrern/pCi ingested or mrem/hr per pCi/m 2)

For Information Only ODCM-QA-005 Revision 4 Page 9 of 49 F = Flow rate in the liquid effluent (cooling tower blowdown flow in ft. 3/sec) .

                    . Mp        =    *Mixing ratio at the point of withdrawal of drinking water or point of harvest of fish
                                =     Reciprocal of the dilution factor DFp (Attachment E)
                                =     1/DFp
                                =     Release rate of nuclide i (Ci/yr)

Rap; = Total annual dose to organ j of individuals of age group a from all radionuclides in the pathway p (mrem/yr)

                                =     Total time elapsed between release of the nuclides and ingestion of food or water (Attachment F) (hr)
                                =     Usage factor that specifies the intake rate or exposure rate for an individual oi age group a associated with pathway p (Attachment F) (kg/yr, I/yr or hr/yr)
                                =      Radioactive decay constant of nuclide i (Attachment D) (hf1) 1119      =                                        3 Factor to convert from (Ci/yr)/(ft /sec) to pCi/liter (Reg Guide 1.109 lists 1100 which is 1119 rounded to nearest hundreth) 111,900   =      Factor to convert from (Ci/yr)/(ft3/sec) to pCi/liter and to account for proportionality constant (100 liter/m2 -day) used in sediment radioactivity model (Reg. Guide 1.109 lists 110,000 which is 111,900 rounded to the nearest ten thousandth)

W = shoreline width factor (Attachment F) (dimensionless) tb = Period of time shoreline is ex.posed to contaminated water (Attachment F) (hr) T1 = Radioactive half-lite of nuclide i (days). It should be noted that although the same notation is used for all three pathways, Mp, Uap. and tp have different values, because the assumed point of withdrawal of drinking water is not the same as the assumed point of fish harvest or shoreline exposure.

For Information Only ODCM-QA-005 Revision 4 Pa!;Je 10 0149 6.2 Projected Dose from Liql.ijd Effluent 6.2.1 Doses from liquid effluents released to unrestricted areas are projected at least every 31 days as required by TRM 3.11.1.3. These projections are made by averaging the doses from previous operating history as appropriate, for what would be indicative of expected future operations. The dose projection from Liquid Effluents Released to Unrestricted Areas can als_o be performed by the following equation: - R .=I[K .. *C._*V*k] apJ i mp] 1 Eq.4 Where: Rapj = Total projected dose during period to organ j from 'fish, water ingestion and shoreline exposure to individuals of age group a from all radionuclides in pathway p (mrem); KaipJ = Composite dose conversion factor (adult, teen, child) or water ingestion dose factor (infant) to organ j of individuals to age group a from radionuclide i in pathway p (mrem/Ci released: Attachment H for Maximum Hypothetical Composite Dose Factors, Attachment I for Maximum Hypothetical Water Ingestion Dose Factors); Average concentration of radionuclide i in undiluted liquid effluent during batch release from radwaste (Ci/ml). v = Total undiluted batch volume released from radwaste (gallons). k = Conversion factor {3. 785E3 ml/gallon). 6.3 Waterborne Effluent Dose Calculations Exceeding Twice the TRM Values 6.3.1 When the results of waterborne dose calculations exceed twice the value of the TR 3.11.1.2.a or 3.11.1.2.b), calculations shall be made including the direct radiation contribution to determine if the limits of TR 3.11.3 have been exceeded. If the limits of TR 3.11.3 have been exceeded, a special report shall be prepared and submitted to the NRC within 30 days addressing the actions specified in TR 3.11.3.

For Information Only ODCM-QA-005 Revision 4 Page 11 of 49

7. RECORDS None

For Information Only Attachment A ODCM-QA-005 Revision 4 Page 12 of 49 DOSE COMMITMENT FACTORS

                                              'FOR THE POTABLE WATER PATHWAY (Ref. 3.15)

Release Type: Liquid Units: (mrem/hr)/(µCi/ml)) Age Group: ADULT Pathway: Potable Water (PWtr) Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB 8.74e+OO 8.74e+OO 8.74e+OO B.74e+OO 8.74e+OO O.OOe+OO 8.74e+OO H-3 O.OOe+OO C-14 2.36e+02 4.73e+Ol 4.73e+Ol 4.73e+Ol 4.73e+Ol 4.73e+Ol O.OOe+OO 4.73e+Ol NA-24 1.4le+D2 l.4le+02 1. 4le+02 l.4le+02 l.4le+02 1. 4le+02 O.OOe+OO 1. 4le+02 Cl) P-32 2.50e+03 9.99e+02 O.OOe+OO O.OOe+OO O.OOe+OO 1.8le+03 O.OOe+OO 6.21e+02 CR-51 O.OOe+OO O.OOe+OO l.32e-Ol 4.BSe-02 2.94e-Ol 5. 57e+Ol O.OOe+OO 2.21e-01 MN-54 O.OOe+OO 3.BOe+02 O.OOe+OO 1.13e+02 O.OOe+OO 1.17e+03 O.OOe+OO 7.26e+Ol Ml\T-56 o.ooe+Oo 9.57e+OO O.OOe+OO l.22e+Ol O.OOe+OO 3.05e+02 O.OOe+OO 1. 70e+OO FE-55 2.29e+02 1. 58e+02 O.OOe+OO O.OOe+OO 8.82e+Ol 9.07e+Ol O.OOe+OO 3.69e+Ol FE-59 3.61e+02 8.49e+02 O.OOe+OO O.OOe+OO 2.37e+02 2.83e+03 O.OOe+OO 3.25e+02 C0-58 O.OOe+OO 6.20e+Ol O.OOe+OO O.OOe+OO O.OOe+OO 1. 26e+03 O.OOe+OO 1.39e+02 C0-60 o.OOe+OO 1. 7Be+02 0.00e+OO O.OOe+OO O.OOe+OO 3.35e+03 O.OOe+OO 3.93e+02 NI-63 l.08e+04 7.50e+02 O.OOe+OO O.OOe+OO O.OOe+OO 1.56e+02 O.OOe+OO 3.63e+02 NI-65 4.39e+Ol 5.7le+OO O.OOe+OO O.OOe+OO O.OOe+OO l.45e+02 O.OOe+OO 2.60e+OO CU-64 O.OOe+OO 6.93e+OO O.OOe+OO l.75e+Ol O.OOe+OO 5.91e+02 0.00e+OO 3.25e+OO ZN-65 4.03e+02 l.28e+03 O.OOe+OO 8.57e+02 0.00e+OO 8.07e+02 0.00e+OO 5.79e+02 ZN-69 8.57e-01 l.64e+OO 0.00e+OO l.07e+OO O.OOe+OO 2.46e-01 0.00e+OO l.14e-01 BR-83 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 4.82e+OO O.OOe+OO 3.35e+OO BR-84 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 3.40e-05 O.OOe+OO 4.34e+OO BR-B5 O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1. 7Be-01 RB-86 o.OOe+OO 1. 76e+03 O.OOe+OO O.OOe+OO 0.00e+OO 3.46e+02 O.OOe+OO 8.18e+02 RB-88 O.OOe+OO 5.03e+OO O.OOe+OO O.OOe+OO O.OOe+OO 6.96e-11 O.OOe+OO 2.67e+OO RB-B9 O.OOe+OO 3.34e+QQ O.OOe+OO O.OOe+OQ O.OOe+QO l.94e-13 O.OOe+OQ 2.35e+OO SR-89 2.56e+04 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OQ 4. lle+03 O.OOe+OO 7.36e+02 SR-90 6.31e+05 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO l.82e+04 O.OOe+OO l.55e+05 SR-91 4.72e+02 O.OOe+OO 0.00e+OO O.OOe+OO 0.00e+OO 2.25e+03 O.OOe+OO l.91e+Ol SR-92 1.?9e+02 0.00e+OO O.OOe+OO O.OOe+OO 0.00e+OO 3.55e+03 O.OOe+OO 7.74e+OO Y-90 8.0le-01 O.OOe+OO O.OOe+OO Q.OOe+OO O.OOe+OO 8.49e+03 O.OOe+OO 2.lSe-02 Y-91 1.17e+Ol O.OOe+OQ 0.00e+OO O.OOe+OO 0.00e+OO 6.46e+03 O.OOe+OO 3.14e-01 Y-91M 7.56e-03 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.22e-02 O.OOe+OO 2.93e-04 Y-92 7.03e-02 0.00e+OO O.OOe+OO O.OOe+OO o.ooe+oo 1. 23e+03 O.OOe+OO 2.06e-03 Y-93 2.23e-Ol O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 7. 07e+03 O.OOe+OO 6.lGe-03 ZR-95 2.53e+OO 8. lle-01 O.OOe-t-00 1. 27e+OO O.OOe+OO 2.57e+03 o.ooe+oo 5.49e-Ol ZR-97 1.40e-01 2.82e-02 O.OOe+OO 4.26e-02 O.OOe+OO 8.74e+03 0.00e+OO 1. 29e-02 NB-95 5.lBe-01 2.BBe-01 O.OOe-rOO 2.BSe-01 O.OOe+OO l.75e+03 O.OOe+OO l.55e-01 M0-99 O.OOe+OO 3.59e+02 O.OOe+OO 8.12e+02 O.OOe+OO 8.31e+02 O.OOe+OO 6.82e+Ol TC-99M 2.06e-02 5.Ble-02 O.OOe+OO 8.82e-01 2.85e-02 3 ;44e+Ol O.OOe+OO 7.40e-01 TC-101 2.lle-02 3.05e-02 O.OOe+OO 5.48e-01 1.56e-02 9.15e-14 O.OOe+OO 2.99e-01 RU-103 1. 54e+Ol 0.00e+OO O,OOe+OO 5.88e+Ol O.OOe+OO l.80e+03 O.OOe+OO 6.63e+OO 1

             < l1ngestion dose factor {tor bone) used in calculation of Dose Commitment Factor for P-32 derived in accordance with information supplied in Reference 3.17. The teen and child bone dose ingestion dose factors were derived by the ratio of the adult bone ingestion dose factors in Reg. Guide 1.109 and "The Importance of P-32 in Nuclear Reactor Liquid Effluents," Branagan,E. F.,.Nichols, C.R;, andWillis, C. A.,

USNRC, 6/82 (Ref 3.17). Page 1 of 8

For Information Only Attachment A ODCM-QA-005 Revision 4 Page 13 of 49 DOSE COMMITMENT FACTORS FOR THE POTABLE WATER PATHWAY (Ref. 3.15) Release Type: Liquid Units: ( (mrem/hr) I (µCi/ml)) Age Group: ADULT Pathway: Potable Water (PWtr) Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-105 1.2Be+OO O.OOe+OO O.OOe+OO l.66e+Ol 0.00e+OO 7.84e+02 O.OOe+OO 5.06e-Ol RU-106 2.29e+02 O.OOe+OO 0.00e+OO 4.42e+02 O.OOe+OO 1.48e+04 O.OOe+OO 2. 90.e+Ol AG-llOM 1.33e+Ol 1.23e+Ol O.OOe+OO 2.42e+Ol O.OOe+OO S.03e+03 0.00e+OO 7.32e+OO TE-125M 2.23e+02 S.08e+Ol 6.7le+Ol 9.07e+02 O.OOe+OO 8.90e+02 O.OOe+OO 2.99e+Ol TE-127 9.15e+OO 3.29e+OO 6.78e+OO 3.73e+Ol O.OOe+OO 7.22e+02 0.00e+OO 1.98e+OO TE-127M 5.63e+02 2.0le+02 1.44e+02 2.29e+03 0.00e+OO l.89e+03 o.ooe+oo 6.87e+Ol TE-129 2.61e+OO 9.82e-01 2.0le+OO l.lOe+Ol O.OOe+OO l.97e+OO O.OOe+OO 6.37e-Ol TE-129M 9.57e+02 3.57e+02 3.29e+02 3.99e+03 0.00e+OO 4.82e+03 O.OOe+OO l.5le+02 TE-131 1. 64e+OO 6.85e-Ol l.35e+OO .7 .18e+OO O.OOe+OO 2.32e-Ol 0.00e+OO 5.18e-Ol TE-131M l.44e+02 7.04e+Ol l.12e+02 7.13e+02 O.OOe+OO 6.99e+03 O.OOe+OO 5.87e+Ol TE-132 2.10e+02 1.36e+02 l.50e+02 l.31e+03 0.00e+OO 6.42e+03 o.ooe+oo l.27e+02 I-130 6.29e+Ol l.86e+02 l.57e+04 2.90e+02 o.ooe+oo 1. 60e+02 O.OOe+OO 7.32e+Ol I-131 3.46e+02 4.95e+02 l.62e+05 8.49e+02 O.OOe+OO 1. 3le+02 O.OOe+OO 2.84e+02 I-132 l.69e+Ol .4.52e+Ol 1.58e+03 .7.20e+Ol O.OOe+OO 8.49e+OO o.ooe+oo 1.58e+Ol I-133 l.18e+02 2.06e+02 3.02e+04 3.59e+02 O.OOe+OO 1.85e+02 o.ooe+oo 6.27e+Ol

             !-134      8.82e+OO    2.40e+Ol  4.1Se+02 3. 8.le+Ol  O.OOe+OO  2.09e-02   O.OOe+OO  8.57e+OO I-135      3.69e+Ol    9.65e+Ol  6.37e+03 1.55e+02    O.OOe+OO  1.09e+02   O.OOe+OO  3.56e+Ol CS-134     5.18e+03    l.23e+04  O.OOe+OO 3.99e+03    l.32e+03  2.16e+02   0.00e+OO  l.Ole+04 CS-136     S.42e+02    2.14e+03  O.OOe+OO l.19e+03    1. 63e+02 2.43e+02   O.OOe+OO  l.54e+03 CS-137     6.63e+03    9.07e+03  G.OOe+OO 3.08e+03    l.02e+03  l.76e+02   G.OOe+OO  5.94e+03 CS-138     4.59e+OO    9.07e+OO  O.OOe+OO 6.67e+OO    6.58e-01  3.87e-05   ri.ooe+oo 4.49e+OO BA-139     8.07e+OO    S.75e-03  O.OOe+OO 5.38e-03    3.26e-03  1.43e+Ol   O.OOe+OO  2.36e-Ol BA-140     l.69e+03    2.12e+OO  O.OOe+OO 7.22e-Ol    1.22e+OO  3.48e+03   O.OOe+OO  l.lle+02 BA-141     3 .92e+OO   2.96e-03  0.00e+OO 2.75e-03    l.68e-03  1.BSe-09   O.OOe+OO  1.32e-01 BA-142     1.77e+OO    1.82e-03  0.00e+OO 1.54e-03    l.03e-03  2.SOe-18   o.ooe+oo   1.12e-01 LA-140     2.08e-Ol    1.0Se-01  O.OOe+OO O.OOe+OO    O.OOe+OO  7.70e+03   O.OOe+OO  2.77e-02 LA-142     1.07e-02    4.84e-03  O.OOe+OO O.OOe+OO    O.OOe+OO  3.54e+01   0.00e+OO   1. 21e-03 CE-141     7.79e-01    S.27e-Ol  O.OOe+OO 2.45e-Ol    0.00e+OO  2.0le+03   O.OOe+OO   S.98e-02 CE-143     l.37e-01    1.02e+02  0.00e+OO 4.47e-02    O.OOe+OO  3.79e+03   O.OOe+OO   l.12e-02 CE-144     4.06e+Ol    1.70e+01   0.00e+OO 1.0le+Ol   O.OOe+OO   1.37e+04  O.OOe+OO   2.18e+OO PR-143     7.66e-01    3.07e-Ol   O.OOe+OO 1. 77e-Ol  0.00e+OO   3.35e+03   O.OOe+OO  3.79e-02 PR-144     2.50e-03    1.04e-03   O.OOe+OO 5.87e-04   O.OOe+OO   3.60e-10   O.OOe+OO  1.27e-04 ND-147      5.23e-Ol   6.05e-Ol   O.OOe+OO 3.54e-Ol   O.OOe+OO   2.90e+03   O.OOe+OO  3. 62e-02 W-187       8.57e+OO   7.17e+OO   O.OOe+OO O.OOe+OO    O.OOe+OO  2.35e+03   o.ooe+oo  2.50e+OO NP-239      9.90e-02   9.74e-03   O.OOe+OO 3.04e-02   0.00e+OO   2.00e+03   O.OOe+OO  5.37e-03 PU-239     6.Q3e+04    7.25e+03   O.OOe+GO 6.75e+G3   O.OOe+OO   5.54e+03   0.00e+OO  1.59e+03 U-235       6.67e+04    O.OOe+OO  O.OOe+OO 1.56e+04    O.OOe+OO  6.50e+03   O.OOe+OO  4.04e+03 Page 2 of 8

For Information Only Attachment A ODCM-OA-005 Revision 4 Page 14 of 49 DOSE COMMITMENT FACTORS FOR THE POTABLE WATER PATHWAY {Ref, 3.15) Release Type: Liquid Units: ( (mrem/hr) I (µCi/ml) l Age Group: TEEN Pathway: Potable Water (PWtr) Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 O.OOe+OO 6.16e+OO 6.16e+OO 6.16e+OO 6.16e+OO 6.16e+OO 0.00e+OO 6.16e+OO C-14 2.36e+02 4.72e+Ol 4. 72e+Ol 4.72e+Ol 4. 72e+Ol 4.72e+Ol 0.00e+OO 4. 72e+Ol NA-24 l.34e+02 l.34e+02 1.34e+02 l.34e+02 l.34e+02 l.34e+02 O.OOe+OO 1. 34e+02 * (l) P-32 2.50e+03 9.94e+02 O.OOe+OO O.OOe+OO O.OOe+OO l.35e+03 0.00e+OO 6.22e+02 CR-51 O.OOe+OO O.OOe+OO 1.16e-Ol 4.59e-02 2.99e-Ol 3.52e+Ol O.OOe+DO 2.D9e-01 MN-54 O.OOe+OO 3.43e+02 O.OOe+OO l.02e+02 0.00e+OO 7.03e+02 O.OOe+OO 6.80e+01 MN-56 o.ooe+oo 9.19e+OO O.OOe+OO l.16e+Ol O.OOe+OO 6.05e+02 O.OOe+OO 1. 63e+OO FE-55 2.20e+02 l.56e+02 O.OOe+OO O.OOe+OO 9.88e+Ol 6.74e+Ol O.OOe+OO 3.63e+Ol FE-59 3.41e+02 7.97e+02 o.ooe.i-OO O.OOe+OO 2.51e+02 1.88e+03 O.OOe+OO 3.08e+02 C0-58 D.OOe+DD 5.65e+Ol O.OOe+OO o.ooe+oo* O.OOe+OO 7.79e+02 o.ooe+oo l.30e+02 C0-60 O.OOe+OO 1. 63e+02 o.6oe+oo O.OOe+OO O.OOe+OO 2.13e+03 0.00e+OO 3.68e+02 NI-63 l.03e+04 7.27e+02 O.OOe+OO O.OOe+OO O.OOe+OO 1.16e+02 O.OOe+OO 3.49e+02 NI-65 4.35e+Ol 5.56e+OO O.OOe+OO O.OOe+OO O.OOe+OO 3.02e+02 0.00e+OO 2.53e+OO CU-64 O.OOe+OO 6.69e+OO O.OOe+OO l.69e+Ol O.OOe+OO 5.19e+02 O.OOe+OO 3.15e+OO ZN-65 3.35e+02 l.16e+03 O.OOe+OO 7.44e+02 O.OOe+OO 4.92e+02 O.OOe+OO 5.42e+02 ZN-69 8.55e-01 1.63e+OO O.OOe+OO 1. 06e+OO O.OOe+OO 3.00e+OO 0.00e+OO l.14e-01 BR-83 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 3.34e+OO BR-84 o.ooe+oo O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO o.ooe+Oo 4.20e+OO BR-85 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1. 77e-01 RB-86 O.OOe+OO l.73e+D3 O.OOe+OO O.OOe+OO O.OOe+OO 2.56e+02 O.OOe+OO 8.14e+02 RB-88 O.OOe+OO 4.95e+OO O.OOe+OO O.OOe+OO O.OOe+OO 4.24e-07 0.00e+OO 2.64e+OO RB-89 0.00e+OO 3.20e+OO O.OOe+OO O.OOe+OO O.OOe+OO 4.90e-09 0.00e+OO 2.26e+OO SR-89 2.56e+04 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+QO 3.05e+03 O.OOe+OO 7.33e+02 SR-90 4.83e+05 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.35e+04 O.OOe+OO 1.19e+OS SR-91 4.69e+02 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.. 13e+03 O.OOe+OO 1.87e+01 SR-92 1.77e+02 O.OOe+OO O.OOe+OO O.OOe+OO 0. OOe+OO 4.52e+03 O.OOe+OO 7.56e+OO Y-90 7.97e-01 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 6. 57e+0.3 o.ooe+oo 2.lSe-02 Y-91 1.17e+Ol O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO 4.79e+03 O.OOe+OO 3.13e-01 Y-91M 7.50e-03 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO 3.54e-01 o.ooe+oo 2.87e-04 Y-92 7.03e-02 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.93e+03 o.ooe+oo 2.03e-03 Y-93 2.23e-01 O.OOe+OO Q.OOe+OO 0.00e+OO O.OOe+OO 6.SOe+03 O.OOe+OO 6.lOe-03 ZR-95 2.40e+OO 7.56e-Ol o.ooe+oo 1.lle+OO 0.00e+OO l.74e+03 0.00e+OO 5.20e-01 ZR-97 1.38e-01 2.73e-02 O.OOe+OO 4.13e-02 O.OOe+OO 7.38e+03 O.OOe+OO 1. 26e-02 NB-95 4.78e-01 2.65e-01 O.OOe+OO 2.57e-Ol O.OOe+OO l.13e+03 O.OOe+OO 1.46e-01 M0-99 O.OOe+OO 3.Sle+02 O.OOe+DO 8.02e+02 O.OOe+OO 6.28e+02 O.OOe+OO 6.69e+Ol TC-99M 1.93e-02 5.38e-02 o.OOe+OO 8.02e-Ol 2.99e-02 3.53e+Ol 0.0Qe+OO 6.98e-Ol TC-101 2.09e-02 2.98e-D2 O.OOe+OO 5.3Be-01 l.Ble-02 5.09e-09 O.OOe+OO 2.92e-Ol RU-103 l.48e+Ol O.OOe+OO O.OOe+OO 5.23e+Ol O.OOe+OO L24e+03 O.OOe+OO 6.34e+OO 1

             < >1nges!ion  dose factor (for bone} used in calculation of Dose Commitment Factor for P-32 derived in accordance with information supplied in Reference 3.17. The teen and child bone dose ingestion dose factors were derived by the ratio of the adult bone ingestion dose factors in Reg. Guide 1.109 and "The Importance of P*32 in Nuclear Reactor liquid Effluents," Branagan, E. F .. Nichols, C.R., and Willis, C. A., USNRC, 6/82 (Ref 3.17}.

Page 3 of 8

For Information Only Attachment A ODCM-QA-005 Revision 4 Page 15 of 49 DOSE COMMITMENT FACTORS FOR THE POTABLE WATER PATHWAY (Ref. 3.15) Release Type: Liquid Units: ((rnrem/hr)/(µCi/rnl)) Age Group: TEEN Pathway: Potable Water (PWtr) Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-105 l.27e+OO O.OOe+OO 0.00e+OO 1.60e+Ol O.OOe+OO l.02e+03 0.00e+OO 4.92e-01 RU-106 2.2Be+02 O.OOe+OO 0.00e+OO 4.40e+02 O.OOe+OO l.09e+04 O.OOe+OO 2.87e+Ol AG-110M 1.19e+Ol l.13e+Ol O.OOe+OO 2.15e+Ol O.OOe+OO 3.17e+03 O.OOe+OO 6.86e+OO TE-125M 2.23@+02 8.02e+Ol 6.22e+Ol O.QQe+QO O.OOe+OO 6.57e+02 O.OOe+OO 2.98e+Ol TE-127 9.19@+00 3.26e+OO 6.34e+OO 3.72e+Ol O.OOe+OO 7.09e+02 O.OOe+OO l.98e+OO TE-127M 5.62@+02 l.99e+02 l.34e+02 2.28e+03 O.OOe+OO l.40e+03 O.OOe+OO 6.69e+Ol TE-129 2.60@+00 9.7le-Ol 1. 86e+OO l.09e+Ol O.OOe+OO 1. 42e+Ol O.OOe+OO 6.34e-Ol TE-129M 9.48e+02 3.52e+02 3.06e+02 3.97e+03 O.OOe+OO 3.56e+03 O.OOe+OO 1. 50e+02 TE-131 1.62@+00 6.69e-01 1.25e+OO 7.09e+OO O.OOe+OO 1.33e-Ol O.OOe+OO 5.07e-01 TE-131M 1.42e+02 6.80e+Ol 1.02e+02 7.09e+02 O.OOe+OO 5.46e+03 O.OOe+OO 5.67e+Ol TE-132 2.03@+02 l.28e+02 l.35e+02 l.23e+03 O.OOe+OO 4.07e+03 O.OOe+OO l.2le+02 I-130 5.99@+01 1. 73e+02 1. 41e+0'4 2.67e+02 O.OOe+OO l.33e+02 O.OOe+OO 6.92e+Ol I-131 3.40@+02 4.76e+02 1. 39e+05 8.20e+02 O.OOe+OO 9.42e+Ol O.OOe+OO 2.56e+02 I-132 1.62e+Ol 4.24e+Ol 1. 43e+03 6.69e+Ol O.OOe+OO l.85e+Ol O.OOe+OO l.52e+Ol I-133 1.17@+02 1. 98.e+02 2.77e+04 3.48e+02 O.OOe+OO 1.50e+02 O.OOe+OO 6.05e+Ol I-134 8.49e+OO 2.25e+Ol 3.75e+02 3.55e+Ol O.OOe+OO 2.97e-01 0.00e+OO B.08e+OO I-135 3.55@+01 9.13e+Ol 5.87e+03 l.44e+02 O.OOe+OO 1. Ole+02 O.OOe+OO 3.38e+Ol CS-134 4.8'7e+03 L 1Se+04 O.OOe+OO 3.64e+03 l.39e+03 1.42e+02 O.DOe+OO 5.31e+03 CS-136 4.99@+02 l.97e+03 O.OOe+OO l.07e+03 l.69e+02 l.58e+02 O.OOe+OO 1. 32e+03 CS-137 6.5le-+03 8.66e+03 O;OOe+OO 2.95e+Ol l.15e+03 1. 23e+02 O.OOe+OO 3.02e+03 CS-138 4.51e+OO 8.66e+OO 0.00e+OO 6.40e+OO 7.44e-Ol 3.93e-03 O.OOe+OO 4.33e+OO BA-139 8.08e+OO 5.69e-03 O.OOe+OO 5.36e-03 3.92e-03 7.2le+Ol O.OOe+OO 2.35e-01 BA-140 l.65e+03 2.02e+OO O.OOe+OO 6.86e-Ol 1.36e+OO 2.55e+03 O.OOe+OO l.06e+02 BA-141 3.90e+OO 2.91e-03 0.00e+OO 2.70e-03 l.99e-03 8.3le-06 O.OOe+OO l.30e-Ol BA-142 1. 74e+OO l.74e-03 O.OOe+OO 1.47e-03 l.16e-03 5.34e-12 O.DOe+OO 1. 07e-Ol LA-140 2.02e-Ol 9.94e-02 O.OOe+OO O.OOe+OD O.ODe+DO 5. 71e+03 O.DOe+DO 2.65e-02 LA-142 1.04e-02 4.62e-03 O.ODe+OO 0.0De+OO O.OOe+OO l.4le+02 0.00e+OO l.15e-03 CE-141 7.73e-Ol 5.16e-01 O.OOe+OO 2.43e-Ol O.OOe+OO l.48e+03 O.OOe+OO 5.93e-02 CE-143 1.37e-Ol 9.94e+Ol O.OOe+DO 4.46e-02 O.OOe+OO 2.99e+03 O.OOe+OO l.11e-02 CE-144 4.05e+Ol 1. 67e+Ol 0.00e+OO 1. OOe+Ol O.OOe+OO l.02e+04 O.OOe+OO 2.17e+OO PR-143 7.62e-Ol 3.04e-01 O.OOe+OO 1. 77e-Ol O.OOe+OO 2.5le+03 O.OOe+OO 3.79e-02 PR-144 2.50e-03 1.02e-03 O.OOe+OO 5.87e-04 O.OOe+OO 2.76e-06 O.DOe+OO 1.27e-04 ND-147 5.45s-Ol 5.93e-01 O.OOe+OO 3.48e-Ol O.OOe+OO 2.14e+03 O.OOe+OO 3.55e-02 W-187 8.49s+OO 6.92e+OO 0.00e+OO 0.00e+OO O.OOe+OO 1.87e+03 O.OOe+OO 2.42e+OO NP-239 1. 02s-01 9.65e-03 O.OOe+OO 3.03e-02 O.OOe+OO l.55e+03 O.OOe+OO 5.36e-03 PU-239 4.45e+04 5.40e+03 O.OOe+OO 4.98e+03 O.OOe+OO 4. lle+03 O.OOe+OO l.17e+03 U-235 6.63e+04 O.OOe+OO O.OOe+OO l.55e+04 O.OOe+OO 4.8le+03 O.OOe+OO 4.04e+03 Page 4 of 8

For Information Only Attachment A ODCM-QA-005 Revision 4 Page 16 of 49 DOSE COMMITMENT FACTORS FOR THE POTABLE WATER PATHWAY (Ref. 3.15) Release Type: Liquid Units: ((mrem/hr)/(µCi/ml)) Age Group: CHILD Pathway: Potable Water (PWtr) Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 O.OOe+OO l.18e+Ol 1.18e+Ol l.18e+Ol l.18e+Ol l.18e+Ol O.OOe+OO l.18e+Ol C-14 7.03e+02 1.4le+02 1.4le+02 l.4le+02 1.41e+02 l.4le+02 O.OOe+OO 1.41e+02 NA-24 3.37e+02 3.37e+02 3.37e+02 3.37e+02 3.37e+02 3.37e+02 O.OOe+OO 3.37e+02 (1) P-32 7.44e+03 2.24e+03 O.OOe+OO O.OOe+OO 0.00e+OO 1.33e+03 O.OOe+OO 1.85e+03 CR-51 O.OOe+OO 0.00e+OO 2.87e-01 7.85e-02 5.24e-Ol 2.74e+Ol O.OOe+OO 5.17e-01 MN-54 O.OOe+OO 6.22e+02 O.OOe+OO l.74e+02 O.OOe+OO 5.22e+02 O.OOe+OO l.66e+02 MN-56 O.OOe+OO 1.94e+Ol O.OOe+OO 2.35e+Ol O.OOe+OO 2.8le+03 O.OOe+OO 4.38e+OO FE-55 6.69e+02 3.55e+02 O.OOe+OO O.OOe+OO 2.0le+02 6.57e+Ol O.OOe+OO 1.10e+02 FE-59 9.59e+02 1.55e+03 0.00e+OO O.OOe+OO 4.50e+02 l.62e+03 O.OOe+OO 7.73e+02 C0-58 O.Ooe+OO l.05e+02 O.OOe+OO O.OOe+OO O.OOe+OO 6.10e+02 O.OOe+OO 3.20e+02 C0-60 o.OOe+OO 3.08e+02 O.OOe+OO O.ODe+QO D.OOe+OO l.7De+03 D.OOe+OO 9.07e+02 NI-63 3.13e+04 l.67e+03 O.OOe+OO 0.00e+OO O.OOe+OO l.13e+02 O.DOe+OO l.D6e+03 NI-65 l.29e+02 l.22e+Ol 0.00e+OO O.OOe+OO o.ooe+oo l.49e+03 O.OOe+OO 7.09e+OO CU-64 O.DDe+OO l.42e+Ol O.OOe+OO 3.44e+Ol 0.00e+OO 6.69e+02 O.OOe+OO 8.60e+OO ZN-65 7.97e+02 2.12e+03 O.OOe+OO l.34e+03 O.OOe+OO 3.73e+02 O.OOe+OO 1.32e+03 ZN-69 2.55e+OO 3.68e+OO 0.00e+OO 2.23e+OO O.OOe+OO 2.32e+02 O.OOe+OO 3.40e-01 BR-83 O.Ooe+OO o.ooe+oo 0.00e+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO 9.94e+OO BR-84 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO l.15e+Ol BR-85 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OD O.OOe+OO 0.00e+OO O.OOe+OO 5.30e-01 RB-86 O.OOe+OO 3.90e+03 O.OOe+OO O.OOe+OO O.OOe+OO 2.51e+02 O.OOe+OO 2.40e+Q3 RB-88 O.OOe+OO l. lOe+Ol O.ODe+OO O.OOe+OO 0.00e+OO 5.42e-Ol O.OOe+OO 7.67e+OO RB-89 O.OOe+OO 6.BOe+OO O.OOe+OO 0.00e+OO O.DOe+OO 5.93e-02 O.OOe+OO 6.05e+OO SR-89 7.67e+04 O.OOe+OO O.OOe+OO D.OOe+OO O.OOe+OO 2.97e+03 O.OOe+OO 2.19e+03 SR-90 9.88e+05 O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO l.33e+04 O.OOe+OO 2.5le+05 SR-91 l.40e+03 O.OOe+OO O.OOe+OD O.OOe+OO 0.00e+OO 3.08e+03 O.OOe+OO 5.27e+Ol SR-92 5.25e+02 0.00e+OO O.OOe+OO O.OOe+OO D.OOe+OO 9.94e+03 O.OOe+OO 2.lOe+Ol Y-90 2.39e+OO 0.00e+OO O.OOe+OO O.DOe+OO O.OOe+OO 6.BOe+03 O.OOe+OO 6.40e-02 Y-91 3.50e+Ol O.OOe+OD O.OOe+OO O.OOe+DO o.ooe+oo 4.66e+03 O.DOe+DO 9.36e-01 Y-91M 2.22e-02 O.OOe+OO D.OOe+OO O.OOe+OO O.OOe+OO 4.35e+Dl O.DOe+OO 8.0Be-04 Y-92 2.09e-Dl 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO 6.05e+03 O.OOe+OO 5.99e-03 Y-93 6.63e-Ol 0.00e+OO O.OOe+OO O.OOe+OO 0.00e+OO 9.88e+03 O.OOe+OO l.82e-02 ZR-95 6.74e+OO l.48e+OO O.OOe+OO 2 .12e+OO O.OOe+OO 1. 55e+03 O.OOe+OO 1.32e+OO ZR-97 4.06e-01 5.B?e-02 O.OOe+OO 8.43e-02 O.OOe+OO 8.90e+03 D.OOe+OO 3.47e-02 NB-95 l.31e+OO 5.09e-Ol O.OOe+OO 4.78e-Ol O.OOe+OO 9.42e+02 O.OOe+OO 3.64e-Ol M0-99 O.OOe+OO 7.73e+02 D.OOe+DO l.65e+03 O.OOe+DO 6.40e+D2 O.OOe+OO 1.9le+02 TC-99M 5.37e-02 1.0Se-01 0.00e+OO l.53e+OO 5.34e-02 5.99e+Ol D.OOe+OO l.74e+OO TC-101 6.22e-02 6.51e-02 O.OOe+OO 1.lle+OO 3.44e-02 2.07e-01 O.OOe+OO 8.26e-01 RU-103 4.25e+Ol O.OOe+OO O.OOe+OO 1. 07e+02 O.OOe+OO 1.10e+03 O.OOe+OO l.63e+Ol 1

             '  '1ngestion dose factor (for bone) used in calculation of Dose Commitment Factor for P-32 derived in accordance with Information supplied in Reference 3.17. The teen and child bone dose ingestion dose factors were derived by the ratio of the adult bone ingestion dose factors in Reg. Guide 1.109 and "The Importance of P-32 in Nuclear Reactor Liquid Effluents," Branagan, E. F., Nichols, C.R., and Willis, C. A .. USNRC, 6/82 (Ref 3.17).

Page 5 of 8

For Information Only Attachment A ODCM-QA-005 Revision 4 Page 17 of 49 DOSE COMMITMENT FACTORS FOR THE POTABLE WATER PATHWAY (Ref. 3.15} Release Type: Liquid Units: ((mrern/hr)/(µCi/ml)) Age Group: CHILD Pathway: Potable Water (PWtr) Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB

             -------------------------------------~---------------------------------------

RU-105 3.75e+OO 0.00e+OO 0.00e+OO 3.30e+Dl O.DOe+OO 2.45e+03 O.OOe+OO l.36e+OO RU-106 6.80e+02 O.OOe+OO O.OOe+OO 9.19e+02 O.OOe+OO 1. 06e+04 O.OOe+OO 8.49e+Ol AG-llOM 3.13e+Ol 2.12e+Ol O.OOe+OO 3.94e+Ol O.OOe+OO 2.52e+03 O.OOe+OO 1.69e+Ol TE-125M 6.63e+02 1.80e+02 l.86e+02 O.OOe+OO 0.00e+OO 6.40e+02 O.OOe+OO 8.84e+Ol TE-127 2.74e+Ol 7.38e+OO l.90e+Ol 7.79e+Ol O.OOe+OO 1. 07e+03 0. OOe+OO 5.87e+OO TE-127M l.68e+03 4.52e+02 4.02e+02 4.79e+03 O.OOe+OO l.36e+03 O.OOe+OO 1.99e+02 TE-129 7.79e+OO 2.17e+OO 5.56e+OO 2.28e+Ol D.OOe+OO 4.85e+02 O.DOe+OO 1. 85e+OO TE-129M 2.83e+03 7.9le+02 9.13e+02 8.31e+03 D.OOe+OO 3.45e+03 O.DOe+OO 4.40e+02 TE-131 4.83e+OO 1.47e+OO 3.69e+OO 1.46e+Ol O.OOe+OO 2.53e+Ol O.OOe+OO l.44e+OO TE-131M 4.l9e+02 l.45e+02 2.98e+02 1.40e+03 O.OOe+OO 5.87e+03 O.OOe+OO l.54e+02 TE-132 S.87e+02 2.60e+02 3.78e+02 2.41e+03 O.OOe+OO 2.62e+03 0.00e+OO 3.14e+02 I-130 1.70e+02 3.43e+02 3.78e+04 5.13e+02 O.OOe+OO l. 60e+02 0.00e+OO 1. 77e+02 I-131 l. 00e+03 1.0le+03 3.33e+05 l.6Se+03 O.OOe+OO 8.95e+Ol O.OOe+OO 5.72e+02 I-132 4.65e+Ol 8.SSe+Ol 3.97e+03 l.31e+02 O.OOe+OO l.Ole+02 0.00e+OO 3.93e+Ol I-133 3.44e+02 4.26e+02 7.9le+04 7.09e+02 O.OOe+OO 1.72e+02 O.OOe+OO l.6le+02 I-134 2.44e+Ol 4.52e+Ol 1.04e+03 6.92e+Ol O.OOe+OO 3.00e+Ol O.OOe+OO 2.08e+Ol I-135 l.02e+02 l.83e+02 l.62e+04 2.8le+02 O.OOe+OO 1.40e+02 0.00e+OO 8.66e+Ol CS-134 1.36e+04 2.23e+04 O.OOe+OO 6.92e+03 2.48e+03 1.20e+02 O.OOe+OO 4. 71e+03 CS-136 l.37e+03 3.76e+03 O.OOe+OO 2.00e+03 2.98e+02 1.32e+02 0.00e+OO 2.43e+03 CS-137 l.90e+04 1.82e+04 O.OOe+OO 5.93e+03 2 .13e+03 1.14e+02 0.00e+OO 2.69e+03 CS-138 l.33e+Ol l.84e+Ol O.OOe+OO l.30e+Ol 1. 40e+OO 8.49e+OO O.OOe+OO 1.17e+Ol BA-139 2.4le+Ol l.28e-02 O.OOe+OO l.12e-02 7.56e-03 1.39e+03 O.OOe+OO 6.98e-01 BA-140 4.83e+03 4.23e+OO O.OOe+OO 1.38e+OO 2.52e+OO 2.45e+03 O.OOe+OO 2.82e+02 BA-141 l.16e+Ol 6.Sle-03 O.OOe+OO 5.63e-03 3.83e-02 6.63e+OO O.OOe+OO 3.78e-01 BA-142 5.0Be+OO 3.66e-03 O.OOe+OO 2.96e-03 2.lSe-03 6.63e-02 O.OOe+OO 2.84e-01 LA-140 5.87e-Ol 2.05e-Dl O.OOe+OO 0.00e+OO O.OOe+OO 5.72e+03 O.OOe+OO 6.92e-02 LA-142 3.0Se-02 9. 71e-03 O.OOe+OO O.OOe+OO O.OOe+OO 1.92e+03 O.OOe+OO 3.04e-03 CE-141 2.3le+OO l.15e+OO 0.00e+OO 5.0Se-01 O.OOe+OO 1.44e+03 0.00e+OO l.71e-Ol CE-143 4.06e-01 2.20e+02 O.OOe+OO 9.24e-02 O.OOe+OO 3.23e+03 O.OOe+OO 3.19e-02 CE-144 1. 2le+02 3.79e+01 0.00e+OO 2.lOe+Ol O.OOe+OO 9.88e+03 O.OOe+OO 6.4Se+OO PR-143 2.28e+OO 6.86e-Ol 0.00e+OO 3. 72e-Ol O.OOe+OO 2.47e+03 O.OOe+OO l.13e-01 PR-144 7.SOe-03 2.32e-03 0.00e+OO 1. 23e-03 O.OOe+OO 4.99e+OO O.OOe+OO 3. 7/e-04 ND-147 1.62e+OO l.31e+OO O.OOe+OO 7.2le-Ol O.OOe+OO 2.08e+03 O.OOe+OO l.02e-01 W-187 2.49e+Ol l.48e+01 O.OOe+OO 0.00e+OO O.OOe+OO 2.08e+03 O.OOe+OO 6.63e+OO NP-239 3.0Se-01 2.19e-02 O.OOe+OO 6.34e-02 O.OOe+OO 1.62e+03 O.OOe+OO 1.54e-02 PU-239 7.50e+04 8.02e+03 O.DOe+OO 7.09e+03 D.OOe+DO 3.98e+03 0.DOe+OO l.92e+03 U-235 1.99e+05 O.OOe+OD O.OOe+OO 3.26e+04 O.OOe+OD 4.67e+03 O.OOe+OO l.20e+04 Page 6 of B

For Information Only Attachment A ODCM-QA-005 Revision 4 Page 18 of 49 DOSE COMMITMENT FACTORS FOR THE POTABLE WATER PATHWAY (Ref. 3.15) Release Type: Liquid Units: ( (mrem/hrl I (µCi/ml) J Age Group: INFANT Pathway: Potable Water (PWtr) Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB

             ----------------------------------------------------------------------------\

H-3 O.OOe+OO 1.16e+Ol 1.16e+Ol l.16e+Ol 1.16e+Ol l.16e+Ol O.OOe+OO l.16e+Ol C-14 8.92e+02 l.90e+02 l.90e+02 l.90e+02 1. 90e+02 l.90e+02 O.OOe+OO 1. 90e+02 NA-24 3.80e+02 3.80e+02 3.80e+02 3.80e+02 3.80e+02 3.80e+02 O.OOe+OO 3.80e+02 P-32 6.40e+04 3.76e+03 O.OOe+OO 0.00e+OO O.OOe+OO 8.65e+02 O.OOe+OO 2.48e+03 CR-51 O.OOe+OO O.OOe+OO 3.46e-Ol 7.56e-02 6.73e-Ol 1.55e+Ol O.OOe+OO 5.30e-Ol MN-54 o.ooe+oo 7.49e+02 O.OOe+OO l.66e+02 O.OOe+OO 2.7Se+02 O.OOe+OO 1. 70e+02 MN-56 O.OOe+OO 3.0Be+Ol O.OOe+OO 2.64e+Ol O.OOe+OO 2.80e+03 O.OOe+DO 5.30e+OO FE-55 5.23e+02 3.3Be+02 O.OOe+OO O.OOe+OO 1.65e+02 4.29e+Ol O.OOe+OO 9.03e+Ol FE-59 1.16e+03 2.02e+03 O.OOe+OO O.OOe+OO 5.98e+02 9.67e+02 o.OOe+OO 7.98e+02 C0-58 O.OOe+OO 1.35e+02 O.OOe+OO O.OOe+OO O.OOe+OO 3.37e+02 o.OOe+OO 3.38e+02 C0-60 O.OOe+OO 4.06e+02 O.OOe+OO 0.00e+OO O.OOe+OO 9.67e+02 O.OOe+OO 9.59e+02 NI-63 2.39e+04 1. 47e+03 O.DOe+OD O.Ooe+OO o.ooe+oo 7.34e+Ol O.OOe+OO B.28e+02 NI-65 1. 77e+02 2.00e+Ol O.OOe+OO O.OOe+OO O.OOe+OO 1. 52e+03 O.OOe+OO 9.lOe+OO CU-64 O.OOe+OO 2.29e+Ol O.OOe+OD 3.87e+Ol O.OOe+OO 4.70e+02 O.OOe+OO l.06e+Ol ZN-65 6.92e+02 2.37e+03 O.OOe+OO 1.15e+03 O.OOe+OO 2.01e+03 O.OOe+OO 1.09e+03 ZN-69 3.Sle+OO 6.32e+OO O.OOe+OO 2.63e+OO O.OOe+OO 5.15e+02 O.OOe+OO 4.70e-01 BR-83 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO o.OOe+OO 1. 37e+Ol BR-84 O.OOe+OO o.ooe+oo O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO l.44e+Ol BR-85 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 7.30e-01 RB-86 O.OOe+OO 6.40e+03 O.OOe+OO 0.00e+OO O.OOe+OO l.64e+02 O.OOe+OO 3.16e+03 RB-88 O.OOe+OO 1.87e+Ol O.OOe+OO O.OOe+OO O.OOe+OO 1. 82e+Ol O.OOe+OD l.03e+Ol RB-89 O.OOe+OO 1.0Be+Ol O.OOe+OO 0.00e+Oci O.OOe+OO 3.66e+OO O.OOe+OO 7.4le+OO SR..:89 9.44e+04 O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO 1.94e+03 o.OOe+OO 2.71e+03 SR-90 6.96e+05 O.OOe+OO O.OOe+OO 0.00e+OO 0.00e+OO 8.69e+03 O.OOe+OO 1. 77e+05 SR-91 1.88e+03 0.00e+OO O.OOe+OO O.OOe+OO 0.00e+OO 2.23e+03 O.OOe+OO 6.81e+Ol SR-92 7.22e+02 O.OOe+OO O.OOe+OQ O.OOe+OO O.OOe+OO 7.79e+03 O.OOe+OO 2.6Be+Ol Y-90 3.27e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 4.51e+03 O.OOe+OO 8.77e-02 Y-91 4.25e+Ol 0.00e+OO O.OOe+DO O.OOe+OO 0.00e+OO 3.05e+03 O.OOe+OO l.13e+OO Y-91M 3.0Se-02 O.ODe+OO O.OOe+OO O.OOe+OO O.OOe+OO l.02e+02 O.OOe+OO l.04e-03 Y-92 2.88e-01 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 5.49e+03 O.OOe+OO 8.09e-03 Y-93 9.14e-01 O.OOe+OO O.OOe+OO O.OOe+OD O.OOe+OO 7.22e+03 o.DOe+OO 2.49e-02 ZR-95 7.75e+OO 1. 89e+OO O.OOe+OO 2.04e+OO O.OOe+OO 9.40e+02 O.OOe+OO 1.34e+OO ZR-97 5.57e-01 9.56e-02 O.OOe+OO 9.63e-02 O.OOe+OO 6.09e+03 O.OOe+OO 4.36e-02 NB-95 1. 58e+OO 6.Sle-01 O.OOe+OO 4.66e-Ol 0.00e+OO 5.49e+02 O.OOe+OO 3.76e-Dl M0-99 O.OOe+OO 1.28e+03 O.OOe+OO 1.9le+03 O.OOe+OO 4.21e+02 O.OOe+OO 2.49e+02 TC-99M 7.22e-02 1. 49e-01 O.OOe+OO 1. 60e+OO 7.79e-02 4.33e+Ol O.OOe+OO l.92e+OO TC-101 8.54e-02 1.0Be-01 O.OOe+OO l.28e+OD 5.87e-02 l.83e+Ol o.OOe+OO l.06e+OO RU-103 5.57e+Ol O.OOe+OO O.OOe+OO 1.16e+02 0.00e+OO 6.77e+02 O.OOe+OO l.86e+Ol Page 7 of 8

For Information Only Attachment A ODCM-QA-005 Revision 4 Page 19 of49 DOSE COMMITMENT FACTORS FOR THE POTABLE WATER PATHWAY (Ref. 3.15) Release Type: Liquid units: {(mrem/hr)/(µCi/ml)J Age Group: INFANT Pathway: Potable Water {PWtr) Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-105 5.12e+OO O.OOe+OO O.OOe+OO 3.76e+Ol 0.00e+OO 2.04e+03 0.00e+OO 1. 72e+OO RU-106 9.07e+02 O.OOe+OO O.OOe+OO l.07e+03 O.OOe+OO 6.B8e+03 O.OOe+OO l.13e+02 AG-110M 3.75e+Ol 2.73e+Ol O.OOe+OO 3.91e+Ol O.OOe+OO 1.42e+03 0.00e+OO 1.Ble+Ol TE-125M 8. 77e+02 2.93e+02 2.95e+02 O.OOe+OO O.OOe+OO 4.18e+02 O.OOe+OO l.19e+02 TE-127 3.76e+Ol l.26e+Ol 3.06e+Ol 9.18e+Ol O.OOe+OO 7.90e+02 O.OOe+OO 8.09e+OO TE-127M 2.20e+03 7.30e+02 6.36e+02 5.42e+03 0.00e+OO 8.88e+02 O.OOe+OO 2.66e+02 TE-129 1. 07e+Ol 3.68e+OO 8.95e+OO 2.66e+Ol 0.00e+OO 8.54e+02 O.OOe+OO 2.49e+OO TE-129M 3.76e+03 l.29e+03 l.44e+03 9.40e+03 0.00e+OO 2.25e+03 O.OOe+OO 5.79e+02 TE-131 6.62e+OO 2.45e+00*5.9le+OO 1. 69e+Ol O.OOe+OO 2.67e+02 O.OOe+OO 1. 86e+OO TE-l31M 5. 72e+02 2.30e+02 4.66e+02 l.5Be+03 O.OOe+OO 3.B7e+03 0.00e+OO 1.90e+02 TE-132 7.82e+02 3.87e+02 5.72e+02 2.42e+03 O.OOe+OO 1.43e+03 O.OOe+OO 3.62e+02 I-130 2.26e+02 4.97e+02 5.57e+04 5.45e+02 O.OOe+OO l.06e+02 0.00e+OO 1.99e+02 I-131 l.35e+03 1.59e+03 S.23e+OS 1.86e+03 0.00e+OO 5.68e+Ol o.ooe+oo 7.DOe+02 I-132 6.24e+Ol l.27e+02 5.94e+03 1.41e+02 O.OOe+OD 1. 03e+02 O.DOe+OO 4.51e+Ol I-133 4.70e+02 6.85e+02 1. 25e+05 8.0Se+02 O.OOe+OO l.16e+02 0.DOe+OO 2.0le+02 I-134 3.27e+Ol 6.70e+Ol 1. 56e+03 7.49e+Ol 0.00e+OO 6.92e+Ol O.OOe+OO 2.38e+Ol I-135 l.37e+02 2. 72e+02 2.4~e+D4 3.04e+02 O.OOe+OO 9.86e+01 O.OOe+OO 9.93e+Ol CS-134 1.42e+04 2.64e+04 O.OOe+OO 6.Ble+03 2.79e+03 7.19e+Ol o.ooe+oo 2. 67e+03 CS-136 l.73e+03 5.08e+03 O.DOe+OO 2.02e+03 4.14e+02 7.7le+Ol O.OOe+OO 1.90e+03 CS-137 1. 96e+04 2.30e+04 O.OOe+OO 6.17e+03 2.50e+03 7.19e+Ol O.OOe+OO 1.63e+03 CS-138 l.Ble+Ol 2.94e+Ol O.OOe+OO 1. 47e+Ol 2.29e+OO 4.70e+Ol O.OOe+OO 1.43e+Ol BA-139 3.3le+Ol 2.20e-02 O.OOe+OO 1. 32e-02 l.33e-02 2.10e+03 O.OOe+OO 9.59e-01 BA-140 6.43e+03 6.43e+OO O.OOe+DO l.53e+OO 3.95e+OO 1. 58e+03 O.OOe+OO 3.31e+02 BA-141 l.60e+Ol l.09e-02 O.OOe+OO 6.58e-03 6.66e-03 l.95e+02 O.OOe+OO 5.04e-01 BA-142 6.92e+OO 5.76e-03 O.OOe+OO 3.31e-03 3.48e-03 2.86e+Ol O.OOe+OO 3.41e-Ol LA-140 7.94e-Ol 3 .13e-01 O.OOe+OO O.OOe+OO O.OOe+OO 3.68e+03 O.OOe+OO 8.0Se-02 LA-142 4.14e-02 1. 52e-02 O.OOe+OO 0.00e+OO 0.00e+OO 2.58e+03 O.OOe+OO 3.64e-03 CE-141 2.96e+OO 1.Ble+OO O.OOe+OO 5.57e-01 O.OOe+OO 9.33e+02 O.OOe+OO 2.13e-01 CE-143 5.57e-01 3.69e+02 O.OOe+OO 1.0Be-01 O.OOe+OO 2.16e+03 O.OOe+OO 4.21e-02 CE-144 1.12e+02 4.59e+01 O.OOe+OO l.85e+Ol O.OOe+OO 6.43e+03 O.OOe+OO 6.28e+OO PR-143 3.06e+OQ l.14e+OQ O.OOe+QO 4.25e-Ol O.OOe+OO 1.6le+03 o.ooe+oo 1. 52e-01 PR-144 l.03e-02 3.99e-03 O.OOe+OO l.44e-03 O.OOe+OO l.85e+02 O.OOe+OO 5.19e-04 ND-147 2.0Be+OO 2.14e+OO O.OOe+OO 8.24e-Ol O.OOe+OO l.35e+03 O.OOe+OO 1.3le-01 W-187 3.40e+Ol 2.36e+Ol O.OOe+OO 0.00e+OO O.OOe+OO l.39e+03 O.OOe+OO B.16e+DO NP-239 4.lBe-01 3.74e-02 O.OOe+OO 7.45e-02 0.00e+OO l.08e+03 O.OOe+OO 2.lle-02 PU-239 5.19e+04 5.B3e+03 O.ODe+OO 4.82e+03 O.OOe+OO 2.60e+03 O.OOe+OO 1.33e+03 U-235 l.76e+05 0.DOe+OO O.OOe+OO 3.74e+04 0.00e+OO 3.05e+03 O.ODe+OO 1.34e+04 Page 8 of 8

For Information* Orily Attachment B ODCM-QA-005 Revision 4 Page 20 of 49 DOSE COMMITMENT FACTORS FOR THE FISH PATHWAY (Ref. 3.15) Release Type: Liquid Units: ((mrem/hr)/(µCi/ml)) Age Group: ADULT Pathway: Fresh water Fish - Sport (FFSP) Nuclide Bone Liver Thyroid Kidney Lung

GI-L1i Skin TB H-3 O.OOe+OO 2.26e-01 2.26e-01 2.26e-Ol 2.26e-01 2.26e-Ol O.OOe+OO 2.26e-Ol C-14 3 .13e+04 6.26e+03 6.26e+03 6.26e+03 6.26e+03 6.26e+03 O.OOe+OO 6.26e+03 NA-24 4.07e+02 4.07e+02 4.07e+02 4.07e+02 4.07e+02 4.07e+02 O.OOe+OO 4.07e+02

{l) P-32 2.15e+05 8.62e+04 O.OOe+OO O.OOe+OO 0.00e+OO 1.56e+05 O.OOe+OO 5.36e+04 CR-51 0.00e+OO O.OOe+OO 7.6le-01 2.8le-Ol 1.69e+OO 3.20e+02 0.00e+OO l.27e+OO MN-54 O.OOe+OO 4.38e+03 O.OOe+OO 1. 30e+03 0. 00.e+OO 1.34e+04 O.OOe+OO 8.35e+02 MN-56 O.OOe+OO 1.10e+02 O.OOe+OO 1. 40e+02 O.OOe+OO 3.51e+03 O.OOe+OO l.95e+Ol FE-55 6.58e+02 4.55e+02 0.00e+OO 0. OOe+OO. 2.54e+D2 2.6le+02 O.OOe+OO l.06e+02 FE-59 l.04e+03 2.44e+03 O.OOe+OO O.OOe+OO 6.82e+02 8.14e+03 O.OOe+OO 9.36e+02 C0-58 0.00e+OO 8.92e+Ol O.OOe+OO O.OOe+OO 0.00e+OO l.8le+03 O.OOe+OO 2.00e+02 C0-60 D.OOe+OO 2.56e+02 O.OOe+OO O.OOe+OO O.OOe+OO 4.81e+03 O.OOe+OO 5.65e+02 NI-63 3.1le+04 2.16e+03 O.OOe+OO O.OOe+OO 0.00e+OO 4.50e+D2 O.OOe+OO l.04e+03 NI-65 1.26e+02 1.64e+Ol O.OOe+OO O.OOe+OO 0.00e+OO 4.17e+02 O.OOe+OO 7.49e+OO CU-64 0.00e+OO 9.97e+OO O.OOe+OO 2.51e+Ol O.OOe+OO 8.50e+02 O.OOe+OO 4.68e+OO ZN-65 2.32e+04 7.37e+04 O.OOe+OO 4.93e+04 0.00e+OO 4.64e+04 O.OOe+OO 3. 33e+04 ZN-69 4.93e+Ol 9.43e+Ol O.OOe+OO 6.13e+Ol O.OOe+OO 1.42e+Ol O.OOe+OO 6.56e+OO BR-83 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.ODe+OO 5.82e+Ol O.OOe+OO 4.04e+Ol BR-84 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 4. lle-04 O.OOe+OO 5.24e+Ol BR-85 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.15e+OO RB-86 0.00e+OO l.Ole+OS O.OOe+OO O.OOe+OO O.OOe+OO 1. 99e+04 O.OOe+OO 4. 7le+04 RB-88 O.OOe+OO 2.90e+02 O.OOe+OO O.OOe+OO O.OOe+OO 4.00e-09 O.OOe+OO 1.54e+02 RB-89 O.OOe+OO l.92e+02 O.OOe+OO O.OOe+OO O.OOe+OO 1.12e-ll O.OOe+OO 1.35e+02 SR-89 2.2le+04 O.OOe+OO O.OOe+OO O.OOe+OO o.ooe+oo 3.55e+03 O.OOe+OO 6.35e+02 SR-90 5.44e+05 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1. 57e+04 O.OOe+OO l.34e+05 SR-91 4.07e+02 O.OOe+OO O.OOe+OO O.DOe+OO O.OOe+OO l.94e+03 O.OOe+OO l.64e+Ol SR-92 l.54e+02 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 3.06e+03 O.OOe+OO 6.68e+OO Y-90 5.76e-Ol O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 6.10e+03 O.OOe+OO l.54e-02 Y-91 8.44e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 4.64e+03 O.OOe+OO 2.26e-Ol Y-91M S.44e-03 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1. 60e-02 O.OOe+OO 2. lle-04 Y-92 5.06e-02 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 8.86e+02 O.OOe+OO 1.48e-03 Y-93 1. 60e-01 O.DOe+DO O.ODe+OO O.OOe+OO O.OOe+OO 5.09e+03 O.OOe+OO 4.43e-03 ZR-95 2.40e-01 7.70e-02 O.OOe+OO l.2le-01 O.OOe+OO 2.44e+02 O.OOe+OO 5.21e-02 ZR-97 l.33e-02 2.68e-03 O.OOe+OO 4.04e-03 O.OOe+OO 8.30e+02 O.OOe+OO l.22e-03 NB-95 4.47e+02 2.48e+02 O.OOe+OO 2.46e+02 O.OOe+OO 1.5le+06 O.OOe+OO 1.34e+02 M0-99 O.OOe+OO 1.03e+02 O.OOe+OO 2.34e+02 O.OOe+OO 2.39e+02 O.OOe+OO 1.96e+01 TC-99M 8.87e-03 2.Sle-02 O.OOe+OO 3.81e-Ol l.23e-02 1.48e+Ol O.OOe+OO 3.19e-Ol TC-101 9.12e-03 1.3le-02 O.OOe+OO 2.37e-Ol 6. 72e-03 3.95e-14 O.OOe+OO l.29e-Ol RU-103 4. 43e+OO O.OOe+OO O.OOe+OO 1.69e+Ol 0.00e+OO 5.17e+02 O.OOe+OO l.91e+OO 1

             < >1ngestion  dose factor (for bone) used in calculation of Dose Commitment Factor for P*32 derived in accordance with information supplied in Reference 3.17. The teen and child bone dose ingestion dose factors were derived by the ratio of the adult bone ingestion dose factors in Reg. Guide 1.109 and The Importance of P-32 in Nuclear Reactor liquid Effluents," Branagan, E. F., Nichols, C.R., and Wiilis, C. A.. USNRC, 6/82 (Ref 3.17).

Page 1 of 8

For Information Only Attachment 8 ODCM-QA-005 Revision 4 Page 21of49 DOSE COMMITMENT FACTORS FOR THE FISH PATHWAY (Ref. 3.15) Release Type: Liquid Dose Factor: { {rnrem/hr) I {µCi/ml)) Age Group: ADULT Pathway: Fresh Water Fish - Sport {FFSP) Nuclide Bone Liver Thyroid Kidney Lung Gl'-Lli Skin TB RU-105 3.69e-Ol O.OOe+OO O.OOe+OO 4.76e+OO O.OOe+OO 2.26e+02 O.OOe+OO l.46e-Ol RU-106 6.58e+Ol O.OOe+OO 0.00e+DO .1. 27e+02 O.OOe+OO 4.26e+03 O.OOe+OO 8.33e+OO AG-llOM 8.Ble-01 8.lSe-01 O.OOe+OO 1.60e+OO O.OOe+OO 3.33e+02 O.OOe+OO 4.84e-01 TE-125M 2.57e+03 9,3Qe+02 7. 72e+02 l.04e+04 O.OOe+OO 1.02e+04 O.OOe+OO 3.44e+02 TE-127 1. 05e+02 3.78e+Ol 7.80e+Ol 4.29e+02 O.OOe+OO 8.31e+03 0.00e+OO 2.28e+Ol TE-127M 6.48e+03 2.32e+03 l.66e+03 2.63e+04 O.OOe+OO 2.17e+04 O.OOe+OO 7.90e+02 TE-129 3.0le+Ol l.13e+Ol 2.3le+Ol 1. 26e+02 O.OOe+OO 2.27e+Ol O.OOe+OO 7.33e+OO TE-129M 1.10e+04 4 .lle+03 3.7Be+03 4.60e+04 O.OOe+OO 5.55e+Ol O.OOe+OO 1.74e+03 TE-131 1.89e+Ol 7.BBe+OO 1. 55e+Ol 8.26e+Ol O.OOe+OO 2.67e+OO O.OOe+OO 5.96e+OO TE-131M 1. 66e+03 8.10e+02 1.28e+03 8.2le+03 O.OOe+OO 8.04e+04 O.OOe+OO 6.75e+02 TE-132 2.41e+03 1 ..56e+03 l.72e+03 1.50e+04 O.OOe+OO 7.38e+04 O.OOe+OO 1. 47e+03 I-130 2.71e+Ol 8.0le+Ol 6.79e+03 l.25e+02 O.OOe+OO 6.89e+Ol O.OOe+OO 3.16e+Ol I-131 l .49e+02 2.14e+02 7.00e+04 3.66e+02 O.OOe+OO 5.64e+Ol O.OOe+OO l.22e+02 I-132 7 .29e+O.O l.95e+Ol 6.82e+02 3.lle+01 O.OOe+OO 3.66e+OO O.OOe+OO 6.82e+OO I-133 5.lOe+Ol 8.87e+Ol l.30e+04 l.55e+02 O.OOe+OO 7.97e+Ol O.OOe+OO 2.70e+Ol I-134 3.Ble+OO 1.03e+Ol 1.79e+02 1.64e+01 O.OOe+OO 9.0le-03 O.OOe+OO 3.70e+OO I-135 1. 59e+Ol 4.17e+Ol 2.75e+03 6.68e+01 O.OOe+OO 4.70e+01 O.OOe+OO l.54e+Ol CS-134 2.9Be+05 7.09e+05 O.OOe+OO 2.29e+05 7.6le+04 l.24e+04 O.OOe+OO 5.79e+05 CS-136 3.12e+04 1.23e+05 0.00e+OO 6.85e+04 9.38e+03 1.40e+04 O.OOe+OO 8.86e+04 CS-137 3.82e+05 5.22e+05 O.OOe+OO l.77e+05 5.89e+04 l.Ole+04 O.OOe+OO 3.42e+05 CS-138 2.64e+02 5.22e+02 0.00e+OO 3.84e+02 3.79e+Ol 2.23e-03 O.OOe+OO 2.59e+02 BA-139 9.29e-01 6.62e-04 O.OOe+OO 6.l9e-04 3.75e-04 l.65e+OO O.OOe+OO 2. 72e-02 BA-140 1.94e+02 2.44e-Ol O.OOe+OO 8.31e+OO l.40e-Ol 4.00e+02 O.OOe+OO l.27e+Ol BA-141 4.Sle-01 3.41e-04 O.OOe+OO 3.17e-04 1. 93e-04 2.13e-10 O.OOe+OO 1.52e-02 BA-142 2.04e-01 2.lOe-04 O.OOe+OO 1. 77e-04 l.19e-04 2.87e-19 O.OOe+OO 1. 2Be-02 LA-140 1.SOe-01 7.54e-02 O.OOe+OO 0.00e+OO O.OOe+OO 5.54e+03 O.OOe+OO l.99e-02 LA-142 7.66e-03 3.48e-03 0.00e+OO O.OOe+OO O.OOe+OO 2.54e+Ol O.OOe+OO 8.6Be-04 CE-141 2.24e-02 1.52e-02 O.OOe+OO 7. 04e-03 O.OOe+OO 5.79e+Ol O.OOe+OO l.72e-03 CE-143 3.95e-03 2.92e+OO O.OOe+OO l.29e-03 O.OOe+OO 1.09e+02 O.OOe+OO 3.23e-04 CE-144 1.17e+OO 4.8.Be-01 0.00e+OO 2.90e-Ol O.OOe+OO 3.95e+02 O.OOe+OO 6.27e-02 PR-143 5.51e-01 2.21e-01 O.OOe+OO 1. 27e-01 O.OOe+OO 2.41e+03 O.OOe+OO 2.73e-02 PR-144 l.BOe-03 7.48e-04 O.OOe+OO 4.22e-04 O.OOe+OO 2.59e-10 O.OOe+OO 9.16e-05 ND-147 3.76e-01 4.35e-01 0.00e+OO 2.54e-01 O.OOe+OO 2.09e+03 0.00e+OO 2.60e-02 W-187 2.96e+02 2.47e+02 O.OOe+OO O.OOe+OO O.OOe+OO 8.10e+04 O.OOe+OO 8.65e+Ol NP-239 2.BSe-02 2.SOe-03 0.00e+OO 8.74e-03 O.OOe+OO 5.75e+02 0.00e+OO 1.54e-03 PU-239 6.08e+03 7.30e+02 0.00e+OO 6.80e+02 O.OOe+OO 5.58e+02 O.OOe+OO l.60e+02 U-235 3.84e+03 0.00e+OO O.OOe+OO 8.95e+02 O.OOe+OO 3.74e+02 O.OOe+OO 2.33e+02 Page 2 of 8

For Information Only Attachment B ODCM-QA-005 Revision 4 Page 22 of 49 DOSE COMMITMENT FACTORS FOR THE FISH PATHWAY (Ref. 3.15) Release Type: Liquid Units: ((rnrem/hr)/(µCi/ml}) Age Group: TEEN Pathway: Fresh Water Fish - Sport (FFSP} Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 O.OOe+OO 1. 74e-Ol 1.74e-01 1.74e-01 1. 74e-Ol 1. 74e-01 O.OOe+OO l.74e-01 C-14 3.4le+04 6.81e+03 6.8le+03 6.8le+03 6.8le+03 6.8le+03 O.OOe+OO 6.81e+03 NA-24 4.20e+D2 4.20e+02 4.2De+02 4.20e+D2 4.20e+D2 4.2De+02 O.OOe+OO 4.20e+02 11) P-32 2.35e+D5 9.36e+04 O.OOe+OO O.OOe+OO O.OOe+OO l.27e+05 O.OOe+OO 5.86e+04 CR-51 O.OOe+OO O.OOe+OO 7.30e-Ol 2.88e-Ol 1.88e+OO 2.21e+02 O.OOe+OO l.31e+OO MN-54 O.OOe+OO 4.30e+03 O.OOe+OD 1.28e+03 O.OOe+OO B.B3e+03 O.OOe+OO 8.54e+02 MN-56 0.00e+OO 1.15e+02 O.OOe+OO l.46e+02 O.OOe+OO 7.59e+03 O.OOe+OO 2.0Se+Ol FE-55 6.89e+02 4.89e+02 O.OOe+OO O.OOe+OO 3.10e+02 2.12e+02 O.OOe+OO l.14e+02 FE-59 1. D7e+03 2.50e+03 O.OOe+OO O.OOe+OO 7.8Be+02 5.9le+03 O.OOe+OO 9.65e+02 C0-58 O.OOe+OO 8.86e+Ol O.OOe+OO O.OOe+OO O.OOe+OO 1.22e+03 O.OOe+OO 2.04e+02 C0-60 O.OOe+OO 2.56e+02 O.OOe+OO O.OOe+OO O.OOe+OO 3.34e+03 O.OOe+OO 5.77e+02 NI-63 3.23e+04 2.28e+03 O.OOe+OO D.OOe+OO O.DDe+OD 3.63e+02 O.OOe+OO 1. 09e+03 NI-65 1.37e+02 l.75e+Ol O.OOe+OD O.OOe+DO O.OOe+OO 9.47e+D2 O.OOe+OO 7.. 95e+OO CU-64 O.OOe+OO 1.05e+Ol O.OOe+OO 2.65e+Ol O.OOe+OO 8.14e+02 O.OOe+OO 4.93e+OO ZN-65 2 .10e+04 7.30e+04 O.OOe+OO 4.67e+04 O.OOe+OO 3.09e+04 O.OOe+OO 3.40e+04 ZN-69 5.36e+Ol 1.02e+02 O.ODe+DO 6.68e+Ol O.OOe+OD 1. 88e+02 O.DOe+OO 7.15e+DO BR-83 O.ODe+OO D.OOe+OO O.OOe+OO D.ODe+OO O.ODe+OO O.ODe+OO O.OOe+OO 4.40e+Ol BR-84 O.OOe+OO O.OOe+OO O.ODe+OO D.OOe+OO 0.00e+OO O.OOe+OO 0.00e+OO 5.53e+Ol BR-85 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+DO 2.34e+OO RB-86 O.OOe+OO 1. 09e+OS O.OOe+OO O.OOe+OO O.OOe+OO 1.61e+04 O.OOe+OO 5. lle+04 RB-88 O.OOe+OO 3. lle+02 O.OOe+OO 0.00e+OO O.OOe+OO 2.66e-05 O.OOe+OO 1. 66e+02 RB-89 O.OOe+OO 2.0le+02 O.DOe+OO D.OOe+OO O.OOe+OO 3.0Be-07 O.OOe+OO 1.42e+02 SR-89 2.4le+04 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.87e+03 O.OOe+OO 6.89e+02 SR-90 4.54e+OS O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO l.27e+04 O.OOe+OO 1.12e+05 SR-91 4.42e+02 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.00e+03 O.OOe+OO 1.76e+Ol SR-92 1.67e+02 D.OOe+OO O.DOe+OO O.OOe+OO O.OOe+OO 4.25e+03 O.OOe+OO 7. lle+OO Y-90 6.25e-Dl O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO S.1Se+03 .o. OOe+OO l.68e-02 Y-91 9.17e+OO O.OOe;t-00 O.OOe+OO 0.DOe+OO O.OOe+OO 3.76e+03 O.OOe+OO 2.46e-01 Y-91M 5.88e-03 O.OOe+OO O.OOe+OO O.OOe+OO* O.OOe+OO 2.78e-01 O.OOe+OO 2.25e-04 Y-92 5.52e-02 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.51e+03 O.OOe+OO 1.60e-03 Y-93 1. 75e-01 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 5.34e+03 O.OOe+OO 4.79e-03 ZR-95 2.48e-01 7.82e-02 O.OOe+OO 1.15e-01 O.OOe+OO 1.Ble+02 O.OOe+OO 5.38e-02 ZR-97 l.43e-02 2.82e-03 O.OOe+DO 4.28e-03 0.00e+DO 7.64e+02 0.00e+OO l.30e-03 NB-95 4.50e+02 2.50e+02 O.OOe+OO 2.42e+02 O.OOe+OO 1. 07e+06 O.OOe+OO 1.37e+02 M0-99 O.OOe+OO 1.10e+02 O.OOe+DO 2.52e+02 O.OOe+OO l.97e+02 0.00e+OO 2.lOe+Ol TC-99M 9.0Be-03 2.53e-02 O.OOe+OO 3.78e-01 1. 41t?-02 1.66e+Ol O.OOe+OO 3.28e-01 TC-101 9.B5e-03 l.40e-02 O.OOe+OO 2.53e-01 8.54e-03 2.39e-09 O.OOe+OO 1.38e-01 RU-103 4.65e+OO 0.00e+OO O.OOe+OO 1. 64e+Ol O.OOe+OO 3.89e+02 O.OOe+OO 1.99e+OO l1l1ngestion dose factor (for bone) used in calculation of Dose Commitment Factor for P-32 derived in accordance with information supplied in Reference 3.i7. The teen and child bone dose ingestion dose factors were derived by the ratio of the adult bone ingestion dose factors in Reg. Guide 1.109 and "The Importance of P-32 in Nuclear Reactor Uquid Effluents,n Branagan, E. F., Nichols, C.R., and Willis, C. A., USNRC, 6/82 (Ref 3.17). Page 3 of 8

For Information Only Attachment B ODCM-QA-005 Revision 4 Page 23 of 49 DOSE COMMITMENT FACTORS FOR THE FISH PATHWAY (Ref. 3.15) Release Type: Liquid Units: l(mrem/hr)/(µCi/ml}) Age Group: TEEN Pathway: Fresh Water Fish - Sport (FFSP) Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-105 3.98e-01 O.OOe+OO O.OOe+OO 5.02e+OO O.OOe+OO 3.2le+02 O.OOe+OO l.54e-Ol RU-106 7.15e+Ol O.OOe+OO 0.00e+OO l.38e+02 O.OOe+OO 3.43e+03 O.OOe+OO 9.0le+OO AG-llOM 8.60e-01 8.14e-01 O.OOe+OO l.55e+OO O.OOe+OO 2.29e+02 O.OOe+OO 4.95e-01 TE-125M 2.79e+03 1. Ole+03 7.81e+02 O.OOe+OO O.OOe+OO 8.24e+03 O.OOe+OO 3.74e+02 TE-127 1.15e+02 *4. 09e+Ol 7.95e+Ol 4. 67e+02 O.OOe+OO 8.90e+03 0.00e+OO 2.48e+Ol TE-127M 7.06e+03 2.50e+03 1.68e+03 2.86e+04 O.OOe+OO 1.76e+04 O.OOe+OO 8.39e+02 TE-129 3.27e+Ol .l.22e+Ol 2.33e+Ol l.37e+02 O.OOe+OO 1.79e+02 O.OOe+OO 7.95e+OO TE-129M 1.19e+04 4.41e+03 3.84e+03 4.98e+04 O.OOe+OO 4.47e+04 O.OOe+OO 1. 88e+03 TE-131 2.04e+Ol 8.39e+OO l.57e+Ol B.90e+Ol O.OOe+OO 1.67e+OO 0.00e+OO 6.36e+OO TE-131M l.78e+03 8.54e+02 1.28e+03 8.90e+03 o.OOe+OO 6.85e+04 O.OOe+OO 7.12e+02 TE-132 2.55e+03 l.61e+03 l.70e+03 l.55e+04 O.OOe+OO 5.lle+04 O.OOe+OO 1.52e+03 I-130 2.82e+Ol 8.lSe+Ol 6.65e+03 l.26e+02 0.0.0e+OO 6.27e+Ol O.OOe+OO 3.26e+Ol I-131 1.60e+02 2.24e+02 6.54e+04 3.86e+02 O.OOe+OO 4.43e+Ol 0.00e+OQ 1.20e+02 I-132 7.63e+OQ 2.00e+Ol 6.73e+02 3.lSe+Ol O.OOe+OO 8.70e+OO O.OOe+OO 7.17e+OO I-133 5.50e+Ol 9.33e+Ol l.30e+04 1. 64e+02 O.OOe+OO 7.06e+Ol 0.00e+OO 2.85e+Ol I-134 3.99e+OO l.06e+Ol 1. 76e+02 1. 67e+Ol O.OOe+OO 1.40e-01 O.QOe+OO 3.BOe+OO I-135 l.67e+Ol 4.30e+Ol 2.76e+03 *6.79e+Ol O.OOe+OO 4.76e+Ol 0.00e+OO l.59e+Ol CS-134 3.05e+05 7.19e+05 O.OOe+OO 2.28e+05 8.72e+04 8.94e+03 O.OOe+OO 3.33e+05 CS-136 3.13e+04 1. 23e+OS O.OOe+OO 6.71e+04 l.06e+04 9. 92e+03 o.ooe+oo 8.28e+04 CS-137 4.09e+05 5.44e+05 0.00e+OO 1. 85e+05 7.19e+04 7.73e+03 O.ODe+OO 1.89e+05 CS-138 2.B3e+02 5.44e+02 D.OOe+OO 4.0le+02 4.67e+Ol 2.47e-01 0.00e+OO 2.72e-t02 BA-139 1. Ole+OO 7.14e-04 O.OOe+OO 6.73e-04 4.92e-04 9.0Se+OO O.OOe+OO 2.95e-02 BA-140 2.07e+02 2.54e-01 O.OOe+OO 8.61e-02 1. 71e-01 3.20e+02 O.OOe+OO 1.34e+Ol BA-141 4.90e-01 3.66e-04 O.OOe+OO 3.39e-04 2.SOe-04 l.04e-06 O.OOe+OO l.63e-02 BA-142 2.18e-01 2.lBe-04 O.OOe+OO 1. BSe-04 l.45e-04 6.70e-13 0.00e+OO l.34e-02 LA-140 l.59e-01 7.80e-02 0.00e+OO 0.00e+OO O.OOe+OO 4.48e+03 0.00e+OO 2.07e-02 LA-142 s:16e-03 3.63e-03 O.OOe+OO 0.00e+OO O.OOe+OO 1.10e+02 O.OOe+OO 9.03e-04 CE-141 2.43e-02 l.62e-02 O.OOe+OO 7.62e-03 O.OOe+OO 4.63e+Ol O.OOe+OO l.86e-03 CE-143 4.29e-03 3.12e+OO o.ooe+oo l.40e-03 O.OOe+OO 9.38e+Ol O.OOe+OO 3.48e-04 CE-144 l.27e+OO 5.25e-Ol O.OOe+OO 3.14e-01 O.OOe+OO 3.19e+02 0.00e+OO 6.82e-02 PR-143 5.97e-01 2.38e-Ol O.OOe+OO 1. 39e-01 O.OOe+OO l.97e+03 O.OOe+OO 2.97e-02 PR-144 l.96e-03 8.03e-04 0.00e+OO 4.61e-04 O.OOe+OO 2.16e-06 O.OOe+OO 9.94e-05 ND-147 4.28e-Ol 4.65e-01 O.OOe+OO 2.73e-Ol O.OOe+OO 1.68e+03 O.OOe+OO 2.79e-02 W-187 3.20e+02 2.60e+02 0.00e+OO 0.00e+OO O.OOe+OO 7.05e+04 O.OOe+OO 9.13e+Ol NP-239 3.2le-02 3.03e-03 O.OOe+OO 9.SOe-03 O.OOe+OO 4.87e+02 O.OOe+OO 1. 68e-03 PU-239 4.B8e+03 5.93e+02 O.OOe+OO 5.47e+02 O.OOe+OO 4.5le+02 0.00e+OO 1.28e+02 U-235 4.16e+03 O.OOe+OO D.OOe+OO 9.74e+02 O.OOe+OO 3.02e+02 O.OOe+OO 2.53e+02 Page 4 of 8

. For Information Only Attachment B ODCM-QA-005 Revision 4 Page 24 of 49 DOSE COMMITMENT FACTORS FOR THE FISH PATHWAY (Ref. 3.15} Release Type: Liquid Units: ((mrem/hr)/(µCi/ml)) Age Group: CHILD Pathway: Fresh Water Fish - Sport (FFSP) Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 O.OOe+OO l.44e-Ol l.44e-01 l.44e-Ol l.44e-01 l.44e-01 O.OOe+OO l.44e-Ol C-14 4.38e+04 8.76e+03 8.76e+03 8.76e+03 8.76e+03 B.76e+03 O.OOe+OO 8.76e+03 NA-24 4.56e+02 4.56e+02 4.56e+02 4.56e+02 4.56e+02 4.56e+02 O.OOe+OO 4.56e+02 (l) P-32 3.02e+05 9.lle+04*0.00e+OO O.OOe+OO O.OOe+OO 5.38e+04 O.OOe+OO 7.50e+04 CR-51 O.OOe+OO O.OOe+OO 7.77e-01 2.12e-Ol 1.42e+OO 7.43e+Ol O.OOe+OO 1.40e+OO MN-54 O.OOe+OO 3.37e+03 O.OOe+OO 9.44e+02 O.OOe+OO 2.83e+03 O.OOe+OO 8.97e+02 MN-56 O.OOe+OO l.05e+02 O.OOe+OO 1.27e+02 O.OOe+OO 1.52e+04 O.DOe+OO 2.37e+Ol FE-55 9.05e+02 4.80e+02 O.OOe+OO O.OOe+OO 2. 71e+02 8.89e+Ol O.OOe+OO 1.49e+02 FE-59 1. 30e+03 2.10e+03 O.OOe+OO O.OOe+OO 6.09e+02 2 ..19e+03 O.OOe+OO l.05e+03 C0-58 O.OOe+OO 7.08e+Ol O.OOe+OO O.OOe+OO O.OOe+OO 4.13e+02 O.OOe+OO 2.17e+02 C0-60 O.OOe+OO 2.08e+02 O.OOe+OO O.OOe+OO 0.00e+OO l.15e+03 O.OOe+OO 6.14e+02 NI-63 4.23e+04 2.27e+03 O.OOe+OO O.OOe+OO O.OOe+OO 1.53e+02 O.OOe+OO l.44e+03 NI-65 1. 75e+02 1. 64e+Ol O.OOe+OO 0.00e+OO O.OOe+OO 2.0le+03 O.OOe+OO 9.S:Oe+OO CU-64 O.OOe+OO 9.64e+OO O.OOe+OO 2.33e+Ol O.OOe+OO 4.52e+02 O.OOe+OO 5.82e+OO ZN-65 2.16e+04 5.74e+04 O.OOe+OO 3.62e+04 O.OOe+OO 1.0le+04 O.OOe+OO 3.57e+04 ZN-69 6.89e+Ol 9.96e+Ol O.OOe+OO 6.04e+Ol O.OOe+OO 6.28e+03 O.OOe+OO 9.20e+OO BR-83 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO 5.65e+Ol BR-84 O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 6.54e+Ol BR-85 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 3.0le+OO RB-86 O.OOe+OO 1.05e+05 O.OOe+OO O.OOe+OO O.OOe+OO 6.78e+03 O.OOe+OO 6.48e+04 RB-88 O.OOe+OO 2.99e+02 O.OOe+OO O.OOe+OO D.OOe+OO l.47e+Ol O.OOe+OO 2.08e+02 RB-89 O.OOe+OO l.84e+02 O.OOe+OO O.OOe+OO O.OOe+OO l.60e+OO O.OOe+OO l.64e+02 SR-89 3.lle+04 O.OOe+OO O.OOe+OO O.OOe+OO D.OOe+OO l.2le+03 O.OOe+OO 8.90e+02 SR-90 4.0le+OS 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO 5.40e+03 O.OOe+OO l.02e+05 SR-91 5.66e+02 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO l.25e+03 O.OOe+OO 2.14e+Ol SR-92 2.13e+02 O.DOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 4.04e+03 O.OOe+OO 8.54e+OO Y-90 8.08e-Ol O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.30e+03 O.OOe+OO 2.16e-02 Y-91 1.18e+Ol O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO l.58e+03 O.OOe+OO 3.17e-Ol Y-91M 7.51e-03 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO l.47e+Ol O.OOe+OO 2.73e-04 Y-92 7.DBe-02 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.05e+03 O.OOe+OO 2.03e-03 Y-93 2.24e-01 O.OOe+OQ O.OOe+OO 0.00e+OO 0.00e+OO 3.34e+03 O.OOe+OO 6.16e-03 ZR-95 3.0le-01 6.62e-02 O.OOe+OO 9.47e-02 O.OOe+OO 6.90e+Ol O.OOe+OO 5.89e-02 ZR-97 1.81e-02 2.62e-03 0.00e+OO 3.76e-03 O.OOe+OO 3.97e+02 O.OOe+OD l.55e-03 NB-95 5.3le+02 2.07e+02 O.OOe+OO l.94e+02 o:ooe+Oo 3.82e+05 O.OOe+OO l.48e+02 M0-99 O.OOe+OO 1. 05e+02 O.OOe+OO 2.23e+02. o. ooe+*oo 8:65e+Ol-0.00e+OO 2.59e+Ol TC-99M 1. 09e-02 2.14e-02 O.OOe+OO 3.lOe-01 1.0Se-02 1.22e+Ol O.OOe+DO 3.54e-01 TC-101 1.26e-02 1.32e-02 O.OOe+OO 2.25e-01 6.99e-03 4.20e-02 O.OOe+OO 1.68e-01 RU-103 5.75e+OO 0.00e+OO O.OOe+OO l.45e+Ol O.OOe+OO l.49e+D2 O.OOe+DO 2.21e+OO 1 c >1ngestion dose factor (for bone) used in calculation of Dose Commitment Factor for P-32 derived in accordance with information supplied in Reference 3.17. The teen and child bone dose ingestion dose factors were derived by the ratio of the adult bone ingestion dose factors in Reg. Guide 1.109 and The Importance of P-32 in Nuclear Reactor Liquid Effluents," Branagan, E. F., Nichols, C.R., and Willis, C. A., USNRC, 6/82 (Ref 3.17). Page 5 of 8

For Information Only

Attachment B ODCM-QA-005 Revision 4 Page 25 of 49 DOSE COMMITMENT FACTORS FOR THE FISH PATHWAY (Ref. 3.15)

Release Type: Liquid Units: ({mrem/hrl/(µCi/ml)) Age Group: CHILD Pathway: Fresh Water Fish - Sport (FFSP) Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-105 5. 07e-Ol O.OOe+OO 0.00e+OO 4.46e+OO O.OOe+OO 3.3le+02 O.OOe+OO 1.B4e-Ol RU-106 9.20e+Ol O.Ooe+OO O.OOe+OO 1.24e+02 O.OOe+OO l.43e+03 0.00e+OO 1.15e+Ol AG-llOM 9.75e-Ol 6.59e-Ol O.OOe+OO 1. 23e+OO O.OOe+OO 7.83e+Ol O.OOe+OO 5.26e-Ol TE-125M 3.59e+03 9. 72e+02 l.Ole+03 O.OOe+OO O.OOe+OO 3.46e+03 O.OOe+OO 4.7Be+02 TE-127 1.48e+02 4.00e+Ol 1.03e+02 4.22e+02 O.OOe+OO 5.79e+03 O.OOe+OO 3.lBe+Ol TE-127M 9.09e+03 2.45e+03 2.17e+03 2.59e+04 O.OOe+OO 7.36e+03 O.OOe+OO l.08e+03 TE-129 4.22e+Ol l.18e+Ol 3.0le+Ol 1.23e+02 O.OOe+OO 2.62e+03 O.OOe+OO 1.00e+Ol TE-129M 1.53e+04 4.28e+03 4.94e+03 4.50e+04 O.OOe+OO l.87e+04 0.00e+OO 2.38e+03 TE-131 2.Gle+Ol 7;96e+OO 2.00e+Ol 7.90e+Ol O.OOe+OO l.37e+02 O.OOe+OO 7.77e+OO TE-131M 2.27e+03 7.83e+02 l.61e+03 7.58e+03 O.OOe+OO 3.18e+04 O.OOe+OO 8.34e+02 TE-132

3 .18e+03 1.41e+03 2.05e+03 1. 31e+0.4 O.OOe+OO l.42e+04 O.OOe+OO 1.70e+03 I-130 3.45e+Ol 6.96e+Ol 7.67e+03 l.04e+02 O.OOe+OO 3.26e+Ol 0.00e+OO 3.59e+Ol I-131 2. 03e+02 2.04e+02 6.75e+04 3.35e+02 O.OOe+OO 1. 82e+Ol O.OOe+OO l.16e+02 I-132 9.44e+OO l.73e+Ol B.05e+02 2.65e+Ol O.OOe+OO 2.04e+Ol o.ooe+oo 7.98e+OO I-133 6.99e+Ol 8.64e+Ol 1. 60e+04 l.44e+02 O.OOe+OO 3.48e+Ol O.OOe+OO 3 .. 27e+Ol I-134 4.94e+OO 9.18e+OO 2 .lle+02 l.40e+Ol O.OOe+OO 6.09e+OO O.OOe+OO 4.22e+OO I-135 2.06e+Ol 3. 72e+Ol 3.29e+03 5.70e+Ol O.OOe+OO 2.83e+Ol O.OOe+OO 1.76e+Ol CS-134 3.68e+05 6.04e+05 o.ooe+oo 1. 87e+05 6. 72e+04 3.26e+03 0.00e+OO 1.27e+05 CS-136 3.70e+04 l.02e+05 O.OOe+OO 5.4le+04 8.07e+03 3.57e+03 0.00e+OO 6.58e+04 CS-137 5.14e+05 4.92e+OS O.OOe+OO l.60e+05 5. 77e+04 3.08e+03 0.00e+OO 7.27e+04 CS-138 3.59e+02 4.99e+02 O.OOe+OO 3.51e+02 3.7Be+01 2.30e+02 0.00e+OO 3.16e+02 BA-139 1.30e+DD 6.9Se-D4 D.DDe+OD 6.07e-04 4.D9e-04 7.52e+Dl 0.00e+OO 3.78e-02 BA-140 2.6le+02 2.29e-Ol O.OOe+OO 7.46e-02 l.37e-Ol l.32e+02 0.00e+OO 1.53e+Ol BA-141 6.29e-Ol 3.52e-04 O.OOe+OO 3.05e-04 2.07e-03 3.59e-Ol O.OOe+OO 2.05e-02 BA-142 2.75e-01 l.98e-04 O.OOe+OO l.60e-04 1. l6e-04 3.59e-03 O.OOe+OO l.54e-02 LA-140 1.99e-Ol 6.94e-02 O.OOe+OO O.OOe+OO O.OOe+OO l.94e+03 0.00e+OO 2.34e-02 LA-142 1. 03e-02 3.28e-03 O.DDe+OD O.DOe+OD D.OOe+OO 6.5le+02 o.ooe+OO l.03e-03 CE-141 3.12e-02 l.56e-02 O.OOe+OO 6.83e-03 O.OOe+OO 1.94e+Ol 0.00e+OO 2.3le-03 CE-143 s.soe-03 2.98e+OO O.OOe+OO l.25e-03 O.OOe+OO 4.37e+Ol O.OOe+OO 4.32e-04 CE-144 1. 64e+OO 5.13e-01 O.OOe+OO .2. 84e-Ol O.OOe+OO l.34e+02 0.00e+OO 8.73e-02 PR-143 7.73e-Ol 2.32e-01 O.OOe+OO 1.26e-Ol O.OOe+OO 8 .34e+02 0.00e+OO 3.83e-02 PR-144 2.54e-03 7.85e-04 O.OOe+OO 4.lSe-04 O.OOe+OO 1. 69e+OO 0.00e+OO l.28e-04 ND-147 S.49e-Ol 4.44e-01 O.OOe+OO 2.44e-Ol O.OOe+OO 7.04e+02 O.OOe+OO 3.44e-02 W-187 4.05e+02 2.40e+02 o.ooe+oo O.OOe+OO O.OOe+OO 3.37e+04 O.OOe+DO 1.08e+02 NP-239 4 .13e-D2 2. 97e-03 O.OOe+OO B.57e-03 0.00e+OO 2.19e+02 O.OOe+DO 2.D8e-D3 PU-239 3.55e+03 3.80e+02 O.OOe+OO 3.36e+02 O.OOe+OO l.89e+02 O.OOe+OO 9 .lle+Ol U-235 5.38e+03 0.00e+OO o.ooe+oo 8.83e+02 O.OOe+OO l.26e+02 O.OOe+OO 3.26e+02 Page 6 of 8

For Information Only Attachment B ODCM-QA-005 Revision 4 Page 26 of 49 DOSE COMMITMENT FACTORS FOR THE FISH PATHWAY (Ref. 3.15} Release Type: Liquid Units: ({mrem/hr)/(µCi/rnl)) Age Group: INFANT Pathway: Fresh Water Fish - Sport (FFSP) Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.DOe+OO C-14 O.OOe+OO o.ooe+oo O.DOe+OO O.OOe+DO O.OOe+OO o.ooe+oo O.OOe+OO O.OOe+OD NA-24 O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+DO P-32 O.OOe+OO O.OOe+OO O.OOe+OO D.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO CR-51 O.OOe+OO D.OOe+OO O.ODe+OO 0.00e+DO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO MN-54 O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO Q.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO MN-56 O.OOe+OO o.ooe+oo Q.OOe+OO O.OOe+OO O.OOe+OO D.OOe+OO O.OOe+OO O.OOe+OO FE-55 O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO FE-59 O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO C0-58 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO C0-60 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.QOe+OO O.OOe+OO O.OOe+OO NI-63 O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO NI-65 O.OOe+OO O.DOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO CU-64 O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO ZN-65 O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO ZN-69 O.ODe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.QOe+OO O.OOe+OO O.OOe+OO BR-83 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO o.ooe+oo O.OOe+OO BR-84 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO BR-85 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO RB-B6 O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO 0.00e+OO RB-88 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO RB-89 O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO 0.00e+OO O.OOe+OO SR-89 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO o.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO SR-90 O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO SR-91 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO Q.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO SR-92 O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO Y-90 O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO Y-91 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO Y-91M 0.00e+OO O.OOe+OO O.OOe+OO 0 .. OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO Y-92 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO Y-93 O.OOe+OO 0.00e+OO O.OOe+OO 0. Ode+OO. O.OOe+OO 0.00e+OO d.ooe+oo O.OOe+OO ZR-95 0.00e+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO ZR-97 O.OOe+OD O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO D.OOe+OO O.OOe+OO NB-95 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO M0-99 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO TC-99M O.OOe+OO o.ooe+oo O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO TC-101 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO RU-103 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO Page 7 of 8

For Information Only Attachment 8 ODCM-QA-005 Revision 4 Page 27 of49 DOSE COMMITMENT FACTORS FOR THE FISH PATHWAY (Ref. 3.15) Release Type: Liquid Units: ( {mrem/hr) I (µCi/ml)) Age Group: INFANT Pathway: Fresh Water Fish - Sport (FFSP) Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-105 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO o.ooe+oo RU-106 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO o.ooe+oo O.OOe+OO AG-llOM O.OOe+Oo O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO 0.00e+OO TE-125M O.OOe+OO o.ooe+oo o.ooe+oo o.ooe+oo O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO TE-127 a.aae+Oa o.aoe+aa O.OOe+Oa O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO TE-127M O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO 0.00e+OO O.OOe+OO TE-129 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO 0.00e+OO o.ooe+oo 0.00e+OO TE-129M 0.00e+OO O.OOe+OQ 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO TE-131 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.Ooe+OO 0.00e+OO TE-131M O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO TE-132 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.Ooe+OO O.OOe+OO 0.00e+OO o.ooe+oo I-130 O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO I-131 O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO I-132 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO I-133 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO Q.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO I-134 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO o.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO I-135 0.00e+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO CS-134 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.DDe+OO O.OOe+OO O.OOe+OO CS-136 O.OOe+OO O.OOe+OO O.OOe+OO 0.QOe+OO O.OOe+OO O,OOe+OO O.OOe+OO O.OOe+OO CS-137 O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO CS-138 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO BA-139 0.00e+OO O.OOe+OO o.ooe+oo 0.00e+OO O.DOe+OO O.OOe+OO O.OOe+OO O.OOe+OO BA-140 O.OOe+OO O.Ooe+OO o.ooe+oo 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO BA-141 O.Ooe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO BA-142 0.00e+OO O.OOe+OO O.OOe+OO *o. ooe+oo o.DOe+OO O.OOe+OO O.OOe+OO O.OOe+OO LA-140 O.OOe+OO O.OOe+OO O.OOe+OO o,ooe+oo O.OOe+OO o.ooe+oo O.OOe+OO O.OOe+OO LA-142 0.00e+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO D.OOe+OO O.OOe+OO O.OOe+OO CE-141 0.00e+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO CE-143 O.OOe+DO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO CE-144 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO PR-143 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO o.ooe+Oo O.OOe+OO PR-144 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO o.ooe+oo O.OOe+OO ND-147 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.Ooe+OO O.ODe+DD W-187 O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.DOe+OO O.OOe+OO O.OOe+OO o:ooe+oo NP-239 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO PU-239 O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO o.ooe+oo O.Ooe+OO O.OOe+OO u.:..235 0.00e+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO 0.00e+OO o.ooe+oo O.OOe+OO Page 8 of 8

For Information OnJy Page 1of8

For Information Only Attachment C ODCM-QA-005 Revision 4 Page 29 of 49 DOSE COMMITMENT FACTORS FOR THE SHORELINE PATHWAY (Ref. 3.15) Release Type: Liquid units: ( (mrem/hr) /(µCi/ml)) Age Group: ADULT Pathway: Shoreline Sediment (SHDp) Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-105 2.28e-02 2.28e-02 2.28e-02 2.28e-02 2.28e-02 2.2Be-02 2.58e-02 2.28e-02 RU-106 1.Sle+Ol l.51e+01 1.5le+Ol 1. 51e+O*l 1.Sle+Ol l.5le+Ol 1. Ble+Ol l.5le+Ol AG-llOM 1.23e+02 1.23e+02 1.23e+02 l.23e+02 1.23e+02 l.23e+02 1.43e+02 l.23e+02 TE-125M 5.55e-02 5.55e-02 5.55e-02 5.55e-02 5.55e-02 5.SSe-02 7.60e-02 5.55e-02 TE-127 1.0?e-04 l.O?e-04 l.07e-04 l.07e-04 1.0?e-04 1.0?e-04 1. l ?e-04 l.07e-04 TE-127M 3.28e-03 3.28e-03 3.2Be-03 3.28e-03 3.28e-03 3.28e-03 3.87e-03 3.28e-03 TE-129 9.40e-04 9.40e-04 9.40e-04 9.40e-04 9.40e-04 9.40e-04 1.lle-03 9.40e-04 TE-129M 7.07e-01 7. D7e-Dl 7.D7e-Ol 7.0?e-01 7.0?e-01 7.07e-Dl 8.27e-Dl 7. 07e-01 TE-131 l.OSe-03 1.DSe-03 l.OSe-03 1. DSe-03 l.OSe-03 1.05e-03 1.23e+OO 1.0Se-03 TE-131M 2.87e-01 2.87e-01 2.87e-01 2.87e-Ol 2.87e-01 2.87e-01 3.39e-01 2.87e-01 TE-132 1.Sle-01 1. Sle-01 1. Sle-01 l.Sle-01 l.Sle-01 1.Sle-01 1. 78e-01 1. Sle-01 I-130 l.97e-01 1. 97e-Ol 1. 97e-Ol 1.97e-Dl l.97e-Ol 1.97e-01 2.39e-01 1. 97e-Ol I-131 6.16e-Ol 6.16e-Ol 6.16e-Ol 6.16e-Ol 6.16e-Ol 6.16e-01 7.47e-01 6.16e-Ol I-132 4.45e-D2 4.45e-02 4.45e-02 4.45e-02 4.45e-02 4.45e-02 5.24e-02 4.45e-02 I-133 8.Boe-02 8.BOe-02 8.80e-02 8.SOe-02 8.BOe-02 8.BOe-02 1.07e-01 8.SOe-02 I-134 l.60e-02 1.60e-02 1.60e-02 l.60e-02 1.60e-02 1.60e-02 1. 90e-02 1.60e-02 I-135 9.0?e-02 9.07e-02 9.07e-02 9.0?e-02 9.07e-02 9.07e-02 1.0Se-01 9.07e-02 CS-134 2.45e+02 2.45e+02 2.45e+02 2.45e+02 2.45e+02 2.45e+02 2.B7e+02 2.45e+02 CS-136 5.40e+OO 5.40e+OO 5.40e+OO 5.40e+OO S.40e+OO 5.40e+OO 6.12e+OO 5.40e+OO CS-137 3.68e+02 3.68e+02 3.68e+02 3.68e+02 3.68e+02 3.68e+02 4.29e+02 3.6Be+02 CS-138 1. 29e-02 l.29e-02 l.29e-02 l.29e-02 l.29e-02 1. 29e-02 1. 47e-02 l.29e-02 BA-139 3.79e-03 3.79e-03 3.79e-03 3.79e-03 3.79e-03 3.79e-03 4.26e-03 3.79e-03 BA-140 7.33e-01 7.33e-01 7.33e-01 7.33e-01 7.33e-01 7.33e-01 B.40e-01 7.33e-01 BA-141 l.49e-03 l.49e-03 l.49e-03 l.49e-03 1.49e-03 1.49e-03 l.70e-03 l.49e-03 BA-142 1.61e-03 1.6le-03 l.Gle-03 l.61e-03 1.61e-03 1.Gle-03 1. 83e-03 l.6le-03 LA-140 6.B7e-Ol 6.87e-01 6.B7e-01 6.B7e-01 6.87e-01 6.87e-01 7.BOe-01 6.87e-01 LA-142 2. 72e-02 2. 72e-02 2.72e-02 2. 72e-02 2. 72e-02 2.72e-02 3.26e-02 2.72e-02 CE-141 4.89e-01 4.89e-01 4.89e-01 4.89e-01 4.89e-01 4.89e-01 5.Sle-01 4.89e-01 CE-143 8.27e-02 8.27e-02 8.27e-02 8.27e-02 8.27e-02 B.27e-02 9.40e-02 8.27e-02 CE-144 2.49e+OO 2.49e+OO 2. 49e+OO* 2;49e+OO 2.49e+OO 2.49e+OO 2.88e+OO 2.49e+OO PR-143 O.OOe+OO O.OOe+OO o.ooe+oo O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO PR-144 6.57e-05 6.57e-05 6.57e-05 6.57e-05 6.57e-05 6.57e-05 7.53e-05 6.57e-05 ND-147 3.0le-01 3.0le-01 3.0le-01 3.0le-01 3.0le-01 3.0le-01 3.61e-01 3.0le-01 W-187 8.40e-02 8.40e-02 8.40e-02 8.40e-02 8.40e-02 8.40e-02 9.BOe-02 8.40e-02 NP-239 6.12e-02 6.12e-02 6.12e-02 6.12e-02 6.12e-02 6.12e-02 7.07e-02 6.12e-02 PU-239 8.20e-02 8.20e-02 8.20e-02 8.20e-02 8.20e-02 8.20e-02 7.99e-01 8.20e-02 U-235 3.32e+02 3.32e+02 3.32e+02 3.32e+02 3.32e+02 3.32e+02 4.15e+02 3.32e+02 Page 2 of 8

For Information Only Attachment C ODCM-QA-005 Revision 4 Page 30 of 49 DOSE COMMITMENT FACTORS FOR THE SHORELINE PATHWAY (Ref. 3.15) Release Type: Liquid Units: ( (mrem/hr) I (µCi/ml)) Age Group; TEEN Pathway: Shoreline Sediment (SHDp) NU elide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO C-14 O.OOe+OO 0.00e+OO 0.00e+OO O.OOe+OO O.OOe+OO o.OOe+OO O.OOe+OO 0.00e+OO NA-24 2.39e+OO 2.39e+OO 2.39e+OO 2.39e+OO 2.39e+OO 2.39e+oq 2. 77e+OO 2.39e+OO P-32 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO o.ooe+oo O.OOe+OO O.OOe+OO CR-51 9.33e-01 9.33e-01 9.33e-01 9.33e-Ol 9.33e-01 9.33e-OJ, 1.lOe+OO 9.33e-Ol MN-54 2.77e+02 2. 77e+02 2. 77e+02 2.77e+02 2. 77e+02 2. 77e+02 3.25e+02 2. 77e+02 MN-56 l.80e-01 1. aoe-01 l.80e-Ol l.BOe-01 1.80e-01 l.80e-01 2.13e-Ol l.80e-Ol FE-55 O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO FE-59 5.45e+Ol 5.45e+Ol 5.45e+Ol 5.45e+Ol 5.45e+Dl 5.45e+Ol 6.41e+Dl 5.45e+Ol C0-58 7.60e+Ol 7.60e+Ol 7.60e+Dl 7.60e+Ol 7.60e+Ol 7.60e+Ol B.87e+Ol 7.60e+Ol C0-60 4.29e+03 4.29e+03 4.29e+03 4.29e+03 4. 29e+03. 4.29e+03 5.05e+03 4.29e+03 NI-63 O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO o.ooe+oo O.OOe+OO O.OOe+OO NI-65 S.93e-02 5.93e-02 5.93e-02 5.93e-02 5.93e-02 5.93e-02 6,87e-02 5.93e-02 CU-64 l.2le-Ol l.21e-01 l.21e-Ol l.21e-Dl 1.2ie-Dl 1.21e-Dl 1~37e-Ol l.21e-Ol ZN-65 1.49e+02 l.49e+D2 1.49e+02 l.49e+02 1.49e+02 l.49e+02 1. 72e+02 l.49e+02 ZN-69 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO 0 ..OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO BR-83 9.73e-04 9.73e-04 9.73e-04 9.73e-04 9.73e-04 9.73e-04 l.41e-03 9.73e-04 BR-84 4.0Se-02 4.0Se-02 4.05e-02 4.05e-02 4.0Se-02 4.0Se-02 4. 72e-02 4.0Se-02 BR-85 O.OOe+OO o.ooe+oo O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO RB-86 l.79e+OO l.79e+OO l.79e+OO 1. 79e+OO 1. 79e+OO 1.79e+OO 2.05e+OO l.79e+OO RB-88 6.61e-03 6.61e-03 6.6le-03 6.61e-03 6.6le-03 6.61e-03 7.53e-03 6.61e-03 RB-89 2.45e-02 2.45e-02 2.45e-02 2.45e-02 2.45e-02 2.45e-02 2.95e-02 2.45e-02 SR-89 4.33e-03 4.33e-03 4.33e-03 4.33e-03 4.33e-03 4.33e-03 5.02e-03 4.33e-03 SR-90 0.00e+OO O.OOe+QO O.OQe+OO 0.00e+OQ O.OOe+OQ O.OOe+OO O.OOe+OO O.OOe+OO SR-91 4.29e-01 4.29e-01 4.29e-Ol 4.29e-01 4.29e-01 4.29e-01 5.02e-Ol 4.29e-01 SR-92 1.55e-Ol l.SSe-01 1.sse-01 1.55e-Ol 1. 55e-01 1. SSe-01 l.73e-Ol 1.SSe-01 Y-90 9.00e-04 9.00e-04 9.00e-04 9.00e-04 9.00e-04 9.00e-04 1. 06e-03 9.00e-04 Y-91 2.lSe-01 2.15e-01 2.15e-Ol 2.lSe-01 2.15e-01 2.lSe-01 2.4le-01 2.l5e-01 Y-91M 2.0le-02 2.Qle-02 2.0le-02 2.0le-02 2.0le-02 2.0le-02 2.32e-02 2.0le-02 Y-92 3.6le-02 3.Gle-02 3.61e-02 3.61e-02 3.61e-02 3.61e-02 4.28e-02 3.6le-02 Y-93 3.67e-02 3.67e-02 3.67e-02 3.67e-02 3.67e-02 3.67e-02 5.0le-02 3.67e-02 ZR-95 4.89e+Ol 4.89e+Ol 4.89e+Ol 4.89e+Ol 4.89e+Ol 4.89e+Ol 5.67e+Ol 4.89e+01 ZR-97 5 .91e-Ol 5.9le-01 5.91e-01 5.9le-01 5.91e-Ol 5.91e-Ol 6.87e-Ol 5.9le-01 NB-95 2.73e+Ol 2.73e+01 2.73e+Ol 2.73e+Ol 2.73e+Ol 2.73e+Ol 3.2le+Ol 2.73e+01 M0-99 8.00e-01 8.00e-01 8.00e-01 8.00e-01 8.00e-01 8.00e-01 9.27e-01 8.00e-01 TC-99M 3.68e-02 3.68e-02 3.68e-02 3.68e-02 3. 6B"e-02 3.58e-02 4.21e-02 3.68e-02 TC-101 4.0?e-03 4.07e-03 4.07e-03 4.07e-03 4.07e-03 4.07e-03 4.52e-03 4.07e-03 RU-103 2.17e+Ol 2.17e+Ol 2.17e+Ol 2.17e+Ol 2.17e+Ol 2.17e+Ol 2.53e+Ol 2.17e+Ol Page 3 of 8

For Information Only Attachment C ODCM-QA-005 Revision 4 Page 31of49 DOSE COMMITMENT FACTORS

                                           . FOR THE SHOREUNE PATHWAY (Ref. 3.15)

Release Type: Liquid Units: ( (mrem/hr) I (µCi/ml) l Age Group: TEEN Pathway: Shoreline Sediment (SHDp) Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-105 l.27e-01 1.27e-Ol 1. 27e-01 1.27e-Ol 1. 27e-Ol l.27e-Ol l.44e-01 l.27e-01 RU-106 8.47e+Ol 8.47e+Ol 8.47e+Ol 8.47e+Ol 8.47e+Ol 8.47e+Ol 1.0le+02 8.47e+Ol AG-llOM 6.87e+02 6.87e+02 6.87e+02 6.87e+02 6.87e+02 6.87e+02 8.00e+02 6.87e+02 TE-125M 3.lOe-01 3.lOe-01 3.lOe-01 3.lOe-01 3.lOe-01 3.lOe-01 4.25e-Ol 3.lOe-01 TE-127 5.95e-04 5.95e-04 5.95e-04 5.95e-04 5.95e-04 5.95e-04 6.55e-04 5.95e-04 TE-127M l.83e-02 l.83e-02 1.83e-02 1.83e-02 1. 83e-02 l.83e-02 2 .17e-02 l.83e-02 TE-129 5.24e-03 5.24e-03 5.24e-03 5.24e-03 5.24e-03 5.24e-03 6.20e-03 5.24e-03 TE-129M 3.95e+OO 3.95e+OO 3.95e+OO 3.95e+OO 3.95e+OO 3.95e+OQ 4.62e+OO 3.95e+OO TE-131 5.83e-03 5.83e-03 5.83e-03 5.83e-03 5.83e-03 5.B3e-03 6.87e+OO 5.83e-03 TE-131M 1.61e+OO 1. 6le+OO 1. 61e+OO 1. 61e+OO l.61e+OO 1. 6le+OO 1.89e+OO l.61e+OO TE-132 8.47e-Ol 8.47e-Ol 8.47e-01 8.47e-01 8.47e-01 8.47e-01 9.93e-01 8.47e-01 I-130 1.lOe+OO l.10e+OO l.lOe+OO 1.lOe+OO l.lOe+OO l.lOe+OO 1.34e+OO 1.lOe+OO I-131 3.44e+OO 3.44e+OO 3.44e+OO 3.44e+OO 3.44e+OO 3.44e+OO 4.17e+OO 3.44e+OO I-132 2.49e-Ol 2.49e-Ol 2.49e-Ol 2.49e-Ol 2.49e-01 2.49e-Ol 2.93e-01 2.49e-Ol I-133 4.90e-01 4.90e-Ol 4.90e-Ol 4.90e-01 4.90e-Ol 4.90e-01 5.95e-01 4.90e-01 I-134 B.93e-02 8.93e-02 8.93e-02 8.93e-02 8.93e-02 8.93e-02 1.06e-01 B.93e-02 I-135 5.05e-Ol 5.05e-01 5.05e-01 5.05e-01 5.0Se-01 5.0Se-01 5.89e-Ol 5.05e-01 CS-134 1.37e+03 l.37e+03 1. 37e+03 l.37e+03 1.37e+03 1.37e+03 l.60e+03 l .37e+03 CS-136 3.0le+Ol 3.0le+Ol 3.0le+Ol 3.0le+Ol 3.0le+Ol 3.0le+Ol 3.42e+Ol 3.0le+Ol CS-137 2.05e+03 2.05e+03 2.05e+03 2.05e+03 2.05e+03 2.05e+03 2.39e+03 2.05e+03 CS-138 7.20e-02 7.20e-02 7.20e-02 7.20e-02 7.20e-02 7.20e-02 B.20e-02 7.20e-02 BA-139 2.lle-02 2. lle-02 2. lle-02 2.lle-02 2.lle-02 2. lle-02 2.3Be-02 2 .lle-02 BA-140 4.lOe+OO 4.lOe+OO 4.lOe+OO 4.lOe+OO 4.lOe+OO 4.lOe+OO 4.69e+OO 4.lOe+OO BA-141 B.33e-03 B.33e-03 8.33e-03 8.33e-03 B.33e-03 8.33e-03 9.47e-03 8.33e-03 BA-142 8.93e-03 8.93e-03 B.93e-03 B.93e-03 8.93e-03 8.93e-03 1.02e-02 B.93e-03 LA-140 3.B4e+OO 3.84e+OO 3.84e+OO 3.84e+OO 3.84e+OO 3.84e+OO 4.35e+OO 3.84e+OO LA-142 1.52e-01 l.52e-01 1. 52e-01 l.52e-Ol 1.52e-Ol 1.52e-01 l.B2e-Ol 1.52e-01 CE-141 2.73e+OO 2.73e+OO 2.73e+OO 2.73e+OO 2.73e+OO 2.73e+OO 3.08e+OO 2.73e+OO CE-143 4.62e-Ol 4.62e-01 4.62e-01 4.62e-Ol 4.62e-Ol 4.62e-01 5.25e-01 4.62e-Ol CE-144 1. 39e+Ol l.39e+Ol l.39e+01 l.39e+Ol l.39e+Ol l.39e+Ol 1.6le+Ol l.39e+Ol PR-143 0.00e+OO O.OOe+OO o.ooe+oo 0.00e+OO D.DOe+OO O.OOe+OO O.DOe+OO O.OOe+OO PR-144 3.67e-04 3.67e-04 3.67e-04 3.67e-04 3.67e-04 3.67e-04 4.2le-04 3.67e-04

             .ND-147     1. 68e+OO  1. 68e+OO  1. 68e+OO   l.68e+OO  1.68e+OO   l.68e+OO   2.0le+OO  1.68e+OO W-187      4.70e-Ol   4.70e-01   4.70e-01    4.70e-Ol  4.70e-Ol   4.70e-Ol   5.46e-01  4.70e-01 NP-239     3.42e-Dl   3.42e-01   3.42e-01    3.42e-Ol  3.42e-Dl  3.42e-Ol   3.95e-01   3.42e-01 PU-239     4.58e-Ol   4.58e-01   4.58e-01    4.SBe-01   4.5Be-01  4.58e-01   4.46e+OO  4.58e-01 U-235      1. 86e+03   1.B6e+03  1.86e+03    1. 86e+03  l.86e+03 1. 86e+03   2.32e+03  1. 86e+03 Page 4 of 8

For Information Only Attachment C ODCM-QA-005 Revision 4 Page 32of49 DOSE COMMITMENT FACTORS FOR THE SHORELINE PATHWAY (Ref. 3.15) Release Type: Liquid Units: ( (mrem/hrl I (µCi/ml)) Age Group: CHILD Pathway: Shoreline Sediment (SHDp) Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO C-14 O.DOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO NA-24 4.99e-01 4.99e-01 4.99e-01 4.99e-01 4.99e-Ol 4.99e-01 5.79e-01 4.99e-01 P-32 0.00e+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO CR-51 l.95e-01 1. 9Se-Ol 1.95e-01 1. 95e-Ol 1. 95e-01 1.95e-01 2.30e-Ol l.95e-01 MN-54 5.79e+Ol 5.79e+Ol 5.79e+Ol 5.79e+Ol 5.79e+Ol 5.79e+Ol 6.80e+Ol 5.79e+Ol MN-56 3.77e-02 3.77e-02 3.77e-02 3. 77e-02 3.77e-02 3.77e-02 4.45e-02 3.77e-02 FE-55 O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO FE-59 1.14e+Ol l.14e+Ol l.14e+Ol l.14e+Ol l.14e+Ol l.14e+Ol l.34e+Ol 1.14e+Ol C0-58 l.58e+Ol l.58e+Ol l.58e+Ol l.58e+Ol l.58e+Ol 1.58e+Ol 1. 85e+Ol 1.58e+Ol C0-60 9.00e+02 9.00e+02 9.00e+02 9.00e+02 9.00e+02 9.00e+02 1.05e+03 9.00e+02 NI-63 O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO NI-65 l.24e-02 1. 24e-02 l.24e-02 l.24e-02 1. 24e-02 l.24e-02 1.44e-02 1. 24e-02 CU-64 2.53e-02 2.53e-02 2.53e-02 2.53e-02 2.53e-02 2.53e-02 2.87e-02 2.53e-02 ZN-65 3.12e+Ol 3.12e+Ol 3.12e+Ol 3.12e+Ol 3.12e+Ol 3.12e+Ol 3.59e+Ol 3.12e+Ol ZN-69 O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO BR-83 2.03e-04 2.03e-04 2.03e-04 2.03e-04 2.03e-04 2.03e-04 2.95e-04 2.03e-04 BR-84 8.47e-03 8.47e-03 8.47e-03 8.47e-03 8.47e-03 8.47e-03 9.87e-03 8.47e-03 BR-85 O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO RB-86 3.7se-b1 3.75e-01 3.75e-01 3.?Se-01 3.75e-01 3.75e-Ol 4.29e-Ol 3.75e-Ol RB-BB 1. 38e-03 l.38e-03 l.38e-03 l.38e-03 l.38e-03 l.38e-03 1.58e-03 l.38e-03 RB-89 5.13e-03 5.13e-03 S.13e-03 5.13e-03 5.13e-03 5.13e-03 6.16e-03 5.13e-03 SR-89 9.0?e-04 9.0?e-04 9.07e-04 9.0?e-04 9.0?e-04 9.0?e-04 1.0Se-03 9.07e-04 SR-90 O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OD SR-91 9.00e-02 9.00e-02 9.00e-02 9.00e-02 9.00e-02 9.00e-02 l.05e-01 9.00e-02 SR-92 3.24e-02 3.24e-02 3.24e-02 3.24e-02 3.24e-02 3.24e-02 3.6le-02 3.24e-02 Y-90 l.87e-04 1. 87e-04 1.87e-04 l.87e-04 1.87e-04 1.87e-04 2.2le-04 1.87e-04 Y-91 4.4Be-02 4.48e-02 4.4Be-02 4.4Be-02 4.4Be-02 4.48e-02 5.04e-02 4.48e-02 Y-91M 4.19e-03 4.19e-03 4.19e-03 4.19e-03 4.19e-03 4.19e-03 4.85e-03 4.19e-03 Y-92 7.53e-03 7.53e-03 7.53e-03 7.53e-03 7.53e-D3 7.53e-03 8.93e-03 7.53e-03 Y-93 7.67e-03 7.67e-03 7.67e-03 7.67e-03 7.67e-03 7.67e-03 l.OSe-02 7.67e-03 ZR-95 1.02e+Ol l.02e+Ol 1. 02e+Ol l.02e+Ol 1.02e+Ol 1.02e+Ol l.19e+Ol 1.02e+Ol ZR-97 1.23e-01 l.23e-01 l.23e-Ol l.23e-01 l.23e-Ol l.23e-01 l.44e-Ol l.23e-01 NB-95 5. ?le+OO 5.7le+OO 5.?le+OO 5.71e+OO 5. 71e+OO 5. ?le+OO .6.73e+OO 5.7le+OO M0-99 l.67e-01 l.67e-01 l.67e-Ol 1.67e-01 1.67e-01 l.67e-01 1.93e-01 1. 67e-01

             'I'C-99M   7.67e-03   7.67e-03   7.67e-03   7.67e-03  7.67e-03  7.67e-03    8.80e-03  7.67e-03
             'I'C-101   B.47e-04   8.47e-04   8.47e-04   B.47e-04  8.47e-04  8.47e-04    9.47e-04  8.47e-04 RU-103     4.52e+OO   4.52e+OO   4.52e+OO   4.52e+OO  4.52e+OO  4.52e+OO    5.27e+OO  4.52e+OO Page 5 of 8

For Information Only Attachment C ODCM-OA-005 Revision 4 Page 33 of 49 DOSE COMMITMENT FACTORS FOR THE SHORELINE PATHWAY (Ref. 3.15) Release Type: Liquid Units: ({rnrem/hr)/(µCi/ml)J Age Group: CHILD Pathway: Shoreline Sediment (SHDp) Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-105 2.66e-02 2.66e-02 2.66e-02 2.66e-02 2.66e-02 2.66e-02 3.0le-02 2.66e-02 RU-106 1. 76e+Ol 1. 76e+Ol l.76e+Ol 1. 76e+Ol 1. 76e+Ol l.76e+Ol 2.lle+Ol 1. 76e+Ol AG-llOM l. 43e+02 l.43e+02 1.43e+02 1. 43e+02 l.43e+02 1.43e+02 1.67e+02 1.43e+02 TE-125M 6.48e-02 6.48e-02 6.4Be-02 6.48e-02 6.48e-02 6.48e-02 8.87e-02 6.4Be-02 TE-127 1.24e-04 l.24e-04 1. 24e-04 l.24e-04 l.24e-04 l.24e-04 l.37e-04 l.24e-04 TE-127M 3.83e-03 3.83e-03 3.83e-03 3.83e-03 3.83e-03 3.83e-03 4.52e-03 3.83e-03 TE-129 l.09e-03 l.09e-03 l.09e-03 .1. 09e-03 l.09e-03 l.09e-03 1. 29e-03 l.09e-03 TE-129M 8.27e-Ol 8.27e-01 8.27e-Ol 8.27e-Ol 8.27e-01 B.27e-01 9.67e-01 8.27e-Ol TE-131 l.22e-03 l.22e-03 1.22e-03 l.22e-03 l.22e-03 l.22e-03 l.44e+OO 1.22e-03 TE-131M 3.35e-01 3.35e-01 3.35e-01 3.35e-01 3.35e-01 3.35e-01 3.95e-01 3.35e-Ol TE-132 1. 77e-01 l.77e-01 1.77e-01 1. 77e-Ol 1. 77e-01 1. 77e-01 2.08e-01 1. 77e-01 r-130 2.30e-01 2.30e-01 2.30e-01 2.30e-Ol 2.30e-01 2.30e-01 2.79e-01 2.30e-01 I-131 7.20e-Ol 7.20e-Ol 7.20e-01 7.20e-Ol 7.20e-01 7.20e-Ol 8.73e-01 7.20e-Ol I-132 5.20e-02 5.20e-02 5.20e-02 5.20e-02 5.20e-02 5.20e-02 6.12e-02 5.2De-02 I-133 l.03e-01 1. 03e-01 1.03e-01 1.03e-Ol 1. 03e-01 1.03e-Ol l.25e-01 l.03e-01 I-134 1. 87e-02 1. 87e-02 1.87e-02 1. 87e-02 l. 87e-02 l.87e-02 2.21e-02 l.87e-02 I-135 1. OSe-01 1. OSe-01 1. OSe-01 l.OSe-01 l.OSe-01 1.05e-Ol 1.23e-Ol 1.0Se-01 CS-134 2.87e+02 2.87e+02 2.87e+02 2.87e+02 2.87e+02 2.87e+02 3.34e+02 2.87e+02 CS-136 6.30e+OO 6. 30e+OO 6.30e+DO 6.30e+OO 6.30e+OO 6.30e+OO 7.13e+OO 6.30e+OO CS-137 4.29e+02 4.29e+02 4.29e+02 4.29e+02 4.29e+0'2 4.29e+02 5.0le+02 4.29e+02 CS-138 1.SOe-02 1. SOe-02 1.50e-02 1. SOe-02 1.SOe-02 1.SOe-02 l.71e-02 l.50e-02 BA-139 4.42e-03 4.42e-03 4.42e-03 4.42e-03 4.42e-03 4.42e-03 4.97e-03 4.42e-03 BA-140

8.60e-Ol B.60e-01 8.60e-Ol 8. 60e-01
8.60e-01 8.60e-Ol 9.BOe-01 8. 60e-01
BA-141 1.74e-03 1. 74e-03 1.74e-03 l.74e-03 1.74e-03 1. 74e-03 1. 99e-03 1.74e-03 BA-142 1.87e-03 l.87e-03 l.87e-03 l.87e-03 l.87e-03 l.87e-03 2. l3e-03 l.87e-03 LA-140 8.00e-01 8.00e-01 8.00e-01 8.00e-01 B.OOe-01 8.00e-01 9.07e-Ol 8.00e-01 LA-142 3.17e-02 3.17e-02 3.17e-02 3.17e-02 3.17e-02 3.17e-02 3.Ble-02 3.17e-02 CE-141 5.7le-Ol 5.71e-01 5.71e-Ol 5.71e-Ol 5.7le-Ol 5. 71e-Dl 6.43e-Ol 5.71e-01 CE-143 9.67e-02 9.67e-02 9.67e-02 9.67e-02 9.67e-02 9.67e-02 1.lOe-01 9.67e-02 CE-144 2.90e+OO 2.90e+OO 2.90e+OO 2.90e+OO 2.90e+OO 2.90e+OO 3.J6e+OO 2.90e+OO PR-143 O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO PR-144 7.67e-05 7.67e-05 7.67e-05 7.67e-QS 7.67e-05 7.67e-05 8.BOe-05 7.67e-05 ND-147 3.Sle-01 3.Sle-01 3.Sle-01 3.Sle-01 3.Sle-01 3.51e-01 4.21e-Ol 3.Sle-01 W-187 9.BOe-02 9.SOe-02 9.BOe-02 9.BOe-02 9.BOe-02 9.BOe-02 l.14e-01 9.BOe-02 NP-239 7.13e-02 7.13e-02 7.13e-02 7 .13e-02 7 .13e-02 7.13e-02 8.27e-02 7.13e-02 PU-239 9.57e-02 9.57e-02 9.57e-02 9.57e-02 9.57e-02 9.57e-02 9.32e-01 9.57e-02 U-235 3.88e+02 3.88e+02 3.88e+02 3.88e+02 3.88e+02 3.8Be+02 4.84e+02 3.8Be+02 Page 6 of B

For Information Only Attachment C ODCM-OA-005 Revision 4 Page 34 of 49 DOSE COMMITMENT FACTORS FOR THE SHORELINE PATHWAY (Ref. 3.15) Release Type: Liquid Units: ( (mrem/hr) I (µCi/ml) l Age Group: INFANT Pathway: Shoreline Sediment (SHDp) Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO C-14 O.OOe+OD O.DOe+OO O.OOe+OO O.DOe+OO O.ODe+OO D.OOe+OO D.DDe+OD 0.00e+OO NA-24 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+DO D.DOe+DD O.DOe+OD P-32 O.OOe+OO D.OOe+OO O.OOe+OO O.OOe+OO O.DOe+OO 0.00e+OO o. o*oe+O o O.OOe+OO CR-51 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO o.ooe+oo 0.00e+OO MN-54 O.OOe+DO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO MN-56 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO FE-55 O.OOe+OO o.ooe+oo O.OOe+OO O.OOe+OO O.OOe+OO 0.00-e+OO o.ooe+oo O.OOe+OO FE-59 O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO C0-58 O.OOe+OO 0.00e+OD O.DOe+OO D.OOe+OD O.OOe+DO D.OOe+OO O.OOe+OO O.OOe+OO C0-60 O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO NI-63 O.OOe+OD O.ODe+OO O.OOe+OO D.OOe+DO O.OOe+DD O.OOe+OO o.ooe+oo D.OOe+OO NI-65 O.ODe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO CU-64 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+DD O.DOe+OO O.OOe+OO ZN-65 0.00e+OO O.DOe+OO O.OOe-rOO 0.00e+OO 0.00e+OO 0.00e+OO O.OOe+OO O.OOe+OD ZN-'69 O.OOe+OO O.OOe+OO O.OOe+OD O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO BR-83 0.00e+DO O.ODe+OO o.OOe+OO 0. OOe.+00 O.OOe+OO O.ODe+OO O.OOe+OO O.OOe+OO BR-84 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO D.OOe+DO D.OOe+OO O.OOe+OO BR-85 0.00e+OO D.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0 *. OOe+OO O.OOe+OO RB-86 o.ooe+oo O.OOe+OO o.OOe+OO O.OOe+OO O.OOe+OO O.QOe+OO o.ooe+oo 0.00e+OO RB-88 0.00e+OO 0.00e+OO o.OOe+OO o~ooe+oo O.OOe+OO O.OOe+OO o.ooe+oo O.OOe+OO RB-89 O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO SR-89 O.OOe+DO D.OOe+DO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO o.ooe+oo O.OOe+OO SR-90 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+QO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO SR-91 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO o.ooe+oo 0.00e+OO SR-92 O.OOe+OO 0.00e+OO O.OOe+OO 0.00e+OO 0.00e+OO 0.00e+OO O.OOe+OO O.ODe+OO Y-90 D.OOe+OO O.OOe+OO Q.OOe+OO 0.00e+OO O.OOe+OO 0.00e+OO O.OOe+OO D.OOe+OO Y-91 0.00e+OO O.OOe+OO O.OOe+OO o.ooe+oo O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO Y-91M O.OOe+DO D.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO o.ooe+oo Y-92 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO Y-93 o.ooe+oo 0.00e+OO O.OOe+OO 0.00e+OO O.OOe+DO O.OOe+OO O.OOe+OO 0.00e+OO ZR-95 O.OOe+OO D.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO 0.00e+OO 0.00e+OO ZR-97 O.OOe+OO O.OOe+OO o.ooe+oo O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO NB-95 0.00e+OO O.OOe+OO o.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO M0-99 O.DOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO TC-99M O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO o.ooe+oo *o.ooe+oo 0.00e+OO TC-101 0.00e+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO RU-103 O.OOe+OO D.OOe+OO O.OOe+OO O.OOe+OO D.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO Page 7 of 8

For Information Only Attachment C ODCM-QA-005 Revision 4 Page 35 of 49 DOSE COMMITMENT FACTORS FOR THE SHORELINE PATHWAY (Ref. 3.15) Release Type: Liquid Units: ((rnrem/hr)/(µCi/rnl)) Age Group: INFANT Pathway: Shoreline Sediment lSHDp) Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-105 O.OOe+OO 0.00etOO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO RU-106 O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO AG-llOM O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OD TE-125M O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO 0.00e+OO O.OOe+OO TE-127 0.. 00e+OO O.OOe+OO O.OOe+OO O.OOe+OO o.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO TE-127M O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO TE-129 O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO TE-129M O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO TE-131 O.OOe+OO O.ODe+OO O.OOe+OO O.OOe+OO O.DOe+OD O.OOe+OO O.OOe+OO D.OOe+DO TE-131M O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO TE-132 O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO I-130 O.OOe+OO O.ODe+DO O.DOe+OO D.OOe+OO D.OOe+DD D.OOe+OO O.ODe+DD O.OOe+OD I-131 O.OOe+OO O.OOe+OD o*. OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO I-132 O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OD I-133 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OD O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO I-134 O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO 0.00e+OO O.OOe+OO 0.00e+OO I-135 O.OOe+OO O.OOe+OO O.DOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO .Q.OOe+OO CS-134 O.OOe+OO O.OOe+OO O.OOe+OO *o.ooe+oo O.OOe+OO 0.00e+OO O.OOe+OO D.OOe+OO CS-136 O.OOe+OO O.ODe+OO O.OOe+OD 0.00e+OO O.OOe+OD O.OOe+OO O.OOe+OO 0.00e+OO CS-137 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO CS-138 0.00e+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO BA-139 O.OOe+OO O.OOe+OO O.DOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.DOe+OO O.OOe+OO BA-140 O.OOe+OO O.ODe+OO O.OOe+OO O.OOe+OO O.OOe+OD O.OOe+OO O.OOe+OO 0.00e+OO BA-141 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO BA-142 O.OOe+OO O.OOe+OO O.OOe+OD O.OOe+OO O.OOe+OD O.OOe+OO O.ODe+OO 0.00e+OO LA-140 O.OOe+OO O.OOe+OO D.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.ODe+OO LA-142 0.00e+OO 0.00e+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO CE-141 0.00e+OO 0.00e+OO O.OOe+OO D.OOe+OO O.OOe+OO D.OOe+OO O.OOe+OO 0.00e+OO CE-143 O.OOe+OO O.DOe+OO O.OOe+OO O.OOe+OO D.OOe+OO O.DOe+OO 0.00e+OO O.OOe+OO CE-144 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO PR-143 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO PR-144 0.00e+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO ND-147 O.OOe+OO 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 0.00e+OO O.OOe+OO W-187 O.OOe+OO O.OOe+OO O.OOe+DO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO NP-239 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO D.OOe+OO O.OOe+OO O.OOe+OO PU-239 O.OOe+OO 0.00e+OO O.OOe+OO 0.00e+OO O.DOe+OO O.OOe+OO O.OOe+OO O.OOe+OO U-235 0.00e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO Page 8 of 8

For Information Only Attachment D ODCM-QA-005 Revision 4 Page 36 of 49 RADIOACTIVE DECAY CONSTANTS (Ref. 3.13) rsotope Half-life Period Decay :rsotope Half-life Period Decay ($.M.R.D.Y) Constant (S.M.H.D.Y) Constant (Hr*1) (Hr-1) 1 H-3 12 .:?B y 6.44E-06 38 Ru-103 39.35 D 7.34E-04 2 C-14 5730 y l.38E-08 39 Ru-105 4.44 H 1. 56E-01 3 Na-24 15 H 4.62E-02 40 Ru-106 368.2 D 7.84E-06 4 l?-32 14.29 D 2. 02E-03 41 Ag-llOm 249.85 D 1.16E-04 5 Cr-51 27. 704 D 1. 04E-03 42 Te-125m 58 D 4.98E-04 6 Mn-54 312.7 D 9.24E-05 43 Te-127m 109 D 2.65E-04 7 Mn-56 2. 5785 H 2.69E-Ol 44 Te-127 9.35 H 7.41E-02 8 :Fe-55 2.7 y 2.93E-05 45 Te-129m 33.6 D 8.60E-04 9 :Fe-59 44.63 D 6.47E-04 46 Te-129 69.6 M S.9BE-01 10 Co-58 70.B D 4.08E-04 47 Te-131m 30 H 2.31E-02 11 Co-60 5.271 y l.50E-05 48 'l'e-131 25 M 1. 66E+OO 12 Ni-63 100.1 y 7.90E-07 49 Te-132 78.2 H 8. B6E-03 13 Ni-65 2.52 H 2.75E-01 50 I-130 12.36 H 5.61E-02 14 Cu-64 12.701 H 5.46E-02 51 I-131 B. 04 D 3.59E-03 15 Zn-65 244.4 D l.18E-04 52 I-132 2.3 H 3.0lE-01 16 Zn-69 55.6 M 7.47E-01 53 I-133 20. 8 H 3.33E-02 17 Br-83 2.39 H 2.90E-Ol 54 I-134 52.6 M 7.89E-01 18 Br-84 31. B M 1.31E+OO 55 I-135 6.61 H l.05E-Ol 19 Br-85 172 s l.45E+Ol 56 Cs-134 2.062 y 3.84E-05 20 Rb-86 18.66 D 1. 55E-03 57 Cs-136 13.16 D 2.19E-03 21 Rb-BB 17.8 M 2.33E+OO 58 Cs-137 30.17 y 2.62E-06 22 Rb-89 15.44 M 2.69E+OO 59 Cs-138 32.2 M l.29E+OO 23 Sr-89 50. 55 D 5.71E-04 60 Ba-139 83.l M 4.99E-.,Ol 24 Sr-90 28.6 y 2. 77E-06 61 Ba-140 12.789 D 2.26E-03 25 Sr-91 9.5 H 7. 30E-02 62 Ba-141 18.27 M 2.27E+OO 26 Sr-92 2.71 H 2.56E-01 63 Ba-142 10.7 M 3.88E+OO 27 Y-90 6;Ll H l.08E-02 64 La-140 40.22 H 1. 72E-02 28 Y-91m 49.71 M B.35E-Ol 65 La-142 95.4 M 4.35E-01 29 Y-91 58.51 D 4.94E-04 66 Ce-141 32.5 D 8.89E-04 30 Y-92 3.54 H 1. 96E-01 67 ce-143 33 H 2.lOE-02 31 Y-93 10.1 H 6. B6E-02 68 Ce-144 284.3 D 1.02E-04 32 zr-95 64.02 D 4.51E-04 69 Pr-143 13.56 D 2.13E-03 33 zr-97 16.9 H 4.lOE-02 70 Pr-144 17.28 M 2.40E+OO 34 Nb-95 35.06 D B.24E-04 71 Nd-147 10.98 D 2. 63E-03 35 Mo-99 66.02 H 1. OSE-02 72 W-187 23.83 H 2.91E-02 36 Tc-99m 6.02 H l.lSE-01 73 Np-239 2.355 D l.23E-02 37 Tc-101 14.2 M 2.92E+OO 74 U-235 7, 04E+08 y l.12E-l3 75 PU-239 2.41E+04 y 3.00E-09 Page 1 of 1

For Information Only Attachment E ODCM-QA-005 Revision 4 Page 37 of 49 DILUTION FACTORS AND TRANSIT TIMES FOR SSES EFFLUENTS TO DANVILLE. PA (Ref. 3.i4 Appendix E-17, E-18) RIVER DEPTH RJ:VER DEPTH R:IVER LEADDIG MEAS. AT ENV. LAB MEAS. AT MCR D:tSCBARGE EDGE D:tLUT:tON

                                    .(FEE'l')            (INCHES)         (CFS)     (KOORS)     FACTOR

1. 5 144 500 68.7 136.4

1. 6 145 530 67.8 140.l

1. 8 148 600 66.3 147.3 2 150 670 64.8 155.5 2.2 152 '730 63.3 164.5 2.4 1.55 780 61. 8 173.9 2.5* 156* 825* 61. l* 179.l*

2.6 157 870 60.3 184.5 2.8 160 930 58.8 195. 7 3 162 1000 57.2 208.3 3.2 164 1200 52.7 250.6 3.4 167 1400 48.2 291. 5 3.5* 168* 1500* 45. 9* ' 280.9* 3.6 169 1600 43.5 271.0 3.8 172 1800 39.0 250.6 4 174 2000 35.5 250.6 4.2 176 2280 35.2 254.5 4.4 179 2560 34.7 259 .. 1 4.5* 180* 2730* 34.5* 261.4* 4.6 181 2900 34.2 263.9 4.8 184 3300 33.7 270.3 5 186 3700 33.0 277.8 5.2 188 4140 32.3 284.1 5.4 191 4580 31.. 7 292.4 5.5* 192* . 4820* 31.4* 297.2* 5.6 193 5060 31.0 302 .1 5.8 196 5580 30.2 312.S 6 198 6100 29. 5 323.6 6.2 200 6780 '28. 5 339.0 6.4 203 7460 27.5 354.6 6.5* 204* 7890* 26 .9 2 366.3* 6.6 205 8320 26.2 378.8

Interpolated value Page 1of2

For Information Only Attachment E ODCM-QA-005 Revision 4 Page 38 of 49 DILUTION FACTORS AND TRANSIT TIMES FOR SSES EFFLUENTS TO DANVILLE, PA (Ref. 3.14 Appendix E-17, E-18) RIVER DEPTH RIVER DEPTH RIVER LEADING MEAS. AT ENV. LAB MEAS. AT MCR DISCHARGE EDGE I>ILUTION (FEET) (INCHES) (CFS) (HOURS) FACTOR 6.8 208 9360 24.7 413.2 7 210 10400 23.0 456.6 7.5 216 12500 20.0 588.2 8 222 14900 16.5 869.6 8.S 228 17500 15.3 980.4 9 234 20700 14.7 1071. 8 9.5 240 24000 14.2 1173.7 10 246 27000 13.S 1285.3 10.5 252 30100 13.0 1373.6 11 258 34570 12.2 1567.4 11.5 264 38730 11.3 1795.3 12 270 42530 10.7 2057.6 12.5 276 46490 10.0 2398.l 13 282 50630 10.0 2597.4 13.5 288 54940 10.0 2832.9 14 294 59430 9.8 3067.S 14.5 300 64090 9.8 3311.3 15 306 68930 9.8 3558.7 15.5* 312* 74030* 9.8* 3802.3* 16 318 79130 9.8 4081. 6 16.5* 324* 84580* 9. 8* 4347.8* 17 330 90030 9.7 4651.2 17 .5* 336* 95830* 9.7* 4926.1* lB 342 1.01630 9.7 5235.6 18.5* 348* 107780* 9.7* 5540.2* 19 354 113930 9.7 5882.4 19.5* 360* 120430* 9.6* 6192.0* 20 366 126930 9.5 6535.9 20.5* 372* 133780* 9.5* 6872.9* 21 378 140630 9 .. 5 7246.4

21. 5* 384* 147830* 9.4* 7604. 6*

22 390 155030 9:3 8000.0

             *Interpolated value Page 2 of 2

For Informatiori Only Attachment F ODCM-QA-005 Revision 4 Page 39 of 49 SITE SPECIFIC INFORMATION Minimum Cooling Tower Slowdown Flow: 5000 gpm (Ref. 3.14) Shorewidth Factor: 0.2 (Ref. 3.8 Table A-2) Sediment exposure time: 131,400 hour (Ref. 3.8, Equation A-4) USAGE FACTORS (Ref. 3.8) PATHWAY INFANT CHILD TEEN ADULT Fish (kQ/vr) 0 6.9 16 21 Potable Water (liter/yr) 330 510 510 730 Shoreline (hr/yr) 0 14 67 12 DILUTION FACTORS (OF) (Ref. 3.12. Table 3 and Appendix E) PATHWAY LOCATION OF Fish Outfall 15.9 Potable Water Danville 388* Shoreline Outfall 15.9

            *For estimating purposes (interpolated value from Ref. 3.12 Appendix E-17). Actual dilution factors at Danville, Pa., for various river levels located in Attachment E.

TRANSIT TIMES (Tp) (Ref. 3.10) PATHWAY LOCATION Tp (hr) Fish Outfall 25 ** Potable Water Danville 25.8

Shoreline Outfall 1

            *For estimating purposes. Actual river transit times at Danville, Pa., for various river levels located in Attachment E.
           **Includes one hour transit from outfall plus 24 hours to consumption.

Page 1 of 1

For Information Only* Attachment G ODCM-QA-005 Revision 4 Page 40 of 49 CONSOLIDATED DOSE CALCULATION The following equation consolidates the methodology as described in Section 6.0 (Regulatory Guide 1.109 methodology). The equation utilizes a dose commitment factor, which incorporates Regulatory Guide 1.109 parameters specific to each exposure pathway. The resultant dose commitment factor correlates dose to the radionuclide concentration received via the applicable exposure pathway. The dose due to radionuclides released in liquid effluent to unrestricted areas during a specified time period via the potable water, fish and shoreline pathways is determined by the following: DCFaipi .. Q.

e*.41tp RaipJ = DFp ~ .. 1 hour/3600 sec Where:

RaipJ = Dose to organ j of individuals of age group a from nuclide i in the pathway

p. (mrem)

DCFaipi = Dose Commitment Factor for organ j of individuals of age group a from nuclide i in the pathway p. (mrem*ml/µCl*hr)

                                    *Dose Commitment Factors listed in Attachments A (Potable Water Pathway), 8 (Fish Pathway) and C (Shoreline Pathway) (Ref. 3.15).
                             =      Activity Released of nuclide i (µCi)
                             =      Radioactive decay constant of nuclide i (Attachment D) (hr"')
                             =      Total time elapsed between release of the nuclides and ingestion of food or water (Attachment F) (hr).

DFp = Dilution Factor (default values in Attachment F, actual values based on current river depth at Main Control Room taken from Attachment E). F = Flow rate in the liquid effluent (cooling tower blowdown flow in ml/sec) The dilution factor, DFp, has been substituted for the mixing ratio, 1/Mp, in the above equation. Page 1 of 2

For Information Only Attachment G ODCM-QA-005 Revision 4 Page 41of49 Pathway Dose Commitment Factor Derivation A dose commitment factor (DCF) for each pathway is derived which incorporates standard parameters outlined in Section 6.0. The calculation of the individual dose commitment factors is as follows: Potable water DCFaipj = l.14e5

U up
Daipj Fish DCFaipj =1.14e5
Uap
B;p
Daipj Shoreline Where: 1.14e5 =unit conversion (pCi*mL "yr)l(µCi*L *hr)

DCFaipi = (mrem*mL)l(µCi*hr) Equilibrium bioaccurnulation factor for nuclide i in pathway p, expressed as the ratio of the concentration in biota (pCi/kg) to the radionuclide concentration in

water (pCi/liter), i.e., liter/kg (Ref. 3.8 Table A-1)

Daipj = Dose factor specific to a given age group a, radionuclide i, pathway p, and organ j, which can be used to calculate the radiation dose from ingestion of a radionuclide or from standing on contaminated ground (Ref. 3.8 Table E-6, E-11 through E-14) (mrem/pCi ingested or mrern/hr per pCi/m2 ) Uap = Usage factor that specifies the intake rate or exposure rate for an individual of age group a associated with pathway p (Attachment F) (kg/yr, I/yr or hr/yr) Ai = Radioactive decay constant of nuclide i (Attachment D) (hr-1) w = shoreline width factor (Attachment F} (dimensionless} tb :: Period of time shoreline is exposed to contaminated water (Attachment F) (hr) Ti = Radioactive half-life of nuclide i (days). Page 2 of 2

For Information Only Attachment H ODCM-QA-005 Revision 4 Page 42 of 49 MAXIMUM HYPOTHETICAL COMPOSITE DOSE FACTORS (Ref. 3.16) Composite Dose Factors: Maximum Hypothetical Adult (Page 1 of 2) Dose Factor Units: mrem/Ci Released Location: Danville (Water lng.)/Outfall (Fisn and Shoreline)/FIXED DILUTION Usage (Uap) (kg/yr: FISH) = 21 Usage (Uap) (kg/yr: WATER)= 730 Usage (Uap) (hr/yr: SHORE)= 12 Dilution (1/Mp:SHORE)::::: 15.9 Dilution (1/Mp:FISH) = 15.9 Dilution (1/Mp:WATER)::::: 321 Transit time (tf) hrs.= 25 Transit time (tw} hrs. = 25.8 Transit time (tp) hrs. = 1 Transit time (tb) hrs.= 131400

Isotope Bone Liver T. Body Thyroid Kidney Lung G:Z:"'.'LL:I Skin l H-3 O.OOE+OO 3.59E-05 3.59E-05 3.59E-05 3.59E-05 3.59E-05 3.59E-05 0.00E+OO 2 C-14 l. 70E+OO 3.41E-Ol 3.4lE-01 3.41E-Ol 3.41E-01 3.41E-01 3.41E-01 0.00E+OO 3 Na-24 7.09E-03 7.09E-03 7 .12E-03 7,09E-03 7.09E-03 7. 09E-03 7.09E-03 2.58E-05 4 P-32 7.lBE+Ol 4.46E+OO 2.77E+OO O.OOE+OO O.OOE+OO O.OOE+OO 8.07E+OO O.OOE+OO 5 Cr-51 O.OOE+OO O.OOE+OO 7. 72E-05 4.07E-05 l.SOE-05 9.04E-05 1. 71E-02 l. 07E-05 6 Mn-54 O.OOE+OO 2.39E-01 4.82E-02 O.OOE+OO 7.lOE-02 O.OOE+OO 7.31E-01 3 .17E-03 7 Mn-56 O.OOE+OO 7.25E-06 2.63E-06 0. OOE+O.O 9.21E-06 O.OOE+OO 2.31E-04 l.59E-06 8 Fe-55 3.64E-02 2. 52E-02 5.87E-03 O.OOE+OO O.OOE+OO 1.40E-02 1.44E-02 O.OOE+OO 9 Fe-59 5.66E-02 1.33E-Ol S.lSE-02 O.OOE+OO O.OOE+OO 3. 72E-02 4.43E-01 6.24E-04 10 Co-58 O.OOE+OO 4.97E-03 l.19E-02 O.OOE+OO O.OOE+OO O.OOE+OO l.OlE-01 8.64E-04 11 Co-60 O.OOE+OO 1.44E-02 7 .37E-02 O.OOE+OO O.OOE+OO O.OOE+OO 2. 71E-01 4.93E-02 12 Ni-63 1. 72E+OO l.19E-Ol 5.78E-02 O.OOE+OO 0. OOE+OO O.OOE+OO 2.49E-02 O.OOE+OO 13 Ni-65 7.20E-06 9.35E-07 B.66E-07 O.OOE+OO 0.00E+OO O.OOE+OO 2.37E-05 5. llE-07 14 Cu-64 O.OOE+OO l.43E-04 6.84E-05 O.OOE+OO 3.61E-04 O.OOE+OO 1.22E-02 1.27E-06 15 Zn-65 l. 26E+OO 4.00E+OO l.BlE+OO O.OOE+OO 2.68E+00 O.OOE+OO 2.52E+OO 1.67E-03 16 Zn-69 2. llE-11 4.03E-ll 2.SOE-12 O.OOE+OO 2.62E-ll O.OOE+OO 6.06E-12 O.OOE+OO 17 Br-83 O.OOE+OO O.OOE+OO l.57E-06 O.OOE+OO O.OQE+OO D. OC>E+OO 2.26E-06 1. 03E-08 18 Br-84 O.OOE+OO O.OOE+OO 1.07E-07 O.OOE+OO O.OOE+OO O.OOE+OO 1.51E-22 1. 25E-07 19 Br-85 O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 20 Rb-86 O.OOE+OO 5.29E+OO 2.47E+OO O.OOE+OO 0.00E+OO O.OOE+OO 1.04E+OO 2.00E-05 21 Rb-88 O.OOE+OO O.OOE+OO 6.27E-09 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 7.17E-09 22 Rb-89 O.OOE+OO O.OOE+OO 1. 63E-08 O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO l.96E-08 23 Sr-89 1.25E+OO O.OOE+OO 3. 60E-02 O.OOE+OO O.OOE+OO O.OOE+OO 2.0lE-01 4.89E-08 24 Sr-90 3 .13E+Ol O.OOE+OO 7. 69E+OO O.OOE+OO O.OOE+OO O.OOE+OO 9.0SE-01 O.OOE+OO 25 Sr-91 3. 77E-03 O.OOE+OO 1.56E-04 O.OOE+OO O.OOE+OO 0.00E+OO 1. BOE-02 4.55E-06 26 Sr-92 1. 47E-05 O.OOE+OO 1. BlE-06 O.OOE+OO O.OOE+OO O.OOE+OO 2.91E-04 1.30E-06 27 Y-90 2.SSE-05 O.OOE+OO 6. 94E-07 O.OOE+OO O.OOE+OO O.DOE+OO 2.71E-01 1.02E-08 28 Y-9lm 2.64E-l6 O.OOE+OO 8.49E-08 O.OOE+OO O.OOE ... 00 O,OOE+OO 7.74E-16 9.83E-08 29 Y-91 4.85E-04 0.00E+OO 1. 51E-05 O.OOE+OO O.OOE+OO O.OOE+OO 2.67E-01 2.35E-06 30 Y-92 2.lBE-08 O.OOE+OO 2.90E-07 O.OOE+OO 0. OOE-1-00 O.DOE+OO 3.82E-04 3.43E-07 31 Y-93 1. 67E-06 O.OOE+OO 3.SOE-07 O.OOE+OO 0.00E ... 00 O.OOE+OO 5. 30E-02 4.5(iE-07 32 Zr-95 1. 97E-05 6.31E-06 4. BlE-04 O.OOE+OO 9.90E-06 O.OOE+OO 2.00E-02 5.53E-04 33 Zr-97 3.90E-07 7.87E-08 5.57E-06 O.OOE+OO 1.19E-07 O.OOE+OO 2.44E-02 6.44E-06 34 Nb-95 2.38E-02 1.33E-02 7. 39E-03 O.OOE+OO 1. 31E-02 O.OOE+OO 8.04E+Ol 3.13E-04 Page 1 of 6

For Information Only Attachment H ODCM-QA-005 Revision 4 Page 43of49 MAXIMUM HYPOTHETICAL COMPOSITE DOSE FACTORS (Ref: 3.16)

Composite Dose Factors: Maximum Hypothetical Adult (Page 2 of 2)

Dose Factor Units: mrem/Ci Released Location: Danville (Water lng.)/Outfall (Fish and Shoreline)/FIXED DILUTION Isotope Bone Liver T, Body Thyroid Kidney Lung GJ:-LLJ: SKIN 35 Mo-99 D.OOE+OO 5.06E-03 9.7DE-04 O.OOE+OO 1. J.SE-02 O.OOE+OO 1.17E-02 8.92E-06 36 Tc-99m 3.00E-08 8.47E-OB J..40E-06 O.OOE+OO 1. 29E-06 4.lSE-08 5.0lE-05 3.66E-07 37 Tc-lOJ. O.OOE+OO O.DOE+OO 2.14E-09 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO 2.37E-09 38 Ru-103 2.77E-04 O.OOE+OO 3.30E-04 O.ODE+OO J..06E-03 O.OOE+OO 3.24E-02 2.46E-04 39 Ru-J.05 4.67E-07 O.OOE+OD l.24E-06 D.OOE+OO 6.03E-06 O.OOE+OO 2.BSE-04. 1. 20E-06 40 Ru-106 4.19E-03 O.OOE+OO J.. 35E-03 0.00E+OO 8.09E-03 O.OOE+OO 2. 7J.E-Ol 9.B?E-04 41 Ag-llOm 8.36E-05 7. 73E-05 6.74.E-03 O.OOE+OO 1.52E-04 O.OOE+OO 3.l6E-02 7.BlE-03 42 Te-:J..25m l.39E-O:J.. 5.02E-02 l.BGE-02 4.17E-02 S.63B-Ol O.OOE+OO S.53E-01 4.14.E-06 43 Te-127m 3.52E-01 1.26E-01 4..29E-02 9.00E-02 l.43E+OO O.OOE+OO l.lBE+OO 2.J.lE-07 44 Te-J.27 9.02E-04 3.24.E-04 1. 95E-04 6.68E-04 3.67E-03 O.OOE+OO 7.12E-02 5.93E-09 45 'I'e-129m 5.89E-01 2.20E-01 9.33E-02 2.02E-Ol 2.46E+OD O.OOE+OD 2 .97E+00 4.50E-05 46 Te-129 l.61E-03 6.05E-04 4.27E-04 1.23E-03 6.76E-03 O.OOE+OO 1.21E-03 4.20E-05 47 Te-131m 5. 08E-02 2.49E-02 2.07E-02 3.94E-02 2.52E-01 O.OOE+OO 2.47E+OO 1. BOE-OS I 48 Te-131 9.69E-22 4.0SE-22 J.. OBE-08 7.97E-22 4.24E-21 O.OOE+OO l.37E-22 1. 28E-05 49 Te-132 l.06E-01 6.84E-02 6.42E-02 7.55E-02 6. SBE-01 O.OOE+OO 3.23E+OO 9.62E-06 50 I-130 4.048-04 1.19E-03 4.SOE-04 l.OlE-01 l.86E-03 O.OOE+OO 1. 02E-03 l.23E-05 51 I-131 8, 28E-03 l.lSE-02 6, 82E-03 3.88E+OO 2. 03E-02 O.OOE+OO 3. l3E-03 4.06E-05 52 I-132 2. 3lE-07 6.lBE-07 2.DlE-06 2 .16E-05 9.BSE-07 O.OOE+OO 1.16E-07 2.llE-06 53 I-133 1. 34E-03 2.33E-03 7. lGE-04 3, 43E-OJ. 4.07E-03 O.OOE+OO 2.lOE-03 S.62E-06 54 I-134 5. 95E-13 l.62E-12 3.96E-D7 2.80E-11 2.57E-12 O.OOE+OO 1. 41E-15 4.70E-07 55 I-135 6.96E-05 l.82E-04 7.17E-05 1. 20E-02 2.92E-04 O.OOE+OO 2.06E-04 5.17E-06 56 Cs-134 l.62E+Ol 3.86E+Ol 3.lSE+Ol O.OOE+DO l.25E+Ol 4.14E+OO 6.75E-01 1. 56E-02 57 Cs-136 1.61E+OO 6.35E+OO 4.57E+OO O.OOE+OO 3.53E+00 4.84E-Ol 7.21.E-Ol 3.32E-04 58 Cs-137 2.08E+Ol 2.84E+Ol l.86E+Ol O.OOE+OO 9.65E+00 3.21E+DO 5.SOE-01 2.34.E-02 59 Cs-138 l.46E-16 2. 87E-16 1.93E-07 O.OOE+OO 2.llE-16 2.09E-17 J.. 23E-21 2.21E-07 60 Ba-139 2.46E-10 1. 75E-13 1.25E-07 O.OOE+OO 1.64E-13 9.94E-14 4.36E-10 l.41E-07 61 Ba-140 1. 43E-02 1. BOE-05 9. 77E-04 O.OOE+OO 6.llE-06 1.03E-05 2.94E-02 4.56E-05 62 Ba-141 O.OOE+OO O.OOE+OO 8.39E-09 O.OOE+OO 0.00E+OO Q.OOE+OO O.OOE+DO 9.57E-09 63 Ba-142 O.OOE+OO D.OOE+OO 1.BlE-09 0.00E+OO 0.00E+OO O.OOE+OO O.OOE+DO 2.06E-09 64 La-140 S.65E-06 2.SSE-06 3.75E-05 O.OOE+OD 0.00E+OO O.OOE+OO 2.09E-Ol 4.17E-05 65 La-142 8. 26E-12 3.76E-12 9.GOE-07 O.OOE+OO 0.DOE+OO O.OOE+OO 2.74E-08 l.15E-06 66 Ce-141 3.2SE-06 2.19E-06 2. 68E-05 O.OOE+OO l.02E-06 O.OOE+OO 8. 39E-03 3.00E-05 67 Ce-143 3.42E-07 2.53E-04 4.44E-06 O.OOE+OO l. llE-07 O.OOE+QO 9.46E-03 5.0lE-06 68 Ce-144 1.73E-04 7.22E-05 l.45E-04 O.OOE+OO 4.28E-05 O.OOE+OO S.84E-02 1. 57E-04 69 Pr-143 3.04E-05 l.22E-05 l.SlE-06 O.OOE+OO 7.03E-06 O.OOE+OO 1. 33E-Ol O.OOE+OO 70 Pr-144 O.OOE+OO O.OOE+OO 3.24E-10 0.0DE+OO O.OOE+OD O.OOE+OO O.OOE+OO 3.73E-10 71 Nd-147 2.05E-05 2.37E-05 1. 77E-05 0.0DE+OO l.39E-05 O.OOE+OO l.14E-01 1.96E-05 72 W-187 7. 79E-03 6. 52E-03 2.28E-03 O.OOE+OO 0.DDE+OO O.OOE+OO 2.13E+OO 5.17E-06 73 Np-239 1. 34.E-06 1. 31E-07 3.36E-06 O.OOE+OO 4.lOE-07 O.OOE+OO 2.69E-02 3.81E-06 Page 2 of 6

For Information Only Attachment H ODCM-QA-005 Revision 4 Page 44 of 49 MAXIMUM HYPOTHETICAL COMPOSITE DOSE FACTORS (Ref. 3.16) Composite Dose Factors: Maximum Hypothetical Teen (Page 1 of 2} Dose Factor Units: mrem/Ci Released Location: Danville (Water lng.)/Outfall (Fish and Shoreline)/FIXED DILUTION Usage (Uap) (kg/yr: FISH)= 16 Usage (Uap) (kg/yr: WATER)= 510 Usage {Uap) {hr/yr: SHORE}= 67 Dilution (1/Mp:SHORE} = 15.9 Dilution (1/Mp:FISH) = 15.9 Dilution (1/Mp:WATERY= 321 Transit time (tf) hrs. = 25 Transit time (tw) hrs. = 25.8 Transit time (tp) hrs. = 1 Transit time (tb) hrs.= 131400 J:11otope Bone Liver T. Body Thyroid Kidney Lung GJ:-LLJ: Skin 1 H-3 O.OOE+OO 2. 61E-05 2.61E-05 2.61E-05 2.61E-05 2.61E-05 2.61E-05 O.OOE+OO 2 C-14 l.85E+OO 3.71E-Ol 3.71E-Ol 3. 71E-01 3.71E-Ol 3.71E-Ol 3. 71E-Ol O.OOE+OO 3 Na-24 7.30E-D3 7.3DE-D3 7 .43E-03 7.3DE-03 7.30E-03 7. 30E-03. 7.3DE-03 1.44E-04 4 P-32 7.82E+Ol 4.84E+OO 3.03E+OO O.OOE+DO O.OOE+OO O.OOE+OO 6.57E+OO O.OOE+OO 5 Cr-51 O.OOE+OO O.OOE+OO 1.21E-04 3.90E-05 1.54E-05 l.OOE-04 1.18E-02 5.98E-05 6 Mn-54 O.OOE+OO 2.35E-Ol 6.16E-02 O.OOE+OO 7, OOE-02 O.OOE+OO 4.SlE-01 1. 77E-02 7 Mn-56 O.OOE+OO 7.59E-06 8.86E-06 O.OOE+OO 9.61E-06 0.00E+OO S .OOE-04 8.BBE-06 B Fe-55 3.BlE-02 2,?0E-02 6.30E-03 O.OOE+OO O.OOE+OO 1. 71E-02 1.17E-02 O.OOE+OO 9 Fe-59 S.82E-02 1. 36E-01 5.55E-02 O.OOE+OO O.OOE+OO 4.29E-02 3.21E-01 3.49E-03 10 Co-58 O.OOE+OO 4. 938-03 1.55E-02 O.OOE+OO O.OOE+OO O.OOE+OO 6.79E-02 4..82E-03 11 Co-60 O.OOE+OO l,44E-02 2.67E-01 O.OOE+OO O.OOE+OO O.OOE+OO 1.87E-Ol 2.75E-01 12 Ni-63 1. 78E+OO 1. 26E-01 6.0SE-02 O.OOE+OO O.OOE+OO O.OOE+OO 2.0lE-02 O.OOE+OO 13 Ni-65 7.77E-06 9.93E-07 2.91E-06 O.OOE+OO O.OOE+OO 0.00E+OO S.38E-05 2.SSE-06 14 Cu-64 O.OOE+OO 1. 50E-04 7.69E-05 O.OOE+OO 3.BOE-04 O.OOE+OO 1.17E-02 7.0BE-06 15 Zn-65 l.14E+OO 3.96E+OO l.86E+OO O.OOE+OO 2.54E+OO O.OOE+OO 1.6BE+OO 9.35E-03 16 Zn-69 2.29E-11 4.37E-11 3.06E-12 O.OOE+OO 2.85E-11 O.OOE+OO 8.0SE-11 O.OOE+OO 17 Br-83 O.OOE+OO O,OOE+OO 1. 74E-06 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 5.76E-08 18 Br-84 O.OOE+OO O.OOE+OO 5.99E-07 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 6.9BE-07 19 Br-85 O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO 20 Rb-86 O.OOE+OO 5.70E+OO 2.68E+OO O.OOE+OO O.OOE+OO O.OOE+OO 8.43E-01 l.12E-04 21 Rb-88 O.OOE+OO O.OOE+OO 3.50E-OB 0.00E+OO O.OOE+OO 0.00E+OO O.OOE+OO 4.00E-08 22 Rb-89 O.OOE+OO O.OOE+OO 9.llE-08 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO l.09E-07 23 Sr-89 l.36E+OO O.OOE+OO 3.89E-02 O.OOE+OO O.OOE+OO O.OOE+OO l. 62E-Ol 2.73E-07 24 Sr-90 2.60E+Ol O.OOE+OO 6.43E+00 0.00E+OO O.OOE+OO O.OOE+OO 7.30E-Ol O.OOE+OO 25 Sr-91 4.07E-03 O.OOE+OO l.84E-04 O.OOE+OO O.OOE+OO O.OOE+OO 1.BSE-02 2.54E-05 26 Sr-92 1.SBE-05 O.OOE+OO 1.22E-06 O.OOE+OO O.OOE+OO O.OOE+OO 4..03E-04. 7.27E-06 21 Y-90 2. 76E-05 O.OOE+OO 7.91E-07 O.OOE+OO D.OOE+OO O.OOE+OO 2.27E-01 5.71E-08 28 Y-9lm 2.84E-16 O.OOE+OO 4.74E-07 O.OOE+OO 0.00E+OO O.OOE+OO 1. 34.E-14 5.49E-07 29 Y-91 5.24.E-04 D.ODE+DD 2.57E-05 O.DOE+DD D.ODE+OO 0.00E+DD 2.lSE-01 l.31E-05 30 Y-92 2.37E-OB O.OOE+OO 1. 61E-06 O.OOE+OO O.OOE+OO O.OOE+OO 6.SOE-04 1. 92E-06 31 Y-93 1. BlE-06 0.DOE+OO 1. 91E-06 O.OOE+OO O.OOE+OO 0.00E+OO 5. 53E-02 2.SSE-06 32 Zr-95 l.97E-05 6.23E-06 2.GGE-03 O.DOE+OD 9.lSE-06 D.OOE+OO 1. 44.E-02 3.09E-03 33 Zr-97 4. 07E-07 8.06E-OB 3. 09E-05 O.OOE+OO 1.22E-07 O.OOE+OO 2.18E-02 3.60E-05 34 Nb-95 2. 40E-02 l.33E-02 8. 81E-03 O.OOE+OO 1.29E-02 O.OOE+DO 5.69E+Ol l.75E-03 Page 3 of 6

For Information Only Attachment H ODCM-QA-005 Revision 4 Page 45 of 49 MAXIMUM HYPOTHETICAL COMPOSITE DOSE FACTORS (Ref. 3.16) Composite Dose Factors: Maximum Hypothetical Teen {Page 2 of 2) Dose Factor Units: mrem/Ci Released Location: Danville {Water lng.)/Outfall (Fish and Shoreline)/FIXED DILUTION

Isotope Bone Liver '1'. Body Thyroid Kidney Lun!J G:I-LL:I SK:IN 35 Mo-99 O.OOE+OO 5.33E-03 1. 06E-03 O.OOE+OO 1.22E-02 O.OOE+OO 9. 54E-03 4.98E-05 36 Tc-99m 3.0SE-08 8.50E-08 2.89E-06 *** 0. OOE+OO - L27E-06 4.72E-08 5.58E-05 2.04E-06 37 Tc-101 O.OOE+OO O.OOE+OO 1.19E-08 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO 1. 33E-08 38 Ru-103 2.88E-04 O.OOE+OO l.30E-03 O.OOE+OO l.OlE-03 O.OOE+OO 2.40E-02 1.37E-03 39 Ru-105 4.98E-07 O.OOE+OO 6.llE-06 O.OOE+OO 6.28E-06 O.OOE+OO 4.02E-04 6.71E-06 40 Ru-106 4. 50E-03 O.OOE+OO 5.16E-03 O.OOE+OO 8. 67E-03 O.OOE+OO 2.16E-01 5.51E-03 41 Ag-110m 7.87E-05 7.45E-05 3.74E-02 0.00E+OO 1.42E-04 O.OOE+OO 2.09E-02 4.36E-02 42 Te-125m 1. SlE-01 5.43E-02 2. 02E-02 4.21E-02 O.OOE+OO O.OOE+OO 4.45E-01 2.31E-05 43 Te-127m 3.83E-01 1.36E-Ol 4.SSE-02 9. llE-02 l. 55E+OO O.OOE+OO 9.54E-01 l.18E-06 44 Te-127 9.87E-04 3 .. 50E-04 2.12E-04 6.81E-04 4.00E-03 O.OOE+OO 7.62E-02 3.31E-08 45 Te-129m 6.36E-Ol 2.36E-01 1. OlE-01 2.0SE-01 2.66E+OO O.OOE+OO 2.39E+OO 2.51E-04 46 Te-129 1. 75E-03 6.52E-04 6.23E-04 1.25E-03 7.34E-03 O.OOE+OO 9.56E-03 2.34E-04 47 Te-13lm S.46E-02 2.62E-02 2.19E-02 3.94E-02 2.73E-01 O.OOE+OO 2.lOE+OO l. OlE-04 48 Te-131 l.OSE-21 4.31E-22 6.0SE-OS 8.0SE-22 4.57E-21 O.OOE+OO B.SBE-23 7.lSE-05 49 Te-132 l.llE-01 7.0GE-02 6.65E-02 7.44E-02 6. 77E-01 O.OOE+OO 2.24E+OO 5.37E-05 so I-130 4.lSE-04 1.20E-03 5 .37E-04 9. 80E-02 1.85E-03 O.OOE+OO 9.24E-04 6.88E-05 51 I-131 8.80E-03 1. 23E-02 6.SOE-03 3.59E+OO 2 .12E-02 O.OOE+OO 2.44E-03 2.26E-04 52 I-132 2.40E-07 6. 29E-07 l.02E-05 2 .12E-05 9.91E-07 0. OOE.+00 2.74E-07 l. lBE-05 53 I-133 1. 43E-03 2.43E-03 7.68E-04 3.40E-01 4.27E-03 O.OOE+OO l. 84E-03 3.14E-05 54 I-134 6.22E-13 l.6SE-12 2.21E-06 2.75E-11 2.60E-12 O.OOE+OO 2.17E-14 2. 63E-06 55 I-135 7.24.E-05 1. 86E-04 9.38E-05 l. 20E-02 2.94E-04 O.OOE+OO 2.07E-04 2.89E-05 56 Cs-134 1. 66E+Ol J.91E+01 l.82E+Ol O.OOE+OO l.24E+Ol 4.74E+OO 4.86E-01 B.70E-02 57 Cs-136 1.62E+OO 6.36E+OO 4.27E+OO O.OOE+DO 3.46E+OO 5,45E-01 5 .12E-01 1. 86E-03 SB Cs-137 2.23E+Ol 2.96E+Ol 1.04E+Ol O.OOE+OO 1.0lE+Ol 3.91E+OO 4.21E-01 1.31E-01 59 Cs-138 1. 56E-16 2.99E-16 1.0BE-06 O.OOE+OO 2 .21E-16 2.57E-17 1.36E-19 l.23E-06 60 Ba-139 2.64E-10 l.85E-13 7.00E-07 0.00E+OO 1.75E-13 l.28E-;t3 2.35E-09 7. BBE-07 61 Ba-140 l. 49E-02 l.82E-05 1.18E-03 O.OOE+OO 6.17E-06 l. 22E-05 2.29E-02 2.55E-04 62 Ba-14.l 0.00E+OO ().OOE+OO 4.. 69E-08 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 5.34.E-OB 63 Ba-142 0.00E+OO O.OOE+OO 1. OlE-08 O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO l.15E-08 64 La-140 5.96E-06 2.93E-06 2.06E-04 O.OOE+OO 0.00E+OO O.OOE+OO 1. 68E-01 2 .33E-04 65 La-142 8. 77E-12 3.89E-12 5.36E-06 O.OOE+OO O.ODE+OO O.OOE+OO 1.19E-07 6.43E-06 66 Ce-141 3. 33E-06 2.22E-06 l.49E-04 O.OOE+OO 1.0SE-06 O.OOE+OO 6.36E-03 1.67E-04 67 Ce-143 3.52E-07 2.56E:-04 2.47E-05 0.00E+OO 1. lSE-07 O.OOE+OO 7.70E-03 2.80E-05 68 Ce-144 l.7BE-04 7.35E-05 7.66E-04 O.OOE+OO 4.39£-05 O.OOE+OO 4.47E-02 B.74E-04 69 Pr-143 3.28E-05 1. 31E-05 1. 63E-06 O.OOE+OO 7.GOE-06 O.OOE+OO l.OBE-01 O.OOE+OO 70 Pr-144 O.OOE+OO O.OOE+OO 1. 81E-09 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 2. 08E-09 71 Nd-147 2.32E-05 2.52E-05 9.26E-05 O.OOE+OO 1.48E-05 O.OOE+OO 9. 09E-02 1. 09E-04 72 W-187 8.42E-03 6.86£-03 2.43E-03 O.OOE+OO O.OOE+OO O.OOE+OO 1.86E+OO 2.89E-05 73 Np-239 1. 49E-06 1. 40E-07 1. 85E-'05 O.OOE+OO 4.40E-07 O.OOE+OO 2.26E-02 2 .13E-05 Page 4 of 6

For Information Only

Attachment H ODCM-QA-005

                                                                                                   . Revision 4 Page 46 of 49 MAXIMUM HYPOTHETICAL COMPOSITE DOSE FACTORS (Ref. 3.16)

Composite Dose Factors: Maximum Hypothetical Child (Page 1 of 2) Dose Factor Units: mrem/Ci Released Location: Danville (Water lng.)/Outfall (Fish and Shoreline)/FIXED DILUTION Usage (Uap) (kg/yr: FISH)= 6.9 Usage (Uap) (kg/yr: WATER)= 510 Usage (Uap) (hr/yr: SHORE)= 14 Dilution (1/Mp:SHORE) = 15.9 Dilution (1/Mp:FISH) = 15.9 Dilution (1/Mp:WATER) = 321 Transit time (tf) hrs. = 25 *Transit time (tw) hrs. = 25.8 Transit time (tp) hrs. = 1 Transit time (tb) hrs. = 131400 reotope Bone Liver T* Body Thyroid Kidney Lung- GJ:-LLJ: Skin 1 H-3 D.OOE+OO 3.96E-05 3.96E-05 3.96E-05 3.96E-05 3.96E-05 3.96E-05 O.OOE+OO

2. C-14 2.38E+OO 4. 77E-Ol 4.77E-Ol 4.77E-01 4. 7'7E-01 4.77E-01. 4..77E-Ol. O.OOE+OO 3 Na-24 8.lOE-03 B.lOE-03 B.12E-03 B.lOE-03 8.lOE-03 8.lOE-03 8.lOE-03 3.0lE-05 4 P-32 l.01E+02 4. 72E+00 3.89E+OO O.OOE+OO O.DOE+OO O.OOE+OO 2.79E+OO 0.00E+OO 5 Cr-51 O.DOE+OO O.OOE+DD B.62E-05 4.20E-05 l.l.5E-05 7.66E-DS 4.0lE-03 l.25E-05 6 Mn-54 O.OOE+OO 1. 84E-Ol. S.23E-02 O.OOE+OO 5.17E-02 O.OOE+OO 1. SSE-01 3.69E-03 7 Mn-56 O.OOE+OO 6.95E-06 3.14E-06 O.OOE+OO 8.41E-06 O.OOE+OO 1. OlE-03 1.SSE-06 8 Fe-55 5.lOE-02 2.71E-02 8.38E-03 D.OOE+OO O.OOE+OO 1. 53E-02 5. OlE-03 0. OOE+OO 9 Fe-59 7.21E-02 1.17E-01 S.87E-02 O.OOE+OO O.OOE+OO 3.38E-02 l.21E-01 7.28E-04 10 co-58 O.DOE+OO 4.09E-03 l.34E-02 O.OOE+OO O.OOE+OD O.OOE+OO 2.39E-02 1.0lE-03 11 Co-60 O.OOE+OO l.21E-02 8.47E-02 0.00E+OO O.OOE+OO O.OOE+OO 6.73E-02 5.75E-02 12 Ni-63 2..39E+OO 1.28E-01 8.12E-02 0.00E+OO O.OOE+OD O.OOE+OO 8.61E-03 O.OOE+OO 13 Ni-65 l.OlE-05 9.50E-07 l.07E-06 O.OOE+OO O.OOE+OO 0.00E+OO 1. 16E-04 5.96E-07 14 Cu-64 O.OOE+OO l.43E-04 B.79E-05 0.00E+OO 3.47E-04 O.OOE+OO 6.73E-03 l.4BE-06 1.5 Zn-65 l.17E+OO 3.12E+OO l.94E+OO O.OOE+OO l.97E+OO O.OOE+OO 5.48E-Ol 1. 95E-03 16 Zn-69 2.95E-ll 4.26E-11 3.94E-12 O.OOE+OO 2.58E-11 O.OOE+OO 2.68E-09 O.OOE+OO 17 Br-83 O.OOE+OO O.OOE+OO 2.21E-06 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1. 20E-08 18 Br-84 O.OOE+OO O.OOE+OO 1.2SE-07 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO l.46E-07 19 Br-85 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO 20 Rb-86 O.OOE+OO 5.53E+OO 3.40E+OO O.OOE+OO O.OOE+OO O.OOE+OO 3.56E-01 2.33E-05 21 Rb-88 O.OOE+OO O.OOE+OO 7 .31E-09 0 .OOE+OO O.DOE+OO O.OOE+OO O.OOE+OO 8.36E-09 22 Rb-89 O.OOE+OO O.OOE+OO l.90E-08 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 2.28E-08 23 Sr-89 1.88E+OO O.OOE+OO 5. 36E-02 O.OOE+OO O.OOE+OO O.OOE+OO 7.26E-02 S.71E-08 24 Sr-90 2.45E+Ol O.OOE+OO 6.21E+OO O.OOE+OO O.OOE+OO O.OOE+OO 3.30E-01 O.OOE+OO 25 Sr-91 5.55E-03 O.OOE+OO 2.14E-04 O.OOE+OO O.OOE+OO O.OOE+OO l.22E-02 5.31E-06 26 Sr-92 2.13E-05 O.OOE+OO 2.22E-06 0.. OOE+OO O.OOE+OO O.OOE+OO 4.03E-04 1. 52E-06 27 Y-90 3.84E-05 0.00E+OO 1. 04E-06 0.00E+OO O.OOE+OO O.OOE+OO l.09E-Ol 1. l.9E-OB 28 Y-9lm 3.78E-16 O.OOE+OO 9.91E-08 0.00E+OO O.OOE+OO O.OOE+OO 7.40E-13 l.lSE-07 29 Y-91 7.30E-04 O.OOE+OO 2.20E-05 O.OOE+OO O.OOE+OO O.OOE+OO 9.72E-02 2.74E-06 30 Y-92 3.24E-08 O.OOE+OO 3.38E-07 O.OOE+OO O.OOE+DD 0.DOE+OO 9.37E-04 4.00E-07 31 Y-93 2.50E-06 O.OOE+OO 4.SBE-07 O.OOE+OO O.OOE+OO 0.00E+OO 3.73E-02 5.32E-07 32 Zr-95 3.42E-05 7.51E-06 5.63E-04 O.OOE+OO 1.08E-05 O.OOE+OO 7.B4E-03 6.45E-04 33 Zr-97 7.34E-07 l.06E-07 6.52E-06 O.OOE+OO 1.52E-07 O.OOE+OO 1. 61E-02 7.51E-06 34 Nb-95 2.83E-02 1.lOE-02 8.19E-03 0.00E+OO l.04E-02 O.OOE+OO 2.04E+Ol 3.65E-04 Page 5 of 6

For Information Only Attachment H ODCM-QA-005 Revision 4 Page 47of49 MAXIMUM HYPOTHETICAL COMPOSITE DOSE FACTORS (Ref. 3.16) Composite Dose Factors: Maximum Hypothetical Child (Page 2 of 2) Dose Factor Units: mrem/Ci Released Location: Danville (Water lng.)/Outfall (Fish and Shoreline)/FIXED DILUTION Isotope Bone Liver T. Body Thyroid Kidney Lun!J Gl-LL:X: SKIN 35 Mo-99 O.OOE+OO 5.97E-03 1. 49E-03 O.OOE+OO 1. 27E-02 O.OOE+OO 4.94E-03 1. 04E-05 36 Tc-99m 4.07E-OB 7.99E-08 l.70E-06 0.00E+OO 1.16E-06 4.06E-08 4.55E-05 4.27E-07 37 Tc-101 O.OOE+OO O.OOE+OO 2.49E-09 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO 2.77E-09 38 Ru-103 4.20E-04 O.OOE+OO 4.07E-04 O.OOE+OO 1. 06E-03 O.OOE+OO l.09E-02 2.87E-04 39 Ru-105 7.37E-07 O.OOE+OO 1. SOE-06 O.OOE+OO 6.48E-06 O.OOE+OO 4.BlE-04 1. 40E-06 40 Ru-106 6.83E-03 O.OOE+OO 1. BlE-03 0.00E+OO 9.22E-03 O.OOE+OO l.06E-01 l.15E-03 41 l\.g-llOm l.37E-04 9.26E-05 7.89E-03 O.OOE+OO l . 73E-04 O.OOE+OO l. lOE-02 9 .llE-03 42 Te-125m 1. 95E-Ol 5.27E-02 2.59E-02 5.46E-02 0.0DE+OO O.ODE+OO 1. 88E-01 4.B3E-06 43 Te-127m 4.96E-01 l.34E-Ol 5.89E-02 l.19E-Ol 1.41E+OO O.ODE+OO 4.02E-01 2. 46E-07 44 Te-127 1.27E-03 3.44E-04 2.73E-04 8.B2E-04 3. 63E-03 O.OOE+OO 4.9BE-02 6.91E-09 45 Te-129m 8.24E-Ol 2.30E-01 l.28E-01 2.66E-Ol 2.42E+OO O.OOE+OO l.OOE+OO 5.25E-05 46 Te-129 2.27E-03 6.33E-04 5.79E-04 1.62E-03 6.63E-03 O.OOE+OO 1. 41E-01 4.90E-05 47 Te-13lrn 6.98E-02 2.41E-02 2. 57E-02 4.97E-02 2.34E-Ol O.OOE+OO 9.79E-01 2.lOE-05 48 Te-131 1.34E-21 4.09E-22 1. 26E-'08 1. 03E-21 4.06E-21 O.OOE+OO 7.0SE-21 1.49E-05 49 Te-132 1.40E-01 6.l9E-02 . 7 .48E-02 9.0lE-02 5. 75E-01 O.OOE+OO 6.23E-01 l.12E-05 50 I-130 5. 69E-04 l. lSE-03 6.04E-04 l.27E-01 1. 72E-03 O.OOE+OO 5.38E-04 l.44E-05 51 I-131 l.26E-02 l.26E-02 7.21E-03 4.!BE+OO 2.07E-02 O.OOE+OO 1.12E-03 4.73E-05 52 I-132 3.27E-07 6.0lE-07 2.37E-06 2.79E-05 9.20E-07 O.OOE+OO 7.0BE-07 2.46E-06 53 I-133 2.0SE-03 2.SJE-03 9.62E-04 4.7DE-01 4.22E-03 0.00E+OO 1.02E-03 6.55E-06 54 I-134 8. 23E-13 l.53E-12 4.62E-07 3 .52E-11 *2 .34E-12 O.OOE+OO l.OlE-12 5.49E-07 55 I-135 1.00E-04 1. BOE-04 9. 03E-05 l.59E-02 2.76E-04 O.OOE+OO l.37E-04 6.03E-06 56 Cs-134 2.0lE+Ol 3.29E+Ol 6.96E+OO 0.0DE+OO 1.02E+Ol 3.66E+00 l.77E-01 1.82E-02 57 Cs-136 l.91E+OO 5.25E+OO 3.39E+OO 0.00E+OO 2.7~E+OO 4.17E-01 l.84E-01 3.BBE-04 58 Cs-137 2.SOE+Dl 2.68E+01 3.99E+OO 0.00E+DO B.75E+OO 3.lSE+OO 1.68E-01 2.73E-02 59 Cs-138 1. 98E-16 2:7SE-16 2.25E-07 0.00E+OD 1. 93E-16 2.0SE-17 l.26E-16 2.57E-07 60 Ba-139 4.32E-10 2.31E-13 l.46E-07 O.OOE+OO 2.0lE-13 l.36B-13 2.49E-OB l.65E-07 61 Ba-140 2.57E-02 2.25E-05 l.SSE-03 O.DDE+OO 7.34E-06 1. 34E-05 1.30E-02 5.32E-05 62 Ba-141 0.00E+OO O.OOE+OO 9.79E-09 O.OOE+OD O.OOE+OO O.OOE+OO O.OOE+DO l.12E-OB 63 Ba-142 D.OOE+OO O.OOE+OD 2 .llE-09 0.00E+OO O.OOE+OO O.OOE+OO Q.OOE+DO 2. 41E-09 64 La-140 8.04E-06 2.BlE-06 4.39E-05 0.00E+OO O.OOE+OO O.OOE+OO 7. B3E-02 4, 86E-DS 65 La-142 1.17E-11 3.73E-12 l.12E-06 O.OOE+OO O.OOE+OO O.OOE+OO 7.38E-07 1.34E-06 66 Ce-141 7.74E-06 3.86E-06 3.16E-05 0.00E+OO 1.69E-06 a .-ooE+Oo 4.82E-03 3.SOE-05 67 Ce-143 8.14E-07 4.41E-04 5.21E-06 O.OOE+DO 1.85E-07 0.00E+OO 6.47E-03 5.85E-06 68 Ce-144 4.14E-04 l.30E-04 l.BOE-04 O.OOE+OO 7 .19E-05 O.OOE+OO 3.38!!:-02 l.83E-04 69 Pr-143 4.57E-05 1. 37E-05 2.27E-06 O.OOE+OO 7.43E-06 0.00E+OO 4.93E-02 O.OOE+OO 70 Pr-144 O.OOE+OO D.OOE+OO 3.78E-10 O.OOE+OO 0.0DE+OO O.OOE+OO O.OOE+OO 4.35E-10 71 Nd-147 3.20E-05 2.60E-05 2.lOE-05 O.OOE+OO l.42E-05 O.OOE+DO 4.llE-02 2.28E-OS 72 W-187 1. 07E-02 6.33E-03 2.84E-03 0.00E+OO O.OOE+OO O.OOE+OO 0.89E-01 6.0JE-06 73 Np-239 2.25E-06 1. 62E-07 3.95E-06 O.OOE+OD 4.68E-07 D.OOE+OO 1.2DE-02 4.45£-06 Page 6 of 6

For Information Only Attachment I ODCM-QA-005 Revision 4 Page 48 of 49 MAXIMUM HYPOTHETICAL WATER INGESTION DOSE FACTORS* INFANT (Ref. 3.16) Water Ingestion Dose Factors: Maximum Hypothetical Infant (Page 1 of 2) Dose Factor Units: mrem/Ci Released Location: Danville Receiver/FIXED DILUTION Usage (Uap) (kg/yr: WATER)= 330 Transit time (WATER) hrs. = 25.8 Dilution (1/Mp:WATER) = 321 l:sotope Bone LiveJ:: 'r. Body Thyroid Kidney Lung Gl:-LLl: 1 H-3 O.OOE+OO 3.12E-05 3 .12E-05 3.12E-05 3.12E-05 3.12E-05 3 .12E-05 2 C-14 2. 40E-03 5 .13E-04 5 .13E-04 5.13E-04 5.13E-04 5.13E-04 5.13E-04 3 Na-24 3. llE-04 3. llE-04 3.llE-04 3. llE-04 3.llE-04 3.llE-04 3. llE-04 4 P-32 l.64E-Ol 9.63E-03 6.34E-03 0.00E+OO O.OOE+OO O.OOE+OO 2.21E-03 5 Cr-51 O.OOE+OO O.OOE+OO 1. 39E-06 9.0BE-07 1. 9BE-07 1. 77E-06 4.0GE-05 6 Mn-54 O.OOE+OO 2.0lE-03 4,56E-04 O.OOE+OO 4.46E-04 O.OOE+OO 7.40E-04 7 Mn-56 O.OOE+OO 8.07E-08 l.39E-08 O.OOE+OO 6.93E-08 O.OOE+OO 7.33E-06 8 Fe-55 l.41E-03 9.lOE-04 2.43E-04 O.OOE+OO O.OOE+OO 4.45E-04 l.16E-04 9 Fe-59 3. 07E-03 5.37E-03 2 .llE-03 O.OOE+OO O.OOE+OO 1.59E-03 2.56E-03 10 Co-58 O.OOE+OO 3.61E-04 9.0lE-04 O.OOE+OO O.OOE+OO O.OOE+OO 9.00E-04 11 Co-60 O.OOE+OO 1. 09E-03 2.59E-03 O.OOE+OO O.OOE+OO O.OOE+OO 2.61E-03 12 Ni-63 6.43E-02 3. 9BE-03 2.23E-03 O.OOE+OO O.OOE+OO O.OOE+OO l.9BE-04 13 Ni-65 3.95E-07 4.47E-08 2.03E-OB 0.00E+OO O.OOE+OO O.OOE+OO 3.40E-06 14 Cu-64 O.OOE+OO l.51E-05 7.00E-06 O.OOE+OO 2.56E-05 O.OOE+OO 3.lOE-04 15 Zn-65 1. 86E-03 6.38E-03 2.94E-03 O.OOE+OO 3.09E-03 O.OOE+OO 5.39E-03 16 Zn-69 4.09E-14 7.36E-14 5.48E-15 O.OOE+OO 3.06E-14 O.OOE+OO 6.00E-12 17 Br-83 O.OOE+OO O.OOE+OO 2.07E-OB 0.00E+OO O.OOE-1-00 O.OOE+OO 0.00E+OO lS Br-84. 0.00E+OO O.OOE+OO 9.19E-20 O.OOE+OO O.OOE-+00 O.OOE+OO 0.00E+OO 19 Br-85 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE-1-00 0.-00E+OO O.OOE+OO 20 Rb-86 O.OOE+OO 1. 66E-02 B.19E-03 O.OOE+OO O.OOE.f-00 O.OOE+OO 4.24E-04 21 Rb-SB O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE-1-00 0.00E+OO O.OOE+OO 22 Rb-89 O.OOE+OO O.OOE+OO 0. OOE+OO _ _O. OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 23 Sr-89 2.51E-Ol 0.00E+OO 7.20E-03 O.OOE+OO O.OOE+OO O.OOE+OO 5.16E-03 24 Sr-90 1.88E+OO O.OOE+OO 4,78E-01 O.OOE+OO O.OOE+OO O.OOE+OO 2.34E-02 25 Sr-91 7. 72E-04 O.OOE+OO 2.79E-05 O.OOE+OO O.OOE-1-00 O.OOE+OO 9. J.4.E-04. 26 Sr-92 2.65E-06 O.OOE+OO 9.SSE-08 O.OOE+OO O.OOE-!-00 0.00E+OO 2.86E-05 27 Y-90 6.67E-06 O.OOE+OO 1.79E-07 O.OOE+OO O.OOE-1-00 O.OOE+OO 9.21E-03 28 Y-9lm 3.62E-17 O.OOE+OO J.. 23E-18 O.OOE+OO O.OOE+OO O.OOE+OO 1.21E-13 29 Y-91 l.13E-04 O.OOE+OO 3.0lE-06 O.OOE+OO O.OOE+OO O.OOE+OO 8. llE-03 30 Y-92 4.96E-09 O.OOE+OO 1.40E-10 O.OOE+OO O.OOE+OO 'O. OOE+OO 9.47E-05 31 Y-93 4.20E-07 O.OOE+OO l.14E-OB O.OOE+OO 0.00E+OO 0.00E+OO 3.31E-03 32 Zr-95 2.07E-05 5.03E-06 3.57E-06 O.OOE+OO 5.42E-06 O.OOE+OO 2.51E-03 33 Zr-97 5.21E-07 B.94E-08 4.0BE-08 O.OOE+OO 9. OlE-08 0.00E+OO 5.?0E-03 34 Nb-95 4.17E-06 1. 72E-06 9. 93E-07 0.00E+OO 1.23E-06 0. OOE+O.O l.45E-03 35 Mo-99 O.OOE+OO 2.63E-03 S.13E-04 O.OOE+OO 3.93E-03 O.OOE+OO B.66E-04 Page 1 of 2

For Information Only Attachment I ODCM-QA-005 Revision 4 Page 49 of 49 MAXIMUM HYPOTHETICAL WATER INGESTION DOSE FACTORS - INFANT (Ref. 3.16) Water Ingestion Dose Factors: Maximum Hypothetical Infant (Page 2 of 2) Dose Factor Units: mrem/Ci Released Location: Danville Receiver/FIXED DILUTION

Csotope Bone Liver T. Body Thyroid Kidney Lung G:C-LLI 36 Tc-99m 9.98E-09 2 .06E-08 2.65E-07 O.OOE+OO 2.22E-07 1. OSE-08 5.98E-06 37 Tc-101 O.OOE-rOO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.ODE+OO O.OOE+O()

38 Ru-103 1. 47E-04 O.OOE+OO 4.93E-05 O.OOE+OO 3.07E-04 O.OOE+OO 1. 79E-03 39 Ru-105 2.46E-07 O.OOE+OO 8.27E-08 O.OOE+OO 1. 81E-06 O.ODE+OO 9. 77E-05 40 Ru-106 2.44E-03 O.ODE+OO 3.05E-04 O.DOE+OO 2.BBE-03 O.OOE+OO 1. BSE-02 41 Ag-llOm 1. OlE-04 7.35E-05 4.B6E-05 O.OOE:+OO 1. 05E-04 0.00E+OO 3.BlE-03 42 Te-125m 2.33E-03 7.BOE-04 3.15E-04 7.85E-04 O.OOE+OO O.OOE+OO 1.llE-03 43 Te-127m 5.89E-03 1. 95E-03 7 .13E-04 l.70E-03 l.45E-02 O.OOE+OO 2.38E-03 44 Te-127 1. 50E-05 5.02E-06 3.22E-06 l.22E-05 3.65E-05 0.00E+OO 3 .15E-04 45 Te-129m 9.92E-03 3.40E-03 1. 53E-03 3.SlE-03 2.48E-02 O.OOE+OO 5. 92E-03 46 Te-129 2.82E-05 9.71E-06 6.58E-06 2.36E-05 7.0lE-05 O.OOE+OO 2.25E-03 47 Te-13lm 8.49E-04 3.42E-04 2.82E-04 6.93E-04 2.35E-03 O.OOE+OO 5.76E-03 48 Te-131 4,46E-24 1. 65E-24 l.25E-24 3.98E-24 1.14E-23 0.00E+OO 1.BOE-22 49 Te-132 1. 68E-03 8.31E-04 7.75E-04 1. 23E-03 5.20E-03 O.OOE+OO 3. 07E-03 50 I-130 l.43E-04 3.15E-04 1. 26E-04 3.53E-02 3.46E-04 0.00E+OO 6.75E-05 51 I-131 3.32E-03 3.91E-03 1. 72E-03 l.28E+OO 4. 57E-03 0. OOE+OO l.40E-04 52 I-132 7.07E-08 l.44E-07 S.llE-08 6.73E-06 1. GOE-07 0.00E+OO 1.16E-07 53 I-133 5.37E-04 7.SlE-04 2.29E-04 1. 42E-Ol 9.19E-04 0.00E+OO l.32E-04 54 I-134 l.27E-13 2 .60E-13 9 .25E-14 6.06E-12 2 .91E-13 O.OOE+OO 2.69E-13 55 I-135 2.47E-05 4.91E-05 1. 79E-05 4.40E-03 5,47E-05 0.00E+OO 1.78E-05 56 Cs-134 3.82E-02 7.12E-02 7.19E-03 O.OOE+OO 1. 83E-02 7.52E-03 1.94.E-04 57 Cs-136 4, 40E-03 l.29E-02 4.B3E-03 O.OOE+OO S.l.6E-03 l..OSE-03 l.%E-04 58 Cs-137 5. 29E-02 6. 20E 4.39E-03 O.OOE+OO l. 66E-02 6.73E-03 1.94E-04 59 Cs-138 l.76E-19 2.86E-19 l.39E-19 O.OOE+OO l. 43E-19 2.23E-20 4.57E-19 60 Ba-139 2.26B-10 1.SOE-13 6.55E-12 O.OOE+OO 9.02E-14 9.09E-14 1.43E-OB 61 Ba-140 1.64E-02 1. 64E-05 B.43E-04 O.OOE+OO 3.SBE-06 1. OOE-05 4.02E-03 62 Ba-141 O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 63 Ba-142 0. OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO 64 La-140 1.37E-06 5.41E-07 1. 39E-07 O.OOE+OO O.OOE+OO O.OOE+OO 6. 35E-03 65 La-142 1.49E-12 5,47E-13 l.31E-13 O.OOE+OO O,OOE+OO O.OOE+OO 9.2BE-OB 66 Ce-141 7. BOE-06 4.76E-06 5.60E-07 0.00E+OO 1.47E-06 O.OOE+OO 2. 46E-03 67 Ce-143 B.73E-07 5.79E-04 6.61E-OB O.OOE+OO l.69E-07 0.00E+OO 3.38E-03 68 Ce-144 3.0lE-04 1. 23E-04 1. 69E-05 O.OOE+OO 4.99E-05 O.OOE+OO 1.73E-02 69 Pr-143 7.BOE-06 2.92E-06 3. 87E-.07 O.OOE+OO 1. OSE-06 0.00E+OO 4.12E-03 70 Pr-144 O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 71 Nd-147 5.24E-06 5.3BE-06 3.30E-07 O.OOE+OO 2.0SE-06 O.OOE+OO 3.4.lE-03 72 W-187 4.32E-05 3.0lE-05 1. 04E-05 0.00E+OO O.OOE+OO 0.00E+OO 1. 77E-03 73 Np-239 8.20E-07 7.34E-08 4.lSE-08 0.00E+OO 1. 46E-07 O.OOE+OO 2 .12E-03 Page 2 of 2

For Information Only PROCEDURE COVER SHEET PPL SUSQUEHANNA, LLC PROCEDURE TOTAL DOSE CALCULATIONS ODCM-QA-006 Revision 2 Page 1of6 ADHERENCE LEVEL: INFORMATION USE QUALITY CLASSIFICATION: APPROVAL CLASSIFICATION: ( X ) QA Program ( ) Non-QA Program ( x) Plant ( ) Non-Plant ( ) Instruction EFFECTIVE DATE:

y/;7/rJ1!!A\

PERIODIC REVIEW FREQUENCY: NIA PERIODIC REVIEW DUE DATE: NIA RECOMMENDED REVIEWS: Nuclear Emergency Planning Procedure Owner: Francis J. Hickey Responsible Supervisor: Manager-Plant Chemistry Responsible FUM: Manager-Plant Chemistry Responsible Approver: Vice President-Nuclear O~erations FORM NDAP-QA-0002-1, Rev. 4, Page 1 of 1 (Electronic Form)

For Information Only ODCM-QA-006 Revision 2 Page 2 of 6 PROCEDURE REVISION

SUMMARY

TITLE: TOTAL DOSE CALCULATIONS Most of the revisions described below are editorial in nature. The changes made do not reduce or compromise the level of effluent control or the accuracy and/or reliability of dose calculations or setpoint determinations as required by 10CFR20.1302, 40CFR190, 10CFR50.36a and 10CFRSO, Appendix I. Additionally, the changes: outlined below: (1) do not alter the conduct of the radiological environmental monitoring program, (2) do not change the radioactive effluent controls and radiological environmental monitoring activities, and (3) do not change the information to be included in the Annual Radiological Environmental Operating and Radioactive Effluent Release Reports.

1) Incorporate PCAF No. 2003-1237.

2) Update title of Chemistry Supervisor-SSES to Manager-Plant Chemistry.

3) Add applicable Adherence Level to procedure cover sheet.

For Information Only ODCM-QA-006 Revision 2 Page 3 of 6 TABLE OF CONTENTS SECTION

1. PURPOSE 4

2. POLICY/DISCUSSION 4

3. REFERENCES 4

4. RESPONSIBILITIES 5 4.1 Manager-Plant Chemistry 5

5. DEFINITIONS 5

6. PROCEDURE 5 6.1 Waterborne Effluent 5 6.2 Airborne Effluent 6 6.3 Total Dose 6

7. RECORDS 6

j For Information Only ODCM-QA-006 Revision 2 Page 4 of 6

1. PURPOSE The purpose of this procedure is to provide the methodology and parameters to determine the total dose to a member of the public from the fuel cycle in the vicinity of the SSES site as required by 40CFR190.

It also ensures that radioactive effluents which result in calculated doses exceeding twice the objectives of 10CFR50, Appendix I, are identified, evaluated and reported. This procedure constitutes part of the SSES Offsite Dose Calculation Manual (ODCM), which is a licensing basis document.

2. POLICY/DISCUSSION 2.1 The cumulative dose to any member of the public due to radioactive releases from the SSES site is determined by summing the calculated doses to critical organs from airborne and liquid effluent sources.

2.2 For all dose calculations from airborne effluents, the deposition rate used in the analysis should be at the receiver location of the individual being evaluated, not the highest calculated annual average relative concentration or relative deposition rate for any area at or beyond the site boundary as given in Attachment B of ODCM-QA-004. 2.3 The direct radiation to any member of the public due to operations at SSES should be determined from the environmental monitoring program results. 2.4 The total dose to members of the public shall include any dose received from activities occurring within the site boundary. Use of realistic occupancy factors for determination of this dose is allowed.

3. REFERENCES

3. "1 TR 3.11.3, Total Dose.

3.2 10CFR50 Appendix I, Numerical Guides for Design Objectives and Limiting Conditions for Operation to Meet the Criterion "As Low as is Reasonably Achievable" for Radioactive Material in Light-water Cooled Nuclear Power Reactor Effluents.

3.3 40CFR190, Environmental radiation protection standards for nuclear power operations. 3.4 ODCM-QA-004, Airborne Effluent Dose Calculations. 3.5 ODCM-QA-005, Waterborne Effluent Dose Calculations.

For Information Only ODCM-QA-006 Revision 2 Page 5 of 6 I 3.6 Regulatory Guide 1.109, Rev. 1, October, 1977, Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purposes of Evaluating Compliance with 10 CFR 50, Appendix I.

4. RESPONSIBILITIES 4.1 Manager-Plant Chemistry 4.1 .1 Ensures adequacy and correctness of methodology to be used to determine the total dose to a member of the public from the fuel cycle.

4.1 .2 Ensures dose calculations necessary for fulfillment of SSES Technical Requirements Surveillances are performed. 4.1.3 Ensures methodology and parameters to be used to determine the total dose to a member of the public from the fuel cycle are developed.

5. DEFINITIONS 5.1 MEMBER(S) OF THE PUBLIC - Shall include arr persons who are not occupationally associated with the plant. This category does not include employees of the utility, its contractors, or vendors. Also excluded from this category are persons who enter the site to service equipment or to make deliveries. This category does include persons who use portions of the site for recreational, occupational, or other purposes not associated with the plant.

6. PROCEDURE 6.1 Waterborne Effluent The annual dose to critical organs of a maximally exposed individual for the liquid effluents shall be determined by using the methodology outlined in Section 6.1 of ODCM-QA-005.

i For Information Only ODCM-QA-006 Revision 2 Page 6 of 6 6.2 Airborne Effluent 6.2.1 The annual dose to critical organs of a real individual for the noble gases released in the gaseous effluents shall be determined by using Equation 3 of ODCM-QA-004 modified by replacing Mi with Ki for the whole-body dose and using Equation 4 modified by replacing Ni by [Li + (1.11 M1)(SF)] for the skin dose. Values of Ki. Li. and Mi are obtained from Attachment A of ODCM-QA-004. D =3.17x10-SL K.(X IQ) (Q. )(SF) (Eq. 1) g i I V ZV Db =3.17x10-SL [L.+(1.llM .)(SF )](XI Q) (Q. ) (Eq. 2)

                                             .                  ;     z        z                viv 6.2.2           The annual dose to critical organs of a real individual for the radionuclides other than noble gases released in the gaseous effluents shall be determined by using Equation 6 of ODCM-QA-004.

6.3 Total Dose 6.3.1 The total dose to a member of the public shall be calculated by summing the direct dose determined by the environmental monitoring program, the airborne dose contribution at the point of interest determined per §6.2, and the total dose from liquid effluent determined per §6.1. 6.3.2 If the results of the calculated dose exceed twice the objectives of 10CFR50, Appendix I, it shall be determined whether the limits of 40CFR90 have been exceeded. If the 40CFR190 limits have been exceeded, a special report shall be prepared and submitted to the NRC within 30 days addressing the actions of TR 3.11.3.

7. RECORDS None

For Information Only PROCEDURE COVER SHEET PPL SUSQUEHANNA, LLC PROCEDURE RADIOACTIVE WASTE TREATMENT SYSTEMS ODCM-QA-007 Revision 2 Page 1of18 ADHERENCE LEVEL: INFORMATION USE QUALITY CLASSIFICATION: APPROVAL CLASSIFICATION: ( X ) QA Program ( ) Non-QA Program ( x) Plant ( ) Non-Plant ( ) Instruction EFFECTIVE DATE: 9ft7

                                                                            . h1J7J.~

PERIODIC REVIEW FREQUENCY: NIA PERIODIC REVIEW DUE DATE: N/A RECOMMENDED REVIEWS: Nuclear Emergency Planning Procedure Owner: Francis J. Hickey Responsible Supervisor: Manager-Plant Chemistry Responsible FUM: Manager-Plant Chemistry Responsible Approver: Vice President-Nuclear O~erations FORM NDAP-QA-0002-1, Rev. 4, Page 1 of 1 (Electronic Form)

For Information Only ODCM-QA-007 Revision 2 Page 2 of 18 PROCEDURE REVISION

SUMMARY

TITLE: RADIOACTIVE WASTE TREATMENT SYSTEMS Most of the revisions described below are editorial in nature. The changes made do not reduce or compromise the level of effluent control or the accuracy and/or reliability of dose calculations or setpoint determinations as required by 10CFR20.1302, 40CFR190, 10CFR50.36a and 10CFR50, Appendix I. Additionally, the changes outlined below: (1) do not alter the conduct of the radiological environmental monitoring program, (2) do not change the radioactive effluent controls and radiological environmental monitoring activities, and (3) do not change the information to be included in the Annual Radiological Environmental Operating and Radioactive Effluent Release Reports.

1) Incorporate PCAF *Nos. 2003-1304 and 2003-1236.

2) Update the title Chemistry Supervisor-SSES to Manager-Plant Chemistry.

3) Add applicable Adherence Level to procedure cover sheet.

4) *Update Attachment C to correspond with changes made via PCAF No.

2003-1304.

5) Revised Annual Effluent and Waste Disposal Report title to Radioactive Effluent Release Report to coincide with LDCN Nos. 3727 and 3728 (Unit 1 and 2 TRM change).

For Information Only ODCM-QA-007 Revision 2 Page 3 of 18 TABLE OF CONTENTS SECTION PAGE

1. PURPOSE 5

2. POLICY/DISCUSSION 5 2.1 Liquid Waste Treatment 5 2.2 Definition of "Appropriate Treatment" for Liquid Wastes 6 2.3 Liquid Effluent Monitoring Instrumentation 8 2.4 Gaseous Waste Treatment 8 2.5 Gaseous Effluent Monitoring Instrumentation 1o 2.6 Solid Waste Treatment Including the Process Control Program (PCP) 1O

3. REFERENCES 11

4. RESPONSIBILITIES 12 4.1 Vice President-Nuclear Operations 12 4.2 General Manager-Nuclear Engineering 12 4.3 Manager-Plant Chemistry 12

5. DEFINITIONS 12

6. PROCEDURE 12 6.1 Liquid Waste Treatment 12 6.2 Gaseous Waste Treatment 12 6.3 Evaluating the Dose Impact of Changes to Waste Treatment Systems 13

7. RECORDS 14 I

For Information Only ODCM-QA-007 Revision 2 Page 4of18 ATTACHMENTS ATTACHMENT PAGE A Ventilation Exhaust Treatment Systems Which Require Offsite Vent 15 Evaluations When Bypassed, Degraded, or Otherwise Rendered Inoperable B SSES Liquid Effluent Release Flowpath 16 c SSES Gaseous Effluent Release Flowpath 17

For Information Only ODCM-QA-007 Revision 2 Page 5of18

1. PURPOSE The purpose of this procedure is to define the operability requirements of the radioactive waste treatment and effluent monitoring systems to keep effluent releases as low as is reasonably achievable. It also includes reporting requirements when changes are made to systems or when operability is not maintained in accordance with the Technical Requirements Manual (TRM).

This procedure constitutes part of the SSES Offsite Dose Calculation Manual (ODCM) which is a licensing basis document.

2. POLICY/DISCUSSION 2.1 Liquid Waste Treatment 2.1.1 The SSES Liquid Waste Management System consists of three processing sub-systems, liquid, chemical and laundry. Redundant and backup equipment, alternate process routes, interconnections and spare volumes are designed into the system to provide for operational and unanticipated surge waste volumes due to refueling, abnormal leakage rates, decontamination activities and equipment downtime, maintenance and repair. The system has piping connections to allow the installation of vendor-supplied equipment to provide specific treatment of off-normal wastes or to enhance the normal treatment capabilities as necessary.

Appropriate vendor-supplied equipment may also be used in place of installed equipment to allow for repair or replacement of components. 2.1.2 Low conductivity liquid wastes are processed in the Liquid Radwaste Treatment Sub"system (LRW). Liquid is collected in three pairs of LRW Collection tanks. Each pair of tanks has an approximate capacity of 28,000 gallons. Surge capacity is maintained with two pairs of LRW Surge Tanks also with a 28,000-gallon/pair capacity. Liquids from these tanks are normally processed through two vertical centrifugal discharge precoat filters with 300 ft 2 filter area at a 100 gpm normal flow rate. Liquid from the filters is then sent to a mixed bed demineralizer with a volume of 140 ft3 and normal flow rate of 100 gpm. The demineralizer effluent is collected in three pairs of LAW Sample Tanks .. Each pair of tanks has an approximate capacity of 28, 100 gallons. The water is isolated in these tanks for analysis prior to recycle, reuse in the plant, or discharge to the Susquehanna River. Off-specification liquids can be recycled back to the Liquid Waste Management System for additional processing.

For Information Only ODCM-QA-007 Revision2 Page 6of18 2.1.3 High conductivity wastes are collected in the Chemical Drain Tank and in specific sumps located in the Turbine and Radwaste Buildings. Liquid from these sources is collected in a Chemical Waste Tank of approximately 12,000 gallons capacity. This liquid can then be sent to any one of two pairs of Chemical Waste Neutralizing Tanks. Each pair has a capacity of 31,000 gallons.

The liquid is then sent to a vendor-supplied Chemical Waste Processing Sub-system for radionuclide removal. The effluent from the Chemical Waste Processing Sub-system is routed to the Evaporator Distillate Sample Tank where it can be isolated for analysis prior to discharge. The capability exists to recycle the liquid for additional processing if necessary. 2 .1 .4 The Laundry Waste Sub-system collects water from washdown, laundry and decontamination facilities in one of two Laundry Drain Tanks. Each tank has a capacity of approximately 820 gallons and has an independent mechanical filter system. One tank is normally valved to receive waste while the other is valved for processing. Effluent from these tanks is routed to the Laundry Drain Sample Tank where it can be isolated for analysis prior to discharge. Off-specification liquid can be returned to the Chemical Waste Processing Sub-system. 2.1.5 A flow diagram of the Liquid Waste Management System is shown in Attachment B. 2.2 Definition of "Appropriate Treatment" for Liquid Wastes 2.2.1 TR 3.11.1.3 requires that the appropriate portions of the liquid waste treatment system be operable and be used to reduce radioactivity in liquid wastes prior to their release when projected doses from each reactor unit to unrestricted areas would exceed 0.06 mrem to the total body or 0.2 mrem to any organ in a 31-day period. 2.2.2 Normal treatment, which is considered appropriate for each subsystem, is as follows:

a. Filtration is considered appropriate treatment for the Liquid Radwaste Laundry Processing Subsystem, which consists of high conductivity liquid wastes, such as those from equipment washdown and personnel decontamination facilities, or laundry.

For Information Only ODCM-QA-007 Revision 2 Page 7 of 18

b. The Mobile Liquid Processing System (a vendor*supplied system which is directed to the Distillate Sample Tank) comprises the Liquid Radwaste Chemical Processing Subsystem. Appropriate treatment options provided by this system consist of filtration and demineralization.

c. Demineralization and filtration are considered appropriate treatment for low conductivity/low organic contaminant liquid wastes entering the Liquid Radwaste Processing Subsystem (LRW collection tanks).

d. Release with filtration alone is considered appropriate treatment for low conductivity/low organic contaminant liquid waste for batches which yield projected doses prior to treatment of less than or equal to 6.45E-04 mrem to the total body and 2.15E-03 mrem to any organ.

e. For batches of liquid radwaste which have no identified gamma activity above the Technical Requirements Manual Liquid Effluent LLD level (TR 3.11.1.1 Table 3.11.1.1-1 ),

release without treatment is considered appropriate.

f. Projected dose threshold values used are derived by dividing the "per-unif' maximum projected doses without treatment (0.06 and 0.2 mrem) by 31 days and by 6, the maximum possible number of batches released per day.

The "per-unit" threshold values are doubled (due to SSES is a twa.unit site) to yield per-batch dose action levels. The two levels of "appropriate" treatment are in place so as not to require application of demineralization for treating low activity, high conductivity water (e.g., from Circulating or Service Water leakage). This would increase the overall efficiency of the solid radwaste program while ensuring calculated doses remain at a suitable fraction of 10CFRSO Appendix I design objectives and TR 3.11.1.2 limit (PLl-70360 and PLl-70612).

g. If liquid waste was discharged without treatment at levels exceeding TR 3.11 .1.3, a special report shall be prepared and submitted to the NRC within 30 days which addresses the actions of TR 3.11.1.3.

For Information Only ODCM-QA-007 Revision 2 Page a of 18 2.3 Liquid Effluent Monitoring Instrumentation 2.3.1 Liquid radwaste monitoring instrumentation shall be maintained as specified in TR 3.11.1.4 and liquid process monitoring instrumentation shall be maintained as specified in TR 3.11 .1.5. When monitoring instrumentation is not operable in accordance with the TRM, the required action of the TAM shall be implemented as stated. If the inoperable condition was not corrected within the specified time frame, a report of the uncorrected condition shall be made in the Radioactive Effluent Release Report. 2.4 Gaseous Waste Treatment 2.4.1 The SSES Off Gas Treatment System operates with four steam jet air ejectors maintaining condenser vacuum. Noncondensible gases are passed through one of three recombiners (one for each reactor unit plus a common recombiner), reducing the amount of gases to be filtered and released. Gases pass through a two to nine minute holdup pipe before entering the Off Gas Treatment System, which consists of one 100 percent capacity system per reactor unit. Each system consists of precoolers, chillers, reheaters, guard beds, and five charcoal absorbers and an outlet HEPA filter. Filtered air then exits to the Turbine Building vent. 2.4.2 The gaseous radwaste treatment system must be in operation whenever the main condenser air ejector system is in operation. This is the appropriate level of gaseous waste treatment. 2.4.3 Filtered exhaust systems serve selected areas of Zone I, II, and Ill of the SSES Reactor Building. The Zone I and Zone II equipment compartment and Zone Ill filtered exhaust systems each consist of two 100% capacity redundant fans and two 55% capacity filter trains. Each filter train has, in the direction of air flow, roughing filters,: upstream HEPA filters, a charcoal filter bed, and downstream HEPA filters. Exhaust fan discharge is then routed to the atmosphere via the Reactor Building vents, where effluents are continuously sampled and monitored. 2.4.4 The containment drywall is vented and purged via the Standby Gas Treatment System (SGTS) to ensure releases from the

                                      . drywall are maintained as low as is reasonably achievable. This provides the appropriate level of treatment.

For Information Only 1 ODCM-QA-007 Revision 2 Page 9of18 2.4.5 The Turbine Building Filtered Exhaust System draws air from those areas of the building that are most likely to become contaminated. Two 100% capacity fans serve each system, which contains two 50% capacity filter housings made up of a particulate prefilter, an upstream HEPA filter arid a charcoal filter. Discharged air is released via the Turbine Building vents, which are continuously sampled and monitored. 2.4.6 The Radwaste Building Filtered Exhaust System draws potentially contaminated air from selected areas of the Radwaste Building. The system contains two 100% capacity fans and two 50% capacity filter housings, each containing a particulate filter bank and a HEPA filter. Filtered air is discharged via the Unit 1 Turbine Building vent. 2.4.7 Ventilation exhaust systems must be drawing air through the HEPA and charcoal filters (where available) as the appropriate level of waste treatment.

2.4.8 In order to minimize the quantities of radioactivity in airborne effluents from the station, the ventilation exhaust treatment (filtered exhaust) systems are normally kept in service at SSES. A flow diagram of the Gaseous Waste Management System is shown in Attachment C.

2.4.9 As the need arises, these systems are periodically rendered inoperable for maintenance or testing activities. If any of the ventilation exhaust treatment systems in Attachment A are bypassed, degraded, or otherwise rendered inoperable, vent evaluations shall be performed in accordance with plant procedures. If the most recent 31-day dose projection indicates that dose may exceed 0.3 mrem to any organ when averaged over the projected 31-day period, treatment systems rendered inoperable will be restored to operable status as quickly as is practicable. 2.4.10 When the Standby Gas Treatment System (SGTS) is not being used, a small amount of flow from the SGTS vent remains. This residual flow originates in the battery rooms and SGTS Equipment Room in the control structure. Because there are no identifiable sources of radioactivity in these rooms, auxiliary particulate and iodine sample and noble gas grab sample at 4-hour intervals are not required from the SGTS vent when the SGTS continuous vent monitor is out of service, provided that

a. the Standby Gas Treatment System is not being used,

For Information Only ODCM-QA-007 Revision 2 Page 10of18

b. there are proper administrative controls in place to ensure that the required sampling will begin within 4 hours if the treatment system is operated.

2.4.11 If inoperable gaseous radwaste treatment systems are not returned to operation as required by TR 3.11.2.4.A, then a special report shall be prepared and submitted to the NRC within 30 days. 2.4.12 Jf gaseous effluents are discharged in excess of the limits of TR 3.11.2.5.A without treatment, then a special report shall be prepared and submitted to the NRC within 30 days. 2.5 Gaseous Effluent Monitoring Instrumentation Gaseous effluents shall be monitored as specified in TR 3.11.2.6. When monitoring instrumentation is not operable in accordance with the TAM, the required action of the TAM shall be implemented as stated. If the inoperable condition is not corrected in the specified time frame, a report of the uncorrected condition shall be made in the Radioactive Effluent Release Report. 2.6 Solid Waste Treatment Including the Process Control Program (PCP) 2.6.1 The SSES Solid Radwaste System collects all wet wastes produced from the operation of other plant systems. A vendor-supplied system processes and packages the wastes into a waste form that meets all applicable federal, state, and local requirements for transportation, storage, and disposal. The Solid Radwaste Process Control Program (NDAP-QA-0646) contains the administrative controls for waste sampling, waste analysis, formulation for solidification or dewatering instructions, verification of solidification or dewatering, and reporting of process failures to ensure liquid waste is properly processed'for disposal. In addition, the Process Control f;lrogram provides requirements for classifying waste in accordance with 10CFR61. 2.6.2 Changes in radioactive solid waste processing and operational changes shall be controlled, reviewed, and approved in accordance with NDAP-QA-0646. 2.6.3 Any changes to the Solid Radioactive Waste Process Control Program shall be provided in the Radioactive Effluent Release Report.

For Information Only ODCM-QA-007 Revision 2 Page 11 of 18

3. REFERENCES 3.1 TR 3.6.1, Containment Venting or Purging 3.2 TR 3.11.1.3, [Radioactive Effluents] Liquid Waste Treatment System 3.3 TR 3.11.1.2, [Radioactive Effluents] Dose 3.4 TR 3.11.4.1, Table 3.11.4.1-3, Detection Capabilities for Environmental Sample Analysis Lower Limit of Detection (LLD) 3.5 TR 3.11.1.4, Liquid Radwaste Effluent Monitoring Instrumentation 3.6 TR 3.11.1.5, Radioactive Liquid Process Monitoring Instrumentation

3. 7 TR 3.11.2.4, Gaseous Radwaste Treatment Systems 3.8 TR 3.11.2.5, Ventilation Exhaust Treatment Systems 3.9 TR 3.11.2.6, Radioactive Gaseous Effluent Monitoring Instrumentation 3.1 O 10CFR50.59, Changes, Tests and Experiments 3.11 10CFR20, Standards for Protection Against Radiation 3.12 FSAR Figure 11.2-8, Liquid Radwaste System Flow Diagram 3.13 FSAR Figure 11.3-1, Offgas System Process Flow Diagram 3.14 NDAP-QA-0646, Solid Radioactive Waste Process Control Program 3.15 NDAP-00-1203, Modification Identification and Scoping Process 3.16 ODCM-QA-005, Waterborne Effluent Dose Calculations 3.17 ODCM-QA-009, Dose Assessment Policy Statements 3.18 PLl-70360, Memo from R. K. Barclay to R. A. Breslin, Calculation of Liquid Isotope Sampling Limits: Use of Atmospheric Demineralizer System, February 4, 1992 3.19 PLl-70612, Memo from R. K. Barclay to R. A. Breslin, Atmospheric Demineralizer Effluent Results, March 4, 1992 3.20 Action Request No. 222585.

For Information Only ODCM-QA-007 Revision 2 Page 12of18

4. RESPONSIBILITIES 4.1 Vice President-Nuclear Operations 4.1.1 Ensures that radioactive waste treatment systems are operated in compliance with the TROs stated in the Technical Requirements Manual and in accordance with this procedure.

4.2 General Manager-Nuclear Engineering 4.2.1 Provides modification engineering and support in accordance with NDAP-00-1203 for equipment and systems involved with the treatment or monitoring of radioactive effluents. 4.3 Manager-Plant Chemistrv 4.3.1 Ensures adequacy and correctness of operability requirements of the radioactive waste treatment systems presented in this procedure. 4.3.2 Ensures adequacy and correctness of pre-release liquid effluent dose assessments.

5. DEFINITIONS 5.1 LRW - Liquid Radwaste 5.2 RCA - Radiologically Controlled Area

6. PROCEDURE 6.1 Liquid Waste Treatment 6.1.1 Chemistry shall perform a dose assessment using the methodology of ODCM-QA-005 prior to release in cases when a batch of liquid waste must be released with treatment less than that specified in Section 2.2, to ensure that the limits of TR 3.11.1.2 are not exceeded.

6.2 Gaseous Waste Treatment 6.2.1 Dose projections shall be performed at least once per 31 days based on the most recently available effluent data. If it is known prior to performing the dose projection that a treatment system will be out of service, and if data exists which indicates how the lack of treatment will impact effluents, these factors will be considered when performing the dose projection.

For Information Only ODCM-QA-007 Revision 2 Page 13of18 6.3 Evaluating the Dose Impact of Changes to Waste Treatment Systems 6.3.1 The Radioactive Effluent Release Report shall include a discussion of any major changes to radwaste systems (liquid, gaseous and solid). Such discussion shall include the following:

a. a summary of the evaluation that led to the determination that the change could be made in accordance with 10CFR50.59,

b. sufficiently detailed information to fully support the change without supplemental information,

c. detailed descriptions of the equipment, components and processes involved and interfaces with other plant systems,

d. an evaluation which shows how the predicted releases of radioactive materials in liquid and gaseous effluents and/or quantity of solid waste differ from those previously predicted in the license application or subsequent amendments,

e. an evaluation of the change which shows the expected maximum exposures to an individual in the unrestricted area and to the general population that differ from those previously estimated in the license application or subsequent amendments,

f. a comparison of predicted releases of radioactive materials in liquid and gaseous effluents and in solid waste to the actual releases for the period prior to when the changes are to be made,

g. an estimate of exposure to plant operating personnel as a result of the change, and documentation that the change was reviewed and approved by PORC.

For Information Only ODCM-QA-007 Revision 2 Page 14of18 6.3.2 If a modification to the liquid waste system results in positioning a radioactive liquid storage tank outside which is not surrounded by a liner, dike, or a wall capable of holding the contents of the tank and the tank does not have an overflow or surrounding area drains connected to the Liquid Radwaste Treatment System, then the tank contents shall be limited to Jess than 10 Curies (not including tritium and dissolved gas). Chemistry will sample the tank per the TRM to ensure the contents are limited to 1O Curies. This is to ensure that a tank failure will not result in radioactivity in the nearest drinking water source in concentrations which exceed 10CFR20, Appendix B, Table 2, Col. 2.

7. RECORDS None

! For Information Only Attachment A ODCM-QA-007 Revision 2 Page 15of18 VENTILATION EXHAUST TREATMENT SYSTEMS WHICH REQUIRE OFFSITE VENT EVALUATIONS WHEN BYPASSED, DEGRADED, OR OTHERWISE RENDERED INOPERABLE UPSTREAM DOWNSTREAM HEPA HEPA FILTER SYSTEM LOCATION **DESIGNATION CHARCOAL DESIGNATION Unit 1 Turbine Building 1F157A/B 1F158A/B N/A Unit 2 Turbine Building 2F157A/B 2F158A/B NIA Unit 1 Zone 1 Reactor Building 1F255A/B 1F257A/B 1F258A/B Unit 1 Zone 3 Reactor Building 1 F216A/B 1F217A/B 1 F218A/B Unit 2 Zone 2 Reactor Building 2F255A/B 2F257A/B 2F258A/B Unit 2 Zone 3 Reactor Building 2F216A/B 2F217A/B 2F218A/B Radwaste Building Exhaust OF355A/B N/A N/A Radwaste Tank Vent OF358 OF359 N/A Control Structure Sample Room OF134 OF135 N/A Control Structure Rad Chem Lab OF137 OF138 N/A Control Structure Rad Chem Lab OF140 OF141 N/A Control Structure Decon Area OF143 OF144 N/A S&A Building OF716 NIA N/A Page 1of1

For Information Only Attachme.nt B ODCM-QA-007 Revision 2 Page 16of18 FROM EVAPORATOR 'HEATING REACTOR WELL SEAL LEAK DRAIN STEAM C:ONDENSATE RETUR.N TANK "EACTOR BUILDING DRAINS FROM PH4SS S!PARATORS. (DECANT) ORYWELL DRAINS SSES LIG UIO EFFLUENT RELEASE FLO WPA1H FROM RH R SYSTEM (SUPPRES°sJON POOL TRANSFERS) TURBINE &UILDING DRAINS [M-161, M-162, M-163 A NO M-164) RADWASTE! BUll.:DENG DRAINS. RADWASTE BUILDJNG DRAINS LIQUJO P.ADWASTe COLLECTIQN AND SURGE TANKS OT-302A THRU F DT-304A TH RU D LJQUIO UQUIO RAD WASTE RAD WASTE flLTfRS DEM?NERALIZER DF*J02A &. B 0-301 C:ONDENSATf STORAGE ro TANKS SPENT RESIN TANKS OT-S;UA Iii B SWMS RADWASTE BUll..DING FUEL l"OOL CLEANUP SAMPLE STAT!ON SYSTEM CHEMl'CAL DECON RWCU Ct1E!MtCAL OECON. CHEHICAL OECON LA.e &. OECON DRAINS AUX. BOJt.l!R. 6LOW00WNS CHEMICAL DRAIN TANK i------*--------i I I I I I I I I RAD WASTE EVAPORATORS OE*l02A, B

                                                                                                                       !+-----------*

I ! (2) CONDl!NSATE O EMJN I RESIN REGEN. TANKS I

..I

_l _ PUMPS OP-327A. B COrtbe~SATE STORAGE TANK DISCHAR.Ge PUMP OP*328 PERSONNEL DECONTAMINATION (0ETERGENT5) FLOOR DECON (SOLUTIONS) CASK CL.fANING DRAINS (3) REGULA."l'ED SHOP DRAINS . LAUNDRY DRAIN FlL TERS OF*3llA1-AJ GF313Bl~B3 (1) RADWASTE EVAPORATOllS (2) COND DEMIN RESINS CURl\ENTLY (J) CONTAMINATED CLO"l'H[NG CURR.fNTl.Y ARE NOT USED NOT R~GENEP.AT!O NOT LAUNDER.EC> DNSITE SUSQUEHANNA RIVER Page 1of1

Attachment C ODCM-QA-007 Revision 2 Page 17 of 18 SSES GASEOUS EFFLUENT RELEASE FLOWPATH Page 1of2 UNIT 1 REACTOR BUILDING i~ ~ (M-175, M-176)

     ;:: *--.*,.;;,;:---'....:.'""*-'*.'"-"..:..:-'c..."*:....*-_..*.*"'--"'"~'.""'.*..:..:**;;,,,;*';_.'"""-*"":.:"".::..;,,;;;;;,,,';,,,;"'""':~""'.:..:..:'.~""~:--*'*'-' c;.;..:;......

ZONE III FILTERED EXHAUST ROOMS ,, TANK VENT FILTER EXHAUST UNIT 1 OFFGAS SYSTEM (M-171) STEAM PACKING EXHAUSTER (M-107) ZONE lII UNIT 1 MECHANICAL VACUUM PUMP (M-107) SMOKE REMOVAL (2) CONTROL FILTER. UNIT (2) ROOMS CON1ROL ROOM KITCHEN

CONlROL ROOM lOILET ACCESS CONlROL AREA lOILET

     .: -:.*                                                                                                                                                                                                              ACCESS AREA GENERAL
     ,, *.,.~."""".,.,...,.,.,,..,,.,..,..-~,,...,,>M~""'1',..,..'""'.:-;;=~"":'.""m""'""""'".:'!'T.';;,::T'

ROOMS

   ~
      ~

ZONE I ROOMS

  *1    .~*    *r     ~:.:::          : * * * ' * .:.. : : .               ~-      .r,*       .~1          *~    *~,.::..

Page 1of2

Attachment C ODCM-QA-007 Revision 2 Page 18of18 UNIT2 UNIT2 REACTOR BUILDING TURBJNE BUILDING EXHAUST VENT EXHAUST VENT SSES GASEOUS EFFWENT REI.EASE Fl.OWPATH UNIT 2 OFFGAS SYSTEM STEAM PACKING EXHAUSTER . UNIT 2 MECHANICAL VAOJUM PUMP ROOMS ROOMS ZONE III ROOMS ZONE II ROOMS Page 2 of 2

For Information Only PROCEDURE COVER SHEET PPL SUSQUEHANNA, LLC PROCEDURE RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM ODCM-QA-008 Revision 18 Page 1of86 ADHERENCE LEVEL: INFORMATION USE QUALITY CLASSIFICATION: APPROVAL CLASSIFICATION: ( X ) QA Program ( ) Non-QA Program (X) Plant ( ) Non-Plant

                                                          -_ ( ) . Instruction EFFECTIVE DATE:           &'/;J /JitJ!S PERIODIC REVIEW FREQUENCY:                        N/A PERIODIC REVIEW DUE DATE:                      N/A RECOMMENDED REVIEWS:

Nuclear Emergency Planning Procedure Owner: Chemistry Responsible Supervisor: Chemistry Support Supervisor Responsible FUM: Manager-Plant Chemistry/Environmental Responsible Approver: Plant General Manager-Nuclear

For Information Only ODCM-QA-008 Revision 18 Page 2 of 86 PROCEDURE REVISION

SUMMARY

TITLE: RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM

1) Update Attachment G with the following changes:

a) Add Airborne Radioiodine and Particulate sampling location 981 (Transmission Line-East of Route 11) and 1OS3 (East of Confers Lane-South of Towers Club) in response to CR No. 2014-20221 (2014 Chemistry/Effluents Audit No. 1689843 action item.)

2) Update Attachments D and E and add Reference 3.22 to correspond with item 1 above.

The changes to ODCM-QA-008 above have been determined to not decrease the level of effluent control or the accuracy and/or reliability of dose calculations or setpoint determinations as required by 10CFR20.1302, 40CFR190, 10CFR50.36a, and 10CFR50, Appendix I.

For Information Only ODCM-QA-008 Revision 18 Page 3 of 86 TABLE OF CONTENTS SECTION

1. PURPOSE

2. POLICY/DISCUSSION 5 2.1 Monitoring Program 5 2.2 Census Program 7 2.3 lnterlaboratory Comparison Program 8 2.4 Dose Computations 8

3. REFERENCES 8

4. RESPONSIBILITIES 10 4.1 Chemistry Support Supervisor 10 4.2 Chemistry Support Personnel 10

5. DEFINITIONS 10

6. PROCEDURE 11 6.1 Dose Computations 11

7. RECORDS 13 ATTACHMENTS ATTACHMENT PAGE A Direct Radiation Monitoring Locations Within One Mile 14 8 Direct Radiation Monitoring Locations From One to Five Miles 15 c Direct Radiation Monitoring Locations Greater Than Five Miles 16 D Environmental Sampling Locations Within One Mile 17 E Environmental Sampling Locations From One to Five Miles 18

For Information Only ODCM-QA-008 Revision 18 Page 4 of 86 ATTACHMENTS ATTACHMENT PAGE F Environmental Sampling Locations Greater Than Five Miles 19 G Operational Radiological Environmental Monitoring Program 20 H REMP Dose Factors for Adult Age Group 24 REMP Dose Factors for Teen Age Group 40 J REMP Dose Factors for Child Age Group 56 K REMP Dose Factors for Infant Age Group 72 L REMP Dose Factors for Shoreline/Sediment Total Body and Skin Dose 80 M Consolidated Dose Calculations 83

For Information Only ODCM-QA-008 Revision 18 Page 5 of 8_6

1. PURPOSE The purpose of this procedure is to provide the methodology and parameters used to determine doses to the public resulting from inhalation, ingestion, and direct shine from radiologically contaminated environmental sampling media based on measured_ activity concentrations in those media. This procedure also describes the Radiological Environmental Monitoring Program (REMP), which includes the Annual Land Use Census Survey and lnterlaboratory Comparison Program.

This procedure constitutes part of the SSES Offsite Dose Calculation Manual (ODCM), which is a licensing basis document.

2. POLICY/DISCUSSION 2.1 Monitoring Program 2.1.1 The results of the Radiological Environmental Monitoring Program are intended to supplement the results of the radiological effluent monitoring by verifying that the measurable concentrations of radioactive materials and levels of radiation are not higher than expected on the basis of the effluent measurements and modeling of the environmental exposure pathways. Thus, the specified environmental monitoring program provides measurements of radiation and of radioactive materials in those exposure pathways and for those radionuclides which lead to the highest potential radiation exposures of individuals resulting from station operation.

2.1.2 Environmental samples shall be collected and analyzed according to Attachment G at locations shown in Attachments A through F. Comparisons to the Reporting Levels of TR Table 3.11.4.1-2 are conducted in accordance with procedure SC-099-003. Analytical techniques used shall ensure that the detection capabilities in TR Table 3.11.4.1-3 are achieved. Potential milk (dairy farms) or garden sampling locations shall be evaluated for monitoring based on the most recent relative deposition (D/Q) meteorological data. If elevated levels of gamma emitting radionuclides (which are the result of station operations) are identified in environmental samples, then consideration should be given to analyze for "hard to detect" radionuclides (e.g. Ni-63, Fe-55, Sr-90, transuranics) as applicable. 2.1.3 Sampling specified in Attachment G shall be performed with a maximum allowable extension not to exceed 25 percent of the specified interval. More restrictive tolerances may be imposed by implementing procedures. I_

For Information Only ODCM-QA-008 Revision 18 Page 6 of 86 2.1.4 Program changes may be proposed based on operational experience. Deviations are permitted from the required sampling schedule if specimens are unobtainable due to hazardous conditions, seasonal unavailability, malfunction of automatic sampling equipment, and other legitimate reasons. If specimens are unobtainable due to sampling equipment malfunction, an effort shall be made to complete corrective action prior to the end of the next sampling period. It is recognized that, at times, it may not be possible or practicable to continue to obtain samples of the media of choice at the most desired location or time. In these instances suitable alternative media and locations may be chosen for the particular pathway in question and appropriate substitutions made within 30 days to the REMP sampling program. All program changes and deviations from the sampling schedule shall be documented In the next Annual Radiological Environmental Operating Report. 2.1.5 An Annual Radiological Environmental Operating Report shall be prepared and.submitted to the NRC prior to May 15 of each year in accordance with Technical Spedfication 5.6.2. The report shall include summaries, interpretations and analyses of trends of the results of the Radiological Environmental Monitoring Program (including any monitoring not conducted in accordance with TR Table 3.11.4.1-1) for the reporting.period. A comparison, as appropriate, of sample analysis results with pre-operational studies, operational controls and results reported in previous reports shall be included. An assessment of environmental impacts of plant operation shall be made. The material provided shall be consistent with the objectives contained in the ODCM and 10CFR50, Appendix I, Sections IV.B.2, IV.B.3 and IV.C. The Annual Radiological Environmental Operating Report shall include the results of analyses of all radiological environmental samples and of all environmental radiation measurements taken during the period at the locations specified in the ODCM as well as the summary and tabulation of results presented in the format of the table in the Radiological Assessment Branch Technical Position, Rev. 1, November 1979. The results of the Land Use Census and the lnterlaboratory Comparison Program are included as well as corrective actions for analyses with results which are outside the control limits specified in the lnterlaboratory Comparison Program. Detected radionuclides which are not the result of plant effluents must be included in the report.

For Information Only ODCM-QA-008 Revision 18 Page 7 of 86 At least two maps, including one near the Site Boundary, showing monitoring/sampling locations that are keyed to table(s) providing distances and directions from the plant centerline shall also be included. In the event that some individual results are not available for inclusion with the report, the report shall note and explain the reasons for the missing results. The missing data shall be submitted in a supplementary report as soon as possible. 2.1.6 Special Reports shall be prepared and submitted to the NRG in accordance with the TROs of the specific sections of the Technical Requirements Manual. 2.1. 7 When performing dose calculations in support,of REMP sample results, consideration should be given to the fact that some monitoring locations may represent multiple exposure pathways (e.g., ground water feeds into the Peach Stand Pond and Lake Took-A-While). 2.2 Census Program 2.2.1 Broad leaf vegetation sampling of at least three different kinds of vegetation may be performed at the site boundary in each of two direction sectors with the highest predicted D/Q's in lieu of the garden census. Specifications for broad leaf vegetation sampling in TR Table 3.11.4.1-1, Item 4C shall be followed, including analysis of control samples. 2.2.2 If a land use census identifies a location(s) with a higher average annual deposition rate (D/Q) than a current indicator location, the following shall apply:

a. If the D/Q is at least 20 percent greater than a previously high D/Q, the new location shall be added to the program within 30 days of documented identification of sampling feasibility. The indicator location having the lowest D/Q may be dropped from the program after October 31 of the year in which the land use census was conducted.

b. If the D/Q is not 20 percent greater than the previously highest D/Q, direction, distance, and D/Q will be considered in deciding whether to replace one of the existing sample locations. If applicable, replacement shall

be within 30 days of documented decision making.

For Information Only ODCM-QA-008 Revision 18 Page 8 of 86 2.2.3 Any evaluations of possible location replacement should include the past history of the location, availability of sample, milk production history, and other applicable environmental conditions. New locations for dose calculations or environmental monitoring shall be reported in the Radioactive Effluent Release Report. 2.2.4 A land use census will be conducted at least once per calendar year by a door-to-door or aerial survey, by consulting local agricultural authorities, or by any combination of these methods. 2.3 lnterlaboratory Comparison Program 2.3.1 The laboratories providing radioanalytical services for the station's Radiological Environmental Monitoring Program (REMP) shall participate in an lnterlaboratory Comparison Program (ICP) which is traceable to NIST and should cover media sampled by the REMP. 2.3.2 Analysis results which are obtained as part of an ICP, that are not

                                       *within acceptance limits established by the ICP, shall be investigated by the laboratory responsible for the analysis.

Corrective action appropriate for the findings of the investigation shall be taken:* Investigation findings and corrective actions taken shall be described in the Annual Radiological Environmental Operating Report: 2.4 Dose Computations 2.4.1 When doses to members of the public are to be determined from REMP sample analysis results reported above LLD, doses should be added across sampling media for the same exposure pathways (airborne or waterborne), if available, to maximize the result for a particular age group and organ.

3. REFERENCES 3.1 Regulatory Guide 1.109, Rev .. 1, October, 1977, Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purposes of Evaluating Compliance with 10CFR50, Appendix I.

3.2 TR Table 3.11.4.1-1, Radiological Environmental Monitoring Program 3.3 TR Table 3.11.4.1-2, Reporting Levels for Radioactivity Concentrations in Environmental Samples 3.4 TR Table 3.11.4.1-3, Detection Capabilities for Environmental Sample Analysis

For Information Only ODCM-QA-008 Revision 18 Page 9 of 86 3.5 TS 5.6.2, Annual Radiological Environmental Operating Report 3.6 10CFR50, Appendix. I, Numerical Guides for Design Objectives and Limiting Conditions for Operation to Meet the Criterion "As Low as is Reasonably Achievable" for Radioactive Material in Light-Water-Cooled Nuclear Power Reactor Effluents

3. 7 40CFR 141, National Primary Drinking Water Regulations 3.8 Regulatory Guide 4.8, December 1975- Environmental Technical Specifications for Nuclear Power Plants 3.9 Branch Technical Position to NRG Reg. Guide 4.8, Rev. 1, November 1979 3.10 ORP/SID 72-2, Environmental Radioactivity Surv~illance Guide 3.11 CH-RM-001, Conduct of Radiological Environmental Monitorin~ Program 3.12 SC-099-003, REMP Quarterly Surveillance 3.13 SC-099-004, Performance of REMP Annual TS/TRM Surveillances 3.14 SC-099-005, REMP Land Use Census Surveillance 3.15 CH-TP-101, Radioactive Effluent Tracking and Dose Assessment Software (RETDAS) User Guide 3.16 PPL Calculation EC-ENVR-1027, SSES REMP Dose Factor Calculations:

c. R. 96-1310 3.17 PLl-92573, 2003 Environmental TLD Reduction Evaluation 3.18 Dames & Moore Report: Assessment of Hydrogeologic Conditions, Susquehanna Steam Electric Station, January 1986 3.19 AR No. 823249 3.20 USNRC Information Notice 2006-13, Ground-Water Contamination Due to Undetected Leakage of Radioactive Water, July 10, 2006 3.21 NUREG-1302, Offsite Dose Calculation Manual Guidance: "Standard Radiological Effluent Controls for Boiling Water Reactors," April 1991 3.22 CR No. 2014-20221

For Information Only ODCM-QA-008 Revision 18 Page 10 of 86

4. RESPONSIBILITIES 4.1 Chemistry Support Supervisor 4.1.1 Is responsible for appointing and supervising Chemistry Support Personnel.

4.2 Chemistry Support Personnel 4.2.1 Have the primary responsibility for developing the REMP and ensuring proper conduct of the REMP.

5. DEFINITIONS 5.1 LLD - Lower Limit of Detection, the smallest concentration of radioactive material in a sample that will yield a net count (above system background) that will be detected with 95 percent probability with only a 5 percent probability of falsely concluding that a blank observation represents a "real" signal.

5.2 REMP- Radiological Environmental Monitoring Program. 5.3 MEMBER(S) OF THE PUBLIC - Shall include all persons who are not occupationally associated with the plant. This category does not include employees of the utility, its contractors, or vendors. Also excluded from this category are persons who enter the site to service equipment or to make deliveries. This category does include persons who use portions of the site for recreational, occupational, or other purposes not associated with the plant. 5.4 Weekly 0N) - at least once per 7 days +/- 1. 75 days 5.5 Bi-Weekly (BW) - at least once per 14 days +/- 3.5 days 5.6 Monthly (M) - at least once per 31 days+/- 7.75 days 5.7 Quarterly (Q) - at least once per 92 days+/- 23 days 5.8 Semi-annually (SA) - at least once per 184 days+/- 46 days 5.9 Annually (A) - at least once per 365 days +/- 91.25 days 5.1 O Special Interest Area - an §lrea monitored for direct radiation such as population centers, nearby residences, schools or hospitals J

For Information Only ODCM-QA-008 Revision 18 Page 11 of 86

6. PROCEDURE 6.1 Dose Computations 6.1.1 Annual Doses to Members of the Public from Ingestion of Radioactive Material

a. The RETDAS Computer Program may be used (as

applicable) to determine annual doses to members of the public from ingestion of radioactive material for various pathways, age groups and organs per CH-TP-101.

b. Alternatively, Chemistry Support Personnel shall determine annual doses to members of the pubiic from ingestion of radioactive material for various pathways, age groups and organs according to the methodology developed in EC-ENVR-1027:

DREMPJING =DFcALCllNG *RESREMP *FSAMP (Eq. 1) where: DREMPJING = Annual dose from ingestion, as determined from REMP sample result (mrem/year). Refer to Attachment M for the regulatory basis of the calculation of DREMP/ING* DFcALc11NG = Dose rate factor for ingestion pathway; mrem-liter/pCi-yr for liquid samples; mrem-kg/pCi-yr for solid samples (Attachments H through K). RESREMP = REMP sample result: pCi/liter for water or milk samples; pCi/kg for vegetable, fruit, meat or fish samples. FsAMP = Correction factor for the fraction of year represented by the sampling period (for cases where only periodic or seasonal sampling is conducted).

For Information Only ODCM-QA-008 Revision 18 Page 12 of 86 6.1.2 Chemistry Support Personnel shall determine annual doses to members of the public from inhalation of radioactive material for various pathways, age groups and organs according to the methodology developed in EC-ENVR-1027: DREMPllNH =DFcALC/INH

RESREMP
FsAMP (Eq. 2) where:

DREMPllNH = Annual dose to organs or total body from inhalation, as determined from REMP sample result (mrem/yr). Refer to Attachment M for the regulatory basis of the calculation of DREMPllNH* DFcALC/INH = Dose rate factor for inhalation pathway (mrem-m 3/pCi-yr) (Attachments H through K). RESREMP = REMP sample result: pCi/m 3 for air samples corrected for absorption effiCiency of filter media. 6.1.3 Chemistry Support Personnel shall determine annual doses to members of the public from exposure to contaminated sediment for total body and skin dose, for various age groups according to the methodology developed in EC-ENVR-1027: DREMP/TB = DFcALC/TB

RESREMP *FsAMP (Eq. 3)

DREMP/SKIN =DFcALC/SKIN

RESREMP
FsAMP (Eq. 4) where:

DREMPITB = Annual total body dose, as determined from REMP sample result (mrem/yr). Refer to Attachment M for the regulatory basis of the calculation of DREMPITB* DREMP/SKIN = Annual skin dose, as determined from REMP sample result (mrem/yr). Refer to Attachment M for the regulatory basis of the calculation of DREMP/SKIN* RESREMP = REMP sample result: pCi/kg sediment. DFcALC/TB = Total body dose rate factor from sediment (mrem-kg/pCi-yr) (Attachment L).

For Information Only ODCM-QA-008 Revision 18 Page 13 of 86 DFCALC/SKIN = Skin dose rate factor from sediment (mrem-kg/pCi-yr) (Attachment L). FsAMP = Correction factor for the fraction of year represented by the sampling period (for cases where only periodic or seasonal sampling is conducted).

7. RECORDS None

For Information Only Attachment A ODCM-QA-008 Revision 18 Page 14 of 86 DIRECT RADIATION MONITORING LOCATIONS WITHIN ONE MILE Page 1 of 1

For Information Only Attachment B ODCM-QA-008 Revision 18 Page 15 of86 DIRECT RADIATION MONITORING LOCATIONS FROM ONE TO FIVE MILES

                       ......~-
                                             }t i,_.P       \                e
                              *....... ~
                                              ~-~*"'
                                                                                                \ *~
                                                                                                     ./
                                                                                .'-'-::~---~~***'
                                                                    /    ~** ~*

Page 1of1

For Information Only Attachment C ODCM-QA-008 Revision 18 Page 16 of 86 DIRECT RADIATION MONITORING LOCATIONS GREATER THAN FIVE MILES Page 1 of 1

For Information Only Attachment D ODCM-QA-008 Revision 18 Page 17 of 86 ENVIRONMENTAL SAMPLING LOCATIONS WITHIN ONE MILE Page 1of1

For Information Only Attachment E ODCM-QA-008 Revision 18 Page 18 of 86 ENVIRONMENTAL SAMPLING LOCATIONS FROM ONE TO FIVE MILES Page 1 of 1

For Information Only Attachment F ODCM-QA-008 Revision 18 Page 19 of 86 ENVIRONMENTAL SAMPLING LOCATIONS GREATER THAN FIVE MILES Page 1of1

For Information Only Attachment G ODCM-QA-008 Revision 18 Page 20 of 86 OPERATIONAL RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM Exposure Pathways and/or Number of Samples Sampling and Type and Sample and Locations* Collection FreguencI FreguencI of Analisis Airborne Radio iodine 12Sl 0.4 mi WSW West Building Laboratory Continual sampler Radioiodine Canister: and 12El 4.7mi WSW Berwick Hospital operation with sample analyze weekly for I-131." Particulates* 3S2 0.5 mi NE SSES Backup Met. Tower collection weekly.

IOS3 0.6mi SSW East of Confers Lane-South Particulate Sample:

.1                                               ofTowers Club                                          Analyze for gross beta 13S6  0.4 mi   w    Former Laydown Area,                                   radioactivity following West of Confer' s Lane                                 filter change. Perform
                           ~ 9Bl   1.3 mi   s    Transmission Line-East of                              isotopic analysis on J                                              Route 11                                               composite sample \by 601   13.5 mi ESE   Freeland Substation°                                   location) quarterly.

8Gl 12.2mi. SSE PPL System Facilities 0 Center, Humboldt Industrial Park Direct Radiation 105 4.0mi N Mocanaqua Sewage Quarterly Gamma Dose: Quarterly. Treatment Plant* 1S2 0.2mi N Perimeter Fence* 2S2 0.9mi NNE Thomas Road 2S3 0.2 mi NNE Perimeter Fence* 2FJ 5.9mi NNE St. Adalberts Cemetery* 3El 4.7mi NE Webb Residence- Lilly Lake" 3G4 17 mi NE Wilkes Barre Service Center** 3S2 0.5 mi NE SSES Backup Met. Tower 383 0.9mi NE ANSP Riverlands Garden 4S3 0.2mi ENE West of SSES APF" 4E2 4.7mi ENE Ruckles Hill & Pond Hill Roads Intersection° 4Gl 14mi ENE Crestwood Industrial Park"* 4S6 0.7mi ENE Riverlands 5E2 4.5 mi E Bloss Farm* 5S7 0.3 mi E Perimeter Fence* SS4 0.8mi E West of Environmental Laboratory 6S4 0.2 mi ESE Perimeter Fence* 6A4 0.6mi ESE Restaurant' 6El 4.7mi ESE St. James Church" 6S9 0.2mi ESE Perimeter Fence* Quarterly Gamma Dose: Quarterly. 786 0.2mi SE .Perimeter Fence* 7EJ 4.2mi SE Harwood Transmission Line Pole #2° 00 7Gl 14mi SE PPL Hazleton Complex 7S7 0.4 mi SE End of Kline's Road 8A3 0.9mi SSE PPL Wetlands Sign (U.S. Route 11) 8S2 0.2 mi SSE Perimeter Fence* 8B2 1.4 mi SSE LaWall Residence' Page 1 of 4

For Information Only Attachment G ODCM-QA-008 Revision 18 Page 21 of 86 OPERATIONAL RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM Exposure Pathways and/or Number of Samples Sampling and Type and Sample and Locations* Collection Freguency

Freguency of Analysis 803 4.0mi SSE Mowery Residence0
9Bl 1.3 mi s Transmission Line - east of Route 11 9S2 0.2mi s Security Fence0 904 3.6mi s Country Folk Store0 10B3 l.7mi SSW Castek Inc.'

lOSl 0.4mi SSW Post South of Switching Station 0 10S2 0.2mi SSW Security Fence 0 1001 3.0mi SSW R&C Ryman Farm llEl 4.7mi SW Thomas Residence* 11S7 0.4mi SW SSES Access Road Gate

                                             #50 12D2 3.7mi     WSW Dagostin Residence 12S3 0.5mi     WSW Confers Lane (east side) at "12 WSW" white sign*

12El 4.7mi WSW Berwick Hospital'" 12Gl 15 mi WSW PPL Bloomsburg Service Center c* 12G4 IO mi WSW Naus Residence 0 12Sl 0.4 mi WSW SSES West Building 12S7 1.1 mi WSW Former Kisner Property 13S2 0.4mi w Perimeter Fence0 13S5 0.4mi w Perimeter Fence 13S6 0.4mi w Former Laydown Area-west ofConfer's Lane 13E4 4.1 mi w Kessler Fann° 1401 3.6mi WNW Moore's Hill/Mingle Inn Road Intersection 14S5 0.5mi WNW Beach Grove Rd. & Confer's Lane Intersection* 15A3 0.9mi NW Hosler Residence' 15Fl 5.4mi NW Zawatski Fann* 0 15S5 0.4mi NW Perimeter Fence 16A2 0.8mi NNW Benkinney Residence' 16Sl 0.3mi NNW Perimeter Fence 16S2 0.3 mi NNW Perimeter Fence* 16Fl 7.8 NNW Hidlay Residence* Page 2of4

For Information Only Attachment G ODCM-QA-008 Revision 18 Page 22 of 86 OPERATIONAL RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM Exposure Pathways and/or Number of Samples Sampling and Type and Sample and Locations* Collection Frequency Frequency of Analysis Waterborne Surface 2S7 Cooling Tower Blowdown discharge line Monthly composite Gamma isotopic analysis. (restricted area) Composite tritium 5S9 Environmental Lab boat rarnp 08

analysis at least quarterly.

6S6 River Water Intake Line0 . 6S5 Susquehanna River below discharge line Weekly grab sample for Gamma isotopic analysis. Monthly composite Composite tritium analysis at least quarterly. LTAW Lake Took-a-While Quarterly grab sample Gamma isotopic and 4S7 0.4 mi ENE Peach Stand Pond tritium analysis 5Sl2 0.4 mi E C-1 Pond 7S12 0.3 mi SE S-2 Pond Drinking 12H2 Danville Water Company (Approximately Monthly composited Gross beta and gamma 30 miles downstream) isotopic analyses monthly. Composite for tritium analysis at least quarterly. Ground 1S3 0.1 mi N MW-1, N. ofRW Bldg. Quarterly Gamma isotopic and Water 2S2 0.9 mi NNE SSES Energy Inf. Ctr. tritium analysis of each 4S4 0.5mi ENE

SSES Learning Ctr. sample.

4SS 0.1 mi ENE MW-2, SE ofE. Diesel Bldg. 4S9 0.3mi ENE MW-3, NW comer of APF parking lot 6Sl0 0.4mi ESE Sewage Treat. Plt.(STP) 6S11A 0.4 mi ESE MW-SA, S. of STP 6SllB 0.4mi ESE MW-SB, S. ofSTP 6Sl2 O.Smi ESE MW-9, W. of River Intake Bldg 7SIO 0.3 mi SE MW-5, N ofS-2 Pond 7811 0.3mi SE MW-10, N. ofS-2 Pond 8S4 0.1 mi SSE MW-4, E ofU-2 CST 11S2 0.4mi SW Towers Club 12F3 5.2mi WSW Berwick Water Co.° 13S7 0.2mi w MW-6, Laydown Area W of cooling towers 2S8 0.1 mi NNE MW-7, Sentinel well NE of site 0 Sediment 28 1.6 mi NNE Gould lsland Semi-annually Gamma isotopic analysis from 7B 1.2 mi SE Bell Bend semi-annually. Shoreline 12F 6.9mi WSW Old Berwick Test Track Page 3 of 4

For Information Only Attachment G ODCM-QA-008 Revision 1a Page 23 of 86 OPERATIONAL RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM Exposure Pathways and/or Number of Samples Sampling and Type and Sample and Locations* Collection Frequency Frequency of Analysis Ingestion Milk** 5E2 4.5 mi E W. Bloss Fann

Semi-monthly when Gamma isotopic and 1-131 13E3 5.0 mi. W J. Dent Fann animals are on pasture, analysis of each sample.

1001 14.0 mi. SSW Davis Farm' monthly otherwise . 12B2 1.7 mi. WSW T&M Berger Farm Fish and IND Outfall area Semi-annually. One Gamma isotopic on edible Invertebrates 2H Falls, Pa' sampler from each of two portions.' (Approximately 30 mi NNE) recreationally important species from any of the following families: bullhead catfish, sunfish, pikes, or perches. Food llDl 3.3mi SW Zehner Fann (vegetable) At time of harvest Gamma isotopic on edible Products 11D2 3.5 mi SW Lupini Field (vegetable) portions. 11F2 5.5 mi SW Chapin (Drake) Field (vegetable) 12F7 8.3 mi WSW Lupini Farm (vegetable) 5S10 0.7mi E PPL Riverlands Parcel 30' (vegetable) 5Sll 1.1 mi E PPL East Side Parcel 25'(vegetable) 3S3 0.9mi NE Riverlands Garden (broadleafvegetation) 8C1 2.9mi SSE Pumpkin Hill Farm (broadleafvegetation) SGI 12.2mi SSE PPL System Facilities Center, Humboldt Industrial Parke (broadleaf vegetation) 10B5 l.3mi SSW S. Bodnar Garden (broadleafvegetation) 11S6 0.5 mi SW SW Garden (broadleafvegetation) 1501 11.4 mi NW Dancing Hen Farm' (broadleafvegetation)

The location of samples and equipment were designed using the guidance in the Branch Technical Position to NRC Reg. Guide 4.8, Rev. I, Nov. 1979, Reg. Guide 4.8 1975 and ORP/SID 72-2 Environmental Radioactivity Surveillance Guide. Therefore, the airborne sampler locations were based upon X/Q and/or D/Q.

             **   All dairy farms within 5 miles are listed. Samples from 3 indicator locations (dairy farms within 5 miles) are collected based on highest dose potential and farm owner participation in the REMP. If a milk sample is unavailable for more than two sampling periods from one or more of the required 3 indicator locations, a vegetation sample shall be substituted until a suitable milk sampling location is identified and added to the REMP. Such an occurrence will be documented in the REMP annual report. See ODCM-QA-008 Section 2.2 and TRM Table 3.11.4.1-1 for additional detail on milk/vegetation sampling.

The charcoal sampler cartridges used in the airborne radioiodine sampling program are designed and tested by the manufacturer to assure a high quality ofradioiodine capture. A certificate from the manufacturer is supplied and retained with each batch of cartridges certifying the percent reduction of radioiodine versus air flow rate through the cartridge. Gross beta activity calculations will be performed in accordance with the procedures of the designated REMP analysis laboratory. Control sample location. Two-week composite if calculated doses due to consumption of water exceed one millirem per year. In these cases, 1-131 analyses will be performed. Emergency Plan dosimetry located at this location in addition to REMP dosimetry. The sample collector will determine the species based upon availability, which may vary seasonally.and yearly. Alternate sample location for 6S6 10 be collected and analyzed according to the required frequencies. Special Interest Area sample location Page 4 of 4

For Information Only Attachment H ODCM-QA-008 Revision 18 Page 24 of 86 REMP DOSE FACTORS FOR ADULT AGE GROUP: MILK SAMPLE (Page 1 of 2) mrem-1 t c*1-yr rtel'.rp

                                ":            - .                                                                              " : :;f;f'f~f-~LI -*
               . *,liiu.C~n::>E   :.:'~g~~t      **;~~!!~,~;;;,:*   r:aoo.~L          tflYROiD*.:    KiONEY~::f i,;I'.:WUNG.

H-3 O.OOE+OO 3.25E-05 3.25E-05 3.25E-05 3.25E-05 3.25E-05 3.25E-05 C-14 8.80E-04 1.76E-04 1.76E-04 1.76E-04 1.76E-04 1.76E-04 1.76E-04 Na-24 O.OOE+OO O.OOE+OO . O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO P-32 5.43E-02 3.38E-03 2.10E-03 O.OOE+OO O.OOE+OO O.OOE+OO 6.11E-03 Cr-51 O.OOE+OO O.OOE+OO 7.84E-07 4.69E-07 1.73E-07 1.04E-06 1.97E-04 Mn-54 O.OOE+OO 1.41 E-03 2.69E-04 O.OOE+OO 4.20E-04 O.OOE+OO 4.32E-03 Mn-56 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Fe-55 8.51E-04 5.88E-04 1.37E-04 D.OOE+OO O.OOE+OO 3.28E-04 3.37E-04 Fe-59 1.30E-03 3.0?E-03 1.18E-03 O.OOE+OO O.OOE+OO

8.56E-04 1.02E-02 Co-58 O.OOE+PO 2.26E~04 5.08E-04 O.OOE+OO O.OOE+OO O.OOE+OO 4.59E-03 Co-60 D.OOE+OO 6.63E-04 1.46E-03 0.00E+OO O.OOE+OO O.OOE+OO 1.25E-02 Ni-63 4.03E-02 2.79E-03 1.35E-03 O.OOE+OO O.OOE+OO O.OOE+OO 5.83E-04 Ni-65 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO ' O.OOE+OD O.OOE+OO O.OOE+OO Cu-64 O.OOE+OD O.OOE+OO O.OOE+OO o:ooE+oo O.OOE+OO O.OOE+OO O.OOE+OO Zn-65 1.49E-03 4.75E-03 2.15E-03 O.OOE+OO 3.17E-03 O.OOE+OO 2.99E-03 Zn-69 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-83 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-84 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-85 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Rb-86 O.OOE+OO 6.0?E-03 2.83E-03 O.QOE+OO O.OOE+OO O.OOE+OO 1.20E-03 Rb-88 O.OOE+OO O.OOE+OO ' O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Rb-89 O.OOE+OO 0.00.E+OO O.OOE+OO O.OOE+OO O.OOE+oo O.OOE+OO O.OOE+OO Sr-89 9.29E-02 O.OOE+OO 2.67E-03 O.OOE+OO O.OOE+OO O.OOE+OO 1.49E-02 Sr-90 2.35E+OO O.OOE+OO 5.77E-01 O.OOE+OO O.OOE+OO O.OOE+OO 6.79E-02 Sr-91 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Sr-92 O.OOE+OO O.OOE+OO O.ObE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-90 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-91m O.ODE+OD O.OOE+OO O.OOE+OO O.OQE+OO O.OOE+QO O.OOE+OO O.OOE+OO Y-91 4.27E-05 O.OOE+OO 1.14E-06 O.OOE+OO O.OQE+OO O.OOE+OO 2.35E-02 Y-92 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO Y-93 O.OOE+OO O.OOE+oo O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Zr-95 9.;:!2E-06 2.96E-06 2.00E-06 O.OOE+OO 4.64E-06 O.OOE+OO 9.37E-03 Zr-97 O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO Nb-95 1.85Ec06 1.03E"06 5.54E-07 O.OOE+OO 1.02E-06 O.OOE+OO 6.26E-03 Mo-99 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Tc-99m O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Page 1 of 16 I

For Information Only Attachment H ODCM-QA-008 Revision 18 Page 25 of 86 REMP DOSE FACTORS FOR ADULT AGE GROUP: MILK SAMPLE (Page 2 of 2) mrem-liter/pCi-yr.

              *. NUCLIDE'

BONE .:.;:** LIVER~( T.BODY THYRd1:0

                                                                                                .,  KIDNEY
                                                                                                      . -;...        LUNG           Gl-LLI
                                             '         ~ *. -'!~-;,. ;;                                                .' .
                                                                                                                         *.:::~

Tc-101 O.OOE+OO

0.0ciE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ru-103 5.54E-05 O.OOE+OO . 2.39E-05 0.00E+OO 2.11E-04 O.OOE+OO 6.46E-03 Ru-105 O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO 0.00E+OO Ru-106 a:49E-04 O.OOE+OO 1.07E-04 O.OOE+OO 1.64E-03 O.OOE+OO 5.50E-02 Ag-110m 4.93E-05 4.56E-05 2.71E-05 O.OOE+OO 8.97E-05 O.OOE+OO 1.86E-02 Te-125m 8.11E-04 2.94E-04 1.09E-04 2.44E-04 3.30E-03 O.OOE+OO 3.24E-03 Te-127m 2.07E-03 7.41E-04 2.53E-04 5.30E-o4 8.42E-03 O.OOE+OO 6.95E-03 Te-127 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO Te-129m 3.42E-03 1.28E-03 5.41 E-04 1.18E-03 1.43E-02 O.OOE+OO 1.72E-02 Te-129 9.34E-06 3.51E-06 2.28E-06 7.17E-06 3.93E-05 O.OOE+OO 7.05E-06 Te-131m O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Te-131 O.OOE+OO O.OOE+OO .O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Te-132 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO 0.00E+OO O.OOE+OO 1-130 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-131 1.09E-03 1.55E-03 a:9oE-04 5.09E-01 2.66E-03 O.OOE+OO 4.10E-04 1-132 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO . O.OOE+OO 1-133 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-134 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-135 O.OOE+OO O.OOE+OO O.OOE+OO *o.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Cs-134 1.92E-02 4.58E-02 3.74E-02 O.OOE+OO 1.48E-02 4.92E-03 8.01E-04 Cs-136 1.82E~03 7.17E-03 5.16E-03 O.OOE+OO 3.99E-03 5.47E-04 8.15E-04 Cs-137 2.47E-02 3.38E-02 2.21E-02 O.OOE+OO 1.15E-02 3.81E-03 6.54E-04 Cs-138 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO o:ooE+oo Ba-139 O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ba-140 S.65E-03 7.09E-06 3.70E-04 O.OOE+OO 2.41 E-06 4.06E-06 1.16E-02 Ba-141 O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ba-142 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO La-140 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO La-142 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ce-141 2.78E-06 1.88E-06 2.13E-07 O.OOE+OO 8.73E-07 O.OOE+OO 7.19E-03 Ce-143 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ce-144 1.51 E-04 6.29E-05 8.08E-06 O.OOE+OO 3.73E-05 O.OOE+OO 5.09E-02 Pr-143 2.57E-06 1.03E-06 1.28E-07 O.OOE+OO 5.96E-07 O.OOE+OO 1.13E-02 Pr-144 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Nd-147 1.72E-06 1.99E-06 1.19E-07 O.OOE+OO 1.16E-06 O.OOE+OO 9.54E-03 W-187 O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Np-239 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Page 2of16

For Information Only Attachment H ODCM-QA-008 Revision 18 Page 26 of 86 REMP DOSE FACTORS FOR ADULT AGE GROUP: LEAFY VEG. SAMPLE (Page 1 of 2) I c*1-yr mrem- k*g/p1 NUCLIDE ,, '."'**BONE LiVEF{;::*** T.BODY THY1foio* KIDNEY ! ...* ii.iN~, ::.: . Gl-LLI H-3 O.OOE+OO 6.72E-06 6.72E-06 6.72E-06 6.72E-06 6.72E-06 6.72E-06 C-14 1.82E-04 3.64E-05 3.64E-05 3.64E-05 3.64E-05 3.64E-05 3.64E-05 Na-24 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO . O.OOE+OO O.OOE+OO O.OOE+OO P-32 1.18E-02 7.32E-04 4.55E-04 O.OOE+OO O.OOE+OO O.OOE+OO 1.32E-03 Cr-51 O.OOE+OO O.OOE+OO 1.66E-07 9.92E-08 3.66E-08 2.20E-07 4.18E-05 Mn-54 O.OOE+OO 2.92E-04 .5.57E-05 O.OOE+OO 8.68E-05 O.OOE+OO 8.94E-04 Mn-56 O.OOE+OO

O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Fe-55 1.76E-04 1.22E-04 2.83E-05 O.OOE+OO O.OOE+OO 6.78E-05 6.97E-05 Fe-59 2.73E-04 6.43E-04 2.46E-04 O.OOE+OO O.OOE+OO 1.80E-04 2.14E-03 Co-58 O.OOE+OO 4.72E-05 1.06E-04
O.OOE+OO O.OOE+OO O.OOE+OO 9.57E-04 Co-60 O.OOE+OO 1.37E-04 3~02E-04 O.OOE+OO O.OOE+OO *. O.OOE+OO 2.57E-03 Ni-63 8.3?E-03 5.77E-04 2.79E-04 . O.OOE+OO O.OOE+OO O.OOE+OO 1.20E-04 Ni-65 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Q.OOE+OO O.OOE+OO Cu-64 O.OOE+OO O,QOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Zn-65 3.09E-04 9.83E-04 4.44E-04 O.OOE+OO 6.57E-04 O.OOE+OO 6.19E-04 Zn-69 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-83 O.OOE+Oc:i O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-84 O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO
O.OOE+OO O.OOE+OO O.OOE+OO Br-85 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO Rb-86 O.OOE+OO 1.30E-03 6.06E-04 O.OOE+OO O.OOE+OO O.OOE+OO 2.57E-04 Rb-88 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Rb-89 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO o:ooE+oo O.OOE+OO Sr-89 1.94E-02 0.00E+OO 5.58E-0.4 O.OOE+OO O.OOE+OO O.OOE+OO 3.12E-03 Sr-90 4.85E-01 O.OOE+OO 1.19E-01 . O.OOE+OO O.OOE+OO O.OOE+OO 1.40E-02 Sr-91 O.OOE+OO O.OOE+OO O.OOE+OO *o.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Sr-92 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-90 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE-1;"00 O.OOE+OO O.OOE+OO Y-91m 0.00E+OO O.OOE+OO 0.00E+OO .O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-91 8.92E-06 O.OOE+OO 2.38E-07 O.OOE+OO O.OOE+OO O.OOE+OO 4.91E-03 Y-92 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-93 O.OOE+OO O.OOE+OO O.OOE+OO 0.00.E+OO O.OOE+OO O.OOE+OO O.OOE+OO Zr-95 1.92E-06 6.17E-07 4.18E-07 0.00E+OO 9.69E-07 O.OOE+OO 1.96E-03 Zr-97 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Nb-95 3.90E-07 2.17E-07 1.17E-07 o.qoE+OO 2.15E-07 O.OOE+OO 1.32E-03 Mo-99 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Tc-99m O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Page 3of16

For Information Only Attachment H ODCM-QA-008 Revision 18 Page 27 of 86 REMP DOSE FACTORS FOR ADULT AGE GROUP: LEAFY VEG. SAMPLE (Page 2 of 2) mrem- kcaroCi-vr I

NUCLfDE ; . ::>eoNE;.c~~r; : UMER

                                                 *.:*.)),. . ,:,f;*T:BODY     THYROID*  , . KIDNEY:*    .*W,N~    '.m:;  GI-LU Tc-101      O.OOE+OO        O.OOE+OO            O.OOE+OO     O.OOE+OO    O.OOE+OO

0.00E+OO O.OOE+OO Ru-103 1.16E-05 O.OOE+OO 5.01E-06 O.OOE+OO 4.44E-05 O.OOE+OO 1.36E-03 Ru-105 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO
O.OOE+OO O.OOE+OO Ru-106 1.76E-04 O.OOE+OO 2.22E-05 O.OOE+OO 3.39E-04 O.OOE+OO 1.14E-02 Ag-110m 1.02E-05 9.45E-06 5.61E-06 O.OOE+OO 1.86E-05 O.OOE+OO 3.85E-03 Te-125m 1.69E-04 6.14E-05 2.27E-05 5.10E-05 6.89E-04 O.OOE+OO 6.77E-04 Te-127m 4.31E-04 1.54E-04 5.25E-05 1.10E-04 1.75E-03 O.OOE+OO 1.44E-03 Te-127 O.OOE+OO O.OOE+OO *o.obE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Te-129m 7.21E-04 2.69E-04 1.14E-04 2.48E-04 3.01E-03 O.OOE+OO 3.63E-03 Te-129 1.97E-06 7.40E-07 4.80E-07 1.51E-06 8.28E-06 O.OOE+OO 1.49E-06 Te-131m O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO Te-131 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Te-132 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-130 O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO . o:ooE+oo 1-131 2.44E-04 3.49E-04 2.00E-04 1.14E-01 5.99E-04 O.OOE+OO 9.22E~05 1-132 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-133 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+.00 O.OOE+OO O.OOE+'OO 1-134 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-135 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Cs-134 3.98E-03 9.46E-03 7.74E-03 O.OOE+OO 3.06E-03 1.02E-03 1.66E-04 Cs-136 3.95E-04 1.56E-03 1.12E-03 O.OOE+OO 8.68E-04. 1.19E-04 1.77E-04 Cs-137 5.1DE-03 6.98E-03 4.57E-03 O.OOE+OO 2.37E-03 7.87E-04 1.35E-04 Cs-138 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ba-139 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ba-140 1.23E-03 1.55E-06 8.06E-05 O.OOE+OO 5.26E-07 8.85E-07 2.53E-03 Ba-141 O.OOE+OO 0.00E+OO O.OOE+OO- O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ba-142 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO La-140 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO . O.OOE:t-00 O.OOE+OO O.OOE+OO La-142 O.OOE+OO O.OOE+OO O.OOE+O~ 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO Ce-141 5.86E-07 3.97E-07 4.50E-08 O.OOE+OO 1.84E-07 O.OOE+OO 1.52E-03 Ce-143 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ce-144 3.12E-05 1.30E-05 1.67E-06 O.OOE+OO 7.73E-06 O.OOE+OO 1.05E-02 Pr-143 5.59E-07 2.24E-07 2.77E-08 O.OOE+OO 1.30E-07 O.OOE+OO 2.45E-03 Pr-144 O.OOE+OO . O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO Nd-147 3.78E-07 4.37E-07 2.61E-08 O.OOE+OO 2.55E-07. O.OOE+OO 2.10E-03 W-187 O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Np-239 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Page 4of16

For Information Only Attachment H ODCM-QA-008 Revision 18 Page 28of86 REMP DOSE FACTORS FOR ADULT AGE GROUP: FRUIT SAMPLE (Page 1 of 2) mrem-kg/pCi-yr 1:;:.1;.~!:1¢wiplE;. _,: ;;*,;~:~.*i~pNi:*.. *,:

                                                                 .~1v~~ *.'<  : :i:T:~~Q.fi>;~'.t~;-   ' THYROID
                                                                                                                . r*.,-:-.**. ~ .. KID~.~~:/. ,/*..LUNG,* :'*
                                                                                                                                                              .'. . .*.*GPb~t::;, '

H-3 O.OOE+OO 5.41E-05 5.41E-05 5.41E-05 . 5.41 E-05 5.41E-05 5.41E-05 C-14 1.48E-03 2.95E~04 2.95E-04 2.95E-04 2.95E-04 2.95E-04 2.95E-04 Na-24 O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO P-32 5.47E-03 3.40E-04 2.11E-04 O.OOE+OO O.OOE+OO O.OOE+OO 6.14E-04 Cr-51 O.OOE+OO O.OOE+OO 3.0BE-07 1.84EcQ7 6.79E-08 4.09E-07 7.75E-05 Mn-54 O.OOE+OO 2.08E-03 3.97E-04 O.OOE+OO 6.19E-04 O.OOE+OO 6.37E-03 Mn-56 O.OOE+OO

O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Fe-55 1.37E-03 9.47E-04 2.21E-04 O.OOE+OO O.OOE+OO 5.28E-04 5.43E-04 Fe-59 8.89E-04 2.09Ec03 8.01E-04 O.OOE+OO O.OOE+OO 5.84E-04 6.96E-03 Co-58 O.OOE+OO 2:15E-04 '4.83E-04 O.OOE+OO . O.OOE+OO O.OOE+OO 4.36E-03 Co-60 O.OOE+OO 1.09E-03 2.40E-03' O.OOE+OO O.OOE+OO O.OOE+OO 2.0SE-02 Ni-63 6.75E-02 4.68E-03 2.26E-03 O.OOE+OO O.OOE+OO O.OOE+OO 9.76E-04 Ni-65 9.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO.
O.OOE+OO O.OOE+OO O.OOE+OO Cu-64. O.OOE+'oo O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Zn-65 2.12E-03 6.75E-03 3.05E-03
O.OOE+OO 4.52E-03 O.OOE+OO 4.25E-03 Zn-69 O.OOE+OO O.OOE+OO O.OOE+OO:. O.OOE+OO 'O.OOE+OO O.OOE+OO O.OOE+OO Br-83 O.OOE+OO O.OOE+OO O.OOE+OO
O.OOE+OO O.OOE+oo O.OOE+OO O.OOE+OO Br-84 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO o.ooE-i;oo O.OOE+OO O.OOE+OO Br-85 O.OOE+OO 0.00E+OO O.OOE+OO
O.OOE-t;OO O.OOE+OO D.OOE+OO O.OOE+OO Rb-86 O.OOE+OO 1.18E-03 5.soi::~04 O.OOE+bO O.OOE+OO O.OOE+OO 2.33E-04 Rb-88 O.OOf::+OO O.DOE+OO O.OOE+OO' O.OOE+OO
O.OOE+OO ' O.DOE+OO O.OOE+OO Rb-89 O.OOE+OO O.OOE+DO D.OOE+oo O.OOE+OO O.OOE+OO O.OOE+DO O.OOE+OO Sr-89 7.03E-02 O.OOE+OO 2.02E-Q3 O.OOE+OO O.OOE+oo O.OOE+OO 1.13E-02 Sr-90 3.93E+OO O.OOE+OO 9.63E~01 ' D.OOE+OO O.OOE+OO O.OOE+OD 1.13E-01 Sr-91 O.OOE+OO O.OOE+OO 0;00Ef00 O.OOE+OO 0.0.0E+.OO O.OOE+OO O.OOE+OO Sr-92 O.OOE+OO O.OOE+DO O.ODE+OO . O.OOE+OO O.OOE+OD O.OOE+OO O.OOE+OO Y-90 O.OOE+OO O.OOE+OO ' :o.OOE+Off O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-91m
O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO D.DOE+OO O.OOE+OO Y-91 3.60E-05 O.OOE+OO 9.63E-07 O.OOE+OO O.D.DE+qo O.OOE+OO 1.98E-02 Y-92 0.00E+OO O.OOE+OO. O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-93 O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+Op O.OOE+OO O.OOE+OO O.OOE+OO Zr-95 8.26E:o5 2.65E-06 1.l9E-06 O.OOE+OO 4.15E-06 O.OOE+OO 8.39E-03 Zr-97 O.OOE+oo O.OOE+OO 'O.OOE+OO O.OOEtOO o.o*oE+oo O.OOE+OO 0.00E+OO Nb-95 9.88E-07 5.49E-07 , 2.95E-07 O.OOE+OO 5.431::-07 O.OOE+OO 3.33E-03 Mo-99 q.OOE+OO. O.OOE+OO 'O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+oo O.OOE+OO Tc-99m O.OOE+OO 0.00E+OO O.OQE+oo O.OOE+OO 0.0,0E+OO O.OOE+DO D.OOE+OO Page 5of16

For Information Only Attachment H ODCM-QA-008 Revision 18 Page 29 of 86 REMP DOSE FACTORS FOR ADULT AGE GROUP: FRUIT SAMPLE (Page 2 of 2). mrem-kg/pCi-yr NUCLIDE. BONE LIVER r.eoDv*'.** *.. THYROID KIDNEY, LUNG** .: Gl~Lu* Tc-101 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO

O.OOE+OO O.OOE+OO Ru-103 3.34E-05 O.OOE+OO 1.44E-05 O.OOE+OO 1.28E-04 O.OOE+OO 3.9DE-03 Ru-105 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ru-106 1.28E-03 O.OOE+OO 1.62E-04 O.OOE+OO 2.47E-03
O.OOE+OO 8.27E-02 Ag-110m 7.04E-05 6.52E-05 3.87E-05 o;ooE+oo 1.28E-04 O.OOE+OO 2.66E-02 Te-125m 6.SOE-04 2.46E-04 9.11E-05 2.0SE-04 2.77E-03 O.OOE+OO 2.72E-03 Te-127m 2.40E-03 8.59E-04 2.93E-04 6.14E-04 9.76E-03 O.OOE+OO 8.06E-03 Te-127 O.OOE+OO O.OOE+OO O.OOE+OO . O.OOE+OO O.OOE+OO O.OOE+oo O.OOE+OO Te-129m 1.73E-03 6.47E-04 2.74E-04 5.96E-04 7.24E-03 O.OOE+OO 8.73E-ci3
Te-129 4.74E-06 1.78E-06 1.15E-06 3.63E-06 1.99E-05 O.OOE+OO 3.57E-06 Te-131m O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO (foOE+OO Te-131 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Te-132 O.OOE~OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-130 O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-131 1.23E-05 1.75E-05 1.01E-05 5.75E-03 3.01E-05 O.OOE+OO 4.63E-06 1-132 O.OOE+OO O.OOE+OO
O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-133 O.OOE+OO O.OOE+OO O.QOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-134 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-135 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Cs-134 3.06E-02 7.28E-02 5.95E-02 O.OOE+OO 2.36E-02 7.82E-03 1.27E-03 Cs-136 1.44E-04 5.67E-04 4.0SE-04 O.OOE+OO 3.15E-04 4.32E-05 6.44E-05 Cs-137 4.13E-02 5.65E-02 3.70E-02 O.OOE+OO 1.92E-02 6.37E-03 1.09E-03 Cs-138 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO Ba-139 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+Op O.OOE+OO Ba-140 4.09E-04 5.13E-07 2.6SE-05 O.OOE+OO 1.74E-07 2.94E-07 8.41E-04 Ba-141 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+'oo O.OOE+OO Ba-142 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO La-140 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO La-142 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ce-141 1.35E-06 9.16E-07 1.04E-07 O.OOE+OO 4.25E-07 O.OOE+OO 3.50E-03 Ce-143 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ce-144 2.19E-04 9.16E-05 1.18E-05 O.OOE+OO 5.44E-05 O.OOE+OO 7.41 E-02 Pr-143 2.23E-07 8.93E-08 1.10E-08 O.OOE+OO 5.16E-08 O.OOE+OO 9.76E-04 Pr-144 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO Nd-147 7.41E-08 8.56E-08 5.12E-09 O.OOE+OO 5.01E-08 O.OOE+OO 4.11E-04 W-187 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Np-239 O.OOE+OO. O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Page 6of16

For Information Only Attachment H ODCM-QA-008 Revision 18 Page 30 of 86 REMP DOSE FACTORS FOR ADULT AGE GROUP: MEAT SAMPLE (Page 1 of2) mrem-kg/pCi-yr

             , NUCI,:JDE   . :>BONE    ...* LIVER :;*:~ii'.1. T.BODY.          THYRO!o   KIDNEY:'***
                                                                                                   ... . LUNG     Gl~l.JLI' H-3         O.OOE+OO    1.15E-05            1.15E-05          1.15E-05 1.15E-05      1.15E-05 1.15E-05 C-14         3.12E-04    6.25E-05            6,.25E-05         6.25E-05 6.25E-05      6.25E-05 6.25E-05 Na-24        O.OOE+OO    O.OOE+OO            O.OOE+OO          O.OOE+OO O.OOE+OO      O.OOE+OO O.OOE+OO P-32        8.05E-03    5.00E-04            3.11E-04          O.OOE+OO O.OOE+OO      O.OOE+OO 9.05E-04 Cr-51        O.OOE+OO    0.00E+OO            1.77E-07          1.06E-07 3.91E-08      2.35E-07 4.46E-05 Mn-54        O.OOE+OO    4.81E-04            9.18E-05          O.OOE+OO 1.43E-04      O.OOE+OO 1.47E-03 Mn-56        0.00E+OO    0.00E+OO            O.OOE+OO          O.OOE+OO O.OOE+OO      O.OOE+OO O.OOE+OO Fe-55        2.98E-04    2.0SE-04            4.80E-05          O.OOE+OO O.OOE+OO      1.15E-04 1.18E-04 Fe-59        3.50E-04    8.22E-04            3.15E-04          O.OOE+OO O.OOE+OO      2.30E-04 2.74E-03 Co-58        O.OOE+OO    6.74E-05            1.51 E-04         O.OOE+OO O.OOE+OO      O.OOE+OO 1.37E-03 Co-60        O.OOE+OO    2.34E-04            5.15E-04          O.OOE+OO O.OOE+OO      O.OOE+OO 4.39E-03 Ni-63        1.43E-02    9.91E-04            4.79E-04          O.OOE+OO O.OOE+OO      O.OOE+OO 2.07E-04 Ni-65        0.00E+OO    O.OOE+OO            O.OOE+OO          O.OOE+OO O.OOE+OO      O.OOE+OO O.OOE+OO Cu-64        O.OOE+OO    O.OOE+OO            O.OOE+OO          0.00E+OO o:ooe+oo      O.OOE+OO O.OOE+OO Zn-65        5.03E-04    1.60E-03            7.23E-04          0.00E+OO 1.07E-03      O.OOE+OO 1.01E-03 Zn-69        O.OOE+OO    O.OOE+OO            O.OOE+OO          0.00E+OO O.OOE+OO      O.OOE+OO O.OOE+OO Br-83        O.OOE+OO    O.OOE+OO            O.OOE+OD          O.OOE+OO O.OOE+OO      O.OOE+OO O.OOE+OO Br-84        O.OOE+OO    O.OOE+OO            O~OOE+OO          O.OOE+OO O.OOE+OO      O.OOE+OO O.OOE+OO Br-85        O.OOE+OO    O.OOE+OO            O.OOE+OO          O.OOE+OO O.OOE+OO      O.OOE+OO O.OOE+OO Rb-86        O.OOE+OO    1.10E-03            5.14E-04          O.OOE+OO O.OOE+OO      O.OOE+OO 2.18E-04 Rb-88        0.00E+OO    O.OOE+OO            0.00E+OO          O.OOE+OO O.OOE+OO      O.OOE+OO 0.00E+OO Rb-89        O.OOE+OO    O.OOE+OO            O.OOE+OO          O.OOE+OO O.OOE+OO      O.ODE+OO O.ODE+OD Sr-89        2.58E-02   O.OOE+OO             7.39E-04          O.OOE+OO O.OOE+OO      O.OOE+OO 4.13E-03 Sr-90        8.33E-01    O.OOE+OO*           2.04E-01          O.OOE+OO O.OOE+OO      O.OOE+OO 2.41E-02 Sr-91        O.OOE+OO    O.OOE+OO            O.OOE+OO          O.ODE+OO O.OOE+OO      O.OOE+OO O.OOE+OO Sr-92        0.00E+OO    O.OOE+OD            O.OOE+OO          O.OOE+OO O.OOE+OO      O.OOE+OO O.OOE+OO Y-90         O.OOE+OO    O.OOE+OO            O.OOE+OO          0.00E+OO O.OOE+OO      O.OOE+OO O.OOE+OO Y-91m         O.OOE+OO   O.OOE+OO             0.00E+OO          O.OOE+OO 0.00E+OO      O.OOE+OO O.OOE+OO Y-91         1.22E-05    O.OOE+OO            3.27E-07          O.OOE+OO O.OOE+OO      O.OOE+OO 6.74E-03 Y-92         O.OOE+OO    O.OOE+OO            O.ObE+OO          O.OOE+OO O.OOE+OO      O.OOE+OO O.OOE+OO Y-93         O.OOE+OO    O.OOE+001           O.OOE+OO          O.OOE+OO 0.00E+OO      O.OOE+OO O.OOE+OO Zr-95        2.69E-06    8.64E-07            5.85E-07          O.OOE+OO 1.36E-06      O.OOE+OO 2.74E-03 Zr-97        O.OOE+OO   O.OOE+OO             O.OOE+OO          0.00E+OO O.OOE+OO      O.OOE+OO O.OOE+OO Nb-95        4.61E-07    2.56E-07            1.38E-07          O.OOE+OO 2.53E-07      O.OOE+OO 1.56E-03 Mo-99        O.OOE+OO   O.OOE+OO             O.OOE+OO          O.OOE+OO O.OOE+OO      O.OOE+OO O.OOE+OO Tc-99m        O.OOE+OO   O.OOE+OO             O.OOE+OO          O.OOE+OO O.OOE+OO      O.OOE+OO O.OOE+OO Page 7of16

For Information Only Attachment H ODCM-QA-008 Revision 18 Page 31of86 REMP DOSE FACTORS FOR ADULT AGE GROUP: MEAT SAMPLE (Page 2 of2) mrem-kg/pCi-yr

                     '*:'  '* - ;;_!¥'60~E
             ,;i\ NUCLIDE.\:                ..._:~.:
                                            .::*:      LIVERi  ...,,   T.60DY   ~'; TH*~,910,~,, . -)):KID~EY ;:.1 *. _ ,.:LUr\!G
                                                                                                               ..:.* ,1
                                                                                                                                   ',A!   GI-LU-Tc-101          O.OOE+OO          O.OOE+OO         O.OOE+OO      O.OOE+OO         O.OOE+OO             O.OOE+OO      O.OOE+OO Ru-103          1.43E-05          O.OOE+OO         6.16E-06      0.00E+OO          5.46E-05            O.OOE+OO      1.67E-03 Ru-105          0.00E+OO          O.OOE+OO         O.OOE+OO      0.00E+OO         O.OOE+OO             O.OOE+OO      O.OOE+OO Ru-106          2.91E-04          O.OOE+OO          3.69E-05     O.OOE+OO          5.63E-04            O.OOE+OO      1.89E-02 Ag-110m          1.67E-05           1.54E-05        9.15E-06      0.00E+OO          3.03E-05            O.OOE+OO      6.29E-03 Te-125m          2.32E-04          8.41E-05         3.11E-05       6.98E-05         9.44E-04            O.OOE+OO      9.27E-04 Te~127m          6.56E-04          2.34E-04         7.99E-05       1.68E-04        2.66E-03             O.OOE+OO      2.20E-03 Te-127          O.OOE+OO          O.OOE+OO         O.OOE+OO      O.OOE+OO         O.OOE+OO             O.OOE+OO      O.OOE+OO Te-129m          8.37E-04          3.12E-04          1.33E-04      2.88E-04         3.SOE-03            O.OOE+OO      4.22E-03 Te-129          2.29E-06          8.59E-07         5.57E-07       1.75E-06         9.61E-06          . O.OOE+OO      1.73E-06 Te-131m          O.OOE+OO          O.OOE+OO         O.OOE+OO      O.OOE+OO         O.OOE+OO             O.OOE+OO      O.OOE+OO Te-131          O.OOE+OO          O.OOE+OO         O.OOE+OO      O.OOE+OO         O.OOE+OO             O.OOE+OO      0.00E+OO Te-132          O.OOE+OO          O.OOE+OO         O.OOE+OO      O.OOE+OO         O.OOE+OO            -o.OOE+OO      O.OOE+OO 1-130          O.OOE+OO          O.OOE+OO         O.OOE+OO      O.OOE+OO         O.OOE+OO             O.OOE+OO      0.00E+OO 1-131          8.16E-05          1.17E-04         6.69E-05      3.82E-02         2.00E-04             O.OOE+OO      3.0BE-05 1-1~2          O.OOE+OO          O.OOE+OO         O.OOE+OO      O.OOE+OO         O.OOE+OO             O.OOE+OO      O.OOE+OO 1-133          O.OOE+OO          O.OOE+OO         O.OOE+OO      O.OOE+OO         O.OOE+OO             O.OOE+OO      O.OOE+OO 1-134          O.OOE+OO          O.OOE+OO         O.OOE+OO      O.OOE+OO         O.OOE+OO             O.OOE+OO      O.OOE+OO 1-135          O.OOE+OO          O.OOE+OO         O.OOE+OO      O.OOE+OO         O.OOE+OO             O.OOE+OO      O.OOE+OO Cs-134          6.72E-03          1.60E-02         1.31E-02      O.OOE+OO         5.17E-03             1.72E-03      2.80E-04 Cs-136          2.50E~04          9.86E-04         7.10E-04      O.OOE+OO         5.49E-04             7.52E-05      1.12E-04 Cs-137          8.76E-03          1.20E-02         7.84E-03      O.OOE+OO         4.06E-03             1.35E-03      2.32E-04 Cs-138          O.OOE+OO          O.OOE+OO         O.OOE+OO      O.OOE+OO         O.OOE+OO             O.OOE+OO      O.OOE+OO Ba-139          o:ooE+oo          O.OOE+OO         0.00E+OO      0.00E+OO         O.OOE+OO             O.OOE+OO      O.OOE+OO Ba-140          7.55E-04          9.49E-07         4.95E-05      O.OOE+OO         3.23E-07             5.43E-07      1.56E-03 Ba-141          O.OOE+OO          O.OOE+OO         O.OOE+OO      O.OOE+OO         O.OOE+OO             O.OOE+OO      O.OOE+OO Ba-142          O.OOE+OO          O.OOE+OO         O.OOE+OO      0.00E+OO         O.OOE+OO             O.OOE+OO      O.OOE+OO La-140          O.OOE+OO          O.OOE+OO         O.OOE+OO      O.OOE+OO         0.00E+OO             O.OOE+OO      O.OOE+OO La-142          O.OOE+OO          O.OOE+OO         O.OOE+OO      O.OOE+OO         O.OOE+OO             O.OOE+OO      O.OOE+OO Ce-141          6.72E-07          4.55E-07         5.16E-08      O.OOE+OO         2.11 E-07            O.OOE+OO      1.74E-03 Ce-143          O.OOE+OO          O.OOE+OO         O.OOE+OO      O.OOE+OO         O.OOE+OO             O.OOE+OO      O.OOE+OO Ce-144          5.11E-05          2.14E-05         2.74E-06      O.OOE+OO         1.27E-05             O.OOE+OO      1.73E-02 Pr-143          3.64E-07          1.46E-07         1.80E-08      O.OOE+OO         8.43E-08             O.OOE+OO      1.59E-03 Pr-144         Ci.OOE+OO          O.OOE+OO         O.OOE+OO      0.00E+OO         O.OOE+OO             O.OOE+OO      O.OOE+OO Nd-147          1.96E-07          2.26E-07         1.35E-08      O.OOE+OO         1.32E-07             O.OOE+OO      1.09E-03 W-187          0.00E+OO           O.OOE+OO         O.OOE+OO      O.OOE+OO         O.OOE+OO             O.OOE+OO      O;OOE+OO Np-239         O.OOE+OO           O.OOE+OO         O.OOE+OO      O.OOE+OO         O.OOE+OO             O.OOE+OO      O.OOE+OO Page 8of16

For Information Only Attachment H ODCM-QA-008 Revision 18 Page 32 of 86 REMP DOSE FACTORS FOR ADULT AGE GROUP: FISH SAMPLE (Page 1 of 2) mrem-kg/pCi-yr *

               .NUGl::!IDE
                *  ~ **;';~-:-r.;*;*:~
                                       ... j(  BONE :*\... : *: : ;:~!~~:~: ..       .T.BODY'     THY.ROID    i :;:;.:J9DNEY  *       µ,µ~c:;   GI-LU*.

H-3 O.OOE+OO 2.20E-06 2.20E-06 2.20E-06 2.20E-06 2.20E-06 2.20E-06 C-14 5.96E-05 1.19E-05 1.19E-05 1.19E-05 1.19E-05 1.19E-05 1.19E-05 Na-24 1.18E-05 1.18E-05 1.18E-05 1.18E-05

1.18E-05 1.18E-05 1.18E-05 P-32 3.86E-03 2.40E-04 1.49E-04 O.OOE+OO O.OOE+OO O.OOE+OO 4.34E-04 Cr-51 O.OOE+OO O.OOE+OO 5.45E-08 3:26E-08 1.20E-08 7.23E-08 1.37E-05 Mn-54 O.OOE+OO 9.58E-05 '1.83E-05 O.OOE+OO 2.85E-05 . O.OOE+OO 2.93E-04 Mn-56 O.OOE+OO 3.81E-09
6.76E-10 . O.OOE+OO 4.84E-09 O.OOE+OO 1.22E-07 Fe-55 5.77E-05 3.99E-05 : 9:30E-06
O.OOE+OO O.OOE+OO 2.22E-05 2.29E-05 Fe-59 8.97E-05 2.11 E-04 8.08E-05 . O.OOE+OO O.OOE+OO 5.89E-05 7.03E-04 Co-58 O.OOE+OO 1.55E-05 3.47E-05 0.00E+OO O.OOE+OO O.OOE+OO 3.14E-04 Co-60 O.OOE+OO 4.49E-05 9.91E-05 : *o.OOE+OO O.OOE+OO O.OOE+OO 8.44E-04 Ni-63 2.73E-03 1.89E-04 9.16E-05 O.OOE+OO O.OOE+OO Q.OOE+OO 3.95E-05 Ni-65 1.51E-08 1.96E-09 8.93E-10 . .O.OOE+OO O.OOE+OO O.OOE+OO 4.96E-08 Cu-64 O.OOE+OO 4.72E-07 2i22E-07 O.OOE+OO 1.19E-06 O.OOE+OO 4.02E-05 Zn-65 1.01E-04 3.22E-.04 1.46E-04 .o.OOE+OO 2.16E-04 O.OOE+OO 2.03E-04 Zn-69 3.58E-15 6.85E-15 4.76E-16 O.OOE+OO 4.45E-15 0.00E+OO 1.03E-15 Br-83 O.OOE+OO O.OOE+OO 8.01E-10 .O.OOE+OO . O.OOE+OO O.OOE+OO 1.15E-09 Br-84 O.OOE+OO O.OOE+OO 2;72E-20 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-85 O.OOE+OO O.OOE+OO O.OOE+OO * ,O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Rb-86 O.OOE+OO 4.27E-04 1:99E-04 *,0.00E+OO 0.00E+OO O.OOE+OO 8.42E-05 Rb-88 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Rb~89 0.00E+OO O.OOE+OO O.OOE+OO * *.o.ooE+OO O.OOE+OO O.OOE+OO O.OOE+OO Sr-89 6.38E-03 O.OOE+OO 1.83E-04 O.OOE+OO O.OOE+OO O.OOE+OO 1.02E-03 Sr-90 1.59E-01 O.OOE+OO
3.91E-02 O.OOE+OO O.OOE+OO O.OOE+OO 4.60E-03 Sr-91 2.0?E-05 O.OOE+OO 8.35E-07 O.OOE+OO, O.OOE+OO O.OOE+OO 9.84E-05 Sr-92 9.74E-08 O.OOE+OO 4.21E-09 O.OOE+OO O.OOE+OO O.OOE+OO 1.93E-06 Y-90 1.56E-07 O.OOE+OO 4:18E-09 *O.OOE+OO O.OOE+OO O.OOE+OO 1.65E-03 Y-91m 3.78E-18 O.OOE+OO 1.47E-19 O.OOE+OO O.OOE+OO .O.OOE+OO 1.11E-17 Y-91 2.93E-06 O.OOE+OO 7!82E-08 . O.OOE+OO O.OOE+OO O.OOE+OO 1.61E-03 Y-92 1.62E-10 O.OOE+OO 4 . 72E-12 :o.ooE+oo O.OOE+OO O.OOE+OO 2.83E-06 Y-93 1.0BE-08 O.OOE+OO 2J99E-10 O.OOE+OO O.OOE+OO O.OOE+OO 3.44E-04 Zr-95 6.32E-07 2.03E-07 1:37E-07 :O.OOE+OO 3.18E-07 O.OOE+OO 6.42E-04 Zr-97 1.32E-08 2.66E-09 1.22E-09 O.OOE+OO 4.02E-09 O.OOE+OO 8.24E-04 Nb-95 1.28E-07 7.12E-08 3.,83E-08 O.OOE+OO
7.04E-08 O.OOE+OO 4.32E-04 Mo-99 O.OOE+OO 7.04E-05 1.:34E-05 : O.OOE+OO 1.59E-04 O.OOE+OO 1.63E-04 Tc-99m 3.27E-10 9.25E-10 1.18E-08 O.OOE+OO 1.40E-08 4.53E.:1Q 5.47E-07 Page 9of16 j

For Information Only Attachment H ODCM-QA-008 Revision 18 Page 33 of 86 REMP DOSE FACTORS FOR ADULT AGE GROUP:. FISH SAMPLE (Page 2 of 2) mrem-kg/pCi-yr NtlCLIDE. . :E~*!;I!,QJ\1 E * .\*:::LIVER .. ")! l;i~:,t T,BODY *..J :. THYROJ9~~:~: ii KION.E"V;1,::... LUN§,i~;ci, Gl'",~LI*. Tc-101 O.OOE+OO O.OOE+OO o:ooE+oo O.OOE+OO O.OOE+OO *. O.OOE+OO O.ODE+DD Ru-103 3.82E-06 O.OOE+DD 1.64E-06 D.OOE+OO .1A.6E-05 O.OOE+OO 4.46E-04 Hu-105 7.63E-09 O.OOE+OO 3.01E-09

O.ODE+OO 9.86E-08 O.OOE+OO 4.67E-06 Ru-106 5.76E-05 O.OOE+OO 7.29E-06 O;ODE+OO 1.11 E-04 O.OOE+OO . 3.73E-03 Ag-110m 3.35E-06 3.10E-06 1.84E-06 O.OOE+OO 6.09E-06 O.OOE+OD 1.26E-03 Te-125m 5.56E-05 2.01E-05 7.45E-06 1.67E-05 2.26E-04 *. O.OOE+OO 2.22E-04 Te-127m 1.41E-04 5.05E-05 1.72E-05 3.61E-05 5.74E-04
O.OOE+OO 4.74E-04 Te-127 3.90E-07 1.40E-07 . 8.44E-08 2.89E-07 1.59E-06 O.OOE:!-00 3.08E-05 Te-129m 2.37E-04 8.83E-05 3.74E-05
8.13E-05 . 9.87E-04 O.OOE+OO 1.19E-03 Te-129 6.46E-07 2.43E-07 1:57E-07 4.96Ec07 2.72E-06 . O.OOE+DO 4.88E-07 Te-131m 2.D9E-05 1.02E-05 8.50E-06 1.62E-05 1.03E-04 O.OOE+OO 1.01E-03 Te-1.31 2.05E~24 O.DDE+OO O.OOE+OO
1.69E-24 8.98E-24 .D.OOE+OO 0.00E+OO Te-132 4.28E-05 2.77E-05 2.60E-05 3.0BE-05 2.67E-04 O.OOE+OO 1.31E-03 1-130 4.13E-06 1.22E-05 4.81E-06 1.03E-03 1.90E-05 O.OOE+OO 1.05E-05 1-131 8.01E-05 1.15E-04 6.57E-05 3.76E-02 1.97E-04 O.OOE+OO 3.02E-05 1-132 3.08E-09 8.24E-09 2.88E-09 2.88E-07 1.31 E-08 O.OOE+OO 1.55E-09 1-133 1.34E-05 2.33E-05 7.11E-06, 3.43E-03 4.07E-05 O.OOE+OO 2.10E-05 1-134 1.33E-14 3.61E-14 1.29E-14 6.25E-13 5.73E-14 0.00E+OO 3.14E-17 1-135 7.51E-07 1.97E-06 7.26E-07 1.30E-04 3.15E-06 O.OOE+OO 2.22E-06 Cs-134 1.30E-03 3.11E-03 2.54E-03 O.OOE+OO 1.00E-03 3.34E-04 5.43E-05 Cs-136 1.30E-04 5.12E-04 3.69E-04 0.00E;+OO 2.85E-04 3.90E-05 5.82E-05 Cs-137 1.67E-03 2.29E-03 1.50E-03 O.OOE+OO 7.77E-04 2.58E-04 4.43E-05 Cs-138 4.25E-20 8.40E-2D 4.16E-20 D.OOE+OO 6.17E-20 6.10E-21 O.OOE+OO .

Ba-139 1.27E-11 9.03E-15 3.71 E-13 O.OOE+OO 8.44E-15 5.12E-15 2.25E-11 Ba-140 4.04E-04 5.07E-07 2.65E-05 O.OOE+OO 1.72E-07 2.90E-07 8.31E-04 Ba-141 O.OOE+OO O.OOE+OO O.OOE+OO O.ODE+OO O.ODE+OO O.ODE+OO 0.00E+OO Ba-142 D.OOE+OO O.ODE+OO. O.OOE+OO O.ODE+OO O.OOE+OO O.OOE+OO O.OOE+OO La-140 3.47E-08 1.75E-08 4.62E-09 O.OOE+OO O.OOE+OO O.OOE+OO 1.28E-03 La-142 7.85E-14 3.57E-14 8.89E-15 O.OOE+OO O.OOE+OO O.OOE+OO 2.61 E-10 Ce-141 1.92E-07 1.30E-07 1.48E-08 O.OOE+OO 6.04E-08 O.OOE+OO 4.97E-04 Ce-143 2.D9E-D8 1.55E-05 1.71 E-09 O.OOE+OO 6.81E-09 O.OOE+OO 5.78E-04 Ce-144 1.02E-05 4.27E-06 5.49E-07 O.OOE+OO 2.53E-06 0.00E+OO 3.46E-03 Pr-143 1.84E-07 7.36E-08

9.10E-09 0.00E+OD 4.25E-08 O.OOE+OD 8.04E-04 Pr-144 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OD O.OOE+OO Nd-147 , 1.24E-07 1.43E-07 8.58E-09 O.OOE+OO 8.38E-08 O.OOE+OO 6.88E-04 W-187 1.0BE-06 9.00E-07 3.14E-07 O.OOE+OO O.OOE+OO O.OOE+OO 2.95E-04 Np-239 1.86E-08 1.83E-09 1.01E-09 O.OOE+OO 5.71E-09 O.OOE+OO 3.75E-04 Page 10of16

For Information Only Attachment H ODCM-QA-008 Revision 18 Page 34 of 86 REMP DOSE FACTORS FOR ADULT AGE GROUP: DRINKING WATER (Page 1 of 2) mrem-liter/pCi-yr

             ,,, fl!ti:suoEc~:* ,<::~~raoN~~ . ; :: . LIV~R, . *A~ : . t;.BOPY'.\i*; * *...THYRQID

i"' '.{~.: KIDNEY.:. ';Lu.NG,: Gl~~U H-3 O.OOE+OO 7.66E-05 7.66E-05 7.66E-05 7.66E-05 7.66E-05 7.66E-05 C-14 2.0?E-03 4.15E-04 4.15E-04 4.15E-04 4.15E-04 4.15E-04 4.15E-04 Na-24 7.13E-04 7.13E-04 7.13E-04 7.13E-04 7.13E-04 7.13E-04 7.13E-04 P-32 1.38E-01 8.55E-03 5.32E-03 O.OOE+OO O.OOE+OO O.OOE+OO 1.55E-02 Cr-51 O.OOE+OO O.OOE+OO 1.92E-06 1.15E-06 4.22E-07 2.54E-06 4.82E-04 Mn-54 O.OOE+OO 3.33E-03 6.36E-04 0.00E+OO 9.92E-04 O.OOE+OO 1.02E-02 Mn-56 O.OOE+OO 3.33E-06 5.92E-07 O.OOE+OO 4.23E-06 O.OOE+OO 1.06E-04 Fe-55 2.01E-03 1.39E-03 3.23E-04 O.OOE+OO O.OOE+OO. 7.74E-04 7.95E-04 Fe-59 3.14E-03 7:39E-03 2.83E-03 O.OOE+OO 0.00E+OO 2.06E-03 2.46E-02 Co-58 O.OOE+OO 5.41E-04 1.21E-03 O.OOE+OO O.OOE+OO O.OOE+OO 1.10E-02 Co-60 O.OOE+OO 1.56E-03 3.44E-03 O.OOE+OO 0.00E+OO O.OOE+OO 2.93E-02 Ni-63 9.49E-02 6.58E-03 3.18E-03 O.OOE+OO O.OOE+OO O.OOE+OO 1.37E-03 Ni-65 1.42E-05 1:a5E-o6 8.4ZE-07 O.OOE+OO O.OOE+OO O.OOE+OO 4.68E-05 Cu-64 O.OOE+OO 3.16E-05 1.48E-05 O.OOE+OO 7.96E-05 O.OOE+OO 2.69E-03 Zn-65 3.53E-03
1.12E-02 5.0?E-03 O.OOE+OO 7.51E-03 O.OOE+OO 7.0?E-03 Zn-69 9.68E-10
1.85E-09 1.29E-10 O.OOE+OO 1.20E-09 O.OOE+OO 2.78E-10 Br-83 O.OOE+OO 0.00E-t;OO 9.04E-07 O.OOE+OO O.OOE+OO O.OOE+OO 1.30E-06 Br-84 O.OOE+Oo*. O.OOE+OO 6.00E-12 O.OOE+OO. 0.00E+OO O.OOE+OO 4.71E-17 Br-85 O.OOE+OO O.OOE+OO b.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Rb-86 O.OOE+OO 1.51 E-02 7.04E-03 0.00E+OO O.OOE+OO O.OOE+OO 2.98E-03 Rb-88 .O.OOE+OO 3.11 E-17 1.65E-17, O.OOE+OO O,OOE+OO O.OOE+OO O.OOE+OO Rb-89 O.OOE+OO 2.86E-19 2.01E-19 O.OOE+OO O,OOE+OO O.OOE+OO O.OOE+OO Sr-89 2.23E-01 O.OOE+OO 6.41E-03 0.00E+OO O.OOE-i;OO O.OOE+OO 3.58E-02 Sr-90 5.53E+OO o.doE+oo ,1.36E+OO O.OOE+OO, O.OOE+OO O.OOE+OO 1.60E-01 Sr-91 1.72E-03
O.OOE+OO 6.96E-05 O.OOE+OO. O.OOE+OO O.OOE+OO 8.21E-03 Sr-92 7.29E-05 O.OOE+OO 3.15E-06 O.OOE+OO
O.OOE+OO O.OOE+OO 1.44E-03 Y-90 6.17E-06. 0.00E+OO 1.65E-07 O.OOE+OO O.OOE+OO O.OOE+OO 6.54E-02 Y-91m 2.95E-12 O.OOE+OO 1.1,4E-13 O.OOE+OO
O.OOE+OO O.OOE+OO 8.68E-12 Y-91 1.02E-04 O.OOE+OO 2.74E-06 O.OOE-1'.00 O.OOE+OO O.OOE+OO 5.63E-02 Y-92 5.88E-08 O.OOE+OO 1.72E-09 O.OOE+OO O.OOE-1'.00 O.OOE+OO. 1.03E-03 Y-93 8.59E-07 0.00E+OO
2.37E-08 O.OOE+OO O.OOE+OO O.OOE+OO 2.72E-02 Zr-95 2.21E-05 7.0BE-06 4.79E-06
O.OOE+OO 1.11E-05 O.OOE+OO 2.24E-02 Zr-97 7.50E-07 1.51E-07 6.92E-08 O.OOE+OO 2.28E-07 O.OOE+OO 4.69E-02 Nb-95 4.50E-06 2.50E~06 .1.34E-06 o.bOE+oo 2.47E-06 O.OOE+OO 1.52E-02 Mo-99 0.00E+OO 2.77E-03 5.2BE-04 O.OOE+OO 6.28Ec03 O.OOE+OO 6.43E-03 Tc-99m 4.53E-08 1.28E-07 1.63E-06 O.OOE+Od 1.94E-06 6.27E-08 7.57E-05 Page 11 of 16

For Information Only Attachment H ODCM-QA-008 Revision 18 Page 35 of 86 REMP DOSE FACTORS FOR ADULT AGE GROUP: DRINKING WATER (Page 2 of 2) mrem-liter/pCi-yr

             ;' NUCLIDE.*. BONE ;i:c{. ',
                                                ,. Ll~E~ *:::*;:::::: i T.BODY       'THYROID'   KIDNEY       <~t,L!)NG   .Gl-LLI Tc-101       1.0BE-22           1.56E-22                1.53E-21      O.OOE+OO  2.81E-21      7.98E-23 O.OOE+OO Ru-103       1.34E-04         O.OOE+OO                  5.77E-05     O.OOE+OO   5.11E-04      O.OOE+OO  1.56E-02 Ru-105       1.73E-06         O.OOE+OO                  6.82E-07     O.OOE+OO   2.23E-05      O.OOE+OO  1.06E-03 Ru-106       2.01E-03         O.OOE+OO                  2.54E-04     O.OOE+OO   3.87E-03      O.OOE+OO  1.30E-01 Ag-110m       1.17E-04           1.0BE-04                6.41E-05     O.OOE+OO   2.12E-04      O.OOE+OO  4.40E-02 Te-125m       1.94E-03           7.05E-04                2.61E-04      5.85E-04  7.91E-03      O.OOE+OO  7.76E-03' Te-127m      4.93E-03            1.76E-03               6.00E-04       1.26E-03  2.00E-02      O.OOE+OO  1.65E-02 Te-127       3.30E-05

1.18E-05 7.14E-06 2.44E-05 1.34E-04 O.OOE+OO 2.60E-03 Te-129m 8.31E-03 3.10E-03 1.31E-03 2.85E-03 3.47E-02 O.OOE+OO 4.18E-02 Te-129 2.27E-05 8.53E-06 5.53E-06 1.74E-05 9.54E-05 O.OOE+OO 1.71 E-05 Te-131m 9.57E-04 4.68E-04 3.90E-04 7.41E-04 4.74E-03 O.OOE+OO 4.65E-02 Te-131 3.20E-14 1.34E-14 1.01E-14 2.63E-14 1.40E-13 O.OOE+OO 4.53E-15 Te-132 1.65E-03 1.07E-03 1.00E-03 1.18E-03 1.03E-02 O.OOE+OO 5.06E-02 1-130 2.82E-04 8.31E-04 3.28E-04 7.04E-02 1.30E-03 O.OOE+OO 7.15E-04 1-131 2.91E-03 4.16E-03 2.38E-03 1.36E+OO 7.13E-03 O.OOE+OO 1.10E-03 1-132 3.98E-06 1.07E-05 3.73E-06 3.73E-04 1.70E-05 O.OOE+OO 2.00E-06 1-133 6.95E-04 1.21E-03 3.69E-04 1.78E-01 2.11E-03 O.OOE+OO 1.09E-03 1-134 5.97E-09 1.62E-08 5.81E-09 2.81E-07 2.58E-08 O.OOE+OO 1.41E-11 1-135 9.19E-05 2.41E-04 8.88E-05 1.59E-02 3.86E-04 O.OOE+OO 2.72E-04 Cs-134 4.54E-02 1.0BE-01 8.83E-02 O.OOE+OO 3.50E-02 1.16E-02 1.89E-03 Cs-136 4.63E-03 1.83E-02 1.32E-02 O.OOE+OO 1.02E-02 1.39E-03 2.08E-03 Cs-137 5.82E-02 7.96E-02 5.21E-02 O.OOE+OO 2.70E-02 8.98E-03 1.54E-03 Cs-138 7.72E-12 1.52E-11 7.55E-12 O.OOE+OO 1.12E-11 1.11E-12 6.50E-17 Ba-139 1.77E-07 1.26E-10 5.17E-09 O.OOE+OO 1.18E-10 7.14E-11 3.13E-07 Ba-140 1.44E-02 1.81E-05 9.45E-04 O.OOE+OO 6.16E-06 1.04E-05 2.97E-02 Ba-141 ~t97E-17 3.76E-20 1.68E-18 O.OOE+OO 3.50E-20 2.13E-20 O.OOE+OO Ba-142 o:ooE+oo O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO La-140 1.48E-06 7.48E-07 1.98E-07 O.OOE+OO O.OOE+OO O.OOE+OO 5.49E-02 La-142 5.05E-10 2.30E-10 5.72E-11 O.OOE+OO O.OOE+OO o:ooE+oo 1.68E-06 Ce-141 6.76E-06 4.57E-06 5.19E-07 0.00E+OO 2.12E-06 O.OOE+OO 1.75E-02 Ce-143 9.36E-07 6.92E-04 7.66E-08 O.OOE+OO 3.05E-07 O.OOE+OO 2.59E-02 Ce-144 3.56E-04 1.49E-04 1.91E-05 O.OOE+OO 8.82E-05 O.OOE+OO 1.20E-01 Pr-143 6.55E-06 2.63E-06 3.24E-07 O.OOE+OO 1.52E-06 O.OOE+OO 2.87E-02 Pr-144 6.67E-21 2.77E-21 3.39E-22 O.OOE+OO 1.56E-21 O.OOE+OO O.OOE+OO Nd-147 4.45E-06 5.14E-06 3.0BE-07 O.OOE+OO 3.01E-06 O.OOE+OO 2.47E-02 W-187 5.30E-05 4.43E-05 1.55E-05 O.OOE+OO O.OOE+OO O.OOE+OO 1.45E-02 Ni:>-239 7.50E-07 7.37E-08 4.06E-08 O.OOE+OO 2.30E-07 O.OOE+OO 1.51E-02 Page 12of16

For Information Only Attachment H ODCM-QA-008 Revision 18 Page 36 of 86 REMP DOSE FACTORS FOR ADULT AGE GROUP:. INHALATION - QUARTERLY SAMPLING (Page 1 of 2) mrem-m 3/pCi-yr H-3 O.OOE+OO 1.27E-03 . . 1.27E-03 1.27E-03 1.27E-03 1.27E-03 1.27E-03 C-14 1.82E-02 3.41 E-03 3.41 E-03 3.41 E-03 3.41 E~03 3.41E-03 3.41E-03 Na-24 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO P-32 1.21 E+01 7.05E-01 4.58E-01 O.OOE+OO O.OOE+OO O.OOE+OO 7.90E-01 Cr-51 0.00E+OO O.OOE+OO 3.13E-04 1.86E-04 7.14E-05 4.51E-02 1.04E-02 Mn-54 O.OOE+OO 4.38E-02 6.97E-03 O.OOE+OO 1.09E~02 1.55E+OO 8.56E-02 Mn-56 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Fe-55 2.54E-02 1.75E-02 4.07E-03 O.OOE+OO 0.00E+OO 7.44E-02 6.23E-03 Fe-59 2.39E-02 5.64E-02 2.14E-02 O.OOE+OO O.OOE+OO 2.06E+OO 3.82E-01 Co-58 O.OOE+OO 2.48E-03 3:24E-03 O.OOE+OO O.OOE+OO 1.45E+OO 1.66E-01 Co-60 O.OOE+OO 1.17E-02 1.50E-02 O.OOE+OO O.OOE+OO 6.07E+OO 2.90E-01 Ni-63 4.32E-01 3.15E-02 .1.45E-02 O.OOE+OO O.OOE+OO 1.79E-01 1.34E-02 Ni-65 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Cu-64 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Zn-65 3.69E-02 1.17E-01 5.30E-02 O.OOE+OO 7.85E-02 9.83E-01 6.08E-02 Zn-69 O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO 0.00E+OO Br-83 o:ooE+oo O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-84 O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-85 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Rb-86 O.OOE+OO 7.36E-01 3.21 E-01 0.00E+OO O.OOE+OO O.OOE+OO 9.06E-02 Rb-88 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Rb-89 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Sr-89 5.68E-01 O.OOE+OO 1.63E-02 O.OOE+OO O.OOE+OO 2.62E+OO 6.54E-01 Sr-90 9.95E+01 O.OOE+OO 6.11E+OO 0.00E+OO O.OOE+OO

9.63E+OO 7.24E-01 Sr-91 O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO Sr-92 O.OOE+OO O.OOE+OO O.OdE+OCi O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-90 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-91ni O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-91 7.94E-01 O.OOE+OO 2.13E-02 O.OOE+OO O.OOE+OO 2.93E+OO 6.61E-01 Y-92 O.OOE+OO O.OOE+OO 0.00E+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-93 O:OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Zr-95 1.76E-01 5.ME-02 3.82E-02 O.OOE+OO 8.88E-02 2.90E+OO 2.46E-01 Zr-97 O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Nb-95 3.47E-02 1.93E-02 1.04E-02 . O.OOE+OO 1.91E-02
1.24E+OO 2.56E-01 Mo-99 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Tc-99m O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO Page 13of16

For Information Only Attachment H ODCM-QA-008 Revision 18 Page 37 of 86 REMP DOSE FACTORS FOR ADULT AGE GROUP: INHALATION - QUARTERLY SAMPLING (Page 2 of 2) 3 mrem-m /pCi-yr

                                                                                           ~..-

NUCLIQ~'.i '! .;~;;~:;;J;.IVER. I, "Gl*LLI:

             !.. *:                  BONE                      T.BODY
                                                                    ..*.*. /
                                                                               . lt!YROJD*         KIDNl$Y         LUNG Tc-101       O.OOE+OO     O.OOE+OO       O.OOE+OO            O.OOE+OO        0.00E+OO       0.00E+OO     O.OOE+OO Ru-103        3.41E-03    O.OOE+OO        1.47E-03           O.OOE+OO         1.30E-02      1.13E+OO     2.47E-01 Ru-105       O.OOE+OO     O.OOE+OO        0.00E+OO           O.OOE+OO        O.OOE+OO       0.00E+OO     O.OOE+OO Ru-106        7.53E-02    O.OOE+oo        9.50E-03           O.OOE+OO         1.46E-01      1.02E+01     9.94E-01 Ag-110m        1.23E-02     1.13E-02       6.75E-03           O.OOE+OO         2.23E-02     5.26E+OO      3.43E-01 Te-125m        5.89E-03     2.73E-03       8.06E-04           1.81E-03         2.14E-02      5.41E-01     1.22E-01 Te-127m        1.69E-02     7.71E-03       2.10E-03           4.39E-03         6.12E-02     1.28E+OO      2.00E-01 Te-127       O.OOE+OO     O.OOE+OO       O.OOE+OO            O.OOE+OO        O.OOE+OO      O.OOE+OO     O.OOE+OO Te-129m        2.50E-02     1.20E-02       4.06E-03           8.82E-03        9.37E-02      2.97E+OO      9.82E-01 Te-129        1.28E-07     6.13E-08       3.18E-OB           9.99E-08        4.80E-07       4.96E-03     4.02E-04 Te-131m       O.OOE+OO     O.OOE+OO       O.OOE+OO            O.OOE+OO        O.OOE+OO      O.OOE+OO     O.OOE+OO Te-131       O.OOE+OO     O.OOE+OO       O.OOE+OO            O.OOE+OO        O.OOE+OO      O.OOE+OO     O.OOE+OO Te-132       O.OOE+OO     O.OOE+OO       O.OOE+OO            O.OOE+OO        O.QOE+OO      O.OOE+OO     O.OOE+OO 1-130       O.OOE+OO     O.OOE+OO       O.OOE+OO           .O.OOE+OO        O.OOE+OO      O.OOE+OO     O.OOE+OO 1-131       1.29E+OO     1.83E+OO       1.05E+OO           6.09E+02         3.13E+OO      0.00E+OO     3.21 E-01 1-132       O.OOE+OO     O.OOE+OO       O.OOE+OO            O.OOE+OO        O.OOE+OO      O.OOE+OO     O.OOE+OO 1-133       O.OOE+OO     O.OOE+OO       O.OOE+OO            O.OOE+OO        O.OOE+OO      O.OOE+OO     O.OOE+OO 1-134       O.OOE+OO     O.OOE+OO       O.OOE+OO            O.OOE+OO        O.OOE+OO      O.OOE+OO     O.OOE+OO 1-135       O.OOE+OO     O.OOE+oo       O.OOE+OO            O.OOE+OO        O.OOE+OO      O.OOE+OO     O.OOE+OO Cs-134       3.89E-01     8.84E-01       7.59E-01            O.OOE+OO        3.00E-01       1.02E-01    1.08E-02 Cs-136       4.32E-01     1.62E+OO       1.22E+OO           O.OOE+OO       . 9.47E-01      1.33E-01     1.29E-01 Cs-137       4.80E-01     6.23Ec01       4.29E-01           O.OOE+OO         2.23E-01      7.54E-02     8.42E-03 Cs-138       O.OOE+OO     0.00.E+OO      O.OOE+OO           O.OOE+OO         O.OOE+OO      O.OOE+OO     O.OOE+OO Ba-139       O.OOE+OO     O.OOE+OO       O.OOE+OO           O.OOE+OO         O.OOE+OO      O.OOE+OO     O.OOE+OO Ba-140       4.63E-01     5.81E-04       3.04E-02           O.OOE+OO         1.98E-04      1.51 E+01    2.59E+OO Ba-141       O.OOE+OO     O.OOE+OO       O.OOE+OO           O.OOE+OO         O.OOE+OO      O.OOE+OO     O.OOE+OO Ba-142       O.OOE+OO     0.00E+OO       O.OOE+OO           O.OOE+OO         O.OOE+OO     *o.ooE+oo     O.OOE+OO La-140       O.OOE+OO     O.OOE+OO       0.00E+OO           O.OOE+OO         O.OOE+OO      O.OOE+OO     O.OOE+OO La-142       O.OOE+OO     O.OOE+OO       O.OOE+OO           O.OOE+OO         O.OOE+OO      O.OOE+OO     O.OOE+OO Ce-141       5.27E-02     3.58E-02       4.04E-03           O.OOE+OO         1.66E-02      9.57E-01     3.18E-01 Ce-143       O.OOE+OO     O.OOE+OO       O.OOE+OO           O.OOE+OO         O.OOE+OO      0.00E+OO     O.OOE+OO Ce-144       3.84E+OO     1.60E+OO       2.06E-01           O.OOE+OO         9.48E-01      8.69E+OO     9.12E-01 Pr-143       9.64E-02     3.86E-02       4.78E-03           O.OOE+OO         2.22E-02      2.89E+OO     2.06E+OO Pr-144       O.OOE+OO     O.OOE+OO       O.OOE+OO           O.OOE+OO         O.OOE+OO      O.OOE+OO     O.OOE+OO Nd-147       9.39E-02     1.09E-01       6.50E-03           0.00E+OO         6.34E-02      3.93E+OO     3.08E+OO W-187        O.OOE+OO    O.OOE+OO        O.OOE+OO          .O.OOE+OO         O.OOE+OO      O.OOE+OO     O.OOE+OO Np-239       O.OOE+OO     O.OOE+OO       0.00E+OO           O.OOE+OO         O.OOE+OO      0.00E+OO     O.OOE+OO Page 14of16

For Information Only Attachment H ODCM-QA-008 Revision 18 Page 38 of 86 REMP DOSE FACTORS FOR ADULT AGE GROUP: INHALATION - WEEKLY SAMPLING (Page 1 of2) mrem-m 3/pCi-yr

             *.*.. NUCLIDE  [~;,. ,1BON,~'> ..          LIVER: * . * ; ..**.*~, T.BODY          .'/fHYRoj0   :KIDNE~~j/
                                                                                                                         ,~

tUNG .:,::' .. '*.'* . ... Gl-LLI

                                            . ,:1; ..                                 ' .* ,/ .                             . ,., ,.*~~.:*l H-3        O.OOE+OO             1.26E-03                  1.26E-03           1.26E-03   1.26E-03         1.26E-03                     1.26E-03 C-14        1.82E-02             3.41E-03                 3.41E-03            3.41E-03  3.41E-03          3.41E-03                     3.41E-03 Na-24       O.OOE+OO             O.OOE+OO                 O.OOE+OO            O.OOE+OO  O.OOE+OO         O.OOE+OO                      O.OOE+OO P-32        1.56E+oo*            9.14E-02                 5.93E-02            0.00E+OO  O.OOE+OO         O.OOE+OO                      1.02E-01 Cr-51       O.OOE+OO             O.OOE+OO                 1.09E-04            6.50E-05  2.49E-05          1.57E-02                     3.62E-03 Mn-54       O.OOE+OO             3.99E-02                 6.35E-03            O.OOE+OO  9.92E-03         1.41E+OO                      7.BOE-02 Mn-56       O.OOE+OO             O.OOE+OO                 O.OOE+OO            O.OOE+OO  O.OOE+OO         O.OOE+OO                      O.OOE+OO Fe-55       2.46E-02             1.70E-02                 3.95E-03            O.OOE+OO  O.OOE+OO          7.23E-02                     6.05E-03 Fe-59       1.24E-02             2.93E-02                  1.11 E-02          0.00E+OO  O.OOE+OO         1.07E+OO                      1.99E-01 Co-58       O.OOE+OO             1.64E-03                 2.14E-03            O.OOE+OO  O.OOE+OO          9.60E-01                     1.10E-01 Co-60       O.OOE+OO             1.15E-02                 1.48E-02            O.OOE+OO  O.OOE+OO         5.98E+oo                      2.85E-01 Ni-63       4.32E-01             3.14E-02                 1.45E-02            O.OOE+OO  O.OOE+OO          1.78E-01                     1.34E-02 Ni-65       O.OOE+OO             O.OOE+OO                 O.OOE+OO            O.OOE+OO  O.OOE+OO         0.00E+OO                      O.OOE+OO Cu-64       0.00E+OO             O.OOE+OO                 O.OOE+OO            O.OOE+OO  O.OOE+OO         O.OOE+OO                      O.OOE+OO Zn-65       3.27E-02             1.04E-01                 4.70E-02            O.OOE+OO  6.96E-02          8.73E-01                     5.40E-02 Zn-69       O.OOE+OO             O.OOE+OO                 O.OOE+OO            O.OOE+OO  0.00E+OO         O.OOE+OO                      O.OOE+OO Br-83       O.OOE+OO             O.OOE+OO                 O.OOE+OO            O.OOE+OO  O.OOE+OO         O.OOE+OO                      O.OOE+OO Br-84       0.00E+OO             O.OOE+OO                 O.OOE+OO            O.OOE+OO  O.OOE+OO

O.OOE+OO O.OOE+OO Br-85 O.OOE+OO O.OOE+OO O.OOE+Oo' O.OOE+OO O.OOE+OO ' O.OOE+OO O.OOE+OO Rb-86 O.OOE+OO 1.54E-01 6.71E-02. O.OOE+OO O.OOE+OO O.OOE+OO 1.90E-02 Rb-88 O.OOE+OO O.OOE+OO O.OOE+OO. O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Rb-89 O.OOE+OO O.OOE+OO
O.OOE+OO O.OOE+oo O.OOE+OO O.OOE+OO O.OOE+OO Sr-89 3.19E-01 O.OOE+OO 9.15E-03: O.OOE+OO O:OOE+OO 1.47E+OO 3.67E-01 Sr-90 9.92E+01 O.OOE+OO 6.1DE+oo* O.OOE;roo O.OOE+OO 9.60E+OO 7.22E-01 Sr-91 o.ooE+oo O.OOE+OO O.OOE+oo* O.OOE+OO O.OOE+do O.OOE+OO O.OOE+OO Sr-92 O.OOE+OO O.OOE+OQ . O.OOE+OO' O.OOE+oo O.OOE+OO O.OOE+OO O.OOE+OO Y-90 O.OOE+OO O.OOE+OO
O.OOE+oo: O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-91m O.OOE+OO O.OOE+OO O.OOE+OO' O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y~91 ~.82E-01 O.OOE+OO 1.29E-02
O.OOE+OO O.OOE+OO 1.78E+OO 4.01E-01 Y-92 O~OOE+OO . O.OOE+OO O.OOE+OO O.OOE+oo O.OOE+OO ' O.OOE+OO O.OOE+OO Y-93 O.OOE+OO O.OOE+Oq O.OOE+OO, O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Zr-95 1.11E-01 3.57E-02 2.42E-02 O.OOE+OO 5.63E-02 1.84E+OO 1.56E-01 Zr-97 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Nb-95 1.51E-02 8.38E-03 4.51E-03 O.OOE+OO 8.29E-03 5.41E-01 1.11 E-01 Mb-99 O.OOE+OO
0.00E+OO *O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Tc-99m O.OOE+OO O.OOE+OO o.ooE:oo O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Page 15of16

For Information Only Attachment H ODCM-QA-008 Revision 18 Page 39 of 86 REMP DOSE FACTORS FOR ADULT AGE GROUP: INHALATION - WEEKLY SAMPLING (Page 2 of 2) mrem-m 3/pCi-yr

.,

r*fliJ:S:L1oeF ***aoNE *

iJW,eR :-r: .* *1.eoov IWif:tfl~Roip\' . . ' YJkiDNEY: *LONG:* Gl-LLl Tc-101 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO o.ooE+oo* O.OOE+OO O.OOE+OO Ru-103 1.63E-03 O.OOE+OO 7.00E-04 O.OOE+OO 6.20E-03 5.37E-01 1.17E-01 Ru-105 O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO o:ooE+oo O.OOE+OO Ru-106 6.96E-02 O.OOE+OO 8.78E-03 .O.OOE+OO 1.34E-01 9.42E+OO 9.18E-01 Ag-110m 1:09E-02 1.01E-02 6.00E-03 O.OOE+OO 1.99E-02 4.68E+oo 3.05E-01 Te-125m 3.56E-03 1.65E-03 4.87E-04 1.09E-03 1.29E-02 3.27E-01 7.37E-02 Te-127m 1.29E-02 5.90E-03 1.60E-03 3.36E-03 4.68E-02 9.82E-01 1.53E-01 Te-127 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Te~129m 1.05E-02 5.02E-03 1.70E-03 3.70E-03 3.93E-02 1.25E+OO 4.12E-01 Te-129 5.35E-OB 2.57E-08 1.33E-OB 4.19E-08 2.01E-01 2.08E-03 1.69E-04 Te-131m O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO ,O.OOE+OO Te-131 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Te-132 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-130 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO 1-131 2.52E-02 3.58E-02 2.05E-02 1.19E+01 6.13E-02. O.OOE+OO 6.28E-03 1-132 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-133 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-134 O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-135 O.OOE+OO O.OOE+OO O.OOE+OO . O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+,00 Cs"134 3.74E-01 8.51.E-01 7.30E-01 O.OOE+OO 2.88E-01 9.79E-02 1.04E-02 Cs-136 4.69E-02 1.76E-01 1.33E-01 O.OOE+OO 1.03E-01 1.44E-02 1.40E-02 Cs~137 4.79E-01 6.21E-01 4.2BE-01 O.OOE+OO 2.22E-01 7.52E-02 8.40E-03 Cs-138 O.OOE+OO . O.OOE+OO O.OOE+oo* o:ooE+oo O.OOE+OO
O.OOE+OO O.OOE+OO Ba-139 O.OOE+OO O.OOE+OO O.OOE+OO 0.00!=+00 O.OOE+OO O.OOE+OO O.OOE+OO Ba-140 4.72E-02 5.93E-05 3.10E-03 O.OOE+O,O 2.02E-05 1.54E+OO 2.64E-01 Ba-141 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+DO Ba-142 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.0.0E+OO La-140 O.OOE+OO 0.00E+OO 0.00E+OO O~OOE+OO 0.00,E+OO O.OOE+OO ,O.OOE+OO La-142 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ce-141 2.15E-02 . 1.46E-02 1.65E-03 O.OOE+OO 6.75E-03 3.90E-01 1.29E-01 Ce-143 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO *O.OOE+OO O.OOE+OO O.OOE+OO Ce-144 3.46E+OO 1.44E+OO 1.86E-01 O.OOE+OO 8.55E-01 7.84E+OO 8.23E-01 Pr-143 1.12E-02 4.49E-03 5.55E-04 O.OOE+OO 2.58E-03 3.36E-01 2.39E-o'1 Pr-144 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO Nd-147 6.58E-03 7.60E-03 4.55E-04 O.OOE+OO 4.44E-03 2.75E-01 . 2.16E-01 W-187 O.OOE+OO O.OOE+OO O.OOE+OO . O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO Np-239 O.OOE+OO O.OOE+OO o.ooE+oo O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Page 16of16

For Information Only Attachment I ODCM-QA-008 Revision 18 Page 40 of 86 REMP DOSE FACTORS FOR TEEN AGE GROUP: MILK (Page 1 of 2) mrem-liter/pCi-yr

             ;;~~:NUCLIDE.~:, *.; :;,8QN~" *:'~; "
                                                   ,jjvEB     .. .....i.

L l;*f;301:l,~:. .~THYROID:,-

                                                                                         ,..       . ... *:1.,;: . . ,:;{:KIDfi.!JiY :

j * 'jLUN.~; GRLl;f*

H-3 O.OOE+OO 4.24E-05 4.24E-05 4.24E-05 4.24E-05 4.24E-05 4.24E-05 C-14 1.62E-03 3.25E-04 3.25E-04 3.25E-04 3.25E-04 3.25E-04 3.25E-04 Na-24 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO P-32 1.00E-01 6.21E-03 3.88E-03 0.00E+OO O.OOE+OO O.OOE+OO 8.42E-03 Cr-51 O.OOE+OO O.OOE+OO 1.37E-06 7.61E-07 3.00E-07 1.96E-06 2.30E-04 Mn-54 O.OOE+OO 2.35E-03 4.66E-04 O.OOE+OO 7.01E-04 O.OOE+OO 4.82E-03 Mn-56 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Fe-55 1.51 E-03 1.07E-03 2.50E-04 O.OOE+OO O.OOE+OO 6.79E-04 4.63E-04 Fe-59 2.28E-03 5.31E-03 2.05E-03 O.OOE+OO O.OOE+OO 1.68E-03 1.26E-02 Co-58 O.OOE+OO 3.?1E-04 8.79E-04 O.OOE+OO O.OOE+OO O.OOE+OO 5.26E-03 Co-60 O.OOE+OO 1.12E-63 2.53E-03 0.00E+OO O.OOE+OO O.OOE+OO 1.46E-02 Ni-63 7.08E-02 5.00E-03 2.40E-03 O.OOE+OO O.OOE+OO O.OOE+OO 7.96E-04 Ni-65 O.OOE+OO O,OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Cu-64 O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO Zn-65 2.29E-03 7.95E-03 3.71E-03 O.OOE+OO 5.09E-03 O.OOE+OO 3.37E-03 Zn-69 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-83 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-84 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO Br-85 O.OOE+OO O.OOE+OO O.OOE+OO O.. OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Rb-86 O.OOE+OO 1.11 E-02 5.20E-03 O.OOE+OO O.OOE+OO O.OOE+OO 1.64E-03 Rb-88 O.OOE+OO O.OOE+OO O.OOE+OO

O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Rb-89 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Sr-89 1.71 E-01 O.OOE+OO 4.90E-03 O.OOE+OO O.OOE+OO O.OOE+OO 2.04E-02 Sr-90 3.32E+OO O.OOE+OO 8.20E-0.1 O.OOE+OO O.OOE+OO O.OOE+OO 9.32E-02 Sr-91 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Sr-92 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-90 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-91m O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O:OOE+OO O.OOE+OO 0.00E+OO Y-91 7.85E-05 O.OOE+OO 2.11 E-06 O.OOE+OO O.OOE+OO O.OOE+OO 3.22E-02 Y-92 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-93 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+oo O.OOE+OO O.OOE+OO O.OOE+OO Zr-95 1.61E-05 5.09E-06 3.50E-06 O.OOE+OO 7.48E-06 O.OOE+OO 1.17E-02 Zr-97 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Nb-95 3.16E-06 1.75E-06 9.65E-07 O.OOE+OO 1.70E-06 O.OOE+OO 7.SOE-03 Mo-99 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O:OOE+OO O.OOE+OO 0.00E+OO Tc"99m O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+oo O.OOE+OO O.OOE+OO O.OOE+OO Page 1 of 16

For Information Only Attachment I

                                                                                   *ODCM-QA-008 Revision 18 Page 41of86 REMP DOSE FACTORS FOR TEEN AGE GROUP: MILK (Page 2 of 2) mrem-liter/pCi-yr Tc-101    D.DDE+OO     O.OOE+OO    O.OOE+OO      O.OOE+OO   O.OOE+OO        O.OOE+OO  O.OOE+OO Ru-103     9.85E-05    O.OOE+OO    4.21 E-05     O.OOE+OO    3.47E-04       O.OOE+OO   8.23E-03 Ru-105    O.OOE+OO     O.OOE+OO    O.OOE+OO      0.00E+OO   O.OOE+OO        O.OOE+OO  O.OOE+OO Ru-106     1.56E-03    O.OOE+OO     1.97E-04     O.OOE+OO    3.01E-03       O.OOE+OO   7.49E-02 Ag-110m     8.15E-05     7.72E-05    4.69E-05

O.OOE+OO 1.47E-04 O.OOE+OO 2.17E-02 Te-125m 1.50E-03 5.39E-04 2.00E-04 4.18E-04 . O.OOE+OO O.OOE+OO 4.41 E-03 Te-127m 3.82E-03 1.35E-03 4.54E-04 9.0BE-04 1.55E-02
O.OOE+OO 9.52E-03 Te-127 D.OOE+OO O.OOE+OO D.OOE+OO O.OOE+OD O.OOE+OO O.OOE+OO O.OOE+OO Te-129m 6.26.E-03 2.32E-03 9.90E-04 2.02E-03 2.62E-02 O.OOE+OO 2.35E-02 Te-129 1.72E-05 6.41E-06 4.18E-06 1.Z3E-05 7.22E-05 0.QOE+OD 9.40E-05 Te-131m O.OOE+OO O.OOE+OO D.OOE+OO O.OOE+OD O.DOE+OO O.OOE+OO O.OOE+OO Te-131 O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Te-132 O.ODE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+Ob O.OOE+OO O.OOE+OO 1-130 O.ODE+DO O:OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO o~ooE:+oo O.OOE+OO 1-131 1.97E-03 2.76E-03 1.48E-03 8.05E-01. 4.75E-03 O.OOE+OO 5.45E-04 1-132 O.ODE+DO O.OOE+OO O.OOE+OO O.OOE+OO D.OOE+OO O.OOE+OO O.OOE+OO 1-133 o;ooE+oo 6.00E+OO 0.0DE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-134 O.DDE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-135 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO .

Cs-134 3.34E-02 7.87E-02 3.65E-02 O.OOE+OO 2.50E-02 9.54E-03 9.78E-04 Cs-136 3.09E-03 1.22E-02 8.17E-03 O.OOE+OO 6.62E-03 1.04E-03 9.79E-04 Cs-137 4.48E-02 5.96E-02 2.0BE-02 O.OOE+OO 2.03E-b2 7.88E-03 8.48E-04 Cs-138 O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO D.OOE+OO O.OOE+OO Ba-139 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O,OOE+OO O.OOE+OO Ba-140 1.02E-Oi 1.25E-06 6.57E-04 O.OOE+OO 4.24E-06 8.40E-06 1.57E-02 Ba-141 D.OOE+OO O.OOE+OO O.OOE+OO O.DOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ba-142 D.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO La-140 O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO La-142 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.DOE+OO O.OOE+OO Ce-141 5.10E-06 3.40E-06 3.91E-07 O.OOE+OO 1.60E-06 O.DOE+OO 9.74E-03 Ce-143 O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ce-144 2.i7E-04 1.15E-04 1.49E-05 O.OOE+OO 6.85E-05 O.OOE+OO 6.97E-02 Pr-143 4.73E-06 1.89E-06 2.35E-07 O.OOE+OO 1.10E-06 O.OOE+OO 1.56E-02 Pr-144 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Nd-147 3.31E-06

3.60E-06 2.15E-07 O.OOE+OO 2.11 E-06 O.OOE+OO 1.30E-02 W-187 O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Np-239
O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Page 2of16

For Information Only Attachment I ODCM-QA-008 Revision 18 Page 42 of 86 REMP DOSE FACTORS FOR TEEN AGE GROUP: LEAFY VEG. SAMPLES (Page 1 of 2) mrem-kg/pCi-yr JNµS:~10§~\j BONE : LIVER ci T.BO~Y. T:f!YROID.: ' KIDN~¥ c,LUNG .GI-LU** H-3 O.OOE+OO 4.45E-06 4.4SE-06 4.45E-06 4.45E-06 4.45E-06 4.45E-06 C-14 1.71E-04 *3.41E-05 3.41E-05 3.41E-05 3.41E-05 3.41E-05 3.41E-05 Na-24 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO P-32 1.10E-02 6.84F04 4.28E-04 O.OOE+OO O.OOE+OO 0.00E+OO 9.28E-04 Cr-51 O.OOE+OO O.OOE+OO 1.47E-07 8.19E-08 3.23E-08 2.11E-07 2.4BE-05 Mn-54 O.OOE+OO 2.47E-04 4.90E-05 0.00E+OO 7.38E-05 O.OOE+OO 5.0?E-04 Mn-56 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO Fe-55 1.59E-04 1.12E-04 2.62E-05 O.OOE+OO O.OOE+OO 7.13E-05 4.87E-05 Fe-59 2.43E-04 5.67E-04 2.19E-04 0.00E+OO O.OOE+OO 1.79E-04 1.34E-03 Co-58 O.OOE+OO 4.04E-05 9.32E-05 0.00E+OO O.OOE+OO O.OOE+OO 5.57E-04 Co-60 O.OOE+OO 1.18E-04 2.66E-04 O.OOE+OO O.OOE+OO O.OOE+OO 1.54E-03 Ni-63 7.43E-03 5.25E-04 .2.52E-04 O.OOE+OO . O.OOE+OO O.OOE+OO 8.36E-05 Ni-65 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO ,0.00E+OO 0.00E+OO Cu-64 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO Zn-65 2.41E-04 8.38E-04 3.91E-04 O.OOE+OO 5.36E-04 O.OOE+OO 3.55E-04 Zn-69 0.00E+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO Br-83 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-84 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-85 0.00E+OO 0.00E+OO

0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Rb-86 0.00E+OO 1.21E-03 5,67E-04 O.OOE+OO O.OOE+OO O.OOE+OO 1.78E-04 Rb-88 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Rb-89 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO 0.00E+OO Sr-89 1.82E-02 O.OOE+OO 5.22E-04 O.OOE+OO O.OOE+OO O.OOE+OO 2.17E-03 Sr-90 3.49E-01 O.OOEi-00 8.61E-02 O.OOE+OO 0.00E+OO O.OOE+OO 9.79E-03 Sr-91 O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Sr-92 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-90 O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-91m O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OQE+OO 0.00E+OO Y-91 8.34E-06 O.OOE+OO 2.24E-07 O.OOE+OO O.OOE+OO O.OOE+OO 3.42E-03 Y-92 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-93 O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Zr-95 1.71E-06 5.40E-07 3.71E-07 O.OOE+OO 7.94E-07 O.OOE+OO 1.25E-03 Zr-97 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO 0.00E+OO Nb-95 3.38E-07 1.88E-07 1.03E-07 O.OOE+OO 1.82E-07 O.OOE+OO 8.03E-04 Mo-99 O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO 0.00E+OO 0.00E+OO Tc-99m O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO Page 3of16

For Information Only Attachment I ODCM-QA-008 Revision 18 Page43 of 86 REMP DOSE FACTORS FOR TEEN AGE GROUP: LEAFY VEG. SAMPLES (Page 2 of 2) mrem-kg/pCi~yr Tc-101 O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO 0.00E+OO . O:QOE+OO O.OOE+OO

Ru-103 1.0SE-05 O.OOE+OO 4.50E-OB O.OOE+OO
3.71E-05 O.OOE+OO 8.79E-04.

Ru-105 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ru-106 1.64E-04 O.OOE+OO 2.0?E-05 0.00E+OO 3.17E-04 O.OOE+OO 7.88E-03 Ag-110m 8.59E-06 8.13E-06 4.94E-06 O.OOE+OO 1.55E-05 O.OOE+OO 2.28E-03 Te-.125m 1.59E-04 5.73E-05 2.12E-05 4.44E-os* O.OOE+OO O.OOE+OO 4.69E-04 Te-127m 4.04E-04 1.43E-04

4.80E-05 9.60E-05 1.64E-03 O.OOE+OO 1.01E-03 Te-127 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO Te-129m 6.71E-04 2.49E-04 1.06E-04 2.16E-04 2.81E-03 O.OOE+OO 2.52E-03 Te-129 1.84E-06 6.87E-07 4.48E-07 1.32E-06 7.73E-06 O.OOE+OO 1.01E-05 Te-131m O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO Te-131 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Te-132 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-130 O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO o:ooE+oo O.OOE+OO O.OOE+OO 1-131 2.25E-04 3.16E-04 1.?0E-04 9.21E-02 5.43E-04 O.OOE+OO 6.24E-05 1-132 *o.OOE+OO O.OOE+OO O.ODE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-133 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-134 O.OOE+OO O.OOE+OO O..OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-135 O.OOE+OO O.OOE+OO O.OOE+OO 0.0.0E+OO O.OOE+OO O.OOE+OO O.OOE+OO Cs-134 3.51E-03 8.27E-03 3~84E-03 O.OOE+OO 2.63E-03 1.00E-03 1.03E-04 Cs-136 '3.42E-04 1.35E-03 9.04E-04 O.OOE+OO '7.33E-04 1.16E-04 1.0SE-04 Cs-137 4.70E-03 6.26E-03 2.18E-03 O.OOE+OO 2.13E-03 B.27E-04 8.90E-05 Cs-138 O.OOE+OO O.OOE+OO O.OOE+OO . O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO Ba-139 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO Ba-140 1.13E-03 1.38E-07 7.28E-05 O.OOE+OO 4.69E-07. 9.31E-07 1.74E-03 Ba-141 O.OOE+OO 0.00E+OO 0.00.E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ba-142 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO La-140 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO La-142 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ce-141 5.47E-07 3.65E-07 4.19E-08 O.OOE+OO 1.72E-07 O.OOE+OO 1.04E-03 Ce-143 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ce-144 2.92E-05 1.21E-05 1.57E-06 O.OOE+OO 7.21E-06 O.OOE+OO 7.33E-03 Pr-143 5.23!';-07 2.09E-07 2.60E-OB O.OOE+OO 1.21E-07 O.OOE+OO 1.72E-03 Pr-144 O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Nd-147 3.70E-07 4.02E-07 2.41E-OB O.OOE+OO 2.36E-07 O.OOE+OO 1.45E-03 W-187 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Np-239 O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Page 4of16

For Information Only Attachment I ODCM-QA-008 Revision 18 Page 44 of 86 REMP DOSE FACTORS FOR TEEN AGE GROUP: FRUIT SAMPLES (Page 1 of 2) mrem-kg/pf::i-yr i'),NUCl,JDE;;*

BONE' }~l:i~lv~~~rk:~ . . *. Ti!:JODi:'.~* 1*: .1'.HY~~fp ' . ~ _;:)~=!~;i!i pN£;¥. -~h1~;;j :: *. . LUNG :
rr~;:i~:~1.1;.i_p~~4;:, '

H-3 O.OOE+OO 6.62E-05 6.62E-05 6.62E-05 '6.62E-05 6.62E-05 6.62E-05 C-14 2.56E-03 5.12E-04 5.12E-04 5.12E-04 5.12E-04 5.12E-04 5.12E-04 Na-24 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO P-32

9.47E-03 5.87E-04 3.67E-04 O.OOE+OO O.OOE+OO O.OOE+OO 7.96E-04 Cr-51 O.OOE+OO O.OOE+OO 5.05E-07 2.81E-07 1.11 E-07 '

7.22E-07 8.49E-05 Mn-54 O.OOE+OO 3.25E-03 6.45E-04 O.OOE+OO 9.71E-04 Q.OOE+OO 6.67E-03 Mn-56 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Fe-55 2.28E-03 1.62E-03 3.77E-04 O.OOE+OO .O.OOE+OO 1.03E-03 7.01E-04 Fe-59 1.46E-03 3AOE-03 1.31E-03 O.OOE+OO O.OOE+OO 1.07E-03 8.04E-03 Co-58 O.OOE+OO 3.40E-04 7.84E-04

O.OOE+OO O.OOE+OO O.OOE+OO 4.69E-03 Co-60 O.OOE+OO 1.73E-03 3.90E-03 O.OOE+OO 0.00E+OO O.OOE+OO 2.26E-02 Ni-63 1.11 E-01 7.87E-03 3.78E-03 O.OOE+OO O.OOE+OO O.OOE+OO 1.25E-03 Ni-65 O.OOE+OO 0.00E+OO O.OOE+OO . ' O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Cu-64 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO

                                                                                                                         '                                 1 Zn-65         3.06E-03                     1.06E-02            4.96E-03              O.OOE+OO            6.80E-03                      0.00E+OO         4.50E-03 Zn-69         O.OOE+OO                    O.OOE+OO             O.OOE+OO              O.OOE+OO            O.OOE+OO                      O.OOE+OO         O.OOE+OO Br-83         O.OQE+OO             '*

O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-84 O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO Br-85 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+Od O.OOE+OO O.OOE+OO O.OOE+OO Rb-86 I O.OOE+OO 2.02E-03 . 9.50E-04 0.00E+OO O.OOE+OO O.OOE+OO 2.99E-04 Rb-88 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO Rb-89 O.OOE+OO O.OOE+OO ' O~OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Sr-89 1.22E-01 O.OOE+OO 3.49E-03 O.OOE+OO O.OOE+OO O.OOE+OO 1.45E-02 Sr-90 5.21E+OO O.OOE+OO 1.29E+OO O,OOE+OO O.OOE+\)O O.OOE+OO 1.46E-01 Sr-91 O.OOE+OO O.OOE+OO O.ODE+OO O.OOE+OO O.OOE+OO 'O.OOE+OO O.OOE+OO Sr-92 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-90 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO., O.OOE+OO O.OOE+OO O.OOE+OO Y-91m O.OOE+OO O.OOE+OO : O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-91 6.22E-05 O.OOE+OO . 1.67E-06 O.OOE+OO O.OOE+OO o.ooE+oo 2.55E-02 Y-92 0.00E+OO O.OOE+OO 'O.OOE+OO O.OOE+OO O.OOE+\)O O.OOE+OO O.OOE+OO Y-93 O.OOE+oo O.OOE+oo O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Zr-95 1.36E-05 4.28E-06 2.94E-06 O,OOE+OO 6.28E-06 0.00E+OO 9.87E-03 Zr-97 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Nb-95 1.58E-06 8.77E"07 4.83E-07 O.OOE+OO 8.50E-07 p.OOE+OO 3.75E-03 Mo-99 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Tc-99m O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO p.OOE+OO O.OOE+OO Page 5of16 I L_ I

For Information Only Attachment I ODCM-QA-'008 Revision 18 Page 45 of 86 REMP DOSE FACTORS FOR TEEN AGE GROUP: FRUIT SAMPLES (Page 2 of 2) mrem-kg/pCi-yr NUCLIDE BONE LIVER T.BODY THYROID KIDNEY LUNG Gl-LLI Tc-101

O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ru-103 5.58E-05 O.OOE+OO 2.39E-05 O.OOE+OO 1.97E-o4. O.OOE+OO 4.66E-03 Ru-105 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ru-106 2.21E-03 O.OOE+OO 2.78E-04 O.OOE+OO 4.25E-03 O.OOE+OO 1.06E-01 Ag-110m 1.09E-04 1.03E-04 6:29E-05 O.OOE+OO 1.97E-04 O.OOE+OO 2.91E-02 Te-125m 1.18E-03 4.24E-04 1.57E-04 3.29E-04 O.OOE+OO O.OOE+OO 3.48E-03 Te-127m 4.16E-03 1.48E-03 4.95E-04 9.89E-04 1.69E-02 0.00E+OO 1.04E-02 Te-127 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Te-129m 2.98E-03 1.11E-03 4.71E-04 9.61E-04 1.25E-02 O.OOE+OO 1.12E-02 Te-129 8.19E-06 3.05E-06 1.99E-06 5.85E-OB 3.44E-05 O.OOE+OO 4.48.E-05 Te-131m O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Te-131 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Te-132 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-130 O.OOE+OO 0.00E+OO O.OOE+OO O.CiOE+OO Q.OOE+OO O.OOE+OO O.OOE+OO 1-131 2.09E-05 2.93E-05 .1.57E-05 8.54E-03 5.04E-05 O.OOE+OO 5.79E-06 1-132 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-133 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-134 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-135 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Cs-134 4.99E-02 1.17E-01 5.45E-02 O.OOE+OO 3.73E-02 1.42E-02 1.46E-03 Cs-136 2.30E-04 9.03E-04 6.07E-04 O.OOE+OO 4.92E-04 7.75E-05 7.27E-05 Cs-137 7.03E-02 9.35E-02 3.2BE-02 O.OOE+OO 3.18E-02 1.24E-02 1.33E-03 Cs-138 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ba-139 O.OOE+OO Q.OOE+OO O.OOE+OO o.cioE+OO O.OOE+OO O.OOE+OO O.OOE+oo Ba-140 6.92E-04 8.48E-08 4.46E-05 O.OOE+OO 2.88E-07 5.71E-07 1.07E-03 Ba-141 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.ODE+OO Ba-142 O.OOE+OO O.OOE+OO O.OOE+OD D.OOE+OO O.ODE+OO O.OOE+OO O.OOE+OD La-140 O.OOE+Ob 0.00E+OO 0.00E+DO O.OOE+OO O.DOE+OO O.OOE+OO O.OOE+OD La-142 O.OOE+OO O.OOE+OO O.OOE+DO O.ODE+OO O.DOE+Oo* O.OOE+OD D.OOE+OD Ce-141 2.33E-06 1.56E-06 1.79E-07 O.OOE;+OO 7.32E-07 O.OOE+OO 4.45E-03 Ce-143 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO Ce-144 3.79E-04 1.57E-04 2.04E-05 O.OOE+OO 9.36E-05 O.OOE+OO 9.52E-02 Pr-143 3.84E-07 1.53E-07 1.91E-08 O.OOE+OO 8.92E-08 O.OOE+OO 1.26E-03 Pr-144 O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OD Nd-147 1.34E-07 1.46E-07 8.72E-09 O.OOE+OO 8.55E-08 O.OOE+OO 5.25E-04 W-187 O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O:OOE+OO Np-239 O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O:OOE+OO O.OOE+OO Page 6of16

For Information Only Attachment I ODCM-QA-008 Revision 18 Page 46 of 86 REMP DOSE FACTORS FOR TEEN AGE GROUP: MEAT SAMPLES (Page 1 of 2) mrem-kg/pCi-yr H-3 O.OOE+OO 6.87E-06 6.87E-06 6.87E-06 6.87E-06 6.87E-06 6.87E-06 C-14 2.64E-04 . 5.28E~05 5.28E-05 5.28E-05 5.28E-05 5.28E-05 5.28E-05 Na-24 O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO P-32 6.80E-03 4.21E-04 2.64E-04 O.OOE+OO 0.00E+OO O.OOE+OO 5.72E-04 Cr-51 O.OOE+OO O.OOE+Op 1.42E-07 7.88E-08 3.11E-08 2.03E-07 2.38E-05 Mn-54 O.OOE+OO 3.67E-04 7.28E-05 O.OOE+OO 1.09E-04 0.00E+OO 7.52E-04 Mn-56 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Fe-55 2.42E-04 1.72E-04 4.01E-05 O.OOE+OO O.OOE+OO 1.09E-04 7.43E-05 Fe-59 2.80E-04 6.53E-04 2.52E-04 0.00E+OO 0.00E+OO 2.06E-04 1.54E-03 Co-58 O.OOE+OO 5.19E-05 1.20E-04 O.OOE+OO O.OOE+OO O.OOE+OO 7.16E-04 Co-60 O.OOE+OO 1.81E-04 4.08E-04 O.OOE+OO O.OOE+OO O.OOE+OO 2.36E-03 Ni-63 1.15E-02 8.12E-04 3.90E-04 O.OOE+OO O.OOE+OO O.OOE+OO 1.29E-04 Ni-65 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Cu-64 O.OOE+OO O.OOE+OO O.OOE+DO O.OOE+OO O.OOE+OO O.OOE+OO O.ODE+OO Zn-65 3.54E-04 1.23E-03 5.73E-04 O.OOE+OO 7.86E-04 O.OOE+OO 5.20E-04 Zn-69 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-83 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-84 O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO 0.00E+OO 0.00E+OO . 0.00E+OO Br-85 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO Rb-86 O.OOE+OO 9.21E-04 4.33E~04 O.OOE+OO O.OOE+OO O.OOE+OO 1.36E-04 Rb-88 O.OOE+OO O.OOE+OO 0.00E+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO Rb-89 O.OOE+OO O.OOE+OO D.OOE+OO O.ODE+OO O.OOE+OO O.OOE+OO O.OOE+OO Sr-89 2.17E-02 O.OOE+OO 6.23E-04 O.OOE+OO O.OOE+OO O.OOE+OO 2.59E-03 Sr-90 5.39E-01 O.OOE+OO 1.33E-01 0.00E+OO 0.00E+OO O.OOE+OO 1.51E-02 Sr-91 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO Sr-92 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-90 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-91m O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-91 1.03E-05 O.OOE+OO 2.76E-07 0.00E+OO O.OOE+OO .O.OOE+OO 4.23E-03 Y-92 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-93 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Zr-95 2.16E-06 6.80E-07: 4.68E-07 O.OOE+oo 1.00E-06 O.OOE+OO 1.57E-03 Zr-97 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+oo O.OOE+OO O.OOE+OO O.OOE+OO Nb-95 3.60E-07 2.00E-07 1.10E-07 O.OOE+OO 1.93E-07 O.OOE+OO 8.54E-04 Mo-99 O.OOE+OO O.OOE+OO O.OOE+OO O.ciOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Tc-99m O.OOE+OO O.DOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Page 7of16

For Information Only Attachment I ODCM-QA-008 Revision 18 Page 47 of 86 REMP DOSE FACTORS FOR TEEN AGE GROUP: MEAT SAMPLES (Page 2 of 2) mrem-kg/pCi-yr Tc-101 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ru-103 1.17E-05 O.OOE+OO 4.98E-06 O.OOE+OO

4.11E-05 O.OOE+OO 9.73E-04 Ru-105 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ru-106 2.45E-04 O.OOE+OO 3.09E-05 O.OOE+OO 4.73E-04 O.OOE+OO 1.18E-02 Ag-110m 1.26E-05 1.19E-05 7.26E-06 0.00E+OO 2.2BE-05 O.OOE+OO 3.35E-03 Te-125m 1.96E-04 7.06E-05 2.62E-05 5.48E-05 O.OOE+OO O.OOE+OO 5.78E-04 Te-127m 5.53E-04 1.96E-04 6.58E-05 1.32E-04 2.24E-03 0.00E+OO 1.38E-03 Te-127 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO Te-129m 7.01E-04 2.60E-04 1.11 E-04 2.93E-03 O.OOE+OO 2.63E-03 Te-129 . 1.93E-06 7.19E-07 4.69E-07 1.38E-06 8.09E-06 O.OOE+OO 1.05E-05 Te-131m O.OOE+OO O.OOE+OO . O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Te-131 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Te-132 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-130, :O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OQE+OO 0.00E+OO O.OOE+OO 1-131 6.78E-05 9.49E-05 5.10E-05 2.77E-02 1.63E-04 0.00E+OO 1.BBE-05 1-132 O.OOE+OO O.OOE+OO O.OOE+OO 0.00E:rOO O.OOE+OO 0.00E+OO O.OOE+OO 1-133 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO
O.OOE+OO O.OOE+OO O.OOE+OO 1-134 O.OOE+OO O.OOE+OO O.OOE+OO o:ooE+oo O.OOE+OO O.OOE+OO O.OOE+OO 1-135 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Cs-134 5.34E-03 1.26E-02 5.83E-03 O.OOE+OO 3.99E-03 1.53E-03 1.56E-04 Cs-136 1.95E-04 7.66E-04 5.15E-04 O.OOE+OO 4.17E-04 6.57E-05 6.17E-05 Cs-137 7.27E-03 9.67E-03 3.37E-03 0.00E+OO 3.29E-03 1.28E-03 1.38E-04 Cs-138 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ba-139 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+,00 . O.OOE+OO O.OOE+OO O.OOE+OO Ba-140 6.24E-04 7.65E-08 4.02E-Q5 O.OOE+OO 2.59E-07 5.14E-07 9.63E-04 Ba-141 0.QOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ba-142 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO La-140 O.OOE+OO
O.OOE+OO O.OOE+OO O.OQE+OO
O.OOE+OO 0.00E+OO O.OOE+OO La-142 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ce-141 5.64E-07 3.77E-07 4.33E-08 O.OOE+OO 1.77E-07 O.OOE+OO 1.08E-03 Ce-143 0.00E+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ce-144 4.31E-05 1.78E-05 2.32E-06 O.OOE+OO 1.06E-05 O.OOE+OO 1,08E-02 Pr-143 3.06E-07 1.22E-07 1.52E.08 O.OOE+OO 7.11 E-08 O.OOE+OO 1.01E-03 Pr-144 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Nd-147 1.73E-07 1.88E-07 1.12E-08 O.OOE+OO 1.10E-07 O.OOE+OO 6.77E-04 W-187 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Np-239 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Page 8of16

For Information Only Attachment I ODCM-QA-008 Revision 18 Page 48 of 86 REMP DOSE FACTORS FOR TEEN AGE GROUP: FISH SAMPLES (Page 1 of 2) mrem-kg/pCi-yr

                     ~'*~*l*
              *. _,,Nl!JCLIDE
                     ~;--
                                   fk>NE        :li!VER      T.BODY         TH'.'.(ROID       KIDNEY         *.LUNG     Gl'-LLI H-3      O.OOE+OO     1.70E-06      1.70E-06        1.70E-06        1.70E-06        1.70E-06 1.70E-06 C-14      6.50E-05     1.30E-05      1.30E-05        1.30E-05        1.30E-05        1.30E-05 1.30E-05 Na-24       1.21E-05

1.21E-05 1.21E-05 1.21E-05 1.21E-05 ** 1.21E-05 1.21 E-05 P-32 4.21E-03 2.61E-04 1.63E-04 O.OOE+OO O.OOE+OO O.OOE+OO 3.54E-04 Cr-51 O.OOE+OO , O.OOE+OO 5.62E-08 3_12E-08 1.23E-08 8.02E-08 9.44E-06 Mn-54 O.OOE+OO 9.42E-05 1.87E-05 *O.OOE+OO 2.81E-05 O.OOE+OO 1.93E-04 Mn-56 O.OOE+OO 3.99E-09 7.09E-10 *O.OOE+OO 5.05E-09 O.OOE+OO 2.63E-07 Fe-55 6.04E-05 4.28E-05 9.99E-06 *0.00E+OO O.OOE+OO 2.72E-05 1.85E-05 Fe-59 9.25E-05 2.16E-04 8.33E-05 O.OOE+OO O.OOE+OO 6.81E-05 5.10E-04 Co-58 O.OOE+OO 1.54E-05 3.55E-05 O.OOE+OO 'O.OOE+OO O.OOE+OO 2.12E-04 Co-60 O.OOE+OO 4.49E-05 1.01 E-04 *b.OOE+OO O.OOE+OO O.OOE+OO 5.85E-04 Ni-63 2.83E-03 2.00E-04 9.60E-05 O.OOE+OO O.OOE+OO O.OOE,rOO 3.18E-05 Ni-65 1.63E-08 2.08E-09 9.48E-10 O~OOE+OO O.OOE+OO O.OOE+OO 1.13E-07 Cu-64 O.OOE+OO 4.97E-07 2.34E-07 O.OOE+OO 1.26E-06 O.OOE+OO 3.85E-05 Zn-65 9.19E-05 3_19E-04 1.49E-04 O.OOE+OO " 2.04E-04 O.OOE+OO 1.35E-04 Zn-69 3.90E-15 7.42E-15 5.19E-16 ,O.OOE+OO ' 4.85E-15 O.OOE+OO 1.37E-14 Br-83 O.OOE+OO O.OOE+OO 8.71 E-10 O.OOE+OO , O.OOE+OO 0.00E+OO O.OOE+OO Br-84 O.OOE+OO O.OOE+OO 2.87E-20 O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO Br-85 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Rb-86 O.OOE+OO 4.59E-04 2.16E-04 0.00E+OO 0.00E+OO 0.00E+OO 6.80E-05

                     . Rb-88        O.OOE+OO    O.OOE+OO      O.OOE+OO       ,O.OOE+OO         O.OOE+OO       O.OOE+OO  O.OOE+OO Rb-89        O.OOE+OO    O.OOE+OO      O.OOE+OO        b.OOE+OO         O.O'oE+OO      O.OOE+OO  O.OOE+OO Sr-89       6.94E-03    O.OOE+OO       1.99E~04       O.OOE+OO         O.OOE+OO       O.OOE+OO  8.27E-04 Sr-90       1.33E-01    O.OOE+OO      3.28E-02        O.OOE+OO         O.OOE+OO        O.OOE+OO 3.73E-03 Sr-91       2.24E-05    O:OOE+OO      8.92E-07        O.OOE+OO         O.OOE+OO       O.OOE+OO  1.02E-04 Sr-92       1.05E-07    O.OOE+OO      4.49E-09        O.OOE+OO      , O.OOE+OO        O.dOE+OO  2.68E+04 Y-90       1.69E-07    O.OOE+OO      4.55E-09        O.OOE+OO         O.OOE+OO       O.OOE+OO  1.39E-03 Y-91m         4.09E-18    O.OOE+OO      1.56E-19        O.OOE+OO         O.OOE+OO       O.OOE+OO  1.93E-16 Y-91       3.18E-06    O.OOE+OO      8.52E-08        p.OOE+OO         O.OOE+OO       O.OOE+OO  1.30E-03 I

Y-92 1.76E-10 o.ooE+oo 5;10E-12 O.OOE+OO O.OOE+OO O.OOE+OO 4.83E-06 Y-93 1.18E-08 O.OOE+OO 3.24E-10 . p.OdE+OO 'O.OOE+OO O.OOE+OO 3.61E-04 Zr-95 6.52E-07 2.06E-07 1.41 E-07 b.DqE+OO 3.02E-07 0.00E+OO 4.75E-04 Zr-97 1.42E-08 2~8DE-09 : 1.29E-09 o.oqE+OO 4.25E-09 O.OOE+OO 7.59E-04 Nb-95 1.29E-07 7.15E-08 3.94E-08 o.oqE+OO 6.93E-08 O.OOE+OO 3.06E-04 Mo-99 O.OOE+OO 7.50E-05 1.43E-05 : Q.DqE+OO 1.'72E-04 O.OOE+OO 1.34E-04 Tc-99m 3.35E-10 9.35E-10 1.21 E~oa 0.00E+OO 1.39E-08 5.19E-10 6.14E-07 Page 9of16

For Information Only Attachment I ODCM-QA-008 Revision 18 Page 49 of 86 REMP DOSE FACTORS FOR TEEN AGE GROUP: FISH SAMPLES (Page 2 of 2) mrem-kg/pCi-yr N~,GLIDE. ...:,JfQNE :

                                             '{J4!YER    '. *; :.~    T.. aoov ,;; ., THYROID'[* : ...  '

KIDNEY:* . LU~~~:F\ .. Gl*t.LI Tc-101 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+:OO O.OOE+OO 0.00E+OO Ru-103 4.01E-06 O.OOE+OO 1.71 E-06 O.OOE+OO 1.41 E-05 O.OOE+OO 3.35E-04 Ru-105 8.23E-09 O.OOE+OO 3.19E-09 O.OOE+OO 1.04E-.07 O.OOE+OO 6.64E-06 Ru-106 6.26E-05 0.00E+OO 7.89E-06 O.OOE+OO 1.21E-04 O.OOE+OO 3.00E-03 Ag-110m 3.27E-06 3.10E~06 1.88E-06 O.OOE+OO 5.90E-06 O.OOE+OO 8.70E-04 Te-125m. 6.06E-05 2.18E-05 8.09E-06 1.69E-05 O.OOE+OO .O.OOE+OO 1.79E-04 Te-127m 1.54E-04 5.45E-05 1.83E-05 3.66E-05 6.23E-04 O.OOE+OO 3.83E-04 Te-127 4.27E-07 1.51E-07 9.18E-08 2.94E-07 1.73E-06 O.OOE+OO. 3.29E-05 Te-129m 2.55E-04 9.48E-05 4.04E-05 8.24E-05 1.07E-03 O.OOE+OO 9.59E-04 Te-129 7.02E-07 2.62E-07

1.71 E-07 5.02E-07 2.9~E-06 O.OOE+OO 3.84E-06

               . Te-131m         2.24E-05       1.0BE-05             8.97E-06         1.62E-05            1.12E-04         O.OOE+OO       8.63E-04 Te-131         2.21E-24      O.OOE+OO              O.OOE+OO         ~ .71 E-24          9.68E-24         0.00E+OO       O.OOE+OO Te-132         4.51E-05       2.86E-05             2.69E-05         3.01E~05            2.74E-04         O.OOE+OO       9.05E-04 1-130         4.29E-06       1.24E-05             4.96E-06         1.01E-03            1.91E-05         O.OOE+OO       9.54E-06 1-131         8.59E-05       1.20E-04            .6.46E-05         3.51E-02            2.07E-04         O.OOE+'oo      2.38E-05 1-132         3.23E-09       8.44E-09             3.03E-09         2.84E-07            1.33E-08         O.OOE+OO       3.68E-09 1-133         1.45E-05       2.45E-05             7.48E-06         3.42E-03            4.30E-05         O.OOE+OO       1.86E-05 1-134         1.39E-14       3.69E-14             1.33E-14         6.15E-13            5.82E-14

O.OOE+OO 4.86E-16 1-135 7.88E-07 2.03E-06 7.52E-07 1.30E-04 3.20E-06 0.00E+OO 2.25E-06 Cs-fa4 1.34E-03 3.15E-03 1.46E-03 0.00E+OO 1.00E-03 . 3.82E-04 3.92E-05

                . Cs-136         1.30E-04       5.13E-04             3.45E-04         O.OOE+OO            2.79E-04         4.40E-05       4.13E-05 Cs-137         1.79E-03       2.38E-03             8.30E-04         O.OOE+OO            8.11E-04         3.15E-04       3.39E-05 Cs-138         4.56E-20       8.75E-20             4.37E-20         O.OOE+OO            6.46E-20         7.52E-21       3.97E-23 Ba-139         1.38E-11       9.74E-15             4.03E-13         O.OOE+OO            9.18E-15         6.71E-15       1.23E-10 Ba-140        4.30E-04        5.27E-08             2.77E~05         O.OOE+OO            1.79E-07         3.55E-07       6.64E-04 Ba-141        O.OOE+OO       O.OOE+OO              O.OOE+OO         O.OOE+OO            O.OOE+OO         O.OOE+OO       O.OOE+OO Ba-142        O.OOE+OO       O.OOE+OO              O.OOE+OO         O.OOE+OO            O.OOE+OO         O.OOE+OO       O.OOE+OO La-140         3.68E-08       1.81E-08             4.81E-09         O.OOE+OO            O.OOE+OO         O.OOE+OO       1.04E-03 La-142         8.36E-14       3.71E-14             9.25E-15         O.OOE+OO           O.OOE+OO          O.OOE+OO       1.13E-09 Ce-141         2.08E-07       1.39E-07             1.60E-08         O.OOE+OO            6.55E-08         O.OOE+OO       3.98E-04 Ce-143        2.27E-08        1.65E-05             1.85E-09         O.OOE+OO         . 7.41 E-09         O.OOE+OO       4.97E-04 Ce-144         1.11E-05       4.60E-06             5.97E-07         O.OOE+OO            2.75E-06         O.OOE+OO       2.79E-03 Pr-143         1.99E-07      7.95E-08              9.91E-09         O.OOE+OO            4.62E-08         O.OOE+OO       6.55E-04 Pr-144        O.OOE+OO       O.OOE+OO             O.OOE+OO          O.OOE+OO           0.00E+OO          O.OOE+OO       O.OOE+OO Nd-147         1.41 E-07      1.53E~07             9.18E-09         O.OOE+OO            9.00E-08         O.OOE+OO       5.53E-04 W-187          1.16E-06       9.47E-07             3.32E-07         O.OOE+OO           O.OOE+OO          O.OOE+OO       2.56E-04 Np-239        2.10E-08        1.98E-09             1.10E-09         O.OOE+OO            6.21E-09         O.OOE+OO       3.18E-04 Page 10of16

For Information Only Attachment I ODCM-QA-008 Revision 18 Page 50 of 86 REMP DOSE FACTORS FOR TEEN AGE_GROUP: DRINKING WATER (Page 1 of 2) mrem-liter/pCi-yr LUNG* H-3 O.OOE+OO 5.41E-05 5.41E-05 5.41E-05 5.41E-05 5.41E-05 5.41E-05 C-14 2.07E-03 4.14E-04 4.14E-04 .4.14E-04 4.14E-04 4.14E-04 4.14E-04 Na-24 6.74E-04 6.74E-04 6.74E-04 6.74E-04 6.74E-04 6.74E-04 6.74E-04 P-32 1.37E-01 8.51E-03 5.33E-03 O.OOE+OO O.OOE+OO O.OOE+OO 1.15E-02 Cr-51 0.00E+OO O.OOE+OO 1.81E-06 1.01E-06 3.97E-07 2.59E-06 3.05E-04 Mn-54 O.OOE+OO 3.01E-03 5.96E-04 O.OOE+OO 8.97E-04 O:OOE+OO 6.16E-03 Mn-56 O.OOE+OO 3.20E-06 5.69E-07 O.OOE+OO 4.05E-06 O.OOE+OO 2.11E-04 Fe-55 1.93E-03 . 1.37E-03 3.19E-04 O.OOE+OO O.OOE+OO 8.67E-04 5.91E-04 Fe-59 2.97E-03 6.93E-03 2.68E-03 . O.OOE+OO O.OOE+OO 2.19E-03 1.64E-02 Co-58 O.OOE+OO 4.93E-04 1.14E-03 O.OOE+OO O.OOE+OO O.OOE+OO 6.80E-03 Co-60 O.OOE+OO 1.43E-03 3.23E-03 O.OOE+OO 0.00E+OO O.OOE+OO 1.87E-02 Ni-63 9.03E-02 6.37E-03 3.06E-03 O.OOE+OO O.OOE+OO O.OOE+OO 1.01E-03 Ni-65 1.41 E-05 1.80E-06 8.20E-07 O.OOE+OO O.OOE+OO O.OOE+OO 9.76E-05 Cu-64 O.OOE+OO 3.05E-05 1.43E-b5 O.OOE+OO 7.71E-05 O.OOE+OO 2.36E-03 Zn-65 2.93E-03 1.02E-02 4.75E-03 O.OOE+OO 6.52E-03 O.OOE+OO 4.31E-03 Zn-69 '9.65E-10 1.84E-09 1.29E-10 O.OOE+oo 1.20E-09 O.OOE+OO 3.39E-09 Br-83 O.OOE+OO O.OOE+OQ 9.02E-07 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-84 O.OOE+OO O.OOE+OO 5.81E-12 . O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-85 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+QO O.OOE+OO O.OOE+OO Rb-86 O.OOE+OO 1.49E-02 ' 7.01E-03 O.OOE+OO O.OOE+OO O.OOE+OQ 2.21E-03 Rb-88 O.OOE+OO 3.06E-17 1.63E-17 O.OOE+OO O.OOE+OO O.OOE+OO 2.62E-24 Rb-89 O.OOE+OO 2.74E-19 1.94E-19 O.OOE+OO O.OOE+QO O.OOE+OO O.OOE+OO Sr-89 2.23E-01 O.OOE+OO ' 6.38E-03 O.OOE+OO O.OOE+OO O.OOE+OO 2.65E-02 Sr-90 4.23E+OO 0.00E+OO 1.05E+OO O.OOE+OO Q.OOE+OO O.OOE+OO 1.19E-01 Sr-91 1.71 E-03 O.OOE+OO ' 6.82E-05 O.OOE+OO O.OOE+OO O.OOE+OO 7.78E-03 Sr-92 7.23E-05 O.OOE+OO 3.08E-06 O.OOE+OO O.OOE+OO . O.OOE+OO 1.84E-03 Y-90 6.14E-06 O.OOE+OO 1.65E-07 O.OOE+OO O.OOE+OO O.OOE+OO 5.06E-02 Y-91m 2.93E-~2 O.OOE+OO 1.12E-13 O.OOE+OO O.OOE+OO O.OOE+OO. 1.38E-10 Y-91 1.02E-04 . O.OOE+OO 2.73E-06 O.OOE+OO O.OOE+OO O.OOE+OO 4.18E-02 Y-92 5.89E-08 O.OOE+OO 1.70E-09 Q.OOE+OO O.OOE+OO O.OOE+OO 1.62E-03 Y-93 8.57E-07 O.OOE+OO 2.35E-a8 O.OOE+OO O.OOE+OO O.OOE+OO 2.62E-02 Zr-95 2.09E~05 6.59E-06*. 4.53E-06 0.00E+OO 9.69E-06 0.00E+OO 1.52E-02 Zr-97 7.39E-07 1.46E-07.: 6.73E-D8 O.OOE+OO 2.22E-07 O.OOE+OO 3.96E-02 Nb~95 4.15E-06 2.30E-06 .1.27E-06. O.OOE+OO 2.23E-06 O.OOE+OO 9.85E-03 Mo-99 O.OOE+OO 2.71E-03 5.17E-04, O.OOE+OO 6.20E-03 O.OOE+OO 4.86E-03 Tc-99m 4.25E-08 1.19E-07 1.54E-06 O:OOE+OO 1:77E-06 6.58E-08 7.79E-05 Page 11 of 16

For Information Only Attachment I ODCM-QA-008 Revision 18 Page 51of86 REMP DOSE FACTORS FOR TEEN AGE GROUP: DRINKING WATER (Page 2 of 2) mrem-liter/pCi-yr

             ,,; ' NUCLIDE' *. sqfit     LIVER   -*T.BODY. THVR@.ID. KlQNEY
                                                                                             ~*
                                                                                                /*LUNG        Gl-LL.1**

Tc-101 1.07E-22 1.53E-22 1.SOE-21 O.OOE+OO 2.76E-21 9.30E-23 O.OOE+OO Ru-103 1.29E-04 O.OOE+OO 5.51E-05 O.OOE+OO 4.54E-04 O.OOE+OO 1.08E-02 Ru-105 1.71E-06 O.OOE+OO 6.63E-07 O.OOE+OO 2.15E-05 O.OOE+OO 1.38E-03 Ru-106 2.00E-03 O.OOE+OO 2.52E-04 O.OOE+OO 3.85E-03 O.OOE+OO 9.58E-02 Ag-110m 1.04E-04 *9.88E-05 6.01E-05 0.00E+OO 1.88E-04 O.OOE+OO 2.78E-02 Te-125m 1.94E-03 7.00E-04 2.BOE-04 5A2E-04 O.OOE+OO O.OOE+OO* 5.73E-03 Te-127m 4.92E-03 1.74E-03 5.85E-04 1.17E-03 1:99E-02 .0.00E+OO 1.23E-02 Te-127 3.31E-05 1.17E-05 7.12E-06 2.28E-05 1.34E-04 O.OOE+OO 2.56E-03 Te-129m

8.23E-03 3.05E-03 1.30E-03 2*.66E:o3 3.44E-02 O.OOE+OO 3.09E-02 Te-129 2.26E-05 8.43E-06 5.50E-06 1.62E-05 9.49E-05 O.OOE+OO 1.24E~04 Te-131m 9.43E-04 4.52E-04 3.77E-04 6.80E-04 4.72E-03 O.OOE+OO 3.63E-02 Te-131 3.17E-14 1.31E-14 9.90E-15 2.44E-14 1.39E-13 O.OOE+OO 2.BOE-15 Te-132 1.60E-03 1.01.E-03 9.54E-04 1.07E-03 9.72E-03 O.OOE+OO 3.21E-02 1-130 2.68E-04 7.75E-04 3.10E-04 6.32E-02 1.19E-03 O.OOE+OO 5.96E-04 1-131 2.86E-03 4.00E-03 2.15E-03 1.17E+DD 6.89E-03 O.OOE+OO 7.91E-04 1-132 3.82E-06 1.00E-05 3.59E-06 3.37E-04 1.58E-05 O.ODE+OO 4.36E:06 1-133 6.87E-04 1.17E-03 3.56E-04 1.63E-01 2.04E-03 O.ODE+OO 8.82E~04 1-134 5.75E-09 1.52E-08 5.47E-09 2.54E-07 2.40E-08 O.OOE+DO 2.01E"10 1-135 8.84E-05 2.27E-04 8.43E-05 1.46E-02 3.59E-04 O.OOE+DO 2.5.2E-04 Cs-134 4.27E-02 1.00E-01 4.66E-02 O.DDE+OD 3.19E-02 1.22E-02 1.25E-03 Cs-136 4.27E-03 1.68E-02 1.13E-02 O.OOE+OO 9.14E-03 1.44E-03 1.35E-03 Cs-137 5.71E-02 7.60E-02 2.65E-02 O.OOE+OO 2.59E-02 1.00E-02 1.08E-03 Cs-138
7.58E-12 1.46E-11 7.28E-12 O.OOE+OO 1.07E-11 1.25E-12 6.60E-15 Ba-139 1.77E-07 1.24E-10 5.15E-09 O.OOE+OO 1.17E-10 8.57E-11 1.5BE-06 Ba-140 1.41 E-02 1.73E-06 9.08E-04 O.OOE+OO 5.86E-06 1.16E-05 2.17E-02 Ba-141 4.95E-17 3.70E-20 1.65E-18 O.OOE+OO 3.43E-20 2.53E-20 1.06E-22 Ba-142 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO La-140 1.44E-06 7.09E-07 1.89E-07 O.OOE+OO O.OOE+OO O.OOE+OO 4.07E-02 La-142 4.93E-10 2.19E-10 5.46E-11 O.OOE+OO O.OOE:+-00 O.OOE+OO 6.67E-06 Ce-141 6.71E-06 4.48E-06 5.15E-07 O.OOE+OO 2.11E-06 O.OOE+OO 1.28E-02 Ce-143 9.31E-07 6.78E-04 7.57E-08 O.OOE+DO 3.04E-07 O.OOE+OD 2.04E-02 Ce-144 3.55E-04 1.47E-04 1.91 E-05 O.OOE+OO 8.76E-05 O.OOE+OO 8.91E-02 Pr-143 6.51E-06 2.60E-OB 3.24E-07 O.OOE+OO 1.51E-06 0.00E+OO 2.14E-02 Pr-144 6.66E-21 2.72E-21 3.37E-22 O.OOE+OO 1.56E-21 O.OOE+OO 7.34E-24 Nd-147 4.64E-06 5.04E-06 3.02E-07 O.OOE+OD 2.96E-06 O.OOE+OO 1.82E-02 W-187 5.25E-05 4.28E-05 1.SOE-05 O.OOE+OO O.OOE+OO O.OOE+OO 1.16E-02 Np-239 7.75E-07 7.31E-08 4.06E-08 0.00E+OO 2.29E-07 O.OOE+OO 1.18E-02 Page 12of16

For Information Only Attachment I ODCM-QA-008 Revision 18 Page 52 of 86 REMP DOSE FACTORS FOR TEEN AGE GROUP: INHALATION - QUARTERLY SAMPLING (Page 1 of 2) mrem-m3/pCi-yr

.Ni.ict.:ioe * . -.. *:-~q~~;l.~~! ~1%';;~;UWER T,BODY : :1 :. THYFfr)10 KIDNEY'.': '

                                                                                                          .!~ *;: *~':\t'.u~ti'*::   Gl-LLI H-3            0.00E+OO           1.28E-03    1.28E-03          1.28E-03 1.28E-03              1.28E-03       1.28E-03 C-14             2.60E-02          4.87E-03    4.87E-03          4.87E-03 4.87E-03              4.87E-03       4.87E-03 Na-24            O.OOE+OO           O.OOE+OO   O.OOE+OO          O~OOE+OO  O.OOE+OO             O.OOE+OO        O.OOE+OO P-32            1.73E+01           1.00E+OO    6.55E-01         O.OOE+OO  O.OOE+OO             O.OOE+OO        8.49E-01 Cr-51            O.OOE+OO

O.OOE+oo* 4.23E-04 2.35E-04 9.62E-05 6.56E-02 9.39E-03 Mn-54 O.OOE+OO 5.66E-02 9.29E-03 O.OOE+OO 1.41 E-02 2.20E+OO 7.39E-02 Mn-56 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO Fe-55 3.45E-02 2.46E-02 5.72E-03 O.OOE+OO O.OOE+OO 1.28E-01 6.60E-03 Fe-59 3.23E-02 7.51E-02 2.91E-02 O.OOE+OO O.OOE+OO 3.10E+OO 3.62E-01 Co-58 O.OOE+OO . 3.24E-03. 4.34E-03 O.OOE+OO O.OOE+OO 2.10E+OO 1.49E-01 Co-60 O.OOE+OO 1.54E-02 2.02E-02 o:ooE+oo O.OOE+OO 8.86E+OO 2.63E-01 Ni-63 5.81E-01 *4.35E-02 1:98E-02 O.OOE+OO O.OOE+OO 3.07E-01 1.42E-02 Ni-65 O.OciE+OO O.OOE+OO O.OOE+OO o:ooE+oo O.OOE+OO O.OOE+OO O.OOE+OO Cu-64 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Zn-65 4.39E-02 1.52E-01 7.10E-02 O:OOE+OO 9.83E-02 1.41 E+OO 5.31E-02 Zn-69 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO, O.OOE+OO O.OOE+OO Br-83 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-84 O.OOE+OO O.OOE+OO O.OOE+OO o:obE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-85 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Rb-86 O.OOE+OO 1.04E+OO 4.57E-01 O.OOE+OO O.OOE+OO O.OOE+OO 9.63E-02 Rb-88 O.OOE.+00 O.OOE+OO. O.OOE+OO O.OOE+OO O.OOE+OO* O.OOE+OO O.OOE+OO Rb-89 O.OOE+OO O.OOE+OO, O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Sr-89 8.12E-01 O.OOE+oo: 2:33E-02 O.OOE+OO O.OOE+OO 4.52E+OO 6.94E-01 Sr-90 1.08E+02 O.OOE+OO 6.70E+OO O.OOE+po O.OOE+OO 1.65E+01 7.67E-01 Sr-91 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Sr-92 0.00~+00 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO* O.OOE+OO O.OOE+OO Y-90 O.OciE+oo O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-,91m O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-91 1.13E+OO O.OOE+OO 3.04E-02 O.OOE+OO O.OOE+OO 5.04E+OO 7.02E-01 Y-92 O.OOE+OO o.ooE+oo: O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+DO Y-93 O.OOE+OO O.OOE+oo: O.!JOE+OO 0.00!=+00 O.OOE+OO O.OOE+OO O.OOE+OO Zr-95 2.39E-01. 7.51E-02. 5:17E-02 O.OOE+OO 1.10E-01 4.41E+OO 2.44E-01 Zr-97 O.OOE+oo O.OOE+ooi O.OOE+OO 0.00E+Oci O.OOE+OO O.OOE+OO O.OOE+OO Nb-95 4.57E-02 2.54E-02. 1.40E-02 O.OOE+OO 2.46E-02 1.85E+OO 2.39E-01 Mo-99 O.OOE+OO O.OOE+OOi o:ooE+oo O.OOE+OO O.OOE+OO 0.00E+OO O.ODE+OO Tc-99m O.OOE+OD O.OOE+oo: o.poE+OO o.ooE+oo O.OOE+OO O.OOE+OO O.OOE+OO Page 13of16

For Information Only Attachment I ODCM-QA-008* Revision 18 Page 53 of 86 REMP DOSE FACTORS FOR TEEN AGE GROUP: INHALATION - QUARTERLY SAMPLING (Page 2 of 2) mrem-m3/pCi-yr

             ;;*NUCLIDE      BONE.*. '     LIVER       .T.B9py      THYROID.t~;* *'

KIDNEY 1:.UNG~'.* Gl-LLI Tc-101 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ru-103 4.70E-03 O.OOE+OO 2.00E-03 O.OOE+OO 1.66E-02 1.75E+OO 2.43E-01 Ru-105 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ru-106 1.07E-01. 0.00E+OO 1.35E-02 O.OOE+OO 2.07E-01 1.75E+01 1.05E+OO Ag-110m 1.57E-02 1.49E-02 9.07E-03 O.OOE+OO 2.84E-02 7.66E+OO

3.10E-01 Te-125m 8.42E-03 3.86E-03 1.15E-03 2.42E-03 O.OOE+OO 9.25E-01 1.29E-01 Te-127m 2.41E-02 1.09E-02 . 2.92E-03 5.86E-03 8.74E-02 2.21E+OO 2.13E-01 Te-127 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO Te-129m 3.57E-02 1.69E-02 5.76E-03 1.17E-02 1.33E-01 5.06E+OO 1.04E+OO Te-129 1.82E-07 8.65E-08 4.51E-08 1.33E-07 6.81E-07 8.45E-03 4.14E-03 Te-131m O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO Te-131 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Te-132 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-130 0.00E+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-131 1.81E+OO 2.51E+OO 1.35E+OO 7.48E+02 4.29E+OO O.OOE+OO 3.31E-01 1-132 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO 1-133 O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-134 O.OOE+OD O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-135 O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OD Cs-134 5.24E-01 1.18E+DO 5.72E-01 O.DDE+OO 3.91E-01 1.53E-01 1.02E-02 Cs-136 . 5.70E-01 2.14E+OO 1.51E+OO D.OOE+OO 1.22E+OO 1.96E-01 1.20E-01 Cs-137 6.72E-01 8.SDE-01 3.12E-01 O.OOE+OO 3.0SE-01 1.21 E-01 8.SDE-03 Cs-138 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ba-139 O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ba-140 6.49E-01 7.95E-04 4.17E-02 O.OOE+OO 2.70E-04 2.41E+01 2.71E+OO Ba-141 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ba-142 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO La-140 O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO La-142 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ce-141 7.51E-02 5.02E-02 5.74E-03 O.OOE+OO 2.35E-02 1.62E+OO 3.34E-01 Ce-143 O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OD O.OOE+OO 0.0DE+OO Ce-144 5.46E+OO 2.26E+OO 2.93E-01 O.DOE+OO 1.35E+OD 1.49E+01 9.66E-01 Pr-143 1.38E-01 5.47E-02 6.82E-03 O.OOE+OO 3.18E-02 4.98E+OO 2.20E+OO Pr-144 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO Nd-147 1.40E-01 1.53E-01 9.14E-03 O.OOE+OO 8.95E-02 6.63E+OO 3.25E+OO W-187 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO Np-239 O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO Page 14of16

For Information Only Attachment I ODCM-QA-008 Revision 18 Page 54 of 86 REMP DOSE FACTORS FOR TEEN AGE GROUP: INHALATION -WEEKLY SAMPLING (Page 1 of 2) mrem-m3/pCi-yr Nµ!3UQE **.:BONE ! i LIV~R. T.BODY ~,z THYR01or KIDNEY . ..*LUNG Gl*LLI' H-3 O.OOE+OO 1.27E-03 1.27E-03 .1.27E-03 1.27E-03 1.27E-03 1.27E-03 C-14 2.60E-02 4.87E-03 4.87E-03 4.87E-03 4.87E-03 4.87E-03 4.87E-03 Na-24 O.OOE+OO O.OOE+OO O.OOE+OO . 0.00E+OO O.OOE+OO 0.00E+OO O.OOE+OO P-32 2.24E+OO 1.30E-01 8.48E-02 O.OOE+OO O.OOE+OO O.OOE+OO 1.10E-01 Cr-51 O.OOE+OO O.OOE+OO 1.48E-04 8.18E-05 3.35E-05 2.29E-02 3.27E-03 Mn-54 O.OOE+OO 5.15E-02 8.47E-03 0.00E+OO 1.28E-02 2.00E+OO 6.73E-02 Mn-56 O.OOE+OO O;OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO Fe-55 3.35E-02 2.39E-02 5.56E-03 O.OOE+OO O.OOE+OO 1.24E-01 6.41 E-03 Fe-59 1.68E-02 3.90E-02 1.51E-02 . O.OOE+OO O.OOE+OO 1.61E+OO 1.88E-01 Co-58 O.OOE+OO 2.14E-03 2.87E-03 O.OOE+OO O.OOE+OO 1.39E+OO 9.85E-02 Co-60 0.00E+OO 1.51 E-02 1.99E-02

O.OOE+OO O.OOE+OO 8.73E+OO 2.60E-01 Ni-63 5.SOE-01 4.34E-02 1.98E-02 O.OOE+OO O.OOE+OO 3.07E-01 1.42E-02 Ni-65 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Cu-64 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Zn-65 3.89E-02 1.35E-01 6.30E-02 O.OOE+OO 8.73E-02 1.25E+OO 4.71E-02 Zn-69 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-83 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO Br-84 O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-85 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO Rb-86 O.OOE+OO 2.17E-01 9.57E-02 O.OOE+OO O.OOE+OO O.OOE+OO 2.01E-02 Rb-88 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Rb-89 O.OOE+OO 0.00,E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Sr-89 4.56E-01 O.OOE+OO 1.31 E-02 O.OOE+OO O.OOE+OQ 2.53E+OO 3.89E-01 Sr-90 1.08E+02 O.OOE+OO 6.68E+OO O.OOE+OO O.OOE+OO 1.65E+01 7.65E-01 Sr-91 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Sr-92 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-90 O.OOE+OO 0.00.E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-91m O.OOE+OO o:ooe+oo O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-91 6.89E-01 O.OOE+OO 1.84E-02 O.OOE+OO O.OOE+OO 3.06E+OO 4.26E-01 Y-92 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-93 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO, O.OOE+OO O.OOE+OO Zr-95 1.51 E-01 4.76E-02 3.27E-02 O.OOE+OO 7.00E-02 2.79E+OO 1.55E-01 Zr-97 O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO Nb-95 1.99E-02 1.11E-02 6.07E-03 O.OOE+OO 1.07E-02 8.05E-01 1.04E-01 Mo-99 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Tc-99m O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO Page 15of16

For Information Only Attachment I ODCM-QA-008 Revision 18 Page 55 of 86 REMP DOSE FACTORS FOR TEEN AGE GROUP: INHALATION -WEEKLY SAMPLING (Page 2 of 2) mrem-m 3/pCi-yr

                                                 .LIVER. *:j~i. ,..T.BODY                                              .,

i~\;NUCUDE [ ~~*.-*: *-.J!9~E';~c- .. '*. *THYROID 19p~EY LUNG-;** :Gl-'LLI Tc-101 O.OOE+OO O.OOE+OO o.ooE+oo O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ru-103 2.24E-03 O.OOE+OO 9.53E-04

O.OOE+OO 7.90E-03 8.33E-01 1.16E-01 Ru-105 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ru-106 9.91E-02 O.OOE+OO 1.25E-02 O.OOE+OO 1.92E-01 1.62E+01 9.66E-01 Ag-110m 1.40E-02 1.32E-02 a:o1E-03 O.OOE+OO 2.53E-02 6.82E+OO 2.75E-01 Te-125m 5.09E-03 2.34E-03 6.96E-04 1.46E-03 O.OOE+OO 5.59E-01 7.82E-02 Te-127m 1,84E-02 8.34E-03 2.23E-03 4.48E-03 6.BBE-02 1.69E+OO 1.63E-01 Te-127 O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Te-129m 1.50E-02 7.0BE-03 2.42E-03 4.92E-03 5.58E-02 2.12E+OO 4.35E-01

                    . Te-129    7.63E-08        3.63E-08          1.89E-08          5.57E-08  2.85E-07       3.54E-03     1.74E-03 Te-131m   O.OOE+OO        O.OOE+OO           O.OOE+OO          O.OOE+OO  O.OOE+OO      O.OOE+OO      O.OOE+OO Te-131  O.OOE+OO        O.OOE+OO           O.OOE+OO          O.OOE+OO  O.OOE+OO      O.OOE+OO      0.00E+OO Te-132  O.OOE:tOO       O.OOE+OO           O.OOE+OO          O.OOE+OO  O.OOE+OO      O.OOE+OO      O.OOE+OO 1-130  O.OOE+OO        O.OOE+OO           0.00E+OO          O.OOE+OO  O.OOE+OO      O.OOE+OO      O.OOE+OO 1-131  3.54E-02        4.91E-02           2.64E-02          1.46E+01  8.40E-02      O.OOE+OO      6.49E-03 1-132  O.OOE+OO        O.OOE+OO           O.OOE+OO          O.OOE+OO  O.OOE+OO      O.OOE+OO      O.OOE+OO 1-133  O.OOE+OO        O.OOE+OO           O.OOE+OO          O.OOE+OO  O.OOE+OO      O.OOE+OO      O.OOE+OO 1-134  O.OOE+OO        O.OOE+OO           O.OOE+OO          O.OOE+OO  O.OOE+OO      O.OOE+OO      0.00E+OO 1-135  O.OOE+OO        O.OOE+OO           O.OOE+OO          O.OOE+OO  O.OOE+OO      O.OOE+OO      O.OOE+OO Cs-134  5.04E-01        1.13E+OO           5.51E-01          O.OOE+OO  3.76E-01      1.47E-01      9.79E-03 Cs-136  6.19E-02        2.33E-01           1.64E-01          O.OOE+OO  1.33E-01      2.14E-02      1.31E-02 Cs-137  6.71 E-01       8.48E-01           3.11 E-01         O.OOE+OO  3.04E-01      1.21 E-01     8.4BE-03 Cs-138  O.OOE+OO        O.OOE+OO           O.OOE+OO          O.OOE+OO  O.OOE+OO      O.OOE+OO      O.OOE+OO Ba-139  O.OOE+OO        O.OOE+OO          O.OOE+OO           O.OOE+OO  O.OOE+OO      O.OOE+OO      O.OOE+OO Ba-140  6.61E-02        8.10E-05           4.26E-03          O.OOE+OO  2.76E-05      2.46E+OO      2.77E-01 Ba-141  O.OOE+OO        O.OOE+OO          O.OOE+OO           O.OOE+OO  O.OOE+OO      O.OOE+OO      O.OOE+OO Ba-142  O.OOE+OO        O.OOE+OO          O.OOE+OO           O.OOE+OO  O.OOE+OO      O;OOE+OO      O.OOE+OO La-140  O.OOE+OO        O.OOE+OO          O.OOE+OO           O.OOE+OO  O.OOE+OO      O.OOE+OO      O.OOE+OO La-142  O.OOE+OO        O.OOE+OO          O.OOE+OO           O.OOE+OO  O.OOE+OO      o.ooe+oo      O.OOE+OO Ce-141  3.0BE-02        2.04E-02           2.34E-03          O.OOE+OO  9.57E-03      6.61E-01      1.36E-01 Ce-143  O.OOE+OO        O.OOE+OO

O.OOE+OO
O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ce-144 4.93E+OO 2.04E+OO* 2.65E-01 O.OOE+OO 1.22E+OO 1.35E+01 8.71E-01 Pr-143 1.BOE-02 6.35E-03 7.92E-04 O.OOE+OO 3.69E-03 5.7BE-01 2.55E-01 Pr-144 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Nd-147 9.81E-03 1.07E-02 6.40E-04 O.OOE+OO 6.27E-03 4.64E-01 2.28E-01 W-187 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Np-239 O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Page 16 of 16

For Information Only Attachment J ODCM-QA-008 Revision 18 Page 56 of 86 REMP DOSE FACTORS FOR CHILD AGE GROUP: MILK (Page 1 of 2) mrem-liter/pCi-yr

              , .'N.,if(QLIDE
                  ...            'aONE     ;; ;;:,i!;lvER'
                                                   -.. i.*.*

r;eoov "ffi\'tRb10* KIO.NEY :LUNG G.1-Ll.I H-3 O.OOE+OO 6.70E-05 6.70E-05 6.70E-05 6.70E-05 6.70E-05 6.70E-05 C-14 3.99E-03 7.99E-04 7.99E-04 7.99E-04 7.99E-04 7.99E-04 7.99E-04 Na-24 O.OOE+OO O.OOE+oo O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO 0.00E+OO P-32 2.47E-01 1.16E-02 9.52E-03 O.OOE+OO O.OOE+OO O.OOE+OO 6.83E-03 Cr-51 O.OOE+OO O.OOE+OO 2.79E-06 1.55E-06 4.24E-07 2.83E-06 1.48E-04 Mn-54 O.OOE+OO 3.52E-03 9.36E-04 O.OOE+OO 9.86E-04 O.OOE+OO 2.95E-03 Mn-56 O.OOE+OO O.OOE+OO -0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Fe-55 3.79E-03 2.01E-03 6.23E-04 O.OOE+OO O.OOE+OO 1.14E-03 3.72E-04 Fe-59 5.28E-03 8.54E-03 4.25E-03 O.OOE+OO O.OOE+OO 2.48E-03 8.89E-03 Co-58 O.OOE+OO 5.82E-04 1.78E-03 O.OOE+OO O.OOE+OO O.OOE+OO 3.40E-03 Co-60 O.OOE+OO 1.74E-03 5.14E~03 O.OOE+OO

O.OOE+OO
O.OOE+OO 9.66E-03 Ni-63 1.78E-01 9.50E-03 *6.04E-03 O.OOE+OO O.OOE+OO O.OOE+OO 6.40E-04 Ni-65 0.00E+OO O.OOE+OO f O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Cu-64 O.OOE+OO O.OOE+OO 'O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Zn-65 4.50E-03 1,20E-02 7.45E-03 O.OOE+OO 7.55E-03 O.OOE+OO 2.10E-03 Zn-69 0.00EtOO
O.OOE+OO O.OOE+OO
O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-83 O'.OOE+OO O.OOE+OO 0.00E+OO o:ooE+oo O.OOE+OO O.OOE+OO O.OOE+OO Br-84 O.OOE+OO O.OOE+OO O.OOE+OO. O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO Br-85 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO I

Rb-86 O.OOE+OO 2.05E-02 1.26E-02 O.OOE+OO

O.OOE+OO O.OOE+OO 1.32E-03 Rb-88 O.OOE+OO O.OOE+OO 'O.OOE+OO O.OOE+OO Iii O.OOE+OO O.OOE+Od O.OOE+OO Rb-89 O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO I. O.OOE+OO O.OOE+OO 0.00E+OO Sr-89 4.24E-01 'O.OOE+OO, 1.21 E-02 'Q.OOE+OO : O.OOE+OO O.OOE+OO 1.64E-02 Sr-90 5.61E+OO O.OOE+OO 1.42E+OO :* 'O.OOE+OO O.OOE+OO O.OOE+OO 7.56E-02 Sr-91 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO Sr-92 O.OOE+OO o:ooE+oo O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-90 O,QOE+OO O. OOE+OO O.OOE+OO
O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+.00 Y-91m O.OOE+OO. O:OOE+OO 0.00E+OO. O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-91 1'.94E-04 O;OOE+OO 5:19E-06 0.00E+OO O.OOE+OO O.OOE+OO 2.58E-02 Y-92 O.ObE+OO O.OOE+OO O~OOEtOci O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO I

Y-93 O.OOE+OO O.OOE+o'o 'o.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Zr-95 3.75E-05 8.23E-06 '7.33E-06 O.OOE+OO 1.18E-05 O.OOE+OO 8.59E-03 Zr-97 O.OOE+OO 0.00E+OO o,poE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO Nb-95 7.14E-06 2.78E-06 *1i99E-06 0.00E+OO 2.61E-06 O.OOE+OO 5.14E-03 Mo-99 O.OOE+OO .O.OOE+OO O.OOE+OO O.OOE+oo O.OOE+OO O.OOE+OO O.OOE+OO Tc-99m O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO ' O.OOE+OO O.OOE+OO O.OOE+OO Page 1 of 16

For Information Only Attachment J ODCM-QA-008 Revision 18 Page 57 of 86 REMP DOSE FACTORS FOR CHILD AGE GROUP: MILK (Page 2 of 2) mrem-liter/pCi-yr

             .~;i,~UCllDE      eqij:f:"p     LIVER    . T.BODY      THYROID         KIDNE\r.~
                                                                                             ~
                                                                                                  -     LUNG    1'.*.; "   Gl-LLI Tc-101      O.OOE+OO     O.OOE+OO       O.OOE+OO   O.OOE+OO . O.OOE+OO           O.OOE+OO           O.OOE+OO Ru-103      2.33E-04     O.OOE+OO       8.95E-05   O.OOE+OO        5.86E-04         .O.OOE+OO            6.02E-03 Ru-105      O.OOE+OO     O.OOE+OO       O.OOE+OO . O.OOE+OO       O.OOE+OO           O.OOE+OO           O.OOE+OO Ru-106      3.85E-03     O.OOE+OO       4.80E-04   O.OOE+OO        5.19E-03         O.OOE+OO             5.98E-02 Ag-110m      1.77E-04    . 1.19E-04      9.55E-05   O.OOE+OO        2.23E-04         O.OOE+OO             1.42E-02 Te-125m      3.67E-03      9.96E-04      4.90E-04

1,03E~03 O.OOE+OO O.OOE+OO 3.54E-03 Te-127m 9.42E-03 2.53E-03 1.12E-03 2.25E-03 2.68E-02 O.OOE+OO 7.62E-03 Te-127 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Te-129m I 1.54E-02 4.31E-03 2.39E-03 4.97E-03. : 4.53.E-OZ O.OOE+OO 1.88E-02 Te-129 4.24E-05 1.18E-05 1.01 E-05 3.03E-05 : 1.24E-04 0.00E+OO 2.64E-03 Te-131m 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO
O.OOEtOO O.OOE+OO O.OOE+OO Te-131 , O.OOE+OO O.OOE+OO -0.00E+OO O.OOE-!;00 : O.OOE+OO O.OOE+.00 O.OOE+OO
Te-132 . O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-130 . O.OOE+OO O.OOE+OO *O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-131 4.78E-03 4.BOE-03 2.73E-03 1.59E+OO 7.89E-03 O~OOE+OO 4.28E-04 1-132 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE-+:00 O.OOE+OO O.OOE+OO 1-133 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-134
O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO. O.OOE+OO O.OOE+OO 1-135
O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO
O.OOE+OO Cs-134 7.71E-02 1.26E-01 2.67E-02 O.OOE+OO . 3.Q2E-02 1.41 E-02 6.82E-04 Cs-136 ' 6.98E-03 1.92E-02 1.24E-02 O.OOE+OO 1.02E-02 1.52E-03 6.74E-04 Cs-137 1.08E-01 1.03E-01 1.52E-02 0.00E-h00 3.3lE-02 1.21E-02 6.47E-04 Cs-138 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ba-139 O.OOE+OO O.OOE+OO O,OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ba-140 2.46E-02 2.16E-05 . 1.44E-03 O.OOE+OO 7.Q2E-06 *1.29E-05 1.25E-02 Ba-141 O.OOE+OO O.OOE+OO o.poE+OO O.OOE+po O.OOE+OO O.OOE+OO O.OOE+OO
Ba-142 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO La-140 O.OOE+OO O.OOE+OO
O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO La-142 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OQE+OO O.OOE+OO Ce-141 1.26E-05 6.26E-06 .9.30E-07 0.00E+OO 2.74E-06 O.OOE+OO 7.81E-03 Ce-143 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ce-144 6.83E-04 2.14E-04 3.65E-05 O.OOE+OO 1.. 19E-04 o.poE+OO 5.58E-02 Pr-143 1.17E-05 3.52E-06 5.81E-07 0.00E+OO . 1.90E-06 O.OOE+OO 1.26E-02 Pr-144 O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO Nd-147 8.11 E-06 6.57E-06 5.09E-07 0.00E+OO 3.61E-06 O.OOE+OO 1.04E-02 W-187 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.QOE+OO O.OOE+OO O.OOE+OO Np-239 O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO Page 2of16

For Information Only Attachment J ODCM-QA-008 Revision 18 Page 58 of 86 REMP DOSE FACTORS FOR CHILD AGE GROUP: LEAFY VEG. (Page 1 of 2) mrem-kg/pCi-yr

              * NUCLIDE;*      BONE*;'. LIV!;R.

T:BODY **THYROID KIDNEY* LUNG',.': GI*!;!;,!.*

H-3 O.OOE+OO 5.28E-06 5.28E-06 5.28E-06 5.28E-06 5.28E-06 5.28E-06 C-14 3.15E-04 6.29E-05 6.29E-05 6.29E-05 6.29E-05 6.29E-05 6.29E-05 Na-24 O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO . O.OOE+OO O.OOE+OO O.OOE+OO P-32 2.04E-02 9.56E-04 7.88E-04 O.OOE+OO O.OOE+OO O.OOE+OO 5.65E-04 Cr-51 O.OOE+OO O.OOE+OO

2.26E-07 *1.25E-07 3.42E-08 2.29E-07 1.20E-05 Mn-54 O.OOE+OO 2.78E-04 7.39E-05 O.OOE+OO 7.78E-05
O.OOE+OO 2.33E-04 Mn-56 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO , 0.00E+OO O.OOE+OO O.OOE+OO Fe-55 2.99E-04 1.58E-04 4.91E-05 0.00E+OO
O.OOE+OO 8.96E-05 2.94E-05 Fe-59 4.22E-04 6.84E-04 3.40E-04 O.OOE+OO 0.00E+OO 1.98E-04 7.12E-04 Co-58 0.00E+OO 4.63E-05 1.42E-04 O.OOE+OO : 0.00E+OO O.OOE+OO 2.70E-04 Co-60 O.OOE+OO 1.37E-04 4.05E-04 O.OOE+OO , 0.00E+OO O.OOE+OO 7.62E-04 Ni-63 1.40E-02 7.49E-04 4.76E-04 O.OOE+OQ : *O.OOE+OO
O.OOE+OO 5.04E~05 Ni-65 O.OOE+OO 0.00E+OO O.OOE+OO ' O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO Cu-64 O.OOE+OO O.OOE+OO . O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO .O.OOE+OO Zri-65 3.55E-04 9.46E-04 5.89E-04 O,OOE+OO : 5.96E-04 O.OOE+OO 1.66E-04 Zn-69 O.OOE+OO 0.00E+00 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-83 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-84. O.OOE+OO O.OOE+OO O.OOE+OO I O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-85 0.00E+OO 0.00E+,00 O.OOE+OO ' 0.00E+OO ! O.OOE+OO O.OOE+OO O.OOE+OO Rb-86 O.OOE+OO 1.68E-03. : 1.03E-03 O.OOE+OO O.OOE+OO O.OOE+OO 1.0BE-04 Rb-88 O.OOE+OO O.OOE+OO . O.OOE+OO
O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Rb-89 O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Sr-89 3.39E-02 O.OOE+OO 9.67E-04 O:OOE+OO O.OOE+OO O.OOE+OO 1.31E-03 Sr-90 4.42E-01 O.OOE+OO 1.12E-:01. . O.OOE+OO *o.opE+OO O.OOE+OO 5.95E-03 Sr-91 . O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Sr-92 O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-90 O.OOE+OO O.OOE-t;OO O.OOE+OO O.OOE+OO 'O.OOE+OO O.OOE'l-00 O.OOE+OO Y-91m O.OOE+OO O.OOE+OO O.OOE+OO O:OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-91 1.55E-05 O.OOE+oo 4.14E-07 O.OOE+OO. O.OOE+OO O.OOE+OO 2.06E-03 Y-92 O.OOE+OO O.OOE+OO o.*ooE+oo O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-93 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Zr-95 2.98E-06 6.56E-07 5.84E-07 O.OOE+OO 9.39E-07 O.OOE+OO 6.84E-04 Zr-97 O.OOE+OO O.OQE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO Nb-95 5.74E-07 2.23E-07 1.60E-.07 O.OOE+OO 2.10E-07 O.OOE+OO 4.13E-04 Mo-99 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Tc-99m O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Page 3of16

For Information Only Attachment J ODCM-QA-008 Revision 18 Page 59 of 86 REMP DOSE FACTORS FOR CHILD AGE GROUP: LEAFY VEG. (Page 2 of 2)

mrem-kg/pCi-yr

[i*t:**

                      . NUCLIQ~~~}~ ;'.:'. BONE:~'j::J:~\;:j C', l'..IVER:,:*'<) r::,,:teoov :. !lg'.1~i*rvR'o10*-**.. bJj~iONEY" * . .    'LUNG.   .  :'."G,ipLU

Tc-101 O.OOE+OO 'O.OOE+OO O.OOE+OO 0.00E+OO
O.OOE+OO O.OOE+OO O.OOE+OO Ru-103 1.87E-05 O.OOE+OO 7.18E-06 O.OOE+OO 4;70E-05 O.OOE+OO 4.83E-04 Ru-105 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ru-106 3.04E-04 O.OOE+OO 3.79E-05 O.OOE+OO 4.10E~04 O.OOE+OO 4.72E-03
Ag-110m 1.40E-05 9.44E-06 7.55E-06 O.OOE+OO 1.76E-05 O.OOE+OO 1.12E-03 Te-125m 2.93E-04 7.94E-05 3.91E-05 8.22E-05 O.OOE+OO O.OOE+OO 2.83E-04 Te-127m 7.47E-04 2.01E-04 8.86E-05 1.79E-04 2.13E-03 O.OOE+OO 6.05E-04 Te-127
O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO .O.OOE+OO Te-129m : " 1.24E-03 3.46E-04 1.93E-04 4.00E-04 3.64E-03 O.OOE+OO 1.51E-03 Te-129 3.41E-06 9.53E-07 8.10E-07 2.43E-06 . 9.98E-06 O.OOE+OO . 2.12E-04 Te-131m O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO Te-131 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO . O.OOE+OO O.OOE+OO Te-132 O.OOE+OO O.OOE+OO O.OOEtOO O.OOE+OO . O.OOE+OO O.OOE+OO O.OOE+OO 1-130 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-131 4.10E-04 4.13E-04 2.34E704 1.36E-01 6.77E-04 O.OOE+OO 3.67E-05 1-132 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-133 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-134 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-135 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO . O.OOE+OO Cs-134 6.08E-03 9.97E-03 2.10E-03 O.OOE+OO 3.09E-03 1.11 E-03 5.38E-05 Cs-136 5.SOE-04 1.59E-03 1.03E-03 O.OOE+OO 8.49E-04 1.27E-04 5.60E-05 Cs-137 8.SOE-03 8.14E-03 1.20E-03 .O.OOE+OO 2.65E-03 9.54E-04 5.10E-05 Cs-138 O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO Ba-139 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ba-140 2.0SE-03 1.79E-06 1.19E-04 O.OOE+OO 5.84E-07 1.07E-06 1.04E-03 Ba-141 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO *o.OOE+OO Ba-142 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO La-140 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO La-142 O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ce-141 1.01E-06 5.04E-07 7.48E-08 O.OOE+OO 2.21E-07 o:ooE+oo 6.29E-04 Ce-143 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ce-144 5.39E-05 1.69E-05 2.88E-06 O.OOE+OO 9.36E-06 O.OOE+OO 4.41E-03 Pr-143 9.71E-07 2.92E-07 4.82E-08 O.OOE+OO 1.58E-07 0.00E+OO 1.0SE-03 Pr-144 O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO Nd-147 6.81E-07 5.52E-07 4.27E-08 O.OOE+OO 3.03E-07 0.00E+OO 8.74E-04 W-187 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Np-239 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO Page 4of16

For Information Only Attachment J ODCM-QA-008 Revision 18 Page 60 of 86 REMP DOSE FACTORS FOR CHILD AGE GROUP: FRUIT (Page 1 of 2) mrem-kg/pCi-yr

             ~; , NtJCi!:iDE
             ~,*  :   .* *;* '

>>130~~%,, /' ',: ;jLl\lER;, .rtf.Joov .,.,; , .*.TliYROio.:.:';.: ;;~,:: KIPNJ;:'( * .: ;.;~;!,tLUNG.-;< * ~l;;LLI . ::::

H-3 O.OOE+OO 1.05E-04 1.05E-04 1.05E-04 1.05E-04 1.05E-04 1.05E-04 C-14 6.29E-03 1.26E-03 1.26E-03 1.26E-03 1.26E-03 1.26E-03

1.26E-03 Na-24 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO P-32 2.34E-02 1.09E-03 9.00E-04 O.OOE+OO O.OOE+bO O.OOE+OO 6.46E-04 Cr-51 O.OOE+OO O.OOE+OO 1.03E-06 5.72E-07 1.56E-07 1.05E-06 5.47E-05 Mn-54 O.OOE+OO 4.87E-03 1.30E-03. O.OOE+OO 1.37E-03 O.OOE+OO 4.09E"03 Mn-56 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Fe-55 5.73E-03 3.04E-o3 9.42E-04 O.OOE+OO O.OOE+OO 1.72E-03 5.63E-04 Fe-59 3.38E-03 5.47E-03 2.72E-03 O.OOE+OO O.OOE+OO 1.59E-03 5.69E-03 Co-58 O.OOE+OO 5.20E-04 1:59E-03 O.OOE+OO O.OOE+OO O.OOE+OO 3.03E-03 Co-60 O.OOE+OO 2.69E-03 7.94E-03 O.OOE+OO O.OOE+OO O.OOE+OO 1.49E-02 Ni-63 2.79E-01 1.50E-02 9.51E-03 0.00E+OO
O.OOE+OO O.OOE+OO 1.01E-03 Ni~65 O.OOE+OO O.OOE+OO p.OOE+OO O.OOE+OO o:ooE+oo O.OOE+OO O.OOE+OO Cu-64 O.OOE+OO O.OOE+OO O:OOE+OO O.OOE+OO *
O:OOE+OO O.OOE+OO O.OOE+OO Zn-65 6.01E-03 *1.60E-b2 9:96E-03 0.00E+OO 1.01E-02 O.OOE+OO. 2.81E-03 Zn-69 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO Br-83 O.OOE+OO O.OOE+OO. O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-84 O.OOE+OO *O.OOE+oo: O.OOE+OO O.OOl~+OO O:OOE+OO O.OOE+OO O.OOE+OO Br-85 O.OOE+OO O.OOE+OO O.OOE+OO ci.OOE+OO . O.OOE+OO O.OOE+OO O.OOE+OO Rb-86 O.OOE+OO 3.75E-03 2.31E-03 O.OOE+OO OpOE+OO O.OOE+OO 2.41E-04 Rb-88 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Rb-89 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Sr-89 3.01 E-01 O.OOE+OO 8.61E-03 O.OOE+OO O.OOE+OO O.OOE+OO 1.17E-02 Sr-90 8.80E+OO O.OOE+OO 2.23E+OO O.OOE+OO O.OOE+OO O.OOE+OO 1.19E-01 Sr-91 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O:OOE+OO O.OOE+OO Sr-92 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-90 O.OOE+OO O.OOE+oo O. OOE+OO ci.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-91m O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-91 1.54E-04 *O,OOE+OO* 4.11E-06 O.OOE+OO O.OOE+OO O.OOE+OO 2.05E-02 Y-92 ci~OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-93 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Zr-95 3.15E-05 6.92E-06 6.16E-06 O.OOE+OO 9.91E-06 O.OOE+OO 7.22E-03 Zr-97 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Nb-95 3.57E-06 1.39E-06 9.94E-07 O.OOE+OO 1.31E-06 O.OOE+OO 2.57E-03 Mo-99 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Tc-99m 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO Page 5of16

For Information Only Attachment J ODCM-QA~008 Revision 18 Page 61of86 REMP DOSE FACTORS FOR CHILD AGE GROUP: FRUIT (Page 2 of 2) mrem-kg/pCi-yr

.. NUCLIDE ::i;iqN:~i'~fi~'U~*~\~l~~R.* r.e()oY:~$~~~TBY.6:C>1fr:-* KIDN~i'f;':' * .;'."'. LUNG,j:,:: 1

                                                                                                                                     ***   Gl-LLi *;,,

Tc-101 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO Ru-103 1.32E-04 O.OOE+OO 5.08E-05 O.OOE+OO 3.33E-04 0.00E+OO 3.42E-03 Ru-105 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+DO O.OOE+OO Ru-106 5.43E-03 O.OOE+OO 6.78E-04 O.OOE+OO 7.34E-03 O.OOE+OO 8.45E-02 Ag-110m 2.37E-04 1.60E-04 1.28E-04 O.OOE+OO 2.98E-04 O.OOE+OO 1.91E-02 Te-125m 2.89E-03 7.84E-04 3.86E-04 8.12E-04 O.OOE+OO O.OOE+OO 2.79E-03

Te-127m 1.03E-02 2.76E-03 1.22E-03 2.45E-03 2.93E-02 O.OOE+OO 8.31E-03 Te-127 O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO 0.00E+OO Te-129m 7.34E-03 2.05E-03 1.14E-03 . 2.37E-03 2.16E-02 O.OOE+OO 8.96E-03 Te-129 5.64E-06 4.SOE-06 1.44E-05 5.91E-05 0.00E+OO 1.26E-03 Te-131m 0.00.E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.ODE+OO 0.00E+OO O.OOE+OO Te-131. O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Te-132 O.OOE+OO 0.00E+OO O.DOE+OO O.OOE+OO 0.00E+OO O.OOE+OO 0.00E+OO 1-130 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-131 .5.07E-05 5.10E-05 2.SOE-05 1.69E-02 8.37.E-05 0.00E+OO 4.54E-06 1-132 O.OOE+OO O.OOE+OO O.ODE:tOO o.'ooE+oo O.OOE+OO O.OOE+OO O.OOE+OO 1-133 O.OOE+OO O.OOE+OO O.OOE+OD O.OOE+OO O.OOE+OO O;OOE+OO O.OOE+OO 1-134 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-135 O.OOE+OO O.ODE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Cs-134 1.15E-01 1.89E-01 3.99E-02 O.OOE+OD 5.86E-02 2.10E-02 1.02E-03 Cs-136 . 5.18E-04 1.42E-03 9.22E-04 O.OOE+OO 7.59E-04 1.13E-04 5.01E-05 Cs-137
1.69.E-01 1.62E-01 2.39E-02 O.OOE+OO 5.28E-02 1.90E-02 1.02E-03 Cs-138 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ba-139 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ba-140
1.67E-03 1.47E-06 9.76E-05 O.OOE+OO 4.77E-07 8~73E-07 8.47E-04 Ba-141 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ba-142 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO La-140 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO La-142 0.00~+00 O.OOE+OO O.OOE+OO O.OOE+OO . O.OOE+OO O.OOE+OO O.OOE+OO Ce-141 5.74.E-06 2.86E-06 4.25E-07 O.OOE+OO 1.26E-06 O.OOE+OO 3.57E-03 Ce-143 O.OOE+OO .O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ce-144 9.34E-04 2.93E-04 4.99E-05 O.OOE+OO 1.62E-04 O.OOE+OO 7.64E-02 Pr-143 9.51E-07 2.86E-07 4.72E-08 O.OOE+OO 1.55E-07 O.OOE+OO 1.03E-03 Pr-144 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO Nd-147 3.29E-07 2.66E-07 2.0SE-08 0.00E+OO 1.46E-07 O.OOE+OO 4.22E-04

                   . W-187    O.OOE+OO           O.OOE+OO     O.OOE+OO         O.OOE+OO      O.OOE+OO             O.OOE+OO               O.OOE+OO Np-239    0.00E+OO           0.00E+OO     O.OOE+OO         D.OOE+OO      O.OOE+OO             0.00E+OO               O.OOE+OO Page 6of16

For Information Only Attachment J ODCM-QA-008 Revision 18 Page 62 of 86 REMP DOSE FACTORS FOR CHILD AGE GROUP: MEAT (Page 1 of 2) mrem-kg/pCi~yr H-3 0.00E+OO 8.30E-06 8.30E-06 8.30E-06 8.30E-06 8.30E-06 8.30E-06 C-14 4.96E-04 9.92E-05 9.92E-05 9.92E-05 9.92E-05 9.92E-05 9.92E-05 Na-24 O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO P-32 1.28E-02 6.00E-04 4.94E-04 O.OOE+OO O.OOE+OO O.OOE+OO 3.54E-04 Cr-51 O.OOE+OO O.OOE+OO 2.21E-07 1.23E-07 3.36E-08 2.24E-07 1.17E-05 Mn-54 O.OOE+OO 4.20E-04 1.12E-04 O.OOE+OO 1.18E-04 O.OOE+OO 3.52E-04 Mn-56 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Fe-55 4.65E-04 2.47E-04 7.64E-05 O:OOE+OO O.OOE+OO 1.39E-04 4.57E-05 Fe-59 4.96E-04 8.02E-04 4.00E-04 O.OOE+OO O.OOE+OO 2.33E-04 8.35E-04 Co-58 O.OOE+OO 6.07E-05 1.89E-04 O.OOE+OO O.OOE+OO O.OOE+OO 3.54E-04 Co-60 O.OOE+OO 2.15E-04 6.35E-04 O.OOE+OO O.OOE+OO O.OOE+OO 1.19E-03 Ni-63 2.20E-02 1.18E-03 7.50E-04 O.OOE+OO O.OOE+OO O.OOE+OO 7.95E-05 Ni-65 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Cu-64 O.OOE+OO o:ooE+oo O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Zn-65 5.31E-04 8.79E-04 O.OOE+OO 8.91E-04 O.OOE+OO 2.48E-04 Zn-69 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-83 O.ObE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-84 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-85 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Rb-86 O.OOE+OO 8.04E-04 O.OOE+OO O.OOE+OO O.OOE+OO 8.41E-05 Rb-88 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Rb-89 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Sr-89 4.11E-02 O.OOE+OO 1.17E-03 O.OOE+OO O.OOE+OO O.OOE+OO 1.59E-03 Sr-90 6.96E-01 Q.OOE-+;00 1.76E-01 O.OOE+OO O.OOE+OO O.OOE+OO 9.38E-03 Sr-91 O.OOE+OO O.OOE+OO p.OOE+OO O.OOE+OO ' O.OOE+OO O.OOE+OO O.OOE+OO Sr-92 O.OOE+OO O.,OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-90 O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-91m O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-91 1.95E-05 O.OOE+OO 5.21E-07 O.OOE+OO O.OOE+OO O.OOE+OO 2.59E-03 Y-92 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-93 O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Zr-95 3.83E-06 8.42E-07 7.49E-07 O.OOE+OO 1.21E-06 O.OOE+OO 8.78E-04 Zr-97 O.OOE+OO O.OOE+oo O:OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Nb-95 6.21E-07 2.42E-07 1.7;3E-07 O.OOE+OO 2.27E-07 O.OOE+OO 4.47E-04 Mo-99 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Tc-99m O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO Page 7of16 j

For Information Only Attachment J ODCM-QA-008 Revision 18 Page 63 of 86 REMP DOSE FACTORS FOR CHILD AGE GROUP: MEAT (Page 2 of 2) mrem-kg/pCi-yr N!J¢pb~i**.: l(.),a,2Ni; . ,. ...pv.pR* :h::*::~*".~:~'.~ppY. .. KIDNt;Y**:~ Gl-Lll ,y: THYROID LUNG** .. *' Tc-101 O.OOE+OO O.OOE+OO O.OOE+oo b.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ru-103 2.11E-05 O.OOE+OO 8.10E-06 O.OOE+OO 5.30E-05 O.OOE+OO 5.45E-04 Ru-105 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O~OOE+OO O.OOE+OO Ru-106 4.62E-04 O.OOE+OO 5.76E-05 O.OOE+OO 6.24E-04 O.OOE+OO 7.19E-03 Ag-110m 2.09E-05 1.41E-05 1.13E-05 O.OOE+OO 2.63E-05 O.OOE+OO 1.68E-03 Te-125m 3.68E-04 9.98E-05 4.91E-05 1.03E-04 O.OOE+OO O.OOE+OO 3.55E-04 Te-127m 1.04E-03 2.81E-04 1.24E-04 2.49E-04 2.97E-03 O.OOE+OO 8.45E-04 Te-127 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Te-129m 1.32E-03 3.69E-04 2.05E-04 4.26E-04 3.88E-03 O.OOE+OO 1.61E-03 Te-129 3.64E-06 1.02E-06 8.63E-07 2.59E-06 1.06E-05 O.OOE+OO 2.26E-04 Te-13'im O.OOE+OO O.OOE+OO O.OOE+OO O.OCiE+OO O.OOE+OO O.OOE+OO O.OOE+OO Te-131 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Te-132 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO 1-130 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-131 1.26E-04 1.26E-04 7.19E-05 4.18E-02 2.0SE-04 O.OOE+OO 1.13E-05 1-132 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-133 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-134 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-135 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Cs-134 9.42E-03 1.55E-02 3.26E-03 O.OOE+OO 4.79E-03 1.72E-03 8.33E-05 Cs-136 3.36E-04 9.24E-04 5.98E-04 O.OOE+OO 4.92E-04 7.34E-05 3.25E-05 Cs-137 1.34E-02 1.28E-02 1.89E-03 O.OOE+OO 4.1~E-03 1.SOE-03 8.03E-05 Cs-138 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO 0.00E+OO Ba-139 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ba-140 1.15E-03 1.01E-06 6.73E-05 O.OOE+OO 3.29E-07 6.02E-07 5.84E-04 Ba-141 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ba-142 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO La-140 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO La-142 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ce-141 1.06E-06 5.30E-07 7.87E-08 O.OOE+OO 2.32E-07 O.OOE+OO 6.61E-04 Ce-143 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ce-144 8.12E-05 2.55E-05 4.33E-06 O.OOE+OO 1.41 E-05 O.OOE+OO 6.64E-03 Pr-143 5.SDE-07 1.74E-07 2.88E-08 O.OOE+OO 9.43E-08 O.OOE+OO 6.25E-04 Pr-144 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Nd-147 3.24E-07 2.62E-07 2.03E-08 O.OOE+OO 1.44E-07 0.00E+OO 4.15E-04 W-187 O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE.+00 Np-239 O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Page 8of16

For Information Only Attachment J ODCM-QA-008 Revision 18 Page 64 of 86 REMP DOSE FACTORS FOR CHILD AGE GROUP: FISH (Page 1 of 2) mrem-kg/pCi-yr

'NUCLIDE ~ONE' ':*=

LIVER ¥{8.oov THYROID* KIDNEY -LUN$:.:*

Gl-LLI H-3 O.OOE+OO 1.40E-06 1.40E-06 1.40E-06 1.40E-06 1.40E-06 1.40E-06 C-14 8.35E-05 1.67E-05 1.67E-05 1.67E-05
1.67E-05 1.67E-05 1.67E-05 Na-24 1.32E-05 1.32E-05 1.32E-05 1.32E-05 1.32E-05 1.32E-05 1.32E-05 P-32 5.42E-03 2.54E-04 2.09E-04 O.OOE+OO O.OOE+OO O.OOE+OO 1.50E-04 Cr-51 O.OOE+OO O.OOE+OO
5.99E-08 . 3.32E-08 9.08E-09 6.07E-08 3.18E-06 Mri-54 O.OOE+OO 7.37E-05 1.96E-05 O.OOE+OO 2.07E-05 O.OOE+OO 6.18E-05 Mn-56 O.OOE+OO 3.64E-09 8.21E-10 O.OOE+OO 4.40E-09 O.OOE+OO 5.27E-07 Fe-55 7.93E-05 4.21E-05 1.30E-05 O.OOE+OO O.OOE+OO 2.38E-05 7.79E-06 Fe-59 1.12E-04 1.81 E-04 9.04E-05 0.00E+OO O.OOE+OO 5.26E-05 1.89E-04 Co-58 O.OOE+OO 1.23E-05 3.76E-05 O.OOE+OO O.OOE+OO O.OOE+OO 7.17E-05 Co-60 0.00E+OO 3.65E-05 1.08E-04 O.OOE+OO O.OOE+OO O.OOE+OO 2.02E:04 Ni-63 3.71 E::-03 1.99E-04 1.26E-04 0.00E+OO O.OOE+OO O.OOE+OO 1.34E-05 Ni-65 2.08E-08 1.96E~09 1.14E-09 O.OOE+OO O.OOE+OO O.OOE+OO 2.40E-07 Cu-64 O.OOE+OO 4.56E-07 2:76E-07 O.OOE+OO 1.10E-06 O.OOE+OO 2.14E-05 Zn-65 9.43E-05 2.51E-04 1.56E-04 O.OOE+OO 1.58E-04 O.OOE+OO 4.41E-05 Zn-69 5.01E-15 7.23E-.15 6.69E:16 O.OOE+OO 4.39E-15 O.OOE+OO 4.56E-13 Br-83 O.OOE+OO O.OOE+OO 1.12E-09 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-84 O.OOE+OO O.OOE+OO 3.40E-20 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-85 O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Rb-86 O.OOE+OO 4.45E-04 2.74E-04 O.OOE+OO O.OOE+OO O.OOE+OO 2.87E-05 Rb-88 O.OOE+OO O.OOE+OO O.CiOE+OO* O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Rb-89 O.OOE+OO O.OOE+OO O_.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO Sr-89 8.98E-03 O.OOE+OO
2.57E-04 O.OOE+OO O.OOE+OO O.OOE+OO 3.48E-04 Sr-90 1.17E-01 0.00E+OO 2.97E-02 0.00.E+OO O.OOE+OO O.OOE+OO 1.58E-03 Sr-91 2.87E-05 O.OOE+OO . 1.0~E-06 O.OOE+OO O.OOE+OO o:ooE+oo 6.35E-05 Sr-92 1.34E-07 O.OOE+OO 5.39E-09 O.OOE+OO O.OOE+OO O.OOE+OO 2.55E-06 Y-90 2.19E-07 O.OOE+oo 5.86E-09 O.OOE+OO O.OOE+OO O.OOE+OO 6.23E-04 Y-91m 5.22E-18 O.OOE+OO 1.90E-19 O.OOE+OO O.. OOE+OO O.OOE+OO 1.02E-14 Y-91 4.10E-06 O.OOE+OO 1.10E-07 O.OOE+OO O.OOE+OO O.OOE+OO 5.47E-04 Y-92 2.26E-10 o.qoE+OO 6.47E-12 O.CiOE+OO O.OOE+OO O.OOE+OO 6.53E-06 Y-93 1.52E-08 O.. OOE+OO 4.16E-10 o.oqE+OO O.OOE+OO O.OOE+OO 2.26E-04 Zr-95 7.92E-07 1.74E-07 1.55E-07 O.OOE+OO 2.49E-07 O.OOE+OO 1.82E-04 Zr-97 1.80E-08 2.60E-09 1.54E-09 O.OOE+OO 3.74E-09 O.OOE+OO 3.94E-04 Nb-95 1.52E-07 5.93E-08 4.23E-08 O.OOE+OO 5.57E-08 O.OOE+OO 1.10E-04 Mo-99 O.OOE+OO 7.13E-05 1.76E-05 O.OOE+OO 1.52E-04 O.OOE+OO 5.90E-05 Tc-99m 4.02E-10 7.88E-10 1.31 E-08 O.OOE+OO 1.14E-08 4.00E-10 4.48E-07 Page 9of16

For Information Only Attachment J ODCM-QA-008 Revision 18 . Page 65 of 86 REMP DOSE FACTORS FOR CHILD AGE GROUP: FISH (Page 2 of 2) mrem-kg/pCi-yr

             !~;,{NU¢L1Dif
                             \ '!;fil~'b,,~~!i!~E )~   LIVER   '   T.BODY       THYROID  *KIDNEY.         LUNG    .Gl-L!:J Tc-101         O.OOE+OO        O.OOE+OO     O.OOE+OO      O.OOE+OO  O.OOE+OO     O.OOE+OO O.OOE+OO Ru-103         4.96E-06        O.OOE+OO      1.91 E-06  . O.OOE+OO  1.25E-05     O.OOE+OO  1.28E-04 Ru-105         1.05E-08        O.OOE+OO      3.81E-09     O.OOE+OO  9.23E-08     O.OOE+OO  6.85E-06 Ru-106         8.06E-05        O.OOE+OO      1.01E-05     O.OOE+OO  1.09E-04     0.00E+OO  1.25E-03 Ag-110m         3.71E-06        2.50E-06     2.00E-06      O.OOE+OO  4.67E-06     O.OOE+OO  2.98E-04 Te-125m         7.77E-05        2.11E-05      1.04E-05     2.18E-05 O.OOE+OO      0.00E+OO  7.50E-05 Te-127m         1.98E-04         5.33E-05     2.35E-05     4.74E-05  5.65E-04     O.OOE+OO  1.60E-04 Te-127         5.48E-07         1.48E-07     1.18E-07     3.80E-07  1.56E-06     O.OOE+OO  2.14E-05 Te-129m         3.29E-04         9.19E-05    5.11 E-05     1.06E-04  9.67E-04     O.OOE+OO 4.01E-04 Te-129      .* 9.06E-07         2.53E-07    2.15E-07      6.46E-07  2.65E-06     O.OOE+OO  5.64E-05 Te-131m         2.85E-05        9.87E-06      1.05E-05     2.03E-05  9.55E-05     O.OOE+OO 4.00E-04 Te-131         2.84E-24        O.OOE+OO     O.OOE+OO      2.17E-24  8.59E-24     0.00E+OO  1.49E-23 Te-132         5.63E-05        2.49E-05     3.01E-05      3.63E-05  2.31E-04     0.00E+OO 2.51E-04 1-130         5.24E;:-06      1.06E-05     5.46E-06      1.17E-03  1.58E-05     O.OOE+OO 4.96E-06 1-131         1.09E-04        1.10E-04     6.22E-05      3.62E-02  1.80E-04     0.00E+OO 9.75E-06 1-132         3.99E-09        7.33E-09     3.37E-09      3.40E-07  1.12E-08    *0.00E+OO 8.62E-09 1-133         1.84E-05        2.27E-05     8.59E-06      4.22E-03 3.78E-05      0.00E+OO 9.15E-06 1-134         1.72E-14        3.20E-14     1.47E-14      7.36E-13 4.89E-14      O.OOE+OO 2.12E-14 1-135         9.75E-07        1.75E-06     8.30E-07      1.55E-04 2.69E-06      O.OOE+OO 1.34E-06 Cs-134         1.61E:-03       2.65E-03     5.58E-04     O.OOE+OO  8.20E704      2.94E-04 1.43E-05 Cs-136         1.54E-04        4.23E-04     2.74E-04     O.OOE+OO  2.25E-04      3.36E-05 1.49E-05 Cs-137         2.26E-03        2.16E-03     3.19E-04     O.OOE+OO  7.04E-04      2.53E-04 1.35E-05 Cs-138         5.77E-20        8.03E-20     5.09E-20     O.OOE+OO  5.65E-20      6.08E-21 3.70E-20 Ba-139         1.7BE-11        9.49E-15     5.15E-13     O.OOE+OO  8.29E-15      5.58E-15 1.03E-09 Ba-140      . 5.43E-04         4.76E-07     3.17E-05     O.OOE+OO  1.55E-07      2.84E-07 2.75E-04 Ba-141        d.OOE+OO         0.00E+OO     O.OOE+OO     O.OOE+OO  O.OOE+OO      O.OOE+OO O.OOE+OO Ba-142        O.OOE+OO         O.OOE+OO     O.OOE+OO     O.OOE+OO  O.OOE+OO      O.OOE+OO O.OOE+OO La-140        4.61E-08         1.61E-08     5.43E-09     O.OOE+OO  O.OOE+OO      O.OOE+OO 4.49E-04 La-142         1.06E-13        3.36E-14     1.05E-14     O.OOE+OO  O.OOE+OO      0.00E+OO 6.67E-09 Ce-141         2.6BE-07        1.34E-07     1.99E-08     O.OOE+OO  5.86E-08      O.OOE+OO 1.67E-04 Ce-143        2.91E-08         1.58E-05     2.29E-09     O.OOE+OO  6.63E-09      O.OOE+OO 2.31E-04 Ce-144         1.43E-05        4.49E-06     7.64E-07     O.OOE+OO  2.48E-06      O.OOE+OO 1.17E-03 Pr-143         2.58E-07        7.74E-08     1.28E-08     O.OOE+Ob  4.19E-08      O.OOE+OO 2.78E-04 Pr-144        Q.OOE+OO         O.OOE+OO     O.OOE+OO     O.OOE+OO  O.OOE+OO      O.OOE+OO O.OOE+OO Nd-147         1.81E-07        1.46E-07     1.13E-08     O.OOE+OO  8.03E-08      O.OOE+OO 2.32E-04 W-187          1.47E-06        8.72E-07     3.91E-07     O.OOE+OO  O.OOE+OO      0.00E+OO 1.23E-04 Np-239        2.70E-08         1.94E-09     1.36E-09     O.OOE+OO  5.60E-09      O.OOE+OO 1.43E-04 Page 10of16

For Information Only Attachment J ODCM-QA-008 Revision 18 Page 66 of 86 REMP DOSE FACTORS FOR CHILD AGE GROUP: DRINKING WATER (Page 1 of 2) mrem-liter/pCi-yr

N~C,l;:lt!Et .-

                             ;  /* ;rsol'lie .*. . .!LIVER'*  *. ¥:ijoo¥( .,~ - THYROID      KIDNEY:\~ . t~;!*;:LUNG  *. Gl"LLI H-3            O.OOE+OO       1.04E-04

1.04E-04 1.04E-04 1.04E-04 1.04E-04 1.04E-04 C-14 6.17E-03 1.23E-03 1.23E-03 1.23E-03 1.23E-03
1.23E-03 1.23E-03 Na-24 1.70E-03 1.70E-03 1.70E-03 1.70E-03 1.70E-03 UOE-03 1.70E-03 P-32 4.11E-01 1.92E-02 1.58E-02 O.OOE+OO O.OOE+OO O.OOE+OO U3E-02 Cr-51 O.OOE+OO O.OOE+OO 4.48E-06 2.49E-06 6.BOE-07 4.54E-06 2.3BE-04 Mn-54 O.OOE+OO 5.45E-03 1.45E-03 , O.OOE+OO 1.53E-03 O.OOE+OO 4.57E-03 Mn-56 O.OOE+OO 6.77E-06 1.53E-06 O.OOE+OO B.18E-06 O.OOE+OO 9.81E-04 Fe-55 5.86E-03 3.11E-03 9.64E-04 . 0.00E+OO O.OOE+OO 1.76E-03 5.76E-04 Fe-59 8.35E-03 1.35E-02 6.73E-03 O.OOE+OO O.OOE+OO 3.92E-03 1.41E-02 Co-58 O.OOE+OO 9.14E-04 2.BOE-03 O.OOE+OO 0.00E+OO O.OOE+OO 5.33E-03 Co-60 O.OOE+OO 2.70E-03 7.95E-03 O.OOE+OO O.OOE+OO O.OOE+OO 1.49E-02 Ni-63 2.74E-01 1.47E-02 9.33E-03 O.OOE+OO O.OOE+OO O.OOE+OO 9.89E-04 Ni-65 4.17E-05 3.93E-06 2.29E-06 0.00E+OO O.OOE+OO O.OOE+OO 4.81E-04 Cu-64 O.OOE+OO 6.49E-05 3.92E-05 O.OOE+OO 1.57E-04 O.OOE+OO 3.05E-03 Zn-65 6.98E-03 1.86E-02 1.16E-02 O.OOE+OO 1.17E-02 O.OOE+OO 3.26E-03 Zn-69 2.87E-09 4.15E-09 3.84E-10 O.OOE+OO 2.52E-09 O.OOE+OO 2.62E-07 Br-83 O.OOE+OO O.OOE+OO 2.69E-06 , O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-84 O.QOE+OO O.OOE+OO t.59E-11 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-85 O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO Rb-86 O.OOE+OO 3.35E-02 2.06E-02 O.OOE+OO 0.00E+OO O.OOE+OO 2.16E-03 Rb-88 O.OOE+OO 6.B3E-17 4.74E-17. O.OOE+oo. O.OOE+OO O.OOE+OO 3.35E-18 Rb-89 O.OOE+OO 5.84E-19 5.19E-19 O.OOE+OO O.OOE+OO O.OOE+OO 5.096-21 Sr-89 6.69E-01 O.OOE+OO 1.91 E-02 O.OOE+OO O.OOE+OO O.OOE+OO 2.59E-02 Sr-90 8.67E+OO O.OOE+OO 2.20E+OO O.OOE+OO O.OOE+OO O.OOE+OO 1.17E-01 Sr-91 5.10E-03 O.OOE+OO 1.93E-04 O.OOE+oo* O.OOE+OO O.OOE+OO 1.13E-02 Sr-92 2.14E-04 O.OOE+OO 8.5BE-06 O.OOE+OO O.OOE+OO O.OOE+OO 4.05E-03 Y-90 1.84E-05 O.OOE+OO 4.93E-07 O.OOE+OO O.OOE+OO O.OOE+OO 5.24E-02 Y-91m 8.67E-12 O.OOE+OO 3.16E-13 O.OOE+OO O.OOE+OO O.OOE+OO 1.70E-08 Y-91 3.05E-04 O.OOE+OO 8.16E-06 O.OOE+OO O.OOE+OO O.OOE+OO 4.07E-02 Y-92 1.75E-07 O.OOE+OO 5~01E-09 O.OOE+OO O.OOE+OO O.OOE+OO 5.06E-03 Y-93 2.55E-06 O.OOE+OO 7.01E-08 O.OOE+OO O.OOE+OO O.OOE+OO 3.B1E-02 Zr-95 5.B8E-05 1.29E-05 1.15E-05 O.OOE+OO
1.85E-05 O.OOE+OO 1.~5E-02 Zr-97 2.18E-06 3.15E-07 1.86E-07 O.OOEtOO 4.52E-07 O.OOE+OO 4.77E-02 Nb-95 1.14E-05 4.42E-06 3.16E-06 *o.OOE+OO 4.16E-06 O.OOE+OO B.18E-03 Mo-99 O.OOE+OO 5.98E-03 1.48E~03 O.OOE+OO 1.28E-02 O.OOE+OO 4.95E-03 Tc-99m 1.18E-07 2.32E-07 : 3c84E-06 O.OOE+.00 3.37E-06 1.18E-07 1.32E-04 Page 11of16

For Information Only Attachment J ODCM-QA-008 Revision 18 Page 67 of 86 REMP DOSE FACTORS FOR CHILD AGE GROUP: DRINKING WATER(Page 2 of 2) mrem-liter/pCi-yr

              li>NUCLIDE

_r; . . BONE LIVER"<

                                                         *. '**'""    T.BODY       THYROID    KIDNEY         LUNG. Gl-LLI Tc-101 .        3.19E-22 3.34E-22             4.23E-21      O.OOE+OO   5.70E-21      1.77E-22  1.06E-21 Ru-103        . 3.70E-04 O.OOE+OO             1.42E-04      O.OOE+OO   9.30E-04     O.OOE+OO  9.55E-03 Ru-105          5.05E-06 O.OOE+OO             1.83E-06      O.OOE+OO  4.44E-05      O.OOE+OO  3.30E-03 Ru-106          5.96E-03 O.OOE+OO             7.44E-04      O.OOE+OO   8.05E-03     O.OOE+OO  9.27E-02 Ag-110m

2.75E-04 1.85E-04 1.48E-04 O.OOE+OO 3.45E-04 O.OOE+OO 2.21E-02 Te-125m 5.78E-03 1.57E-03 7.71E-04 1.62E-03 0.00E+OO O.OOE+OO 5.58E-03 Te-127m 1.47E-02 3.96E-03 1.74E-03 3.51E-03 4.19E-02 O.OOE+OO 1.19E-02 Te-127 9.87E-05 2.66E-05 2.12E-05 6.83E-05 2.81E-04 O.OOE+OO 3.86E-03 Te-129m 2.46E-02 6.86E-03 3.82E-03 7.92E-03 7.22E-02 O.OOE+OO 3.00E-02 Te-129 6.76E-05 1.89E-05 1.61E-05 4.83E-05 1.98E-04 O.OOE+OO 4.21E-03 Te-131m 2.78E-03 9.62E-04 1.02E-03 1.98E-03 9.31E-03 O.OOE+OO 3.90E-02 Te-131 9.43E-14 2.87E-14 2.BOE-14 7.21 E-14 2.85E-13 O.OOE+OO 4.95E-13 Te-132 4.63E-03 2.05E-03 2.48E-03 2.99E-03 1.90E-02 0.00E+OO 2.06E-02 1-130 7.60E-04 1.54E-03 7.91E-04 1.69E-01 2.29E-03 O.OOE+OO 7.18E-04 1-131 8.40E-03 8.45E-03 4.BOE-03 2.79E+OO 1.39E-02 O.OOE+OO 7.52E-04 1-132 1.10E-05 2.02E-05 9.27E-06 9.35E-04 3.0BE-05 O.OOE+OO 2.37E-05 1-133 2.02E-03 2.50E-03 9.47E-04 4.65E-01 4.17E-03. O.OOE+OO 1.01 E-03 1-134 1.65E-08 3.06E-08 1.41 E-08 7.05E-07 4.69E-08 O.OOE+OO 2.03E-08 1-135 2.54E-04 4.56E-04 2.16E-04 4.04E-02 7.00E-04 O.OOE+OO 3.48E-04 Cs-134 1.19E-01 1.96E-01 4.13E-02 O.OOE+OO 6.07E-02 2.18E-02 1.06E-03 Cs-136 1.17E-02 3.21E-02 2.0BE-02 O.OOE+OO 1.71 E-02 2.55E-03 1.13E-03 Cs-137 1.67E-01 1.60E-01 2.36E-02 O.OOE+OO 5.20E-02 1.87E-02 1.00E-03 Cs-138 2.23E-11 3.10E-11 1.96E-11 O.OOE+OO 2.1 BE-11 2.34E-12 1.43E-11 Ba-139 5.27E-07 2.81E-10 1.53E-08 O.OOE+OO 2.46E-10 1.65E-10 3.04E-05 Ba-140 4.12E-02 3.61E-05 2.41E-03 O.OOE+OO 1.18E-05 2.15E-05 2.09E-02 Ba-141 1.48E-16 8.26E-20 4.BOE-18 O.OOE+OO 7.15E-20 4.86E-19 8.41E-17 Ba-142 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO La-140 4.19E-06 1.46E-06 4.94E-07 O.OOE+OO O.OOE+OO O.OOE+OO 4.0BE-02 La-142 1.44E-09 4.60E-10 1.44E-10 O.OOE+OO O.OOE+OO O.OOE+OO 9.12E-05 Ce-141 2.00E-05 9.99E-06 1.48E-06 O.OOE+OO 4.38E-06 O:OOE+OO 1.25E-02 Ce-143 2.77E-06 1.50E-03 2.18E-07 O.OOE+OO 6.30E-07 O.OOE+OO 2.20E-02 Ce-144 1.06E-03 3.32E-04 5.65E-05 O.OOE+OO 1.84E-04 O.OOE+OO 8.66E-02 Pr-143* 1.95E-05 5.87E-06 9.69E-07 O.OOE+OO 3.18E-06 O.OOE+OO 2.11E-02 Pr-144 2.00E-20 6.18E-21 1.00E-21 O.OOE+OO 3.27E-21 O.OOE+OO 1.33E-17 Nd-147 1.38E-05 1.12E-05 8.65E-07 O.OOE+OO 6.13E-06 O.OOE+OO 1.77E-02 W-187 1.54E-04 9.14E-05 4.10E-05 O.OOE+OO O.OOE+OO O.OOE+OO 1.28E-02 Np-239 2.31E-06 1.66E-07 1.17E-07 O.OOE+OO 4.BOE-07 O.OOE+OO 1.23E-02 Page 12of16

For Information Only Attachment J ODCM-QA-008 Revision 18 Page 68of86 REMP DOSE FACTORS FOR CHILD AGE GROUP: INHALATION - QUARTERLY SAMPLING (Page 1 of 2) 3 mrem-m /pCi-yr H-3 O.OOE+OO 1.13E-03 1.13E-03 1.13E-03 *1.13E-03 1.13E-03 1.13E-03 C-14 3.59E-02 6.73E-03 6.73E-03 6.73E-03 6.73E-03 6.73E-03 6.73E-03 Na-24 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO P-32 2.3BE+01 1.05E+OO 9.03E-01 O.OOE+OO O.OOE+OO 0.00E+OO 3.86E-01 Cr-51 O.OOE+OO o:ooE+oo 4.83E-04 2.6BE-04 7.61E-05 5.32E-02 3.39E-03 Mn-54 ' O.OOE+OO 4.75E-02 1.05E-02 O.OOE+OO 1.11E~02 1.74E-02 2.53E-02

Mn-56 O:OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO. O.OOE+OO Fe-55 4.S9E-02 2.60E-02 B.02E-03 O.OOE+oo O.OOE+OO 1.15E-01 2.96E-03 Fe-59 6.79E-02 3.39E-02 O.OOE+OO O.OOE+OO 2.58E+OO 1.44E-01 Co-58 0.00E+OO 2.77E-03 4.94E-03 O.OOE+OO. O.OOE+OO 1.73E+OO 5.37E-02 Co-60 O.OOE+OO 1.34E-02 . , 2.30E-02 :o.OOE+OO O.OOE+OO 7.18E+OO 9.78E-02 Ni-63 B.22E-01 4.63E-02 2.BOE-02 O.OOE+OO O.OOE+OO 2.75E-01 6.33E-03 Ni-65 O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Cu-64 O.OOE+OO O.OOE+OO . O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Zn-65 .4.84E-02 1.29E-01 8.00E-02 O.OOE+OO 8.13E-02 1.13E+OO 1.86E-02 Zn-69 O.OOE+OO O.OOE+OO O.OOE+OO .O.OOE+OO
o.'ooE+oo O.OOE+OO O.OOE+OO Br-83 O.OOE+OO O.OdE+OO O.OOE+OO O.OOE+OO O.OOE;t-00 O.OOE+OO O.OOE+OO Br-84 . O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO Br-85 O.OOE+OO O.OOE+OO O.OOE+OO d.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Rb-86 I b.OOE+OO 1.08E+OO 6.23E-01 O.OOE+OO . O.OOE+OO O.OOE+OO 4.35E-02 Rb-88 O.OOE+OO d.OOE+OO O.OOE+OO O.OOE+OO : O.OOE+OO O.OOE+OO O.OOE+OO Rb-89 o.ooE+oo O.OOE+OO O.OOE+OO i O.OOE+OO O.OOE+OO O.OOE+OO Sr-89 1.12E+OO O.OOE+OO '3.22E-02 O.OOE+OO b.OOE+OO 4.03E+OO 3.13E-01 Sr-90 1.01E+02 O.OOE+OO 6.46E+OO : ' O,OOE+OO O.OOE+OO 1.48E+01 3.44E-01 Sr-91 O.OOE+OO 0.00E+OO O.OOE+oo 'O.OOE+QO ' O.OOE+OO, *o.OOE+OO O.OOE+OO Sr-92 O.OOE+OO 0.00E+OO 0.00E:tOO , , . O.OOE+OO
O.OOE+OO O.OOE+OO 0.00E+OO Y-90 O.OOE+OO O.OOE+OO
0.00.E+OO . :
O.OOE+OO O.OOE+OO O.OOE+OO Y-91m O.OOE+OO O.OOE+OO O.OOE+OO .Cl.OOE+OO . O.OOE+OO O.OOE+OO O.OOE+OO Y-91 1.57E+OO O.OOE+OO 4.19E-02 O.OOE+OO 0.00.E+OO 4.51E+OO 3.16E-01 Y-92 O.OOE+OO O.OOE+OO 0.0,0E-+:00 .*I b~OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-93 O.OOE+OO O.OOE+OO *
0.0,0E+OO '* iO.OOE+OO , O.OOE+OO O.OOE+OO O.OOE+OO Zr-95 3.11E-01 6.85E-02 6.06E-02 :o.OOE+OO 9.76E-02 3.66E+OO 1.00E-01 Zr-97 O.OOE+OO O.OOE+oo O.OOE+OO ib.OOE+qo 0.00E+OO . O.OOE+OO O.OOE+OO Nb-95 5.79E-02 2.26E-02 1.~1E-02 ;o.OOE+OO
2.12E-02 1.51E+OO 9.12E-02 Mo-99 O.OOE+OO O.OOE+OO O.OOE+OO i 1 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO Tc-99m O.OOE+OO O.OOE+OO O.OOE+OO .O:OOE+oo O.OOE+OO 0.00E+OO O.OOE+OO Page 13 of 16

For Information Only Attachment J ODCM-QA-008 Revision 18 Page 69 of 86 REMP DOSE FACTORS FOR CHILD AGE GROUP: INHALATION - QUARTERLY SAMPLING (Page 2 of 2) mrem-m 3/pCi-yr . Tc-101 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ru-103 6.24E-03 O.OOE+OO 2.40E-03 O.OOE+OO 1.57E-02 1.48E+OO 1.00E-01

Ru-105 O.OOE+OO O.OOE+OO. O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ru-106 1.48E-01 O.OOE+OO 1.84E-02 O.OOE+OO 2.00E-01 1.56E+01 4.68E-01 Ag-110m 1.91E-02 1.29E-02 1.04E-02 O.OOE+OO 2.41E-02 6.21E+OO 1.14E-01 Te-125m 1.16E-02 4.01E-03
1.58E-03 3.32E-03 O.OOE+OO 0.23i::-01 5.83E-02 Te-127m 3.32E-02
1.14E-02 4.04E-03 8.11E-03 8.51E-02 1.98E+OO 9.54E-02 Te-127 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO Te-129m 4.92E:-02 ,1.75E-02 7.80E-03 1.62E-02 1.29E-01 4.51E+OO 4.66E-01 Te-129 2.50E-07 8.96E-08 6.11E-OB 1.83E-07 6.5BE-07 7.52E-03 6.53E-02 Te-131m O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Te-131
O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO *O.OOE+OO O.OOE+OO Te-132 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-130 O.OOE+.00
O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+,00 O.OOE+OO 1-131 2A6E+OO 2.46E+OO 1.39E+OO 8.30E+02 4.03E.+OO O.OOE+OO 1.45E-01 1-132 :o:ooE+.oo O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO
O.OOE+OO O.OOE+OO 1-133 O'.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO 1-134 O~OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-135* O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO Cs-134 6.79E-01 1.06E+OO 2.34E-01 O.OOE+OO 3.45E-01 *1.26E-01 4.01E-03 Cs-136 7.20E-01 *1.89E+OO 1.28E+OO O.OOE+OO 1.06E+OO 1-.61 E-01 4.62E-02 Cs-137 9.09E-01 8.27E-01 1.29E-01 0.00E+OO 2.83E-01 1.04E-01 3.63E-03 Cs-138 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO Ba-139 O.OOE+OO O.OOE+OO O.OOE+OO
O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ba-140 8.77E-01 7.68E-04 . 5.13E-02 .O.OOE+OO 2.50E~04 2.07E+01 1.21E+OO Ba-141 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ba-142 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO La-140 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO

                 *La-142    O.OOE+OO     O.OOE+OO      O.OOE+OO      O.OOE+OO  O.OOE+OO        O.OOE+OO    O.OOE+OO Ce-141    1.04E-01     5.17E-02      7.67E-03      O.OOE+OO  2.26E-02        1.44E+OO    1.50E-01 Ce-143    O,OOE+OO     O.OOE+OO      O.OOE+OO      O.OOE+OO  O.OOE+OO        O.OOE+OO    0.00E+OO Ce-144    7.57E+OO     2.37E+OO      4.04E-01      O.OOE+OO  1.31E+OO        1.34E+01    4.34E-01 Pr-143    1.90E-01     5.72E-02      9.41 E-03     O.OOE+OO  3.09E-02        4.46E+OO    1.00E+OO Pr-144    0.00E+OO     O.OOE+OO     O.OOE+OO       O.OOE+OO  O.OOE+OO        0.00E+.00   O.OOE+OO

Nd-147 1.93E-01 1.56E-01 1.21 E-02 O.OOE+OO 8.57E-02 5.85E+OO 1.46E+OO W-187 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE-\-00 O.OOE+OO Np-239 O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO Page 14 of 16

For Information Only Attachment J ODCM-QA-008 Revision 18 Page 70 of 86 REMP DOSE FACTORS FOR CHILD AGE GROUP: INHALATION -WEEKLY SAMPLING (Page 1 of 2)

mrem-m 3/pCi-yr .

                                      *LIVER            1".800¥ .        THY.R6io,                     LUNG      .G.l~LLI H-3    O.OOE+OO    1.13E-03          1.13E-03          1.13E-03  . 1.13E-03        1.13E-03  1.13E-03 C-14    3.59E-02   6.73E-03           6.73E-03       **6.73E-03      6.73E-03       6.73E-03 6.73E-03 Na-24   O.OOE+OO   O.OOE+OO          O.OOE+OO           0.00E+OO    O.OOE+OO       O.OOE+OO  O.OOE+OO P-32   3.09E+OO   1.35E-01           1.17E-01       *0.00E+OO      O.OOE+OO       O.OOE+OO  5.00E-02 Cr-51   O.OOE+OO   O.OOE+OO           1.68E-04          9.33E-05    2.65E-05        1.85E-02 1.18E-03 Mn-54   0.00E+OO   4.33E-02          9.58E-03 ,         O.OOE+OO. 1.01 E-02      1.59E-02 2.31E-02 Mn-56   O.OOE+OO   O.OOE+OO          0.00E+OO           O.OOE+OO    O.OOE+OO       0.00E+OO  0.00E+OO Fe-55   4.75E-02   2.52E-02           7.79E-03          O.OOE+OO    0.00E+OO        1.11E-01 2.87E-03 Fe-59   2.18E-02   3.53E-02           1.76E-02          O.OOE+OO    O.OOE+OO       1.34E+OO  7.46E-02 Co-58   O.OOE+OO   1.831:;-03'       3.27E-03         .O.OOE+OO     O.OOE+OO '     1.14E+OO  3.56E-02 Co-60   O.OOE+OO   1.32E-02          2.27E-02           O.OOE+OO    O.OOE+OO       7.08E+OO  9.63E-02 Ni-63   8.21E-01   4.63E-02          2.80E-02           O.OOE+oo    O.OOE+OO       2.75E-01  6.33E-03 Ni-65   O.OOE+OO   O.OOE+OO          O.OOE+OO           O.OOE+OO    O.OOE+OO       O.OOE+OO  O.OOE+OO
                 *Cu-64   O.OOE+OO   O.OOE+OO    I     O.OOE+OO          0.00E+OO     O.OOE+OO       O.OOE+OO  O.OOE+OO Zn-65   :4.30E-02  1.14E-01          7.10E~02          O.OOE+OO     7.21E-02       1.01E+OO  1.65E-02 Zn-69   O.OOE+OO   O.OOE+OO          O.OOE+OO           O.OOE+OO    O.OOE+OO       O.OOE+OO  O.OOE+OO Br-83   O.ODE+OO   O.OOE+OO        : O.OOE+OO           O.OOE+OO    O.ODE+OO       O.OOE+OO  O.OOE+OO Br-84   O.OOE+OO   O.OOE+OO          O.OOE+OO          O.OOE+OO     O.OOE+OO       O.OOE+OO  O.OOE+OO Br-85   O.OOE+OO   O.OOE+OO          O.OOE+OO          O.OOE+OO   . O.OOE+OO       O.OOE+OO  0.00E+OO
                .Rb-86    O.OOE+OO   2.26E-01          1.30E-01     ,. q.OOE+OO     O.QOE+OO       O.OOE+OO  9.10E-03 Rb-88   Q.OOE+OO   O.OOE+OO          O.OOE+OO *,       O.ODE+OO     O.OOE+OO       O.OOE+OO  O.OOE+OO Rb-89   O.OOE+OO   O.OOE+OO          O.OOE+OO          O.OOE+OO'    O.OOE+OO       O.OOE+OO  O.OOE+OO Sr-89   6.29E-01   O.OOE+OO           1.81E~o2*        q.OOE+OO     O.OOE+OO       2.26E+OO  1.75E-01 Sr-90   1.01E+02   O.OOE+OO          6.44E-+;OO

O.OOE+OO O.OOE+OO 1.48E+01 3.43E-01 Sr-91 O.OOE+OO O.OOE+OO O.,OOE+oo O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Sr-92 O.OOE+OO O.OOE+OO O.OOE~OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-90 O.OOE+OO O,.OQE+OO O..OOE+OO q.OOEtOO O.OOE+OO O.OOE+OO O.OOE+OO Y-91m O.OOE+OO O.OOE+OO O.OOE+OO Q.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-91 9.53E-01 O.OOE+OO 2.54E-02 O.OOE+OO O.OOE+OO 2.74E+OO 1.92E-01 Y-92 O.OOE+OO O.OOE+OO , O.OOE;t-00 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-93 O.OOE+OO O.OOE+OO O.OOE"".00 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Zr-95 1.S7E-01 4.34E-02 3.84E-02 O.OOE+OO 6.19E-02 2.32E+OO 6.34E-02 Zr-97 O.OOE+OO o.opE+OO O.OOE+OO* O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Nb-95 2.52E-02 9.83E-03 7!02E-03 ,O.OOE+oo 9.24E-03 6.58E-01 3.97E-02 Mo-99 O.OOE+OO O.OOE+OO O.OOE+OO.* O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Tc-99m O.OOE+OO O.OOE+OO O.OOE+OO, O.OOEtOO 0.00E+OO O.OOE+OO O.OOE+OO Page 15of16

For Information Only Attachment J ODCM-QA-008 Revision 18 Page 71of86 REMP DOSE FACTORS FOR CHILD AGE GROUP: INHALATION -WEEKLY SAMPLING (Page 2 of 2) 3 mrem-m /pCi-yr NUCLIDE: :';,, BQNE l*::;W*~ .LIVER .T~BODY THYRQJ.~ .: . KIDNE:V:~~:,,: LUNG. .. ,

                                                                                                                                    *(?1"LL.I Tc-101      O.OOE+OO         O.OOE+OO         O.OOE+OO     O.OOE+OO          O.OOE+OO         O.OOE+OO           O.OOE+OO Ru-103       2.97E-03        0.00E+OO         1.14E-03     O.OOE+OO         . 7.48E"03         7.04E-01           4.76E-02 Ru-105      O.OOE+OO         O.OOE+OO         O.OOE+OO     O.OOE+OO          O.OOE+OO         O.OOE+OO           O.OOE+OO Ru-106       1.37E-01        O.OOE+OO         1.70E-02     O.OOE+OO           1.85E-01       .1.44E+01            4.32E-01 Ag-110m       1.70E-02         1.15E-02        9.23E-03     O.OOE+OO           2.14E-02        5.53E+OO            1.01E-01 Te-125m       7.02E-03        2.43E-03        *9.53E-04      2.01E-03         O.OOE+OO          4.98E-01           3.52E-02 Te-127m       2.54E-02         8.74E-03        3.09E-03      6:20E-03          6.51E-02         1.51E+OO           7.30E-02 Te-127      O.OOE+OO         O.OOE+OO         O.OOE+OO     O.OOE+OO          O.OOE+OO         O.OOE+OO           O.OOE+OO Te-129m      2.06E-02         7.36E-03         3.27E-03      6.80E-03          5.41E-02        1.89E+OO            1.95E-01 Te-129       1.05E-07         3.76E-08        2.56E-08      7.68E-08         2.76E-07          3.15E-03         . 2.74E-02 Te-131m      O.OOE+OO         O.OOE+OO         O.OOE+OO     O.OOE+OO          O.OOE+OO         O.OOE+OO .         O.OOE+OO Te-131      O.OOE+OO         O.OOE+OO        O.OOE+OO      O.OOE+OO

O.OOE+OO O.OOE+OO O.OOE+OO Te-132 O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-130 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-131 4.81E-02 4.81E-02 2.73E-02 1.62E+01 7.88E-02 O.OOE+OO 2.84E-03 1-132 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO *o.OOE+OO O.OOE+OO 1-133 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-134 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO 1-135 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Cs-134 6.53E-01 1.02E+OO 2.25E-01 O.OOE+OO 3.31E-01 1.21 E-01 3.86E-03 Cs-136 7.83E-02 2.06E-01 1.40E-01 O.OOE+OO 1.15E-01 1.75E-02 5.03E-03 Cs-137 9.07E-01 8.25E-01 1.28E-01 0.00E+OO 2.82E-01 1.04E-01 3.62E-03 Cs-138 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ba-139 *O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ba-140 8.95E-02 7.83E-05 5.23E-03 O.OOE+OO 2.55E-05 2.11E+OO 1.23E-01 Ba-141 O.OOE+OO O.OOE+OO O.OOE+OO 0.0,0E+OO *O.OOE+OO O.OOE+OO O.OOE+OO Ba-142 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O:OOE+OO O.OOE+OO La-140 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO La-142 O:OOE+pO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ce-141 4.23E-02 2.11 E-02 3.12E-03 O.OOE+OO 9.21E-03 5.86E-01 6.10E-02 Ce-143 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ce-144 6.83E+OO 2.13E+OO 3.65E-01 o.cioE+OO 1.18E+OO 1.21E+01 3.92E-01 Pr-143 2.21E-02 6.64E-03 1.09E-03 0.00E+OO 3.59E-03 5.18E-01 1.16E-01 Pr-144 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO . O.OOE+OO O.OOE+OO 0.00E+OO Nd-147 1.35E-02
1.09E-02 8.49E-04 O.OOE+OO 6.00E-03 4.09E-01 1.02E-01 W-187 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Np-239 O.OOE+OO O.OOE+OO O.OOE+OO o.o'OE+OO O.OOE+OO O.OOE+OO O.OOE+OO Page 16of16

For Information Only Attachment K ODCM-QA-008 Revision 18 Page 72 of 86 REMP DOSE FACTORS FOR INFANT AGE GROUP: MILK (Page 1 of 2) mrem-liter/pCi-yr

:;:rfiuJC[IDE

..:.'.'!!l:~-, .. *:~if'!~~~NE :~!VER,,. * :*,:~T,~Eioov

                                                                  ..     -**.. :  TB~:~orb    'RIQNEY*        LUNG.*    Gl~tl:fr H-3      O.OOE+OO    1.02E-04            1.02E~04   1.02E-04     1.02E-04      1.02E-04 1.02E-04 C-14        7.82E-03   1.67E-03            1.67E-03   1.67E-03     1.67E-03      1.67E-03 1.67E-03 Na-24        O.OOE+OO    O.OOE+OO           O.OOE+OO. O.OOE+OO    O.OOE+OO      O.OOE+OO  O.OOE+OO P-32        5.09E-01   2.99E-02            1.97E-02   O.OOE+OO    O.OOE+OO      O.OOE+OO  6.89E-03 Cr-51        O.OOE+OO    O.OOE+OO           4.43E~06    2.89E-06    6.31E-07      5.62E-06  1.29E-04 Mn-54         0.00E+OO    6.54E-03            1.48E-03   O.OOE+OO    1.45E-03      O.OOE+OO  2.40E-03 Mn-56         O.OOE+OO    O.OOE+OO           O.OOE+OO    O.OOE+OO    O.OOE+OO      O.OOE+OO  O.OOE+OO Fe-55        4.58E-03    2.96E-03           7.91E-04    O.OOE+OO    O.OOE+OO       1.45E-03 3.76E-04 Fe-59        9.85E-03    1.72E-02           6.78E-03    O.OOE+OO    O.OOE+OO      5.09E-03  8.22E-03 C0-:58       O.OOE+OO    1.16E-03           2.91E-03    O.OOE+OO    O.OOE+OO      O.OOE+OO  2.90E-03 Co-60        O.OOE+OO    3.56E-03           8.41E"03    O.OOE+OO    O.OOE+OO      O.OOE+OO  8.47E-03 Ni-63       2.09E-01    1.29E-02           7.26E-03    O.OOE+OO    O.OOE+OO      O.OOE+OO  6.43E-04 Ni-65       O.OOE+OO    O.OOE+OO           O.OOE+OO    O.OOE+OO    O.OOE+OO      O.OOE+OO  O.OOE+OO Cu-64         O.OOE+OO    0.00E+OO           O.OOE+OO    O.OOE+OO    O.OOE+OO      O.OOE+OO  O.OOE+OO Zn-65         6.04E-03    2.0?E-02           9.55E-03    O.OOE+OO    1.00E-02      O.OOE+OO  1.75E-02 Zn-69        O.OOE+OO    O.OOE+OO           O.OOE+OO    O.OOE+OO    O.OOE+OO      O.OOE+OO  O.OOE+OO Br-83       O.OOE+OO    O.OOE+OO           O.OOE+OO   .O.OOE+OO    O.OOE+OO      O.OOE+OO  O.OOE+OO Br-84       O.OOE+OO    O.OOE+OO           O.OOE+OO    O.OOE+OO    O.OOE+OO      O.OOE+OO  O.OOE+OO Br-85       O.OOEi:OO   O.OOE+OO           0.00E+OO    O.OOE+OO    O.OOE+OO      O.OOE+OO  O.OOE+OO Rb-86         O.OOE+OO    5.21E-02           2.57E-02    0.00E+OO    O.OOE+OO      O.OOE+OO  1.33E-03 Rb-88         O.OOE+OO    O.OOE+OO          .0.00E+OO    O.OOE+OO    0.00E+OO      O.OOE+OO  O.OOE+OO Rb-89         O.OOE+OO    O.OOE+OO        'O.OOE+OO      O.OOE+OO   .O.OOE+OO      O.OOE+OO  O.OOE+OO Sr-89        8.06E-01    O.OOE+OO           2.31E-02    O.OOE+OO    O.OOE+OO      O.OOE+OO  1.66E-02 Sr-90        6.10E+OO    O.OOE+OO           1:55E+OO    O'.OOE+OO   O.OOE+OO      O.OOE+OO  7.62E-02 Sr-91        O.OOE+OO    O.OOE+OO           O.OOE+OO    O.OOE+OO    O.OOE+OO      O.OOE+OO  O.OOE+OO Sr-92        O.OOE+OO    O.OOE+OO           O.OOE+OO    O.OOE+OO    O.OOE+OO      O.OOE+OO  O.OOE+OO Y-90        O.OOE+OO    O.OOE+OO           O.OOE+OO    O.OOE+OO    O.OOE+OO      O.OOE+OO  O.OOE+OO Y-91m          O.OOE-+;00  O.OOE+OO           O.OOE+OO    O.OOE+OO    O.OOE+OO      O.OOE+OO  O.OOE+OO Y-91        3.64E-04    O.OOE+OO           9.?0E-06    O.OOE+OO  . O.OOE+OO      O.OOE+OO  2.61E-02 Y-92        O.OOE+OO    O.OOE+OO           O.OOE+OO    O.OOE+OO    O.OOE+OO      O.OOE+OO  O.OOE+OO Y-93        O.OOE+OO    O.OOE+OO           o.o*oe+oo   O.OOE+OO    O.OOE+OO      O.OOE+OO  O.OOE+OO Zr-95        6.65E-05    1.62E-05           1.15E-05    O.OOE+OO    1.75E-05      O.OOE+OO  8.0?E-03 Zr-97         O~OOE+OO    O.OOE+oo           O.OOE+OO    O.OOE+OO    O.OOE+OO      O.OOE+OD  D.OOE+OO Nb-95         1.33E-05    5.49E-06           3.17E-06    O.OOE+OO    3.93E-06      0.00E+OO  4.63E-03 Mo-99          O.OOE+OO    O.OOE+OO           O.OOE+oo    O.OOE+OO    O.OOE+OO      O.OOE+OO  O.OOE+OO Tc-99m            O.OOE+OO    O.OOE+OO           O.OOE+OO    O.OOE+OO    O.OOE+OD      O.OOE+OD  O.OOE+OO Page 1 of 8

For Information Only Attachment K ODCM-QA-008 Revision 18 Page 73 of 86 REMP DOSE FACTORS FOR INFANT AGE GROUP: MILK (Page 2 of 2) mrem-liter/pCi-yr NiJCLID~lJ':: BONE:;' LIVER:~; :, T.BODY THYRdJt>* * . KIDNEY/' .. LUNG Gi~l.LI Tc-101 O.OOE+OO O.OOE+OO O.OOE+OO -0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO Ru-103 4.71E-04 O.OOE+OO 1.58E-04 0.00E+OO 9.81E-04 O.OOE+OO 5.73E-03 Ru-105 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOEtOO O.OOE+OO O.OOE+OO Ru-106 7.92E-03 O.OOE+OO 9.90E-04 0.00E+OO 9.37E-03 O.OOE+OO 6.02E-02 Ag-110m 3.27E-04, 2.39E-04 1.58E-04 0.00E+OO 3.41E-04 . O.OOE+OO 1.24E-02 Te-125m 7.51E-03 2.51E-03 1.01E-03 2.53E-03 O.OOE+OO O.OOE+OO 3.58E?03 Te-127m 1.91E-02. 6.32E-03 2.31E-03 5.51E-03 4.69E-02 O.OOE+OO 7.69E-03 Te-127 0.00E+OO O.OOE+OO

O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO Te-129m 3.17E-02 1.09E-02 4.88E-03 1.22E-02 7.92E-02 O.OOE+OO 1.89E-02 Te-129 8.99E~05 3.10E-05 2.10E-05 7.54E-05 2.24E-04 O.OOE+OO 7.19E-03 Te-131m O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Te-131 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE-l;OO O.OOE+OO O.OOE+OO O;OOE+OO Te-132 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-130 : 0.00E+OO O.OOE+OO . O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-131 9.97E-03 1.17E-02 5.17E-03 3.86E+OO 1.37E-02 O.OOE.+00 4.19E-04 1-132 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-133 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 1-134 'O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.ODE+OO O.OOE+OO 1-135 0.00E+OO O.OOE+Oc:i O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Cs-134 1.24E-01 2.32E-01 2.34E-02 O.OOE+OO 5.96E-02 2.44E-02 6.29E-04 Cs-136 1.36E-02 4.01E-02 1.50E-02 O.OOE+OO 1.60E-02 3.27E-03 6.09E-04 Cs-137 1.7~E-01 2.02E-01 1.43E-02 O.OOE+OO 5.41E-02 2.19E-02 6.30E-04 Cs-138 O.OOE+OO O.OOE+OO
O.OOE+OO p.OOE-+;00 O.OOE+OO O.OOE+OO O.OOE+OO Ba-139 O.OOE+OO O.ODE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ba-140 :5.06E-02 5.06E-05 2.61E-03 O.OOE-t;OO 1.20E-05 3.11 E-05 1.241:;-02 Ba-141 *O.OOE+OO O.OOE+OO O.OOE+OO . O.OOE+OO O.OOE+OO O.OOE+OO o.ociE+OO Ba-142 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO La-140 O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO La-142 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ce-141 2.49E-05 1.52E-05 1.79E-06 O.OOE+OO 4.68E-06 O.OOE+OO 7.84!=-03 Ce-143 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O;OOE+OO Ce-144 9.79E-04 4.01E-04 5.48E-05 O.OOE+OO 1.62E-04 O.OOE+OO 5.62!=-02 Pr-143 2.42E-05. 9.06E-06 1.20E-06 O.OOE+OO 3.37E-06 O.OOE+OO 1.28E-02 Pr-144 0.001;:+00 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Nd-147 1.61E-05 1.65E-05 1.01E-06 O.OOE+OO 6.37E-06 O.OOE+OO 1.0SE-02 W-187 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Np-239 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO . O.OOE+OO O.OOE+OO Page 2 of 8

For Information Only Attachment K ODCM-QA-008 Revision 18 Page 74 of 86 REMP DOSE FACTORS FOR INFANT AGE GROUP: DRINKING WATER (Page 1 of 2) mrem-liter/pCi-yr i.[*~i~~c.~1.0;. * ~,:j3P,~i: *.. :-:* !~i¥~$: *. '. T.~OPY THYROIP',i:f \)W:~l{.IDNE=:Y ~~::ii ;~.:>l:UNG -:,:.~~<:?(*L;LI '* ... H-3 O.OOE+OO 1.02E-04 1.02E-04 1.02E-'04 1.02E-04 1.02E-04 1.02E-04 C-14 7.82E-03 1.67E-03 1.67E-03 1.67E-03 1.67E-03 1.67E-03 1.67E-03 Na-24 1.91E-03 1.9.1E-03 1.91E-03 1.91E-03 1.91E-03 1.91E-03 1.91E-03 P-32 5.48E-01 3.22E-02 2.12E-02 O.OOE+OO O.OOE+OO O.OOE+OO 7.41E-03 Cr-51 O.OOE+OO O.OOE+OO 4.60E-06 3.00E~06 6.55E-07 5.83E-06 1.34E-04 Mn-54 O.OOE+OO 6.56E-03 1.49E-03 O.OOE+OO 1.45E-03 O.OOE+OO 2.41 E-03 Mn-56 O.OOE+OO 1.07E-05 1.85E-06 O.OOE+OO 9.22E-06 O.OOE+OO 9.74E-04 Fe-55 4.59E-03 2.96E-03 7.92E-04 0.00E+OO O.OOE+OO 1.45E-03 3.76E-04 Fe-59 1.01E-02 1.76E-02 6.94E-03 O.OOE+OO 0.00E+OO 5.21E-03 8.42E-03 Co-58 O.OOE+OO 1.18E-03 2.95E-03 O.OOE+OO 0.00E+OO O.OOE+OO 2.95E-03 Co-60 O.OOE+OO 3.56E-03 8.41E-03 O.OOE+OO O.OOE+OO O.OOE+OO 8.48E-03 Ni-63 2.09E-01 1.29E-02 7.26E-03

O.OOE+OO O.OOE+OO O.OOE+OO 6.43E-04 Ni-65 5.72E-05 6.47E-06 2.94E-06 O.OOE+OO O.OOE+OO O.OOE+OO 4.93E-04 Cu-64 O.OOE+OO 1.04E-04 4.83E-05 O.OOE+OO 1.77E-04 O.OOE+OO 2.14E-03 Zn-65 6.06E-03 2.08E-02 9.59E-03 O.OOE+OO 1.01E-02 O.OOE+OO 1.76E-02 Zn-69 3.96Ecog 7.13E-09 5.31E-10 O.OOE+OO 2.96E-09 O.OOE+OO 5.82E-07 Br-83 O.OOE+OO O.OOE+OO 3.69E-06 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-84 O.OOE+OO O.OOE+OO 1.99E-11 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-85 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Rb-86 O.OOE+OO 5.51E-02 2.72E-02 O.OOE+OO O.OOE+OO O.OOE+OO 1.41 E-03 Rb-88 O.OOE+OO 1.16E-16 6.35E-17 O.OOE+OO O.OOE+OO O.OOE+OO 1.13E-16 Rb-89 O.OOE+OO 9.23E-19 6.36E-19 O.OOE+OO O.OOE+OO O.OOE+OO 3.14E-19 Sr-89 8.23E-01 O.OOE+OO 2.36E-02 O.OOE+OO O.OOE+OO O.OOE+OO 1.69E-02 Sr-90 6.10E+OO O.OOE+OO 1.55E+OO 0.00E+OO 0.00E+OO O.OOE+OO 7.62E-02 Sr-91 6.87E-03 O.OOE+OO 2.49E-04 O.OOE+OO O.OOE+OO O.OOE+OO 8.14E-03 Sr-92 2.94E-04 O.OOE+OO 1.09E-05 . O.OOE+OO O.OOE+OO O.OOE+OO 3.17E-03 Y-90 2.52E-05 O.OOE+OO 6.75E-07 O.OOE+OO O.OOE+OO O.OOE+OO 3.48E-02 Y-91m 1.19E-11 O.OOE+OO 4.06E-13 O.OOE+OO O.OOE+OO O.OOE+OO 3.97E-08 Y-91 3.71E-04 O.OOE+OO 9.87E-06 O.OOE+OO O.OOE+OO O.OOE+OO 2.66E-02 Y-92 2.41E-07 O.OOE+OO 6.77E~09 O.OOE+OO O.OOE+OO O.OOE+OO 4.60E-03 Y-93 3.52E-06 O.OOE+OO 9.59E-08 O.OOE+OO O.OOE+OO O.OOE+OO 2.78E-02 Zr-95 6.76E-05 1.65E-05 1.17E-05 O.OOE+OO 1.78E-05 O.OOE+OO 8.21E-03 Zr-97 2.99E-06 5.12E-07 2.34E-07 0.00E+OO 5.16E-07 O.OOE+OO 3.27E-02 Nb-95 1.37E-05 5.65E-06 3.27E-06 O.OOE+OO 4.05E-06 O.OOE+OO 4.77E-03 Mo-99 O.OOE+OO 9.89E-03 1.93E-03 O.OOE+OO 1.48E-02 O.OOE+OO 3.26E-03 Tc-99m 1.59E-07 3.28E-07 4.23E-06 O.OOE+OO 3.53E-06 1.72E-07 9.53E-05 Page 3 of 8

For Information Only Attachment K ODCM-QA-008 Revision 18 Page 75 of 86 REMP DOSE FACTORS FOR INFANT AGE GROUP: DRINKING WATER (Page 2 of 2) mrem-Iiter/pCi-yr Tc-101 4.38E-22 5.52E-22 5.46E-21 O.OOE+OO 6.56E-21 3.01E-22 9.38E-20 Ru-103 4.84E-04 O.OOE+OD 1.62E-04 D.OOE+OO 1.01E-03 D.DOE+OO 5.89E-03 Ru-105 6.89E-06 O.OOE+OO 2.32E-06 O.OOE+OO 5.07E-05 O.OOE+OD 2.74E-03 Ru-106 7.95E-03 O.OOE+OO 9.92E-04 O.OOE+OO 9.4DE-03 O.DOE+OD 6.03E-02 Ag-110m

3.28E-04 2.40E-04 1.59E-04 O.OOE+OO 3.43E-04 O.OOE+OO 1.24E-02 Te-125m 7.64E-03 2.56E-D3 1.03E-03 2.57E-03 O.OOE+OO O.OOE+OO 3.64E-03 Te-127m 1.92E-02 6.38E-03 2.33E-03 5.56E-03 4.74E-02 O.OOE+OO 7.76E-03 Te-127 1.36E-04 4.54E-05 2.91E-D5 1.10E-04 3.31E-04 O.OOE+OO 2.85E-03 Te-129m 3.27E-02 1.12E-02 5.03E-03 1.25E-02 8.17E-02 O.OOE+OO 1.95E-02 Te-129 9.28E-05 3.20E-D5 2.17E-05 7.77E-05 2.31E-04 O.OOE+OO 7.41E-03 Te-131m 3.80E-03 1.53E-03 1.26E-03 3.10E-03 1.0SE-02 O.OOE+OO 2.58E-02 Te-131 1.29E-13 4.78E-14 3.63E-14 1.15E-13 3.31 E-13 O.OOE+OO 5.22E-12 Te-132 6.17E-03 3.06E-03 2.85E-03 4.51E-03 1.91E-02 O.ODE+OO 1.13E-02 1-130 1.01 E-03 2.22E-03 8.92E-04 2.49E-01 2.44E-03 O.OOE+OO 4.76E-04 1-131 1.13E-02 1.34E-02 5.88E-03 4.39E+OO 1.56E-02 O.OOE+OO 4.77E-04 1-132 1.47E-05 2.99E-05 1.06E-D5 1.40E-03 3.34E-05 O.OOE+OO 2.42E-05 1-133 2.77E-03 4.03E-03 1.18E-03 7.32E-01 4.73E-03 O.OOE+OO 6.81E-04 1-134 2.21E-08 4.54E-08 1.61 E-08 1.06E-06 5.07E-08 O.OOE+OO 4.69E-08 1-135 3.41E-04 6.79E-04 2.48E-04 6.08E-02 7.57E-04 O.OOE+OO 2.46E-04 Cs-134 1.24E-D1 2.32E-01 2.34E-02 O.OOE+OO 5.97E-02 2.45E-02 6.30E-04 Cs-136 1.48E-02 4.34E-02 1.62E-02 O.OOE+OO 1.73E-02 3.54E-03 6.59E-04 Cs-137 1.72E-01 2.02E-01 1.43E-02 O.OOE+OO 5.41E-02 2.19E-02 6.30E-04 Cs-138 3.D4E-11 4.94E-11 2.40E-11 O.OOE+OO 2.47E-11 3.85E-12 7.90E-11 Ba-139 7.25E-07 4.81E-10 2.10E~OB O.OOE+OD 2.89E-10 2.91E-10 4.59E-05 Ba-140 5.49E-02 5.49E-05 2.83E-03 O.OOE+OO 1.30E-05 3.37E-05 1.35E-02 Ba-141 2.03E-16 1.39E-19 6.40E-18 O.OOE+OO 8.36E-20 8.45E-20 2.48E-15 Ba-142 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OD O.OOE+OO O.OOE+OO 1.52E-24 La~140 5.66E-06 2.23E-06 5.74E-07 O.OOE+OO O.OOE+OO O.OOE+OO 2.62E-02 La-142 1.96E-09 7.20E-10 1.72E-10 O.OOE+OO O.OOE+OD O.OOE+OO 1.22E-04 Ce-141 2.57E-05 1.57E-05 1.84E-06 O.OOE+OO 4.83E-06 O.OOE+OO 8.10E-03 Ce-143 3.80E-06 2.52E-03 2.87E-07 O.OOE+OO 7.34E-07 O.OOE+OO 1.47E-02 Ce-144 9.82E-04 4.02E-04 5.50E-05 O.OOE+OO 1.62E-04 O.OOE+OO 5.64E-02 Pr-143
2.62E-05 9.78E-06 1.30E-06 O.OOE+OO 3.63E-06 O.OOE+OO 1.38E-02 Pr-144 2.74E-20 1.06E-20 1.38E-21 O.OOE+OO 3.85E-21 O.OOE+OO 4.94E-16 Nd-147 1.77E-05 1.82E-05 1.11E-06 O.OOE+OO 7.00E-06 O.OOE+OO 1.15E-02 W-187 2.10E-04 1.46E-04 5.05E-05 0.00E+OO O.OOE+OO O.OOE+OO 8.59E-03 Np-239 3.16E-06 2.83E-07 1.60E-07 0.00E+OO 5.64E-07 O.OOE+OO 8.17E-03 Page 4 of 8

For Information Only Attachment K ODCM-QA-008 Revision 18 Page 76 of 86 REMP DOSE FACTORS FOR INFANT AGE GROUP:INHALATION - QUARTERLY SAMPLING (Page 1 of 2) mrem-m 3/pCi-yr

**Nl;JCLip~i.1IT1 !~:f~::: eoiiJE:';'.:*;v f.~ivER;. '1~: ~;:,:::.taoov ,*;:.i.!'!rt!i¥RQfrf:{1 ~',~~~~:U;>NEY .**, >,,~~;~VNG * .*.*:(;1~LLI H-3 O.OOE+OO 6.51E-04 6.51E-04 6.51E-04 6.51E-04 6.51E-04 6.51E-04 C-14 2.65E-02 5.31E-03 5.31E-03 5.31E-03 5.31E-03 5.31E-03 5.31E-03 Na-24 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO 0.00E+OO O.OOE+OO P-32 1.86E+01 1.03E+OO 7.0BE-01 O.OOE+OO O.OOE+OO O.OOE+OO 1.47E-01 Cr-51 O.OOE+OO O.OOE+OO 2.BOE-04 1.BOE-04 4.14E-05 4.02E-02 1.12E-03 Mn-54 0.00E+OO 2.80E-02 5.51E-03 O.OOE+OO 5.51E-03 1.11E+OO 7.81E-03 Mn-56 O.OOE+OO 0.00E+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Fe-55 2.04E-02 1.21E-02 3.44E-03 O.OOE+OO 0.00E+OO 8.98E-02 1.13E-03 Fe-59 2.76E-02 4.78E-02 1.93E-02 O.OOE+OO O.OOE+OO 2.06E+OO 5.03E-02 Co-58 O.OOE+OO 1.91E-03 2.84E-03 O.OOE+OO O.OOE+OO 1.21E+OO 1.74E-02 Co-60 O.OOE+OO 8.15E-03 1.20E-02 O.OOE+OO O.OOE+OO 4.58E+OO 3.24E-02 Ni-63 3.39E-01 2.05E-02 1.16E-02 0.00E+OO O.OOE+OO 2.09E-01 2.42E-03 Ni-65 O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Cu-64 O.OOE+OO 0.00E+OO O.OOE+OO

O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Zn-65 2.20E-02 7.12E-02 3.54E-02 O.OOE+OO 3.70E-02 7.36E-01 5.85E-02 Zn-69 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-83 O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-84 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-85 O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Rb-86 O.OOE+OO 1.04E+OO 4.80E-01 O.OOE+OO *o.OOE+OO O.OOE+OO 1.65E-02 Rb-88 O.OOE+OO O.OOE+OO O.OOE+OO O:OOE+OO 0.0eiE+OO O.OOE+OO O.OOE+OO Rb-89 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Sr-89 7.43E-01 O.OOE+OO 2.13E-02 O.OOE+OO O.OOE+OO 3.79E+OO 1.20E-01 Sr-90 4.10E+01 o:ooE+oo 2.60E+OO O.OOE+OO O.OOE+OO 1.13E+01 1.31E-01 Sr-91 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Sr-92 O.OOE+oo 0.0,0E+OO O.OOE+OO . O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-90 o.oonoo O.OOE+OO o.ooE+oo O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-91m O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-91 1.01E+OO O.OOE+OO 2.69E-02 O.OOE+OO 0.00E+OO 4.21E+OO 1.21 E-01 Y-92 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-93 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO Zr-95 1.89E-01 4.57E-02 3.33E-02 0.00E+OO 5.09E-02 2.87E+OO 3.56E-02 Zr-97 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Nb-95 3.86E-02 1.58E-02 9.32E-03 O.OOE+OO 1.16E-02 1.18E+OO 3.12E-02 Mo-99 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Tc-99m O.OOE+oo O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Page 5 of 8

For Information Only Attachment K ODCM-QA-008 Revision 18 Page 77 of 86 REMP DOSE FACTORS FOR INFANT AGE GROUP: INHALATION - QUARTERLY SAMPLING (Page 2 of 2) 3 mrem-m /pCi-yr i~J?r¢~~DE -"** 'BP~J;:,,. :.. LIY~~jt\:\ .

                                                         **i
                                                             . T.BOD,Y.
                                                                  * ..\:.*
                                                                                 .THYR.()1~::;.:r;;' ~:*I ': KIDNEY* * :i:,1'*:*.:,'L..VNG*
                                                                                                                                               ';>A~~l*LLI Tc-101      O.OOE+OO        O.OOE+OO          O.OOE+OO           O.OOE+OO                  O.OOE+OO          O.OOE+OO            O.OOE+OO Ru-103      4.50E-03        O.OOE+OO          1.52E-03           O.OOE+OO                  9.48E-03          1.23E+OO             3.60E-02 Ru-105      O.OOE+OO        O.OOE+OO          O.OOE+OO           O.OOE+OO                  O.OOE+OO         O.OOE+OO             O.OOE+OO Ru-106      9.46E-02        O.OOE+OO          1.19E-02           0.00E+OO                  1.16E-01          1.26E+01             1.78E-01 Ag-110m       1.13E-02       8.20E-03          5.67E-03           O.OOE+OO                  1.24E-02         4.16E+OO              3.75E-02 Te-125m      8.21E-03        3.43E-03          1.14E-03            2.80E-03                O.OOE+OO           7.70E-01             2.23E-02 Te-127m      2.23E-02        9.23E-03          2.77E-03            6.51E-03                 5.01E-02          1.75E+OO             3.65E-02 Te-127      O.OOE+OO        0.00E+OO          O.OOE+OO           O.OOE+OO                 O.OOE+OO          O.OOE+OO             O.OOE+OO Te-129m      3.62E-02        1.56E-02          5.71E-03            1.40E-02                 8.15E-02         4.31E+OO              1.77E-01 Te-129      2.02E-07        8.90E-08          4.81E-08            1.73E-07                 4.49E-07          7.68E-03             6.75E-02 Te-131m      O.OOE+OO        O.OOE+OO          O.OOE+OO           O.OOE+OO                 O.OOE+OO          O.OOE+OO             O.OOE+OO Te-131      O.OOE+OO        O.OOE+OO          O.OOE+OO           O.OOE+OO                 O.OOE+OO          O.OOE+OO             O.OOE+OO Te-132      O.OOE+OO        O.OOE+OO          O.OOE+OO           O.OOE+OO                 0.00E+OO          O.OOE+OO             O.OOE+OO 1-130      O.OOE+OO        O.OOE+OO          O.OOE+OO           O.OOE+OO                 O.OOE+OO          O.OOE+OO             O.OOE+OO 1-131      3.79E-02        4.44E-02          1.96E-02           1.48E+01                  5.18E-02         O.OOE+OO              1.06E-03 1-132      O.OOE+OO        0.00E+OO          O.OOE+OO           O.OOE+OO                 0.00E+OO          O.OOE+OO             O.OOE+OO 1-133      O.OOE+OO        O.OOE+OO          O.OOE+OO           O.OOE+OO                 O.OOE+OO          O.OOE+OO             O.OOE+OO 1-134      O.OOE+OO        O.OOE+OO         .O.OOE+OO           O.OOE+OO                 O.OOE+OO          O.OOE+OO             O.OOE+OO 1-135      O.OOE+OO        O.OOE+OO          O.OOE+OO           O.OOE+OO                 O.OOE+OO          O.OOE+OO             O.OOE+OO Cs-134      4.13E-01        7.33E-01          7.77E-02           O.OOE+OO                  1.99E-01          8.31E-02            1.39E-03 Cs-136      5.34E-01        1.49E+OO          5.85E-01           O.OOE+OO                  6.24E-01          1.30E-01            1.58E-02 Cs-137      5.50E-01        6.14E-01          4,56E-02           O.OOE+OO                  1.73E-01          7.15E-02            1.34E-03 Cs-138      O.OOE+OO        O.OOE+OO          O.OOE+OO           O.OOE+OO                 O.OOE+OO          O.OOE+OO             O.OOE+OO Ba-139     O.OOE+OO         O.OOE+OO          O.OOE+OO           O.OOE+OO                 O.OOE+OO.         O.OOE+OO             O.OOE+OO Ba-140      6.64E-01        6.64E-04          3.44E-02           O.OOE+OO                  1.59E-04         1.89E+01             4.55E-01 Ba-141     O.OOE+OO         O.OOE+OO          O.OOE+OO           O.OOE+OO                 O.OOE+OO          O.OOE+OO             O.OOE+OO Ba-142     0.00.E+OO        O.OOE+OO          O.OOE+OO           O.OOE+OO                 O.OOE+OO          O.OOE+OO             O.OOE+OO La-140     O.OOE+OO         O.OOE+OO          O.OOE+OO

O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO La-142 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ce-141 7.33E-02 4.41E-02 5.26E-03 O.OOE+OO 1.39E-02 1.37E+OO 5.70E-02 Ce-143 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ce-144 3.57E+OO 1.35E+OO 1.97E-01 O.OOE+OO 6.01 E-01 1.10E+01 1.66E-01 Pr-143 1.44E-01 5.39E-02 7.20E-03 O.OOE+OO 2.03E-02 4.46E+OO 3.84E-01 Pr-144 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Nd-147 1.41E-01 1.45E-01 8.91E-03 O.OOE+OO 5.61E-02 5.74E+OO 5.56E-01 W-187 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Np-239 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Page 6 of 8

For Information Only Attachment K ODCM-QA-008 Revision 18 Page 78 of 86 REMP DOSE FACTORS FOR INFANT AGE GROUP: INHALATION~ WEEKLY SAMPLING (Page 1 of 2) 3 mrem-m fpCi-yr

             ~. .t-Juc~10~;~;'.j , ; : BONE:)r,:d ,,... LIVER. *,::  ft r;eooyY *:.: 'flt~YRoip ' fP~'~!KiDNEY .. :,:;;;}j:;°ONG .. *.* *::;~:~~:~~i:L.~1 H-3            O.OOE+OO             6.47E-04       6.47E-04         6.47E-04        6.47E-04         6.47E-04              6.47E-04 C-14             2.65E-02            5.31E-03       5.31E-03         5.31E-03        5.31E-03         5.31E-03              5.31E-03 Na-24

0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO P-32 2.41E+OO 1.33E-01 9.17E-02 O.OOE+OO O.OOE+OO O.OOE+OO 1.91E-02 Cr-51 O.OOE+OO O.OOE+OO 9.76E-05 6.28E-05 1.44E-05 1.40E-.02 3.90E-04 Mn-54 O.OOE+OO 2.55E-02 5.02E-03 O.OOE+OO 5.02E-03 1.01E+OO 7.11E"03 Mn-56 O.OOE+OO . O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Fe-55 1.98E-02 1.18E-02 3.34E-03 O.OOE+OO O.OOE+OO 8.72E-02 1.10E-03 Fe-59 1.43E-02 2.48E-02 1.00E-02 O.OOE+OO O.OOE+OO 1.07E+OO 2.62E-02 Co-58 0.00E+OO 1.26E-03 1.88E-03 O.OOE+OO O.OOE+OO 8.04E-01 1.15E-02 Co-60 O.OOE+OO 8.03E-03 . 1.1'8E-02 O.OOE+OO O.OOE+OO 4.51E+OO 3.20E-02 Ni-63 3.39E-01 2.04E-02 1*.16E-02 O.OOE+OO O.OOE+OO 2.09E-01 2.42E-03 Ni-65 O.OOE+OO .O.OOE+OO O:OOE+OO 0.00E+OO O.OOE+OO O.OOE+OO O.OOE+OO Cu-64 O.OOE+OO O.OOE+OO O:O.OE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Zn-65 1.95E-02 6.32E-02 3.14E-02 O.OOE+OO 3.28E-02 6.53E-01 5.19E-02 Zn-69 O.OOE+OO o:ooE+oo O.OOE+OO O.OOE+OO, O.OOE+OO O.OOE+OO O.OOE+OO Br-83 O.OOE+OO O.OOE+'oo O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Br-84 O.OOE+OO o.ooE:+oo O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+.00 Br-85 O.OOE+OO O.OOE+oo o:ooE+oo . O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Rb-86 O.OOE+OO 2.17E-01 : 1.00E-01 O.OOE+OO O.OOE+OO O.OOE+OO 3.46E-03 Rb-88 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O:OOE+OO Rb-89 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Sr-89 4.17E-01 O.OOE+OO 1.20E-02 O.OOE+OO O.OOE+OO 2.13E+OO 6.71E-02 Sr-90 4.09E+01 O,OOE+OO 2.59E+OO O.OOE+OO O.OOE+OO 1.1'2E+01 1.31E-01 Sr-91 O.OOE+OO O.OOE+OO .Q.OOE+OO O.OOE+OO O.OOE+OO O.QOE+OO O,OOE+OO Sr-92 O.OOE+OO O.OOE+OO I O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-90 O.OOE+OO 0.00E+OO " O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-91m O.OOE+oo* O.OOE+OO O.OOE+OO .Q.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-91 6.13E-01 O.OOE+OO 1.63E-02 : O.OOE+OO O.OOE+OO 2.55E+OO 7.33E-02 Y-92 O.OOE+OO O,OOE+OO O.OOE+oo O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Y-93 O.OOE+OO O:OOE+bo o:ooE+oo O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Zr-95 1.20E-01 2.89!=-02 2:11 E-02* . O.OOE+OO 3.23E-02 1.82E+OO 2.25E-02 Zr-97 O.OOE+OO O:OOE+OO O.OOE+QO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Nb-95 1.aaE-02 6.B9F-o3' 4:05E-03' O.OQE+OO 5.06E-03 5.13E-01 1.36E-02 Mo-99. O.OOE+OO O.OOE+OO O.'OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Tc-99m O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Page 7 of 8

For Information Only Attachment K ODCM-QA-008 Revision 18 Page 79 of 86 REMP DOSE FACTORS FOR INFANT AGE GROUP: INHALATION -WEEKLY SAMPLING (Page 2 of 2) _ 3 mrem-m /pCi-yr -

Gl-LLI Tc-101 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ru-103 2.14E-03 O.OOE+OO 7.22E-04 O.OOE+OO 4.51 E-03 5.87E-01 1.71E-02 Ru-105 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO _ O.OOE+OO O.OOE+OO Ru-106 8.74E-02 O.OOE+OO 1.09E-02 O.OOE+OO 1.0_7E-01 1.16E+01 1.65E-01 Ag-110m 1.01E-02 7.29E-03 5.05E-03 O.OOE+OO 1.10E-02 3.70E+OO 3.34E-02 Te-125m 4.96E-03 2.07E-03 6.86E-04 1.69E-03 - O.OOE+ciO -4_.66E-01 1.35E-02

               -Te-127m    1.70E-02  7.06E-03   2.12E-03      4.98E-03     3.84E-02        1.34E+OO   2.79E-02 Te-127   O.OOE+OO   O.OOE+OO   O.OOE+OO      O.OOE+OO    O.OOE.f;OO      O.OOE+OO   O.OOE+OO Te-129m    1.52E-02  6.55E-03   2.39E-03      5.88E-03    3.42E-02         1.81E+OO   7.42E-02 Te-129    8.47E-08  3.73E-08   2.02E-08      7.25E-08    1.88E       3.22E-03  2.83E-02 Te-131m   O.OOE+OO   O.OOE+OO   O.OOE+OO      O.OOE+OO    O..OOE+OO       O.OOE+OO   O.OOE+OO Te-131   O.OOE+OO   O.OOE+OO   O.OOE+OO      O.OOE+OO    O.OOE+OO        0.00E+OO   O.OOE+OO Te-132   O.OOE+OO   O.OOE+OO   O.OOE+OO      O.OOE+OO    O.OOE-+;00      O.OOE+OO   O.OOE+OO 1-130   O.OOE+OO   O.OOE+OO   O.OOE+OO      O.OOE+OO    O.OOE-+;00      O.OOE+OO   Ci.OOE+OO 1-131    3.79E-02  4.44E-02   1.96E-02      1.48E+01    5-.18E-02       O.OOE+OO    1.06E-03 1-132   O.OOE+OO   O.OOE+OO   O.OOE+OO      O.OOE+OO    O,OOE+OO       .O.OOE+OO   O.OOE+OO 1-133   O.OOE+OO   O.OOE+OO   O.OOE+OO      O.OOE+OO    O.OOE+OO        O.OOE+OO   O.OOE+OO 1-134   O.OOE+OO   O.OOE+OO   O.OOE+OO      O.OOE+Oci   O.OOE+OO        O.OOE+OO   O.OOE+OO 1-135   O.OOE+OO   O.OOE+OO   O.OOE+OO      o.oo*E+oo   O.OOE+OO        O.OOE+OO   O.OOE+OO Cs-134:   3.97E-01  7~05E-01   7.47E-02      O.OOE+OO    1.91 E-01       -7.99E-02  1.34E-03 Cs-13S    5.81.E-02 1.62E-0,1  6.36~-02      O.OOE+OO    6.78E-02         1.41 E-02 1.72E-03 Cs-137    5.49E-01             4.55E-02      O.OOE+OO    1.72E-01         7.13E-02  1.33E-03 Cs-138   0.00E+OO   O.OOE+OO   O.OOE+OO     O.OOE+OO     O.OOE+OO        O.OOE+OO   O.OOE+OO Ba-139   O.OOE+OO   0.00.E+OO  O.OOE+OO      O.OOE+OO    O.OOE+OO        O.OOE+OO   O.OOE+OO Ba-14!)   6.77E-02  6.77E-05   3.50E-03      O.OOE+OO    1.62E-05        1.93E+OO   4.64E-02 Ba-14~   O.OOE+OO   O.OOE+OO   O.OOE+OO     O.OOE+OO     O.OOE+OO        O.OOE+OO   O.OOE+OO Ba-142   O.OOE+OO   O.OOE+OO   O.OOE+OO     O.OOE+OO

O.OOE+OO O.OOE+OO O.OOE+OO La-140 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO La-142 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ce-141 2.99E-02 1.BOE-02 2.14E-03 O.OOE+OO s:66E-03 5.57E-01 2.32E-02 Ce-143 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Ce-144 3.22E+OO 1.22E+OO 1.78E-01 O.OOE+OO 5.42E-01 9.93E+OO 1.50E-01 Pr-143 1.67E-02 6.26E-03 8.35E-04 O.OOE+OO 2.36E-03 5.17E-01 4.45E-02 Pr-144 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OciE+OO O.OOE+OO 0.00E+OO Nd-147 9.90E-03 1.01E-02 6.23E-04 O.OOE+OO 3.93E-03 4.02E-01 3.89E-02 W-187 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Np-239 O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO O.OOE+OO Page 8 of 8

For Information Only Attachment L ODCM-QA-008 Revision 18 Page 80 of 86 REMP DOSE FACTORS FOR ADULT AGE GROUP: SHORELINE/SEDIMENT TOTAL BODY AND SKIN DOSE* mrem-kg/pCi-yr NUCLIDE T.aoov **sKIN;( NOC~IDE T.BODY SKIN ::;R H-3 O.OOE+OO* O.OOE+OO Ru-103' 6.91E-07 8.06E-07 C-14 O.OOE+OO O.OOE+OO Ru-105 8.64E-07 9.79E-07 Na-24 4.BOE-06 5.57E-06 Ru-106 2.88E-07 3.46E-07 P-32 O.OOE+OO O.OOE+OO Ag-110m 3.46E-06 4.03E-06 Cr-51 4.22E-08 4.99E-08 Te-125m 6.72E-09 9.22E-09 Mn-54 1.11 E-06 1.31 E-06 Te-127m 2.11E-10 2.50E-10 Mn-56 2.11E-06 2.50E-06 Te-127 1.92E-09 . 2.11E-09 Fe-55 O.OOE+OO O.OOE+OO Te-129m 1.48E-07 1.73E-07 Fe-59 1.54E-06 1.80E-06 T~-129 " 1.36E-07 1.61E-07

                          . Co-58          1.34E-06       1.57E-06    Te-131m,        1.61E-06       1.90E-06 Co-60          3:26E-06       3.84E-06      Te-131        4.22E-07       4.99E-04 Ni-63        O.OOE+OO        0.00E+OO      Te-132

3.26E-07 3.84E-07 Ni-65 7.10E-07 8.26E-07 1-130 ,, 2.69E-06 ' 3;26E-06 Cu-64
3.05E-07 3.26E-07 1~131 5.38E-07 6.53E-07 Zn-65 7.68E-07 8.83E-07 1-132 3.26E-06 3.84E-06 Zn-69 O.OOE+OO I O.OOE+OO H33 7.10E-07 8.64E-07 Br-83 1.23E-08 1.79E-08 1-134 3.07E-06 3:65E-06 Br-84 2.30E-06 2.69E-06 1..:135 2.30E-06 2.69E-06 Br~85 O.OOE+OO 0.00E+OO Cs-134 2.30E-06 2.69E-06 Rb-86 1.21E-07 1.38E-07 Cs-136 2.88E-06 . 3.26E-06 Rb-88 . 6.72E-07 7.68E-07 Cs-137 8.06E-07 9.41E-07 Rb-89 2.88E-06 3.46E-06 Cs-138 4.03E-06 . 4.61E-06 Sr-89 *
1.08E-10 1.25E-10 Ba-139 4.61E-07 5.'18E-07 Sr-90 O.OOE+OO O.OOE+OO
Ba-140 4.03E-07 4.61E-07 Sr-91 1.36E-06 1.59E-06 Ba-141 .8.26E-07 9.41E-07.

Sr-92 .. 1.73E-06 1.92E-06 Ba-142 1.52E-06 1.73E-06 Y-90 4.22E-10 4.99E-10 I La-140 2.88E-06 3.26E,"06 Y-91m . 7.30E-07 8.45E-07 ' La-142 2.8aE:oa , 3.46E-06 Y-91 4.61E-09 5.18E-09 Ce-141 1.06E-07 1.19E-07 Y-92 ;, 3.07E-07 , 3.65E-07 Ce-143 4.22E-07 4.80E-07 Y"93 1.o9E-07 1.50E-07 Ce-144 6.14E-08 7.10E~08 Zr-95 . 9.60E-07 1.11E-06 Pr-143 O.OOE+OO O.OOE+OO

Zr-97 1.06E-06 1.23E-06 Pr-144 3.84E-08 4.42E-08 Nb-95 ! 9.79E-07 1.15E-06 Nd-147 1.92E-07 2.30E-07 Mo-99 , 3.65E-07 4.22E~07 W-187 5.95E-07 6.91E-07 Tc-99m .1.84E-07 2.11E-07 Np-239 1.82E-07 2.1.1E-07 Tc:.:101 , 5.18E-07 5.76E-07 Page 1of3

For Information Only Attachment L ODCM-QA-008 Revision 18 Page 81of86 REMP DOSE FACTORS. FOR TEEN AGE GROUP:SHORELINE/SEDIMENT TbTAL BODY AND SKIN DOSE mrem-kg/pCi-yr H-3 O.OOE+OO O.OOE+OO Ru-103 3.86E-06 4.50E-06 C-14 O.OOE+OO O.OOE+OO Ru-105 4.82E-06 5.47E-06 Na-24 2.68E-05 3.11 E-05 Ru-106 1.. 61 E-06 1.93E-06 P-32 O.OOE+OO O.OOE+OO Ag-11 Om 1.93E-05 2.25E-:05 Cr-51 . 2.36E-07 2.79E-07 Te-125m 3.75E-08 5.15E-08 Mn-54 6.22E-06 7.29E-06' Te-127m 1.18E-09 1.39E-09 Mn-56 1.18E-05 1.39E-05 Te-127 1.07E-08 1.18E-08 Fe-55 O.OOE+OO 0.00E+OO.

Te-129m 8.25E-07 9.65E-07 Fe-59 8.58E-06 1.01 E-05 Te-129 7.61E-07 9.00E-07 Co-58 7.50E-06 8.79E-06 Te-131m 9.00E-06 1.06E-05 Co-60 1.82E-05 2.14E-05 Te-131 2.36E-06 2.79E-03 Ni-63 0.00E+OO* O.OOE+OO Te-132. 1.82E-06 2.14E-06 Ni-65 3.97E-06 4.61E-06 l-130
1.SOE-05 1.82E-05 1

Cu-64 1:.70E-06 1.82E-06 1-131 ' 3.00E-06 3.64E-06 Zn-65 4.29E-06 4.9.3E-06 1-132 1.82E-05 2.14E-05 Zn-69 O.OOE+OO O.OOE+OO 1-133 3.97E-06 4.82E-06 Br-83 6.86E-08 9.97E-08 Jo.134 1.72E-05 2.04E-05 1.29E-05 1.50E-05 I-135 . 1.29E-05 1.50E-05 Br-85 O.OOE+OO O.OOE+OO Cs-134 1.29E-05 1.SOE-05 6,75E-07 7.72E-07 Cs-136 1.61E-05 **1.82E-05

                          , Rb-88     3.75E-06

4:29E-06 Cs-137 4.50E-06 5.25E-06

                          ' Rb-89     1.61 E-05    1.93E-05        Cs-138     2.25E-05          2.57E-05 Sr-89    6'.00E-10    6.97E-10        Ba-139     2.57E-06          2.89E-06 Sr,90    O'.OOE+OO    O.OOE+OO        Ba-140     2.25E-06          2.57E-06
                          '  Sr,91    7.61E-06. 8°.90E-06       Ba-141     4.61 E-06         5.25E-06 Sr-92                 1.07E-05        Ba-142     8.47E-06          9.65E-06 Y-90 .. 2.36E-09     2.79E-09        La-140     1.61E-05          1.82E-05 Y-91m     4.07E-06     4.72E-06        La-142     1.61E-0.5         1.93E-05 2.57E-08     2.89E-08       Ce-141      5.90E-07          6.65E-07 Y-92     1.72E-06     2.04E-06       Ce-143      2.36E-06          2.68E-06 Y-93                  8.36E-07                   3.43E-07          3.97E-07 Zr-95    5.36E-06     6.22E-06        Pr-143   . 0.0.0E+OO        O.OOE+OO Zr-97    5.90E-06     6.86E-06        Pr-144     2.14E-07          2.47E-07 Nb-95    5.47E-06   . 6.43E-06       Nd-147       1.07E~06         1.29E-06 Mo-99'   2.04E-06     2.36E-06        W-187      3.32E-06          3.86E-06 Tc-99m    1.03E~06     1.18E-06       Np-239      1.02E-06          1.18E-06 Tc-101    2.a9E-06     3.22E-06 Page 2of3

For Information Only Attachment L ODCM-QA-008 Revision 18 Page 82 of 86 REMP DOSE FACTORS FOR CHILD AGE GROUP: SHORELINE/SEDIMENT TOTAL BODY AND SKIN DOSE mrem-kg/pCi-yr NU6LIDE . ..~:J".BOD'(;* SKIN **NUCLIDE

                                                                        'r*-'.'*       ...,.... T.BdDY
                                                                                                     .=-::**
                                                                                                                .SKIN   '.=
                                                                                                                        ... ~

H-3 0.00E+OO O.OOE+OO Ru-103 8.06E-07 9.41E-07 C-14 O.OOE+OO O.OOE+OO Ru-105 1.01E-06 1.14E-06 Na-24 5.60E-06 6.50E-06 Ru-106 3.36E-07 4.03E-07 P-32 O.OOE+OO O.OOE+OO Ag-110m 4.03E-06 4.70E-06 Cr-51 4.93E-08 5.82E-08 Te-125m 7.84E-09 1.08E-08. Mn-54

1.30E-06. 1.52E-06 Te-127m 2.46E-10 2.91E-10 Mn-56 2.46E-06 2.91E-06 Te-127 2.24E-09 2.46E-09 Fe-55 O.OOE+OO O.OOE+OO. Te-129m 1.72E-OY. 2.02E-07 Fe-59 1.79E-06 2.11E-06 Te-129 1.59E-07 1.88E-07 Co-58 1.57E-06 1.84E-06 Te-131m 1.88E-06 .2.22E-06 Co-60 3.81 E-06 4.48E-06 Te-131 4.93E-07 *5.82E-04 Ni-63 O.OOE+OO
O.OOE+OO Te-132 3.81E-07 4.48E-07 Ni-65 8.29E-07 9.63E-07 1-130 3.14E-06 3.81E-06 Cu.,64 3.56E-07 3.81E-07 1-13.1 6.27E-07 7.62E-07 Zn-65 8.96E-07 1.03E-06. 1-132 3.81E~06 4.48E-06 Zn-69 O.OOE+OO O.OOE+OO 1-133 8.29E-07 1.01E-06 Br-83 1.43E-08 2.08E-08 1-134 3.58E-06 4.26E-06 Br-84 2.69E-06 3.14E-06 I 1..:135 2.69E-06 3.14E-06.

Br-85 O.OOE+OO O.OOE+OO, Cs-134 2.69E-06 3.14E-06 Rb-86 1.41 E-07 1.61 E-07 Cs-136 3.36E-06 3.81 E-06 Rb-88 7.84E-07 8.96E-07 C~-137 9.41E-07 1.10E-06 Rb-89 3.36E-06 4.03E-06 Cs-138 4.70E~06 5.38E-06 Sr-89 1.25E-10 1.46E-1.0 Ba-139 5.38E-07 6.05E-07 Sr-90 O.OOE+OO 0.00E+OO Ba-140 4.70E-07 5.38E-07 Sr-91 1.59E-06 1.86E-06. Ba-141 9.63E-07 1.10E-06 Sr-92 2.02E-06 2.24E-06 " Ba-142 1.77E-06 2.02E-06 Y-90 4.93E-10 5.82E-10 La-140 3.36E-06 '3.81 E-06 Y-91m 8.51E-07 fi'.86E-07 La-142 3.36E-06 4.03E-06 Y-91 5.38E-09 6.05E-09 Ce-141 1.23E-07 1.39E-07 Y-92 3.58E-07 4.26E-07 Ce-143 4.93E.:.07 5.BOE-07 Y-93 1.28E~07 1.75E-07 . ' Ce-144 7.17E-08 8.29E-08 Zr-95 1.12E-06 1.30E~06 Pr-143 O.OOE+OO O.OOE+OO Zr-97 1.23E-06 1.43E-06 I Pr-144 4.48E-08 5.15E-08 Nb-95 1.14E~06 . 1'.34E~06 Nd-147 2.24E-07 ,2.69E-07 Mo-99 4.26E-07' 4.93E~07 W-1~7 6.94E-07 8.0BE-07 Tc-99m 2.15E-07 2.46E-07 Np-239 2.13E-07 2.46E-07 Tc-101. 6.05E-07 6~72E~07 Page 3of3

For Information Only Attachment M ODCM-QA-008 Revision 18 Page 83 of 86 CONSOLIDATED DOSE CALCULATIONS Equations 1 - 4 in Section 6.0 of ODCM-QA-008 consolidate the methodology of Regulatory Guide (RG) 1.109 (Ref. 3.1). Equations 1, 3, and 4 are related to Equation A-1 of Appendix A to Revision 1 of RG 1.109. This equation is a generalized equation for calculating the radiation dose to man via. liquid effluent p~thways. Equation A-1 is expressed as follows: Raipj = CipUapDaipj Where Raipf is the annual dose to organ j of an individual of age group a from nuclide i via pathway p, in mrem/yr; C;p is the concentration of nuclide i in the media of pathway p, in pCi/I, pCi/kg, or pCi/m 2 ; is the exposure time or intake rate (usage) associated with pathway p for age group a, in I/yr, hr/yr or kg/yr (as appropriate); and Daipj is the dose factor, specific to age group a, radionuclide i, pathway p, and organ j. It represents the dose due to the intake of a radionuclide, in mrem/pCi, or from exposure to a given concentration of a radionuclide in sediment, in mrem per hr/pCi per m2

C;p of Equation A-1 corresponds to the RESREMP. and Raipj corresponds to DREMP/ING. DREMPrrs.

and DREMPISKIN of Equations 1, 3, and 4. The major differences between Equation A-1 and Equations 1, 3 and 4 o.f Section 6.0 of ODCM-QA-008 are as follows:

1. As shown in EC-ENVR-1027 (Ref. 3.13),. the dose factors (DcALc11NG. DcALcrrs. and DcALcisKiN} of Equations 1, 3, and 4 in Section 6.0 of ODCM-QA-008 incorporate both the usage factor, Uap. and the dose factor, Daipj found in equation A-1 from RG 1.109.

2. DcALcrrs. & DcALc1sK1N of Equations 3 and 4 from the ODCM have been modified by an 2

assumed area density (80 kg/m > for the first two inches of sediment to accommodate activity concentrations for sediment expressed in pCi/kg. *

3. In addition to the variables already discussed, all three of the ODCM equations incorporate the variable FsAMP to account for consumption periods (e.g., wat~r and fish) or exposure times (shoreline sediment} less than one year. This is necessary because the dose factors, Daipj. from RG 1.109 used by EC-ENVR-1027 for the derivation of DcALCJING.

DcALcrrs. & DcALc1sK1N are based on continuous intakes or exposures'over a one-year period. However, activity concentrations for REMP samples may represent consumption or exposure periods of a week, two weeks, a month, a quarter, or in exceptional cases periods of other duration less than one year. Page 1 of 4

For Information Only Attachment M ODCM-QA-008 Revision 18 Page 84 of 86

4. As shown in EC-ENVR-1027, the dose factors of Equation 1 for certain media monitored by the REMP, such as monthly composited drinking water samples, incorporate an **

additional factor not included in Equation A-1. This additional factor calculates the dose from activity concentrations that might be consumed at the midpoint of the compositing period rather than the end of the period. Equation 1 in Section 6.0 of ODCM-QA-008 may also be used to determine doses associated with the airborne exposure pathway resulting from the ingestion of such foods as milk, fruits, and vegetables. The use of Equation 1 for this purpose is similar to the intended use of Equation C-13 in Appendix C of RG 1.109 (Ref. 3.1 ). Equation C-13 is expressed as follows: Where Dja(r, f)) is the annual dose to organ j of an individual of age group a from the dietary intake of atmospherically released radionuclides, in mrem/yr for sector ()at distance r,

C; is the concentration of nuclide i in produce, milk, meat or leafy vegetables, in pCi/I or pCi/kg for sector Bat distance r, Ua are the ingestion rates of produce, milk, meat, or leafy vegetables, respectively for individuals in age group a, in I/yr or kg/yr (as appropriate);

DFlija is the dose conversion factor for the ingestion of nuclide i, organ j and age group a, in mrem/pCi; and fg,1 are fractions that may be assumed to represent the portion of the total of that food product that is radiologically contaminated which is consumed during the period of interest. C; of Equation C-13 corresponds to the RESR~MP, and. DFlua corresponds to DREMPllNG. of Equation 1 as it applies to food products containing radionuclides from the airborne pathway. The major differences between Equation C-13 and Equation 1 of Section 6.0 of ODCM-QA-008 are as follows:

1. Equation C-13 was formulated to calculate the total dose from the consumption of various foods (produce, milk, meat, and leafy vegetables) and radionuclides simultaneously, whereas Equation 1 is intended to calculate the doses separately for each item of food and each radionuclide.

2. Equation C-13, similar to Equation A-1 discussed above, states usage factors and other factors for ingestion separately while equation 1 has incorporated these factors into the dose factors presented in the tables of Attachments H through L of ODCM-QA-008. This is shown in EC-ENVR-1027 (Ref. 3.16)

Page 2of4

For Information Only Attachment M ODCM-QA-008 Revision 18 Page 85 of 86

3. In addition to the variables already discussed for Equation C-13, Equation 1 of the ODCM incorporates the variable FsAMP to account for consumption periods (e.g., milk and produce) less than one year. This is necessary because the dose factors, DFlija. from RG 1.109 used by EC-ENVR-1027 for the derivation of DcALCllNG are based on continuous intakes over a one year period. However, activity concentrations for REMP samples may represent consumption or exposure periods of a week, two weeks, a month, a quarter, or in exceptional cases periods of other duration less than one year.

Equation 2 in Section 6.0 of ODCM-QA-008 may also be used to determine doses associated with the inhalation of radionuclides. The use of Equation 2 for this purpose is similar to the intended use of Equation C-4.in Appendix C of RG 1.109 (Ref. 3.1). Equation C-4 is expressed as follows: D~a(r,fJ) = RaLX;(r,fJ) DFAlja i Where is the annual dose in mrem/yr associated with inhalation of all radionuclides, to organ j of an individual in age group a is the inhalation rate in m3/yr for the appropriate age group xi(r, ()) is the annual average ground-level concentration of nuclide i in air in sector 0 at distance r, in pCi/m 3 DFAua is the dose conversion factor for the inhalation of nuclide i, organ j and age group a, in mrem/pCi; z; of Equation C-4 corresponds to the RESREMP. and DFAua corresponds to DRi:MPllNH. of Equation 2 as it applies to the inhalation of air containing radionuclides.

The major differences between Equation C-4 and Equation 2 of Section 6.0 of-ODCM-'QA-008 are as follows:

1. Equation C-4 was formulated to calculate the total dose from inhalation of multiple radionuclides at different concentrations simultaneously, whereas Equation 2 is intended to calculate the doses separately for each radionuclide and concentration.

2. Equation C-4 states breathing rates for inhalation separately, while Equation 2 has incorporated these into the dos~ factors presented in the tabies of Attachments H through L of ODCM-QA-008. This is shown in EC-ENVR-1027 (Ref. 3.16)

Page 3 of 4

For Information Only Attachment M ODCM-QA-008 Revision 18 Page 86 of 86

3. In addition to the variables already dis.cussed for equation C-4, Equation 2 of the ODCM incorporates the variable FsAMP to account for consumption inhalation periods less than one year. This is necessary because the dose factors, DFAija. from RG 1.109 used by EC-ENVR-1027 for the derivation of DcALCnNH is based on continuous inhalation over a one-year period. However, activity concentrations for REMP air samples may represent inhalation periods of a week, a quarter, or in exceptional cases periods of other duration less than one year.

4. As shown in EC-ENVR-1027, the dose factors of Equation 2 incorporate an additional factor not included in Equation C-4. This additional factor calculates the dose from activity concentrations that might be consumed at the midpoint of a quarterly compositing period rather than the end of the period.

Page 4 of 4

For Information Only ' PROCEDURE COVER SHEET I PPL SUSQUEHANNA, LLC PROCEDURE DOSE ASSESSMENT POLICY STATEMENTS ODCM-QA-009 Revision 3 Page 1 of 12 ADHERENCE LEVEL: INFORMATION USE QUALITY CLASSIFICATION: APPROVAL CLASSIFICATION: ( X ) QA Program ( ) Non-QA Program ( x) Plant ( ) Non-Plant ( ) Instruction

                                                                                ?   ,.

EFFECTIVE DATE: I//11 b(J(}8 PERIODIC REVIEW FREQUENCY: NIA PERIODIC REVIEW DUE DATE: N/A RECOMMENDED REVIEWS: Nuclear Emergency Planning Procedure Owner: Francis J. Hickey Responsible Supervisor: Chemistry Support Supervisor Responsible FUM: Manager-Plant Chemistry Responsible Approver: Vice President-Nuclear Operations FORM NDAP-QA-0002-1, Rev. 4, Page 1 of 1 (Electronic Form)

For Information Only ODCM-QA-009 Revision 3 Page 2of12 PROCEDURE REVISION

SUMMARY

TITLE: DOSE ASSESSMENT POLICY STATEMENTS

1) Revise definition 5.1 (Insignificant Effluent Pathway). Current definition does not correctly define the referenced effluent pathway.

2) Incorporate PCAF 2005-1535

3) Update uChemistry Support Supervisor-SSES" title to "Chemistry Support Supervisor

4) Miscellaneous typographical corrections.

The Changes to ODCM-QA-009 above have been determined to not decrease the level of effluent control or the accuracy and/or reliability of dose calculations or setpoint determinations as required by 1OCRF20.1302, 40CFR190, 1OCRF50.36a, and 10CFR50, Appendix I.

, For Information Only ODCM-QA-009 Revision 3 Page 3 of 12 TABLE OF CONTENTS SECTION PAGE

1. PURPOSE 4

2. POLICY/DISCUSSION 4 2.1 Evaluation and Monitoring Criteria for Effluent Pathways 4 2.2 Low-Level Radioactivity in the Sewage Treatment Plant (STP) 5

3. REFERENCES 6

4. RESPONSIBILITIES. 8 4.1 Manager - Plant Chemistry 8

5. DEFINITIONS 8

6. PROCEDURE 9

7. RECORDS 9 ATI ACHMENTS ATIACHMENT PAGE A Systems Classified as Insignificant Effluent Pathway 10 B Systems Classified as Significant Effluent Pathway 11 c Systems with NRC l/E Bulletin 80-10 Applicability 12

For Information Only ODCM-QA-009 Revision 3 Page 4 of 12

1. PURPOSE The purpose of this procedure is to state dose and effluent policy statements that are not directly associated with any other section of the ODCM.

This procedure constitutes part of the SSES Offsite Dose Calculation Manual (ODCM) which is a licensing basis document.

2. POLICY/DISCUSSION 2.1 Evaluation and Monitoring Criteria for Effluent Pathways

                           . 2.1.1          Pot~ntial effluent pathways will be evaluated on a case-by-case basis. The evaluation will include identification of systems which are normally non-radioactive (as described in the FSAR) but could possibly become radioactive through interfaces with radioactive systems (

Reference:

NRC IE Bulletin No. 80-1 O). The evaluation will determine the*significance of any potential effluent pathways and extent of sampling and/or monitoring required. The frequency of sampling or monitoring will be determined based on the potential for contamination, the potential for inadvertent releases, the potential levels of. contamination and releases, and the potential impact on station offsite doses. 2.1.2 Results of sampling and/or evaluation will be used to classify systems into one of the following categories:

a. Not an Effluent Pathway

b. Insignificant Effluent Pathway

c. Significant Effluent Pathway

d. Systems with NRC 1/E Bulletin 80-1 O Applicability Listings of systems classified as Insignificant or Significant Effluent Pathways or have 80-10 applicability are provided in Attachments A, B, and C, respectively.

For Information Only ODCM-QA-009 Revision 3* Page 5 of 12 2.1 .3 Certain holding tanks for liquids and/or sludges that are not physically connected to radioactively contaminated systems also could become radioactively contaminated if they were to receive and concentrate radioactive materials from undetectable to detectable levels. All such tanks/vessels that receive/collect materials that have been in the station's Radiologically Controlled Areas, that allow these materials to contact liquids, and from which the liquid contents of the tanks could be released to the environment should be considered as 80-10 systems. All 80-1 O systems shall be sampled and analyzed for radioactivity periodically in accordance with station procedures. If an 80-1 O system becomes radioactively contaminated, a Condition Report (CR) shall be initiated. Further use of the system shall be evaluated and documented in Operability Assessments in response to the CR. Compensatory measures, if any, shall be subject to 50.59 screening and/or evaluation. If the resolution of the Condition Report is to continue operation of the system as contaminated (i.e., "use-as-is"}, this shall require the performance of a 50.59 screening and/or evaluation. 2.1.4 Positively detected radioactive material in samples collected from all airborne and waterborne offsite'release pathways will be reported in the Radioactive Effluent Release Report. 2.2 !,.ow-Level Radioactivity in the Sewage Treatment Plant (STP) 2.2.1 Sewage processing facilities, such as the SSES sewage treatment plant, can under certain unusual conditions become contaminated with licensee generated radioactive materials (NRC IN 88-22). 2.2.2 Sewage treatment plant sludge is typically shipped to, and disposed of at, an offsite facility. The following guidelines have been established to support the disposal of sewage treatment sludge:

a. Sludge collected for disposal at an offsite facility should be sampled and analyzed to environmental LLD criteria, to quantify any radioactivity present above natural background levels prior to free release.

For Information Only OOCM-QA-009 Revision 3 Page 6of12

b. When sludge is determined to be contaminated with radionuclides generated from SSES operations, which have half-lives sufficiently long to make hold-up for decay impractical, the following options should be considered:

(1) Dispose of the sludge as low level radioactive waste. (2) Obtain a special permit pursuant to the requirements of 10 CFR 20.2002.

c. The sewage treatment plant liquid effluent should be sampled monthly for radioactivity.

2.2.3

A common source term for radionuclides identified in the STP is when individuals who work on-site have been subjected to the medical administration of radio-pharmaceuticals for diagnostic or therapeutic purposes. In these cases, normal biological elimination processes can easily result in levels of radioactivity in sewage treatment plant. solutions and suspensions that are within the detection capabilities of the associated sampling and analysis program. *Naturally occurring background radioisotopes and weapons testing fallout radioisotopes may also be identified in STP effluents or sludge. The radionuclides referenced above (naturally occurring, weapons testing fallout, medical) can be eliminated from consideration (regarding radioactive liquid effluent compliance or free release of sludge) once a determination has of been made and documented that the source the radionuclides is not due to SSES operations (i.e.,' licensee byproduct material).

3. REFERENCES 3.1 10CFR20.2002, Method for Obtaining Approval of Proposed Disposal Procedures 3.2 10CFR20 Appendix B, Annual Limits on Intake (ALis) and Derived .

Concentrations (DACs) of Radionuclides for Occupational Exposure; Effluent Concentrations; Concentrations for Release to Sewerage 3.3 10CFRSO Appendix I, Numerical Guides for Design Objectives and Limiting Conditions for Operation to Meet the Criterion "As Low as is Reasonably Achievable" for Radioactive Material in Light-water Cooled Nuclear Power Reactor Effluents 3.4 10CFR50.59, Changes, Tests, and Experiments

For Information Only ODCM-QA-009 Revision 3 Page 7of12 3.5 NRG IE Bulletin No. 80-10, Contamination of Nonradioactive System and Resulting Potential for Unmonitored, Uncontrolled Release of Radioactivity to Environment

3.6 FSAR Section 11.2, Liquid Waste Management Systems 3.7 FSAR Section 11.3, Gaseous Waste Management Systems 3.8 ODCM-QA-003, Effluent Monitor Setpoints 3.9 PPL Calculation EC-ENVR-1008, Unmonitored Release Analysis: Systems Identified in PLl-77223 3.1 O Safety Evaluation NL-92-007, Operation of LLRWHF at SSES 3.11 Safety Evaluation NL-95-001, Refueling Outage Decay Heat Removal and Tie-In of the SOHR Temporary Cooling Equipment 3.12 Safety Evaluation NL-95-015, Operation of the Sewage Treatment Plant with Sludge Activity Ab.ove Environmental .LLDs 3.13 PU- 77223, Letter from D. L. Hagan to K. E. Shank, "Potential Unmonitored Release Assessment

3.14 NDAP-QA-1180, Radiological Effluent Monitoring and Control 3.15 NRC Generic Letter No. 91-18, Revision 1; Information to Licensees Regarding NRC Inspection Manual Section on Resolution of Degraded and Nonconforming Conditions, October 8, 1997 3.16 Condition Report #95876 3.17 Unit 1 and Unit 2 Technical Requirements Manual 3.18 PLl-86027, Insignificant Pathway - Noble Gas Entrained in Liquid Effluent 3.19 Condit.ion Report #457463 and Action Request #457461 3.20 NRC IN 88-22

For Information Only ODGM-QA-009 Revision 3 Page 8of12

4. RESPONSIBILITIES 4.1 Manager - Plant Chemistry 4.1.1 Ensures adequacy and correctness of dose and effluent policy statements.

4. i .2 Ensures effluent pathways are properly evaluated based on calculations or other appropriate methods.

5. DEFINITIONS 5.1 Insignificant Effluent Pathway - Evaluation and/or periodic sampling demonstrate that the pathway may contain radioactive effluents, however, these effluents may I not be reasonably expected to exceed the appropriate Unrestricted Area EC value (fractional ECs summed when appropriate) listed in Table 2 of Appendix B to 10 CFR 20. A release pathway which falls in this category will be sampled periodically.

5.2 EGL - Effluent Concentration Limit as defined in 10CFR20, Appendix B. 5.3 Not An Effluent Pathway - Realistic evaluation (e.g., engineering design, system operation, radionuclide inventory) demonstrates that the pathway has no potential for release of radioactive material. Although not required, periodic sampling may at times be performed to confirm the result of the evaluation. 5.4 Significant Effluent Pathway - Evaluation and/or periodic sampling demonstrate that the pathway may contain radioactive effluents, and these effluents may be reasonably expected to exceed 1o times the appropriate Unrestricted Area EC value {fractional ECs summed when appropriate) listed in Table 2 of Appendix B to 10 CFR 20. Significant Effluent Pathways are not always sampled continuously. They will be sampled and/or monitored continuously except where TRO Action Statements allow something different. Monitoring will occur in accordance wit.h TR requirements. 5.5 80-1 O Systems are those systems considered as non*radioactive (or described as non-radioactive in the FSAR), which could become radioactive through interfaces with radioactive systems (a non-radioactive system that could become contaminated due to leakage, valving errors, or other operating conditions in the radioactive systems). These normally non-radioactive systems are considered 80-10 Systems in accordance with NRC IE Bulletin 80-10 if they have both a potential for radioactive contamination and a release pathway to the environment. Monitoring systems or sample analysis must be capable of detecting the Effluent Lower Limits of Detection (LLDs) referenced in the TRM.

For Information Only I . ODCM-QA-009 Revision 3 Page 9 of 12

6. PROCEDURE Chemistry Support shall perform dose calculations as required to support classification ot effluent pathways. Use may be made of incoming requests tor revision of the ODCM, or other relevant information that may be received from Nuclear Engineering or other PPL Susquehanna, LLC groups.

7. RECORDS None

For Information Only Attachment A ODCM-QA-009 Revision 3 Page 10 of 12 SYSTEMS CLASSIFIED AS INSIGNIFICANT EFFLUENT PATHWAY SYSTEM NO. DESCRIPTION REFERENCE 037B Condensate Storage and Transfer 1 0370 Refueling Storage and Transfer 1 048 RFPT Lube .Oil 1 095 H2Seal Oil 1 093 Main Turbine Lube Oil 1 0990 Sewage Treatment Plant 2 040 Batch Lube Oil Tank 3

                          --              Noble Gas Entrained in Liquid Effluent                    4 Notes:

1. PPL Calculation EC-ENVR-1008

2. Sewage treatment plant is designed to be operated as a non-radioactive system.

Classification as an Insignificant Effluent Pathway is in accordance with Safety Evaluation NL-95-015

3. PLl-77223

4. PLl-86027 dated July 24, 1998, Insignificant Effluent Pathway - Noble Gas Entrained in Liquid Effluent Page 1of1

For Information Only Attachment B ODCM-QA-009 Revision 3 Page 11 of 12 SYSTEMS CLASSIFIED AS SIGNIFICANT EFFLUENT PATHWAY SYSTEM NO.

DESCRIPTION REFERENCE 069 Liquid Waste Management Systems 1 068 Solid Radwaste Processing Systems 3 072 Offgas System 2 012F Unit 1 and Unit 2 Reactor Building Vents 2 012B Unit 1 and Unit 2 Turbine Building Vents . 2 070 Standby Gas Treatment System Vent 2 Notes:

1. SSES FSAR Chapter 11.2

2. SSES FSAR Chapter 11 .3

3. SSES FSAR Chapter 11.4 Page 1 of 1

Attachment C ODCM-QA-009 Revision 3 Page 12of12 SYSTEMS WITH NRC l/E BULLETIN 80a10 APPLLICABILITY SYSTEM NO. DESCRIPTION REFERENCE 011 Service Water (F/P HTX Discharge) 1 I I 016 AHR Service Water 1 018 Instrument Air 1 019 Service Air 1 r 022 Makeup Demineralizers 1 027 Station Auxiliary Boiler/Auxiliary Steam . 1 011 Shutdown Decay Heat Removal Service Water 3 042 Circulating Water 1 054 Emergency Service Water 1 086 Low Level Radwaste Handling Facility 2 Notes:

1. PLl-77223

2. Safety Evaluation NL-92-007, Rev. 2, Operation of LLRWHF at SSES

3. Safety Evaluation NL-95-001, Rev. 2 Page 1 of 1

For Information Only Liquid Effluents Concentration PPL Rev. 1 3.11.1.1 3.11 Radioactive Effluents 3.11.1 Liquid Effluents 3.11.1.1 Liquid Effluents Concentration TRO 3.11.1.1 The concentration of radioactive material released in liquid effluents to UNRESTRICTED AREAS (See FSAR Section 2.1.1.3) shall be limited to 10 times the concentrations specified in Appendix B, Table 2, Column 2 to 10CFR 20.1001-20.2402 for radionuclides other than dissolved or entrained noble gases. For dissolved or entrained noble gases, the concentration shall be limited to 2E-4 µCi/ml total activity. APPLICABILITY: At all times. ACTIONS.

                 ---------------------------------------------------------- NOTE -----------------------------------------------------------

1. The provisions of TRO 3.0.4 are not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. Concentration of A 1. Restore the concentration Immediately radioactive material to within the above released in liquid limits effluents to UNRESTRICTED AREAS (See FSAR Section 2.1.1.3) exceeds the limits specified in TRO 3.11.1.1 SUSQUEHANNA - UNIT 1 TRM / 3.11-1 EFFECTIVE DATE 03/31/2006

For Information Only Liquid Effluents Concentration PPL Rev. 1 3.11.1.1 TECHNICAL REQUIREMENT SURVEILLANCE SURVEILLANCE FREQUENCY TRS 3.11.1.1.1 The radioactivity content of each batch of Prior to each radioactive liquid waste shall be release determined by sampling and analysis in accordance with Table 3.11.1.1-1. The results of pre-release analyses shall be used with the calculational methods and parameters in the ODCM to assure that the concentration at the point of release is maintained within the limits of TRO 3.11.1.1 TRS 3.11.1.1.2 Post release analyses of samples composited According to from batch releases shall be performed in theODCM accordance with Table 3.11.1.1-1. The results of the previous post-release analyses shall be used with the calculational methods and parameters in the ODCM to assure that the concentrations at the point of release were maintained within the limits ofTRO 3.11.1.1 SUSQUEHANNA - UNIT 1 TRM/3.11-2 EFFECTIVE DATE 8/31/1998

For Information Only Liquid Effluents Concentration PPL Rev. 1 3.11.1.1 TABLE 3.11.1.1-1 RADIOACTIVE LIQUID WASTE SAMPLING AND ANALYSIS PROGRAM Lower Limit Minimum of Detection Liquid Release Sampling Analysis Type of Activity (LLD) Type Frequency Frequency Analysis (µCi/ml) Batch Waste Prior to Prior to release Principal Gamma 5E-7 Release Tanks Release Each Batch E.rilitters Each Batch 1~131 1E-6 Prior to 31 days Dissolved and 1E-5 Release Entrained Gases One Batch per (Gamma Emitters) month Prior to 31 days H-3 1E-5 Release Composite<a> Each Batch Gross Al~ha 1E-7 Prior to 92 days Sr-89, Sr-90 5E-8 Release Composite<a> Each Batch Fe-55 1E-6 Cal Minimum frequency for initiation of required analysis. SUSQUEHANNA - UNIT 1 TRM I 3.11-3 EFFECTIVE DATE 8/31/1998

For Information Only Liquid Effluents Dose PPL Rev. 1 3.11.1.2 3.11 Radioactive Effluents 3.11.1 Liquid Effluents 3.11.1.2 Liquid Effluents Dose TRO 3.11.1.2 The dose or dose commitment to a MEMBER OF THE PUBLIC from rad.ioactive materials in liquid effluents released from each reactor unit to UNRESTRICTED AREAS shall be limited:

a. During any calendar quarter to less than or equal to 1.5 mrems to the total body and to less than or equal to 5 mrems to any organ.

b. During any calendar year to less than or equal to 3.0 mrems to the total body and to less than or equal to 10 mrems to any organ.

APPLICABILITY: At all times. ACTIONS

                    --------------------------------------------------------- NOTE ----------------------------------------------------------

1. The provisions of TRO 3.0.4 are not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. Calculated dose from A 1. Prepare and submit a Within 30 days the release of Special Report to the radioactive materials Commission in liquid effluents exceeding any of the above limits SUSQUEHANNA- UNIT 1 TRM/3.11-4 EFFECTIVE DATE 03/31/2006

For Information Only Liquid Effluents Dose PPL Rev. 1 3.11.1.2 TECHNICAL REQUIREMENT SURVEILLANCE SURVEILLANCE FREQUENCY TRS 3.11.1.2.1 Determine cumulative dose contributions 31 days from liquid effluents for the current calendar quarter and the current calendar year in accordance with methodology and parameters in the ODCM SUSQUEHANNA - UNIT 1 TRM I 3.11-5 EFFECTIVE DATE 8/31/1998

For Information Only Liquid Waste Treatment System PPL Rev. 1 3.11.1.3 3.11 Radioactive Effluents 3.11.1 Liquid Effluents 3.11.1.3 Liquid Waste Treatment System TRO 3.11.1.3 The appropriate portions of the Liquid Radwaste Treatment System, as described in the ODCM, shall be OPERABLE. Appropriate portions of the Liquid Waste Treatment System shall be used to reduce the radioactive materials in liquid effluent, prior to their discharge, when projected doses due to liquid effluent releases from each reactor unit to UNRESTRICTED AREAS would exceed 0.06 mrem to the total body or 0.2 mrem to any organ in a 31 day period. APPLICABILITY: At all times ACTIONS

                    ----------------~----------------------~----------------- NOTE ----------------------------------------------------------

1. The provisions of TRO 3.0.4 are not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. Liquid effluent A 1. Prepare and submit a 30 days releases being Special Report to the discharged without Commission treatment and in excess of the TRO limit. SUSQUEHANNA - UNIT 1 TRM I 3.11-6 EFFECTIVE DATE 03/31/2006

For Information Only Liquid Waste Treatment System PPL Rev. 1 3.11.1.3 TECHNICAL REQUIREMENT SURVEILLANCE SURVEILLANCE FREQUENCY TRS 3.11.1.3.1 Project doses due to liquid releases from 31 days each reactor unit to UNRESTRICTED AREAS in accordance with the methodology and parameters in the ODCM.

TRS 3.11.1.3.2 ----------------------------NOTE-----------------------------

Not required to be performed if the liquid radwaste system has been utilized to process radioactive liquid during the previous 92 days Demonstrate the Liquid Radwaste (LRW) 92 days Treatment System OPERABLE by operating LRW Treatment System equipment for at least 10 minutes. SUSQUEHANNA - UNIT 1 TRM/3.11-7 EFFECTIVE DATE 8/31/1998

For Information Only Liquid Radwaste Effluent Monitoring Instrumentation PPL Rev. 2 3.11.1.4 3.11 Radioactive Effluents 3.11.1 Liquid Effluents 3.11.1.4 Liquid Radwaste Effluent Monitoring Instrumentation TRO 3.11.1.4 The Radioactive Liquid Radwaste Effluent Monitoring Instrumentation channels shown in Table 3.11.1.4-1 shall be OPERABLE with their setpoints established in accordance with the ODCM to ensure that the alarm/trip will occur prior to exceeding the limits of TRO 3.11.1.1. APPLICABILITY: *At all times. ACTIONS

                    ----------------------------------------------------------- N0 TE --------------------------------------------------------

1. Separate condition entry is allowed for each channel

2. The provisions of TRO 3.0.4 are not applicable CONDITION REQUIRED ACTION COMPLETION TIME A. One or more radioactive A.1 Suspend the release of Immediately liquid effluent monitoring radioactive liquid effluents instrumentation alarm/trip monitored by the affected channels setpoint less channel conservative than the limits allowed by TRO 3.11.1.1 A.2 Declare the channel Immediately inoperable (continued)

SUSQUEHANNA - UNIT 1 TRM I 3.11-8 EFFECTIVE DATE 08/31/1998

For Information Only Liquid Radwaste Effluent Monitoring Instrumentation PPL Rev. 2 3.11.1.4 ACTIONS (continued) CONDITION REQUIRED ACTION COMPLETION TIME B. Liquid Radwaste releases B.1 Analyze at least two Prior to initiating each are necessary and Effluent independent samples in release. Line Gross Radioactivity accordance with

Monitoring Instrumentation TRO 3.11.1.1 inoperable. AND B.2 Independently determine Prior to initiating each release rates for samples release.

analyzed per Action B.1 AND B.3 Perform and independently Prior to initiating each verify discharge valve lineup release. AND B.4 Restore monitoring 30 days instrumentation C. Liquid Radwaste releases C.1 Maintain at least one isolation Within 1 hour of are not in progress .and the valve closed between each securing froin release Gross Radioactivity source of release and the or discovery of Monitoring instrumentation. liquid radwaste discharge inoperable is inoperable because the valve. instrument. inoperable channel is caused by a discharge valve interlock in an off-normal condition or not functioning. (continued) SUSQUEHANNA - UNIT 1 TRM I 3.11-9 EFFECTIVE DATE 10/09/2012

For Information Only Liquid Radwaste Effluent Monitoring Instrumentation PPL Rev. 2 3.11.1.4 ACTIONS (continued) CONDITION REQUIRED ACTION COMPLETION TIME D. Liquid Radwaste releases D.1 Estimate Flow Rate. Once per 4 hours are necessary and Effluent during releases. Line or Cpoling Tower AND Slowdown Flow Monitoring Instrumentation inoperable. D.2 Restore Monitoring 30 days Instrumentation. E. Liquid Radwaste releases E.1 Maintain at least one isolation Within 1 hour of are not in progress and valve closed between each securing release or cooling tower blowdown source of release and the discovery of flow monitoring liquid radwaste discharge inoperable instrumentation is valve. instrument. inoperable because the inoperable channel is a discharge valve interlock in an off-normal condition or not functioning. F. Required Action and F.1 ----------------NOTE---------------- Associated Completion Only applicable to Conditions Time of Conditions B, C, D, Band D or E not met. ----------------------------------------

                    '                                     Effluent releases via this              Immediately pathway may continue (up to 45 days from initial TRO entry) provided that Required Actions 8.1, 8.2, 8.3 and D.1 are performed as applicable (within associated Completion Times). Otherwise, suspend release of radioactive effluents via this pathway AND In the next F.2    Explain why the inoperability           Radioactive Effluent was not corrected in a timely             Release Report per
                                                        . manner.                                 TS Section 5.6 SUSQUEHANNA - UNIT 1                  TRM I 3.11-10                   EFFECTIVE DATE 10/09/2012

For Information Only Liquid Radwaste Effluent Monitoring Instrumentation PPL Rev. 2 3.11.1.4 TECHNICAL REQUIREMENT SURVEILLANCE

                    ---------------------------------------------------------- NOTE ---------------------------------------------------------

Refer to Table 3.11.1.4-1 to determine which TRSs apply for each Monitoring Function. SURVEILLANCE FREQUENCY TRS 3.11.1.4.1 Perform CHANNEL CHECK. 24 hours TRS 3.11.1.4.2 Perform CHANNEL CHECK including a Prior to commencing source check. release TRS 3.11.1.4.3 Perform CHANNEL FUNCTIONAL TEST 92 days TRS 3.11.1.4.4 Perform CHANNEL CALIBRATION 24 months SUSQUEHANNA - UNIT 1 TRM/3.11-11 EFFECTIVE DATE 08/31/1998

For Information Only Liquid Radwaste Effluent Monitoring Instrumentation PPL Rev. 2 3.11.1.4 TABLE 3.11.1.4-1 LIQUID RADWASTE EFFLUENT MONITORING INSTRUMENTATION REQUIRED SURVEILLANCE FUNCTION CHANNELS REQUIREMENTS

1. GROSS RADIOACTIVITY MONITORS PROVIDING AUTOMATIC TERMINATION OF RELEASE

a. Liquid Radwaste Effluent Line 1 TRS 3.11.1.4.2 TRS 3.11.1.4.3 TRS 3.11.1.4.4 2 .. FLOW RATE MEASUREMENT DEVICES

a. Liquid Radwaste Effluent Line 1 TRS 3.11.1.4.1 (a)

TRS 3.11.1.4.3 TRS 3.11.1.4.4

b. Cooling Tower Slowdown 1 TRS 3.11.1.4.1 (a)

TRS 3.11.1.4.3 TRS 3.11.1.4.4 (a) Only required when performing batch releases. SUSQUEHANNA - UNIT 1 TRM I 3.11-12 EFFECTIVE DATE 08/31/1998

For Information Only Radioactive Liquid Process Monitoring Instrumentation PPL Rev. 3 3.11.1.5 3.11 Radioactive Effluents 3.11.1 Liquid Effluents 3.11.1.5 Radioactive Liquid Process Monitoring Instrumentation TRO 3.11.1.5 The Radioactive Liquid Process Monitoring Instrumentation channels shown in Table 3.11.1.5-1 shall be OPERABLE with their setpoints established in accordance with the ODCM to ensure the alarm will occur prior to exceeding the limits of TRO 3.11.1.1. APPLICABILITY: As specified in Table 3.11.1.5-1. ACTIONS

                    ----------------------------------------------------------- NOTE --------------------------------------------------------

1. Separate condition entry is allowed for each channel.

2. TRO 3.0.4.c is applicable.

3. The provisions of TRO 3.0.6 are not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. One or more Radioactive A.1 Suspend the release of Immediately Liquid Process Monitoring liquid effluents Instrumentation alarm/trip monitored by the affected channels setpoint less channel conservative than the limits allowed by TRO 3.11. 1.1. OR A.2 Declare the channel Immediately inoperable (continued) SUSQUEHANNA - UNIT 1 TRM I 3.11-13 EFFECTIVE DA TE 02/19/2015

For Information Only Radioactive Liquid Process Monitoring Instrumentation PPL Rev. 3 3.11.1.5 ACTIONS (continued) REQUIRED ACTION COMPLETION TIME CONDITION B. Radioactive Liquid Process B.1.1 Suspend the release of Immediately Monitoring Instrumentation liquid effluents monitored otherwise inoperable. by the affected channel. OR B.1.2 Analyze grab samples for Once per 8 hours isotopic activity to the when the associated required LLDs for liquid pathway is in service effluents (Table 3.11.1.1-1). AND B.2 Restore monitoring 30 days instrumentation C. Required Action and C.1 Explain why the inoperability In the next Associated Completion was not corrected in a timely Radioactive Effluent Time of Conditions B not manner Release Report per met. TS Section 5.6 D. RHR Heat Exchanger to be D.1 Analyze grab samples from Prior to draining RHR drained to the spray pond. the RHR Heat Exchanger for Heat Exchanger to isotopic activity to the required the spray pond. LLDs for liquid effluents (Table 3.11.1.1-1). SUSQUEHANNA - UNIT 1 TRM I 3.11-14 EFFECTIVE DATE 12/03/2004

For Information Only Radioactive Liquid Process Monitoring Instrumentation PPL Rev. 3 3.11.1.5 TECHNICAL REQUIREMENT SURVEILLANCE

                 ---------------------------------------------------------- NOTE ---~--------------------------~-------~--~--------------

Refer to Table 3.11.1.5-1 to determine which TRSs apply for-each Monitoring Function. SURVEILLANCE FREQUENCY TRS 3.11.1.5.1 Perform CHANNEL CHECK. 24 hours TRS 3.11.1.5.2 Perform a Source Check 31 days TRS 3.11.1.5.3 Perform CHANNEL FUNCTIONAL TEST 92 days TRS 3.11.1.5.4 Perform CHANNEL CALIBRATION 24 months SUSQUEHANNA - UNIT 1 TRM I 3.11-15 EFFECTIVE DATE 9/01/1998

For Information Only Radioactive Liquid Process Monitoring Instrumentation PPL Rev. 3 3.11.1.5 TABLE 3.11.1.5-1 RADIOACTIVE LIQUID PROCESS MONITORING INSTRUMENTATION REQUIRED SURVEILLANCE FUNCTION CHANNELS APPLICABILITY REQUIREMENTS GROSS RADIOACTIVITY MONITORS NOT PROVIDING AUTOMATIC TERMINATION OF RELEASE

1. Service Water System Effluent Line 1 (a) TRS 3.11.1.5.1 TRS 3.11.1.5.2 TRS 3.11.1.5.3 TRS 3.11.1.5.4

2. Supplemental Decay Heat Removal 1 (a) TRS 3.11.1.5.1 Service Water TRS 3.11.1.5.2 TRS 3.11.1.5.3 TRS 3.11.1.5.4

3. RHR Service Water System Effluent 1/Loop (b) TRS 3.11.1.5.1 Line. TRS 3.11.1.5.2 TRS 3.11.1.5.3 TRS 3.11.1.5.4 (a) System aligned through Fuel Pool Cooling Heat Exchanger. Alignment change between Service Water System Effluent Line and Supplemental Decay Heat Removal ServiCe Water is not considered to be a change in the applicable condition.

(b) At all times SUSQUEHANNA - UNIT 1 TRM I 3.11-16 EFFECTIVE DATE 9/01/1998

For Information Only Dose Rate PPL Rev. 3 3.11.2.1 3.11 Radioactive Effluents 3.11.2 Gaseous Effluents 3.11.2.1 Dose Rate TRO 3.11.2.1

The dose rate due to radioactive materials released in gaseous effluents to areas at and beyond the SITE BOUNDARY (See FSAR Section 2.1.1.3) .

shall be limited to the following: I. For Noble Gases: A. Less than or equal to 500 mrems/yr to the total body, and B. Less than or equal to 3000 mrems/yr to the skin II. For iodine-131, iodine-133, tritium, and all radionuclides in particulate form with half lives greater than 8 days A. Less than or equal to 1500 mrem/yr to any organ . (Inhalation pathways only.) APPLICABILITY: At all times. ACTIONS

                    ------------------------------------------------------------ N0 TE ---~---------------------------------------------------

1. The provisions of TRO 3.0.4 are not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. Dose rate(s) exceed A.1 Restore the release rate Immediately the above limits to within the above limits SUSQUEHANNA - UNIT 1 TRM I 3.11-17 EFFECTIVE DATE 03/31 /2006

For Information Only Dose Rate PPL Rev. 3 3.11.2.1 TECHNICAL REQUIREMENT SURVEILLANCE SURVEILLANCE FREQUENCY TRS 3.11.2.1.1 Determine the dose rate due to noble See ODCM gases in gaseous effluents. TRS 3.11.2.1.2 The dose rate due to iodine-131, iodine- See Table 133, tritium, and all radionuclides in 3.11.2.1-1 particulate form with half-lives greater than 8 days in gaseous effluents shall be determined to be within the limits in accordance with the methodology and parameters of the ODCM by obtaining representative samples and performing analyses in accordance with the sampling

                                . and analysis program specified in Table 3.11.2.1-1 SUSQUEHANNA - UNIT 1                   3.11-18            EFFECTIVE DATE 8/31/1998

For Information Only Dose Rate PPL Rev. 3 3.11.2.1 TABLE 3.11.2.1-1 RADIOACTIVE GASEOUS EFFLUENT SAMPLING AND ANALYSIS Sampling Lower Limit of Minimum Method and Detection (LLD) Analysis Type of Activity Gaseous Release Type Frequency (µCi/ml) Frequency Analysis A, Containment Purge Prior to each purge Prior to each Principal Noble 1E-4 Grab Sample purge Gas Gamma Emitters H-3 1E-6 B. Reactor Building 31 days(al 31 days'"1 Principal Noble 1E-4 Vents, Turbine Grab Sample Gas Gamma Building Vents, and Emitters SGTS H-3 1E-6 ContinuousCbl Iodine 7_days<cl 1-131 1E-12 Cartridge Sample 1-133 1E-10 Continuous(bl 7 daysCcJ Principal 1E-11 Particulate Gamma Particulate sam~le Emitters 1-131 Continuous(bJ 92 days Gross Alpha 1E-11 Composite(dl Particulate Sam~le Continuous(bJ 92 days Sr-89, Sr-90 1E-11 CompositeCdJ Particulate sam['.le ContinuousCbl Noble Gas Noble Gases, Gross 1E-6 Monitor Beta or Gamma (Xe-133 equivalent) (al Noble gas analyses shall be performed following shutdown, startup, or a THERMAL POWER change exceeding 15% of the RATED THERMAL POWER within a 1-hour period. (bJ The ratio of the sample flow rate to the sampled stream flow rate shall be known for the time period covered by each dose or dose rate calculation made in accordance with TR Os 3.11.2.1, 3.11.2.2, and 3.11.2.3. (cJ Samples shall be changed at least:

1. Once per 7 days; and

2. Once per 24 hours for a least 7 days following each shutdown, startup,. or thermal power change

                          . exceeding 15% of rated thermal power in 1 hour if: (1) analysis has shown that the dose equivalent 1-131 concentration in the primary coolant is >1.0E-4 µCi/g and has increased by more than a factor of 3; or (2) the noble gas monitor or grab samples show that effluent activity is >1 E-6 µCi/cc and has increased by more than a factor of 3.

Analyses shall be completed within 48 hours after change-outs. When samples collected for~ 24 hours are analyzed, the corresponding LLD may be increased by a factor of 1o. (dl Minimum frequency for initiation of required analysis. SUSQUEHANNA - UNIT 1 TRM I 3.11-19 EFFECTIVE DATE 08/15/2005

For Information Only Dose - Noble Gases PPL Rev. 1 3.11.2:2 3.11 Radioactive Effluents 3.11.2 Gaseous Effluents 3.11.2.2 Dose - Noble Gases TRO 3. 11.2.2 The air dose due to noble gases released in gaseous effluents,,from each reactor unit, to areas at and beyond the SITE BOUNDARY (See FSAR Section 2.1.1.3) shall be limited to the following:

a. During any calendar quarter: Less than or equal to 5 mrads for gamma radiation and less than or equal to 10 mrads for beta radiation, and

b. During any calendar year: Less than or equal to 10 mrads for gamma radiation and less than or equal to 20 mrads for beta radiation.

APPLICABILITY: At all times. ACTIONS

                  --------------------------------------------------------- NOTE -----------------------------------------------------------

1. The provisions of TRO 3.0.4 are not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. The calculated air A.1 Prepare and submit a Special 30 days dose exceeds the Report to the Commission limits. TECHNICAL REQUIREMENT SURVEILLANCE SURVEILLANCE FREQUENCY TRS 3.11.2.2.1 Determine the cun:iulative dose contributions 31 days for the current calendar quarter and current calendar year for these sources in accordance with the methodology and parameters in the ODCM SUSQUEHANNA - UNIT 1 TRM I 3.11-20 EFFECTIVE DATE 03/31/2006

For Information Only Dose - Iodine, Tritium, and Radionuclides in Particulate Form PPL Rev. 1 3.11.2.3 3.11 Radioactive Effluents 3.11.2 Gaseous Effluents 3.11.2.3 Dose - Iodine, Tritium, and Radibnuclides in Particulate Form TRO 3.11.2.3 The dose to a MEMBER OF THE PUBLIC from iodine-131, iodine-133, tritium, and all radionuclides in particulate form with half-lives greater than 8 days in gaseous effluents released, from each reactor unit, to areas at and beyond the SITE BOUNDARY shall be limite.d to the following:

a. During any calendar quarter: Less than or equal to 7.5 mrems to any organ and,'

b. During any calendar year: Less than or equal to 15 mrems to any organ.

APPLICABILITY: At all times. ACTIONS

                    ---------------------------------------------------------_NOTE ----------------------------------------------------------

1. The provisions of TRO 3.0.4 are not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. The calculated dose A.1 Prepare and submit a 30 days from the release Special Report t~ the exceeds the limits. Commission. TECHNICAL REQUIREMENT SURVEILLANCE SURVEILLANCE FREQUENCY TRS 3.11.2.3.1 Determine the cumulative dose contributions 31 days for the current calendar quarter and current calendar year for these sources in accordance with the methodology and parameters in the ODCM. SUSQUEHANNA - UNIT 1 TRM I 3.11-21 EFFECTIVE DATE 03/31/2006

Gaseous Radwaste Treatment System PPL Rev. 0 3.11.2.4 3.11 Radioactive Effluents 3.11.2 Gaseous Effluents 3.11.2.4 GASEOUS RADWASTE TREATMENT SYSTEM TRO 3.11.2.4 The GASEOUS RADWASTE TREATMENT SYSTEM shall be OPERABLE and in operation. APPLICABILITY: When the main condenser air ejector (evacuation) system is in operation. ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A GASEOUS RADWASTE A.1 Restore GASEOUS 7 days TREATMENT SYSTEM RADWASTE TREATMENT inoperable. SYSTEM to OPERABLE status. B. Required Action and B.1 Prepare and submit a 30 days associated Completion Special Report to the Time not met. Commission. TECHNICAL REQUIREMENT SURVEILLANCE SURVEILLANCE FREQUENCY TRS 3.11.2.4.1 Verify GASEOUS RADWASTE TREATMENT 92 days SYSTEM to be in operation. SUSQUEHANNA - UNIT 1 -TRM I 3.11-22 EFFECTIVBE DATE 04/02/2002

For Information Only Ventilation Exhaust Treatment System PPL Rev. 4 3.11.2.5 3.11 Radioactive Effluents 3.11.2 Gaseous Effluents 3.11.2.5 VENTILATION EXHAUST TREATMENT SYSTEM TRO 3.11.2.5 The appropriate subsystems of the VENTILATION ExHAUST TREATMENT SYSTEM, as described in the Offsite Dose Calculation Manual (ODCM), shall be OPERABLE.

                                          ----------------------------------------------N 0 TE----------------------------------------------

A pp ro pri ate subsystems- of the VENTILATION EXHAUST TREATMENT SYSTEM shall be us~d to reduce radioactive materials in gaseous waste prior to their discharge when projected doses due to gaseous effluent releases from either reactor unit to areas at and beyond the SITE BOUNDARY would exceed 0.3 mrem to any organ in a 31 day period. APPLICABILITY: At all times. ACTIONS

                 ------------------------------------------------------------ NOTE --------------------..:-----------------------------------

1. Separate Condition entrv is allowed for each_subsvstem.

2. The provisions of TRO 3.0.4 are not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. A subsystem of the A.1 Restore subsystem to 31 days VENTILATION OPERABLE status. EXHAUST TREATMENT SYSTEM inoperable. B. Required Action and B.1 Prepare and submit a Special 30 day Associated Completion Report to the Commission. Time of Condition A not met. OR Gaseous waste from either reactor unit being discharged without appropriate treatment and in excess of 0.3 mrem to any organ in a 31 day period. SUSQUEHANNA - UNIT 1 TRM I 3.11-23 EFFECTIVE DATE 11/14/2006

For Information Only Ventilation Exhaust Treatment System PPL Rev. 4 3.11.2.5 TECHNICAL REQUIREMENT SURVEILLANCE SURVEILLANCE FREQUENCY TRS 3.11.2.5.1 Perform dose' projection due to gaseous 31 days releases from each reactor unit to areas at and beyond the SITE BOUNDARY in accordancewith the.methodology and parameters in the ODCM. TRS 3.11.2.5.2 ---------------------------N 0TE---------------------- Not required if the appropriate subsystem has been utilized to process radioactive gaseous effluents during the previous 92 days. Verify each subsystem of the VENTILATION 92 days EXHAUST TREATMENT SYSTEM is OPERABLE by operating the subsystem ~10 minutes. TRS 3.11.2.5.3 Perform required HVAC filter testing in In accordance with the accordance with the Filter Testing Program. Filter Testing Program SUSQUEHANNA - UNIT 1 TRM I 3.11-24 EFFECTIVE 06/18/2013

For Information Only Radioactive Gaseous Effluent Monitoring Instrumentation Rev. 7 3.11.2.6 3.11 Radioactive Effluents 3.11.2 Gaseous Effluents 3.11.2.6 Radioactive Gaseous Effluent Monitoring Instrumentation TRO 3.11.2.6 The radioactive gaseous effluent monitoring instrumentation channels shown in Table 3.11.2.6-1 shall be OPERABLE with their setpoints established in accordance with the ODCM to ensure that the limits of Requirement 3.11.2.1 are not exceeded. APPLICABILITY: According to Table 3.11.2.6~1 ACTIONS

                    ----------------------------------------------------------- NOTE --------------------------------------------------------

1. Separate condition entry is allowed for each channel. .

2. The provisions of TRO 3.0.6 are not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. Radioactive gaseous A.1 Suspend the release of Immediately effluent monitoring radioactive gaseous effluents instrumentation channel monitored by the affected alarm/trip setpoint less channel conservative than required to ensure that the limits of OR Requirement 3.11.2.1 are not exceeded A.2 Declare the channel Immediately inoperable (continued) SUSQUEHANNA - UNIT 1 TRM I 3.11-25 EFFECTIVE DATE 04/12/2007

For Information Only Radioactive Gaseous Effluent Monitoring Instrumentation Rev. 7 3.11.2.6 ACTIONS (continued) CONDITION REQUIRED ACTION COMPLETION TIME B. Reactor Building B.1 Take grab samples Once per 8 hours Ventilation System while release is Noble Gas Activity in progress. Monitor low range AND channel inoperable B.2 Analyze grab samples for Within 24 hours isotopic activity to the required of grab sample LLDs for principal noble gas gamma emitters (Table 3.11.2.1-1) AND B.3 Restore monitoring 30 days instrumentation C. Deleted D. Reactor Building D.1 Estimate flow rate Once per 4 hours Ventilation Monitoring while release is System Effluent System in progress Flow Rate Monitor or AND Sampler Flow Rate Monitor inoperable D.2 Restore monitoring 30 days instrumentation

                                                                                                  . (continued)

SUSQUEHANNA - UNIT 1 TRM I 3.11-26 EFFECTIVE DATE 01/21/2004

For Information Only Radioactive Gaseous Effluent Monitoring Instrumentation Rev. 7 3.11.2.6 ACTIONS (continued) CONDITION REQUIRED ACTION COMPLETION TIME E. Turbine Building Ventilation E.1 Verify mechanical vacuum Immediately System Noble Gas Activity pump is not in operation Monitor low range channel inoperable AND E.2 Take grab samples Once per 8 hours while release is in progress. AND E.3 Analyze grab samples for Within 24 hours after isotopic activity to the sample required LLDs for the principal noble gas gamma emitters (Table 3.11.2.1-1) AND E.4 Restore monitoring instrumentation 30 days F. Deleted G. Turbine Building Ventilation G.1 Estimate flow rate Once per 4 hours Monitoring System: while release is in Effluent Flow Rate Monitor progress. or Sample (Bypass or Low AND Range) Flow Rate Monitor inoperable G.2 Restore monitoring 30 days instrumentation (continued) SUSQUEHANNA - UNIT 1 TRM I 3.11-27 . EFFECTIVE DATE 08/11/2016

For Information Only Radioactive Gaseous Effluent Monitoring Instrumentation Rev. 7 3.11.2.6 ACTIONS (continued) CONDITION REQUIRED ACTION COMPLETION TIME H. Standby Gas Treatment H.1 Take grab samples Once per 4 hours System Noble Gas Activity during operation of Monitor low range channel SGTS inoperable AND H.2 Analyze grab samples for Within 24 hours isotopic activity to the required of grab sample LLDs for principal noble gas being taken gamma emitters (Table 3.11.2.1-1) AND H.3 Restore monitoring 30 days instrumentation I. Deleted J. SGTS Ventilation J.1 Estimate flow rate Once per 4 hours Monitoring System: during operation of Effluent flow rate monitor SGTS or sample (Bypass or Low AND Range) flow rate monitor inoperable J.2 Restore monitoring 30 days instrumentation (continued) SUSQUEHANNA - UNIT 1 TRM I 3.11-28 EFFECTIVE DATE 10/06/2016

For Information Only Radioactive Gaseous Effluent Monitoring Instrumentation Rev. 7 ' 3.11.2.6 ACTIONS (continued) CONDITION REQUIRED ACTION COMPLETION TIME K. Required Actions and K.1 Explain why this inoperability In the next Completion Times not met was not corrected in a timely Radioactive Effluent for Conditions B through J manner Release Report per TS Section 5.6 TECHNICAL REQUIREMENT SURVEILLANCE

                 ---------------------------------------------------------- NOTE ---------------------~-----------------------------------

Refer to Table 3.11.2.6-1 to determine which TRSs apply for each Monitoring Function. SURVEILLANCE FREQUENCY TRS 3.11.2.6.1 Perform CHANNEL CHECK 24 *hours TRS 3.11.2.6.2 Deleted TRS 3.11.2.6.3 Perform Source Check 31 days TRS 3.11.2.6.4 Perform CHANNEL FUNCTIONAL TEST 92 days TRS 3.11.2.6.5 Perform CHANNEL CALIBRATION 24 months SUSQUEHANNA - UNIT 1 TRM I 3.11-29 EFFECTIVE DATE 12/03/2004

For Information Only Radioactive Gaseous Effluent Monitoring Instrumentation Rev. 7 3.11.2.6 TABLE 3.11.2.6-1(Page1 of3) RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION REQUIRED SURVEILLANCE FUNCTION APPLICABILITY CHANNELS REQUIREMENTS

1. REACTOR BUILDING VENTILATION MONITORING SYSTEM

a. Noble Gas Activity Monitor At all Times TRS 3.11.2.6.1 (Low Range) TRS 3.11.2.6.3 TRS 3.11.2.6.4 TRS 3.11.2.6.5

b. Deleted

c. Deleted

d. Effluent System Flow Rate At all Times TRS 3.11.2.6.1 Monitor TRS 3.11.2.6.4 TRS 3.11.2.6.5

e. Sampler Flow Rate Monitor . At all Times TRS 3.11.2.6.1 TRS 3.11.2.6.4 TRS 3.11.2.6.5 (continued)

SUSQUEHANNA~ UNIT 1 TRM I 3.11-30 EFFECTIVE DATE 01/21/2004

For Information Only Radioactive Gaseous Effluent Monitoring Instrumentation Rev. 7 3.11.2.6 TABLE 3.11.2.6-1 (Page 2 of 3) . RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION REQUIRED SURVEILLANCE FUNCTION APPLICABILITY CHANNELS REQUIREMENTS

2. TURBINE BUILDING VENTILATION MONITORING SYSTEM

a. Noble Gas Activity Monitor At al.I Times TRS 3.11.2.6.1 (Low Range) TRS 3.11.2.6.3 TRS 3.11.2.6.4 TRS 3.11.2.6.5

b. Deleted

c. Deleted

d. Effluent System Flow Rate At all Times TRS 3.11.2.6.1 Monitor TRS 3.11.2.6.4 TRS 3.11.2.6.5

e. Sample Flow Rate Monitor At all Times TRS 3.11.2.6.1 (Bypass) TRS 3.11.2.6.4 TRS 3.11.2.6.5

f. Sample Flow Rate Monitor At all Times TRS 3.11.2.6.1 (Low Range) TRS 3.11.2.6.4 TRS 3.11.2.6.5 (continued)

SUSQUEHANNA - UNIT 1 TRM I 3.11-31 EFFECTIVE DATE 08/11 /2016

For Information Only Radioactive Gaseous Effluent Monitoring Instrumentation Rev. 7 3.11.2.6 TABLE 3.11.2.6-1 (Page 3 of 3) RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION REQUIRED SURVEILLANCE FUNCTION APPLICABILITY CHANNELS REQUIREMENTS

3. STANDBY GAS TREATMENT SYSTEM (STGS) MONITOR

a. Noble Gas Activity Monitor During TRS 3.11.2.6.1 (Low Range) operation of TRS 3.11.2.6.3 SGTS(a) TRS 3.11.2.6.4 TRS 3.11.2.6.5

b. Deleted

c. Deleted

d. Effluent System Flow Rate During TRS 3.11.2.6.1 Monitor operation of TRS 3.11.2.6.4 SGTs<al TRS 3.11.2.6.5

e. Sample Flow Rate Monitor During TRS 3.11.2.6.1 (Bypass) operation of TRS 3.11.2.6.4 SGTS(a) TRS 3.11.2.6.5

f. Sample Flow Rate Monitor During operation

TRS 3.11.2.6.1 (Low Range) of SGTS(a) TRS 3.11.2.6.4 TRS 3.11.2.6.5 (a) TRO 3.0.4.c is applicable.

SUSQUEHANNA - UNIT 1 TRM I 3.11-32 EFFECTIVE DATE 10/06/2016

For Information Only Total Dose PPL Rev. 1 3.11.3 3.11 Radioactive Effluents 3.11.3 Total Dose TRO 3.11.3 The annual (calendar year) dose or dose commitment to any MEMBER OF THE PUBLIC, due to releases of radioactivity and radiation, from uranium fuel cycle sources shall be limited to less than or equal to 25 mrem to the total body or any organ, except the thyroid, which shall be limited to less than or equal to 75 mrem. APPLICABILITY: At all times ACTIONS

                 ---------------------------------------------------- l'J()TE: ----------------------------------------------------

1. The provisions of TR() 3.0.4 are not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. Calculated doses from A.1 Initiate actions to Immediately the release of calculate whether the radioactive materials TRO limits have been in liquid or gaseous exceeded effluents exceed twice the limits of Requirements 3.11.1.2.a, 3.11.1.2.b, 3.11.2.2.a, 3.11.2.2.b, 3.11.2.3.a, or

                     . 3.11.2.3.b B. TRO limits exceeded                B.1     Prepare and submit a                   30 days Special Report to the Commission SUSQUEHANNA - UNIT 1                          TRM I 3.11-33                EFFECTIVE DATE 03/31/2006

For Information Only Total Dose PPL Rev. 1 3.11.3 TECHNICAL REQUIREMENT SURVEILLANCE SURVEILLANCE FREQUENCY TRS 3.11.3. 1 Determine the cumulative dose from liquid 31 days and gaseous effluents in accordance with the methodology and parameters in the ODCM TRS 3.11.3.2 Determine cumulative dose contributions 12 months from direct radiation from unit operation in accordance with the methodology and parameters in the ODCM SUSQUEHANNA - UNIT 1 TRM 3.11~34 EFFECTIVE DATE 8/31/1998

For Information Only Monitoring Program PPL Rev. 5 3.11.4.1: 3.11 Radioactive Effluents 3.11.4 Radiological Environmental Monitoring 3.11.4.1 Monitoring Program TRO 3.11.4.1 The radiological environmental monitoring program shall be conducted as specified in Table 3.11.4 ..1-1. APPLICABILITY: At all times ACTIONS

                 -------------------------~-------------------------------- N 0 TE ------------------------------------------------------------

1. The provisions of TRO 3.0.4 are not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. Radiological A.1 Generate a Condition Report to 72 hours Environmental describe the deficiency and any monitoring program not actions taken to prevent their being conducted as recurrence in the applicable specified in Table Annual Radiological 3.11.4.1-1 Environmental Operating Report B. The average level of B.1 Generate a Condition Report to 72 hours radioactivity over any prepare and submit a Special calendar quarter as Report to the Commission within the result of an individual 30 days of identification of the radionuclide in plant Condition. effluents in a particular environmental exposure pathway in a particular environmental sampling medium, at a specified location exceeds the applicable reporting level of Table 3.11.4.1-2 (continued) SUSQUEHANNA - UNIT 1 TRM I 3.11-35 EFFECTIVE DATE 03/31/2006

For Information Only Monitoring Program PPL Rev. 5 . 3.11.4.1 ACTIONS (continued) CONDITION REQUIRED ACTION COMPLETION TIME C. More than one of the C.1 Generate a Condition Report to 72 hours radionuclides in Table prepare and submit a Special 3.11.4.1-2 are detected in a Report to the Commission particular environmental within 30 days of identification exposure pathway at a of the Condition. specified monitoring location and are the result of plant effluents The sum of the ratios of the quarterly average activity levels to their corresponding reporting levels of each detected radionuclide, from Table 3.11.4.1-2, is;:: 1.0 (continued) SUSQUEHANNA - UNIT 1 TRM I 3.11-36 EFFECTIVE DATE 11/30/2005

For Information Only Monitoring Program PPL Rev. 5 3.11.4.1 ACTIONS (continued) CONDITION REQUIRED ACTION COMPLETION TIME D. One or more D.1 Generate a Condition Report 72 hours Radionuclide(s) other than to prepare and submit a those in Table 3.11.4.1-2

Special Report to the are detected in a particular Commission within 30 days of .

environmental exposure identification of the Condition. pathway at a specified location and are the result of plant effluents AND The potential annual dose to a MEMBER OF THE PUBLIC from all detected radionuclides that are the result of plant effluents is greater than or equal to the calendar year limits of TROs 3.11.1.2, 3.11.2.2 and 3.11.2.3 E. All requirements for a E.1 Generate a Condition Report 72 hours Special Report per either to describe the reasons for not Condition B, C, or D are met attributing identified except that the radionuclides radionuclides to plant effluents detected are not the result of in the applicable Annual plant effluents Radiological Environmental Operating Report. (continued) SUSQUEHANNA - UNIT 1 TRM /3.11-37 EFFECTIVE DATE 11/30/2005

For Information Only Monitoring Program PPL Rev. 5 3.11.4.1 ACTIONS (continued) CONDITION REQUIRED ACTION COMPLETION TIME F. Milk or fresh leafy vegetable -------------------- NOTE --------------- samples are unavailable from one or more of the The specific locations from which sample locations required by samples were unavailable may Table 3.11.4.1-1 then be deleted from the monitoring program. F.1 Generate a Condition Report 72 hours to identify locations for obtaining replacement samples and to add them to the radiological environmental monitoring program within 30 days of identification of the Cond~on

F.2 Generate a Condition Report 72 hours to identify the cause of the unavailability of samples and to identify the new location(s) for obtaining replacement samples in the applicable Radioactive Effluent Release Report SUSQUEHANNA - UNIT 1 TRM I 3.11-38 EFFECTIVE DATE 11/30/2005

For Information Only Monitoring Program PPL Rev. 5 3.11.4.1 NOTE: The provisions of TRS 3.0.3 are not applicable to the below surveillances. TECHNICAL REQUIREMENT SURVEILLANCE SURVEILLANCE FREQUENCY TRS 3.11.4. 1.1 Collect the radiological environmental As required by monitoring samples pursuant to Table 3.11.4.1-1 Table 3.11.4.1-1 TRS 3.11.4.1.2 Analyze samples pursuant to the As required by requirements of Table 3.11.4.1-1 with Table 3.11.4.1-1 equipment meeting the detection capabilities required by Table 3.11.4.1-3 TRS 3.11.4.1.3 Determine annual cumulative potential dose Annually contributions from radionuclides detected in environmental samples in accordance with the methodology and parameters in the ODCM. SUSQUEHANNA - UNIT 1 TRM I 3.11-39 EFFECTIVE DATE 11/30/2005

For Information Only Monitoring Program PPL Rev. 5 3.11.4.1 TABLE 3.11.4.1-1(Page1 of3) RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM NUMBER OF REPRESENTATIVE SAMPLING EXPOSURE SAMPLES AND AND TYPE AND FREQUENCY PATHWAY SAMPLE LOCATIONS COLLECTION OF ANALYSIS AND/OR SAMPLE FREQUENCY

1. DIRECT 40 routine monitoring stations with two or Quarterly Gamma dose quarterly RADIATION more dosimeters or with one instrument for measuring and recording dose rate continuously placed as follows:

1. An inner ring of stations, one in each meteorological sector, in the general area of the SITE BOUNDARY 2 An outer ring of stations, one in each meteorological sector, in the 3 to 9 mile range from the site

3. The balance of the stations placed in special interest areas such as population centers, nearby residences, schools, and in 1 or 2 areas to serve as control stations

2. AIRBORNE Radioiodine Samples from 5 locations Continual Radioiodine Canister:

and sampler 1-131 Analysis weekly Particulates a. 1 sample from close to each of the 3 SITE operation with BOUNDARY locations (in different sectors) with sample the highest calculated annual average collection groundlevel D/Q weekly, or more

b. 1 sample from the vicinity of the community frequently if Particulate Sampler:

having one of the highest calculated annual required by Gross Beta radio activity ground level D/Q dust loading analysis following filter I change(a) Gamma isotopic

c. 1 sample from a control location, between 15 and analysis of composite (by 30 km distant and in the least prevalent wind location) quarterly direction of wind blowing from the plant (continued)

(a) Airborne particulate sample filters shall be analyzed for gross beta radioactivity 24 hours or more after sampling to allow for radon and thorn daughter decay. If gross beta activity in air particulate samples is greater than ten times the yearly mean of control samples, gamma isotopic analysis shall be performed on the individual samples. SUSQUEHANNA - UNIT 1 TRM I 3.11-40 EFFECTIVE DATE 02/19/2015

For Information Only Monitoring Program PPL Rev. 5 3.11.4.1 TABLE3.11.4.1-1 (Page2of3). RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM

NUMBER OF REPRESENTATIVE SAMPLING AND EXPOSURE PATHWAY SAMPLES AND COLLECTION TYPE AND FREQUENCY AND/OR SAMPLE SAMPLE LOCATIONS FREQUENCY OF ANALYSIS

3. WATERBORNE

a. Surface 1 sample upstream Composite Gamma isotopic 1 sample downstream sample over analysis monthly.

one-month Composite for period tritium analyses quarterly

b. Ground Samples from 1 or 2 sources only if likely to Quarterly Gamma isotopic and be affected tritium analyses quarterly

c. Drinking 1 sample from each of 1 to 3 of the nearest Composite 1-131 analysis on each.

water supplies that could be affected by its discharge sample over composite when the dose 2-week period calculated for the 1 sample from a control location when 1-131 consumption of the water is analysis is greater than 1 mrem per performed, year. Composite for gross monthly beta and gamma isotopic composite analyses monthly. otherwise Composite for tritium analyses quarterly

d. Sediment from 1 sample from downstream area with existing or Semiannually Gamma isotopic analyses shoreline potential recreational value semiannually (continued)

SUSQUEHANNA - UNIT 1 TRM I 3.11-41 EFFECTIVE DATE 08/31/1998

For Information Only Monitoring Program PPL Rev. 5 3.11.4.1 TABLE 3.11.4.1-1 (Page 3 of 3) RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM NUMBER OF REPRESENTATIVE SAMPLING AND. EXPOSURE PATHWAY SAMPLES AND COLLECTION TYPE AND FREQUENCY AND/OR SAMPLE SAMPLE LOCATIONS FREQUENCY OF ANALYSIS

4. INGESTION

a. Milk a. Samples from milking animals in 3 locations Semimonthly when Gamma isotopic and 1-131 within 5km from the plant having the highest dose animals are on analysis semimonthly when potential. If there are none, then, 1 sample from pasture, monthly at animals are on pasture; milking animals in each of 3 areas between 5 and other times. monthly at other times.

8km distant where doses are calculated to be greater than 1 mrem per year. 1 sample from milking animals at a control location (between 15 and 30km from the plant preferably in the least prevalent direction for wind blowing from the plant).

b. Fish and/or b. 1 sample of each of two recreationally important Sample in season, Gamma isotopic analysis Invertebrates species in vicinity of plant discharge area. or semiannually if on edible portions.

they are not 1 sample of same species in areas not influenced seasonal. by plant discharge.

c. Food c. 1 sample of each principal class of food products At time of harvest Gamma isotopic analysis Products from any area, which is irrigated by water in on edible portions.

which liquid plant wastes have :been discharged. Samples of 3 different kinds of broad leaf Monthly when Gamma isotopic and 1-131 vegetation grown nearest each of two different available analysis. offsite locations of highest predicted annual average ground level D/Q if mil.k sampling is not performed. 1 sample of each of the similar.broad leaf Monthly when Gamma isotopic and 1-131 vegetation grown between 15 to 30km from the available analysis. plant, preferably, in the least prevalent direction for wind blowing from the plant:if milk sampling is not performed. SUSQUEHANNA - UNIT 1 TRM I 3.11-42 EFFECTIVE DATE 08/31/1998

For Information Only Monitoring Program PPL Rev. 5 3.11.4.1 TABLE 3.11.4.1-2 REPORTING LEVELS FOR RADIOACTIVITY CONCENTRATIONS IN ENVIRONMENTAL SAMPLES Reporting Levels Water Airborne Particulate Fish Milk Food Products Analysis (pCi/I) or Gases (pCi/m 3) (pCi/kg, wet) (pCi/I) (pCi/kg, wet) H-3 20,000<0 > Mn-54 1,000 30,000 Fe-59 400 10,000 Co-58 1,000 30,000 Co-60 300 10,000 Zn-65 300 20,000 Zr-Nb-95 400(b) 1-131 2 0.9 *3 100 Cs-134 30 10 1,000 60 1,000 Cs-137 50 20 2,000 70 2,000 Ba-La-140 200(b) 300 (a) For drinking water samples. This is 40 CFR Part 141 value. If no drinking water pathway exists, a value of 30,000 pCi/I may be used. (b) Total for parent and daughter. SUSQUEHANNA - UNIT 1 TRM / 3.11-43 EFFECTIVE DATE 08/31/1998

For Information Only Monitoring Program PPL Rev. 5 3.11.4.1 TABLE 3.11.4.1-3 DETECTION CAPABILITIES FOR ENVIRONMENTAL SAMPLE ANALYSIS LOWER LIMIT OF DETECTION (LLD) Food Airborne Products Sediments Water - Particulate Or Fish Milk (pCi/kg, (pCi/kg, Analysis (pCi/I) Gases (pCi/m 3) (pCi/kg, wet) (pCi/I) wet) dry) Gross Beta 4 0.01 H-3 2000 Mn-54 15 130 Fe-59 30 260 Co-58, 60 15 130 Zn-65 30 260 Zr-95 30 Nb-95 15 1-131 1<a) 0.07 60 Cs-134 15 0.05 130 15 60 150 Cs-137 18 0.06 150 18 80 180 Ba-140 60 60 La-140 15 15 (a) LLD drinkingwater samples SUSQUEHANNA - UNIT 1 TRM I 3.11-44 EFFECTIVE DATE 08/01/2006

For Information Only Land Use Census PPL Rev. 2 3.11.4.2 3.11 Radioactive Effluents 3.11.4 Radiological Environmental Monitoring 3.11.4.2 Land Use Census TRO 3.11.4.2 A land use census shall be conducted. APPLICABILITY: At all times. ACTIONS

                    --------------------------------------------------------- NOTE ----------------------------~----------------------------

1. The provisions of TRO 3.0.4 are not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. Land use census identifies A.1 Identify the new location(s) in As defined by the a location(s) which yields a the next Radioactive Effluent Radioactive Effluent calculated dose or dose Release Report Release Report commitment greater than the values currently being calculated in Requirement 3.11.2.3 B. Land use census identifies 8.1 Add the new location(s) to the 30 days a location(s) that yields a radiological environmental calculated dose or dose monitoring program commitment (via the same exposure pathway) 20 AND percent greater than at a location from which 8.2 Identify the new location(s) in As defined in samples are currently the next Radioactive Effluent Radioactive Effluent being obtained in Release Report per Release Report accordance with TS Section 5.6 Requirement 3.11.4.1 SUSQUEHANNA - UNIT 1 TRM I 3.11-45 EFFECTIVE DATE 03/31/2006

For Information Only Land Use Census PPL Rev. 2 3.11.4.2 TECHNICAL REQUIREMENT SURVEILLANCE SURVEILLANCE FREQUENCY TRS 3.11.4.2.1 Conduct the land use census 12 months SUSQUEHANNA - UNIT 1 3.11-46 EFFECTIVE DATE 8/31/1998

For Information Only lnterlaboratory Comparison Program PPL Rev. 1 3.11.4.3 3.11 Radioactive Effluents 3.11.4 Radiological Environmental Monitoring 3.11.4.3 lnterlaboratory Comparison Program TRO 3.11.4.3 Analyses shall be performed on radioactive materials supplied as part of an lnterlaboratory Comparison Program. APPLICABILITY: At all times. ACTIONS

                 --------------------------------------------------------- l\JOl"E -----------------------------------------------

1. l"he provisions of l"RO 3.0.4 are not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. Analyses not being A. 1 Report the corrective As required performed actions taken to prevent a recurrence to the Commission TECHNICAL REQUIREMENT SURVEILLANCE SURVEILLANCE FREQUENCY TRS 3.11.4.3.1 Include a summary of the results obtained Annually as part of the above required lnterlaboratory Comparison Program in the Annual Radiological Environmental Operating Report SUSQUEHANNA - UNIT 1 TRM I 3.11-47 EFFECTIVE DATE 03/31/2006

Liquid Effluents Concentration PPL Rev. 0 B 3.11.1.1 B 3.11.1.1 Liquid Effluents Concentration BASES TRO This requirement is provided to ensure that the concentration of radioa.ctive materials released in liquid waste effluents to UNRESTRICTED AREAS will be less than 10 times the concentration levels specified in 10 CFR Part 20.1001 to 20.2402, Appendix B, Table 2, Column 2. The requirement provides operational flexibility for releasing liquid effluents in concentrations to follow the Section.II.A and 11.C design objectives of Appendix I to 10 CFR part 50. This limitation provides reasonable assurance that the levels of radioactive materials in bodies of water in UNRESTRICTED AREAS will result in exposures within (1) the Section II.A design objectives of Appendix I, 10 CFR 50, to a Member of the Public and (2) restrictions authorized by 10 CFR 20.1301 (e). The concentration limit for dissolved or entrained noble gases is based upon the assumptions that Xe-135 is the controlling radionuclide and its effluent concentration in air (submersion) was converted to an equivalent concentration in water. This requirement does not affect the requirement to comply with the annual limitations of 10 CFR 20.1301 (a). This reqairement applies' to the release of radioactive materials in

liquid efflu~nts from all units at the site. The required detection capabilities for radioactive materials in liquid waste samples are tabulated in terms of the lower limits of detection (LLDs). Detailed discussion of the LLD and the other detection limits can be found in Curie, LA., "Lower Limit of Detection:

Definition and Elaboration of a Proposed Position for Radiological Effluent and Environmental Measu'rements." (References 2, ,3, and 4) This section of the TRM is also part of the ODCM (Reference 2). Actions The Actions are defined to ensure proper corrective measures are taken in response to exceeding the TRO limits. TRS The TRSs are defined to b.e performed at the specified Frequency to ensure that the parameters are maintained within the TRO limits. Table 3.11.1.1-1 defines Radioactive Liquid Waste Sampling and Analysis Program. The lower limit of detection (LLD) is defined, for purposes of these Requirements, as the smallest concentration of radioactive material in a sample that will yield a net count, (continued) SUSQUEHANNA - UNIT 1 TRM/ B 3.11-1 EFFECTIVE DATE 8/30/98

Liquid Effluents Concentration PPL Rev. 0 B 3.11.1.1 B 3.11.1.1 Liquid Effluents Concentration BASES TRS above system background,* that will be detected with 95% (continued) probability with only 5% probability of falsely concluding that a blank observation represents a "real" signal. *For a particular measurement system, which may include radiochemical separation: LLD= _ _ _ _4_._66_s_b_ _ __ E

V
2.22E6
Y
exp(-J.M)

Where: LLD is the a priori lower limit of detection as defined above (as microcuries per unit mass or volume). Sh is the standard deviation of the background counting rate or of the counting rate of a blank sample as appropriate (as counts per minute}, E is the counting efficiency, .as *counts per disintegration, V is the sample size, in units of mass or volume, 2.22 E6 is the number of disintegrations per minute per microcurie, Y is the fractional radiochemical yi~ld, when applicable. A is the radioactive decay constant for the particular radionuclide, and M for plant effluents is the elapsed time between the midpoint of sample collection and time of counting. Typical values of E, V, Y, and M should be used in the calculation. It should be recognized that the LLD is defined as an a priori (before the fact) limit representing the capability .of a measurement system and notas an a posteriori (after the fact) limit for a particular measurement. A batch release is the discharge of liquid wastes of a discrete volume. Prior to sampling for analyses, each batch shall be isolated, and then thoroughly mixed to assure representative sampling. (continued) SUSQUEHANNA - UNIT 1 TRM I B 3.11-2 EFFECTIVE DATE 8/30/98

Liquid Effluents Concentration PPL Rev. 0 B 3.11.1.1 B 3.11.1.1 Liquid Effluents Concentration .BASES (continued) TRS The principal gamma emitters for which the LLD specification (continued) applies include the following radionuclides: Mn-54, Fe-59, Co-58, Co-60, Zn-65, Mo-99, Cs-134, Cs-137, Ce-141 and Ce-144. The dissolved and entrained gases (gamma emitters) for which the LLD specification applies include the following radionuclides: Kr-85, Kr-85m. Kr-87, Kr-88, Ar-41, Xe-133, Xe-133m, Xe-135, and Xe-135m. This list does not mean that only these nuclides are to be considered. Other gamma peaks that are identifiable, together with those of the above nuclides, shall also be analyzed and reported in accordance with the ODCM. A composite sample is one in which the quantity of liquid sampled is proportional to the quantity of liquid waste discharged and in which the method of sampling employed results in a specimen that is representative of the liquids released over a period no longer than the Minimum Analysis Frequency. The Minimum Analysis Frequency as listed for the Composite

Samples shall mean the minimum* frequency for initiation of the required analyses, not completion of the analyses and evaluation of the results. Since the analysis involves sending the samples to an offsite laboratory and performance of involved sample preparation and wet chem.ical analyses, there will be a delay between initiation of the analysis and receipt of the results.

The analysis initiation shall normally be done on a calendar month for the 31 day frequency or calendar quarter for a 92 day frequency.

REFERENCES 1. Technical Specification 5.5.4 - Radioactive Effluent Controls program.

2. Technical Specification 5.5.1 - Offsite Dose Calculation Manual.

3. NUREG/CR-4007, September, 1984.

4. 10 CFR Part 20.

SUSQUEHANNA - UNIT 1 TRM I B 3.11-3 EFFECTIVE DATE 8/30/98

Liquid Effluents Dose PPL Rev. 0 B 3.11.1.2 B 3.11.1.2 Liquid Effluents Dose BASES TRO This requirement is provided to implement the requirements of Sections II.A, Ill.A and IV.A of Appendix I, 10 CFR Part 50. The Technical Requirement for Operation implements the guides set forth in Section II.A of Appendix I. Also, for fresh water sites with drinking water supplies which can be potentially affected by plantoperations, there is reasonable assurance that the operation of the facility will not result in radionuclide concentrations in the finished drinking water that are in excess of the requirements of 40 CFR 141. The dose calculation methodology and parameters in t.he ODCM implement the requirements in Section Ill.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on models and data, such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially underestimated. The equations specified in the ODCM for calculating the doses due to the actual release rates of radioactive materials in liquid effluents are consistent with the methodology provided in Regulatory Guide 1.109, "Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating 'Compliance with 10 CFR Part 50, Appendix I," Revision 1, October 1977 and Regulatory Guide 1.113, "Estimating Aquatic Dispersion of Effluents from Accidental and Routine Reactor Releases for the Purpose of Implementing Appendix I," April 1977. (References 2, 3, 4, and 5) This section of the TRM is. also part of the ODCM (Reference 2). Actions The ACTION statements provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive material in liquid effluents will be kept "as low as is reasonably achievable." The Special Report to the Commission under Action A.1 shall (continued) SUSQUEHANNA - UNIT 1 TRM I B 3.11-4 EFFECTIVE DATE 8/30/98

Liquid Effluents Dose PPL Rev. 0 8 3.11.1.2 B 3.11.1.2 Liquid Effluents Dose BASES ACTIONS identify the cause(s) for exceeding the limit(s) and define the (continued) .corrective actions that have been taken to reduce the releases and the proposed corrective actions to be taken to assure that subsequent releases will be in compliance with the specified limits. This Special Report shall also include the radiological impact on finished drinking water supplies at the nearest downstream drinking water source. TRS The TRSs are defined to be performed at the specified Frequency to ensure that the TRO limits are maintained. REFERENCES 1. Tech Spec 5.5.4 -: Radioactive Effluent Controls program

2. Tech Spec 5.5.1 - Offsite Dose Calculation Manual

3. 10 CFR Part 20

4. Regulatory Guide 1.109, "Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I,"

Revision *1, October 1977.

5. Regulatory Guide 1.113, "Estimating Aquatic Dispersion of Effluents from Accidental and Routine Reactor Releases for the Purpose of Implementing Appendix I," April 1977.

SUSQUEHANNA - UNIT 1 TRM I 8 3.11-5 EFFECTIVE DATE 8/30/98

Liquid Waste Treatment System PPL Rev. 0 B 3.11.1.3 B 3.11.1.3 Liquid Waste Treatment System BASES TRO The OPERABILITY of the liquid radwaste treatment system ensures that this system will be available for use whenever liquid effluents require treatment prior to release to the environment. The requirement that the appropriate portions of this system be used when specified provides assurance that the releases of radioactive materials in liquid effluents will be kept "as low as is reasonably achievable". This Requirement implements the.requirements of 10 CFR Part 50.36a, General Design Criterion 60 of Appendix A to 10 CFR Part 50 and the design objective given in Section 11.D of Appendix I to *10 CFR Part 50. The specified limits governing the use of appropriate portions of the liquid radwaste treatment system were specified as a suitable fraction of the dose design objectives set forth in Section II.A of Appendix I, .10 CFR part 50, for liquid effluents. (Reference 3) This section of the TRM is also part of the ODCM (Reference 2). Actions The Actions are defined to ensure proper corrective measures are taken in response to the inoperable components. The Special Report to the Commission under Action A.1 shall include the following:

1. Explanation of why liquid radwaste was being discharged without treatment, identification of any inoperable equipment or subsystems and the reason for the inoperability,

2. Action(s) taken to restore the inoperable equipment to OPERABLE status, and

3. Summary description of action(s) taken to prevent a recurrence.

TRS The TRSs are defined to be performed at the specified Frequency

                *to ensure that the system is maintained OPERABLE. OPERABILITY is demonstrated by operating the liquid radwaste treatment system equipment for at least 10 minutes.

REFERENCES 1. Technical Specification 5.5.4 - Radioactive Effluent Controls program.

2. Technical Specification 5.5.1 - ODCM.

3. 10 CFR Part 50.

SUSQUEHANNA - UNIT 1 TRM I B 3. 11-6 EFFECTIVE DATE 8/30/98

Liquid Radwaste Effluent Monitoring Instrumentation PPL Rev. 0 B 3.11.1.4 B 3.11.1.4 Liquid Radwaste Effluent Monitoring Instrumentation BASES TRO The radioactive liquid effluent instrumentation are provided to monitor and control, as applicable, the releases of radioactive materials in liquid effluents during actual or potential releases of liquid effluents. The alarm/trip setpoints for these instruments shall be calculated in accordance with the procedures in the ODCM (Reference 2) to ensure that the alarm/trip will occur prior to exceeding the 10 times the concentration values specified in Appendix B, Table 2, Column 2 of 10CFR20.1001 - 10CFR20.2401 (Ref. 2). The OPERABILITY and use of this instrumentation is consistent with the requirements of General Design Criteria 60, 63, arid 64 of Appendix A to 10 CFR Part 50. (Reference 4) OPERABILITY of the radiation monitoring instrumentation requires their alarm/trip setpoints set to ensure that the limits of Requirement 3.11.1.1 are not exceeded. The alarm/trip setpoints of these channels shall be determifled in accordance with the methodology and parameters described in the ..QDCM. , OPERABILITY of the Liquid Radwaste Effluent Line gross radioactivity monitor includes the proper functioning of the discharge valve interlocks (sample pump low flow, .high radiation alarm, and radiation monitor failure). OPERABILITY of the Cooling Tower Slowdown flow rate measurement device includes the proper functioning of the Liquid Radwaste Effluent Line discharge valve interlock (i.e. cooling tower blowdown low flow). , The Required Channels for each function in Table 3.11.1.4-1 are as follows: (continued) SUSQUEHANNA - UNIT 1 TRM I B 3.11-7 EFFECTIVE DATE 8/30/98

Liquid Radwaste Effluent Monitoring Instrumentation PPL Rev. 0 B 3.11.1.4 B 3.11.1.4 Liquid Radwaste Effluent Monitoring Instrumentation BASES. TRO a. Liquid Radwaste Effluent rad monitor (Function 1.a) one instrument per (continued) station.

b. Liquid Radwaste Effluent flow rate (Function 2.a) one instrument per station.

c. Cooling Tower Slowdown flow rate (Function 2.b) one instrument per station.

It should be noted that the radioactive liquid waste stream is diluted in the Cooling Tower blowdown line prior to entering the Susquehanna River. The setpoint for this dilution water flow is 5000 gpm from the combination* of the Unit 1 blowdown, Unit 2 blowdown flow, and Spray Pond Discharge. Options exist to ensure the requirement of one OPERABLE Cooling Tower Slowdown flow Instrument per station is met as required by Table 3.11.1.4-1, Function 2,b. As long as any one of three instruments (Unit 1 Tower, Unit 2 Tower, Total Site Slowdown) are OPERABLE and alignment of HS-06443A and HSS-01503 on panel OC301 is such that the OPERABLE instrument(s) are in the circuit, then the TRM Requirement is met. This section of the TRM is also part of the ODCM (Reference 2). Actions The Actions are defined to ensure proper corrective measures are taken in response to the inoperable components. Pump curves generated in situ may be used to estimate flow for Action D.1. TRS The TRSs are defined to be performed at the specified Frequency to ensure that the monitoring instrumentation is maintained OPERABLE. The TRSs shall be performed in accordance with the Technical Specification definition for the test with the following additional requirements:. The Liquid Radwaste Effluent Line radiation monitor CHANNEL FUNCTIONAL TEST shall also demonstrate that automatic isolation of this pathway and control room alarm annunciation occur if any (continued) SUSQUEHANNA - UNIT 1 TRM I B 3.11-8 EFFECTIVE DATE 8/30/98

Liquid Radwaste Effluent Monitoring Instrumentation PPL Rev. 0 B 3.11.1.4 B 3.11.1.4 Liquid Radwaste Effluent Monitoring Instrumentation BASES TRS of the following conditions exist: (continued)

1. Instrument indicates measured levels above the alarm/trip setpoint.

2. Circuit failure.

3. Instrument indicates a downscale failure.

The liquid Radwaste Effluent Line radiation monitor initial CHANNEL CALIBRATION shall be performed using one or more of the reference standards certified by the National Institute of Standards and Technology (NIST) or using standards that have been obtained from suppliers that participate in measurement assurance activities with NIST. These standards shall permit calibrating the system over its intended range of energy and measurement range. For subsequent CHANNEL CALIBRATION, sources that have been: related to the initial calibration may be used in lieu of the reference standards associated with the initial calibration. The Liquid Radll'l(aste Effluent Line flow rate monitor and Cooling Tower Slowdown flow rate monitor CHANNEL CHECK shall consist of verifying indication of flow during periods of release. CHANNEL CHECK shall be made at least 6n,ce per 24 hours on days on which continuou~. periodic, or batch releases are made. REFERENCES 1. Technical Specification 5.5.4 - Radioactive Effluent Controls program

2. Technical Specification 5.5.1 - Offsite Dose Calculation Manual

3. 10 CFR Part 20

4. 10 CFR Part 50 SUSQUEHANNA - UNIT 1 TRM I B 3.11-9 EFFECTIVE DATE 8/30/98

Radioactive Liquid Process Monitoring Instrumentation PPL Rev. 0 B 3.11.1.5 B 3.11.1.5 Radioactive Liquid Process Monitoring Instrumentation BASES TRO The radioactive liquid process instrumentation is provided to monitor and control, as applicable, the releases of radioactive materials in liquid effluents during actual or potential releases of liquid effluents. The alarm/trip setpoints for these instruments shall be calculated in accordance with the procedures in the ODCM (Reference 2) to ensure that the alarm/trip will occur prior to exceeding 10 times the concentration values specified in Appendix B, Table 2, Column 2 of 10CFR20.1001 -20.2401(Reference3). The OPERABILITY and use of this instrumentation is consistent with the requirements of General Design Criteria 60, 63, and. 64 of Appendix A to 10 CFR Part 50. (Reference 4)

This section of the TRM is also part*of the ODCM (Reference 2).

Actions The Actions are defined to ensure proper corrective measures are taken in response to the inoperable components. If an RHR heat exchanger and its applicable RHRSW loop are in service there is a pathway from the heat exchanger to the spray

pond. If the heat exchanger and RHRSW loop are not in service (i.e., valved-out, RHRSW pump not running, or piping drained) then a pathway does not exist.

If there is no pathway, the requirement to perform grab sampling is*not applicable when the RHR Service Water System Effluent Line Radiation Monitor has been declared inoperable. The function of pumping down the RHR heat exchanger and RHRSW system piping to the Spray Pond provides a pathway for a release of potentially radioactively contaminated water. The RHRSW system is considered an 80-10 system because a pathway to the environment from this system exists through the Spray Pond and because the system, although normally not radioactively contaminated, has the potential for becoming radioactively contaminated in the event that a leak develops across an RHR heat exchanger. Therefore, grab samples must be collected periodically when the RHRSW system radiation monitor for a particular loop is inoperable (malfunctioning) and water from that loop of the system is being returned to the Spray Pond. Also, grab samples must be collected prior to operations in which water from the RHRSW system will be drained to the Spray Pond. (continued)

SUSQUEHANNA - UNIT 1 TRM I B 3.11-10 EFFECTIVE DATE 2/01/99

Radioactive Liquid Process Monitoring Instrumentation PPL Rev. 0 B3.11.1.5 BASES (continued) TRS The TRSs are defined to be performed at the specified Frequency to ensure that the monitoring instrumentation is maintained OPERABLE. Performance* of the CHANNEL CHECK ensures that a gross failure of the instrument has not occurred. A CHANNEL CHECK is normally a comparison of the parameter indicated on one channel against a similar parameter on other channels. It is based on the assumption that instrument channels monitoring the same parameter should read approximately the same value. Significant deviations between instrument channels could an indication of excessive instrument drift in one of the channels or something even more serious. A CHANNEL CHECK will detect gross channel

failure; thus, it is key to verifying the instrument continues to operate properly between each CHANNEL CALIBRATION.

Agreement criteria, which are developed by the plant staff based on an investigation of a combination of the channel instrument uncertainties, may be used to support this parameter comparison and include indication and readability. If a channel is outside the criteria, it may be an indication that the instrument has drifted outside* its limit and does not necessarily indicate the channel is inoperable. The TRSs shall be performed in accordance with the Technical Specification definition for the test with the following additional requirements: The CHANNEL FUNCTIONAL TEST shall also demonstrate that control room alarm annunciation occurs if any of the following conditions exists:

1. Instrument indicates measured levels above the alarm setpoint.

2. Circuit failure.

3. Instrument indicates a downscale failure, and

4. Instrument controls not set in operate mode.

(continued) SUSQUEHANNA - UNIT 1 TRM I B 3.11-11 EFFECTIVE DATE 04/07/2000

Radioactive Liquid Process Monitoring Instrumentation PPL Rev. 0 B 3.11.1.5 BASES (continued) TRS The initial CHANNEL CALIBRATION shall be performed using one or (continued) more of the reference standards certified by the National Institute of Standards and Technology (NIST) or using standards that have been obtained from suppliers that participate in. measurement assurance activities with NIST. These standards shall permit calibrating the system over its intended range of energy and measurement range. For subsequent CHANNEL CALIBRATION, sources that have been ,related to the initial calibration may be used in lieu of the reference standards associated with the in.itial calibration. REFERENCE.S 1. Technical Specification 5.5.4 - Radioactive Effluent Controls program

2. Technical Specification 5.5.1 - Offsite Dose Calculation Manual

3. 10 CFR Part 20

4. 10 CFR Part 50 SUSQUEHANNA - UNIT 1 TRM I B 3.11-11a EFFECTIVE DATE 04/07/2000

For Information Only Dose Rate PPL Rev. 1 B 3.11.2.1 B 3.11.2.1 Dose Rate BASES TRO This requirement provides reasonable assurance that radioactive material discharged in gaseous effluents will not result in the exposure of a Member of the Public either within or outside the Site Boundary, in excess of the design objectives of Appendix I to 10 CFR 50. It provides operational flexibility for releasing gaseous effluents while satisfying section 11.B and 11.C design objectives of Appendix I. For individuals who may at times be within the Site Boundary, the occupancy of the individual will usually be sufficiently low to compensate for ariy increase in atmospheric diffusion factor above that for the Site Boundary. The specified release rate limits restrict, at all times, the corresponding dose rates above background to a Member ofthe Public at or beyond the Site Boundary to less than or equal to 500 mrem/yr to the total body or to less than or equal 'to 3000 mrem/yr to the skin. These release rate limits also restrict, at all times, the corresponding thyroid dose rate above background to an individual via the inhalation pathway to less than or equal to 1500 mrem/yr. These limits provide reasonable assurance that radioactive material discharged in gaseous effluents will not result in the exposure of a MEMBER OF THE PUBLIC either within or outside the SITE BOUNDARY, to annual average concentrations exceeding the limits specified in Appendix B, Table II of 10 CFR Part 20. (Reference 3) This Requirement applies to the release of gaseous effluents from all reactors atthe site. This section of the TRM is also part of the ODCM (Reference 2). (continued) SUSQUEHANNA - UNIT 1 TRM/B3.11-12 EFFECTIVE DATE 2/01/99

For Information Only Dose Rate PPL Rev. 1 B 3.11.2.1 B 3.11.2.1 Dose Rate BASES (continued) ACTIONS The Actions are defined to ensure proper corrective measures are taken in response to the limits being exceeded. TRS The TRSs are defined to be performed at the specified Frequency to ensure that the dose rates are maintained within limits. Dose rates are determined in accordance with the methodology and parameters of the ODCM. Table 3.11.2.1-1 defir;ies Radioactive Gaseous Waste Sampling and Analysis Program. The lower limit of detection (LLD) is defined, for purposes of these requirement, as the smallest concentration of radioactive material in a sample that will yield a net count, above system background, that will be detected with 95% probability with only 5% probability of falsely concluding that a blank observation represents a "real" signal. For a particular measurement system, which may include radiochemical separation: LLD = _ _ _ _4_._66_S_b_ _ __ E

V
2.22E6
Y
exp(-A.Lit)

Where: LLD is the a priori lower limit of detection as defined above (as microcuries per unit mass or volume), Sb is the standard deviation of the background counting rate or of the counting rate of a blank sample as appropriate (as counts per minute), E is the counting efficiency, as counts per disintegration, V is the sample size, in units of mass or volume, 2.22 E6 is the number of disintegrations per minute per microcurie, Y is the fractional radiochemical yield, when applicable, A. is the radioactive decay constant for the particular radionuclide, and Lit for plant effluents is the elapsed time between the midpoint of sample collection and time of counting (for plant effluents, not environmental samples). (continued) SUSQUEHANNA - UNIT 1 TRM I B 3.11-13 EFFECTIVE DATE 2/01/99

For Information Only Dose Rate PPL Rev. 1 B 3.11.2.1 B 3.11.2.1 Dose Rate BASES TRS The value of Sb used in the calculation of the LLD for a detection system (continued) shall be based on the actual observed variance of the background counting rate or of the counting rate of the blank samples (as appropriate) rather than on an unverified theoretically predicted variance. Typical values of E, V, Y, and ~t shall be used in the calculation. The principal gamma emitters for which the LLD specification applies include the following radionuclides: Kr-87, Kr-88, Xe-133, Xe-133m, Xe-135, Xe-135m and Xe-138 for gaseous emissions and Mn-54, Fe-59, Co-58, Co-60, Zn-65, Mo-99, Cs-134, Cs-137, Ce-141 and Ce-144 for particulate emissions. This list does not mean that only these nuclides are to be considered. Other gamma peaks which are identifiable, together with those of the above nuclides, shall also be analyzed and reported in the Radioactive Effluent Release Report. The design of the systems for the sampling of particulates and iodines provide for sample nozzle entry velocities which are approximately isokinetic with instack air velocities. Gaseous particulate and iodine samples are gathered continuously, with the sample size proportional to the stack emissions; a composite gaseous sample is a combination of all the particulate filters gathered in a sampling period. Particulate or iodine sampling required to be in continuous service will be considered toremain and have been in continuous service when its service is interrupted for a time period not to exceed 1 hour per sampling period. For particulate and iodfne sampling, this is a small fraction of the normal minimum analysis frequency. The minimum Analysis Frequency as listed for the Composite Samples shall mean the minimum frequency for initiation of the required analyses, not completion of the analysis and evaluation of the results. Since the analysis involves sending the samples to an offsite laboratory and performance of involved sample preparation and wet chemical analyses, there will be a delay between initiation of the analysis and receipt of the results. The analysis i11itiation shall normally be done on a calendar quarter for a 92 day frequency. (continued) SUSQUEHANNA - UNIT 1 TRM/83.11-14 EFFECTIVE DATE 12/03/2004

For Information Only Dose Rate PPL Rev. 1 B 3.11.2.1 B 3.11.2.1 Dose Rate BASES (continued) REFERENCES 1. Technical Specification 5.5.4 - Radioactive Effluent Controls Program

2. Technical Specification 5.5.1 - Offsite Dose Calculation Manual

3. 10 CFR Part 20 SUSQUl;HANNA - UNIT 1 TRM I B 3.11-15 EFFECTIVE DATE 2/01/99

Dose - Noble Gases PPL Rev. 0 B 3.11.2.2 B 3.11.2.2 Dose - Noble Gases BASES TRO This requirement is provided to implement the requirements of Sections 11.B, Ill.A and IV.A of Appendix I, 10 CFR Part 50. (Reference 5) .The Technical Requirement for Operation implements the guide,s set forth in Section 11.B of Appendix I. This section of the TRM is also part of the ODCM (Reference 2). Actions The ACTION statements provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive material in gaseous effluents will be kept "as low as is reasonably achievable". , The Special Report required under Action A.1 shall identify the cause(s) for exceeding the limit(s) and define the corrective actions that have been taken to reduce the releases and the proposed corrective actions to be takeh to assure that subsequent releases will be in compliance with the above limits. TRS The TRSs implement the requirements in Section Ill.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on models and data such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially underestimated. The dose calculation established in the ODCM for calculating the doses due to the actual release rates of radioactive noble gases ih gaseous effluents are consistent with the methodology provided in Regulatory Guide 1.109, "Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I," Revision 1, October 1977 and Regulatory Guide 1.111, "Methods for estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water Cooled Reactors," Revision 1, July 1977. The ODCM equations provided for determining the air doses at and beyond the SITE BOUNDARY are based upon the historical average atmospheric conditions. (References 2, 3 and 4) (continued) SUSQUEHANNA - UNIT 1 TRM I B 3.11-16 EFFECTIVE DATE 08/30/98

Dose - Noble Gases PPL Rev. 0 B 3.11.2.2 B 3.11.2.2 Dose - Noble Gases BASES REFERENCES 1. Technical Specification 5.5.4 - Radioactive Effluent Controls program

2. Technical Specification Spec 5.5.1 - Offsite Dose Calculation Manual

3. Regulatory Guide 1.109, "Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I",

Revision 1, October 1977.

4. Regulatory Guide 1.111, "Methods for estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water Cooled Reactors," Revision 1, July 1977.

5. 10 CFR Part 50.

SUSQUEHANNA - UNIT 1 TRM I B 3.11-17 EFFECTIVE DATE 08/30/98

Dose - Iodine, Tritium, and Radionuclides in Particulates Form PPL Rev. 0 B 3.11.2.3 B 3.11.2.3 Dose - Iodine, Tritium, and Radionuclides in Particulates Form BASES TRO This requirement is provided to implement the requirements of Sections 11.C, Ill.A and IV.A of Appendix I, 10 CFR Part 50. The Limiting Conditions for Operation are the guides set forth iil Section 11.C of Appendix I. (Reference 5)

This section of the TRM is also part of the ODCM (Reference 2).

Actions The ACTION statements provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive materials in 'gaseous effluents will be kept" as low as is reasonably achievable." ** The Special Report required under Action A.1 shall identify the cause(s) for exceeding the limit(s) and define the corrective actions that ~ave been taken to reduce the releases and the proposed corrective actions to be taken to assure that subsequent releases will be in compliance with the above limits. I TRS The TRSs are defined to be performed at the specified Frequency to ensure that the TRO limits are maintained.

               ' The ODCM calculational methods specified in the TRSs implement the requirements in Section Ill.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on models and data, such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to:be substantially.underestimated. The ODCM calculational: methods for calculating the doses due to the actual release rates of the subject materials are consistent with the methodology provided in Regulatory Guide 1.109, "C.alculation bf Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part.'50, Appendix I," Revision 1, October 1977 and Regulatory Guide 1.111, "Methods for Estimating Atmospheric Transport arid Dispersion of Gaseous Effluents in Routine Releases fro.m Light-:Water-Cooled Reactors," Revision 1, July 1977. These equations also provide for determining the actual (continued)

SUSQUEHANNA"' UNIT 1 TRM I B 3.11-18 EFFECTIVE DATE 08/30/98

Dose - Iodine, Tritium, and Radionuclides in Particulates Form PPL Rev. 0 B 3.11.2.3 B 3.11.2.3 Dose - Iodine, Tritium, and Radionuclides in Particulates Form BASES TRS doses based upon the historical average atmospheric conditions. (continued) , The release rate Requirements for iodine-131, iodine-133, tritium, and radionuclides in particulate form with half lives greater than 8 days are dependent on the existing radionuclide pathways to man in areas at and beyond the SITE BOUNDARY. The pathways which were exa,mined in the development of these calculations were: 1) individual inhalation of airborne radio-nuclides, 2) deposition of radionuclides onto green leafy vegetation with subsequent consumption by man, 3) deposition onto grassy areas where milk animals and meat producing animals graze with consumption qf the milk and meat by man, and 4) deposition on the ground with subsequent exposure of man.* (References 2, 3 and 4) REFERENCES 1. Technical Specification 5.5.4 - Radioactive Effluent Controls program.

2. Technical Specification 5.5.1 - Offsite Dose Calculation Manual.

3. Regulatory Guide 1.109. Calculation. of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose

                       . of Evaluating Compliance with 10 CFR Part 50, Appendix I,"

Revision 1, October 1977.

4. Regulatory Guide 1.111, "Methods for Estimating Atmospheric Transport.and Dispersion of Gaseous Effluents in Routine Releases from Light-Water-Cooled Reactors," Revision 1, July 1977.. .

5. 10 CFR Part 50 SUSQUEHANNA - UNIT 1 TRM I B 3.11-19 EFFECTIVE DATE 08/30/98

Gaseous Radwaste Treatment System PPL Rev. 0 B 3.11.2.4 B 3.11.2.4 Gaseous Radwaste Treatment System BASES (continued) TRO This TRO ensures that the GASEOUS RADWASTE TREATMENT SYSTEM is OPERABLE and in operation to reduce radioactive materials in gaseous waste prior to discharge when the main condenser air ejector (evacuation) system is in operation. This requirement provides reasonable assurance that the releases of radioactive materials in gaseous effluents will be kept "as low as is reasonably achievable". This TRO implements the requirements of 10 CFR Part 50.36a, General Design Criterion 60 of Appendix A to 10 CFR Part 50, and the design objectives given in Section 11.D of Appendix I to 10 CFR Part 50. The limits governing the use of the system were specified as a suitable fra'ction of the dose design objectives set forth in Sections 11.B and 11.C of Appendix I, 10 CFR Part 50, for gaseous effluents (Ref. 1). This section of the TRM is part of the Offsite Dose Calculation Manual (Ref.

2) and implements the requirements of the Radiological Effluent Controls Program (Ref. 3).

ACTIONS The ACTIONS are defined to ensure proper corrective measures are taken in response to the inoperable components. With the GASEOUS RADWASTE TREATMENT SYSTEM inoperable, action must be taken to restore it to OPERABLE status in order to maintain radioactive releases from the main condenser as low as reasonably achievable, and in compliance with regulatory requirements. The 7 day Completion Time is reasonable to perform repairs and to maintain radioactive release objectives. If the Required Action and Completion Time of Condition A are not met, a Special Report must be prepared and submitted to the Commission. The 30 day Completion Time is reasonable for preparation of the report. The Special Report should include the following information:

1. Identification of the inoperable equipment or subsystems and the reason for inoperability,

2. Action(s) taken to restore the inoperable equipment to OPERABLE status, and

3. Summary description of action(s) taken to prevent a recurrence.

(continued) . SUSQUEHANNA - UNIT 1 TRM I B 3.11-20 EFFECTIVE DATE 04/02/2002

Gaseous Radwaste Treatment System PPL Rev. 0 B 3.11.2.4 TRS The TRSs are performed at the specified Frequency to ensure that the GASEOUS RADWASTE TREATMENT SYSTEM is maintained OPERABLE. TRS 3.11.2.4.1 This surveillance requires verification that the GASEOUS RADWASTE TREATMENT.SYSTEM is in operation when the main condenser air ejector (evacuation) system is in operation. Th.e Frequency of 92 days is appropriate considering the performance of monthly dose projections. REFERENCES 1. 10 CFR Part 50

2. Technical Specification 5.5.1 - Offsite Dose Calculation Manual

3. Technical Specification 5.5A - Radioactive Effluent Controls program.

SUSQUEHANNA - UNIT 1 TRM I B 3.11-20a EFFECTIVE DATE 04/02/2002

For Information Only VENTILATION EXHAUST TREATMENT SYSTEM PPL Rev. 5 B 3.11.2.5 B 3.11.2.5 VENTILATION EXHAUST TREATMENT SYSTEM BASES TRO This TRO ensures that the appropriate subsystems of the VENTILATION EXHAUST TREATMENT SYSTEM, as described in the Offsite Dose Calculation Manual (ODCM) are OPERABLE at all times. The TRO is modified by a Note which requires that the appropriate subsystems of the VENTILATION EXHAUST TREATMENT SYSTEM be used to reduce radioactive materials in gaseous waste prior to their discharge when projected doses due to gaseous effluent releases from either reactor unit to areas at and beyond the SITE BOUNDARY would exceed 0.3 mrem to any organ in a.31 day period. This requirement provides reasonable assurance that the releases of radioactive materials in gaseous effluents will be kept "as low as reasonably achievable." This TRO implements the requirements of 10 CFR Part 50.36a, Gen~ral Design Criterion 60 of Appendix A to 10 CFR Part 50, and the design objectives given in Section 11.D of Appendix I to 10 CFR Part 50. The limits governing the use of appropriate subsystems of the systems were specified as a suitable fraction of the dose design objectives set forth in Sections 11.B and 11.C of Appendix I, 10 CFR Part 50, for gaseous effluents (Ref .. 1).

The VENTILATION EXHAUST TREATMENT SYSTEM is comprised of the following Unit 1 subsystems, as described in the ODCM:

The Unit 1 Zone 1 Reactor Building filtered exhaust subsystem, including the following filters: 1F255A, 1F255B, 1F257A, 1F257B, 1F258A AND 1F258B. The Unit 1 Zone 3 Reactor Building filtered exhaust subsystem, including the following filters: 1F216A, 1F216B, 1F217A, 1F217B, 1F218A, and 1F218B. The Unit 1 Turbine Building filtered exhaust subsystem, including the following filters: 1F157A, 1F157B, 1 F1 SBA, and 1F158B. The Radwaste Building filtered exhaust subsystem, including the following filters: OF355A and OF355B. (continued) SUSQUEHANNA - UNIT 1 TRM I B 3.11-21 EFFECTIVE DATE 05/13/2005

For Information Only VENTILATION EXHAUST TREATMENT SYSTEM PPL Rev. 5 B 3.11.2.5 B 3.11.2.5 VENTILATION EXHAUST TREATMENT SYSTEM BASES TRO The Radwaste Tank Vent exhaust subsystem, including the following (continued) filters: OF358 and OF359.

The S&A Hot Shop exhaust subsystem, including the following filters:

OF716. The Control Structure Sample Room exhaust subsystem, including the following filters: OF134 and OF135. The Control Structure Rad Chem. Lab exhaust subsystem, including the following filters: OF137 and OF138. The Control Structure Rad Chem. Lab exhaust subsystem, including the following filters: OF140 and OF141. The Control Structure Decon Area exhaust subsystem, including the following filters: OF143 and OF144. This section of the TRM is part of the ODCM (Ref. 2) and implements the requirements of the Radiological Effluent Controls Program (Ref. 3). ACTIONS The ACTIONS have been modified by .a NOTE that. allows separate Condition entries for each subsystem. The ACTIONS are defined to ensure proper corrective measures are taken in response to the inoperable components. (continued) SUSQUEHANNA - UNIT 1 TRM I B 3.11~22 EFFECTIVE DATE 11 /14/2006

For Information Only VENTILATION EXHAUST TREATMENT SYSTEM PPL Rev. 5 B 3.11.2.5 B 3.11.2.5 VENTILATION EXHAUST TREATMENT SYSTEM BASES ACTIONS (continued) A.1 The appropriate subsystem of the VENTILATION EXHAUST TREATMENT SYSTEM will be declared inoperable if any of the following conditions exist:

1. , Failure of a surveillance test;

2. Broken or non-functional component which prevents the subsystem from being run (e.g. both 100% fans or one 50% fan in the subsystem); or

3. Bypass or degradation of subsystem filtration in which effluent flow continues without full treatment.

With a subsystem of the VENTILATION EXHAUST TREATMENT SYSTEM inoperable, action must be taken to restore it to OPERABLE status. The 31 day Completion Time is a reasonable time frame to repair the inoperable components. If the Required Action and Completion Time of Condition A are not met, or gaseous waste is being discharged without treatment and in excess of the TRO limit, a Special Report must be prepared and submitted to the Commission. The 30 day Completion Time is reasonable for preparati,on of the report. The Special Report should include the following information:

1. Identification of the inoperable equipment or subsystems and the reason for inoperability;

2. Action(s) taken to restore the inoperable equipment to OPERABLE status; and

3. Summary description of action(s) taken to prevent a recurrence.

(continued) SUSQUEHANNA - UNIT 1 TRM I B 3.11-23 EFFECTIVE DATE 11/14/2006

For Information Only Ventilation Exhaust Treatment System PPL Rev. 5 B 3.11.2.5 B 3.11.2.5 VENTILATION EXHAUST TREATMENT SYSTEM BASES (continued) TRS The TRSs are performed at the specified Frequency to ensure that the VENTILATION EXHAUST TREATMENT SYSTEM is maintained OPERABLE. TRS 3.11.2.5.1 This surveillance requires that a dose projection be performed in accordance with the methodology and parameters in the ODCM. The dose projection is performed based on the most recently available effluent data. If it is known prior to performing the dose projection that a treatment subsystem will be out of service, and if data exists which indicates how the lack of treatment will impact effluents, these factors will be considered when performing the dose projection. The 31 day Frequency is consistent with Reference 3. TRS 3.11.2.5.2 This surveillance verifies that each of the subsystems of the VENTILATION EXHAUST TREATMENT SYSTEM is OPERABLE by operating the subsystem ;:::: 10 minutes. Operation of the subsystem for at least 10 minutes provides sufficient time to verify the appropriate parameters are within their normal operating range. The Frequency of 92 days is appropriate considering the performance of monthly dose projections. This TRS is modified by a Note which states that the TRS is not required to be performed if the appropriate subsystem has been utilized to process radioactive gaseous effluents during the previous 92 days. This allowance is appropriate because actual processing of radioactive gaseous effluents demonstrates subsystem OPERABILITY. TRS 3.11.2.5.3 This SR verifies that the required filter testing is performed in accordance with the Filter Testing Program. The Filter Testing Program includes testing HEPA filter performance, charcoal adsorber efficiency, and the physical properties of the activated charcoal (general use and following specific operations). Specific test frequencies and additional information are discussed in detail in the Filter Testing Program. The following filters will be tested: SUSQUEHANNA - UNIT 1 TRM I B 3.11-23a EFFECTIVE DATE 06/18/2013

For Information Only Ventilation Exhaust Treatment System PPL Rev. 5 B 3.11.2.5 B 3.11.2.5 VENTILATION EXHAUST TREATMENT SYSTEM BASES (continued) TRS TRS 3.11.2.5.3 (continued) Unit 1 RB Zone 1 filtered exhaust: 1F255A, 1 F255B, 1F257A, 1F257B, 1F258A and 1F258B Unit 1 RB Zone 3 filtered exhaust: 1F216A, 1F216B, 1F217A, 1F217B, 1F218A and 1F218B Unit 1 TB filtered exhaust: 1F157A, 1F157B, 1F158A and 1F158B Radwaste Building filtered exhaust: OF355A and OF355B Radwaste Tank Vent exhaust: OF358 and OF359 S&A Hot Shop exhaust: OF716 Control Structure Sample Room: OF134 and OF135 Control Structure Chem Lab: OF137, OF138, OF140 and OF141 I Control Structure Decon Area: OF143 and OF144 I REFERENCES 1. 10 CFR Part 50.

2. Technical Specification 5.5.1 - Offsite Dose C.alculation Manual.

3. Technical Specification 5.5.4 - Radioactive Effluent Controls program.

SUSQUEHANNA - UNIT 1 TRM I B 3.11-23b EFFECTIVE DATE 06/18/2013

For Information Only Radioactive Gaseous Effluent Monitoring Instrumentation Rev. 2 B 3.11.2.6 B 3.11.2.6 Radioactive Gaseous Effluent Monitoring Instrumentation BASES TRO The radioactive gaseous effluent instrumentation is provided to monitor and control, as applicable, the releases of radio~ctive materials in gaseous effluents during actual or potential releases of gaseous effluents. The alarm/trip setpoints for these instruments shall be calculated in accordance with the procedures in the ODCM (Reference 2) to ensure that the alarm/trip will occur prior to exceeding the release rate limits corresponding to dose rates above background to a member of the public at or beyond the site boundary to ::::; 500 mrem/yr to the total body or to ::::; 3000 mrem/yr to the skin. The OPERABILITY and use of this instrumentation is consistent with the requirements of General Design Criteria 60, 63, and 64 of Appendix A to 10 CFR Part 50. (References 3 and 4) OPERABILITY requires their alarm/trip setpoints set to ensure that the limits of Requirement 3.11.2.1 are not exceeded. The alarm/trip setpoints of these channels shall be determined in accordance with the methodology and parameters in the ODCM. Thi.s section of the TRM is also part of the ODCM (Reference 2). The vent effluent monitor for the Turbine Building and Standby Gas Treatment System (SGTS) is a wide range noble gas monitor. The Effluent channel #4 for each of the Turbine and SGTS displays the release rate in uCi/min using the best detector in range. Upscale and failure alarIT)s originate from the Effluent channel. There are 3 detectors for each wide range gas monitor, low, mid and high range. During normal plant operations, the low range channel will be selected for Effluent channel calculation. The mid and high range detectors are in standby mode. The mid and high range detectors are activated and selected automatically based upon the monitored noble gas concentration. During high range noble gas releases, the mid and high range detectors are activated and the low range noble gas detector loop is selected in standby mode. Faults detected by the vent effluent monitor will be annunciated in the main control room overhead annunciator via the Effluent channel. These loops can be considered Operable if the Effluent release rate channel is not alarmed. (continued) SUSQUEHANNA - UNIT 1 TRM I B 3.11-24 EFFECT.IVE DATE 08/11/2016

For Information Only Radioactive Gaseous Effluent Monitoring Instrumentation Rev. 2 B 3.11.2.6 B 3.11.2.6 Radioactive Gaseous Effluent Monitoring Instrumentation BASES TRO The Turbine Building and SGTS vent sample flow system operates (continued) to support the detector selection requirements. Normally the low range sample flow is operating to support the low range detector. On detection of an upscale noble gas release, the mid/high range sample pump that is normally in standby mode is activated to draw a sample through the mid and high range noble gas detectors and low range sample flow system is in standby mode. The mid I high range sample is then selected and low range sample flow is activated automatically when noble gas concentrations return to normal levels. The bypass sample flow system is designed to make up the proper sample flow rate from the isokinetic nozzle array. For the Turbine Building monitor, the bypass system is required to operate continuously. For the SGTS, the bypass system is in standby mode until high range noble gas is *sensed and the bypass system is automatically activated and selected as required. These loops can be considered Operable if the Effluent release rate channel is not alarmed. ACTIONS The Actions are defined to ensure proper corrective measures are taken in response to the inoperable components. Low range Noble Gas channel readings from the local vent monitor may be used to meet the requirement for a Noble Gas grab sample and grab sample analysis. Noble Gas release grab samples are not required to be taken when there are no releases via that pathway. Effluent flow is to be determined by vent flow instrumentation or by a vent flow estimate every 4 hours. Continuous sample collection shall be on the same basis as described in the Bases for TRO 3.11.2.1 Monitoring may be interrupted for up to 30 minutes to perform particulate filter/iodine cartridge changeout required by TRM Table 3.11.2-1 without entering the TRO ACTIONS. (continued) SUSQUEHANNA - UNIT 1 TRM I B 3.11-24a EFFECTIVE DATE 08/11/2016

For Information Only Radioactive Gaseous Effluent Monitoring Instrumentation Rev.2 B 3.11.2.6 B 3.11.2.6 Radioactive Gaseous Effluent Monitoring Instrumentation BASES (continued) TRS .The TRSs are defined to be performed at the specified Frequency to ensure that the monitoring instrumentation is maintained OPERABLE. The TRSs shall be performed in accordance with the Technical Specification definition for the test with the following additional requirements: The CHANNEL FUNCTIONAL TEST for all noble gas activity monitors shall also demonstrate that control room alarm annunciation occurs if any of the following conditions exists:

1. Instrument indicates measured levels above the alarm/trip setpoint,

2. Circuit failure, and

3. Instrument indicates a downscale failure.

The initial CHANNEL CALIBRATION for all noble gas activity monitors shall be performed using one or more of the reference standards certified by the National Institute of Standards and Technology (NIST) or using standards that have been obtained from suppliers that participate in measurement assurance activities with NIST. These standards shall permit calibrating the system over its intended range of energy and measurement range. For subsequent CHANNEL CALIBRATION, sources that have been related to the initial calibration may be used in lieu of reference standards associated with the initial calibration. Particulate or iodine sampling required to be in continuous service will be considered to remain and have been in continuous service when its service is interrupted for a period of time not to exceed 1 hour per sampling period. For particulate and iodine sampling, this is a small fraction of the normal minimum analysis frequency. REFERENCES 1. Technical Specification 5.5.4 - Radioactive Effluent Controls program.

2. Technical Specification 5.5.1 - Offsite Dose Calculation Manual.

3. 10 CFR Part 20.

4. 10 CFR Part 50.

SUSQUEHANNA - UNIT 1 TRM I B 3.11-25 EFFECTIVE DATE 01/21/2004

Total Dose PPL Rev. 0 B 3.11.3 B 3.11.3 Total Dose BASES TRO

This Requirement is provided to meet the dose limitations of 40 CFR 190 that have been incorporated into 10 CFR 20 by 46 CFR
18525. The Requirementrequires the preparation and submittal of a Special Report whenever the calculated doses from plant radioactive effluents exceed twice the design objective doses of Appendix I. For sites containing up to 4 reactors, it is highly unlikely that the resultant dose to a MEMBER OF THE PUBLIC will exceed the dose limits of 40 CFR 190 if the individual reactors remain within the reporting requirement level. The Special Report will describe a course .of action that should result in the limitation of the annual dose to a MEMBER OF THE PUBLIC to within the 40 CFR 190 limits. For the purposes of the Special Report, it may be assumed that the dose com.mitment to the MEMBER OF THE PUBLIC from other uranium fuel cycle sources is negligible, with the exception that .dose contributions fro'11 other nuclear fuel cycle facilities at the same site or within a radius of 5 miles must be considered. If the dose to any MEMBER OF THE PUBLIC is estimated to 'exceed the requirements of 40 CFR 190, the Special Report with a request for a. variance (provided the release conditions. ~esulting in violation of 40 CFR .190 have not already b~en corrected), in accordance with the provisions of 40 CFR 190.11 is considerE;ld to be a timely request and fulfills the requirements of 40 CFR 190 until NRG.staff action is completed. An individual is not consi'dered a MEMBER OF THE PUBLIC during any* period in which he/she is engaged in carrying out any operation that is part of. the nuclear fuel cycle.

Reference 3 Actions The Actions are defined to ensure proper corrective measures are taken when requirements are not met. Calculations required by Action B.1 shall include direct radiation contributions from both reactor units and from outside storage tanks to determine whether the limits of this TRO have been exceeded. (continued) SUSQUEHANNA - UNIT 1 TRM I B 3.11-26 EFFECTIVE DATE 08/30/98

Total Dose PPL Rev. 0 B 3.11.3 B 3.11.3 Total Dose . BASES (continued) ACTIONS The Special Report to be issued per Action B.1 shall define the (continued) corrective action to be taken to reduce subsequent releases, to prevent recurrence of exceeding the above limits, and include the schedule for achieving conformance with the above limits. This Special Report shall include an analysis that estimates the radiation exposure (dose) to a MEMBER OF THE PUBLIC from uranium fuel cycle sources, including all effluent pathways and direct radiation, for the calendar year that includes the release(s) covered by this report. It shall also describe levels of radiation and concentrations of radioactive material involved, and the cause of the exposure levels or concentrations. If the estimated dose(s) exceeds the above limits, and if the release condition resulting in violation of 40 CFR Part 190 has not already been corrected, the Special Report shall include a request for a variance in accordance with the provisions of 40 CFR Part 190, Submittal of the report is considered a timely request, and a variance is granted until staff action on the request is complete. TRS The TRSs are defined to be performed at the specified Frequency to ensure that requirements are implemented. TRS 3.11.3.1 cumulative dose contributions from liquid and gaseous effluents shall be determined in accordance with TROs 3.11.1.2, 3.11.2.2, and 3.11.2.3, The direct radiation dose is determined from the results of radiation monitoring with TLDs that is conducted by the SSES REMP. The REMP TLDs are processed quarterly. There is no requirement to show compliance with the 40CFR190 dose limits more frequently than an annual basis. Demonstration of compliance with this dose limit considers the combined dose contributions from liquid and gaseous effluents and direct radiation. REFERENCES 1. Technical Specification 5.5.4 - Radioactive Effluent Controls program

2. Technical Specification 5.5.1 - Offsite Dose Calculation Manual

3. 40 CFR 190 SUSQUEHANNA- UNIT 1 TRM I B*3.11-27 EFFECTIVE DATE 08/30/98

For Information Only Monitoring Program PPL Rev. 5 B 3.11.4.1 B 3.11.4.1 Monitoring Program BASES TRO The radiological environmental monitoring program required by this Requirement provides representative measurements of radiation and of radioactive materials in those environmental exposure pathways and for those radionuclides that lead to the highest potential radiation exposures of MEMBERS OF THE PUBLIC resulting from the station operation. This monito'ring program thereby supplements the radiological effluent monitoring program by verifying that the measurable concentrations of radioactive materials and'levels of radiation are not higher than expected on the basis of the effluent measurements and modeling of the environmental exposure pathways. Changes to the radiological environmental monitoring program specified in Table 3. 11.4.1-1 may be made based on expected SSES operation and the results of radiological environmental monitoring during SSES operation. The required detection capabilities for environmental sample analyses are tabulated in terms of the lower limits of detection (LLDs). The LLDs required by Table 3.11.4. 1-3 are considered optimum for routine eiwiro11mental measurements in industrial laboratories. It should be recognized that the LLD is defined as an a priori (before the fact) limit representing the capability of a measurement system ar:id not as an a posteriori (after the fact) limit for a particular measurement. Detailed discussion of the LLD, and other detection limits, can be found in HASL Procedures Manual, HASL-300 (revised annually); Currie, L.A.,

                                  "Limits for Qualitative Detection and Quantitative Determination -

Application to Radiochemistry" Anal.. Chem. 40, 586-93 (1968); and Hartwell, J. K., "Detection Limits for Radioanalytical Counting Techniques," Atlantic Richfield Hanford Company Report ARH-SA-215 (June 1975). (Reference 1) This section of the TRM is also part of the ODCM (Reference 2). ACTIONS The Actions are defined to ensure proper corrective measures are taken when requirements are not met. Once a Condition Report is generated (per the applicable Action), the TRO may be exited because at that time, the Condition that caused the TRO is no longer out of compliance with the program. * (continued) SUSQUEHANNA - UNIT 1 TRM I B 3.11-28 EFFECTIVE DATE 11 /30/2005

For Information Only Monitoring Program PPL Rev. 5 B 3.11.4.1 B 3.11.4.1 Monitoring Program BASES ACTIONS Per Action A.1, the Annual Radiological Environmental Operating Report (continued) shall provide a description of the reasons for not conducting the program as required and the plans for preventing a recurrence. The Special Report submitted per Action B.1 shall identify the cause(s) for exceeding the limit(s) and define the corrective actions to be taken to reduce radioactive effluents so that the potential annual dose to a MEMBER OF THE PUBLIC is less than the calendar year limits of Requirements 3.11.1.2, 3.11.2.2 and 3.11.2.3. Include revised figure(s) and table for the ODCM reflecting the new locations for obtaining samples per Action F.1 in the next Radioactive Effluent Release Report. TRS The TRSs are defined to be performed at the specified frequency to ensure that the requirements are implemented. Monitoring samples collected per TRS 3.11.4.1.1 shall be from the specific locations given in the table and figure in the ODCM. (Reference 2) The TRSs are modified by a Note to take exception to TRS 3.0.3. Table 3.11.4.1-1 Sample Locations Specific parameters of distance and direction sector from the centerline of one reactor, and additional description where pertinent; shall be provided for each and every sample location in this Table and in a table and figure(s) in the ODCM. Refer to NUREG-0133, "Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants," October 1978, and to Radiological Assessment Branch Technical Position, Revision 1, November 1979. (Reference 3) and NUREG-1302, Offsite Dose Calculation Manual Guidance: "Standard Radiological Effluent Controls for Boiling Water Reactors," April 1991. (Reference 5). Deviations are permitted from the required sampling schedule if specimens are unobtainable due to hazardous conditions, seasonal unavailability, malfunction of automatic sampling equipment and other legitimate reasons. If specimens are unobtainable due to sampling equipment malfunction, every effort shall be made to complete corrective action prior to the end of the next s~mpling (continued) SUSQUEHANNA - UNIT 1 TRM I B 3.11-29 EFFECTIVE DATE 02/19/2015

For Information Only Monitoring Program PPL Rev. 5 B 3.11.4.1 B 3.11.4.1 Monitoring Program BASES TRS period. All deviations from the sampling schedule shall be documented in (continued) the Annual Radiological Environmental Operating Report. It is recognized that, at times, it may not be possible or practicable to continue to obtain samples of the media of choice at the most desired location or time. In these instances suitable alternative media and locations may be chosen for the particular pathway in question and appropriate substitutions made within 30 days in the radiological environmental monitoring program. Identify the cause of the unavailability of samples for that pathway and identify the new location(s) for obtaining replacement samples in the next Radioactive Effluent Release Report and also include in the report a revised figure(s) and table for the ODCM reflecting the new location(s). Direct Radiation One or niore instruments, such as a pressurized ion chamber, for measuring and recording dose rate continuously may be used in place of, or in. addition to, integrating dosimeters. Film badges shall not be used as dosimeters for measuring direct radiation. Radioiodine and Particulates - Sampling and Collection Frequency The charcoal cartridges used in the airborne radioiodine sampling conducted as part of the radiological environmental monitoring program are designed and tested by the manufacturer to assure a. high efficiency in the capture of radioibdine. Certificates* from the manufacturer of the cartridges are provided with each batch of cartridges certifying the percent retention of the radiodine for' stated air flows.

Radioiodine and Particulates - Particulate Sample; Waterborne - Surface.

Ground. Sediment; Food Products Gamma isotopic analysis means the identification and quantification of gamma-emitting radionuclides that may be attributable to the effluents from the facility. Waterborne - Surface The "upstream sample" shall be taken at a distance beyond significant influence of the discharge. The "downstream" sample shall be taken within the discharge line or just downstream of the discharge line near the mixing zone. (continued) SUSQUEHANNA - UNIT 1 TRM I B 3.11-30 EFFECTIVE DATE 05/29/2013

For Information Only Monitoring Program PPL Rev. 5 B 3.11.4.1 B 3.11.4.1 Monitoring Program BASES. TRS Waterborne - Drinking - Sampling and Collection Frequency A composite (continued) sample is one in which the quantity (aliquot) of liquid sampled is

                                  . proportional to the quantity of flowing liquid and in which the method of sampling employed results in a specimen that is representative of the liquid

flow. In this program composite samples shall be collected at time intervals that are very short (e.g., hourly) relative to the compositing period (e.g., monthly) in order to assure obtaining a representative sample.

Waterborne - Ground - Samples and Sample Locations Groundwater samples shall be taken when this source is. tapped for drinking or irrigation purposes in areas where the hydraulic gradient or recharge properties are suitable for contamination. Drinking Water 131 Analyses Calculation of the dose projected from 1-131 in drinking water to determine if 1-131 analyses of the water are required shall be performed for the

maximum organ and age group using the methodology and parameters of the ODCM.

Food Products - Sampling and Collection Frequency If harvest occurs more than once a year, sampling shall be performed during each discrete harvest. If harvest occurs continuously, sampling shall be monthly. Attention shall be paid to including samples of tuborous and root food products. Table 3.11.4.1-3 This list does not mean that only these nuclides are to be considered. Other peaks that are identifiable at 95% confidence level together with those of the above nuclides, shall also be analyzed and reported in the Annual Radiological Environmental Operating report. Required detection capabilities for dosimeters used for environmental measurements are given in Regulatory Guide 4.13. (Reference 4) (continued) SUSQUEHANNA - UNIT 1 TRM I B 3.11-31 EFFECTIVE DATE 05/29/2013

For Information Only Monitoring Program PPL Rev. 5 B 3.11.4.1 B 3.11.4.1 Monitoring Program BASES TRS The LLD is defined, for purpose of these Requirements, as the smallest (continued) concentration of radioactive material in a sample that will yield a net count (above system background) that will be detected with 95% probability with only 5% probability of falsely concluding that a blank observation represents a "real" signal. For a particular measurement system (which may include radiochemical separation): LLD= 4.66sb E* V

2.22*Y
exp(-Ut)

Where: 1.-LD is the a priori lower limit of detection as defined above (as picrocuries per unit mass or volume), sb is the standard deviation of the background counting rate or of the countingrate of a blank sample as appropriate (as counts per minute), E is the counting efficiency, as counts per disintegration, V is the sample size, in units of mass or volume, 2.22.is the number of disintegrations per minute per picrocurie, Y is the fractional radiochemical yield, when applicable,

                                    /.., is the radioactive decay constant for the particular radionuclide, and
                                   ~t     for environmental samples is the elapsed time between sample collection (or end of the sample collection period) and time of counting.

Typical values of E, V, Y, and ~t should be used in the calculation. (continued) SUSQUEHANNA - UNIT 1 ,TRM I B 3.11-32 EFFECTIVE DATE 08/30/1998

For Information Only Monitoring Program PPL Rev. 5 B 3.11.4.1 B 3.11.4.1 Monitoring Program BASES TRS It should be recognized that the LLD is defined as a priori (before the fact) (continued) limit representing the capability of a measurement system and not as an a posteri.ori (after the fact) limit for a particular measurement. Analyses shall be performed in such a manner that the stated LLDs will be achieved under routine conditions. Occasionally background fluctuations, unavoidably small sample sizes, the presence of interfering nuclides, or other uncontrollable circumstances may render these LLDS unachievable. In such cases, the contributing factors shall be identified and described in the Annual Radiological Environmental Operating Report. REFERENCES 1. HASL Procedures Manual, HASL-300 (revised annually); Curie, L.A.,

                                        "Limits for Qualitative Detection and Quantitative Determination -

Application to Radiochemistry" Anal. Chem. 40, 586-93 (1968); and Hartwell, J. K., "Detection Limits for Radioanalytical Counting Techniques," Atlantic Richfield Hanford Company Report ARH-SA-215 (June 1975) Offsite Dose Calculation Manual

2. Technical Specification 5.5.1 -Offsite Dose Calculation Manual

3. NUREG-0133, "Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants," October 1978, and to Radiological Assessment Branch Technical Position, Revision 1, November 1979

4. Regulatory Guide 4.13

5. NUREG-1302, Offsite Dose Calculation Manual Guidance: "Standard Radiological Effluent Controls for Boiling Water Reactors," April 1991 SUSQUEHANNA - UNIT 1 TRM I B 3.11-33 EFFECTIVE DATE 06/30/2010

Land Use Census PPL Rev. 0 B 3.11.4.2 B 3.11.4.2 Land Use Census BASES TRO The Land Use Census shall identify within a distance of 8 km (5 miles) the location in each of the 16 meteorological sectors of the nearest milk animal, the nearest residence and the nearest garden of greater than 50m 2 (500ft2 ) producing broad leaf vegetation. This Requirement is provided to ensure that changes in the use of areas at and beyond the SITE BOUNDARY are identified and that modifications to the monitoring program are made if required by the results of this census. The best information from the door-to-door survey, aerial survey or consulting with local agricultural authorities or any combination of these methods shall be used. This census satisfies the requirements of Section IV.B.3 of Appendix I to 10 CFR Part 50. Restricting the census to gardens of greater than 500 square feet provides assurance that significant exposure pathways via leafy vegetables will qe identified and monitored since a garden of this size is the minimum required to produce the quantity (26 kg/year) of leafy vegetables assumed in Regulatory Guide 1.109 for consumption by a child. To determine this minimum garden size, the following assumptions were used: 1) that 20% of the garden was used for growing broad leaf vegetation (Le., similar to lettuce and cabbage), and 2) a vegetation yield of 2 kg/square meter. (Reference 1 and 2) Broad leaf vegetation sampling of at least three different kinds of vegetation may be performed at the site boundary in each of two different direction sectors with the highest predicted D/Qs in lieu of the garden census. Specifications for broad leaf vegetation sampling in Table 3.11.4.1-1 item 4c shall be followed, including analysis of control samples. This section of the TRM is also part of the ODCM (Reference 3). Actions The Actions are defined to ensure proper corrective measures are taken in when requirements are not met. {continued) SUSQUEHANNA - UNIT 1 TRM I B 3.11-34 EFFECTIVE DATE 08/30/98

Land Use Census PPL Rev. 0 B 3.11.4.2 B 3.11.4.2 Land Use Census BASES (continued) ACTIONS The sampling location(s), excluding the control station (continued) location, having the lowest calculated dose, or dose commitment(s) (via the same exposure pathway) may be deleted from the monitoring program after October 31 of the year in which the land use census was conducted. TRS The TRS.s are defined to be performed at the specified Frequency to ensure that the requirements are implemented. The Land Use Census shall be conducted during the growing season at least once per 12 months using that information that will provide the best results, such as by a door-to-door survey, aerial survey, or by consulting local agriculture authorities. The results of the land use census shall be included in the Annual Radiological Environmental Operating Report. REFERENCES 1. 10 CFR Part 50

2. Regulatory Guide 1.109, "Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I,"

Revision 1, October 1977

3. Technical Specification 5.5.1 -*Offsite Dose Calculation Manual SUSQUEHANNA - UNIT 1 TRM I B 3.11-35

EFFECTIVE DATE 08/30/98

lnterlaboratory Comparison Program

PPL Rev. 0 8 3.11.4.3 B 3.11.4.3 lnterlaboratory Comparison Program BASES TRO The lnterlaboratory-Comparison Program shall be accepted by the Commission. The requirement for participation in an lnterlaboratdry Comparison Program is provided to ensure that independent checks on the precision and accuracy of the measurements of radioactive material in environmental sample matrices are performed as part of the quality assurance program for environmental monitoring in order to demonstrate that the results are reasonably valid for the purpose of Section IV.8.2 of Appendix I to 10 CFR Part 50. (Reference 1)

This part of the TRM is also part of the ODCM (Reference 2) Actions The Actions are defined to ensure proper corrective measures are taken in response to the detection of unacceptably large deviations (systematic biases) from known values for the quantities being measured. The corrective actions taken to prevent a recurrence shall be reported to the Commission in the Annual Radiological Environmental Operating Report. TRS The TRSs are defined to be performed at the specified Frequency to ensure that the requirements are implemented. REFERENCES 1. 10 CFR Part 50

2. Technical Specification 5.5.1 - Offsite Dose Calculation Manual

SUSQUEHANNA - UNIT 1 TRM I 8 3.11-36 EFFECTIVE DATE 2/12/99

VENTING or PURGING PPL Rev. 0 3.6.1 3.6 Containment 3.6.1 VENTING or PURGING TRO 3.6:1 VENTING or PURGING of the primary containment shall be performed only with the following conditions established: *

1. Both Standby Gas Treatment Systems shall be OPERABLE in accordance with LCO 3.6.4.3 "Standby Gas Treatment (SGT)

System" and whenever the purge system is in use during MODE 1, 2, or 3, only one of the SGT System trains *may be used.

2. LCO 3.3.6.1 "Primary Containment Isolation Instrumentation" Function 2.e "SGTS Exhaust Radiation -

High" shall be OPERABLE. APPLICABILITY: Whenever primary containment VENTING or PURGING is in progress. ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A VENTING and PURGING A.1 Suspend all VENTING and Immediately requirements not met. PURGING of the primary containment. TECHNICAL REQUIREMENT SURVEILLANCE SURVEILLANCE FREQUENCY TRS 3.6.1.1 Verify that the requirements of TRO 3.6.1 Within 4 hours "VENTING and PURGING" are met. prior to start of VENTING or PURGING of the primary containment 12 hours SUSQUEHANNA - UNIT 1 TRM / 3.6-1 EFFECTIVE DATE 8/31/1998

VENTING or PURGING PPL Rev. 0 B 3.6.1 B 3.6.1 VENTING or PURGING BASES TRO This TRO establishes the requirements necessary to VENT or PURGE the Primary Containment to provide reasonable assurance that releases from the Primary Containment. during purging operations will be maintained As Low As Reasonably Achievable for unrestricted areas. The following requirements are specified: Flow must be maintained through Standby Gas Treatment System and when venting or purging both SGTS must be OPERABLE *and only one can be aligned for purging. This requirement is established to ensure all flow is filtered through the SGTS System, to minimize the chance of an inadvertent release and to ensure, during purging, SGTS capability is maintained by ensuring the redundant system is available. Ventilation evolutions to support habitability of the Drywell or the Suppression Chamber performed in Modes 4 and 5 shall be performed with the "SGTS Exhaust Radiation - High" Isolation Instrumentation OPERABLE. This is required to ensure all releases are monitored and any detection of excessive radiation results in the automatic termination of the evolution. In MODES 1, 2, or 3, this instrument Function is required to be OPERABLE per Technical Specification, so no redundant requirement is necessary in this TRO. (Reference 2) PURGING and VENTING as defined in the Technical Requirements Manual Definitions refer to the controlled process of discharging air or gas from a "confinement" in order to maintain various operating conditions, either with or without replacement air or gas. The basis for this requirement is to provide a reasonable assurance that releases from the Primary Containment purging operations will not exceed the annual dose limits of 10 CFR Part 20 for unrestricted areas. (continued) SUSQUEHANNA - UNIT 1 TRM I 83.6~1 EFFECTIVE DATE 07/26/2001

VENTING or PURGING PPL Rev. 0 B 3.6.1 B 3.6.1 VENTING or PURGING BASES (continued) TRO Any ventilation evolutions performed during MODES 4, 5 or defueled, to . (continued) support habitability of the Drywell or the Suppression Chamber, with any of the Containment _hatches removed or access doors open with interlocks defeated, do not constitute VENTING or PURGING as defined. This is due to the fact that in such cases, the Drywell or the Suppression Chamber is not a "confinement". Therefore, the provisions of this TRO requiring two OPERABLE trains of the Standby.Gas Treatment System are not applicable. ACTIONS The Actions are defined to ensure proper corrective measures are taken in response to the non-compliance with the TRO requirements. TRS The TRSs are defined .to be performed at the specified Frequency to ensure compliance with the TRO requirements REFERENCES 1. 10 CFR Part 20

2. FSAR Section 6.5.1.1 SUSQUEHANNA- UNIT 1 . TRM I B 3.6-2 EFFECTIVE DATE 02/01/1999

For Information Only Liquid Effluents Concentration PPL Rev. 1 3.11.1.1 3.11 Radioactive Effluents 3.11.1 Liquid Effluents 3.11.1.1 Liquid Effluents Concentration TRO 3.11.1.1 The concentration of radioactive material released in liquid effluents to UNRESTRICTED AREAS (See FSAR Section 2.1.1.3) shall be limited to 10 times the concentrations specified in Appendix B, Table 2, Column 2 to 10CFR 20.1001-20.2402 for radionuclides other than dissolved or

entrained noble gases. For dissolved or entrained noble gases, the concentration shall be limited to 2E-4 µCi/ml total activity.

APPLICABILITY: At all times. ACTIONS

                 ------------------------------------------------------------ N0 TE ---------------------------------------------------------

1. The provisions of TRO 3.0.4 are not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. Concentration of

A 1. Restore the concentration to Immediately radioactive material
within the above limits released in liquid effluents to UNRESTRICTED AREAS (See FSAR Section 2.1.1.3) exceeds the limits specified in TRO 3.11.1.1 SUSQUEHANNA - UNIT 2 TRM I 3.11-1 EFFECTIVE DATE 03/31/2006

For Information Only Liquid Effluents Concentration PPL Rev. 1 3.11.1.1 TECHNICAL REQUIREMENT SURVEILLANCE SURVEILLANCE FREQUENCY TRS 3.11.1.1.1 The radioactivity content of each batch of radioactive Prior to each liquid waste shall be determined by*sampling and release analysis in accordance with Table 3.11.1 ..1-1. The results of pre-release analyses shall be used with the

                                . calculational methods and parameters in the ODCM to assure that the concentration at the point of release is maintained within the limits of TRO 3.11.1.1 TRS 3.11.1.1.2   Post release analyses of samples composited from          According to the batch releases shall be performed in accordance with      ODCM Table 3.11.1.1-1. The results of the previous post-release analyses shall be used with the calculational methods and parameters in the o*ocM to assure that the concentrations at the point of release were maintained within the limits of TRO 3.11.1.1 SUSQUEHANNA - UNIT 2                       3.11-2                EFFECTIVE DATE 08/31/1998

For Information Only Liquid Effluents Concentration PPL Rev. 1 3.11.1.1 TABLE 3.11.1.1-1 RADIOACTIVE LIQUID WASTE SAMPLING AND ANALYSIS PROGRAM Lower Limit Minimum of Detection Liquid Release Sampling Analysis Type of Activity (LLD) Type Frequency Frequency Analysis (µCi/ml) Batch Waste Prior to Prior to Principal Gamma 5E-7 Release Tanks Release Release Emitters Each Batch Each Batch 1-131 1E-6 Prior to 31 days Dissolved and 1E-5 Release Entrained Gases One Batch per (Gamma Emitters) month Prior to 31 day H-3 1E-5 Release Composite<*l Each Batch Gross Alpha 1E-7 Prior to 92 days SR-89. Sr-90 5E-8 Release Composite(a) Each Batch Fe-55 IE-6 (a) Minimum frequency for.initiation of required analysis. SUSQUEHANNA - UNIT 2 3.11-3 EFFECTIVE DATE 08/31/1998

For Information Only Liquid Effluents Dose PPL Rev. 1 3.11.1.2 3.11 Radioactive Effluents 3.11.1 Liquid Effluents 3.11.1.2 Liquid Effluents Dose TRO 3.11.1.2 The dose or dose commitment to a MEMBER OF THE PUBLIC from

radioactive materials in liquid effluents released from each reactor unit UNRESTRICTED AREAS shall be limited:

a. During any calendar quarter to less than or equal to 1.5 mrems to the total body and to less than or equal to 5 mrems to any organ.

b. During any calendar year to less than or equal to 3.0 mrems to the total body and to less than or equal to 10 mrems to any organ:

APPLICABILITY: At all times. ACTIONS

                 ------------------------------------------------------------ NOTE ---------------------------------------------------------

1. The provisions of TRO 3.0.4 are not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. Calculated dose from the A 1. Prepare and submit a Within 30 days release of radioactive Special Report to the materials in liquid effluents Commission exceeding any of the above limits SUSQUEHANNA - UNIT 2 TRM/3.11-4 EFFECTIVE DATE 03/31/2006

For Information Only Liquid Effluents Dose PPL Rev. 1 3.11.*1.2 TECHNICAL REQUIREMENT SURVEILLANCE SURVEILLANCE FREQUENCY TRS 3.11.1.2.1 Determine cumulative dose contributions from liquid 31 days effluents for the current calendar quarter and the current calendar year in accordance with methodology and parameters in the ODCM SUSQUEHANNA - UNIT 2 3.11-5 EFFECTIVE DATE 08/31/1998

For Information Only Liquid Waste Treatment System PPL Rev. 1 3.11.1.3 3.11 Radioactive Effluents 3.11.1 Liquid Effluents 3.11.1.3 Liquid Waste Treatment System TRO 3.11.1.3 The appropriate portions of the Liquid Radwaste Treatment System, as described in the ODCM, shall be OPERABLE. Appropriate portions of the Liquid Waste Treatment System shall be used to reduce the radioactive materials in liquid effluent, prior to their discharge, when projected doses due to liquid effluent releases from each reactor unit to UNRESTRICTED AREAS would exceed 0.06 mrem to the total body or 0.2 mrem to any organ in a 31 day period. APPLICABILITY: At all times. ACTIONS

                 ------------------------------------------------------------ N0 TE -'--------------------------------------------------------

1. The provisions of TRO 3.0.4 are not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A Liquid effluent releases A 1. Prepare and submit a 30 days being discharged without Special Report to the treatment and in excess of Commission the TRO limit. SUSQUEHANNA - UNIT 2 TRM I 3.11-6 EFFECTIVE DATE 03/31/2006

For Information Only Liquid Waste Treatment System PPL Rev. 1 3.11.1.3 TECHNICAL REQUIREMENT SURVEILLANCE SURVEILLANCE FREQUENCY TRS 3.11.1.3.1 Project doses due to liquid releases from each 31 days reactor unit to the UNRESTRICTED AREAS in accordance with the methodology and parameters in the ODCM. TRS 3.11.1.3.2 -------------------------------NOTE------------------------------ Not required to be performed if the liquid radwaste system has been utilized to process radioactive liquid during the previous 92 days Demonstrate the Liquid Radwaste (LRW) Treatment 92 days System OPERABLE by operating LRW Treatment System equipment for at least 10 minutes. SUSQUEHANNA--UNIT 2 3.-11-7 EFFECTIVE DATE 08/31/1998

For Information Only Liquid Radwaste Effluent Monitoring Instrumentation PPL Rev. 2 3.11.1.4 3.11 Radioactive Effluents 3.11.1 Liquid Effluents 3.11.1.4 Liquid Radwaste Effluent Monitoring Instrumentation TRO 3.11.1.4 The Radioactive Liquid Radwaste Effluent Monitoring Instrumentation channels shown in Table 3.11.1.4-1 shall be OPERABLE with their setpoints established in accordance with the ODCM.to ensure that the alarm/trip will occur prior to exceeding the limits of TRO 3.11.1.1. APPLICABILITY: At all times. ACTIONS

                 -------------------------------------~-------------------------N 0 TE-----------------------------------------------------

1. Separate condition entry is allowed for each channel

2. The provisions of TRO 3.0.4 are not applicable CONDITION REQUIRED ACTION COMPLETION TIME A. One or more radioactive A. 1 Suspend the release of Immediately liquid effluent monitoring radioactive liquid effluents instrumentation alarm/trip monitored by the affected channels setpoint less channel conservative than the limits OR allowed by TRO 3.11.1.1 A.2 Declare the channel Immediately inoperable (continued)

SUSQUEHANNA - UNIT 2 TRM/3.11-8 EFFECTIVE DATE 08/31/1998

For Information Only Liquid Radwaste Effluent Monitoring Instrumentation PPL Rev. 2 3.11.1.4 ACTIONS (continued) CONDITION REQUIRED ACTION COMPLETION TIME

8. Liquid Radwaste releases 8.1 Analyze at least two Prior to initiating are necessary and Effluent *independent samples in each release.

Line Gross Radioactivity accordance with TRO 3.11.1.1 Monitoring Instrumentation AND inoperable. 8.2 Independently determine Prior to initiating release rates for samples each release. analyzed per Action 8.1 AND 8.3 Perform and independently Prior to initiating verify discharge valve lineup each release. AND 8.4 Restore monitoring 30 days instrumentation C. Liquid Radwaste releases C.1 Maintain at least one isolation Within 1 hour of are not in progress and the valve closed between each securing from Gross Radioactivity source of release and the release or Monitoring instrumentation liquid radwaste discharge discovery of is inoperable because the valve. inoperable inoperable channel is instrument. caused by a discharge valve interlock in an off-normal condition or not functioning. (continued) SUSQUEHANNA - UNIT 2 TRM I 3.11-9 EFFECTIVE DATE 10/09/2012

For Information Only Liquid Radwaste Effluent Monitoring Instrumentation PPL Rev. 2 3.11.1.4 ACTIONS (continued) CONDITION REQUIRED ACTION COMPLETION TIME D. Liquid Radwaste releases D.1 Estimate Flow Rate. Once per 4 hours are necessary and Effluent during releases. Line or Cooling Tower AND Slowdown Flow Monitoring Instrumentation inoperable. D.2 Restore Monitoring 30 days Instrumentation. E. Liquid Radwaste releases E.1 Maintain at least one Within 1 hour of are not in progress and isolation valve closed securing release or cooling tower blowdown between each source of discovery of flow monitoring release and the liquid inoperable instrument. instrumentation is radwaste discharge valve. inoperable because the inoperable channel is a discharge valve interlock in an off-normal condition or not functioning. F. Required Action and F.1 --------------NOTE------------- Associated Completion Only applicable to Time of Conditions B, C, D, Conditions B and D or E not met.. ------------------------------------ Effluent releases via this Immediately pathway may continue (up to 45 days from initial TRO entry) provided that Required Actions B.1, B.2, B.3 and D.1 are performed as applicable (within associated Completion Times). Otherwise, suspend release of radioactive effluents via this pathway AND In the next F.2 Explain why the Radioactive Effluent inoperability was not Release Report per corrected in a timely TS Section 5.6 manner SUSQUEHANNA - UNIT 2 TRM I 3.11-10 EFFECTIVE DATE 10/09/2012

For Information Only Liquid Radwaste Effluent Monitoring Instrumentation PPL Rev. 2 3.11.1.4 TECHNICAL REQUIREMENT SURVEILLANCE

                 --------------------------------------------------------------NOTE---------------~--------------------------------

Refer to Table 3.11.1.4-1 to determine which TRSs apply for each Monitoring Function. SURVEILLANCE FREQUENCY TRS 3. 11. 1.4.1 Perform CHANNEL CHECK. 24 hours TRS 3.11.1.4.2 Perform CHANNEL CHECK including a source Prior to check. ' commencing release TRS 3.11.1.4.3 . Perform CHANNEL FUNCTIONAL TEST 92 days TRS 3. 11. 1.4.4 Perform CHANNEL CALIBRATION 24 months SUSQUEHANNA - UNIT 2 TRM I 3.11-11 EFFECTIVE DATE 08/31/1998

For Information Only Liquid Radwaste Effluent Monitoring Instrumentation PPL Rev. 2 3.11.1.4 TABLE 3.11.1.4-1 LIQUID RADWASTE EFFLUENT MONITORING INSTRUMENTATION REQUIRED SURVEILLANCE FUNCTION CHANNELS REQUIREMENTS

1. GROSS RADIOACTIVITY MONITORS PROVIDING AUTOMATIC TERMINATION OF RELEASE

a. Liquid Radwaste Effluent Line TRS 3.11.1.4.2 TRS 3.11.1.4.3 TRS 3.11.1.4.4

2. FLOW RATE MEASUREMENT DEVICES

a. Liquid Radwaste Effluent Line . TRS 3.11.1.4.1Ca>

TRS 3.11.1.4.3

                                                                                               . TRS 3.11: 1.4.4

b. Cooling Tower Slowdown TRS 3.11.1.4.1Cal TRS 3.11.1.4.3 TRS 3.11.1.4.4 (a)

Only required when performing batch releases. SUSQUEHANNA - UNIT 2 TRM I 3.11-12 EFFECTIVE DATE 08/31/1998

For Information Only Radioactive Liquid Process Monitoring Instrumentation PPL Rev. 3 3.11.1.5 3.11 Radioactive Effluents 3.11.1 Liquid Effluents 3.11.1.5 Radioactive Liquid Process Monitoring Instrumentation TRO 3.11.1.5 The Radioactive Liquid Process Monitoring Instrumentation channels shown in Table 3.11.1.5-1 shall be OPERABLE with their setpoints established in accordance with the ODCM to ensure the alarm will occur prior to exceeding the limits of TRO 3.11.1.1. APPLICABILITY: As specified in Table 3.11.1.5-1. ACTIONS

                 -------------------------------------------------------------N0 TE------------------------------------------------------*

1. Separate condition entry is allowed for each channel.

2. TRO 3.0.4.c is applicable.

3. The provisions of TRO 3.0.6 are not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A One or more Radioactive A.1 Suspend the release of liquid Immediately Liquid Process Monitoring effluents monitored by the Instrumentation alarm/trip affected channel channels setpoint less OR conservative than the limits A.2 Declare the channel Immediately allowed by TRO 3.11.1.1. inoperable (continued) SUSQUEHANNA - UNIT 2 TRM I 3.11-13 EFFECTIVE DATE 02/19/2015

For Information Only Radioactive Liquid Process Monitoring Instrumentation PPL Rev. 3 3.'.11.1.5 ACTIONS (continued) CONDITION REQUIRED ACTION COMPLETION TIME B. Radioactive Liquid Process B.1.1 Suspend the release of Immediately Monitoring Instrumentation liquid effluents monitored by otherwise inoperable. the affected channel. OR B.1.2 Analyze grab samples for Once per 8 hours isotopic activity to the when the required.LLDs for liquid associated pathway effluents (Table 3.11.1.1-1). is in service AND B.2 Restore monitoring 30 days instrumentation C. Required Action and C.1 Explain why the inoperability

In the next Associated Completion was not corrected in a timely Radioactive Time of Conditions B not manner Effluent Release met. Report per TS Section 5.6 D. RHR Heat Exchanger to be D.1 Analyze grab samples from Prior to draining drained to the spray pond. the RHR Heat Exchanger for RHR Heat isotopic activity to the required Exchanger to the LLDs for liquid effluents (Table spray pond.

3.11.1.1-1). SUSQUEHANNA - UNIT 2 TRM / 3.11-14 EFFECTIVE DATE 12/03/2004

For Information Only Radioactive Liquid Process Monitoring Instrumentation PPL Rev. 3 3.11.1.5 TECHNICAL REQUIREMENT SURVEILLANCE

                 --------------------------------------------------------------NOTE-------------------------------------------------

Refer to Table 3.11.1.5-1 to determine which TRSs apply for each Monitoring Function. SURVEILLANCE FREQUENCY TRS 3.11.1.5.1 Perform CHANNEL CHECK. 24 hours TRS 3.11.1.5.2 Perform a Source Check 31 days TRS 3.11.1.5.3 Perform CHANNEL FUNCTIONAL TEST 92 days TRS 3.11.1.5.4 Perform CHANNEL CALIBRATION 24 months SUSQUEHANNA - UNIT 2 TRM I 3.11-15 EFFECTIVE DATE 09/01/1998

For Information Only Radioactive Liquid Process Monitoring Instrumentation PPL Rev. 3 3.11.1.5 TABLE 3.11.1.5-1 RADIOACTIVE LIQUID PROCESS MONITORING INSTRUMENTATION REQUIRED SURVEILLANCE FUNCTION CHANNELS APPLICABILITY REQUIREMENTS GROSS RADIOACTIVITY MONITORS NOT PROVIDING AUTOMATIC TERMINATION OF RELEASE

1. Service Water System Effluent Line (a) TRS 3.11.1.5.1 TRS 3.11.1.5.2 TRS 3.11.1.5.3 TRS 3.11.1.5.4

2. Supplemental Decay Heat Removal (a) TRS 3.11.1.5.1 Service Water TRS 3.11.1.5.2 TRS 3.11.1.5.3 TRS 3.11.1.5.4

3. RHR Service Water System Effluent 1/Loop . (b) TRS 3.11.1.5.1 Line. TRS 3.11.1.5.2 TRS 3.11.1.5.3 TRS 3.11.1.5.4 (a) System aligned through Fuel Pool Cooling Heat Exchanger. Alignment change between Service Water System Effluent Line and Supplemental Decay Heat Removal Service Water is not considered to be a change in the applicable condition.

(b) At all times SUSQUEHANNA - UNIT 2 TRM / 3.11-16 EFFECTIVE DATE 09/01/1998

For Information Only Dose Rate PPL Rev. 3 3.11.2.1 3.11 Radioactive Effluents 3.11.2 Gaseous Effluents 3.11.2.1 Dose Rate TRO 3.11.2.1 The dose rate due to radioactive materials released in gaseous effluents to areas at and beyond the SITE BOUNDARY (See FSAR Section 2.1.1.3) shall be limited to the following: I. For Noble Gases: A. Less than or equal to 500 mrems/yr to the total body, and B. Less than or equal to 3000 mrems/yr to the skin II. For iodine-131, iodine-133, tritium, and all radionuclides in particulate form with half lives greater than 8 days A. Less than or equal to 1500 mrem/yr to any organ (Inhalation pathways only.) APPLICABILITY: At all times. ACTIONS

                 ------------------------------------------------------------ NOTE ---------------------------------------------------------

1. The provisions of TRO 3.0.4 are not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. Dose rate(s) exceed the A.1 Restore the release rate to lmmedicitely above limits within the above limits SUSQUEHANNA - UNIT 2 TRM I 3.11-17 EFFECTIVE DATE 03/31/2006

For Information Only Dose Rate PPL Rev. 3 3.11.2.1 TECHNICAL REQUIREMENT SURVEILLANCE SURVEILLANCE FREQUENCY TRS 3.11.2.1.1 Determine the dose rate due to noble gases in See ODCM gaseous effluents. TRS 3.11.2.1.2 The .dose rate due to iodine-131, iodine-133, See Table tritium, and all radionuclides in particulate form 3.11.2.1-1 with half-lives greater than 8 days in gaseous effluents shall be determined to be within the limits in accordance with the methodology and parameters of the ODCM by obtaining representative samples and performing analyses in accordance with the sampling and analysis program specified in Table 3.11.2.1-1 SUSQUEHANNA - UNIT 2 3.11-18 EFFECTIVE DATE 08/31/1998

For Information Only Dose Rate PPL Rev. 3 3.11.2.1 TABLE 3.11.2.1-1 RADIOACTIVE GASEOUS EFFLUENT SAMPLING AND ANALYSIS Sampling Minimum Analysis Lower Limit of Type of Activity Gaseous Release Type Method and Detection (LLD) Frequency Analysis Frequency (µCi/ml) A, Containment Purge Prior to each purge Prior to each Principal Noble 1E-4 Grab Sample purge Gas Gamma Emitters H-3 1E-6 B. Reactor Building 31 daysC*l 31 dayC*l Principal Noble 1E-4 Vents, Turbine Grab Sample Gas Gamma Emitters Building Vents, and SGTS H-3 1E-6 0 Continuous<bl Iodine 7 days< l 1-131 1E-12 Cartridge Sample 1-133 1E-10 C~ntinuousCbJ 7 days(c) Principal 1E-11 Particulate sample Particulate Gamma Emitters 1-131 Continuous<bl 92 days Gross Alpha 1E-11 Composite<dl Particulate Sample Continuous<bl 92 days Sr-89, Sr-90 1E-11 Composite<dl Particulate sample Continuous<bl Noble Gas Noble Gases, Gross 1E-6 Monitor Beta or Gamma (Xe-133 equivalent) (a) Noble gas analyses, shall be performed following shutdown, startup, or a THERMAL POWER change exceeding 15% of the RATED THERMAL POWER within a 1-hour period. (bl The ratio of the sample flow rate to the sampled stream flow rate shall be known for the time period covered by each dose or dose rate calculation made in accordance with TROs 3.11.2.1, 3.11.2.2, and 3.11.2.3. (c) Samples shall be changed at least:

1. Once per 7 days; and

2. Once per 24 hours for a least 7 days following each shutdown, startup, or thermal power change exceeding 15% of rated thermal power in 1 hour if: (1) analysis has shown that the dose equivalent 1-131 concentration in the primary coolant is >1.0E-4 µCi/g and has increased by more than a factor of 3; or (2) the noble gas monitor or grab samples show that effluent activity is >1 E-6 µCi/cc and has increased by more than a factor of 3.

Analyses shall be completed within 48 hours after change-outs. When samples collected for~ 24 hours are analyzed, the corresponding LLD may be increased by a factor of 10. (d) Minimum frequency for initiation of required analysis. SUSQUEHANNA - UNIT 2 TRM/3.11-19 EFFECTIVE DATE 08/15/2005

For Information Only Dose - Noble Gases PPL Rev. 1 3.11.2.2 3.11 Radioactive Effluents 3.11.2 Gaseous Effluents 3.11.2.2 Dose - Noble Gases TRO 3.11.2.2 The air dose due to noble gases released in gaseous effluents, from each reactor unit, to areas at and beyond the SITE BOUNDARY (See FSAR Section 2.1.1.3) shall be limited to the following:

a. During any calendar quarter: Less than or equal to 5 mrads for gamma radiation and less than or equal to 10 mrads for beta radiation, and

b. During any calendar year: Less than or equal to 10 mrads for gamma radiation and less thari orequal to 20 mrads for beta radiation.

APPLICABILITY: At all times. ACTIONS

                 ------------------------------------------------------------ NOTE ---------------------------------------------------------

1. The provisions of TRO 3.0.4 are not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. The calculated air dose A.1 Prepare and submit a Special 30 days exceeds the limits. Report to the Commission TECHNICAL REQUIREMENT SURVEILLANCE SURVEILLANCE FREQUENCY TRS 3.11.2.2.1 Determine the cumulative dose contributions for 31 days the current calendar quarter and current calendar year for these sources in accordance with the methodology and parameters in the ODCM SUSQUEHANNA - UNIT 2 TRM I 3.11-20 EFFECTIVE DATE 03/31/2006

For Information Only Dose - Iodine, Tritium, and Radionuclides in Particulate Form PPL Rev. 1 3.11.2.3 3.11 Radioactive Effluents 3.11.2 Gaseous Effluents 3.11.2.3 Dose - Iodine, Tritium, and Radionuclides in Particulate Form TRO 3.11.2.3 The dose to a MEMBER OF THE PUBLIC from iodine-131,. iodine-133,

                                          . tritium, and all radionuclides in particulate form with half-lives greater than 8 days in gaseous effluents released, from each reactor unit, to areas at and beyond the SITE BOUNDARY shall be limited to the following:

a. During any calendar quarter: Less than or equal to 7.5 mrems to any organ and,

b. During any calendar year: Less than or equal to 15 mrems to any organ.

APPLICABILITY: At all times. ACTIONS

                 ------------------------------------------------------------ NOTE ---------------------------------------------------------

1. The provisions of TRO 3.0.4 are not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. The calculated dose from A.1 Prepare and submit a 30 days the release exceeds the Special Report to the limits. Commission. TECHNICAL REQUIREMENT SURVEILLANCE SURVEILLANCE FREQUENCY TRS 3.11.2.3.1 Determine the cumulative dose contributions for 31 days the current calendar quarter and current calendar year for these sources in accordance with the methodology and parameters in the ODCM. SUSQUEHANNA - UNIT 2 TRM / 3.11-21 EFFECTIVE DATE 03/31/2006

GASEOUS RADWASTE TREATMENT SYSTEM PPL Rev. 0 3.11.2.4 3.11 Radioactive Effluents 3.11.2 Gaseous Effluents 3.11.2.4 GASEOUS RADWASTE TREATMENT SYSTEM TRO 3.11.2.4 The GASEOUS RADWASTE TREATMENT SYSTEM shall be OPERABLE and in operation. APPLICABILITY: When the main condenser air ejector (evacuation) system is in operation. ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A. GASEOUS RADWASTE A.1 Restore GASEOUS 7 days TREATMENT SYSTEM RADWASTETREATMENT inoperable. SYSTEM to OPERABLE status. B. Required Action and B.1 Prepare and submit a 30 days associated Completion Special Report to the Time not met. Commission. TECHNICAL REQUIREMENT SURVEILLANCE SURVEILLANCE FREQUENCY TRS 3.11.2.4.1 Verify GASEOUS RADWASTE TREATMENT 92 days SYSTEM to be in operation. SUSQUEHANNA - UNIT 2 TRM I 3. 11-22 EFFECTIVE DATE 04/02/2002

For Information Only VENTILATION EXHAUST TREATMENT SYSTEM PPL Rev. 4 3.11.2.5 3.11 Radioactive Effluents 3.11.2 Gaseous Effluents 3.11.2.5 VENTILATION EXHAUST TREATMENT SYSTEM TRO 3.11.2.5 The appropriate subsystems of the VENTILATION EXHAUST TREATMENT SYSTEM, as described in the Offsite Dose Calculation Manual (ODCM), shall be OPERABLE. .

                                          ----------------------------------------------N0 TE----------------------------------------------

A pp ro p ri ate subsystems of the VENTILATION EXHAUST TREATMENT SYSTEM shall be used to reduceradioactive materials in gaseous waste prior to their discharge when projected doses due to gaseous effluent releases from either reactor unit to areas at and beyond the SITE BOUNDARY would exceed 0.3 mrem to any organ in a 31 day period. APPLICABILITY: At all times. ACTIONS

                 ----------------------------------------------:---------------N0 TE--------------------------------------------------------

1. Separate Condition eintry is allowed for each subsystem.

2. The provisions of TRO 3.0.4 are not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. A subsystem of the A.1 Restore subsystem to 31 days VENTILATION EXHAUST OPERABLE status. TREATMENT SYSTEM inoperable. B. Required Action and B.1 Prepare and submit a 30 days Associated Completion Special Report to the Time of Condition A not Commission. met. OR Gaseous waste from either reactor unit being discharged without appropriate treatment and in excess of 0.3 mrem to any organ in a 31 day period. SUSQUEHANNA - UNIT 2 TRM I 3.11-23 EFFECTIVE DATE 11/14/2006

For Information Only VENTILATION EXHAUST TREATMENT SYSTEM PPL Rev. 4 3.11.2.5 TECHNICAL REQUIREMENT SURVEILLANCE SURVEILLANCE FREQUENCY TRS 3.11.2.5.1 Perform dose projection due to gaseous releases 31 days from each reactor unit to areas at and beyond the SITE BOUNDARY in accordance with the methodology and parameters in the ODCM. TRS 3.11.2.5.2 - --------------------------N 0 TE----------------------------- Not required if the appropriate subysterri has been utilized to process radioactive gaseous effluents during the previous 92 days.

Verify each subsystem of the VENTILATION 92 days EXHAUST TREATMENT SYSTEM is OPERABLE by operating the subsystem ~ 10 minutes.

TRS 3.11.2.5.3 Perform required HVAC filter testing in -In accordance with accordance with the Filter Testing Program. the Filter Testing Program SUSQUEHANNA - UNIT 2 TRM / 3.11-24 EFFECTIVE DATE 06/18/2013

For Information Only Radioactive Gaseous Effluent Monitoring Instrumentation Rev. 7 3.11.2.6 3.11 Radioactive Effluents 3.11.2 Gaseous Effluents 3.11.2.6 Radioactive Gaseous Effluent Monitoring Instrumentation TRO 3.11.2.6 The radioactive gaseous effluent monitoring instrumentation channels shown in Table 3.11.2.6-1 shall be OPERABLE with their setpoints

established in accordance with the ODCM to ensure that the limits of Requirement 3.11 :2.1 are not exceeded.

APPLICABILITY: According to Table 3.11.2:6-1 ACTIONS

                 ------------------------------------~----------------------~NOTE---------------------------------------------------------

1. Separate condition entry is allowed for each channel.

2. The provisions of TRO 3.0.6 are not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. Radioactive gaseous A.1 Suspend the release of Immediately effluent monitoring radioactive gaseous effluents instrumentation channel monitored by the affected alarm/trip setpoint less channel conservative than OR required to ensure that the limits of Requirement A.2 Dedare the channel Immediately 3.11.2.1 are not inoperable exceeded (continued) SUSQUEHANNA - UNIT 2 TRM I 3.11-25 EFFECTIVE DATE 04/12/2007

For Information Only Radioactive Gaseous Effluent Monitoring Instrumentation 3.11.2.6 Rev. 7 ACTIONS (continued)

CONDITION REQUIRED ACTION COMPLETION TIME B. Reactor Building B.1 Take grab samples Once per 8 hours Ventilation System Noble while release is in Gas Activity Monitor low . progress.

range channel inoperable . AND B.2 Analyze grab samples for Within 24 hours of isotopic activity to the grab sample required LLDs for principal noble gas gamma emitters (Table 3.11.2.1-1) AND B.3 Restore monitoring 30 days instrumentation. C. Deleted D. Reactor Building Once per 4 hours D.1 Estimate flow rate. Ventilation Monitoring while release is in System Effluent System progress Flow Rate Monitor or Sampler Flow Rate Monitor inoperable 30 days D.2 Restore monitoring instrumentation. (continued) SUSQUEHANNA - UNIT 2 TRM I 3.11-26 EFFECTIVE DATE 01/21/2004

For Information Only Radioactive Gaseous Effluent Monitoring Instrumentation 3.11.2.6 Rev. 7 ACTIONS (continued) CONDITION REQUIRED ACTION COMPLETION TIME E. Turbine Building Ventilation E.1 Verify mechanical vacuum Immediately System Noble Gas Activity pump is not in operation. Monitor low range channel inoperable AND E.2 Take grab samples. Once per 8 hours while release is in progress AND E.3 Analyze grab samples for Within 24 hours after isotopic activity to the sample required LLDs for principal noble gas gamma emitters (Table 3.11.2.1-1 ). AND E.4 Restore monitoring 30 days instrumentation F. Deleted G. Turbine Building Ventilation G.1 Estimate flow rate. Once per 4 hours Monitoring System: Effluent while release is in Flow Rate Monitor or progress. Sample (Bypass or Low AND Range) Flow Rate Monitor inoperable G.2 Restore monitoring 30 days instrumentation (continued) SUSQUEHANNA - UNIT 2 TRM / 3.11-27 EFFECTIVE DA TE 08/11/2016

For Information Only Radioactive Gaseous Effluent Monitoring Instrumentation 3.11.2.6 Rev. 7 ACTIONS (continued) CONDITION REQUIRED ACTION COMPLETION TIME H. Standby Gas Treatment H.1 Take grab samples. Once per 4 hours System Noble Gas Activity during operation of Monitor low range channel SGTS inoperable AND H.2 Analyze grab samples for

Within 24 hours of isotopic activity to the required grab sample being
LLDs for principal noble gas taken.

gamma emitters (Table 3.11.2.1-1). AND H.3 Restore monitoring 30 days instrumentation. I. Deleted J. SGTS Ventilation J.1 Estimate flow rate. Once per 4 hours Monitoring System: during operation .of Effluent flow rate monitor or SGTS sample (Bypass or Low AND Range) flow rate monitor Inoperable. J.2 Restore monitoring 30 days Instrumentation. (continued) SUSQUEHANNA - UNIT 2 TRM I 3.11-28 EFFECTIVE DATE 10/06/2016

For Information Only Radioactive Gaseous Effluent Monitoring Instrumentation 3.11.2.6 Rev. 7 ACTIONS (continued) CONDITION. REQUIRED ACTION COMPLETION TIME K. Required Actions and K.1 Explain why this inoperability In the next Completion Times not was not corrected in a timely Radioactive Effluent met for Conditions B manner. Release Report per through J. TS Section 5.6. TECHNICAL REQUIREMENT SURVEILLANCE

                 --------------------------------------------------------------NOTE----------------------------------------------------

Refer to Table 3.11.2.6-1 to determine which TRSs apply for each Monitoring Function. SURVEILLANCE FREQUENCY TRS 3.11.2.6.1 Perform CHANNEL CHECK 24 hours TRS 3.11.2.6.2 Deleted TRS 3.11.2.6.3 Perform Source Check 31 days TRS 3.11.2.6.4 Perform CHANNEL FUNCTIONAL TEST 92 days TRS 3.11.2.6.5 Perform CHANNEL CALIBRATION 24 months SUSQUEHANNA - UNIT 2 TRM / 3.11-29 EFFECTIVE DA TE 12/03/2004

For Information Only Radioactive Gaseous Effluent Monitoring Instrumentation 3.11.2.6 Rev. 7 TABLE 3.11.2.6-1 (Page 1 of 3) RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION REQUIRED SURVEILLANCE FUNCTION APPLICABILITY CHANNELS REQUIREMENTS

1. REACTOR BUILDING VENTILATION MONITORING SYSTEM

a. Noble Gas Activity Monitor At all Times TRS 3.11.2.6.1 (Low Range) TRS 3.11.2.6.3 TRS 3.11.2.6.4 TRS 3.11.2.6.5

b. Deleted

c. Deleted d Effluent System Flow Rate Monitor At all Times TRS 3.11.2.6.1 TRS 3.11.2.6.4 TRS 3.11.2.6.5

e. Sampler Flow Rate Monitor At all Times TRS 3.11.2.6.1 TRS 3.11.2.6.4 TRS 3.11.2.6.5 (continued)

SUSQUEHANNA - UNIT 2 TRM / 3.11-30 EFFECTIVE DATE 01/21/2004

For Information Only Radioactive Gaseous Effluent Monitoring Instrumentation 3.11.2.6 Rev. 7 TABLE 3.11.2.6-1 (Page 2 of 3) RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION REQUIRED SURVEILLANCE FUNCTION APPLICABILITY CHANNELS REQUIREMENTS

2. TURBINE BUILDING VENTILATION MONITORING SYSTEM

a. Noble Gas Activity Monitor At all Times TRS 3.11.2.6.1 (Low Range) TRS 3.11.2.6.3 TRS 3.11.2.6.4

                                                                                                  .TRS 3.11.2.6.5

b. Deleted

c. Deleted

d. Effluent System Flow Rate Monitor At all Times TRS 3.11.2.6.1 TRS 3.11.2.6.4 TRS 3.11.2.6.5

e. Sample Flow Rate Monitor (Bypass) At all Times TRS 3.11.2.6.1 TRS 3.11.2.6.4 TRS 3.11.2.6.5

f. Sample Flow Rate Monitor At all Times TRS 3.11.2.6.1 (Low Range) TRS 3.11.2.6.4 TRS 3.11.2.6.5 (continued)

SUSQUEHANNA - UNIT 2 TRM / 3.11-31 EFFECTIVE DATE 08/11/2016

For Information Only Radioactive Gaseous Effluent Monitoring Instrumentation 3.11.2.6 Rev. 7 TABLE 3.11.2.6-1(Page3 of3) RADIOACTIVE GASEOUS EFFLUENTMONITORING INSTRUMENTATION REQUIRED SURVEILLANCE FUNCTION APPLICABILITY CHANNELS REQUIREMENTS

3. STANDBY GAS TREATMENT SYSTEM (SGTS) MONITOR

a. Noble Gas Activity Monitor During TRS 3.11.2.6.1 (Low Range) operation of TRS 3.11.2.6.3 SGTs<a> TRS 3.11.2.6.4 TRS 3.11.2.6.5

b. Deleted

c. Deleted

d. Effluent System Flow Rate Monitor During TRS 3.11.2.6.1 operation of TRS 3.11.2.6.4 SGTs<a> TRS 3.11.2.6.5

e. Sample Flow Rate Monitor (Bypass) During TRS 3.11.2.6.1 operation of TRS 3.11.2.6.4 SGTs<a> TRS 3.11.2.6.5

f. Sample Bypass Flow Rate Monitor During TRS 3.11.2.6.1 (Low Range) operation of TRS 3.11.2.6.4 SGTs<*> TRS 3.11.2.6.5 (a) TRO 3.0.4.c is applicable.

SUSQUEHANNA - UNIT 2 TRM / 3.11-32 EFFECTIVE DATE 10/06/2016

For Information Only Total Dose PPL Rev. 1 3.11.3 3.11 Radioactive Effluents 3.11.3 Total Dose TRO 3.11.3 The annual (calendar yeqr) dose or dose commitment to any MEMBER OF THE PUBLIC, due to releases of radioactivity and radiation, from*uranium fuel cycle sources shall be limited to less than or equal to 25 mrem to the total body or any organ, except the thyroid, which shall be limited to less than or equal to 75 mrem. APPLICABILITY: At all times ACTIONS

                 ----------------------------------------------------------- NOTE -----------------------------------------------------

1. The provisions of TRO 3.0.4 are not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. Calculated doses from the A.1 Initiate actions to calculate Immediately release of radioactive whether the TRO limits materials in liquid or have been exceeded gaseous effluents exceed twice the limits of Requiremen-ts *3.11.1.2.a, 3.11.1.2.b, 3.11.2.2.a, 3.11.2.2.b, 3.11.2.3.a, or 3.11.2.3.b B. TRO limits exceeded B.1 Prepare and submit a 30 days Special Report to the Commission SUSQUEHANNA - UNIT 2 TRM I 3.11-33 EFFECTIVE DATE 03/31/2006

For Information Only Total Dose PPL Rev. 1 3.11.3 TECHNICAL REQUIREMENT SURVEILLANCE SURVEILLANCE FREQUENCY TRS 3.11.3.1 .Determine the cumulative dose from liquid and 31 days gaseous effluents in accordance with the methodology and parameters in the ODCM TRS 3.11.3.2 Determine cumulative dose contributions from direct . 12 months radiation from unit operation in accordance with the methodology and parameters in the ODCM SUSQUEHANNA - UNIT 2 3.11-34 EFFECTIVE DATE 08/31/1998

For Information Only Monitoring Program PPL Rev. 4 3.11.4.1 3.11 Radioactive Effluents 3.11.4 Radiological Environmental Monitoring 3.11.4.1 Monitoring Program TRO 3.11.4.1 The radiological environmental monitoring program shall be conducted as specified in Table 3.11.4.1-1.

APPLICABILITY: At all times ACTIONS

                 ----------------------------------------------------------- NOTE -----------------------~-------~--------------------------

1. The provisions of TRO 3.0.4 are not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. Radiological environmental A.1

Generate a Condition 72 hours monitoring program not Report to describe the being conducted as deficiency and any actions specified in Table taken to prevent their 3.11.4.1-1 recurrence in the applicable Annual Radiological Environmental Operating Report.

B. The average level of B.1 Generate a Condition 72 hours radioactivity over any Report to prepare and calendar quarter as the submit a Special Report to result of_ an individual the Commission within 30 radionuclide in plant days of identification of the effluents in a partic!Jlar Condition. environmental exposure pathway in a particular environmental sampling medium, at a specified location exceeds the applicable reporting level of Table 3.11.4.1-2 (continued) SUSQUEHANNA - UNIT 2 TRM I 3.11-35 EFFECTIVE DATE 03/31/2006

For Information Only Monitoring Program PPL Rev. 4 . 3.11.4.1 ACTIONS (continued) CONDITION REQUIRED ACTION COMPLETION TIME C. More than one of the C.1 Generate a Condition 72 hours radionuclides in Table Report to prepare and 3.11.4.1-2 are detected in a submit a Special Report to particular environmental the Commission within 30 exposure pathway at a days of identification of the specified monitoring Condition.

location and are the result of plant effluents AND The sum of the ratios of the quarterly average activity levels to their corresponding reporting levels of each detected radionuclide, from Table 3.11.4.1-2, is ~ 1.0 (continued)

SUSQUEHANNA - UNIT 2 TRM I 3.11-36 EFFECTIVE DATE 11/30/2005

For Information Only Monitoring Program PPL Rev. 4 3.11.4.1 ACTIONS (continued) CONDITION REQUIRED ACTION COMPLETION TIME D. One or more D.1 Generate a Condition 72 hours Radionuclide(s) other than Report to prepare and those in Table 3.11.4.1-2 submit a Special Report to

are detected in a particular the Commission within 30 environmental exposure days of identification of ttie pathway at a specified Condition.

location and are the result of plant effluents AND The potential annual dose to a MEMBER OF THE PUBLIC from all detected radionuclides that are the result of plant effluents is greater than or equal to the calendar year limits of TROs 3.11.1.2, 3.11.2.2 and 3.11.2.3 E.1 Generate a Condition E. All requirements for a 72 hours Report to describe the Special Report per either reasons for not attributing Condition B, C, or D are identified radionuclides to met except that the plant effluents in the radionuclides detected are applicable Annual not the result of plant Radiological Environmental effluents Operating Report. (continued) SUSQUEHANNA - UNIT 2 TRM I 3.11-37 EFFECTIVE DATE 11/30/2005

For Information Only Monitoring Program PPL Rev. 4 3.11.4.1 ACTIONS (continued) CONDITION REQUIRED ACTION COMPLETION TIME F. Milk or fresh leafy ---------------------N 0 TE------------------ vegetable samples are T he specific locations from which unavailable from one or samples were unavailable may then more of the sample be deleted from the monitoring locations required by Table program. 3.11.4.1-1 F.1 Generate a Condition Report 72 hours to identify locations for obtaining replacement samples and to add them to the Radiological Environmental Monitoring Program within 30 days of identification of the Condition AND F.2 Generate a Condition Report 72 hours to identify the cause of the unavailability of samples and to identify the new location(s) for obtaining replacement samples in the applicable R.adioactive Effluent Release Report. SUSQUEHANNA - UNIT 2 TRM I 3.11-38

EFFECTIVE DATE 11/30/2005

For Information Only Monitoring Program PPL Rev. 4 3.11.4.1 NOTE: The provisions of TRS 3.0.3 are not applicable to the below surveillances. TECHNICAL REQUIREMENT SURVEILLANCE SURVEILLANCE FREQUENCY TRS 3. 11.4.1.1 Collect the radiological environmental monitoring As required by samples pursuant to Table 3.11.4.1-1 Table 3.11.4.1-1 TRS 3. 11.4.1.2 Analyze samples pursuant to the requirements of As required by Table 3.11.4.1-1 with equipment meeting the Table 3.11.4.1-1 detection capabilities required by Table 3.11.4.1-3 TRS 3.11.4.1.3 Determine annual cumulative potential dose Annually contributions from radionuclides detected in environmental samples in accordance with the methodology and parameters in the ODCM. SUSQUEHANNA - UNIT 2 TRM I 3.11-39 EFFECTIVE DATE 11/30/2005

For Information Only Monitoring Program PPL Rev. 4 3.11.4:1 TABLE 3.11.4.1-1 (Page 1 of 3) . RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM NUMBER OF REPRESENTATIVE SAMPLING AND EXPOSURE PATHWAY SAMPLES AND COLLECTION TYPE AND FREQUENCY AND/OR SAMPLE SAMPLE LOCATIONS FREQUENCY OF ANALYSIS

1. DIRECT RADIATION 40 routine monitoring stations with two or Quarterly Gamma dose quarterly more dosimeters or with one instrument for measuring and recording dose rate continuously placed as follows:

1. An inner ring of stations, one in each meteorological sector, in the general area of the SITE BOUNDARY

2. An outer ring of stations, one in each meteorological sector, in the 3 to 9 mile range from the site

3. The balance of the stations placed in special interest areas such as population centers, nearby residences, schools, and in 1 or 2 areas to serve as control stations

2. AIRBORNE Radioiodine and Samples from 5 locations Continual sampler Radioiodine Canister:

Particulates operation with 1-131 Analysis weekly

a. 1 sample from close to each of the 3 sample collection SITE BOUNDARY locations (in weekly, or more Particulate Sampler:

different sectors) with the highest frequently if required Gross Beta radio activity . calculated annual average by dust loading analysis following filter groundlevel D/Q change(aJ Gamma isotopic

b. 1 sample from the vicinity of the analysis of composite (by community having one of the highest location) quarterly calculated annual ground level D/Q

c. 1 sample from a control location, between 15 and 30 km distant and in the least prevalent wind direction of wind blowing from the plant (continued)

(aJ Airborne particulate sample filters shall be analyzed for gross beta radioactivity 24 hours or more after sampling to allow for radon and thorn daughter decay. If gross beta activity in air particulate samples is greater than ten times the yearly mean of control samples, gamma isotopic analysis shall be performed on the individual samples. SUSQUEHANNA - UNIT 2 TRM I 3.11-40 EFFECTIVE. DATE 02/19/2015

For Information Only Monitoring Program PPL Rev. 4 3.11.4.1 TABLE 3.11.4.1-1 (Page 2 of 3) RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM NUMBER OF REPRESENTATIVE SAMPLING AND TYPE AND EXPOSURE PATHWAY SAMPLES AND COLLECTION FREQUENCY AND/OR SAMPLE SAMPLE LOCATIONS FREQUENCY OF ANALYSIS

3. WATERBORNE

a. Surface 1 sample upstream Composite sample over Gamma

1 sample downstream one-month period isotopic analysis monthly.

Composite for tritium analyses quarterly

b. Ground Samples from 1 or isour~es only if likely to be Quarterly Gamma affected isotopic and tritium analyses quarterly

c. Drinking 1 sample from each of 1 to 3 of the nearest water Composite sample over 2- 1-131 analysis supplies that could be affected by its discharge week period when 1-131 on each analysis is performed, composite 1 sample from a control location monthly composite when the dose otherwise calculated for the consumption of the water is greater than 1 mrem per year.

Composite for gross beta and gamma isotopic analyses monthly. Composite for tritium analyses quarterly

d. Sediment 1 sample from downstream area with existing or Semiannually Gamma from potential recreational value isotopic shoreline analyses semiannually (continued)

SUSQUEHANNA - UNIT 2 TRM I 3.11-41 EFFECTIVE DATE 08/31/1998

For Information Only Monitoring Program PPL Rev. 4 3.11.4.1 TABLE 3.11.4.1-1(Page3 of3) RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM SAMPLING NUMBER OF REPRESENTATIVE AND TYPE AND EXPOSURE PATHWAY SAMPLES AND COLLECTION FREQUENCY AND/OR SAMPLE SAMPLE LOCATIONS FREQUENCY OF ANALYSIS

4. INGESTION

a. Milk a. Samples from milking animals in 3 Semimonthly Gamma isotopic and locations within 5km from the plant when animals 1-131 analysis having the highest dose potential. If are on pasture, semimonthly when there are none, then, 1 sample from monthly at animals are on milking animals in each of 3 areas other times. pasture; monthly at between 5 and 8km distant where other times.

doses are calculated to be greater than 1 mrem per year. 1 sample from milking animals at a control location (between 15 and 30km from the plant preferably in the least prevalent direction for wind blowing from the plant).

b. Fish and/or. b. 1 sample of each of two recreationally Sample in Gamma isotopic Invertebrates important species in vicinity of plant season, or analysis *on edible discharge area. semiannually if portions.

they are not 1 sample of same species in areas not seasonal. influenced by plant discharge.

c. Food c. 1 sample of each principal class of food At time of Gamma isotopic Products products from any area which is harvest analysis on edible irrigated by water in which liquid plant portions.

wastes have been discharged. Samples of 3 different kinds of broad leaf vegetation grown nearest each of Monthly when Gamma isotopic and two different offsite locations of highest available 1-131 analysis. predicted annual average ground level D/Q if milk sampling is not performed. 1 sample of each of the similar broad Monthly when Gamma isotopic and leaf vegetation grown between 15 to available 1-131 analysis. 30km from the plant, preferably, in the least prevalent direction for wind blowing from the plant if milk sampling is not performed. SUSQUEHANNA - UNIT 2 TRM / 3.11-42 EFFECTIVE DATE 08/31/1998

For Information Only Monitoring Program PPL Rev. 4 3.11.4.1 TABLE 3.11.4.1-2 REPORTING LEVELS FOR RADIOACTIVITY CONCENTRATIONS IN ENVIRONMENTAL SAMPLES Reporting Levels Water Airborne Particulate Fish Milk Food Products 3 Analysis (eCi/I) or Gases (eCi/m ) (eCi/kg, wet) (eCi/I) (eCi/kg, wet) H-3 20,oooCaJ Mn-54 1,000 30,000 Fe-59 400 10,000 Co-58 1,000 30,000 Co-60 300 10,000 Zn-65 300 20,000 Zr-Nb-95 400(b) 1-131 2 0.9 3 100 Cs-134 30 10 1,000 60 1,000 Cs-137 50 20 2,000 70 2,000. Ba-La-140 200(b) 300 (a) For drinking water samples. This is 40 CFR Part 141 value. If no drinking water pathway exists, a value of 30,000 pCi/1 may be used. Cb) Total for parent and daughter. SUSQUEHANNA - UNIT 2 TRM I 3.11-43 EFFECTIVE DATE 08/31/1998

For Information Only Monitoring Program PPL Rev. 4 3.11.4.1 TABLE 3.11.4.1-3 DETECTION CAPABILITIES FOR ENVIRONMENTAL SAMPLE ANALYSIS LOWER LIMIT OF DETECTION (LLD) Water Airborne Fish Milk Food Sediments Analysis (pCi/1) Particulate Or (pCi/kg, wet) Products (pCi/kg, dry) 3 (pCi/1) Gas (pCi/m ) (pCi/kg, wet Gross Beta 4 0.01 H-3 2000 Mn-54 15 130 Fe-59 30 260 Co-58, 60 15 130 Zn-65 30 260 Zr-95 30 Nb-95 15 1-131 1(a) 0.07 60 Cs-134 15 0.05 130 15 60 150 Cs-137 18 0.06 150 18 80 180 Ba-140 60 60 La-140 15 15 (a) LLD for drinking water samples. SUSQUEHANNA - UNIT 2 TRM I 3.11-44 EFFECTIVE DATE 08/31/1998

For Information Only Land Use Census PPL Rev. 2 3.11.4.2 3.11 Radioactive Effluents 3.11.4 Radiological Environmental Monitoring 3.11.4.2 Land Use Census TRO 3.11.4.2 A land use census shall be conducted. APPLICABILITY: At all times. ACTIONS

                 ----------------------------------------------------------- N0 TE ----.------------------------------------------------------

1. The provisions of TRO 3.0.4 are not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. Land use census identifies A.1 Identify the new As defined by the a location(s) which yields a location(s) in the next Radioactive Effluent calculated dose or dose Radioactive Effluent Release Report

commitment greater than Release Report the values currently being calculated in Requirement 3.11.2.3 B. Land use census identifies 8.1 Add the new location(s) 30 days a location(s) that yields a to the radiological calculated dose or dose environmental commitment (via the same monitoring program exposure pathway) 20 AND percent greater than at a location from which 8.2 Identify the new As defined in Radioactive samples are currently being location(s) in the next Effluent Release Report obtained in accordance Radioactive Effluent with Requirement 3.11.4.1 Release Report per TS Section 5.6 SUSQUEHANNA - UNIT 2 TRM I 3.11-45 EFFECTIVE DATE 03/31/2006

For Information Only Land Use Census PPL Rev. 2 3.11.4.2 TECHNICAL REQUIREMENT SURVEILLANCE SURVEILLANCE FREQUENCY TRS 3.11.4.2.1 Conduct the land use census 12 months SUSQUEHANNA - UNIT 2 3.11-46 EFFECTIVE DATE 08/31/1998

For Information Only lnterlaboratory Comparison Program PPL Rev. 1 3.11.4.3 3.11 Radioactive Effluents 3.11.4 Radiological Environmental Monitoring 3.11.4.3 lnterlaboratory Comparison Program TRO 3.11.4.3 Analyses shall be performed on radioactive materials supplied as part of an lnterlaboratory Comparison Program.* APPLICABILITY: At all times. ACTIONS

                 ---------------------------------------------------------- *NOTE --------------------------- ----~---------------------------

1. The provisions of TRO 3.0.4 are not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. Analyses not being A.1 Report the corrective actions As required performed taken to prevent a recurrence to the Comrnission TECHNICAL REQUIREMENT SURVEILLANCE SURVEILLANCE FREQUENCY TRS 3.11.4.3.1 Include a summary of the results. obtained as Annually part of the above required lnterlaboratory Comparison Program in the Annual Radiological Environmental Operating Report SUSQUEHANNA - UNIT 2 TRM I 3.11-47 EFFECTIVE DATE 03/31/2006

For Information Only Liquid Effluents Concentration Rev. 1 B 3.11.1.1 B 3.11.1.1 Liquid Effluents Concentration BASES TRO This requirement is provided to ensure that the concentration of radioactive materials released in liquid waste effluents to UNRESTRICTED AREAS will be less than 10 times the concentration levels specified in 10 CFR Part 20.1001to20.2402, Appendix B, Table 2, Column 2. The requirement provides operational flexibility for releasing liquid effluents in concentrations to follow the Section II.A and 11.C design objectives of Appendix I to 10 CFR part 50. This limitation provides reasonable assurance that the levels of radioactive materials in bodies of water in UNRESTRICTED AREAS will result in exposures within (1) the Section II.A design objectives of Appendix I, 10 CFR 50, to a Member of the Public and (2) restrictions authorized by 10 CFR 20.1301 (e). The concentration limit for dissolved or. entrained noble gases is based upon the assumptions thatXe-135 is the controlling radionuclide and its effluent concentration in air (submersion) was converted to an equivalent concentration in water. This requirement does 11ot affect the requirement to comply with the annual limitations of 10 CFR 20.1301 (a). This requirement applies to the release of radioactive materials in liquid effluents from all units at the site. The required detection capabilities for radioactive materials in liquid waste samples are *tabulated in terms of the lower limits of detection (LLDs). Detailed discussion of.the LLD and the other detection limits can be found in Curie, L.A., "Lower Limit of Detection: Definition and Elaboration of a Proposed Position for Radiological Effluent and Environmental Measurements." (References 2 1 3, and 4) This section of the TRM is also part of the ODCM (Reference 2). Actions The Actions are defined to ensure proper corrective measures are taken in response to exceeding the TRO limits. TRS The TRSs are defined to be performed at the specified Frequency to ensure that the parameters are maintained within the TRO limits. Table 3.11.1.1-1 defines Radioactive Liquid Waste Sampling and Analysis Program. The lower limit of detection (LLD) is defined, for purposes of these Requirements, as the smallest concentration of radioactive material in a sample that (continued) SUSQUEHANNA - UNIT 2 TRM I B 3.11-1 EFFECTIVE DATE 08/31/1998 _J

For Information Only Liquid Effluents Concentration Rev. 1 B 3.11.1.1 B 3.11.1.1 Liquid Effluents Concentration BASES (continued) TRS will yield a net count, above system background, that will be detected with (continued) 95% probability with only 5% probability of falsely concluding that a blank observation represents a "real" signal. For a particular measurement system, which may include radiochemical separation: LLD= _ _ _ _4_.6_6_s_b_ _ __ E

V
2.22E6
Y
exp(-Mt)

Where: LLD is the a priori lower limit of detection as defined above (as microcuries per unit mass 6r volume). Sb is the standard deviation of the background counting rate or of the counting rate of a blank sample as appropriate (as counts per minute), E is the counting efficiency, as counts per disintegration, Vis.the sample size, in units of mass or volume, 2.22 E6 is the number of disintegrations per minute per microcurie, Y is the fractional radiochemical yield, when appli~ble. A, is the radioactive decay constant for the particular radionuclide, and tit for plant effluents is the elapsed time between the midpoint of sample collection and time of counting. Typical values of E, V, Y, and tit should be used in the calculation. It should be recognized that the LLD is defined as an a priori (before the fact) limit representing the capability of a measurement system and not as an a posteriori (after the fact) limit for a particular measurement. A batch release is the discharge of liquid wastes of a discrete volume. Prior to sampling for analyses, each batch shall be isolated, and then thoroughly mixed to assure representative sampling. (continued) SUSQUEHANNA - UNIT 2 TRM I B 3.11-2 EFFECTIVE DATE 08/31/1998

l For Information Only Liquid Effluents Concentration Rev.1 B 3.11.1.1 B 3.11.1.1 Liquid Effluents Concentration BASES (continued) TRS The principal gamma emitters for which the LLD specification applies include (continued) the following radionuclides: Mn-54, Fe-59, Co-58, Co-60, Zn-65, Mo-99, Cs-134, Cs-137, Ce-141 and Ce-144. The dissolved and entrained gases (gamma emitters) for which the LLD specification applies include the following radionuclides: Kr-85, Kr-85m. Kr-87, Kr-88, Ar-41, Xe-133, Xe-133m, Xe-135, and Xe-135m. This list does not mean that only these nuclides are to be considered. Other gamma peaks that are identifiable, together with those of the above nuclides, shall also be analyzed and reported in accordance with the ODCM. . A composite sample is one inwhich the quantity of liquid sampled is proportional to the quantity of liquid waste discharged and in which the method of sampling employed results in a specimen that is representative of the liquids released over a period no longer than the Minimum Analysis Frequency. The Minimum Analysis Frequency as listed for the Composite Samples shall mean the minimum frequency for initiation of the required analyses, not completion of the analyses* and evaluation of the results. Since the analysis involves sending the samples to an offsite laboratory and performance of involved sample preparation and wet chemical analyses, there will be a delay between initiation of the analysis and r~ceipt of the results. The analysis initiation shall normally be done on a calendar month for the 31 day frequency or calendar quarter for a 92 day frequency. REFERENCES 1. Technical Specification 5.5.4 - Radioactive Effluent Controls program.

2. Technical Specification 5.5.1 - Offsite Dose Calculation Manual.

3. NUREG/CR-4007, September, 1984.

4. 10 CFR Part 20.

SUSQUEHANNA - UNIT 2 TRM I B 3.11-3 EFFECTIVE DATE 04/28/2016

Liquid Effluents Dose PPL Rev. 0 B 3.11.1.2 B 3.11.1.2 Liquid Effluents Dose BASES TRO This requirement is provided to implement the ,requirements of Sections II.A, Ill.A and IV.A of Appendix I, 10 CFR Part 50. The Technical Requirement for Operation implements the guides set forth in Section II.A of Appendix I. Also, for fresh water sites wit.h drinking water supplies which can be potentially affected by plant operations, there is reasonable assurance that the operation of the facility will not result in radionuclide concentrations in the finished drinking water that are in excess of the requirements of 40 CFR 141. The dose calculation methodology and parameters in the ODCM implement the requirements in Section Ill.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on models and data, such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to b.e substantially underestimated. The equations specified in the ODCM for calculating the doses due to the actual release rates of radioactive materials in liquid effluents are consistent with the methodology provided in Regulatory Guide 1.109, "Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I," Revision 1, October 1977 and Regulatory Guide 1.113, "Estimating Aquatic Dispersion of Effluents from Accidental and Routine Reactor Releases for the Purpose of Implementing Appendix I," April 1977. (References 2, 3, 4, and 5) This section of the TRM is also part of the ODCM (Reference 2). Actions The ACTION statements provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive material in liquid effluents will be kept "as low as is reasonably achievable." The Special Report to the Commission under Action A.1 shall (continued) SUSQUEHANNA - UNIT 2 TRM/B 3.11-4 EFFECTIVE DATE 08/31/1998

Liquid Effluents Dose PPL Rev. 0 .8 3.11.1.2 B 3.11.1.2 Liquid Effluents Dose BASES (continued) ACTIONS identify the cause(s) for exceeding the limit(s) and define the corrective (continued) actions that have been taken to reduce the releases and the proposed corrective actions to be taken to assure that subsequent releases will be in compliance with the specified limits .. This Special Report shall also include the radiological impact*on finished drinking water supplies at the nearest

                . downstream
                        .       drinking water
                                          . source.

TRS The TRSs are defined to be performed at the specified Frequency to ensure that the TRO limits are maintained. REFERENCES 1. Tech Spec 5.5.4 - Radioactive Effluent Controls program

2. Tech Spec 5.5.1 - Offsite Dose Calculation Manual

3. 10 CFR Part 20

4. Regulatory Guide 1.109, "Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I," Revision 1, October 1977.

5. Regulatory Guide 1.113, "Estimating Aquatic Dispersion of Effluents from Accidental and Routine Reactor Releases for the Purpose of Implementing Appendix I," April 1977.

SUSQUEHANNA - UNIT 2 TRM/B 3.11-5 EFFECTIVE DATE 08/31/1998

Liquid Waste Treatment System PPL Rev. 0 B 3.11.1.3 B 3.11.1.3 Liquid Waste Treatment. System BASES TRO The OPERABILITY of the liquid radwaste treatment system ensures that this system will be available for use whenever liquid effluents require treatment prior to release to the environment. The requirement that the appropriate portions of this system be used when specified provides assurance that the releases of radioactive materials in liquid effiuents will be kept "as low as is reasonably achievable". This Requirementimplements the requirements of 10 CFR Part 50.36a, General Design Criterion 60 of Appendix A to 10 CFR Part 50 and the design objective given in Section 11. D of Appendix I to 10 CFR Part 50. The specified limits governing the use of appropriate portions of the liquid radwaste treatment system were specified as a suitable fraction of the dose design objectives set forth in Section II.A of Appendix I, 10 CFRpart 50,

for liquid effluents. (Reference 3) .

This section of the TRM is also part of the ODCM. (Reference 2).

Actions The Actions are defined to ensure proper corrective measures are taken in response to the inoperable components ..

The Special Report to the Commission under Action A 1 shall include the following: '

1. Explanation ofwhy liquid radwaste was being discharged without treatment, identification of any inoperable equipment or subsystems and the reason for the inoperability,

2. Action(s) taken to restore the inoperable equipment to OPERABLE status, and

3. Summary description of action(s) taken to prevent a recurrence.

TRS The TRSs are defined to be performed at the specified Frequency to ensure that the system is maintained OPERABLE. OPERABILITY is demonstrated by operating the liquid radwaste treatment system equipment for at least 10 minutes. REFERENCES 1. Technical Specification 5.5.4 - Radioactive Effluent Controls program.

2. Technical Specification 5.5.1 - ODCM.

3. 10 CFR Part 50 SUSQUEHANNA - UNIT 2 TRM/B 3.11-6 EFFECTIVE DATE 8/31/1998

liquid Radwaste Effluent Monitoring Instrumentation PPL Rev. 0 B 3.11.1.4 B 3.11.1.4 Liquid Radwaste Effluent Monitoring Instrumentation BASES TRO The radioactive liquid effluent instrumentation are provided to monitor and control, as applicable, the releases of radioactive materials in liquid effluents during actual or potential releases of liquid effluents. The alarm/trip setpoints for the_se instruments shall be calculated in accordance with the procedures in ttie. ODCIVl (Reference 2) to ensure that the alarm/trip will occur prior to exceeding the 10 times the concentration values specified in Appendix B,Table 2, Column 2of10CFR20.1001-10CFR20.2401 (Ref. 2). The OPERABILITY and u.se of this instrumentation-is consistent with the requirements of General Design Criteria 60, 63, and 64 of Appendix A to 1o CFR Part 50. (Reference 4) - - OPERABILITY of the radiation monitoring instrumentation requires their alarm/trip setpoints set to ensure that the limits of Requirement 3.11.1.1 *are not exceeded. The alarm/trip setpoints of these channels shall be determined in accordance with the methodology and parameters described in the ODCM. OPERABILITY of the Liquid Radwaste Effluent Line gross radioactivity monitor includes the proper functioning of.the discharge valve interlocks (sample pump low flow, high radiation alarm, and radiation monitor failure). OPERABILITY of the Cooling Tower Slowdown flow rate measurement device includes the proper functioning of the Liquid Radwaste Effluent Line discharge valve interlock (i.e. co.cling tower blowdown low flow). The Required Channels for each function in Table 3.11: 1.4-1 are as follows: (continued) SUSQUEHANNA - UNIT 2 TRM/B 3.11-7 EFFECTIVE DATE 8/31 /1998

Liquid Radwaste Effluent Monitoring Instrumentation PPL Rev. 0 B 3.11.1.4 B 3.11.1.4 Liquid Radwaste Effluent Monitoring Instrumentation BASES (continued) TRO a. Liquid Radwaste Effluent rad monitor (Function 1.a) one instrument per (continued) station.

b. Liquid Radwaste Effluent flow rate (Function 2.a) one instrument per station.

c. Cooling Tower Slowdown flow rate (Function 2.b) one instrument per station.

It should be noted that the radioactive liquid waste stream is diluted in the

               * - Cooling Tower blowdown line prior to entering the Susquehanna River. The setpoint for this dilution water flow is 5000 gpm from the combination of the Un.it 1 blowdown, Unit 2 blowdown flow, and S~ray P.ond Discharge.

Options exist to ensure the requirement of one OPERABLE Cooling Tower Blowdownflow Instrument per station is met as required by Table 3.11.1.4-1, Function 2.b. As long as any one of three instruments (Unit 1 Tower, Unit 2 Tower, Total Site Slowdown) are OPERABLE and alignment of HS-06443A

                  -and HSS-01503 on panel OC301 is such that the OPERABLE instrument(s) are in the ci.rcuit, then the TRM Requirement is met.

This section of the TRM is also part of the ODCM *(Reference 2). Actions The Actions are defined _to ensure proper corrective measures are taken in response to the inoperable components. Pump curves generated in situ may be used to estimate flow for Action D.1. TRS The TRSs are defined to be performed at the specified Frequency to ensure that the monitoring instrumentation is maintained OPERABLE. The TRSs shall be performed in accordance with the Technical Specification definition for the test with the following additional requirements: The Liquid Radwaste Effluent Line radiation monitor CHANNEL FUNCTIONAL TEST shall also demonstrate that automatic isolation of this pathway an.d control room alarm annunciation occur if any (continued) SUSQUEHANNA-* UNIT 2 TRM/B 3.11-8 EFFECTIVE DATE 8/31/1998

Liquid Radwaste Effluent Monitoring Instrumentation PPL Rev. 0 B 3.11.1.4 Liquid Radwaste Effluent Monitoring Instrumentation B 3.11.1.4 B 3.11.1.4 Liquid Radwaste Effluent Monitoring Instrumentation BASES (continued) TRS of the following conditions exist: (continued)

1. Instrument indicates measured levels above the alarm/trip setpoint.

2. Circuit failure.

3. Instrument indicates a downscale failure.

The liquid Radwaste Effluent Line radiation monitor initial CHANNEL CALI BRATl ON shall be performed using one or more of the reference standards certified by the National Institute of Standards and Technology (NIST) or using standards that have been obtained from suppliers that participate in measurement assurance activities with NIST. These standards shall permit calibrating the system over its intended range of energy and measurement range. For subsequent CHANNEL CALIBRATION, sources that have been related to the initial calibration may be used in lieu of the reference standards associated with the initial calibration. The Liquid Radwaste Effluent Line flow rate monitor and Cooling Tower Slowdown flow rate monitor CHANNEL CHECK shall consist of verifying indication of flow during periods of release. CHANNEL CHECK shall be made at least once per 24 hours on days on which continuous, periodic, or batch releases are made. REFERENCES 1. Technical Specification 5.5.4 - Radioactive Effluent Controls program

2. Technical Specification 5.5.1 - Offsite Dose Calculation Manual

3. 10 CFR Part 20

4. . 10 CFR Part 50 SUSQUEHANNA - UNIT 2 TRM/B 3.11-9 EFFECTIVE DATE 8/31/1998

Radioactive Liquid Process Monitoring Instrumentation PPL Rev. 0 B 3.11.1.5 B 3.11.1.5 Radioactive Liquid Process Monitoring Instrumentation BASES TRO The radioactive liquid process instrumentation is provided to monitor and control, as applicable, the releases of radioactive materials in liquid effluents during actual or potential releases of liquid effluents. The alarm/trip setpoints for these instruments shall be calculated in accordance with the procedures in the ODCM (Reference 2) to ensure th.at the alarm/trip will occur prior to exceeding 10 times the concentration values specified in Appendix B, Table 2, Column 2 of 10CFR20.1001 - .20.2401 (Reference 3). The OPERABILITY and use of this instrumentation is consistent with the requirements of General Design Criteria 60, 63, and 64 of Appendix A to 10 CFR Part 50. (Reference 4) This section of the TRM is also part of the ODCM (Reference 2). Actions The Actions are defined to ensure proper corrective measures are taken in response to ,the inoperable components. If an RHR heat exchanger and its applicable RHRSW loop are in service there is a pathway from the heat exchanger to the spray pond. If the heat exchanger and RHRSW loop are not in service (i.e., valved-out, RHRSW pump not running, or piping drained) then a pathway does not exist. If there is no pathway, the requirement to perform grab sampling is not applicable when the RHR Service Water System Effluent Line Radiation Monitor has been declared inoperable. The function of pumping down the RHR heat exchanger and RHRSW system piping to the Spray Pond provides a pathway for a release of potentially radioactively contaminated water. The RHRSW system is considered an 80-10 system because a pathway to the environment from this system exists through the Spray Pond and because the system, although normally not radioactively contaminated, has the potential for becoming radioactively contaminated in the event that a leak develops across an RHR heat exchanger. Therefore, grab samples must be collected periodically when the RHR$W system radiation monitor for a particular loop is inoperable (malfunctioning) and water from that loop of the system is being returned to the Spray Pond. Also, grab samples must be collected prior to operations in which water from the RHRSW system will be drained to the Spray Pond. (continued) SUSQUEHANNA - UNIT 2 TRM/B 3.11-10 EFFECTIVE DATE 2/01/1999

Radioactive Liquid Process Monitoring Instrumentation PPL Rev. 0 B 3.11.1.5 BASES (continued) TRS The TRSs are defined to be performed at the specified Frequency to ensure that the monitoring instrumentation is maintained OPERABLE. Performance of the CHANNEL CHECK ensures that a gross failure of the instrument has not occurred. A CHANNEL CHECK is normally a comparison of the parameter indicated on one channel against a similar parameter on other channels. It is based on the assumption that instrument channels

              *monitoring the same parameter should read approximately the same value.

Significant deviations between instrument channels could be an indication of excessive instrument drift in one*of the channels or something even more serious. A CHANNEL CHECK will detect gross .channel failure; thus, it is key to verifying the instrument continues to operate properly between each CHANNEL CALIBRATION. Agreement criteria, which are developed by the plant staff based on an investigation of a combination of the channel instrument uncertainties, may be used to support this parameter comparison and include indication and readability. If a channel is outside the criteria, it may be an indication that the instrument has drifted outside its limit and does not necessarily indicate the channel is inoperable. The TRSs shall be performed in accordance with the Technical Specification definition for the test with the following additional requirements: The CHANNEL FUNCTIONAL TEST shall also demonstrate that control room alarm annunciation occurs if any of the following conditions exists:

               .1. Instrument indicates measured levels above the alarm setpoint.

2. Circuit failure.

3. Instrument indicates a downscale failure, and

4. Instrument controls not set in operate mode.

(continued) SUSQUEHANNA - UNIT 2 TRM/B 3.11-11 EFFECTIVE DATE 04/07/2000

Radioactive Liquid Process Monitoring Instrumentation PPL Rev. 0 B 3.11.1.5 BASES (continued) TRS The initial CHANNEL CALIBRATION shall be performed using one or more (continued) of the reference standards certified by the National Institute of Standards and Technology (NIST) or using standards that have been obtained from suppliers that participate in measurement assurance activities with NIST. These standards shall permit calibrating the system over its intended range of energy and measurement range. For subsequent CHANNEL CALIBRATION, sources that have been related to the initial calibration may be used in lieu of the reference standards associated with the initial calibration. REFERENCES 1. Technical Specification 5.5.4 - Radioactive Effluent Controls program

2. Technical Specification 5.5.1 - Offsite Dose Calculation Manual

3. 10 CFR Part 20

4. 10 CFR Part 50 SUSQUEHANNA - UNIT 2 TRM/B 3.11-11a EFFECTIVE DATE 4/07/2000

For Information Only Dose Rate PPL Rev. 1 B 3.11.2.1 B 3.11.2.1 Dose Rate BASES TRO This requirement provides reasonable assurance thatradioactive material discharged in gaseous effluents will not result in the exposure of a Member of the Public either within or outside the Site Boundary, in excess of the design objectives of Appendix 1*to 10CFRSO. It provides operational flexibility for releasing gaseous effluents while satisfying section 11.B and 11.C design

objectives of Appendix I. For individuals who may at times be within the Site Boundary, the occupancy of ~he individual will usually be sufficiently low to compensate for any increase. in atmospheric diffusion factor above that for the Site Boundary. The specified release rate limits restrict, at all times, the corresponding dose rates above backgrou11d to a Member ofthe Public at or beyorid the Site Boundary to less than or equal to 500 mrem/yr to the total body or to less than or equal' to 3000 mrem/yr to the skin~ These release rate limits also restrict, at all times, the corresponding thyroid dose rate above background to an individual via the inhalation pathway to less than or equal to 1500 mrem/yr. These limits provide reasonable assurance that radioactive material discharged in gaseous effluents will not result in the exposure of a MEMBER OF THE PUBLIC either within or outside the SITE BOUNDARY, to annual average concentrations exceeding the limits specified in Appendix B, Table II of 10 CFR Part 20. (Reference 3)

This Requirement applies to the release* of .gaseous effluents from all reactors at the site. This section of the TRM is also part of the ODCM (Reference 2). (continued) SUSQUEHANNA - UNIT 2 TRM I B 3.11-12 EFFECTIVE DATE 2/01/1999

For Information Only Dose Rate PPL Rev. 1 B 3.11.2.1 B 3.11.2.1 Dose Rate BASES (continued) Actions The Actions are defined to ensure proper corrective measures are taken in response to the limits being exceeded. TRS The TRSs are defined to be performed at the specified Frequency to ensure that the dose rates are maintained within limits. Dose rates are determined in accordance with the methodology and parameters of the ODCM. Table 3.11.2.1-1 defines Radioactive Gaseous Waste Sampling and Analysis Program. The lower limit of detection (LLD) is defined, for purposes of these requirement, as the smallest concentration of radioactive material in a sample

                               . that will yield a net count, above system background, that will be detected with 95% probability with only 5% probability of falsely concluding that a blank observation represents a "real" signal. For a particular measurement system, which may include radiochemical separation:

LLD= 4.66Sb . E

V
2.22E6* Y
exp(-A,M)

Where: LLD is the a priori lower limit of detection as defined above (as microcuries per unit mass or volume),

Sb is the Standard deviation Of the background counting rate 0[ Of the counting rate of a blank sample as appropriate (as counts per minute),

E is the counting efficiency, as counts per disintegration, . V is the sample size, in units of mass or volume, 2.22 E6 is the number of disintegrations per minute per microcurie, Y is the fractional radiochemical yield, when applicable,

                                  )., is the radioactive de~ay constant for the particular radionuclide, and l1t for plant effluents is the elapsed time between the midpoint of sample collection and time of counting (for plant effluents, not environmental samples).

(continued) SUSQUEHANNA - UNIT 2 TRM I B 3.11-13 EFFECTIVE DATE 2/01/1999

For Information Only Dose Rate PPL Rev. 1 B 3.11.2.1 B 3.11.2.1 Dose Rate BASES (continued) TRS The value of Sb used in the calculation of the LLD for a detection system shall (continued) be based on the actual observed variance of the background counting rate or of the counting rate of the blank'samples (as appropriate) rather than on an unverified theoretically predicted variance. Typical values of E, V, Y, and ~t shall be used in the calculation. The principal gamma emitters for which the LLD specification applies include the following radionuclides: Kr-87, Kr-88, Xe-133, Xe-133m, Xe-135, Xe-135m and Xe-138 for gaseous emissions and Mn-54, Fe-59, Co-58, Co-60, Zn-65,

Mo-99, Cs-134, Cs-137, Ce-141 and Ce-144 for particulate emissions. This list does not mean that only these nuclides are to be considered. Other gamma peaks which are identifiable, together with those of the above nuclides, shall also be analyzed and reported in the Radioactive Effluent Release Report.

The design of the systems for the sampling of particulates and iodines provide for sample nozzle entry velocities which are approximately isokinetic with instack air velocities. Gaseous particulate and iodine samples are gathered continuously, with the sample size proportional to the stack emissions; a composite gaseous sample is a combination of all the particulate filters gathered in a sampling period. Particulate or iodine sampling required to be in continuous service will be considered to remain and have been in continuous service when its service is interrupted for a time period not to exceed 1 hour per sampling period. For particulate and iodine sampling, this is a small fraction of the normal *minimum analysis frequency. The minimum Analysis Frequency as listed for the Composite Samples shall mean the minimum frequency for initiation of the required analyses, not completion of the analysis and evaluation of the results. Since the analysis involves sending the samples to an offsite laboratory and performance of

                               *involved sample preparation and wet chemical analyses, there will be a delay between initiation of the analysis and receipt of the results. The analysis initiation shall normally be done on a calendar quarter for a 92 day frequency.

(continued) SUSQUEHANNA - UNl.T 2 TRM I B 3.11-14 EFFECTIVE DATE 12/03/2004

For Information Only Dose Rate PPL Rev. 1 B 3.11.2.1 B 3.11.2.1 Dose Rate BASES (continued) REFERENCES 1.. Technical Specification 5.5.4 - Radioactive Effluent Controls Program

2. Technical Specification 5.5.1 - Offsite Dose Calculation Manual

3. 10CFR Part 20 SUSQUEHANNA - UNIT 2 TRM I B 3.11-15 EFFECTIVE DATE 2/01/1999

Dose - Noble Gases PPL Rev. 0 B 3.11.2.2 B 3.11.2.2 Dose - Noble Gases BASES TRO This requirement is provided to implement the requirements of Sections 11.B, Ill.A and IV.A of Appendix I, 10 CFR Part 50. (Reference 5) The Technical Requirement for Operation implements the guides set forth in Section 11.B of Appendix I. This section of the TRM is also part of the ODCM (Reference 2). Actions The ACTION statements provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive material in gaseous effluents will be . kept "as low as is reasonably achievable". The Special Report required under Action A.1 shall identify the cause(s) for exceeding the limit(s) and define the corrective actions that have been taken to reduce the releases and the proposed corrective actions to be taken to assure that subsequent releases will be in compliance with the above limits. TRS The TRSs implement the requirements in Section Ill.A of Appendix I that conformance with the! guides of Appendix I be shown by calculational procedures based on models and data such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially underestimated. The dose calculation established in the ODCM for calculating the doses due to the actual release rates of radioactive noble gases in gaseous effluents are consistent with the methodology provided in Regulatory Guide 1.109, "Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I, " Revision 1, October 1977 and Regulatory Guide 1.111, "Methods for estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water Cooled Reactors," Revision 1, July 1977. The ODCM equations provided for determining the air doses at and beyond the SITE BOUNDARY are based upon the historical

            . average atmospheric conditions. (References 2, 3 and 4)

(continued) SUSQUEHANNA - UNIT 2 TRM/B 3.11-16 EFFECTIVE DATE 8/31/1998

Dose - Noble Gases PPL Rev. 0 B 3.11 .2.2 8 3.11.2.2 Dose - Noble Gases BASES (continued) REFERENCES 1. Technical Specification 5.5.4 - Radioactive Effluent Controls program

2. Technical Specification Spec 5.5.1 - Offsite Dose Calculation Manual

3. Regulatory Guide 1.109, "Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I", Revision 1, October 1977.

4. Regulatory Guide. 1.111, "Methods for estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water Cooled Reactors," Revision 1, July 1977. *

5. 10 CFR Part 50.

SUSQUEHANNA - UNIT 2 TRM/B 3.11-17 EFFECTIVE DATES/31/1998

Dose - Iodine, Tritium, and Radionuclides in Particulates Form B 3.11.2.3 B 3.11.2.3 Dose - Iodine, Tritium, and Radionuclides in Particulates Form BASES TRO

This requirement is provided to implement the requirements of Sections 11.C, Ill.A and IV.A of Appendix I, 10 CFR Part 50. The Limiting Conditions for Operation are the guides set forth in Section 11.C of Appendix I. (Reference 5)

This section of the TRM is also part of the ODCM (Reference 2). Actions The ACTION statements provide the required operating flexibility and at the

same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive materials in gaseous effluents will be kept" as low as is reasonably achievable."

The Special Report required under Action A.1 shall identify the cause(s) for exceeding the limit(s) and define the corrective actions that have been taken to reduce the releases and the proposed corrective actions to be taken to assure that subsequent releases will be in compliance with the above limits. TRS The TRSs are defined to be performed at the specified Frequency to ensure that the TRO limits are maintained. The ODCM calculational methods specified in the TRSs implement the requirements in Section Ill.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on models and data, such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially underestimated. The ODCM calculational methods for calculating the doses due to the actual release rates of the subject materials are consistent with the methodology provided in Regulatory Guide 1.109, "Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I," Revision 1, October 1977 and Regulatory Guide 1.111, "Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water-Cooled Reactors," Revision 1, July 1977. These equations also provide for determining the actual (continued) SUSQUEHANNA - UNIT 2 TRM/B 3.11-18 EFFECTIVE DATE 8/31/1998

Dose - Iodine, Tritium, and Radionuclides in Particulates Form B 3.11.2.3 B 3.11.2.3 Dose - Iodine, Tritium, and Radionuclides in Particulates Form. BASES (continued) TRS doses based upon the historical average atmospheric conditions. The release (continued) rate Requirements for. iodine:-131, iodine-133, tritium, and* radionuclides in particulate form with half lives greater than 8 days are dependent on the existing radionuclide pathways to man in areas atand beyond the SITE BOUNDARY. The pathways which were examined in the development of these calculations were: 1) individual inhalation of airborne radio-nuclides,

2) deposition of radionuclides onto green leafy vegetation with subsequent consumption by man, 3) depositi.on on~o grassy areas where milk animals and meat producing animals graze with cons4mption of the milk and meat by man, and 4) deposition on the ground with subsequent exposure of man.

(References 2, 3 and 4)

REFERENCES 1. Technical Specification 5.5.4 - _Radioactive Effluent Controls program.

2. Technical Specification 5.5.1 - Offsite Dose Calculation Manual.

3. Regulatory Guide 1.109. "Calculation of Annual Doses- to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I," Revision 1, October 1977

4. Regulatory Guide 1. 111, "Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water-Cooled Reactors," Revision 1, July 1977. *

5. 10 CFR Part 50 SUSQUEHANNA - UNIT 2 TRM/B 3.11-19 EFFECTIVE DATE 8/31/1998

GASEOUS RADWASTE TREATMENT SYSTEl\/1 B3.11.2.4 B 3.11.2.4 GASEOUS RADWASTE TREATMENT SYSTEM BASES TRO This TRO ensures that the GASEOUS RADWASTE TREATMENT SYSTEM is OPERABLE and in operation to reduce radioactive materials in gaseous

            . waste prior to discharge when the main condenser air ejector (evacuation) system is in operation. This requirement provides reasonable assurance that the releases of rad.ioactive materials in gaseous effluents will be kept "as low as is reafionably achievaole". This TRO implements the requirements of 10 CFR Part 50.36a, General Design Criterion 60 of Appendix A to 10 CFR Part 50, and the design objectives given in Section.11.D of Appendix I to 10 CFR Part 50. The limits governing the use of the system were specified as a suitable fraction of the* dose design objectives set forth in Sections 11.B and 11.C of Appendix I, 10 CFR Part 50, .for gaseous effluents (Ref. 1).

This section of the TRM is part of the Offsite Dose Calculation Manual (Ref.

2) and implements the requirements of the Radiological Effluent Controls Program (Ref. 3).

ACTIONS The ACTIONS are defined to ensure proper corrective measures are taken

             .in response to the. inoperable components ..

A.1 With the GASEOUS RADWASTE TREATMENT SYSTEM inoperable, action must be taken to restore it.to OPERABLE status in order to maintain

radioactive releases from the main condenser as low as reasonably achievable, and in compliance with regulatory requirements. The 7 day Completion Time is reasonable to perform repairs and to maintain radioactive release objectives.

If the Required Action and Completion Time of Condition A are not met, a Special Report must be prepared and submitted to the Commission. The 30 day Completion Time is reasonable for preparation of the report. The Special Report should include the following information:

1. Identification of the. inoperable equipment or subsystems and the reason for inoperability,

2. Action(s) taken to restore the inoperable equipment to OPERABLE status, and

3. Summary description of action(s) taken to prevent a recurrence.

(continued) SUSQUEHANNA - UNIT 2 TRM I B 3.11-20 EFFECTIVE DATE 04/02/2002

GASEOUS RADWASTE TREATMENT SYSTEM B 3.11.2.4 B 3.11.2.4 GASEOUS RADWASTE TREATMENT SYSTEM BASES TRS The TRSs are performed at the specified Frequency to ensure that the GASEOUS RADWASTE TREATMENT SYSTEM is maintained OPERABLE. TRS 3.11.2.4.1 This surveillance requires verification that the GASEOUS RADWASTE TREATMENT SYSTEM is in operation when the main condenser air ejector (evacuation) system is in operation. The Frequen*cy of 92 days is appropriate considering the performance of monthly c;lose projections. REFERENCES 1: 10 CFR Part 50.

2. Technical Spedfication 5.5.1 - Offsite Dose Calculation Manual

3. Technica.1 Specification 5.5.4 - Radioactive Effluent Controls program.

SUSQUEHANNA - UNIT 2 TRM I B 3.11-20a EFFECTIVE DATE 04/02/2002

For Information Only VENTILATION EXHAUST TREATMENT SYSTEM PPL Rev. 5 B 3.11.2.5 B 3.11.2.5 VENTILATION EXHAUST TREATMENT SYSTEM BASES TRO This TRO ensures that the appropriate subsystems of the VENTILATION EXHAUST TREATMENT SYSTEM, as described in the Offsite Dose Calculation Manual (ODCM) are OPERABLE atall times. The TRO is modified by a Note which requires that the appropriate subsystems of the VENTILATION EXHAUST TREATMENT SYSTEM be used to reduce radioactive materials in gaseous waste prior to their discharge when projected doses due to gaseous effluent releases from either reactor unit to areas at and beyond the SITE BOUNDARY would exceed 0.3 mrem to any organ in a 31 day period. This requirement provides reasonable assurance that the releases of radioactive materials in gaseous effluents will be kept "as low as reasonably achievable." This TRO implements the requirements of 10 CFR Part 50.36a, General Design Criterion 60 of Appendix A to 10 CFR Part 50, and the design objectives given in Section 11.D of.

Appendix I to 10 CFR Part 50. The limits governing the use of appropriate subsystems of the systems were specified as a suitable fraction* of the dose design objectives set forth in Sections 11.B and 11.C of Appendix I, 10 CFR Part 50, for gaseous effluents (Ref. 1).

The VENTILATION EXHAUST TREATMENT SYSTEM is comprised of the following Unit 2 subsystems, as described in the ODCM:

The Unit 2 Zone 2 Reactor Building filtered exhaust subsystem, including the following filters: *

2F255A, 2F255B, 2F257A, 2F257B, 2F258A AND 2F258B.

The Unit 2 Zone 3 Reactor Building filtered exhaust subsystem, including the following filters: 2F216A, 2F216B, 2F217A, 2F217B, 2F21.BA, and 2F218B. The Unit 2 Turbine Building filtered exhaust subsystem, including the following filters: 2F157A, 2F157B, 2F158A, and 2F158B. (continued) SUSQUEHANNA - UNIT 2 TRM I B 3.11-21 EFFECTIVE DATE 05/13/2005

For Information Only VENTILATION EXHAUST TREATMENT SYSTEM PPL Rev. 5 B 3.11.2.5 B 3.11.2.5 VENTILATION EXHAUST TREATMENT SYSTEM BASES TRO (continued) This section of the TRM is part of the. ODCM (Ref. 2) and implements the requirements of the Radiological Effluent Controls Program (Ref. 3). ACTIONS The ACTIONS have been modified by a Note that allows separate Conditions entries for each subsystem. The ACTIONS are defined to ensure proper corrective measures are taken in response to the inoperable components. (continued) SUSQUEHANNA - UNIT 2 TRM I B 3.11-22 EFFECTIVE DATE 11/14/2006

For Information Only VENTILATION EXHAUST TREATMENT SYSTEM PPL Rev. 5 83.11.2.5 B 3.11.2.5 VENTILATION EXHAUST TREATMENT SYSTEM BASES ACTIONS (continued) A.1 The appropriate subsystem of the VENTILATION EXHAUST TREATMENT

SYSTEM will be declared inoperable if any of the following conditions exist:

1. Failure of a surveillance test;

2. Broken or non-functional component which prevents the subsystem from being run (e.g., both 100% fans or one 50% fan in the subsystem); or

3. Bypass or degradation of subsystem filtration in which effluent flow continues without full treatment.

With a subsystem of the VENTILATION EXHAUST TREATMENT SYSTEM inoperable, action must be taken to restore it to OPERABLE status. The 31 day Completion Time* is a reasonable time frame to repair the inoperable components. If the Required Action and Completion Time of Condition A are not met, or gaseous waste is being discharged without treatment and in excess of the TRO limit, a Special Report must be prepared and submitted to the Commission. The 30 day Completion Time is reasonable for preparation of the report. The Special Report should include the following information:

1. Identification of the inoperable equipment or subsystems and the reason for i'noperability;

2. Action(s) taken to restore the inoperable equipment to OPERABLE status; and

3. Summary description of action(s) taken to prevent a recurrence.

(continued) SUSQUEHANNA - UNIT 2 TRM I B 3.11-23 EFFECTIVE DATE 11/14/2006

For Information Only VENTILATION EXHAUST TREATMENT SYSTEM PPL Rev. 5 B3.11.2.5 B 3.11.2.5 VENTILATION EXHAUST TREATMENT SYSTEM BASES (continued) TRS The TRSs are performed at the specified Frequency to ensure that the VENTILATION EXHAUST TREATMENT SYSTEM is maintained OPERABLE. TRS 3.11.2.5.1 This surveillance requires that a dose projection be performed in accordance with the methodology and parameters in the ODCM. The dose projection is performed based on the most recently available effluent data. If it is known prior to performing the dose projection that a treatment subsystem will be out of service, and if data exists which indicates how the lack of treatment will impact effluents, these factors will be considered when performing the dose projection. The 31 day Frequency is consistent with Reference 3.

TRS 3.11.2.5.2 This surveillance verifies that each of the subsystems of the VENTILATION EXHAUST TREATMENT SYSTEM is OPERABLE by operating the system

                                   ~ 10 minutes. Operation of the subsystem for at least 10 minutes provides.

sufficient time to verify the appropriate parameters are within their normal operating range. The Frequency of 92 days is appropriate considering the performance of monthly dose projections. This TRS is modified by a Note which states that the TRS is not required to be performed if the appropriate subsystem has been utilized to process radioactive gaseous effluents during the previous 92 days. This allowance is appropriate because actual processing of radioactive gaseous effluents demonstrates subsystem OPERABILITY. TRS 3.11.2.5.3 This SR verifies that the required filter testing is performed in accordance with the Filter Testing Program. The Filter Testing Program includes testing HEPA filter performance, charcoal adsorber efficiency, and the physical properties of the activated charcoal (general use and following specific operations). Specific test frequencies and additional information are discussed in detail in ttie Filter Testing Program. The following filters will be tested: SUSQUEHANNA - UNIT 2 TRM I B 3.11-23a EFFECTIVE DATE 06/18/2013

For Information Only VENTILATION EXHAUST TREATMENT SYSTEM PPL Rev. 5 B 3.11.2.5 B 3.11.2.5 VENTILATION EXHAUST TREATMENT SYSTEM , BASES (continued) TRS TRS 3.11.2.5.3 (continued) Unit 2 RB Zone 2 filtered exhaust: 2F255A, 2F255B, 2F257A, 2F257B, 2F258A and 2F258B Unit 2 RB Zone 3 filtered exhaust: _2F216A, 2F216B, 2F217A, 2F217B, 2F218A and2F218B Unit 2 TB filtered exhaust: 2F157A, 2F157B, 2F158A and 2F158B REFERENCES 1. 10 CFR Part 50.

2. Technical Specification 5.5.1 - Offsite Dose Calculation Manual.

3. Technical Specification 5.5.4 - Radioactive Effluent Controls program.

SUSQUEHANNA - UNIT 2 TRM I B 3.11-23b EFFECTIVE DATE 06/18/2013

For Information Only Radioactive Gaseous Effluent Monitoring Instrumentation Rev. 2 B 3.11.2.6 B 3.11.2.6 Radioactive Gaseous Effluent Monitoring Instrumentation BASES TRO The radioactive gaseous effluent instrumentation is provided to monitor and control, as applicable, the releases of radioactive materials in gaseous effluents during actual or potential releases of gaseous effluents. The alarm/trip setpoints for these instruments shall be calculated in accordance with the procedures in the ODCM (Reference 2) to ensure that the alarm/trip will occur prior to exceeding the release rate limits corresponding to dose rates above background to a member of the public at or beyond the site boundary to ::;; 500 mrem/yr to the total body or to::;; 3000 mrem/yr to the skin. The OPERABILITY and use of this instrumentation is consistent with the requirements of General Design Criteria 60, 63, and 64 of Appendix A to 10 CFR Part 50. (References 3

                                 ~d~                                      .

OPERABILITY requires their alarm/trip setpc:iints set to ensure that the limits of Requirement 3.11.2.1 are not exceeded: The alarm/trip setpoints of these channels shall be determined in accordance with the methodology and parameters inthe ODCM.

This section of the TRM is also part of the ODCM (Reference 2).

The vent effluent monitor for the Turbine Building and Standby Gas Treatment System (SGTS) is a wide range noble gas monitor. The Effluent channel #4 for each of the Turbine and SGTS displays the release rate in uCi/min using the best detector in range. *Upscale and failure alarms originate from the Effluent channel. There are 3 detectors for each wide range gas monitor, low, mid and high range. During normal plant operations, the low range channel* will be selected for Effluent channel calculation. The mid and high range detectors are in

standby mode. The mid and high range detectors are activated and
selected automatically based upon the monitored noble gas
concentration. During high range noble gas releases, the mid and high range detectors are activated and the low range noble gas detector loop is selected in standby mode. Faults detected by the vent effluent monitor will be annunciated in the main control room overhead annunciator via the Effluent channel. These loops can be considered Operable if the Effluent release rate channel is not alarmed.

(continued) SUSQUEHANNA - UNIT 2 TRM I B 3.11-24 EFFECTIVE DATE 08/11/2016

For Information Only Radioactive Gaseous Effluent Monitoring Instrumentation Rev. 2 B 3.11.2.6 B 3.11.2.6 Radioactive Gaseous Effluent Monitoring Instrumentation BASES TRO The Turbine Building and SGTS vent sample flow system operates to (continued) support the detector selection requirements. Normally the low range sample flow is operating to support the low range detector. On detection of an upscale noble gas release, the mid/high range sample pump that is normally in standby mode is activated to draw a sample through the mid and high range noble gas detectors and low range sample flow system is in standby mode. The mid I high range sample is then selected .and low range sample flow is activated automatically when noble gas concentrations return to normal levels. The bypass sample flow system is designed to make up the proper sample flow rate from the isokinetic nozzle array. For the Turbine Building monitor, the bypass system is required to operate continuously. For the SGTS, the bypass system is in standby mode until high range noble gas is* sensed and the bypass system is automatically activated and selected as required. These loops can be considered Operable if the Effluent release rate channel is not alarmed. ACTIONS The Actions are defined to ensure proper corrective measures are taken in response to the inoperable components. Low range Noble Gas channel readings from the local vent monitor may be used to meet the requirement for a Noble Gas grab sample and.grab sample analysis. Noble Gas release grab samples are not required to be taken when there are no releases via that pathway. Effluent flow is to be determined by vent flow instrumentation or by a vent flow estimate every 4 hours. Continuous sample collection shall be on the same basis as described in the Bases for TRO 3.11.2.1 Monitoring may be interrupted for up to 30 minutes to perform particulate filter/iodine cartridge changeout required by TRM Table 3.11.2-1 without entering the TRO ACTIONS. (continued) SUSQUEHANNA~ UNIT 2 TRM I B 3.11-24a EFFECTIVE DATE 08/11/2016

For Information Only Radioactive Gaseous Effluent Monitoring Instrumentation Rev. 2 B 3.11.2.6 B 3.11.2.6 Radioactive Gaseous Effluent Monitoring Instrumentation BASES (continued) TRS The TRSs are defined to be performed at the specified Frequency to ensure that the monitoring instrumentation is maintained OPERABLE. The TRSs shall be performed in accordance with the Technical Specification definition for the. test with the following additional requirements: The CHANNEL FUNCTIONA~ TEST for all noble gas activity monitors shall also demonstrate that control room alarm annunciation occurs if any of the following conditions exists:

1. Instrument indicates measured levels above the alarm/trip setpoint,

2. Circuit failure, and

3. Instrument incjicates a downscale failure.

The initial CHANNEL CALIBRATION for all noble gas activity monitors shall be performed using one or more of the reference standards certified by the National Institute of Standards and Technology (NIST) or using standards that have been obtained from suppliers that participate in measurement assurance activities with NIST. These standards shall permit calibrating the system over its intended range of energy and measurement range. For subsequent CHANNEL CALIBRATION, sources that have been related to the initial calibration may be used in lieu of reference standards associated with the initial calibration. Particulate or iodine sampling required to be in continuous service will be considered to remain and have been in continuous service when its service is interrupted for a period of time not to exceed 1 hour per sampling period. For particulate and iodine sampling, this is a small fraction of the normal minimum analysis frequency. REFERENCES 1. Technical Specification 5.5.4 - Radioactive Effluent Controls program.

2. Technical Specification 5.5.1 - Offsite Dose Calculation Manual.

3. 10 CFR Part 20.

4. 10 CFR Part 50.

SUSQUEHANNA - UNIT 2 TRM I B 3.11-25 EFFECTIVE DATE 01/21/2004

Total Dose PPL Rev. 0 B 3.11.3 B 3.11.3 Total Dose BASES TRO This Requirement is provided to meet the dose limitations of 40 CFR 190 that have been incorporated into 10 CFR 20 by 46 CFR 18525. The Requirement requires the preparation and submittal of a Special Report whenever the calculated doses from plant radioactive effluents exceed twice the design objective doses of Appendix I. For sites containing up to 4 reactors, it is highly unlikely that the resultant dose. to a MEMBER OF THE PUBLIC will exceed the dose limits of 40 CFR 190 if the individual reactors remain within the reporting requirement level. The Special Report will describe a course of action that* should result in the limitation of the annual dose to a MEMBER OF THE PUBLIC to within the 40 CFR 190 limits. For the purposes of the Special Report, it may be assumed that the dose commitment to the MEMBER OF THE PUBLIC from other uranium fuel cycle sources is negligible, with the exception that dose contributions from other nuclear fuel cycle faciliti'es at the same site or within a radius of 5.miles must be considered. If the.dose to any MEMBER OF THE PUBLIC is estimated to exceed the requirements of40 CFR 190, the Special Report with a request for a variance (provided the release conditions resulting in violation of 40 CFR 190 have not already been corrected), in accordance with the provisions of 40 CFR 190.11 is considered to be a timely request and fulfills the requirements of 40 CFR 190 until NRC staff action is a completed. An individual is not considered MEMBER OF THE PUBLIC during any period in which he/she is engaged in carrying out any operation that is part of the nuclear fuel cycle: Reference 3 Actions The Actions are defined to ensure proper corrective measures are taken when requirements are not met.

Calculations required by Action B.1 shall include direct radiation contributions from both reactor units and from outside storage tanks to determine whether the limits of this TRO have been exceeded.

(continued) SUSQUEHANNA - UNIT 2 TRM/B 3.11-26 EFFECTIVE DATE 8/31/1998

Total Dose PPL Rev. 0 B 3.11.3 B 3.11.3 Total Dose BASES (continued) ACTIONS The Special Report to be issued per Action B.1 shall define the corrective (continued) action to be taken to reduce subsequent releases, to prevent recurrence of exceeding the a.bove limits, and include the schedule for achieving conformance with ttie above limits. This Special Report shall include an analysis that estimates the radiation exposure (dose) to a MEMBER OF THE PUBLIC from uranium fuel cycle sources, including all effluent pathways and direct radiation, for the calendar year that includes the release(s) covered by this report. It shall also describe levels of radiation and concentrations of radioactive material involved, and the cause of the exposure levels or concentrations. If.the estimated dose(s) exceeds the above limits, and if the release condition resulting in violation of 40 CFR Part 190 has not already been corrected, the Special Report shall include a request for a variance in acc.ordance with the provisions of 40 CFR Part 190, Submittal of the report is considered a timely request, and a variance is granted until staff action on the request is complete . TRS . The TRSs are defined to be performed at the specified Frequency to ensure that requirements are implemented. TRS 3.11.3.1 cumulative dose contributions from liquid and gaseous effluents shall be determined in accordance with TROs 3.11.1.2, 3.11.2.2, and 3.11.2.3, The direct radiatio.n dose is determined from the results of radiation monitoring with TLDs that is conducted by the SSES REMP. The REMP TLDs are proc~ssed quarterly. There is no requirement to show compliance with the 40CFR190 dose limits more frequently than an annual basis. Demonstration of compliance with this dose limit considers the combined dose contributions from liquid and gaseous effluents and direct radiation. REFERENCES 1. Technical Specification 5:5.4 - Radioactive Effluent Controls program

2. Technical Specification 5.5.1 - Offsite Dose Calculation Manual

3. 40 CFR 190 SUSQUEHANNA - UNIT 2 TRM/B 3.11-27 EFFECTIVE DATE 8/31/1998

For Information Only Monitoring Program PPL Rev. 5 B 3.11.4.1 B 3.11.4.1 Monitoring Program BASES TRO The radiological environmental monitoring program required by this Requirement provides representative measurements of radiation and of radioactive materials in those environmental exposure pathways and for those radionuclides that lead to the highest potential radiation exposures of MEMBERS OF THE PUBLIC resulting from the station operation. This monitoring program thereby supplements the radiological effluent monitoring

program by verifying that the measurable con.centrations of radioactive materials and levels of radiation are not higher than expected on the basis of the effluent measurements and modeling of the environmental exposure pathways. Changes to the radiological environmental monitoring program specified in Table 3.11.4.1-1 may be made based on expected SSES operation and the results of radiological environmental monitoring during SSES operation.

The required detection capabilities for environmental sample analyses are tabulated in terms of the lower limits of detection (LLDs). The LLDs required by Table 3.11.4.1-3 are considered optimum for routine environmental measurements in industrial laboratories. It should be recognized that the LLD is defined as an a priori (before the fact) limit representing the capability of a measurement system and not as an a posteriori (after the fact) limit for a particular measurement.

Detailed discussion of the LLD, and other detection limits, can be found in HASL Procedures Manual, HASL-300 (revised annually); Currie, L.A., "Limits for Qualitative Detection and Quantitative Determination - Application to Radiochemistry" Anal. Chem. 40, 586~93 (1968); and Hartwell, J. K., "Detection Limits for Radioanalytical Counting Techniques," Atlantic Richfield Hanford Company Report ARH-SA-215 (June 1975). (Reference 1)

This section of the TRM is also part of the ODCM (Reference 2). Actions The Actions are defined to ensure proper corrective measures are taken when requirements are not met. Once a Condition Report is generated (per the applicable Action),* the TRO may be exited because at that time, the Condition that caused the TRO is no longer out of compliance with the program. (continued) SUSQUEHANNA - UNIT 2 TRM I B 3.11-28 . EFFECTIVE DATE 11/30/2005

For Information Only Monitoring Program PPL Rev. 5 B 3.11.4.1 B 3.11.4.1 Monitoring Program BASES ACTIONS Per Action A.1, the Annual Radiological Environmental Operating Report shall (continued) provide a description of the reasons for not conducting the program as required and the plans for preventing a recurrence. The Special Report submitted per Action B.1 shall identify the cause(s) for exceeding the limit(s) and define the corrective actions to be taken to reduce

radioactive effluents so that the potential annual dose to a MEMBER OF THE PUBLIC is less than the calendar year limits of Requirements 3.11.1.2, 3.11.2.2 and 3.11.2.3.

Include revised figure(s) and table for the ODCM reflecting the new locations for obtaining samples per Action F.1 in the next Radioactive Effluent Release Report. TRS The TRSs are defined to be performed at the specified frequency to ensure that the requirements are implemented. Monitoring samples collected per TRS 3.11.4.1.1 shall be from the specific locations given in the table and figure in the ODCM. (Reference 2) The TRSs are modified by a Note to take exception to TRS 3.0.3. Table 3.11.4.1-1 Sample Locations Specific parameters of distance and direction sector from the centerline of one reactor, and additional description where pertinent, shall be a provided for each and every sample location in this Table and in table and figure(s) in the ODCM. Refer to NUREG-0133, "Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants," October 1978, and to Radiological Assessment Branch Technical Position, Revision 1, November 1979. (Reference 3) and NUREG-1302, Offsite Dose Calculation Manual Guidance: "Standard Radiological Effluent Controls for Boiling Water Reactors," April 1991. (Reference 5). Deviations are permitted from the required sampling schedule if specimens are unobtainable due to hazardous conditions, seasonal unavailability, malfunction of automatic sampling equipment and other legitimate reasons. If specimens are unobtainable due to sampling equipment malfunction, every effort shall be made to complete corrective action prior to the end of the next sampling (continued) SUSQUEHANNA - UNIT 2 TRM I B 3.11-29 EFFECTIVE DATE 02/19/2015

For Information Only Monitoring Program PPL Rev. 5 B 3.11.4.1 B 3.11.4.1 Monitoring Program BASES TRS period. All deviations from the sampling schedule shall be documented in the (continued) Annual Radiological Environmental Operating Report. It is recognized that, at times, it may not be possible or practicable to continue to obtain samples of the media of choice at the most desired location or time. In these instances suitable alternative media and locations may be chosen for the particular pathway in question and appropriate substitutions made within 30 days in the radiological environmental monitoring program. Identify the cause of the unavailability of samples for that pathway and identify the new location(s) for obtaining replacement samples in the next Radioactive Effluent Release Report and also include in the report a revised figure(s) and table for the ODCM reflecting the newlocation(s).

Direct Radiation One or more instruments, such as a pressurized ion chamber, for measuring and recording dose rate continuously may be used in place of, or in addition to, integrating dosimeters. Film badges shall not be used as dosimeters for measuring direct radiation.

Radioiodine and Particulates - Sampling and Collection Frequency The charcoal cartridges used in the airborne radioiodine sampling conducted as part of the radiological environmental monitoring program are designed and tested by the manufacturer to assure a high efficiency in the capture of radioiodine. Certificates from the manufacturer of the cartridges are provided with each batch of cartridges certifying the percent retention of the radiodine for stated air flows. Radioiodine and Particulates - Particulate Sample; Waterborne -Surface. Ground, Sediment; Food Products Gamma isotopic analysis means the identification and quantification of gamma-emitting radionuclides that may be attributable to the effluents from the facility. Waterborne - Surface The "upstream sample" shall be taken at a distance beyond significant influence of the discharge. The "downstream" sample shall be taken within the discharge line or just downstream of the discharge line near the mixing zone. (continued) SUSQUEHANNA~ UNIT 2 TRM I B 3.11-30 EFFECTIVE DATE 05/29/2013

For Information Only Monitoring Program PPL Rev. 5 B 3.11.4.1 B 3.11.4.1 Monitoring Program BASES TRS Waterborne - Drinking - Sampling and Collection Frequency A composite (continued) sample is one in which the quantity (aliquot) of liquid sampled is proportional to the quantity of flowing liquid and in which the method of sampling employed results in a specimen that is representative of the liquid flow. In this program composite samples shall be collected at time intervals that are very short (e.g., hourly) relative to the compositing period (e.g., monthly) in order to assure obtaining a representative sample. Waterborne - Ground - Samples and Sample Locations Groundwater samples shall be taken when this source is tapped for drinking or irrigation purposes in areas where the hydraulic gradient or recharge properties are suitable for contamination. Drinking Water- 1-131 Analyses Calculation of the dose projected from 1-131 in drinking water to determine if 1-131 analyses of the water are required shall be performed for the maximum organ and age group using the methodology and parameters of the ODCM. Food Products - Sampling and Collection Frequency If harvest occurs more than once a year, sampling shall be performed during each discrete harvest. If harvest occurs continuously, sampling shall be monthly. Attention shall be paid to including samples of tuborous and root food products. Table 3.11.4.1-3 This list does not mean that only the~e nuclides are to be considered. Other peaks that are identifiable at 95% confidence level together with those of the above nuclides, shall also be analyzed and reported in the Annual Radiological Environmental Operating report. Required detection capabilities for dosimeters used for environmental measurements are given in Regulatory Guide 4.13. (Reference 4) (continued) SUSQUEHANNA - UNIT 2 TRM I B 3.11-31 EFFECTIVE DATE 05/29/2013

For Information Only Monitoring Program PPL Rev. 5 B 3.11.4.1 B 3.11.4.1 Monitoring Program BASES TRS The LLD is defined, for purpose of these Requirements, as the smallest (continued) concentration of radioactive material in a sample that will yield a net count (above system background) that will be detected with 95% probability with only 5% probability of falsely concluding that a blank observation represents a "real" signal. For a particular measurement system (which may include radiochemical separation): LLD= A.66sb E

V
2.22
Y
exp(-A.Llt)

Where: LLD is the a priori lower limit of detection as defined above (as picrocuries per unit mass or volume), sb is the standard deviation of the background counting rate or of the countingrate of a blank sample*as appropriate (as counts per minute), E is the counting efficiency, as counts per disintegration, V is the sample size, in units of mass or volume, 2.22 is the number of disintegrations per minute per picrocurie, y is the fractional radiochemical yield, when applicable, A. is the radioactive decay constant for the particular radionuclide, and

                                 ~t   for environmental samples is the elapsed time between sample collection (or end of the sample collection period) and time of counting.

Typical values of E, V, Y, and ~t should be used in the calculation. (continued) SUSQUEHANNA - UNIT 2 .* TRM I B 3.11-32 EFFECTIVE DATE 08/31/1998

For Information Only Monitoring Program PPL Rev. 5 B 3.11.4.1 B 3.11.4.1 Monitoring Program BASES TRS It should be recognized that the LLD is defined as a priori (before the fact) (continued) limit representing the capability of a measurement system and not as an a posteriori (after the fact) limit for a particular measurement. Analyses shall be performed in such a manner that the stated LLDs will be achieved under routine conditions. Occasionally background fluctuations, unavoidably small sample sizes, the presence of interfering nuclides, or other uncontrollable circumstances may render these LLDS unachievable. In such cases, the contributing factors shall be identified and described in the Annual Radiological Environmental Operating Report.

REFERENCES 1. HASL Procedures Manual, HASL-300 (revised annually); Curie, L.A.,

                                       "Limits for Qualitative Detection and Quantitative Determination -

Application to Radiochemistry" Anal. Chem. 40, 586-93 (1968); and

Hartwell, J. K., "Detection Limits for Radioanalytical Counting Techniques," Atlantic Richfield Hanford Company Report ARH-SA-215 (June 1975) Offsite Dose Calculation Manual.

2. Technical Specification 5.5.1 - Offsite Dose Calculation Manual

3. NUREG'...0133, "Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants," October 1978, and to Radiological Assessment Branch Technical Position, Revision 1, November 1979.

4. Regulatory Guide 4.13

5. NUREG-1302, Offsite Dose Calculation Manual Guidance: "Standard Radiological Effluent Controls for Boiling Water Reactors," April 1991.

SUSQUEHANNA - UNIT 2 TRM I B 3.11-33 EFFECTIVE DATE 06/30/2010

Land Use Census B 3.11.4.2 B 3.11.4.2 Land Use Census BASES TRO The Land Us~ Census shall identify within ~ distance of 8 km (5 miles) the location in each of the 16 meteorological sectors of the nearest milk animal, the nearest residence and the nearest garden of greater than 50m 2 (500ft2)

               *producing broad leaf vegetation. *

This Requirement is provided to ensure that changes in the use of areas at and beyond the SITE BOUNDARY are identified and that modifications to the monitoring program are made if required by the results of this census. The best information from the door-to-door survey, aerial survey or consultingwith local agricultural authorities or any combination of these methods shall be used. This census satisfies the requirements of Section IV.B.3 of Appendix I to 10 CFR Part 50. Restricting the census to gardens of greater than 500 square feet provides assurance that significant exposure pathways via leafy vegetables will be identified and monitored since a garden of this size is the minimum required to produce the quantity (26 kg/year) of leafy vegetables assumed in Regulatory Guide 1.109 for consumption by a child. To determine this minimum garden size, the following assumptions were used: 1) that 20% of the garden was used for growing broad leaf vegetation (i.e., similar to lettuce and cabbage), and 2) a vegetation yield of 2 kg/square meter. (Reference 1 and 2)
Broa_d leaf vegetation sampling of at least three different kinds of vegetation may be performed at the site boundary in each of two different direction sectors with the highest predicted D/Qs in lieu of the garden census. Specifications for broad leaf vegetation sampling in Table 3.11.4, 1-1 item 4c shall be followed, including analysis of control samples.

This section of the TRM is also part of the ODCM (Reference 3). Actions The Actions are defined to ensure proper corrective measures are taken in when requirements are not met. (continued) SUSQUEHANNA - UNIT 2 TRM/B 3.11-34 EFFECTIVE DATE 8/31/1998

Land Use Census B 3.11.4.2 B 3.11.4.2 Land Use Census BASES (continued) ACTIONS The sampling location(s), excluding the control station location, having the (continued) lowest calculated dose, or dose commitment(s) (via the same exposure pathway) may be deleted from the monitoring program after October 31 of the year in which the land use census was conducted. TRS The TRSs are defined to be performed at the specified Frequency to ensure that the requirements are implemented. The Land Use Census shall be conducted during the growing season at least once per 12 months using that information that will provide the best results, such as by a door-to-door survey, aerial survey, or by consulting local agriculture authorities. The results of the land use census shall be included in the Annual Radiological Environmental Operating Report. REFERENCES 1. 10 CFR Part 50

2. Regulatory Guide 1.109, "Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I," Revision 1, October 1977

3. Technical Specification 5.5.1 - Offsite Dose Calculation Manual SUSQUEHANNA - UNIT 2 TRM/B 3. 11-35 EFFECTIVE DATE 8/31/1998

lnterlaboratory Comparison Program B 3.11.4.3 B 3.11.4.3 lnterlaboratory Comparison Program BASES TRO The lnterlaboratory Comparison Program shall be accepted by the

Commission. The requirement for participation in an lnterlaboratory Comparison Program is provided to ensure that independent checks on the precision and accuracy of the measurements of radioactive material in environmental sample matrices are performed as part of the quality assurance program for environmental monitoring in order to demonstrate that the results are reasonably valid for the purpose of Section IV.B.2 of Appendix I to 10 CFR Part 50. (Reference 1)

This part of the TRM is also part of the ODCM (Reference 2) Actions The Actions are defined to ensure .proper corrective measures are taken in response to the detection of unacceptably large deviations (systematic biases) from known values for the quantities being measured. The corrective actions taken to prevent a recurrence shall be reported to the Commission in the Annual Radiological Environmental Operating Report. TRS The TRSs are defined to be performed at the specified Frequency to ensure that the requirements are implemented. REFERENCES 1. 10 CFR Part 50

2. Technical Specification 5.5.1 - Offsite Dose Calculation Manual SUSQUEHANNA - UNIT 2 TRM/B 3. 11-36 EFFECTIVE DATE 2/12/1999

VENTING or PURGING PPL Rev. 0 3.6.1 3.6 Containment 3.6.1 VENTING or PURGING TRO 3.6.1 VENTING or PURGING of the primary containment shall be performed only with the following conditions established:

1. Both Standby Gas Treatment Systems shall be OPERABLE in accordance with LCO 3.6.4.3 "Standby Gas Treatment (SGT) System" and whenever the purge system is in use during MODE 1, 2, or 3, only one of the SGT System trains may be used.

2. LCO 3.3.6.1 "Primary Containment Isolation Instrumentation" Function 2.e "SGTS Exhaust Radiation - High" shall be OPERABLE.

APPLICABILITY: Whenever primary containment VENTING or PURGING is in progress. ACTIONS CONDITION REQUIRED ACTION COMPLETION TIME A. VENTING and A.1 Suspend all VENTING Immediately PURGING and PURGING of the requirements not met. primary containment SUSQUEHANNA - UNIT 2 TRM I 3.6-1 EFFECTIVE DATE 8/31/1998

VENTING or PURGING PPL Rev. 0 3.6.1 TECHNICAL REQUIREMENT SURVEILLANCE SURVEILLANCE FREQUEN CY TRS 3.6.1.1 Verify that the requirements of TRO 3.6.1 Within 4 hours pri or to start "VENTING and PURGING" are met. of VENTING or PU RGING of the primary containment AND 12 hours SUSQUEHANNA - UNIT 2 TRM / 3.6-2 EFF.ECTIVE DATE 8/31/1998 i

VENTING or PURGING PPL Rev. 0 B 3.6.1 B 3.6.1 VENTING or PURGING BASES TRO This TRO establishes the requirements necessary to VENT or PURGE the Primary Containment to provide reasonable assurance that releases from the Primary Co.ntainment during purging operations will be maintained As Low As Reasonably Achievable for unrestricted areas. The following requirements are specified: Flow must be maintained through Standby Gas Treatment System and when venting or purging both SGTS must be OPERABLE and only one can be aligned for purging. This requirement is established to ensure all flow is filtered through the SGTS System, to minimize the chance of an inadvertent release and to ensure, during purging, SGTS capability is maintained by ensuring the redundant system is available. Ventilation evolutions to support habitability of the Drywell or the Suppression Chamber performed in Modes 4 and 5 shall be performed with the "SGTS Exhaust Radiation - High" Isolation Instrumentation OPERABLE. This is required to ensure all releases are monitored and any detection of excessive radiation results in the automatic termination of the evolution. In MODES 1, 2, or 3, this instrument Function is required to be OPERABLE per Technical Specification, so no redundant requirement is necessary in this TRO. (Reference 2) PURGING and VENTING as defined in the Technical Requirements Manual Definitions refer to the controlled process of discharging air or gas from a "confinement" in order to maintain various operating conditions, either with or without replacement air or gas. The basis for this requirement is to provide a reasonable assurance that releases from the Primary Containment purging operations will not exceed the annual dose limits of 10 CFR Part 20 for unrestricted areas. (continued) SUSQUEHANNA - UNIT 2 TRM I B 3.6-1 EFFECTIVE DATE 07/26/2001

                                                                    ------------\,
                                                                                               ',~

VENlHN.G or PURGING PPL Rev. 0 B 3:6.1 B 3.6.1 VENTING or PURGING BASES (continued) TRO Any ventilation evolutions performed during MODES 4, 5 or defueled, to (continued) support habitability of the Drywell or the Suppression Chamber, with any of the Containment hatches removed or,access doors open with interlocks defeated, do not constitute VENTING or PURGING as defined. This is due to the fact that in such cases, the Drywell or the Suppression Chamber is not a "confinement". Therefore, the provisions of this TRO requiring two OPERABLE trains of the Standby Gas Treatment System are not applicable. The Actions are defined to ensure proper corrective measures are taken in ACTIONS response to the non-compliance with the TRO requirements. TRS The TRSs are defined to be performed at the specified Frequency to ensure compliance with the TRO requirements REFERENCES 1. 10 CFR Part 20

2. FSAR Section 6.5.1.1 SUSQUEHANNA - UNIT 2 TRM I 8*3.6-2 EFFECTIVE DATE 02/01/1999}}

PLA-7607, Submittal of Annual Radioactive Effluent Release Report for 2016

Contents

Text

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

Reference:

Navigation menu

PLA-7607, Submittal of Annual Radioactive Effluent Release Report for 2016

Text

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

Reference:

Navigation menu

Search